data_2kpl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.386 15.0 t . . . . . 0 N--CA 1.417 -2.084 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.147 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 5' ' ' THR . 18.2 ptt-85 155.18 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.736 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.6 t-20 -55.86 111.88 3.67 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 112.779 -2.01 . . . . 0.0 112.913 -175.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.2 Cg_exo -63.96 -27.16 66.38 Favored 'Trans proline' 0 CA--C 1.476 -2.407 0 C-N-CA 121.234 1.289 . . . . 0.0 109.997 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -85.4 -14.92 44.78 Favored 'General case' 1 N--CA 1.358 -5.063 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.652 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.736 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.4 pt-20 -72.69 -36.2 67.83 Favored 'General case' 0 C--N 1.376 1.752 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.453 ' CD2' ' HH ' ' A' ' 101' ' ' TYR . 87.0 mt -59.99 136.0 57.88 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.16 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -98.34 177.49 5.35 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.648 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.6 -99.71 2.48 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.765 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -145.79 128.22 15.94 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.408 0.623 . . . . 0.0 109.352 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.73 115.21 29.8 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -126.12 152.41 33.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.058 -175.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.686 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 14.7 t-160 -127.33 99.89 5.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -124.2 141.3 52.17 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.047 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -86.71 131.14 34.22 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.685 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.54 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.7 mp -115.02 123.35 48.85 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -86.22 115.44 23.78 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HG3' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -45.17 102.35 0.03 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 123.95 0.9 . . . . 0.0 109.234 169.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -123.14 135.93 54.56 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 125.274 1.609 . . . . 0.0 108.939 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m 55.12 28.62 11.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.068 0.947 . . . . 0.0 113.143 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.734 ' N ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 77.5 102.91 0.07 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.632 1.573 . . . . 0.0 108.368 176.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.55 -137.32 13.53 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.289 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.636 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.6 m-85 -124.29 -82.76 0.64 Allowed 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.525 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 119.64 56.02 0.25 Allowed Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.432 ' CD1' HD12 ' A' ' 43' ' ' ILE . 28.2 p90 -160.9 143.65 12.79 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.444 HG22 ' CB ' ' B' ' 160' ' ' GLN . 40.0 p -107.99 134.94 50.19 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-O 122.134 0.969 . . . . 0.0 109.199 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 2.2 p -135.55 136.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.957 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.044 -169.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.2 m -115.39 131.82 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.261 -177.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.1 -145.35 17.13 Favored Glycine 0 CA--C 1.457 -3.57 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 48.39 70.11 0.82 Allowed Glycine 0 CA--C 1.464 -3.137 0 O-C-N 126.599 1.999 . . . . 0.0 112.031 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -116.93 -29.25 6.06 Favored 'General case' 0 C--N 1.259 -3.332 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.296 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.6 pt-20 -159.21 174.23 4.23 Favored Pre-proline 0 CA--C 1.467 -2.242 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.579 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.445 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 77.1 Cg_exo -61.72 -25.83 79.23 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 122.435 2.09 . . . . 0.0 109.388 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -84.01 -21.39 31.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.347 -2.206 . . . . 0.0 112.306 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -122.75 119.41 30.58 Favored 'General case' 0 C--O 1.264 1.837 0 O-C-N 121.492 -0.755 . . . . 0.0 110.471 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.0 165.67 12.74 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.249 2.22 . . . . 0.0 108.495 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.3 mp -93.08 146.47 23.62 Favored 'General case' 0 C--O 1.183 -2.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.583 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.0 tt0 -137.18 144.49 42.93 Favored 'General case' 0 C--O 1.191 -2.006 0 CA-C-N 118.56 0.618 . . . . 0.0 110.318 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.432 HD12 ' CD1' ' A' ' 29' ' ' PHE . 23.4 mm -79.94 119.63 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 O-C-N 121.829 -0.544 . . . . 0.0 109.848 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 1.2 pptp? -103.28 -19.79 14.34 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.951 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 44' ' ' LYS . 45.6 m -161.14 128.16 4.08 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 1.5 pp -87.63 128.35 35.28 Favored 'General case' 0 N--CA 1.395 -3.183 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.725 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.525 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.6 t -80.2 127.51 39.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 86.8 mt -64.5 133.99 53.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.6 t70 84.73 11.08 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.385 1.678 . . . . 0.0 109.608 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.93 155.57 23.17 Favored Glycine 0 CA--C 1.487 -1.702 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.572 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.5 Cg_endo -72.02 -25.32 19.64 Favored 'Trans proline' 0 N--CA 1.425 -2.556 0 CA-C-N 121.266 2.533 . . . . 0.0 110.486 -170.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.85 85.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.62 88.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 122.861 1.315 . . . . 0.0 109.879 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 87.4 mt -72.42 -45.73 58.36 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 112.785 -2.007 . . . . 0.0 114.459 -174.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -68.78 -24.69 64.45 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.74 3.2 9.43 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-N 114.186 -1.37 . . . . 0.0 115.893 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -110.44 19.42 18.8 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.996 1.379 . . . . 0.0 109.802 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ttt -146.67 133.21 19.77 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 44.4 mt-10 -140.43 162.11 36.11 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.354 0.662 . . . . 0.0 109.738 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.0 m -57.02 119.01 5.56 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.51 -18.5 5.73 Favored Glycine 0 C--N 1.302 -1.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.47 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 99' ' ' ARG . 11.1 m-20 -67.79 136.63 54.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -101.38 130.35 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 43.3 mm -82.22 111.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.299 3.702 0 C-N-CA 123.343 0.657 . . . . 0.0 109.856 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 60.4 t -91.85 -57.92 3.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 126.346 2.279 . . . . 0.0 108.764 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -157.74 170.96 21.19 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.925 -0.484 . . . . 0.0 111.24 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -152.67 120.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.018 0.437 . . . . 0.0 112.145 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.18 58.63 5.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.907 1.283 . . . . 0.0 111.258 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.26 -30.09 0.2 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.504 -1.68 . . . . 0.0 113.033 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 m -65.83 127.12 30.73 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 121.444 0.64 . . . . 0.0 111.14 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.9 t -79.05 78.24 5.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.233 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.499 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 87.2 t -83.89 5.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 122.786 1.279 . . . . 0.0 109.49 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 6' ' ' ARG . 13.3 tp -66.62 110.13 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.92 45.0 95.73 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.205 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.499 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 1.7 t60 -79.72 147.99 31.7 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.5 m -74.87 143.57 43.78 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 117.73 -1.128 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -48.07 -49.28 32.16 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.246 0.93 . . . . 0.0 112.33 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.7 71.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 124.063 0.852 . . . . 0.0 110.988 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -80.28 -48.57 12.83 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.125 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.8 -43.14 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.603 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.7 p -64.53 -35.97 76.06 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -42.99 85.89 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.261 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -72.25 -50.65 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 CA-C-O 122.474 1.131 . . . . 0.0 109.528 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.66 -29.67 69.75 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.049 -1.887 . . . . 0.0 113.327 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 mp0 -86.71 -25.18 24.88 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 p -85.57 -22.36 28.1 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.539 HD11 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -52.43 151.35 7.6 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.4 Cg_endo -102.49 159.54 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.242 3.961 . . . . 0.0 112.302 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.734 HG12 ' N ' ' A' ' 25' ' ' ARG . 26.9 mt -67.96 131.21 33.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.297 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.03 11.4 34.43 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.961 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -103.39 176.88 5.0 Favored 'General case' 0 C--O 1.202 -1.444 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.496 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.502 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 30.1 t -134.57 148.32 50.44 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.082 -0.386 . . . . 0.0 110.675 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.07 149.75 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 C-N-CA 124.104 0.961 . . . . 0.0 111.169 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.686 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.9 m-20 -100.23 111.75 24.04 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.526 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.32 125.09 35.97 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.937 0.399 . . . . 0.0 110.315 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 35.2 mt-10 -104.27 105.45 15.59 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.43 157.29 45.36 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.254 -172.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.9 t -131.7 120.09 22.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.344 0.592 . . . . 0.0 109.739 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 19.4 ttp85 -114.98 158.62 21.8 Favored 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 124.086 0.955 . . . . 0.0 109.858 -174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.22 -15.34 2.54 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.453 ' HH ' ' CD2' ' A' ' 11' ' ' LEU . 89.7 m-85 . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 113.989 -1.105 . . . . 0.0 108.222 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 8.5 m -115.67 89.01 3.0 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.444 ' CB ' HG22 ' A' ' 30' ' ' THR . 5.1 pm0 -76.97 114.06 15.34 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.263 0.554 . . . . 0.0 110.631 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.427 -1.593 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.63 -175.074 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.461 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 8.8 t . . . . . 0 N--CA 1.432 -1.345 0 CA-C-O 121.585 0.707 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 47.67 41.12 13.22 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 124.049 1.881 . . . . 0.0 112.107 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.78 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -111.42 114.81 52.64 Favored Pre-proline 0 C--N 1.248 -3.845 0 CA-C-N 112.82 -1.991 . . . . 0.0 112.98 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.305 14.6 Cg_exo -57.53 -36.06 98.72 Favored 'Trans proline' 0 CA--C 1.48 -2.203 0 CA-C-O 123.948 1.562 . . . . 0.0 109.076 172.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -73.94 -15.87 61.11 Favored 'General case' 1 N--CA 1.344 -5.737 0 CA-C-N 110.626 -2.988 . . . . 0.0 112.403 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.1 pt-20 -80.85 -30.42 35.66 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.6 mt -66.76 137.22 56.48 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.473 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -82.86 179.86 7.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.453 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.55 -129.73 9.47 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.619 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 144.98 50.49 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 122.757 0.423 . . . . 0.0 110.362 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -113.03 112.26 23.57 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -127.08 152.54 35.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.229 -175.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.82 108.13 14.01 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -131.96 147.17 52.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.682 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -92.8 140.82 29.12 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.952 0.501 . . . . 0.0 111.368 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.541 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -122.14 127.4 50.04 Favored 'General case' 0 C--O 1.258 1.512 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -85.88 113.95 22.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.659 ' HG3' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -42.35 106.07 0.06 Allowed 'General case' 0 CA--C 1.475 -1.921 0 C-N-CA 125.441 1.496 . . . . 0.0 112.267 172.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -120.34 129.91 54.19 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.607 ' C ' HG12 ' A' ' 89' ' ' ILE . 10.9 m 61.16 -165.22 0.22 Allowed 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -84.57 61.03 6.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.636 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.41 -121.0 1.05 Allowed Glycine 0 N--CA 1.406 -3.313 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.284 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.525 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 76.4 m-85 -135.28 -101.02 0.22 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.921 -1.14 . . . . 0.0 112.032 -168.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.26 57.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.455 ' HA ' HG23 ' A' ' 47' ' ' VAL . 50.7 p90 -160.55 143.58 13.28 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -101.35 135.31 43.04 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 117.792 -1.563 . . . . 0.0 109.932 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.552 HG13 ' O ' ' B' ' 159' ' ' THR . 11.3 p -126.0 143.42 39.57 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.516 -170.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -115.65 132.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.837 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.22 -144.36 15.02 Favored Glycine 0 C--N 1.277 -2.727 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.264 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.453 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.76 63.52 2.48 Favored Glycine 0 CA--C 1.457 -3.592 0 O-C-N 126.483 1.931 . . . . 0.0 111.946 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 76' ' ' THR . 8.5 t70 -105.18 -42.48 5.27 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.322 -0.939 . . . . 0.0 108.514 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.1 pt-20 -160.03 172.61 5.75 Favored Pre-proline 0 CA--C 1.472 -2.026 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.324 -170.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 18.7 Cg_exo -76.01 64.53 6.91 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.152 3.235 . . . . 0.0 108.57 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -172.83 -47.27 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 111.789 -2.46 . . . . 0.0 107.373 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -105.11 119.32 38.75 Favored 'General case' 0 C--O 1.273 2.335 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.947 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 73' ' ' LEU . 9.8 m-85 -93.12 166.22 12.45 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 128.682 2.793 . . . . 0.0 108.905 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.1 mp -96.37 145.87 25.25 Favored 'General case' 0 C--O 1.172 -3.016 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.421 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 40.4 tt0 -139.78 144.34 37.34 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 118.488 0.586 . . . . 0.0 110.093 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 43' ' ' ILE . 1.2 mp -81.82 118.42 29.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 O-C-N 121.913 -0.492 . . . . 0.0 109.683 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -98.75 -24.39 15.04 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.432 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -152.37 127.99 10.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.644 -0.66 . . . . 0.0 109.673 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 pp -86.97 116.51 25.08 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 29' ' ' PHE . 67.0 t -87.91 134.73 27.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.273 -173.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 95.7 mt -60.24 142.54 54.39 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.7 t70 79.87 3.42 2.06 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.784 1.302 . . . . 0.0 110.558 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.658 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -95.05 155.74 21.57 Favored Glycine 0 CA--C 1.489 -1.571 0 CA-C-O 118.362 -1.243 . . . . 0.0 110.45 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.525 ' HD3' ' C ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -71.89 -25.64 19.71 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 CA-C-N 120.931 2.365 . . . . 0.0 111.062 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.8 97.12 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.9 74.45 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.542 1.163 . . . . 0.0 109.954 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 79.7 mt -71.58 -40.3 70.0 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-N 112.933 -1.94 . . . . 0.0 114.165 -172.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.77 -24.58 58.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.94 -3.98 11.49 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.997 -1.456 . . . . 0.0 115.893 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -94.08 -42.58 8.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.449 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 22.5 ttt -82.12 133.84 35.29 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -139.76 168.74 19.12 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.094 0.949 . . . . 0.0 112.073 -169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . 20.7 m -64.16 126.23 27.08 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.383 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.09 -9.93 12.01 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.618 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 18.9 m-20 -78.37 144.17 36.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.327 0.1 OUTLIER -115.48 119.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.544 0.688 . . . . 0.0 111.094 171.086 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.67 113.76 4.77 Favored 'Isoleucine or valine' 0 C--O 1.299 3.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.215 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 87.6 t -102.39 -54.96 6.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 112.254 -2.248 . . . . 0.0 110.203 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.9 t -143.65 158.22 43.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.388 -0.82 . . . . 0.0 110.213 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.15 112.1 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.03 0.443 . . . . 0.0 111.641 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 71.24 -66.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.137 1.375 . . . . 0.0 111.875 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.66 -37.61 0.1 Allowed 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.844 1.658 . . . . 0.0 109.035 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -67.71 127.69 33.7 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.781 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.3 t -85.69 90.3 7.98 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 9.7 p -80.26 4.09 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 122.701 1.239 . . . . 0.0 109.928 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 40' ' ' PHE . 19.6 tp -67.43 111.79 4.27 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.563 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.78 37.54 88.74 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.528 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.52 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -82.49 148.22 28.25 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 83.2 m -78.77 143.22 36.32 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.776 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -47.26 -50.55 21.15 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.288 0.949 . . . . 0.0 113.096 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.12 74.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.845 0.716 . . . . 0.0 110.702 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.68 -50.41 15.49 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.02 -45.25 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.667 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.57 -36.0 76.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.416 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -59.08 -47.88 83.62 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.486 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -72.46 -49.96 38.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.385 0 CA-C-O 122.18 0.991 . . . . 0.0 110.121 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -61.41 -40.44 94.42 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.529 -1.668 . . . . 0.0 113.141 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.63 -14.07 46.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -91.76 -2.21 57.05 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.119 0.485 . . . . 0.0 110.824 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.659 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.2 mt -53.35 140.51 44.97 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.051 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -97.82 150.78 0.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.618 2.879 . . . . 0.0 113.042 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.607 HG12 ' C ' ' A' ' 24' ' ' SER . 23.6 mt -67.59 135.89 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.432 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.6 12.43 58.23 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.222 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -108.5 -170.63 1.71 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.147 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.0 t -150.04 142.17 24.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 22' ' ' LYS . 27.4 m -145.51 155.35 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.818 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.775 173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.05 113.81 27.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 124.929 1.393 . . . . 0.0 109.197 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.7 mm? -91.12 120.32 31.97 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.517 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 20.4 mt-10 -98.71 110.21 22.84 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.406 HD12 ' HG3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.49 156.52 45.74 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.046 -170.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 63.3 m -109.99 125.91 53.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.606 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 tpp85 -102.82 153.52 20.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.98 -5.77 7.84 Favored Glycine 0 CA--C 1.486 -1.72 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.938 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.1 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' B' ' 158' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.565 0 CA-C-O 122.182 0.991 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.552 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.4 m -75.83 107.82 8.27 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.95 93.94 9.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.704 -0.622 . . . . 0.0 110.629 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.717 -177.386 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 8.8 t . . . . . 0 N--CA 1.419 -1.995 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 5' ' ' THR . 10.2 ptm180 56.02 13.47 1.16 Allowed 'General case' 0 N--CA 1.516 2.842 0 C-N-CA 126.423 1.889 . . . . 0.0 113.653 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.737 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.7 m-80 -93.8 115.03 64.59 Favored Pre-proline 0 C--N 1.251 -3.712 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.288 10.8 Cg_exo -62.06 -29.69 81.71 Favored 'Trans proline' 0 CA--C 1.475 -2.444 0 N-CA-C 108.019 -1.57 . . . . 0.0 108.019 170.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 t -69.79 -25.68 63.91 Favored 'General case' 1 N--CA 1.354 -5.255 0 CA-C-N 111.271 -2.695 . . . . 0.0 110.962 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.737 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.0 pt-20 -78.27 -31.26 48.96 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.01 133.92 55.35 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.547 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 176.08 6.72 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.803 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.23 -116.19 5.44 Favored Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.324 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.4 156.42 48.21 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -122.07 112.47 18.28 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -119.85 152.22 22.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-O 121.209 0.528 . . . . 0.0 110.737 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.611 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.3 t-160 -133.26 99.64 4.6 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 14.9 t -126.27 142.09 51.66 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.677 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -86.84 133.36 33.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.019 0.928 . . . . 0.0 111.637 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -115.45 127.34 55.26 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -88.06 103.94 16.19 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.58 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.53 118.23 1.03 Allowed 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 19.3 t -92.51 -137.05 0.17 Allowed 'General case' 0 N--CA 1.403 -2.785 0 O-C-N 126.104 2.128 . . . . 0.0 106.717 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -63.84 83.29 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.402 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 60.69 27.99 17.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.395 1.878 . . . . 0.0 112.009 174.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.45 -139.48 5.41 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.69 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.7 m-85 -124.66 -87.84 0.61 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.92 52.54 0.11 Allowed Glycine 0 C--N 1.295 -1.72 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.037 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.479 ' CD1' HD12 ' A' ' 43' ' ' ILE . 42.2 p90 -160.96 141.94 11.61 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 172.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.6 p -107.62 138.04 44.57 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 19.3 m -124.89 159.29 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -167.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.526 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.9 m -115.87 133.7 61.48 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 C-N-CA 124.516 1.127 . . . . 0.0 109.968 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.18 -143.91 18.24 Favored Glycine 0 C--N 1.278 -2.689 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.467 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.77 58.09 4.34 Favored Glycine 0 CA--C 1.452 -3.87 0 O-C-N 126.115 1.714 . . . . 0.0 111.228 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' THR . 6.3 t70 -102.67 -35.49 8.67 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.328 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.9 pt-20 -158.45 168.44 12.44 Favored Pre-proline 0 CA--C 1.469 -2.151 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.404 -169.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -75.94 58.18 5.39 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 124.298 3.332 . . . . 0.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.81 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 112.085 -2.325 . . . . 0.0 106.732 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.42 118.73 34.55 Favored 'General case' 0 C--O 1.272 2.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.279 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.18 165.96 13.65 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 127.976 2.51 . . . . 0.0 108.348 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.9 mp -95.76 144.38 26.2 Favored 'General case' 0 C--O 1.175 -2.858 0 C-N-CA 118.506 -1.277 . . . . 0.0 109.639 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 36.5 tt0 -130.1 156.28 44.8 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 29' ' ' PHE . 12.6 mm -90.01 127.27 42.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.67 -19.86 13.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.479 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.0 m -155.73 127.28 7.3 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 tp -83.14 114.96 21.69 Favored 'General case' 0 N--CA 1.402 -2.84 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 58.4 t -86.99 122.71 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.19 146.17 50.93 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 84.37 3.03 0.79 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.489 1.743 . . . . 0.0 109.795 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.691 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -86.91 158.98 31.06 Favored Glycine 0 C--O 1.207 -1.579 0 CA-C-O 117.872 -1.516 . . . . 0.0 109.576 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.6 Cg_endo -72.59 -25.17 17.92 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 CA-C-N 121.725 2.762 . . . . 0.0 110.633 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.2 98.83 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.241 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.36 82.12 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.668 1.223 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 82.6 mt -71.67 -44.74 63.73 Favored 'General case' 0 N--CA 1.405 -2.715 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.517 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.16 -19.61 50.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.36 1.076 . . . . 0.0 108.242 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.98 27.92 65.39 Favored Glycine 0 CA--C 1.48 -2.097 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.593 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 26.4 tptp -102.06 -13.08 17.66 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.331 -173.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.464 ' HG2' HD13 ' A' ' 97' ' ' LEU . 67.5 mtp -123.11 144.31 49.4 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.43 141.39 25.9 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -45.16 114.14 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.726 1.21 . . . . 0.0 111.332 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.6 -18.77 5.12 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.461 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.64 146.51 45.2 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.288 1.2 p -117.87 116.18 50.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.964 174.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.08 120.02 25.25 Favored 'Isoleucine or valine' 0 C--O 1.284 2.882 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.692 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.12 -34.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-N 112.334 -2.212 . . . . 0.0 110.138 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -170.62 169.49 7.16 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.17 115.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 63.3 t30 37.43 76.59 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.14 1.776 . . . . 0.0 113.918 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 70.89 -18.93 0.24 Allowed 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.76 122.53 33.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.39 77.2 8.29 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 122.023 0.916 . . . . 0.0 110.134 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.94 -0.91 4.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.426 1.108 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 6' ' ' ARG . 30.7 tp -59.04 110.52 1.06 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 170.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.59 48.77 84.54 Favored Glycine 0 N--CA 1.431 -1.641 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.298 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.17 141.14 28.78 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 24.0 m -74.04 144.09 45.22 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.247 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -46.72 -47.54 20.53 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.135 0.879 . . . . 0.0 113.103 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.901 0.857 . . . . 0.0 111.081 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 79.2 mm-40 -78.51 -49.75 12.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.651 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.46 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.387 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.93 -44.64 98.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -72.79 -27.04 61.75 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.27 -1.372 . . . . 0.0 113.276 -175.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -73.02 -51.21 27.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 122.03 0.919 . . . . 0.0 109.003 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.46 -39.09 92.3 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.703 -1.59 . . . . 0.0 112.755 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' B' ' 161' ' ' VAL . 14.2 mm100 -85.65 -20.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -96.17 4.96 52.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.211 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.58 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 3.1 mt -48.47 147.08 4.35 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.302 1.041 . . . . 0.0 112.709 170.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -94.27 150.56 2.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.246 2.631 . . . . 0.0 111.436 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 23' ' ' SER . 24.8 mt -68.75 143.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.305 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.52 12.06 70.4 Favored Glycine 0 CA--C 1.497 -1.052 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.483 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.71 -176.34 3.71 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.274 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.564 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.7 t -147.03 142.68 27.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.255 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 4.7 m -151.98 144.24 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 O-C-N 124.2 0.938 . . . . 0.0 111.002 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.611 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 2.5 m-20 -97.79 117.73 32.76 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.696 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 3.2 mm? -90.67 121.98 33.05 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -91.05 108.18 19.7 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -141.61 147.74 38.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.062 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.28 136.77 44.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.841 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 18.4 tpp85 -114.08 149.98 34.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.24 3.95 6.61 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 122.788 0.435 . . . . 0.0 111.389 179.106 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.2 mp0 . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.41 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 14.3 m -81.44 128.29 33.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -98.47 124.91 43.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.44 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.5 t . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 121.031 0.443 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 5' ' ' THR . 31.1 ptt180 54.67 15.53 1.1 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 126.159 1.784 . . . . 0.0 113.559 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.806 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.9 m-80 -94.62 114.22 62.94 Favored Pre-proline 1 C--N 1.242 -4.065 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.269 7.2 Cg_exo -58.36 -29.97 89.78 Favored 'Trans proline' 0 CA--C 1.483 -2.034 0 C-N-CA 121.552 1.501 . . . . 0.0 109.336 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -72.99 -25.43 60.98 Favored 'General case' 1 N--CA 1.365 -4.721 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.313 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.806 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -76.02 -34.54 59.69 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -55.07 130.61 42.51 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 122.406 1.098 . . . . 0.0 111.748 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.17 170.88 12.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.282 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.67 -109.65 3.05 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.045 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -147.33 145.13 29.22 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 123.082 0.553 . . . . 0.0 110.646 -176.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -110.22 111.45 22.77 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.401 HD11 ' N ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -124.07 147.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.005 0.907 . . . . 0.0 112.152 -177.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -118.05 99.79 7.12 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -129.69 137.02 50.39 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.562 0.696 . . . . 0.0 111.588 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -73.36 133.54 43.83 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.07 0.948 . . . . 0.0 112.008 -176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 52' ' ' ALA . 1.5 tp -124.49 134.41 53.04 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -93.66 114.72 27.09 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.555 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -42.71 99.5 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 125.0 1.32 . . . . 0.0 111.099 168.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.3 m -118.48 125.44 49.9 Favored 'General case' 0 N--CA 1.417 -2.092 0 O-C-N 125.527 1.767 . . . . 0.0 107.655 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 58.46 47.7 13.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.777 0.799 . . . . 0.0 111.035 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.7 mpt_? 84.7 -62.74 0.08 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 126.635 1.974 . . . . 0.0 111.702 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . -100.29 -115.06 3.74 Favored Glycine 0 N--CA 1.406 -3.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.211 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.636 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 81.2 m-85 -129.97 -84.5 0.54 Allowed 'General case' 0 N--CA 1.397 -3.12 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.002 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.26 53.86 0.07 OUTLIER Glycine 0 C--N 1.295 -1.73 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.008 -170.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.459 ' HA ' HG23 ' A' ' 47' ' ' VAL . 44.0 p90 -161.64 142.85 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.412 HG23 ' HB2' ' B' ' 160' ' ' GLN . 76.9 p -104.24 135.12 46.31 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.823 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 1.0 OUTLIER -115.77 162.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.791 -171.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.0 132.31 47.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 C-N-CA 123.505 0.722 . . . . 0.0 109.237 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.91 -147.85 18.84 Favored Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.46 60.64 3.59 Favored Glycine 0 CA--C 1.462 -3.263 0 O-C-N 126.352 1.854 . . . . 0.0 113.085 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -106.03 -24.23 12.44 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 114.348 -0.926 . . . . 0.0 109.148 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -158.49 172.06 6.63 Favored Pre-proline 0 C--O 1.196 -1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.426 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -67.54 -15.34 44.8 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 123.117 2.545 . . . . 0.0 109.439 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -92.6 -24.04 18.83 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.995 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 35.3 tt0 -123.22 117.93 26.45 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -84.61 165.54 17.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.253 2.221 . . . . 0.0 108.619 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.513 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -91.37 144.72 25.29 Favored 'General case' 0 C--O 1.183 -2.441 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.085 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 16.3 tt0 -128.07 169.49 14.0 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.3 mm -112.9 135.68 51.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.432 ' C ' HG23 ' A' ' 60' ' ' THR . 21.6 pttp -114.54 -13.64 12.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -159.75 127.98 4.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.512 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 3.7 pp -90.92 119.28 30.99 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.459 HG23 ' HA ' ' A' ' 29' ' ' PHE . 92.4 t -75.67 126.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-O 121.142 0.496 . . . . 0.0 109.711 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.63 135.02 56.45 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.4 t70 87.47 2.2 0.41 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 125.422 1.701 . . . . 0.0 110.255 -173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.39 159.54 37.07 Favored Glycine 0 C--O 1.208 -1.5 0 CA-C-O 118.175 -1.347 . . . . 0.0 110.887 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -72.46 -25.52 17.96 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 121.307 2.554 . . . . 0.0 110.155 -170.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' A' ' 58' ' ' MET . . . -67.4 -43.11 82.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.476 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.35 76.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.499 1.143 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 95.2 mt -71.86 -39.7 69.5 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.926 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.97 -17.26 47.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 122.554 1.168 . . . . 0.0 109.773 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.84 46.38 76.44 Favored Glycine 0 CA--C 1.494 -1.233 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.106 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.2 tpmt? -126.9 6.34 6.62 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.588 0.709 . . . . 0.0 110.956 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 52' ' ' ALA . 1.8 tmt? -147.93 150.57 34.3 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 10.8 pt-20 -136.02 166.95 22.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.275 1.036 . . . . 0.0 111.152 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 46' ' ' LEU . 69.0 m -68.75 119.62 13.42 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.39 -25.69 4.77 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.59 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.566 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.2 m-20 -54.99 150.71 9.87 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.179 0.514 . . . . 0.0 111.625 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.267 0.8 OUTLIER -115.15 120.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 175.344 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.4 mm -78.03 119.35 26.7 Favored 'Isoleucine or valine' 0 C--O 1.302 3.82 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.496 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.63 -52.87 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.112 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 p -164.1 174.06 11.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.683 0.278 . . . . 0.0 111.543 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.95 152.6 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' CB ' ' H ' ' A' ' 94' ' ' ASP . 3.8 t30 -26.66 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.526 1.53 . . . . 0.0 112.725 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 t70 85.03 -52.42 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.26 1.824 . . . . 0.0 114.11 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -93.95 127.19 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.384 1.088 . . . . 0.0 113.322 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.15 89.37 5.99 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.605 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.27 9.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 122.408 1.099 . . . . 0.0 109.599 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 6' ' ' ARG . 23.6 tp -64.18 110.19 2.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.89 43.61 87.46 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.979 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.2 150.53 38.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -77.42 143.1 38.87 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.675 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.458 ' O ' HG11 ' A' ' 81' ' ' VAL . 73.0 t60 -47.7 -49.99 26.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.871 0.759 . . . . 0.0 112.191 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.84 75.29 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.829 0.706 . . . . 0.0 110.944 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -76.65 -50.4 13.83 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.881 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.31 -44.49 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.367 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 77' ' ' HIS . 10.9 p -64.79 -36.07 76.66 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.669 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -60.63 -45.84 92.52 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.733 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -73.12 -50.32 32.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.394 1.092 . . . . 0.0 109.425 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.29 -28.69 69.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.467 -1.697 . . . . 0.0 113.306 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 15.6 mm-40 -88.19 -17.47 30.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 p -95.63 -4.07 45.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.499 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -61.99 154.52 68.3 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.959 0.409 . . . . 0.0 111.212 174.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 35.6 Cg_endo -102.86 153.57 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.778 3.652 . . . . 0.0 112.704 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.425 HG12 ' H ' ' A' ' 25' ' ' ARG . 59.9 mt -65.58 128.86 29.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.014 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.4 10.7 33.09 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.613 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.08 177.06 5.2 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.432 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.561 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 31.3 t -140.0 150.84 44.93 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 123.427 0.691 . . . . 0.0 110.155 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.8 m -155.55 164.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 124.894 1.278 . . . . 0.0 109.96 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.416 ' H ' ' CB ' ' A' ' 68' ' ' ASN . 14.5 m-20 -107.38 107.7 18.71 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.73 122.19 34.05 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -103.28 110.67 22.73 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.51 156.76 45.71 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 84.7 m -111.5 126.41 54.93 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.566 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -97.3 146.11 25.45 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.17 -19.66 2.86 Favored Glycine 0 CA--C 1.491 -1.453 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.825 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 120.752 0.311 . . . . 0.0 110.82 176.446 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 37.7 tt0 . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.444 ' HB ' HG21 ' A' ' 31' ' ' VAL . 12.3 m -115.23 97.89 6.46 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.412 ' HB2' HG23 ' A' ' 30' ' ' THR . 4.0 pm0 -76.95 120.4 22.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.361 12.1 t . . . . . 0 N--CA 1.415 -2.215 0 CA-C-O 119.402 -0.332 . . . . 0.0 111.798 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.444 ' O ' HD13 ' A' ' 73' ' ' LEU . 8.7 ptm85 153.88 -29.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 125.64 1.576 . . . . 0.0 107.44 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.77 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 21.5 t30 -57.78 114.43 8.43 Favored Pre-proline 0 C--N 1.266 -3.058 0 CA-C-N 112.145 -2.298 . . . . 0.0 114.136 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.259 7.2 Cg_exo -58.86 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.469 -2.737 0 C-N-CA 122.818 2.345 . . . . 0.0 110.666 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.416 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 71.4 m -79.58 -12.65 59.84 Favored 'General case' 1 N--CA 1.348 -5.53 0 CA-C-N 112.464 -2.153 . . . . 0.0 112.257 -173.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.77 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -78.45 -35.5 46.7 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -54.52 129.9 37.82 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.693 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -77.14 179.47 6.29 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.372 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.0 -114.84 4.16 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.962 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.592 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.59 154.22 46.43 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.084 0.554 . . . . 0.0 110.289 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -119.43 115.62 24.46 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.04 140.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.599 0.714 . . . . 0.0 111.234 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.735 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.1 t60 -124.77 99.59 6.23 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -112.8 133.62 54.71 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.562 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -75.68 137.27 40.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -125.95 121.59 33.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -77.91 123.06 26.31 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.642 ' N ' ' HZ1' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -52.1 108.33 0.28 Allowed 'General case' 0 CA--C 1.471 -2.085 0 C-N-CA 123.905 0.882 . . . . 0.0 112.151 174.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.1 t -83.49 -148.38 0.09 Allowed 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 126.754 2.534 . . . . 0.0 108.389 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -61.62 76.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 87' ' ' ILE . 23.7 mmt180 67.04 48.08 1.29 Allowed 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.43 1.11 . . . . 0.0 110.938 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.92 -123.05 1.45 Allowed Glycine 0 N--CA 1.4 -3.732 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.679 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.687 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.8 m-85 -130.47 -83.99 0.53 Allowed 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.068 -1.066 . . . . 0.0 110.637 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.551 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.78 49.89 0.12 Allowed Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.239 -171.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 27' ' ' PHE . 28.4 p90 -161.35 142.72 11.52 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 16.5 p -104.09 136.3 43.98 Favored 'General case' 0 C--N 1.259 -3.352 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 22.9 m -123.6 157.89 29.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG12 ' HG2' ' A' ' 44' ' ' LYS . 3.2 m -115.35 174.58 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 C-N-CA 125.281 1.432 . . . . 0.0 111.029 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.92 -130.4 9.89 Favored Glycine 0 CA--C 1.481 -2.089 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 29.92 59.46 0.2 Allowed Glycine 0 CA--C 1.473 -2.579 0 C-N-CA 127.523 2.487 . . . . 0.0 113.81 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.52 -28.44 7.85 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 114.166 -1.017 . . . . 0.0 108.505 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -158.37 169.97 9.7 Favored Pre-proline 0 CA--C 1.47 -2.111 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.959 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -61.91 -26.54 79.08 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.459 2.106 . . . . 0.0 109.6 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.47 -29.95 59.77 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 112.504 -2.135 . . . . 0.0 111.729 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -122.11 119.09 30.31 Favored 'General case' 0 C--O 1.27 2.165 0 O-C-N 121.77 -0.581 . . . . 0.0 110.739 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -85.97 166.11 16.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.941 2.496 . . . . 0.0 109.547 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.1 mp -88.33 145.57 25.76 Favored 'General case' 0 C--O 1.178 -2.702 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.846 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.4 tt0 -135.54 158.94 43.13 Favored 'General case' 0 C--O 1.18 -2.569 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 62' ' ' ASP . 18.9 mm -87.95 127.74 40.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.47 -22.83 13.59 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 48.8 m -155.04 126.94 7.57 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.53 106.39 15.22 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.9 t -85.36 135.8 24.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.87 0.843 . . . . 0.0 110.974 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.48 141.7 57.81 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.584 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.7 t70 78.94 4.6 2.38 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.722 1.249 . . . . 0.0 110.903 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.651 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.73 159.5 36.44 Favored Glycine 0 C--O 1.201 -1.955 0 CA-C-O 118.085 -1.397 . . . . 0.0 109.897 173.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.48 -24.54 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.825 0 CA-C-N 121.438 2.619 . . . . 0.0 109.678 -173.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.64 78.66 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.405 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.06 -48.24 63.26 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.572 1.177 . . . . 0.0 109.289 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 77.8 mt -72.08 -43.59 64.6 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 112.461 -2.154 . . . . 0.0 115.558 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' HE3' ' A' ' 57' ' ' LYS . 5.0 t0 -83.26 -20.75 33.92 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -140.89 19.04 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 119.913 -1.136 . . . . 0.0 110.87 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE3' ' OD1' ' A' ' 55' ' ' ASP 0.344 0.0 OUTLIER 53.36 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.472 1.909 . . . . 0.0 115.42 -176.704 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 39.8 ttm -68.83 141.37 55.15 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 109.282 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -151.0 144.47 24.92 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 m -45.38 114.73 0.79 Allowed 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 124.635 1.209 . . . . 0.0 110.869 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.3 -30.42 3.03 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.501 ' O ' HG12 ' A' ' 43' ' ' ILE 0.375 0.9 OUTLIER -69.16 143.29 54.12 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.669 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -103.2 118.27 49.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.131 -174.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 mt -74.9 123.24 30.14 Favored 'Isoleucine or valine' 1 C--O 1.307 4.101 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.9 -45.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 111.498 -2.592 . . . . 0.0 110.105 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -160.27 170.67 20.62 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.356 -0.84 . . . . 0.0 112.016 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.93 112.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.184 0.516 . . . . 0.0 112.109 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 65.9 -48.04 0.4 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.489 2.316 . . . . 0.0 115.57 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.49 -39.86 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 125.605 1.562 . . . . 0.0 109.347 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -71.44 134.35 46.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.625 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.2 t -84.28 84.44 7.63 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.541 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -86.27 17.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 123.763 1.744 . . . . 0.0 109.796 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 6' ' ' ARG . 12.5 tp -71.72 110.83 6.53 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.48 -1.691 . . . . 0.0 106.459 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.46 36.72 92.97 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -77.16 128.29 34.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.9 m -62.58 145.82 53.45 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.208 0.943 . . . . 0.0 110.439 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -45.59 -51.42 12.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.189 0.596 . . . . 0.0 112.47 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.97 78.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 124.299 0.999 . . . . 0.0 110.538 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -76.03 -50.15 15.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.318 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 41' ' ' LEU . 14.5 p -65.06 -42.24 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.827 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.85 -36.38 76.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -62.15 -41.5 98.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.243 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.0 -50.41 32.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 122.502 1.144 . . . . 0.0 109.717 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 7.5 m-85 -66.65 -35.59 80.54 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.446 -1.707 . . . . 0.0 112.969 -174.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -85.58 -13.51 48.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.2 t -77.73 -23.75 49.3 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.589 HD12 ' CE2' ' A' ' 27' ' ' PHE . 2.0 mt -48.37 136.62 12.13 Favored Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 86.0 Cg_endo -99.13 153.45 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.212 3.274 . . . . 0.0 112.398 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 25' ' ' ARG . 41.1 mt -68.6 140.59 18.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.107 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.51 12.31 61.28 Favored Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.012 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -105.9 -169.77 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.501 -171.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.401 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.1 p -149.27 138.46 21.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -169.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.488 HG23 ' HE2' ' A' ' 22' ' ' LYS . 27.3 m -145.56 156.13 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.735 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 31.7 m-20 -99.46 106.96 19.06 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.8 tp -95.96 125.94 40.85 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.015 0.436 . . . . 0.0 110.942 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -107.74 115.2 29.72 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.639 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.21 157.68 44.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.235 0.541 . . . . 0.0 111.382 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.0 m -117.89 140.01 50.32 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.0 tpp85 -110.08 132.22 54.36 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.97 -30.21 0.14 Allowed Glycine 0 C--N 1.296 -1.671 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.408 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 43.8 mt-10 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.304 0.573 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -150.49 119.55 6.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.468 ' HA ' HG21 ' A' ' 30' ' ' THR . 29.3 tt0 -84.07 130.53 34.86 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 29' ' ' PHE . 10.7 m . . . . . 0 N--CA 1.407 -2.611 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.355 12.9 t . . . . . 0 N--CA 1.423 -1.78 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.475 ' O ' HD23 ' A' ' 73' ' ' LEU . 15.6 ptm180 152.77 -19.45 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 126.667 1.987 . . . . 0.0 108.379 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.808 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.1 m-80 -66.42 118.46 53.87 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -171.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.307 21.4 Cg_exo -62.48 -35.87 69.01 Favored 'Trans proline' 0 CA--C 1.467 -2.844 0 N-CA-C 107.734 -1.679 . . . . 0.0 107.734 172.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m -66.78 -23.64 66.1 Favored 'General case' 1 N--CA 1.333 -6.297 0 CA-C-N 109.925 -3.307 . . . . 0.0 112.236 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.808 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.7 pt-20 -79.48 -30.9 42.24 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.1 mt -59.12 133.95 56.56 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.385 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -81.26 168.57 18.33 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.453 -1.703 . . . . 0.0 113.887 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 90.85 -114.61 4.49 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.61 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -140.8 146.51 37.72 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.551 1.14 . . . . 0.0 110.118 -178.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -113.56 116.91 30.26 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 154.47 40.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 123.403 0.681 . . . . 0.0 112.358 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.1 p-80 -126.71 112.5 15.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.263 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.488 ' OG1' ' HE2' ' A' ' 57' ' ' LYS . 7.5 t -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.308 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -85.07 136.61 33.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.2 mp -124.66 129.04 49.77 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 69.9 ttt180 -86.95 112.64 22.0 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 87' ' ' ILE . 2.1 mptp? -36.12 111.26 0.13 Allowed 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 125.225 1.41 . . . . 0.0 111.579 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -89.0 -143.19 0.14 Allowed 'General case' 0 N--CA 1.415 -2.194 0 O-C-N 125.48 1.738 . . . . 0.0 108.186 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -58.89 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.438 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.8 mtp180 57.29 40.27 27.91 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 125.474 1.51 . . . . 0.0 112.486 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.75 -130.72 2.21 Favored Glycine 0 N--CA 1.406 -3.313 0 CA-C-N 113.49 -1.686 . . . . 0.0 108.956 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.672 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.4 m-85 -134.61 -75.58 0.46 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.07 46.53 0.2 Allowed Glycine 0 C--N 1.294 -1.765 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.239 -169.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 43' ' ' ILE . 45.0 p90 -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 172.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' B' ' 160' ' ' GLN . 69.9 p -108.39 136.23 48.37 Favored 'General case' 0 C--N 1.271 -2.814 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.259 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.495 HG22 HD23 ' A' ' 41' ' ' LEU . 1.1 m -114.9 162.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.36 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.63 -132.03 10.03 Favored Glycine 0 C--O 1.27 2.4 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.244 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.555 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.95 45.27 7.53 Favored Glycine 0 CA--C 1.458 -3.472 0 C-N-CA 126.245 1.878 . . . . 0.0 112.594 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.12 -22.2 18.03 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-O 121.296 0.57 . . . . 0.0 110.612 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 39' ' ' GLU . 7.2 pt-20 -157.28 171.3 7.63 Favored Pre-proline 0 N--CA 1.413 -2.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 -168.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 51.5 Cg_exo -64.02 -36.28 49.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.874 1.716 . . . . 0.0 108.201 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.16 -27.24 66.25 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.982 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 41.0 tt0 -125.5 117.69 24.16 Favored 'General case' 0 C--O 1.267 1.988 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.372 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -84.22 165.26 18.53 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 126.669 2.481 . . . . 0.0 108.25 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.4 mp -86.43 144.53 27.25 Favored 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.708 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -128.88 164.78 22.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.4 mm -107.04 123.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 118.795 0.725 . . . . 0.0 110.963 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -100.93 -26.69 13.65 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 123.436 0.46 . . . . 0.0 111.954 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 44.3 m -149.87 126.99 11.26 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.646 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.16 113.15 15.84 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 85.0 t -87.04 121.51 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.7 mt -67.4 142.73 56.62 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.33 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 34.9 t70 82.91 5.99 0.87 Allowed 'General case' 0 C--O 1.216 -0.668 0 O-C-N 125.103 1.502 . . . . 0.0 109.579 -172.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.638 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -88.81 165.4 33.34 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-O 118.113 -1.382 . . . . 0.0 110.175 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 27.9 Cg_endo -72.41 -25.47 18.17 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.338 2.569 . . . . 0.0 110.547 -170.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.441 ' HB1' HD21 ' A' ' 20' ' ' LEU . . . -68.66 -37.08 79.36 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.871 175.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.64 65.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 122.81 1.29 . . . . 0.0 109.264 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 81.2 mt -72.4 -46.19 56.35 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.537 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.48 -26.71 58.43 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.89 -165.88 51.43 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HE2' ' OG1' ' A' ' 18' ' ' THR . 6.2 ttpm? 72.81 -49.95 0.7 Allowed 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.429 ' HG2' HD13 ' A' ' 97' ' ' LEU . 1.5 tmt? -87.21 133.02 33.7 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.14 166.85 24.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.543 0.687 . . . . 0.0 111.359 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -58.12 129.89 44.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.438 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.86 -6.27 25.76 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.132 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 43' ' ' ILE . 14.8 m-20 -79.91 129.35 34.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 2.7 p -98.11 115.93 39.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.852 173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.3 mm -71.03 113.78 7.9 Favored 'Isoleucine or valine' 0 C--O 1.294 3.432 0 C-N-CA 125.078 1.351 . . . . 0.0 110.669 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.4 t -103.22 -54.72 6.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.687 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.8 t -144.92 160.27 41.58 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.077 -0.389 . . . . 0.0 110.159 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.31 105.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.487 ' CB ' HG12 ' A' ' 93' ' ' VAL . 27.6 t-20 65.97 -65.58 0.18 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.718 1.607 . . . . 0.0 114.341 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.22 -39.64 0.25 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 124.98 1.312 . . . . 0.0 108.884 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.5 m -70.04 127.33 32.48 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.304 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.2 t -87.26 87.23 7.38 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p -77.11 2.25 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 122.496 1.141 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 6' ' ' ARG . 22.9 tp -63.75 111.6 2.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.226 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 68.35 27.78 73.59 Favored Glycine 0 N--CA 1.425 -2.073 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.95 138.3 46.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 62.1 m -71.05 143.01 50.86 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' O ' HG12 ' A' ' 81' ' ' VAL . 51.1 t-80 -49.08 -45.05 42.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -174.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.94 81.37 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.656 0.598 . . . . 0.0 110.471 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 73.4 mm-40 -69.32 -56.0 8.81 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.276 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 41' ' ' LEU . 5.4 p -61.25 -47.36 93.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.598 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.1 p -62.7 -35.9 72.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.618 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -41.18 96.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 123.152 0.283 . . . . 0.0 111.418 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -51.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 122.401 1.096 . . . . 0.0 108.741 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -64.01 -30.26 71.35 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.236 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 tp-100 -85.96 -23.22 27.01 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.4 p -94.98 2.91 55.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.587 . . . . 0.0 111.511 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.516 HG23 ' HG2' ' A' ' 22' ' ' LYS . 7.0 mt -48.13 143.52 6.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.791 1.236 . . . . 0.0 114.081 173.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 39.8 Cg_endo -95.75 142.86 1.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.632 2.888 . . . . 0.0 110.467 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 25' ' ' ARG . 39.0 mt -68.45 142.97 15.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.835 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.66 72.34 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.068 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -98.65 -171.41 2.11 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.615 -171.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.42 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.7 p -147.85 138.24 22.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -168.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 68' ' ' ASN . 1.3 m -151.24 155.72 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.834 174.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.36 109.76 21.86 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.726 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.9 mm? -90.66 113.72 25.85 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 46.7 mt-10 -92.19 107.83 19.5 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -139.48 153.8 47.6 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 120.926 0.393 . . . . 0.0 110.545 -172.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.5 t -113.87 126.73 55.51 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.485 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 21.5 tpp85 -96.92 137.91 35.28 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.13 1.92 Allowed Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.772 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.422 -1.861 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.274 176.487 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.457 ' HB3' HE22 ' B' ' 160' ' ' GLN . 48.2 mm-40 . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.402 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.43 93.28 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.492 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.7 mp0 -82.38 110.05 17.18 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.166 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.645 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.5 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.698 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.3 ptm180 57.21 19.14 4.67 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.921 2.088 . . . . 0.0 112.789 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.746 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.5 114.24 58.84 Favored Pre-proline 1 C--N 1.231 -4.549 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.081 176.451 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 10.5 Cg_exo -58.0 -29.49 86.92 Favored 'Trans proline' 0 CA--C 1.48 -2.214 0 C-N-CA 121.528 1.485 . . . . 0.0 109.278 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -71.46 -24.27 61.98 Favored 'General case' 1 N--CA 1.366 -4.658 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.671 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -79.33 -31.62 43.16 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.1 129.74 41.19 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.745 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -80.23 179.19 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.031 -1.895 . . . . 0.0 113.231 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.01 -126.59 8.01 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.845 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -128.54 146.87 50.71 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.91 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.18 116.87 28.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 153.39 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.736 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.638 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.8 t-160 -125.31 111.44 15.19 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 t -128.42 151.49 49.31 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.93 136.34 42.94 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 2.4 mp -117.59 116.48 27.18 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -86.47 106.78 17.72 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -36.86 117.72 0.53 Allowed 'General case' 0 CA--C 1.472 -2.035 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 25.2 t -87.87 -152.95 0.22 Allowed 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 126.236 2.21 . . . . 0.0 108.306 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -65.61 80.43 0.06 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' N ' HG12 ' A' ' 89' ' ' ILE . 24.4 mmt180 71.44 73.88 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.47 1.108 . . . . 0.0 111.392 174.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.48 -131.9 10.13 Favored Glycine 0 N--CA 1.405 -3.372 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.886 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.634 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.9 m-85 -129.08 -78.9 0.56 Allowed 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.437 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.597 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.64 55.41 0.18 Allowed Glycine 0 C--N 1.285 -2.265 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -170.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CD1' HD13 ' A' ' 43' ' ' ILE . 19.3 p90 -162.2 146.5 12.28 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.0 p -108.31 135.04 50.29 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.219 1.009 . . . . 0.0 109.577 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 3.2 p -131.59 144.11 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.96 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.256 -167.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.0 m -120.42 132.54 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 124.317 1.047 . . . . 0.0 111.347 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.77 -139.19 10.73 Favored Glycine 0 N--CA 1.396 -3.997 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.51 44.37 5.2 Favored Glycine 0 C--O 1.18 -3.278 0 O-C-N 125.898 1.587 . . . . 0.0 110.184 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -82.44 -41.97 19.15 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 113.252 -1.474 . . . . 0.0 107.875 -172.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -160.28 170.88 7.89 Favored Pre-proline 0 CA--C 1.48 -1.712 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -73.74 59.08 4.12 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 124.49 3.46 . . . . 0.0 108.842 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -166.88 -39.46 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 111.871 -2.422 . . . . 0.0 108.257 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.21 122.23 38.67 Favored 'General case' 0 C--O 1.27 2.147 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.978 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.28 166.06 14.02 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 128.673 2.789 . . . . 0.0 109.937 -174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -90.39 144.81 25.46 Favored 'General case' 0 C--O 1.168 -3.221 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.184 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 2.6 tt0 -138.53 145.33 40.59 Favored 'General case' 0 C--O 1.185 -2.34 0 CA-C-N 118.67 0.668 . . . . 0.0 109.575 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.458 HD13 ' CD1' ' A' ' 29' ' ' PHE . 37.0 mm -88.27 121.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.99 0 O-C-N 121.477 -0.765 . . . . 0.0 111.855 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' C ' HG21 ' A' ' 60' ' ' THR . 46.5 mtmt -101.39 -19.35 15.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.889 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.508 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 58.5 m -150.47 127.3 11.02 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.185 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 tp -84.02 109.15 17.42 Favored 'General case' 0 N--CA 1.386 -3.636 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.597 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.5 t -83.05 121.57 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.64 150.42 48.77 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.396 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 76.47 12.13 2.63 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 125.012 1.445 . . . . 0.0 109.59 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.639 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.45 160.83 27.06 Favored Glycine 0 C--O 1.201 -1.962 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.671 171.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 3.8 Cg_endo -71.97 -25.21 19.9 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 CA-C-N 121.672 2.736 . . . . 0.0 109.931 -172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.15 93.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.99 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.29 -45.51 80.14 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.367 1.079 . . . . 0.0 110.432 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.7 mt -72.18 -35.69 69.06 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.795 -172.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.7 t70 -83.57 -23.83 31.82 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.67 69.57 Favored Glycine 0 CA--C 1.492 -1.351 0 CA-C-N 113.219 -1.809 . . . . 0.0 113.287 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HB2' ' HZ3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -99.72 -15.62 18.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.963 -0.618 . . . . 0.0 111.142 -173.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.444 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 35.5 ttm -122.98 139.73 53.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -147.41 164.0 34.72 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.478 0.656 . . . . 0.0 109.469 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.435 HG21 ' C ' ' A' ' 44' ' ' LYS . 8.5 m -54.2 117.91 3.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.914 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.94 -1.67 9.19 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.583 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.603 ' CG ' HD12 ' A' ' 97' ' ' LEU . 1.2 p30 -102.25 156.61 17.46 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.664 -0.903 . . . . 0.0 112.667 172.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -113.18 122.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.748 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.05 116.69 19.44 Favored 'Isoleucine or valine' 0 C--O 1.304 3.964 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.14 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.4 -53.84 7.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.758 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -143.44 161.83 37.39 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.131 -0.981 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.19 97.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.896 0.855 . . . . 0.0 112.501 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 65.12 -84.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.769 1.628 . . . . 0.0 112.918 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.34 -7.23 3.77 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.295 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.5 m -98.72 133.16 43.44 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.479 0.657 . . . . 0.0 109.336 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 t -87.65 82.79 7.31 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.81 -3.08 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.774 1.274 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.698 HD21 ' O ' ' A' ' 6' ' ' ARG . 22.4 tp -64.23 111.03 2.41 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.384 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 38.87 96.76 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.644 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.44 149.92 31.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.7 m -73.24 141.92 47.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.5 ' O ' HG13 ' A' ' 81' ' ' VAL . 39.6 t-80 -52.89 -47.89 67.57 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 118.893 0.77 . . . . 0.0 112.026 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.75 -35.4 68.57 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -76.2 -50.47 14.42 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.277 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 77' ' ' HIS . 6.6 p -61.12 -44.42 98.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 123.312 0.382 . . . . 0.0 111.531 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 77' ' ' HIS . 14.8 p -64.02 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.686 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.27 -42.86 87.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.52 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -72.89 -51.04 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.32 1.057 . . . . 0.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -65.01 -30.58 71.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 113.506 -1.679 . . . . 0.0 113.51 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -85.95 -22.76 27.22 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 122.112 -0.368 . . . . 0.0 111.88 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.0 m -79.33 -14.82 58.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.808 0.337 . . . . 0.0 110.95 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.517 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.7 mt -47.94 135.67 11.18 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.0 Cg_endo -99.58 156.46 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.35 3.367 . . . . 0.0 111.43 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.57 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -68.02 138.53 22.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.816 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.46 55.83 Favored Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.554 -1.308 . . . . 0.0 112.079 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.39 -175.37 3.19 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.058 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.517 ' N ' ' HE3' ' A' ' 22' ' ' LYS . 11.4 p -148.22 136.82 21.58 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 m -154.16 147.84 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 124.02 0.928 . . . . 0.0 111.229 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.638 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 1.9 m-20 -105.22 108.13 19.49 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 124.272 1.029 . . . . 0.0 109.519 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.8 mm? -91.43 124.25 35.48 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.349 0.595 . . . . 0.0 111.715 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -97.31 119.0 35.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.9 pt? -142.7 159.06 42.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 60.4 m -120.49 108.52 14.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.131 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.28 144.5 28.06 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.776 0.831 . . . . 0.0 108.807 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.99 14.84 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.574 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . 0.256 10.7 pt-20 . . . . . 0 C--O 1.244 0.773 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.444 ' HB ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -100.86 120.65 40.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -99.75 115.59 29.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.434 -1.242 0 O-C-N 123.38 0.425 . . . . 0.0 109.973 -175.261 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.427 -1.577 0 CA-C-O 121.621 0.724 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.582 ' O ' HD21 ' A' ' 73' ' ' LEU . 28.8 ptt180 50.64 26.83 2.64 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.994 2.118 . . . . 0.0 113.662 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.771 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 9.8 m-80 -103.18 114.56 65.01 Favored Pre-proline 1 C--N 1.236 -4.362 0 CA-C-N 113.588 -1.642 . . . . 0.0 114.264 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 11.9 Cg_exo -55.95 -33.93 90.53 Favored 'Trans proline' 0 CA--C 1.479 -2.227 0 C-N-CA 121.583 1.522 . . . . 0.0 109.197 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 t -65.97 -26.73 67.7 Favored 'General case' 1 N--CA 1.371 -4.378 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.648 -177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.771 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -77.81 -31.95 52.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.08 133.94 55.94 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.254 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 100' ' ' GLY . 17.1 ptmt -82.53 -177.52 6.72 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.579 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 84.73 -112.63 3.66 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.479 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 4.6 ptmt -146.46 149.13 33.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.017 0.927 . . . . 0.0 109.565 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.37 116.11 28.41 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -131.15 152.44 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.44 0.638 . . . . 0.0 111.846 -177.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.73 110.69 12.88 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.027 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -129.53 142.6 50.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -73.44 133.86 43.82 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.3 128.01 53.74 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -82.96 108.33 16.2 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.331 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.538 ' CG ' HG21 ' A' ' 87' ' ' ILE . 2.4 mptp? -40.04 106.34 0.05 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 124.144 0.978 . . . . 0.0 111.136 170.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -127.38 141.58 51.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 125.131 1.52 . . . . 0.0 110.141 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 54.73 32.63 17.82 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.477 1.511 . . . . 0.0 114.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 87' ' ' ILE . 23.9 mmt180 73.79 53.89 0.11 Allowed 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 122.63 1.205 . . . . 0.0 109.605 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.26 -120.45 1.17 Allowed Glycine 0 N--CA 1.401 -3.7 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.696 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.0 m-85 -135.48 -78.52 0.43 Allowed 'General case' 0 C--N 1.275 -2.649 0 C-N-CA 122.743 0.417 . . . . 0.0 111.763 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.491 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.96 48.56 0.12 Allowed Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.728 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HA ' HG21 ' A' ' 47' ' ' VAL . 50.9 p90 -161.47 143.53 11.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 37.9 p -105.11 135.48 46.38 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.598 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.79 147.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.107 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' CG2' ' HG3' ' A' ' 44' ' ' LYS . 15.2 m -120.32 135.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.867 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.37 -131.25 8.28 Favored Glycine 0 C--N 1.281 -2.522 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 36.82 60.08 1.03 Allowed Glycine 0 CA--C 1.479 -2.182 0 C-N-CA 126.647 2.07 . . . . 0.0 113.99 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -115.76 -18.68 10.75 Favored 'General case' 0 C--N 1.25 -3.742 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.712 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.35 168.43 12.49 Favored Pre-proline 0 CA--C 1.466 -2.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -61.38 -38.52 63.74 Favored 'Trans proline' 0 CA--C 1.49 -1.708 0 C-N-CA 122.074 1.85 . . . . 0.0 108.513 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.15 -12.06 60.75 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 111.961 -2.381 . . . . 0.0 111.709 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 32.2 tt0 -132.34 118.18 19.09 Favored 'General case' 0 C--O 1.279 2.61 0 O-C-N 121.823 -0.548 . . . . 0.0 111.74 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -85.76 166.19 16.29 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.748 2.819 . . . . 0.0 107.981 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.523 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -91.2 145.17 24.89 Favored 'General case' 0 C--O 1.17 -3.129 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.891 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.4 tt0 -128.91 160.44 32.64 Favored 'General case' 0 C--O 1.169 -3.146 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 43' ' ' ILE . 1.2 mp -105.65 127.19 60.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.497 ' HG3' ' CG2' ' A' ' 32' ' ' VAL 0.305 42.1 mtmt -113.28 -7.94 13.52 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.926 172.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.508 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 73.1 m -149.69 127.51 11.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.632 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.89 117.69 24.06 Favored 'General case' 0 N--CA 1.404 -2.77 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.491 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 86.4 t -88.29 128.55 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.05 145.99 41.9 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 81.44 5.72 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 125.501 1.75 . . . . 0.0 108.502 -171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.45 159.52 38.82 Favored Glycine 0 C--O 1.204 -1.758 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.42 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 19.9 Cg_endo -72.8 -25.78 16.55 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 120.853 2.327 . . . . 0.0 109.971 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -45.23 90.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.428 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.24 -50.94 63.89 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.681 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.5 mt -71.48 -36.5 71.18 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 112.688 -2.051 . . . . 0.0 114.854 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -79.75 -19.7 48.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.0 108.751 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.54 42.97 99.87 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.827 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.99 -25.47 2.52 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.035 -0.583 . . . . 0.0 111.485 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.481 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 1.6 tmt? -120.24 146.03 46.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -142.9 166.99 23.14 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.557 1.17 . . . . 0.0 113.498 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -63.57 123.04 17.8 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 113.807 -1.542 . . . . 0.0 107.469 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.21 -11.23 10.71 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.965 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.473 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 15.0 m-20 -74.34 157.9 34.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -128.22 123.81 61.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 49.2 mm -73.93 113.18 11.76 Favored 'Isoleucine or valine' 0 C--O 1.3 3.733 0 C-N-CA 125.041 1.336 . . . . 0.0 110.683 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.9 t -105.4 -54.79 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 126.019 2.074 . . . . 0.0 110.673 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 40.3 t -147.56 158.33 43.95 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.959 -0.463 . . . . 0.0 110.943 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.91 89.52 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 CA-C-O 122.22 1.01 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.435 43.6 p30 42.15 -89.12 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -171.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -93.53 -30.95 14.74 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.827 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.7 m -91.25 131.11 36.98 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.085 0.945 . . . . 0.0 110.962 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.7 t -88.69 86.63 7.03 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.253 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.51 1.59 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 122.54 1.162 . . . . 0.0 109.628 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 6' ' ' ARG . 28.7 tp -60.68 111.7 1.72 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.999 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.43 38.6 95.04 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.41 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -81.07 133.23 35.44 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -62.36 145.29 54.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.6 t60 -45.61 -51.89 11.46 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.622 0.646 . . . . 0.0 112.19 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.92 72.65 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 124.102 0.877 . . . . 0.0 111.186 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -80.55 -47.36 14.32 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.489 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 12.0 p -65.17 -42.28 93.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 77' ' ' HIS . 14.3 p -65.87 -37.79 80.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.676 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -58.86 -45.16 90.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.307 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.1 mt -73.75 -51.21 25.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-O 122.174 0.988 . . . . 0.0 109.615 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.92 -29.48 69.9 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.098 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -86.32 -23.81 26.11 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -80.25 -12.0 59.67 Favored 'General case' 0 C--O 1.249 1.062 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.813 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.576 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 6.7 mt -47.69 139.98 8.41 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.8 1.24 . . . . 0.0 113.5 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.5 Cg_endo -99.0 145.11 0.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.894 3.062 . . . . 0.0 111.333 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.459 HG12 ' H ' ' A' ' 25' ' ' ARG . 37.7 mt -68.3 142.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.45 11.32 57.27 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.431 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -105.43 -177.03 3.25 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.828 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.438 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.8 p -148.95 145.89 27.59 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -153.37 158.41 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 C-N-CA 123.754 0.822 . . . . 0.0 111.038 174.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -96.55 107.5 19.93 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.45 114.04 26.0 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 30.3 mt-10 -97.7 111.75 23.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.411 HD13 ' CG ' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.07 157.46 45.27 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.799 -173.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.0 t -112.55 130.2 56.1 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.481 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 21.6 tpp85 -103.17 152.38 21.52 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.419 ' O ' ' HE2' ' A' ' 12' ' ' LYS . . . 110.9 8.18 24.43 Favored Glycine 0 CA--C 1.493 -1.283 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.366 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.421 -1.921 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.779 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 CA--C 1.548 0.888 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 23.2 m -132.51 117.73 18.38 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' THR . 53.9 tt0 -79.62 122.41 26.48 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.354 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.408 -2.569 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.665 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.419 -2.001 0 CA-C-O 121.692 0.758 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 61.13 36.1 18.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.585 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.789 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -121.86 120.11 28.67 Favored Pre-proline 0 C--N 1.268 -2.95 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 16.3 Cg_exo -62.92 -32.93 76.55 Favored 'Trans proline' 0 CA--C 1.473 -2.528 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -71.09 -22.25 62.13 Favored 'General case' 1 N--CA 1.365 -4.708 0 CA-C-N 111.899 -2.41 . . . . 0.0 110.97 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.789 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.2 pt-20 -77.07 -36.62 55.7 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.409 ' CD2' ' HH ' ' A' ' 101' ' ' TYR . 95.9 mt -54.28 131.31 41.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.271 0.982 . . . . 0.0 111.146 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -86.06 169.16 13.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.048 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.57 -108.24 3.65 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.249 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 144.88 29.95 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 122.834 0.453 . . . . 0.0 110.911 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -111.19 122.08 46.95 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -135.57 152.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.26 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.649 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.1 t60 -128.27 101.49 6.26 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -117.66 137.02 52.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.15 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -79.17 133.6 36.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.115 -0.366 . . . . 0.0 110.273 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -118.02 119.46 34.87 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -81.25 104.64 11.86 Favored 'General case' 0 N--CA 1.403 -2.797 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.88 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.585 ' CG ' HG23 ' A' ' 87' ' ' ILE . 1.9 mptp? -33.41 106.76 0.04 OUTLIER 'General case' 0 CA--C 1.483 -1.632 0 C-N-CA 125.357 1.463 . . . . 0.0 112.112 174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 t -81.65 -150.78 0.08 Allowed 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 125.983 2.052 . . . . 0.0 108.283 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -61.69 83.25 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.41 ' H ' HG12 ' A' ' 89' ' ' ILE . 27.2 mtp85 58.31 44.26 18.82 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.852 1.261 . . . . 0.0 113.66 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.6 -133.91 3.83 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.624 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.4 m-85 -129.77 -77.79 0.55 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.62 52.1 0.16 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.741 -171.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.495 ' CD2' HD12 ' A' ' 43' ' ' ILE . 37.2 p90 -161.64 142.6 11.0 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.4 p -106.25 136.56 45.75 Favored 'General case' 0 C--N 1.265 -3.074 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.269 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 17.5 m -123.39 158.02 28.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.887 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 HG11 ' HD2' ' A' ' 44' ' ' LYS . 8.9 m -121.53 133.06 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.854 0 C-N-CA 124.334 1.053 . . . . 0.0 109.599 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.64 -142.06 13.34 Favored Glycine 0 CA--C 1.455 -3.708 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.009 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.431 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.45 57.07 1.5 Allowed Glycine 0 CA--C 1.458 -3.475 0 O-C-N 127.136 2.316 . . . . 0.0 111.385 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -104.72 -32.16 9.0 Favored 'General case' 0 C--N 1.251 -3.676 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -137.76 170.68 9.93 Favored Pre-proline 0 N--CA 1.405 -2.701 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.102 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 32.0 Cg_exo -71.81 -8.72 23.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.296 2.664 . . . . 0.0 108.709 174.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -111.67 -10.66 14.07 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.837 1.655 . . . . 0.0 110.811 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.82 120.18 30.99 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 121.999 -0.438 . . . . 0.0 109.989 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -87.32 165.45 15.62 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 127.444 2.297 . . . . 0.0 110.61 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 5.5 mp -93.15 145.24 24.56 Favored 'General case' 0 C--O 1.176 -2.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.304 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 37.0 tt0 -133.92 155.91 49.06 Favored 'General case' 0 C--O 1.162 -3.515 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 29' ' ' PHE . 12.2 mm -87.27 126.38 41.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 118.88 0.764 . . . . 0.0 109.243 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HD2' HG11 ' A' ' 32' ' ' VAL . 20.9 ptmt -102.09 -23.46 14.07 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 123.137 0.273 . . . . 0.0 110.317 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 38.7 m -151.49 126.43 9.74 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.88 108.96 19.0 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 79.8 t -85.76 127.63 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 121.87 0.843 . . . . 0.0 111.661 -173.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.52 85.33 4.6 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.459 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 165.12 -22.52 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 125.115 1.509 . . . . 0.0 109.822 -170.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -99.55 166.28 20.6 Favored Glycine 0 CA--C 1.48 -2.116 0 CA-C-N 115.456 -0.793 . . . . 0.0 114.045 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 6.1 Cg_endo -67.72 -23.85 41.71 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.142 1.895 . . . . 0.0 111.077 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 58' ' ' MET . . . -58.35 -52.34 66.01 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.971 0.909 . . . . 0.0 111.395 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.552 ' HB1' ' CD2' ' A' ' 54' ' ' LEU . . . -73.74 -37.15 65.18 Favored 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 122.879 1.324 . . . . 0.0 110.049 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 50' ' ' GLY . 1.0 OUTLIER -71.25 -38.44 71.92 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 111.755 -2.475 . . . . 0.0 111.175 -170.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.87 -26.07 37.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.564 1.173 . . . . 0.0 108.049 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.73 86.06 Favored Glycine 0 CA--C 1.481 -2.076 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.429 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -122.08 0.67 9.68 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.694 -174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.61 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 67.3 mtp -128.04 159.2 35.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.42 164.16 30.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.476 0.655 . . . . 0.0 110.719 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -71.24 116.73 11.9 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.36 -23.89 4.24 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 43' ' ' ILE . 7.3 m-20 -58.16 140.96 51.86 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 120.716 0.294 . . . . 0.0 110.62 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.323 0.2 OUTLIER -109.17 115.96 50.85 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-O 121.578 0.704 . . . . 0.0 111.891 174.23 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.8 mm -68.82 114.62 5.88 Favored 'Isoleucine or valine' 0 C--O 1.301 3.777 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.791 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.83 -58.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 112.361 -2.199 . . . . 0.0 110.1 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.5 m -158.31 173.32 16.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.0 -0.438 . . . . 0.0 110.471 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.1 p -145.55 153.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.413 ' HB3' HG13 ' A' ' 93' ' ' VAL . 9.8 t30 -31.31 113.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.01 1.324 . . . . 0.0 111.782 172.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 75.04 -38.9 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.98 1.712 . . . . 0.0 115.231 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -100.2 122.66 43.38 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.894 0.854 . . . . 0.0 111.497 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.4 t -83.56 83.38 7.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.973 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.55 -2.62 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.346 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -66.77 110.48 3.28 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.12 28.51 70.13 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.74 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.428 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.05 140.97 43.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 122.017 -0.696 . . . . 0.0 109.693 178.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 m -74.78 143.61 43.93 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 117.526 -1.225 . . . . 0.0 108.044 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -47.84 -49.46 29.17 Favored 'General case' 0 CA--C 1.485 -1.52 0 CA-C-N 118.952 0.796 . . . . 0.0 111.7 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.05 74.33 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 124.758 1.286 . . . . 0.0 111.084 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -75.23 -53.37 8.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -61.65 -42.66 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.579 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 8.9 p -62.49 -45.34 99.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 C-N-CA 121.264 -0.174 . . . . 0.0 110.532 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -57.12 -41.51 79.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.697 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -72.65 -50.23 35.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.161 0.981 . . . . 0.0 108.912 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.95 -29.1 70.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.453 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.7 pt20 -86.69 -24.01 25.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -93.08 2.81 56.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.585 HG23 ' CG ' ' A' ' 22' ' ' LYS . 4.3 mt -51.19 144.04 15.95 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.964 1.306 . . . . 0.0 113.618 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -92.74 140.43 1.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.517 2.811 . . . . 0.0 111.048 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.9 mt -68.49 138.91 21.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.47 12.52 62.77 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.493 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -101.48 -171.47 1.99 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.648 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.526 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.5 t -148.88 144.39 26.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.855 -0.528 . . . . 0.0 112.187 -171.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -152.95 154.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 C-N-CA 124.221 1.008 . . . . 0.0 110.25 173.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 5.5 m-20 -99.74 107.7 19.83 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 tp -99.73 115.24 29.04 Favored 'General case' 0 C--N 1.269 -2.929 0 CA-C-O 120.803 0.335 . . . . 0.0 110.166 -174.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -103.3 123.8 47.46 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.4 OUTLIER -141.52 163.26 33.4 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.705 -173.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.2 t -116.69 128.33 55.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.61 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 22.2 tpp85 -103.66 152.49 21.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.88 -43.03 1.26 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.409 ' HH ' ' CD2' ' A' ' 11' ' ' LEU . 84.9 m-85 . . . . . 0 C--N 1.297 -1.686 0 CA-C-N 114.644 -0.778 . . . . 0.0 109.342 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.4 pm0 . . . . . 0 N--CA 1.414 -2.245 0 CA-C-O 121.816 0.817 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 18.1 m -105.4 110.21 22.47 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.456 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.1 mp0 -85.17 104.44 15.05 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.428 -1.546 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.439 -177.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 15.0 t . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 5' ' ' THR . 33.2 ptt180 56.97 14.03 1.74 Allowed 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 127.486 2.314 . . . . 0.0 114.889 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.699 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 14.4 m-80 -92.6 124.7 58.24 Favored Pre-proline 1 C--N 1.241 -4.135 0 CA-C-N 114.18 -1.373 . . . . 0.0 113.109 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.272 11.3 Cg_exo -60.35 -32.57 94.21 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 122.046 1.83 . . . . 0.0 108.781 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -68.72 -22.86 64.31 Favored 'General case' 1 N--CA 1.367 -4.59 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.219 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.6 pt-20 -79.34 -38.5 35.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.43 130.06 44.58 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.509 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -77.34 177.95 7.54 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.153 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.25 -122.65 6.55 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.321 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 99' ' ' ARG . 13.4 mmmm -107.8 149.61 28.01 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 123.473 0.709 . . . . 0.0 109.317 -177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.51 111.25 16.59 Favored 'General case' 1 C--N 1.241 -4.121 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 151.99 36.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.952 0.882 . . . . 0.0 112.854 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.566 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.2 t60 -132.95 103.45 6.07 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -128.66 140.15 51.9 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.238 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -73.54 135.2 43.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.495 177.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.84 120.87 37.73 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.401 ' C ' ' HZ2' ' A' ' 22' ' ' LYS . 24.3 ttm180 -72.73 124.29 25.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.116 0.484 . . . . 0.0 109.9 -176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.651 ' N ' ' HZ2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -57.56 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 123.59 0.756 . . . . 0.0 110.989 171.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -107.93 126.11 52.3 Favored 'General case' 0 N--CA 1.405 -2.707 0 O-C-N 126.187 2.179 . . . . 0.0 108.09 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m 47.15 56.34 6.96 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.297 1.439 . . . . 0.0 113.974 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.645 ' N ' HG12 ' A' ' 89' ' ' ILE . 19.9 mmt180 68.31 42.71 1.62 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.248 0.547 . . . . 0.0 112.123 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.9 -124.43 1.48 Allowed Glycine 0 N--CA 1.403 -3.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.235 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.624 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -132.74 -87.06 0.45 Allowed 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 114.367 -0.916 . . . . 0.0 111.753 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.473 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 123.9 52.28 0.2 Allowed Glycine 0 C--N 1.289 -2.062 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -167.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 43' ' ' ILE . 18.0 p90 -160.71 143.72 13.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.503 HG21 ' HA ' ' B' ' 160' ' ' GLN . 17.3 p -107.45 135.14 49.44 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 122.173 0.987 . . . . 0.0 109.68 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 3.5 p -130.46 137.61 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.753 -169.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 m -114.49 154.1 15.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 125.03 1.332 . . . . 0.0 113.545 -174.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.86 -127.88 9.37 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.547 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 40.53 74.66 0.14 Allowed Glycine 1 CA--C 1.449 -4.068 0 O-C-N 126.648 2.028 . . . . 0.0 113.194 178.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -130.75 -20.44 2.86 Favored 'General case' 0 C--N 1.259 -3.333 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.169 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 7.7 pt-20 -156.68 170.92 8.1 Favored Pre-proline 0 N--CA 1.415 -2.203 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.031 -166.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 75.8 Cg_exo -61.14 -38.13 69.43 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 122.649 2.233 . . . . 0.0 108.895 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.22 -25.3 61.6 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.88 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.36 118.83 24.89 Favored 'General case' 0 C--O 1.274 2.367 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.134 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.584 ' CD1' HD11 ' A' ' 73' ' ' LEU . 3.1 m-85 -87.27 165.67 15.49 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 128.134 2.574 . . . . 0.0 108.795 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 6.1 mp -89.27 147.01 24.36 Favored 'General case' 0 C--O 1.18 -2.582 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.077 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 6.6 tt0 -136.04 144.99 45.55 Favored 'General case' 0 C--O 1.175 -2.844 0 CA-C-N 118.698 0.681 . . . . 0.0 109.163 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 62' ' ' ASP . 34.4 mm -83.25 117.81 29.75 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 O-C-N 121.599 -0.688 . . . . 0.0 111.081 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 -18.95 19.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -159.6 127.84 4.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 pp -82.31 117.04 22.09 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.473 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 90.3 t -83.45 129.24 37.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.1 142.05 54.8 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.117 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 80.09 5.29 1.84 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.58 1.175 . . . . 0.0 109.744 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.724 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -93.31 160.38 24.7 Favored Glycine 0 CA--C 1.484 -1.904 0 CA-C-O 118.153 -1.359 . . . . 0.0 109.886 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 32.1 Cg_endo -72.01 -25.21 19.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.95 2.375 . . . . 0.0 110.208 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -61.03 -49.25 78.16 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.468 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.91 86.53 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.134 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.0 mt -72.06 -38.3 69.5 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 112.921 -1.945 . . . . 0.0 114.55 -172.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 12.9 t70 -71.75 -27.26 62.86 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.66 2.72 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.887 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 17.3 ptpt -77.32 -34.34 55.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.824 1.312 . . . . 0.0 112.549 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.551 ' SD ' ' HB1' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -79.44 139.04 37.78 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.76 167.94 21.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.458 1.123 . . . . 0.0 112.242 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -61.23 135.37 57.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.573 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.87 -16.03 43.77 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 43' ' ' ILE . 10.4 m-20 -66.47 132.99 49.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.268 0.2 OUTLIER -101.13 120.71 51.05 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.759 176.094 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -73.0 115.62 14.08 Favored 'Isoleucine or valine' 0 C--O 1.302 3.848 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.15 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.8 t -102.2 -58.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 126.395 2.309 . . . . 0.0 109.814 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 13.4 m -146.3 172.06 14.05 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 13.7 p -144.43 154.78 14.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -34.18 112.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 64.36 15.59 9.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.2 1.4 . . . . 0.0 114.045 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.1 m -142.18 125.15 16.17 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.477 1.132 . . . . 0.0 112.493 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.5 108.94 14.54 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.231 -1.35 . . . . 0.0 107.967 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 41.1 t -86.04 -2.71 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 40' ' ' PHE . 2.6 mm? -66.92 123.28 19.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.205 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 36' ' ' GLU . . . 81.46 9.44 85.81 Favored Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.832 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.8 111.03 10.73 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.1 m -62.0 149.73 40.02 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.23 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -47.55 -43.79 25.44 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.97 0.804 . . . . 0.0 111.713 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -36.01 82.49 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 27.5 mm-40 -79.32 -48.27 14.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.291 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 14.9 p -63.87 -40.74 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.137 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.51 -36.27 76.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 4.5 tmmm? -57.2 -47.97 79.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.44 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.2 mt -72.94 -50.28 33.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 CA-C-O 122.283 1.039 . . . . 0.0 109.883 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.508 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 5.4 m-85 -63.96 -38.04 89.62 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.308 -1.769 . . . . 0.0 114.017 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -86.2 -19.87 29.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.117 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.8 m -75.6 -17.62 59.97 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.653 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.571 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.8 mt -44.74 135.68 4.65 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.463 1.105 . . . . 0.0 113.459 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 74.0 Cg_endo -97.79 154.42 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.179 3.253 . . . . 0.0 112.127 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.645 HG12 ' N ' ' A' ' 25' ' ' ARG . 7.3 mt -69.05 143.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.263 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.24 11.93 71.5 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.832 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -105.45 -170.5 1.76 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.88 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -149.66 138.29 20.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 27.5 m -133.47 152.3 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.373 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.07 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.566 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -94.23 107.32 19.26 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.08 123.3 45.71 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.335 0.588 . . . . 0.0 109.995 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.1 tt0 -103.17 115.14 30.0 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.444 HD12 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.92 159.13 42.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.584 -175.402 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.3 t -122.57 140.06 53.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.467 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 20.1 tpp85 -110.64 142.2 42.85 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.71 -18.19 1.63 Allowed Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.914 -1.136 . . . . 0.0 111.89 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.1 pm0 . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 17.9 m -114.11 109.76 18.94 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 102.527 -3.138 . . . . 0.0 102.527 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.503 ' HA ' HG21 ' A' ' 30' ' ' THR . 46.9 tt0 -86.94 96.07 10.13 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.564 0.697 . . . . 0.0 111.078 -174.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.418 -2.036 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.205 -173.61 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.424 HG23 ' OE1' ' A' ' 10' ' ' GLU . 13.6 t . . . . . 0 N--CA 1.428 -1.533 0 CA-C-O 122.273 1.035 . . . . 0.0 108.36 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.611 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.0 ptt180 46.15 36.12 2.99 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 126.249 1.82 . . . . 0.0 112.974 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.777 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -108.14 111.54 61.85 Favored Pre-proline 1 C--N 1.219 -5.096 0 CA-C-N 112.29 -2.232 . . . . 0.0 113.645 178.783 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.299 17.3 Cg_exo -58.13 -36.44 97.9 Favored 'Trans proline' 0 CA--C 1.478 -2.306 0 C-N-CA 121.757 1.638 . . . . 0.0 109.355 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 m -66.01 -26.65 67.63 Favored 'General case' 1 N--CA 1.36 -4.941 0 CA-C-N 111.284 -2.689 . . . . 0.0 112.571 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.777 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.1 pt-20 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.7 131.58 48.38 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -80.94 -175.18 5.24 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.097 -1.411 . . . . 0.0 113.365 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.2 -119.77 4.95 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.468 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.17 157.87 45.11 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 123.821 0.848 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.93 111.11 16.67 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.27 135.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.264 0.554 . . . . 0.0 111.378 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.419 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 21.6 t60 -112.66 99.65 8.1 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.442 ' CB ' ' HG2' ' A' ' 57' ' ' LYS . 10.6 t -118.34 140.16 50.26 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.298 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -81.24 130.41 35.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.73 132.56 56.6 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -92.13 119.57 31.91 Favored 'General case' 0 N--CA 1.387 -3.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HG3' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -53.21 99.97 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 166.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 89' ' ' ILE . 70.9 m -87.25 -54.89 4.06 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 124.509 1.131 . . . . 0.0 113.365 -167.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -144.89 70.8 1.28 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.455 ' N ' HG12 ' A' ' 89' ' ' ILE . 29.2 mmt180 67.78 78.8 0.23 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 104.63 -141.31 15.26 Favored Glycine 0 N--CA 1.411 -3.017 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.063 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.701 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.4 m-85 -119.3 -82.33 0.64 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.325 -0.938 . . . . 0.0 111.562 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.24 50.34 0.2 Allowed Glycine 0 C--N 1.291 -1.948 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.995 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' A' ' 43' ' ' ILE . 46.2 p90 -161.59 143.35 11.52 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.1 p -104.73 146.21 29.27 Favored 'General case' 0 C--N 1.256 -3.46 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.71 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 43' ' ' ILE . 29.9 m -128.26 157.2 40.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG11 ' HD2' ' A' ' 44' ' ' LYS . 10.5 m -119.74 132.59 69.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 C-N-CA 124.959 1.304 . . . . 0.0 110.205 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 124.88 -144.25 15.08 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.485 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.57 61.56 3.24 Favored Glycine 0 CA--C 1.466 -2.986 0 O-C-N 125.93 1.606 . . . . 0.0 112.048 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.68 -32.7 6.57 Favored 'General case' 0 C--N 1.261 -3.274 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.403 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.03 170.43 8.93 Favored Pre-proline 0 CA--C 1.478 -1.791 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.633 -171.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.92 63.29 8.11 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.968 3.112 . . . . 0.0 107.76 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.78 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 111.822 -2.445 . . . . 0.0 106.851 -172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.33 119.52 39.27 Favored 'General case' 0 C--O 1.269 2.122 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.357 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' O ' ' HA3' ' A' ' 33' ' ' GLY . 37.7 m-85 -95.09 164.91 12.68 Favored 'General case' 0 N--CA 1.508 2.427 0 C-N-CA 127.858 2.463 . . . . 0.0 108.408 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.496 ' O ' HG21 ' A' ' 63' ' ' VAL . 4.7 mp -96.3 144.83 26.12 Favored 'General case' 0 C--O 1.169 -3.151 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.609 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 tt0 -134.49 151.34 51.07 Favored 'General case' 0 C--O 1.168 -3.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 62' ' ' ASP . 11.6 mm -78.46 126.6 38.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD2' HG11 ' A' ' 32' ' ' VAL . 10.3 ptmm? -105.35 -22.21 13.08 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 122.342 0.257 . . . . 0.0 111.188 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 15.9 m -156.03 126.91 6.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.3 tp -83.29 114.77 21.62 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 57.4 t -90.45 119.88 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.63 144.0 55.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.319 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 83.49 8.02 0.65 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 125.412 1.695 . . . . 0.0 109.702 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.627 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.16 158.11 27.62 Favored Glycine 0 C--O 1.203 -1.817 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 172.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 58.5 Cg_endo -73.22 -25.37 15.84 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 CA-C-N 121.852 2.826 . . . . 0.0 110.112 -170.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.84 94.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.189 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.31 66.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-O 122.621 1.2 . . . . 0.0 110.076 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 89.1 mt -71.4 -48.07 52.1 Favored 'General case' 0 N--CA 1.395 -3.191 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.875 -172.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.9 t70 -70.52 -28.29 64.83 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.07 26.97 70.74 Favored Glycine 0 CA--C 1.487 -1.707 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.828 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -90.62 -20.53 22.45 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.457 -0.871 . . . . 0.0 109.563 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 66.3 mtp -125.72 152.35 45.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.872 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.37 167.34 26.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.603 0.716 . . . . 0.0 111.882 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.404 HG22 ' C ' ' A' ' 44' ' ' LYS . 7.3 m -60.4 116.52 4.35 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.56 -42.03 1.43 Allowed Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.559 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.3 148.94 50.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.302 0.3 OUTLIER -110.51 119.15 58.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -172.403 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.83 115.03 2.78 Favored 'Isoleucine or valine' 0 C--O 1.302 3.842 0 C-N-CA 126.478 1.911 . . . . 0.0 110.765 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.49 -58.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.183 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.9 m -154.9 173.35 16.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.306 -0.871 . . . . 0.0 112.147 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 9.8 p -140.97 159.32 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -31.96 105.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.396 1.478 . . . . 0.0 114.76 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.95 33.78 9.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.772 1.629 . . . . 0.0 112.224 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 15.5 m -140.61 120.71 13.76 Favored 'General case' 0 N--CA 1.421 -1.901 0 O-C-N 121.424 -0.797 . . . . 0.0 109.371 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -81.58 77.07 8.47 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.516 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 91.2 t -74.08 -8.0 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 123.173 1.463 . . . . 0.0 108.62 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 6' ' ' ARG . 24.7 tp -64.89 111.13 2.68 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.138 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.71 74.01 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.477 -176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -74.6 139.78 43.89 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 30.7 m -72.84 145.08 47.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 117.458 -1.258 . . . . 0.0 108.381 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 81' ' ' VAL . 70.3 t60 -47.33 -48.44 25.3 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.276 0.944 . . . . 0.0 112.216 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.44 70.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.816 0.698 . . . . 0.0 110.843 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 64.8 mm-40 -80.14 -49.4 11.74 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.835 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.72 -42.68 96.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.445 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.5 p -65.33 -36.05 76.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.834 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 38.6 ttpt -55.26 -48.19 74.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.436 0.294 . . . . 0.0 111.428 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -72.27 -50.26 37.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 122.706 1.241 . . . . 0.0 109.515 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.34 -28.27 68.54 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.024 -1.898 . . . . 0.0 112.792 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.1 mp0 -86.65 -22.93 25.84 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 p -90.0 -18.48 25.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.484 HD13 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -54.47 151.41 14.27 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -102.84 163.05 0.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.874 3.716 . . . . 0.0 112.283 -177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 23' ' ' SER . 64.4 mt -67.92 131.91 32.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.931 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.28 10.97 46.74 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.79 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.88 -179.2 4.09 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 118.456 1.128 . . . . 0.0 111.82 -175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.431 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 17.2 t -138.68 153.62 48.56 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 109.94 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.3 m -153.89 151.16 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 C-N-CA 124.341 1.057 . . . . 0.0 110.391 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 14.8 m-20 -95.57 107.59 19.78 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.04 116.39 31.88 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.29 125.05 52.72 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.396 0.617 . . . . 0.0 110.77 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 2.1 pt? -141.95 163.21 33.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.656 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 78.7 m -109.57 124.4 51.07 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.328 0.585 . . . . 0.0 110.662 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 6.7 tpp85 -98.95 147.31 25.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.32 -28.88 2.44 Favored Glycine 0 CA--C 1.486 -1.773 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 N--CA 1.429 -1.502 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.404 175.697 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.429 -1.487 0 CA-C-O 121.297 0.57 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 15.0 m -132.78 122.82 25.08 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.77 110.77 22.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.839 -177.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.425 -1.699 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 41.81 42.86 2.33 Favored 'General case' 0 C--N 1.372 1.558 0 C-N-CA 126.527 1.931 . . . . 0.0 113.189 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.804 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.6 m-80 -112.5 119.45 43.44 Favored Pre-proline 1 C--N 1.223 -4.893 0 CA-C-N 112.412 -2.177 . . . . 0.0 113.315 176.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.317 24.1 Cg_exo -60.71 -37.33 79.74 Favored 'Trans proline' 0 CA--C 1.474 -2.491 0 C-N-CA 121.788 1.659 . . . . 0.0 108.436 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.1 m -64.8 -23.62 67.3 Favored 'General case' 1 N--CA 1.346 -5.653 0 CA-C-N 109.848 -3.342 . . . . 0.0 112.432 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.804 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.9 pt-20 -80.97 -34.59 32.99 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.9 mt -55.79 129.98 41.57 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 122.772 1.273 . . . . 0.0 112.052 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.84 173.74 7.85 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 112.801 -1.999 . . . . 0.0 112.376 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 78.01 -121.35 5.7 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.67 155.52 49.55 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.916 0.486 . . . . 0.0 109.914 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.33 111.63 20.37 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.41 152.88 37.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-O 121.484 0.659 . . . . 0.0 111.961 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -125.91 113.79 17.67 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.664 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 11.2 t -125.48 137.3 53.96 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.269 0.557 . . . . 0.0 110.633 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -74.82 131.35 40.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.561 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.46 126.31 53.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.45 105.46 17.63 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.551 ' CG ' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -39.8 113.97 0.39 Allowed 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 175.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.8 t -89.26 -149.65 0.19 Allowed 'General case' 0 N--CA 1.406 -2.628 0 O-C-N 126.182 2.176 . . . . 0.0 107.951 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -61.96 80.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.468 ' N ' HG12 ' A' ' 89' ' ' ILE . 17.4 mmm180 65.54 56.9 0.91 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.59 -131.55 5.22 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.149 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.658 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -130.0 -83.64 0.55 Allowed 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.305 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.574 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 135.03 53.18 0.07 OUTLIER Glycine 0 C--N 1.297 -1.595 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.877 -170.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CD1' HD11 ' A' ' 43' ' ' ILE . 35.4 p90 -162.39 152.11 16.09 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.3 p -112.03 144.07 42.0 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.051 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 76.1 t -113.45 149.38 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.072 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 42' ' ' GLN . 1.2 m -119.87 129.76 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.47 -132.7 9.15 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 33.46 59.98 0.5 Allowed Glycine 1 CA--C 1.445 -4.327 0 O-C-N 126.215 1.773 . . . . 0.0 111.391 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.55 -29.6 9.55 Favored 'General case' 0 C--N 1.252 -3.67 0 CA-C-N 113.933 -1.134 . . . . 0.0 109.214 -170.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -159.15 173.78 4.65 Favored Pre-proline 0 CA--C 1.483 -1.606 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.655 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 73.6 Cg_exo -62.22 -25.95 77.24 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.907 2.405 . . . . 0.0 109.921 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.66 -22.76 27.75 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.996 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.44 119.98 31.61 Favored 'General case' 0 C--O 1.264 1.849 0 O-C-N 121.735 -0.603 . . . . 0.0 110.368 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -86.62 164.87 16.58 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.766 2.026 . . . . 0.0 110.805 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.8 mp -89.16 144.82 25.84 Favored 'General case' 0 C--O 1.183 -2.398 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.2 tt0 -138.76 158.73 43.68 Favored 'General case' 0 C--O 1.188 -2.16 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.447 HD11 ' CD1' ' A' ' 29' ' ' PHE . 32.0 mm -92.6 124.15 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 122.527 0.331 . . . . 0.0 110.216 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -104.85 -18.93 14.05 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 123.452 0.47 . . . . 0.0 110.404 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.527 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 54.4 m -154.94 127.63 8.03 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.904 0.383 . . . . 0.0 110.539 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.2 tp -81.14 106.72 13.35 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.574 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.1 t -79.82 115.02 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.95 143.52 57.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.614 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.44 ' HA ' HD23 ' A' ' 54' ' ' LEU . 33.1 t70 79.43 14.69 1.01 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 125.252 1.595 . . . . 0.0 109.51 -172.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -97.18 165.27 22.73 Favored Glycine 0 C--O 1.207 -1.579 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.5 Cg_endo -72.51 -25.12 18.22 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 121.816 2.808 . . . . 0.0 110.772 -169.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.81 -45.41 89.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.77 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.36 -46.08 71.05 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 124.637 1.175 . . . . 0.0 110.301 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 92.2 mt -71.66 -34.01 69.36 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.506 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 14.1 t70 -77.91 -27.6 49.54 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.59 29.33 69.83 Favored Glycine 0 CA--C 1.484 -1.898 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.336 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 5.0 tppp? -97.12 -50.81 4.45 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.209 -0.995 . . . . 0.0 111.349 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.475 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 62.7 mtp -88.86 158.34 18.14 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.352 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.78 159.0 43.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 m -62.98 118.68 8.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.28 -31.18 3.05 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.1 m-20 -53.25 140.43 26.59 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.018 0.481 . . . . 0.0 111.615 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.5 OUTLIER -107.8 114.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.175 0.512 . . . . 0.0 111.497 175.805 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -70.25 116.5 11.58 Favored 'Isoleucine or valine' 0 C--O 1.298 3.641 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.166 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.3 t -99.57 -59.17 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.395 -176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 p -151.79 166.21 32.07 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.452 -175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.95 110.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.88 ' ND2' ' HB ' ' A' ' 93' ' ' VAL . 14.7 m-80 43.13 65.21 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 76.46 -38.05 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.663 1.585 . . . . 0.0 112.869 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 m -59.23 122.74 14.61 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.728 0.775 . . . . 0.0 110.382 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -83.33 76.75 9.88 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.602 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.93 -7.18 10.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.635 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 tp -69.43 110.7 4.86 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 76.84 32.68 48.97 Favored Glycine 0 N--CA 1.411 -2.974 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.959 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -88.78 137.26 32.48 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 38.1 m -72.35 144.18 48.35 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 117.942 -1.028 . . . . 0.0 108.838 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -47.71 -50.86 23.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 119.046 0.839 . . . . 0.0 112.849 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.7 72.15 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.64 0.587 . . . . 0.0 110.969 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 33.5 mm-40 -75.95 -52.46 10.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.362 0.601 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -64.43 -43.49 96.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.811 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.8 p -63.57 -35.84 74.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.413 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.83 95.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.905 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.2 -50.54 35.73 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 122.383 1.087 . . . . 0.0 109.455 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.13 -34.87 79.43 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.83 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 72.0 mm-40 -85.9 -15.2 42.47 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -82.72 -16.43 48.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.225 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.551 HG23 ' CG ' ' A' ' 22' ' ' LYS . 5.5 mt -43.8 138.82 3.04 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 53.4 Cg_endo -95.96 148.06 1.28 Allowed 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 123.478 2.786 . . . . 0.0 110.858 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' SER . 20.2 mt -67.54 139.86 20.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.72 57.08 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.851 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.96 -176.65 3.5 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.007 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.429 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 5.9 p -149.39 138.13 21.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.909 -0.495 . . . . 0.0 111.828 -173.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.88 ' HB ' ' ND2' ' A' ' 68' ' ' ASN . 2.5 m -153.36 143.18 14.54 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 C-N-CA 122.645 0.378 . . . . 0.0 111.953 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.674 ' N ' HD22 ' A' ' 68' ' ' ASN . 19.9 m-20 -78.07 106.98 10.3 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 125.865 1.666 . . . . 0.0 107.749 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.4 tp -96.12 118.75 33.33 Favored 'General case' 0 C--N 1.26 -3.307 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.6 116.51 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -141.94 159.98 41.12 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 -175.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 73.8 m -112.82 127.45 56.17 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.532 0.682 . . . . 0.0 110.631 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.576 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 22.7 tpp85 -97.2 146.01 25.5 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.36 -32.24 2.18 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.799 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 C--N 1.311 -1.079 0 CA-C-O 120.641 0.257 . . . . 0.0 110.472 177.299 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.413 -2.317 0 CA-C-O 121.548 0.689 . . . . 0.0 111.334 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 19.9 m -94.69 101.55 13.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -83.88 122.57 28.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.312 -1.027 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.4 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.383 9.9 t . . . . . 0 N--CA 1.421 -1.909 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.51 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' HD11 ' A' ' 73' ' ' LEU . 18.0 ptt180 157.88 -33.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.739 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 20.2 t30 -53.94 111.45 2.83 Favored Pre-proline 0 C--N 1.269 -2.904 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.637 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.274 7.6 Cg_exo -57.4 -36.54 98.82 Favored 'Trans proline' 0 CA--C 1.463 -3.035 0 C-N-CA 122.921 2.414 . . . . 0.0 111.241 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.1 m -77.94 -9.32 59.03 Favored 'General case' 1 N--CA 1.347 -5.611 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.424 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.739 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.3 pt-20 -80.23 -36.56 34.58 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.3 mt -57.23 134.51 55.99 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.941 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.62 170.8 16.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.153 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 93.87 -117.01 5.37 Favored Glycine 0 N--CA 1.424 -2.106 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.052 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -150.38 145.78 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 110.465 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.92 112.49 24.18 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 152.49 37.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.471 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 p-80 -123.48 116.38 23.12 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.396 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -122.46 140.98 52.11 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.631 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -73.77 132.73 42.92 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.978 178.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.04 127.39 54.86 Favored 'General case' 0 C--O 1.256 1.435 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -86.87 105.84 17.33 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.702 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.536 ' CG ' HG23 ' A' ' 87' ' ' ILE . 1.6 mptm? -36.65 108.74 0.08 Allowed 'General case' 0 C--O 1.257 1.495 0 C-N-CA 125.115 1.366 . . . . 0.0 112.38 173.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 t -124.32 142.42 51.29 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 125.034 1.459 . . . . 0.0 108.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 m 52.56 39.4 27.98 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.46 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 67.52 35.15 4.3 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.013 1.325 . . . . 0.0 110.989 176.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.31 -120.95 0.83 Allowed Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.5 m-85 -137.92 -93.25 0.21 Allowed 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 153.03 54.46 0.01 OUTLIER Glycine 0 C--N 1.292 -1.916 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.453 ' HA ' HG22 ' A' ' 47' ' ' VAL . 44.7 p90 -160.64 166.48 28.82 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.509 HG21 ' HA ' ' B' ' 160' ' ' GLN . 29.3 p -120.51 136.23 54.83 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 121.192 -0.942 . . . . 0.0 109.126 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.67 140.09 47.52 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.687 -170.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.8 m -115.24 169.05 6.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.101 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.8 -125.79 7.35 Favored Glycine 0 C--O 1.191 -2.558 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 31.89 58.5 0.36 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 125.87 1.7 . . . . 0.0 113.863 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.57 -32.11 5.98 Favored 'General case' 1 C--N 1.233 -4.494 0 CA-C-N 113.033 -1.583 . . . . 0.0 109.431 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.6 172.24 6.39 Favored Pre-proline 0 CA--C 1.466 -2.274 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.397 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 50.0 Cg_exo -63.83 -26.02 67.65 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.206 1.937 . . . . 0.0 108.914 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.43 -35.47 70.95 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.638 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.87 119.11 26.94 Favored 'General case' 0 C--O 1.275 2.415 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.188 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 8.6 m-85 -82.46 166.03 19.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.849 2.46 . . . . 0.0 110.699 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 3.9 mp -85.36 145.42 27.5 Favored 'General case' 0 C--O 1.187 -2.214 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.122 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.2 tt0 -145.04 148.38 33.64 Favored 'General case' 0 C--O 1.191 -1.977 0 CA-C-N 118.817 0.735 . . . . 0.0 109.264 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.4 mm -81.7 123.26 37.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -103.41 -19.96 14.24 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.053 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.2 m -155.31 127.74 7.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.11 111.3 18.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.2 t -86.67 121.47 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.0 145.42 55.42 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.542 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 t70 84.41 6.03 0.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 125.56 1.788 . . . . 0.0 109.319 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.609 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.72 158.51 25.2 Favored Glycine 0 C--O 1.2 -1.995 0 CA-C-O 118.322 -1.266 . . . . 0.0 110.66 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.3 Cg_endo -72.13 -25.11 19.49 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 CA-C-N 120.858 2.329 . . . . 0.0 110.192 -171.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 58' ' ' MET . . . -62.43 -46.81 86.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.977 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.64 81.76 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.609 1.164 . . . . 0.0 110.753 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.5 mt -71.92 -41.58 67.71 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 113.336 -1.756 . . . . 0.0 114.378 -174.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.8 -25.09 61.02 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.78 -0.32 86.42 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 117.941 1.937 . . . . 0.0 117.941 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -94.47 -49.54 5.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 120.348 2.074 . . . . 0.0 114.03 -176.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.431 ' HG2' HD12 ' A' ' 97' ' ' LEU . 65.8 mtp -64.62 139.46 58.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.187 0.304 . . . . 0.0 110.894 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.27 167.12 18.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.343 0.592 . . . . 0.0 110.939 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -60.83 128.19 35.29 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.54 -35.03 4.02 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.455 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.561 ' O ' HG12 ' A' ' 43' ' ' ILE . 3.5 m-20 -52.78 129.07 28.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.383 0.673 . . . . 0.0 110.613 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.255 0.8 OUTLIER -93.4 116.23 34.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.335 0.588 . . . . 0.0 112.184 -179.161 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.8 mm -72.77 115.52 13.6 Favored 'Isoleucine or valine' 0 C--O 1.295 3.476 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.829 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.7 t -98.45 -56.69 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 112.293 -2.23 . . . . 0.0 110.54 -175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.4 m -157.66 174.66 15.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.699 -0.626 . . . . 0.0 110.98 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.9 p -140.02 159.78 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.63 ' OD1' HG13 ' A' ' 93' ' ' VAL . 28.4 p-10 -29.22 109.86 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.524 1.129 . . . . 0.0 113.31 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 69.8 -37.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.995 1.318 . . . . 0.0 113.729 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.0 m -82.67 124.35 30.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.076 0.941 . . . . 0.0 111.865 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.82 78.72 9.83 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.985 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.44 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 23.8 t -77.17 3.71 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.302 1.049 . . . . 0.0 109.068 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 6' ' ' ARG . 12.1 tp -65.74 111.55 3.28 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.514 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 62.96 37.9 95.7 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.589 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -74.13 137.85 43.5 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 47.3 m -72.76 146.96 46.01 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.527 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.531 ' O ' HG13 ' A' ' 81' ' ' VAL . 1.2 t60 -44.43 -49.63 9.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.236 0.614 . . . . 0.0 112.045 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.81 80.35 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 123.748 0.655 . . . . 0.0 111.102 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 25.6 mm-40 -75.33 -53.41 8.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.72 -44.59 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.725 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 77' ' ' HIS . 11.7 p -69.48 -36.13 69.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.062 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 3.7 tmmm? -59.96 -44.07 94.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.7 -50.68 37.31 Favored 'Isoleucine or valine' 0 C--O 1.262 1.729 0 CA-C-O 122.507 1.146 . . . . 0.0 108.895 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 13.2 m-85 -66.18 -33.76 76.49 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.398 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.82 -19.21 32.84 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.349 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.3 m -84.08 -10.01 58.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.069 0.461 . . . . 0.0 110.879 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.536 HG23 ' CG ' ' A' ' 22' ' ' LYS . 6.1 mt -49.78 138.07 18.0 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 68.7 Cg_endo -101.58 149.16 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.209 3.273 . . . . 0.0 111.254 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 25' ' ' ARG . 22.8 mt -68.4 143.25 15.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.052 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.19 11.42 57.44 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -107.09 -173.36 2.27 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.547 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 31.1 t -149.52 151.94 34.73 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -169.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.63 HG13 ' OD1' ' A' ' 68' ' ' ASN . 1.1 m -157.12 153.72 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 C-N-CA 124.206 1.002 . . . . 0.0 111.245 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.02 107.49 19.54 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.7 tp -96.03 116.57 29.16 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.55 113.96 25.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 HD12 ' HG2' ' A' ' 58' ' ' MET . 1.4 pt? -141.48 157.8 44.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.1 t -111.63 123.58 50.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.497 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 tpp85 -92.12 143.06 26.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.15 -36.16 1.41 Allowed Glycine 0 C--N 1.294 -1.769 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.09 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 N--CA 1.438 -1.025 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 54.4 m -147.33 117.02 7.09 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.509 ' HA ' HG21 ' A' ' 30' ' ' THR . 9.8 tt0 -91.51 109.22 20.51 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.276 -2.596 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.305 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.3 t . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 5' ' ' THR . 12.8 ptm180 53.23 16.43 0.81 Allowed 'General case' 0 N--CA 1.518 2.933 0 C-N-CA 127.12 2.168 . . . . 0.0 113.686 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.719 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.78 110.28 36.26 Favored Pre-proline 0 C--N 1.257 -3.426 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.793 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.263 7.7 Cg_exo -58.38 -31.86 94.91 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 121.225 1.283 . . . . 0.0 109.114 171.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -72.74 -19.52 61.37 Favored 'General case' 1 N--CA 1.361 -4.9 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.851 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.8 pt-20 -79.77 -31.53 40.9 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 40' ' ' PHE . 86.7 mt -63.46 137.55 58.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.649 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.84 174.0 7.47 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.652 -174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.83 -115.52 5.33 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.382 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.38 149.15 46.75 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.54 115.55 23.03 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -134.89 153.13 34.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 -176.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -129.44 123.64 32.11 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.59 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.432 ' HB ' ' HD3' ' A' ' 57' ' ' LYS . 15.2 t -127.89 133.05 49.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.292 0.568 . . . . 0.0 111.758 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -81.86 128.3 33.89 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.5 mp -111.06 127.97 55.72 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -87.49 108.26 18.95 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.67 ' HE2' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -40.48 108.43 0.09 Allowed 'General case' 0 CA--C 1.462 -2.434 0 C-N-CA 125.857 1.663 . . . . 0.0 112.246 175.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -87.54 -143.21 0.12 Allowed 'General case' 0 N--CA 1.401 -2.896 0 O-C-N 126.598 2.436 . . . . 0.0 107.298 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -67.01 82.6 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.13 24.34 13.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 112.063 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -130.33 1.68 Allowed Glycine 0 C--O 1.276 2.78 0 C-N-CA 118.588 -1.768 . . . . 0.0 113.692 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 78.8 m-85 -133.83 -91.65 0.35 Allowed 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.33 53.15 0.1 Allowed Glycine 0 C--N 1.306 -1.089 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -169.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.439 ' HA ' HG22 ' A' ' 47' ' ' VAL . 32.8 p90 -162.0 145.86 12.27 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -108.13 135.87 48.76 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 42' ' ' GLN . 1.9 p -123.41 140.4 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 CA-C-N 113.403 -1.726 . . . . 0.0 111.02 -171.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.5 m -124.02 133.65 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 C-N-CA 124.677 1.191 . . . . 0.0 110.691 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 -140.78 12.2 Favored Glycine 0 CA--C 1.461 -3.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.46 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.4 55.86 2.47 Favored Glycine 0 CA--C 1.45 -3.977 0 O-C-N 126.695 2.056 . . . . 0.0 112.101 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.24 -31.62 15.36 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.639 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.7 167.69 13.92 Favored Pre-proline 0 CA--C 1.48 -1.724 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.484 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -77.76 64.45 8.16 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 124.189 3.259 . . . . 0.0 107.805 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.15 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.065 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.421 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 8.5 tp10 -107.35 119.97 40.85 Favored 'General case' 0 C--O 1.267 1.992 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 11' ' ' LEU . 20.5 m-85 -84.32 164.37 19.03 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 127.804 2.442 . . . . 0.0 111.778 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.9 mp -90.45 147.89 23.12 Favored 'General case' 0 C--O 1.201 -1.473 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.9 tt0 -139.63 155.27 47.53 Favored 'General case' 0 C--O 1.184 -2.367 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.3 123.47 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.588 -0.695 . . . . 0.0 110.811 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -102.62 -23.59 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 123.357 0.411 . . . . 0.0 112.02 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 m -151.88 127.05 9.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.48 108.17 19.25 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 62.9 t -85.82 134.35 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.494 0.664 . . . . 0.0 110.197 -173.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.15 140.92 57.53 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.189 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HA ' HD22 ' A' ' 54' ' ' LEU . 34.0 t70 80.54 5.29 1.65 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.238 1.415 . . . . 0.0 110.996 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.702 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -81.62 159.36 40.32 Favored Glycine 0 C--O 1.203 -1.817 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.558 173.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 13.5 Cg_endo -72.0 -25.09 19.94 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 CA-C-N 121.559 2.68 . . . . 0.0 109.855 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 20' ' ' LEU . . . -64.97 -42.37 94.62 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.64 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.43 76.99 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.767 1.27 . . . . 0.0 109.782 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 65.9 mt -72.11 -46.91 54.79 Favored 'General case' 0 C--N 1.267 -3.007 0 CA-C-N 112.64 -2.073 . . . . 0.0 115.188 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.76 -24.65 56.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.05 -155.94 33.6 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.007 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.7 tttp 70.25 -58.79 0.53 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.135 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.9 ttt -77.65 137.64 38.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.639 0.776 . . . . 0.0 109.076 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -152.16 143.69 23.47 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.741 0.416 . . . . 0.0 109.941 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 m -45.81 116.38 1.19 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.215 1.006 . . . . 0.0 110.811 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.78 -11.04 7.05 Favored Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.57 145.45 56.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 3.4 m -106.99 132.65 53.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 117.961 -1.496 . . . . 0.0 107.213 168.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.272 5.8 mt -83.74 119.55 33.16 Favored 'Isoleucine or valine' 1 C--O 1.31 4.267 0 CA-C-O 121.564 0.697 . . . . 0.0 112.599 -178.531 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' HD13 ' A' ' 73' ' ' LEU . 93.7 t -109.23 -50.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 O-C-N 127.356 2.91 . . . . 0.0 112.382 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 29.2 m -145.48 158.63 43.81 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.491 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.41 HG12 ' HB ' ' A' ' 70' ' ' THR . 5.2 p -135.23 86.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.482 37.3 p30 54.93 -90.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.361 2.265 . . . . 0.0 114.761 -171.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -89.59 -37.65 14.52 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.609 0.719 . . . . 0.0 110.172 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.41 ' HB ' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -77.91 127.84 33.0 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.842 -172.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.98 96.68 10.35 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 14.5 p -90.67 -1.11 9.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.783 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 65' ' ' VAL . 17.4 tp -69.56 112.0 5.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.43 27.33 43.93 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.599 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -81.42 150.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.3 m -76.48 142.47 40.94 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 117.824 -1.084 . . . . 0.0 108.764 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -48.27 -48.66 35.47 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.061 0.846 . . . . 0.0 112.894 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.49 69.55 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.303 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.55 -46.23 16.11 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 HD22 ' A' ' 41' ' ' LEU . 7.6 p -61.92 -43.73 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.917 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.3 -35.93 74.1 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.559 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.81 -46.69 81.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.733 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.5 -50.69 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.208 1.004 . . . . 0.0 109.362 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -62.26 -36.28 81.58 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.479 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.57 -20.04 32.12 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.699 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 t -80.8 -13.08 59.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.625 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.6 mt -48.67 134.11 13.79 Favored Pre-proline 0 CA--C 1.565 1.558 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 88.3 Cg_endo -99.95 157.63 0.53 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.233 3.288 . . . . 0.0 112.286 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' SER . 22.7 mt -68.97 142.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 123.656 0.782 . . . . 0.0 110.425 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.99 13.27 69.51 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.206 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -109.94 -170.19 1.61 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.486 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.479 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.4 t -149.95 148.88 29.61 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.917 -0.489 . . . . 0.0 112.281 -172.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.536 HG21 ' HE3' ' A' ' 22' ' ' LYS . 6.5 m -155.24 145.92 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 124.844 1.258 . . . . 0.0 110.05 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 68' ' ' ASN . 7.0 m-20 -95.9 107.75 20.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.682 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.6 mm? -92.06 120.87 33.08 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.092 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.77 122.44 38.55 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 mm? -116.51 151.57 35.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.891 0.744 . . . . 0.0 109.737 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.3 t -117.92 111.51 19.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 168.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.406 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 13.4 tpp85 -100.28 158.01 16.19 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.4 -15.52 6.38 Favored Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.42 -1.938 0 CA-C-N 113.889 -1.156 . . . . 0.0 108.165 176.692 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 15.0 pt-20 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.466 ' HB ' HG12 ' A' ' 31' ' ' VAL . 11.0 m -93.04 124.16 36.82 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 172.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -106.11 101.89 11.34 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.724 -0.61 . . . . 0.0 109.977 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.722 -172.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.584 0.706 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 6.8 tpt180 61.75 30.97 18.57 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.413 1.578 . . . . 0.0 109.97 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.78 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -120.29 108.18 38.35 Favored Pre-proline 0 C--N 1.263 -3.193 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -177.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.276 8.0 Cg_exo -55.22 -30.19 70.33 Favored 'Trans proline' 0 CA--C 1.486 -1.882 0 C-N-CA 121.527 1.485 . . . . 0.0 110.289 169.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -75.36 -23.01 57.1 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.601 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -73.99 -33.23 63.75 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.419 HD12 ' SG ' ' A' ' 98' ' ' CYS . 74.8 mt -62.09 133.28 55.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.785 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB3' ' HZ1' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -80.31 175.81 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.451 -1.704 . . . . 0.0 113.672 -171.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 87.94 -132.0 10.95 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.47 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.39 142.8 51.01 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 123.819 0.848 . . . . 0.0 109.331 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -107.22 116.15 31.42 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -133.67 151.94 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.66 -177.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 13.2 t-160 -123.31 105.23 9.68 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -124.18 136.9 54.51 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.158 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.643 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -78.12 129.84 35.66 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.331 0.653 . . . . 0.0 110.324 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -117.31 120.17 37.39 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 176.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -84.77 103.1 13.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.97 115.07 0.36 Allowed 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 176.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -88.52 -148.31 0.16 Allowed 'General case' 0 N--CA 1.41 -2.431 0 O-C-N 126.241 2.213 . . . . 0.0 108.056 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -62.69 83.79 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 89' ' ' ILE . 22.2 mmt180 67.35 49.61 1.03 Allowed 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 124.964 1.306 . . . . 0.0 112.492 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.32 -123.16 2.22 Favored Glycine 0 N--CA 1.401 -3.682 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.685 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.693 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 64.1 m-85 -125.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.261 -3.265 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.471 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.47 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.26 49.64 0.18 Allowed Glycine 0 C--N 1.292 -1.867 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.052 -172.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 27' ' ' PHE . 28.3 p90 -161.16 142.26 11.52 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 73.9 p -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 11.0 m -125.7 159.16 33.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.885 -170.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 ' CD ' ' A' ' 44' ' ' LYS . 4.2 m -120.53 131.59 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 C-N-CA 124.07 0.948 . . . . 0.0 110.519 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.58 -137.24 9.36 Favored Glycine 0 C--O 1.291 3.701 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.527 174.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.83 61.86 3.21 Favored Glycine 1 CA--C 1.436 -4.886 0 O-C-N 127.109 2.299 . . . . 0.0 110.953 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' THR . 13.5 t0 -99.19 -48.66 4.76 Favored 'General case' 0 C--N 1.248 -3.833 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 5.9 pt-20 -160.35 175.97 2.84 Favored Pre-proline 0 C--N 1.287 -2.14 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.661 -170.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 32.2 Cg_exo -72.42 64.89 3.68 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.154 3.236 . . . . 0.0 107.97 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 1.8 t70 -171.66 -41.49 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.498 -2.137 . . . . 0.0 108.637 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.87 120.09 28.36 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.204 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -88.61 166.1 14.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 128.242 2.617 . . . . 0.0 108.114 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -89.77 144.13 26.23 Favored 'General case' 0 C--O 1.166 -3.329 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.903 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 tt0 -130.59 156.28 45.12 Favored 'General case' 0 C--O 1.17 -3.089 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.05 128.9 44.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 CA-C-N 119.161 0.891 . . . . 0.0 109.823 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' HG12 ' A' ' 32' ' ' VAL . 4.5 ptmm? -107.82 -23.96 11.86 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.535 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 39.7 m -151.61 126.96 9.95 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.686 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.1 112.33 18.37 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 57.6 t -89.93 122.56 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.05 146.3 54.84 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.605 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 83.05 4.27 0.94 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 125.055 1.472 . . . . 0.0 109.771 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.646 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.98 158.77 36.93 Favored Glycine 0 C--O 1.205 -1.673 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.541 173.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.9 Cg_endo -72.17 -25.26 19.18 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 CA-C-N 121.549 2.674 . . . . 0.0 109.716 -171.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' SD ' ' A' ' 58' ' ' MET . . . -60.65 -48.18 82.93 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.88 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.89 82.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.163 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 83.9 mt -72.07 -39.51 68.96 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.975 -172.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.45 -21.07 45.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.42 40.97 98.35 Favored Glycine 0 CA--C 1.49 -1.503 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.753 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -141.95 27.54 1.8 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.185 0.993 . . . . 0.0 110.315 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.646 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.7 tmt? -160.24 137.49 9.4 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.634 ' HG2' ' NE ' ' A' ' 99' ' ' ARG . 7.9 pt-20 -154.95 160.07 40.86 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 119.309 0.959 . . . . 0.0 112.336 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -53.72 123.15 11.47 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.519 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.56 -1.09 21.93 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.954 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.526 ' CB ' ' HA ' ' A' ' 99' ' ' ARG . 3.1 p30 -100.94 161.92 13.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.432 172.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.701 HG11 ' SG ' ' A' ' 98' ' ' CYS 0.342 0.2 OUTLIER -118.31 125.3 74.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -179.093 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.77 114.17 6.71 Favored 'Isoleucine or valine' 0 C--O 1.303 3.914 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.605 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' C ' ' HG ' ' A' ' 66' ' ' SER . 88.2 t -93.59 -58.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 112.471 -2.15 . . . . 0.0 110.007 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 65' ' ' VAL . 67.5 m -162.22 173.96 13.54 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.99 -0.444 . . . . 0.0 110.871 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.0 p -143.68 156.64 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -30.18 111.28 0.07 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.8 1.64 . . . . 0.0 113.033 170.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.5 t70 75.39 -27.2 0.19 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.63 1.572 . . . . 0.0 113.677 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 m -112.44 116.24 29.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.979 0.895 . . . . 0.0 111.403 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.3 t -82.75 96.0 8.04 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.47 0.09 4.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.431 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.07 110.99 2.69 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.256 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.26 80.62 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.433 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.411 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -74.03 145.4 44.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 44.2 m -76.69 142.83 40.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.216 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.422 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.7 t60 -48.08 -49.22 32.4 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 118.993 0.815 . . . . 0.0 112.537 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.06 75.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 124.298 0.999 . . . . 0.0 110.517 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -77.95 -49.96 13.11 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.012 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -63.59 -43.92 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.444 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.8 p -63.78 -40.26 88.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.228 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -58.45 -44.21 89.14 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.825 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.28 -48.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 122.057 0.932 . . . . 0.0 109.977 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.52 -32.24 73.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.958 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.81 -16.64 38.13 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.877 0.37 . . . . 0.0 110.968 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.4 t -77.81 -23.45 49.07 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.531 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.6 mt -50.28 139.36 19.23 Favored Pre-proline 0 N--CA 1.434 -1.261 0 C-N-CA 124.382 1.073 . . . . 0.0 113.292 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -99.69 158.5 0.56 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 124.185 3.257 . . . . 0.0 111.422 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' SER . 23.6 mt -68.32 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.245 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.72 12.61 60.56 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.561 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.02 -175.27 2.9 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.281 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.643 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 13.2 t -148.22 139.2 23.18 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.886 -0.509 . . . . 0.0 112.338 -172.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.9 m -151.64 158.98 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.063 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.565 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 8.2 m-20 -102.87 108.01 19.06 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 tp -100.79 120.96 40.88 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 12.6 pt-20 -103.16 124.4 48.51 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD11 ' NH1' ' A' ' 99' ' ' ARG . 4.2 pp -141.64 165.31 27.83 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.407 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.701 ' SG ' HG11 ' A' ' 63' ' ' VAL . 3.0 p -118.73 113.42 21.12 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.458 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -90.38 137.32 32.45 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.484 -173.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.94 23.79 5.44 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.599 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.6 t80 . . . . . 0 C--N 1.303 -1.421 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.584 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 44' ' ' LYS . 9.0 tp10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.448 0.642 . . . . 0.0 111.815 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 4.8 m -115.01 102.78 10.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.28 95.22 9.55 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.427 -174.153 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.32 12.6 t . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.475 ' O ' HD21 ' A' ' 73' ' ' LEU . 26.7 ptt180 156.39 -30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.29 1.836 . . . . 0.0 106.276 177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.739 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 39.4 t-20 -40.6 107.68 0.49 Allowed Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.414 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.261 9.6 Cg_exo -61.67 -32.95 87.16 Favored 'Trans proline' 0 CA--C 1.465 -2.932 0 C-N-CA 121.918 1.745 . . . . 0.0 110.374 -178.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -80.04 -18.92 48.88 Favored 'General case' 1 N--CA 1.338 -6.046 0 CA-C-N 111.972 -2.376 . . . . 0.0 111.726 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.739 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.2 pt-20 -73.24 -36.22 66.4 Favored 'General case' 0 C--N 1.379 1.859 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 85.3 mt -54.94 129.37 37.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.785 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.9 -162.58 0.55 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.26 -171.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 65.92 -102.0 0.66 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.003 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.471 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 149.06 32.93 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 123.259 0.624 . . . . 0.0 109.861 178.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.64 110.98 21.46 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.18 153.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.708 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 26.8 p-80 -132.05 107.59 8.76 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.928 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -122.51 132.18 54.2 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -76.29 136.26 39.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.43 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.562 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.0 130.53 54.78 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -82.89 124.23 30.14 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.511 ' HZ1' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -53.28 109.46 0.44 Allowed 'General case' 0 CA--C 1.466 -2.257 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 173.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.7 t -85.14 -146.18 0.1 Allowed 'General case' 0 N--CA 1.413 -2.306 0 O-C-N 126.624 2.453 . . . . 0.0 107.82 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 m -64.12 84.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.429 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.0 mpt_? 59.86 43.99 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 125.698 1.599 . . . . 0.0 111.353 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.24 -127.0 1.8 Allowed Glycine 1 N--CA 1.394 -4.143 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.935 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.691 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m-85 -133.68 -82.57 0.46 Allowed 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 114.349 -0.926 . . . . 0.0 111.356 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.524 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.33 54.76 0.18 Allowed Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -169.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HA ' HG22 ' A' ' 47' ' ' VAL . 18.8 p90 -161.32 148.77 15.04 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -113.08 136.66 52.46 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.909 0.861 . . . . 0.0 109.154 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' B' ' 159' ' ' THR . 6.2 p -128.63 150.54 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.523 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.472 -167.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 12.3 m -114.33 154.3 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 124.829 1.252 . . . . 0.0 113.106 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.23 -123.91 6.8 Favored Glycine 0 C--O 1.291 3.706 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.94 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.64 47.79 3.06 Favored Glycine 0 CA--C 1.47 -2.781 0 O-C-N 126.455 1.914 . . . . 0.0 112.081 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -95.4 -29.31 14.5 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . 13.2 mt-10 -140.95 172.64 5.86 Favored Pre-proline 0 N--CA 1.41 -2.442 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.062 -169.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_exo -73.66 -8.4 21.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.532 2.822 . . . . 0.0 108.149 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.03 -9.13 15.69 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.047 -1.888 . . . . 0.0 110.183 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.0 tt0 -131.24 119.41 21.77 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.639 -0.663 . . . . 0.0 110.9 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 8.4 m-85 -86.57 166.18 15.62 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.428 2.291 . . . . 0.0 110.232 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.8 mp -93.77 146.38 23.91 Favored 'General case' 0 C--O 1.181 -2.535 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.468 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 28.7 tt0 -138.48 144.92 40.26 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-N 118.803 0.729 . . . . 0.0 109.949 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 29' ' ' PHE . 27.0 mm -80.28 120.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.743 0 O-C-N 121.498 -0.751 . . . . 0.0 110.734 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 44.1 pttt -100.75 -22.0 15.01 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 123.473 0.483 . . . . 0.0 111.544 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.7 m -158.46 127.48 5.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.44 121.07 27.05 Favored 'General case' 0 N--CA 1.402 -2.872 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.524 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.7 t -85.0 129.3 37.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.63 138.59 58.53 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.434 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 t70 81.65 8.04 1.02 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.777 1.298 . . . . 0.0 110.766 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.679 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.1 161.12 27.66 Favored Glycine 0 C--O 1.21 -1.395 0 CA-C-O 117.894 -1.504 . . . . 0.0 109.798 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.3 Cg_endo -72.13 -24.74 19.9 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 CA-C-N 121.501 2.651 . . . . 0.0 110.271 -169.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -49.94 75.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.188 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.44 80.76 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.961 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 74.3 mt -71.77 -40.31 69.36 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-N 112.745 -2.025 . . . . 0.0 115.46 -172.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.07 -21.58 56.59 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.696 1.236 . . . . 0.0 107.785 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.76 30.98 73.99 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 112.894 -1.957 . . . . 0.0 114.022 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.07 -1.27 3.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.742 0.782 . . . . 0.0 111.058 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.451 ' HG2' HD13 ' A' ' 97' ' ' LEU . 1.5 tmt? -132.5 125.41 30.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.19 167.53 21.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.702 0.763 . . . . 0.0 112.122 -167.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 m -56.35 119.93 6.8 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.778 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.43 5.85 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 26.7 m-20 -72.18 135.36 46.12 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.1 OUTLIER -104.77 120.2 54.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 CA-C-O 121.519 0.676 . . . . 0.0 110.837 173.254 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.89 111.75 4.09 Favored 'Isoleucine or valine' 0 C--O 1.299 3.679 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.595 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 91.8 t -93.61 -58.25 3.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.53 0 O-C-N 126.315 2.259 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -151.43 171.06 18.11 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.833 -0.542 . . . . 0.0 110.102 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 7.7 p -146.87 114.4 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 93' ' ' VAL 0.4 0.2 OUTLIER 31.23 66.88 0.14 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.951 1.3 . . . . 0.0 114.146 -171.31 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.44 -37.43 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.283 1.433 . . . . 0.0 114.102 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.4 m -57.81 121.99 11.8 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.446 0.641 . . . . 0.0 110.754 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.0 t -80.88 78.73 7.64 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.32 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.503 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 56.0 t -80.83 0.23 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 123.325 1.536 . . . . 0.0 108.851 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 6' ' ' ARG . 17.1 tp -67.68 110.74 3.86 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 65.62 43.02 95.15 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.486 -174.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.503 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -87.58 141.89 28.27 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.6 m -68.77 141.73 55.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.464 ' CE1' ' HG1' ' B' ' 159' ' ' THR . 6.4 t60 -54.17 -38.35 65.47 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.428 1.091 . . . . 0.0 112.079 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.7 90.23 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.109 0.881 . . . . 0.0 110.067 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.47 -48.84 18.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.811 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.09 -43.0 97.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.883 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.46 -36.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.263 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -42.16 97.45 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.378 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.51 -50.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 122.394 1.092 . . . . 0.0 108.991 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.63 -33.63 76.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.411 -1.722 . . . . 0.0 113.706 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -85.71 -22.66 27.72 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 m -83.28 -10.94 58.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.418 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.59 HD13 ' CE2' ' A' ' 27' ' ' PHE . 1.5 mt -46.74 136.58 7.69 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.357 1.063 . . . . 0.0 113.823 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.3 Cg_endo -97.28 150.65 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.798 2.999 . . . . 0.0 112.08 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 25' ' ' ARG . 17.8 mt -68.05 142.02 16.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.519 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.31 11.48 64.49 Favored Glycine 0 CA--C 1.485 -1.831 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.162 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -105.37 -170.1 1.7 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.77 -171.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 24.3 t -149.86 146.07 26.91 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 17.2 m -150.6 153.9 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 C-N-CA 123.483 0.713 . . . . 0.0 109.725 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 19.7 t70 -100.81 112.68 25.15 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.0 mm? -90.8 113.76 25.98 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.501 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 38.3 tt0 -94.97 109.21 21.26 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.451 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.48 159.34 42.43 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 0.0 112.359 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 t -110.27 122.98 48.95 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HB3' ' CG ' ' A' ' 14' ' ' LYS . 17.3 tpp85 -104.21 147.22 27.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.51 -13.92 4.24 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.064 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 120.509 0.195 . . . . 0.0 110.852 177.13 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 C--O 1.237 0.422 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.54 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 5.3 m -89.68 125.87 35.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -109.54 115.34 29.74 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.426 -1.651 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.402 -173.401 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.458 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 15.1 t . . . . . 0 N--CA 1.425 -1.682 0 CA-C-O 122.307 1.051 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 45.55 42.75 8.39 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 123.991 1.853 . . . . 0.0 112.606 178.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.794 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.8 OUTLIER -115.2 114.02 43.41 Favored Pre-proline 1 C--N 1.242 -4.085 0 CA-C-N 113.083 -1.871 . . . . 0.0 114.186 178.367 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.9 Cg_exo -56.72 -30.52 84.53 Favored 'Trans proline' 0 CA--C 1.481 -2.154 0 C-N-CA 121.314 1.343 . . . . 0.0 109.693 168.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -79.54 -13.22 59.69 Favored 'General case' 1 N--CA 1.362 -4.857 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.485 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.794 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -81.38 -32.11 32.99 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 8' ' ' PRO . 79.2 mt -61.81 143.32 56.49 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.896 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.72 -179.33 7.09 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.426 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.2 -128.36 9.38 Favored Glycine 0 N--CA 1.432 -1.603 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.833 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.489 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 2.4 ptmm? -127.53 151.62 48.65 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 123.882 0.873 . . . . 0.0 110.847 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.84 119.32 37.6 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.02 152.82 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 121.647 0.737 . . . . 0.0 111.923 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.5 p-80 -135.35 105.08 6.11 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.476 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -115.83 140.19 49.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.277 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.551 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -74.15 131.89 41.71 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.4 tp -117.12 121.67 41.93 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.89 114.53 21.25 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.48 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.648 ' N ' ' HZ1' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -48.42 111.49 0.46 Allowed 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 125.108 1.363 . . . . 0.0 112.802 177.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 22.8 t -88.17 -144.28 0.14 Allowed 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 127.159 2.787 . . . . 0.0 107.327 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 p -62.56 84.27 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.3 mpt_? 59.88 29.85 19.4 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 126.414 1.886 . . . . 0.0 112.215 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.42 -123.05 1.02 Allowed Glycine 0 N--CA 1.412 -2.94 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.173 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.701 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 76.3 m-85 -130.88 -90.45 0.45 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.055 -1.073 . . . . 0.0 111.324 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.591 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 128.07 54.99 0.12 Allowed Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.002 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.434 ' HA ' HG21 ' A' ' 47' ' ' VAL . 38.4 p90 -161.52 142.95 11.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HA ' ' B' ' 160' ' ' GLN . 25.5 p -105.68 136.04 46.01 Favored 'General case' 0 C--N 1.284 -2.283 0 O-C-N 121.336 -0.852 . . . . 0.0 109.497 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 14.4 m -125.78 160.01 33.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.724 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.408 ' CG1' ' HD3' ' A' ' 44' ' ' LYS . 25.2 m -124.04 132.49 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 174.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.515 ' HA2' ' OE2' ' A' ' 39' ' ' GLU . . . 129.77 -139.73 11.18 Favored Glycine 0 N--CA 1.41 -3.091 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.068 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.506 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.41 48.52 8.55 Favored Glycine 1 CA--C 1.443 -4.413 0 C-N-CA 125.754 1.645 . . . . 0.0 111.204 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.99 -32.64 17.52 Favored 'General case' 0 C--N 1.252 -3.669 0 CA-C-N 114.566 -0.817 . . . . 0.0 109.712 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -158.67 167.9 13.49 Favored Pre-proline 0 N--CA 1.415 -2.21 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.464 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -77.46 51.15 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.409 3.406 . . . . 0.0 109.916 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -162.79 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.194 -2.275 . . . . 0.0 108.257 -171.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.515 ' OE2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 tt0 -111.78 120.15 41.0 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.48 165.67 16.96 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 128.29 2.636 . . . . 0.0 109.282 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 3.9 mp -95.06 146.14 24.48 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.003 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 1.2 tm0? -131.79 151.58 51.57 Favored 'General case' 0 C--O 1.169 -3.147 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 62' ' ' ASP . 8.2 mm -90.54 122.34 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 118.827 0.74 . . . . 0.0 109.237 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.408 ' HD3' ' CG1' ' A' ' 32' ' ' VAL . 53.6 pttt -106.02 -18.18 14.11 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.765 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.9 m -156.34 127.74 7.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.023 0.439 . . . . 0.0 111.326 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.01 121.28 21.74 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 97.2 t -92.98 123.44 45.07 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.88 148.93 48.4 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.708 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.3 t70 80.6 4.71 1.67 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.982 1.426 . . . . 0.0 109.743 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.662 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.5 164.63 31.91 Favored Glycine 0 C--O 1.209 -1.468 0 CA-C-O 117.893 -1.504 . . . . 0.0 110.544 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 10.1 Cg_endo -72.5 -25.72 17.61 Favored 'Trans proline' 0 C--O 1.191 -1.868 0 CA-C-N 121.639 2.719 . . . . 0.0 110.482 -171.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.24 87.53 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.676 0.751 . . . . 0.0 109.408 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.39 68.06 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 122.536 1.16 . . . . 0.0 109.252 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.4 mt -72.13 -50.0 31.43 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 112.619 -2.082 . . . . 0.0 115.522 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.01 -24.52 55.29 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.77 45.62 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.086 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 69.85 -61.37 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.366 1.466 . . . . 0.0 112.637 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 97' ' ' LEU . 1.3 tmt? -77.7 136.24 38.16 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -146.02 167.05 24.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.151 0.5 . . . . 0.0 111.107 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.8 m -58.24 128.04 35.11 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.6 -13.28 10.89 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.521 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 43' ' ' ILE . 24.8 m-20 -75.65 161.49 29.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 10.4 m -123.31 133.95 67.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 40.1 mm -81.0 109.22 15.14 Favored 'Isoleucine or valine' 0 C--O 1.302 3.866 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.84 -56.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 O-C-N 126.225 2.203 . . . . 0.0 109.717 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -156.44 173.23 17.21 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.518 -0.739 . . . . 0.0 110.054 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.68 120.84 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.252 4.8 p-10 16.58 84.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.542 1.937 . . . . 0.0 115.216 -172.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 74.73 -37.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.403 1.481 . . . . 0.0 113.09 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.6 m -66.46 125.25 25.11 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-O 121.922 0.867 . . . . 0.0 110.195 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 47.3 t -89.14 91.41 8.78 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.542 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.46 3.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.76 1.267 . . . . 0.0 108.767 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.38 111.08 11.45 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 38.36 60.82 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.846 -173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 145.92 29.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.4 m -75.43 142.31 43.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 117.468 -1.253 . . . . 0.0 107.691 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -48.58 -48.04 39.19 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 119.211 0.914 . . . . 0.0 112.815 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -36.13 76.23 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 124.367 1.042 . . . . 0.0 110.536 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -75.0 -51.56 13.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.666 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -44.08 97.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.47 -42.13 90.11 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.535 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.26 -39.13 92.23 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -71.5 -46.59 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 122.187 0.994 . . . . 0.0 108.402 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.0 -28.89 69.22 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.745 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.09 -23.77 26.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.6 t -92.55 -2.64 56.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.38 0.61 . . . . 0.0 110.163 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.58 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -54.49 138.26 60.25 Favored Pre-proline 0 N--CA 1.424 -1.754 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.787 173.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -93.39 149.27 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.239 2.626 . . . . 0.0 111.794 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 25' ' ' ARG . 26.3 mt -67.86 141.81 17.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.46 12.37 63.01 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.637 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -106.89 -169.06 1.49 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.804 -171.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.551 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 27.9 t -148.14 148.1 30.21 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.841 -0.537 . . . . 0.0 112.218 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 18.3 m -146.58 161.15 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.014 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.553 173.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -107.41 107.75 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.6 tp -92.01 114.09 26.53 Favored 'General case' 0 C--N 1.253 -3.591 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.976 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -90.76 107.63 19.31 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -141.47 161.72 37.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.4 ' HB2' HG21 ' A' ' 63' ' ' VAL . 74.4 m -124.27 123.49 40.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.966 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 18.9 tpp85 -93.35 147.17 23.16 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.54 5.64 1.71 Allowed Glycine 0 C--N 1.296 -1.661 0 C-N-CA 119.101 -1.523 . . . . 0.0 112.586 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 116.714 0.257 . . . . 0.0 110.469 176.412 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 2.9 m -100.06 113.89 26.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' THR . 55.0 tt0 -88.66 104.8 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 29' ' ' PHE . 10.1 m . . . . . 0 N--CA 1.418 -2.062 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.096 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.335 8.9 t . . . . . 0 N--CA 1.418 -2.038 0 CA-C-O 120.553 0.216 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.571 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.2 ptm180 164.03 -30.12 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.699 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.6 t-20 -46.07 108.66 0.85 Allowed Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.846 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.1 -27.35 73.38 Favored 'Trans proline' 0 CA--C 1.469 -2.755 0 C-N-CA 121.565 1.51 . . . . 0.0 110.882 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -81.83 -19.71 40.52 Favored 'General case' 1 N--CA 1.354 -5.235 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.031 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.9 pt-20 -75.26 -34.41 61.37 Favored 'General case' 0 C--N 1.372 1.571 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.5 132.86 49.55 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.921 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -80.06 171.16 15.46 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.772 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 97.42 -123.49 7.82 Favored Glycine 0 N--CA 1.417 -2.569 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.271 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -135.72 141.38 44.88 Favored 'General case' 0 C--N 1.282 -2.349 0 C-N-CA 123.479 0.712 . . . . 0.0 109.55 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -108.83 111.64 23.48 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.44 152.13 23.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.564 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.1 t60 -131.84 99.71 4.85 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -114.22 145.57 41.54 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.759 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -84.88 134.68 34.27 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -117.23 119.98 36.84 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -81.49 110.95 17.36 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HG3' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.19 104.4 0.04 OUTLIER 'General case' 0 CA--C 1.465 -2.3 0 O-C-N 123.85 0.719 . . . . 0.0 109.398 170.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 65.1 m -92.34 -117.32 0.08 Allowed 'General case' 0 N--CA 1.388 -3.534 0 O-C-N 125.125 1.515 . . . . 0.0 109.953 -176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.6 m -78.81 79.53 5.21 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 119.907 1.23 . . . . 0.0 113.079 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' A' ' 87' ' ' ILE . 16.8 mmt180 62.84 51.19 3.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.143 0.973 . . . . 0.0 111.322 173.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.85 -124.78 2.93 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.697 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 74.5 m-85 -127.79 -81.33 0.59 Allowed 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.516 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.5 51.41 0.1 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.456 -172.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.529 ' CD2' HD11 ' A' ' 43' ' ' ILE . 27.4 p90 -162.05 146.81 12.71 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.96 0.904 . . . . 0.0 108.715 174.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 HG23 ' HA ' ' B' ' 160' ' ' GLN . 68.0 p -109.92 136.14 49.68 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.891 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 15.4 m -117.45 168.45 9.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.193 -168.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG12 ' HG2' ' A' ' 44' ' ' LYS . 5.7 m -127.38 133.06 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 125.482 1.513 . . . . 0.0 109.739 173.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.87 -135.6 12.3 Favored Glycine 0 C--N 1.273 -2.951 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.811 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.452 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 38.66 50.8 2.48 Favored Glycine 0 CA--C 1.461 -3.299 0 O-C-N 126.214 1.773 . . . . 0.0 111.142 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -95.75 -36.05 11.31 Favored 'General case' 0 C--N 1.251 -3.69 0 CA-C-N 113.324 -1.438 . . . . 0.0 110.361 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -158.82 173.65 4.79 Favored Pre-proline 0 N--CA 1.411 -2.38 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.756 -172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 52.0 Cg_exo -66.42 -13.89 41.81 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 123.012 2.475 . . . . 0.0 109.538 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.77 -14.55 24.6 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.234 -1.803 . . . . 0.0 111.826 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -139.25 120.28 14.56 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 111.301 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 14.5 m-85 -79.97 166.04 22.0 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 127.412 2.285 . . . . 0.0 111.569 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 4.6 mp -88.41 146.04 25.46 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.638 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 tt0 -142.38 154.71 44.86 Favored 'General case' 0 C--O 1.181 -2.539 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.529 HD11 ' CD2' ' A' ' 29' ' ' PHE . 18.9 mm -93.22 127.01 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 118.914 0.779 . . . . 0.0 109.065 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -105.49 -21.21 13.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.1 m -157.24 128.43 6.79 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.76 123.07 27.36 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 123.714 0.806 . . . . 0.0 108.83 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.516 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.3 t -94.96 111.82 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.9 145.43 52.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.902 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.5 t70 86.01 3.05 0.56 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 125.824 1.953 . . . . 0.0 109.098 -171.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.653 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.43 159.97 34.09 Favored Glycine 0 C--O 1.204 -1.773 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.072 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 34.2 Cg_endo -72.61 -25.85 17.11 Favored 'Trans proline' 0 N--CA 1.435 -1.929 0 CA-C-N 121.148 2.474 . . . . 0.0 110.515 -171.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.28 -46.04 91.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.737 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.91 85.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.501 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.1 mt -72.0 -40.09 68.77 Favored 'General case' 0 N--CA 1.405 -2.699 0 CA-C-N 113.384 -1.734 . . . . 0.0 114.832 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -75.05 -24.7 58.3 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.24 15.38 65.45 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 113.296 -1.775 . . . . 0.0 115.486 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.05 22.37 7.96 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.8 1.286 . . . . 0.0 109.805 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.8 ttt -140.17 128.69 22.83 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.38 149.32 30.67 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -167.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.2 m -44.75 117.52 1.33 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.643 1.177 . . . . 0.0 110.819 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.11 -7.56 8.66 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.532 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.63 150.33 39.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -108.36 129.7 62.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.5 mm -84.93 115.93 27.61 Favored 'Isoleucine or valine' 0 C--O 1.302 3.83 0 CA-C-O 121.701 0.762 . . . . 0.0 109.26 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.24 -58.21 3.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.81 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.727 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -155.59 166.74 32.61 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.899 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 p -152.9 115.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' CB ' HG11 ' A' ' 93' ' ' VAL . 16.3 t-20 51.33 52.41 14.88 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.945 1.298 . . . . 0.0 111.78 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 69.33 -6.76 0.91 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.889 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.4 m -81.06 126.48 31.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.2 t -82.45 73.82 9.46 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.955 0.883 . . . . 0.0 110.595 -172.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 80.0 t -79.55 -4.11 6.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 122.66 1.219 . . . . 0.0 109.202 177.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 6' ' ' ARG . 13.6 tp -66.93 112.03 4.1 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 70.92 37.01 65.12 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.418 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -82.61 147.17 28.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 87.7 m -76.24 143.28 41.09 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 117.599 -1.191 . . . . 0.0 109.171 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -46.77 -47.66 20.76 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.336 0.971 . . . . 0.0 113.164 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 82' ' ' LYS . . . -63.53 -32.25 73.65 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.474 0.654 . . . . 0.0 110.821 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 32.0 mm-40 -77.82 -49.91 13.36 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.15 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.46 HG23 HD21 ' A' ' 41' ' ' LEU . 7.4 p -61.35 -44.75 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.148 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 11.6 p -60.85 -45.13 98.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.416 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -60.18 -38.75 84.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.3 mt -73.12 -48.28 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-O 122.502 1.144 . . . . 0.0 108.909 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.108 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.8 pt20 -86.71 -24.46 25.18 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.769 -0.582 . . . . 0.0 111.798 174.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -75.46 -26.22 58.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.541 HD13 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -59.61 152.23 57.68 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.4 Cg_endo -102.25 159.51 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.063 3.842 . . . . 0.0 111.942 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 23' ' ' SER . 45.4 mt -67.78 131.01 33.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.97 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.45 10.88 40.19 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 119.773 -0.46 . . . . 0.0 113.981 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 22' ' ' LYS . . . -99.35 -176.43 3.29 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.578 1.189 . . . . 0.0 111.902 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.561 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.2 t -140.99 145.39 35.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.704 -0.623 . . . . 0.0 111.75 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.43 157.64 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 C-N-CA 123.964 0.905 . . . . 0.0 111.486 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 4.2 m-20 -104.56 107.11 17.88 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.413 HD22 HD21 ' A' ' 20' ' ' LEU . 15.4 tp -99.53 121.51 41.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-O 121.123 0.487 . . . . 0.0 111.608 -172.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HG2' ' HD1' ' A' ' 17' ' ' HIS . 47.1 mt-10 -98.02 114.47 26.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.52 148.12 40.57 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.113 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.0 t -117.64 120.1 36.99 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.3 tpp85 -95.18 139.87 30.89 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.84 -28.35 1.03 Allowed Glycine 0 C--N 1.3 -1.444 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.306 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.306 -1.292 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.457 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 41.4 tt0 . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 120.826 0.346 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 6.7 m -123.39 133.66 54.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.418 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER -100.02 116.58 32.39 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.419 -1.975 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.178 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.666 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 13.5 t . . . . . 0 N--CA 1.426 -1.644 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 5' ' ' THR . 5.7 ptm180 60.13 12.5 3.29 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 127.264 2.225 . . . . 0.0 113.413 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.786 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 12.0 m-80 -97.39 115.25 65.71 Favored Pre-proline 0 C--N 1.251 -3.686 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.289 13.2 Cg_exo -61.06 -30.17 88.93 Favored 'Trans proline' 0 CA--C 1.483 -2.069 0 N-CA-C 107.906 -1.613 . . . . 0.0 107.906 170.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 t -68.66 -25.6 64.89 Favored 'General case' 1 N--CA 1.363 -4.815 0 CA-C-N 110.993 -2.822 . . . . 0.0 111.003 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.786 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.3 pt-20 -80.3 -33.79 37.32 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.72 135.29 57.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.655 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 100' ' ' GLY . 45.8 pttt -78.66 166.01 23.0 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.337 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 98.82 -122.98 7.74 Favored Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.514 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.0 147.07 46.04 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 124.712 1.205 . . . . 0.0 110.014 -177.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.5 123.4 49.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.6 152.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 43.5 p-80 -126.11 100.49 6.35 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 122.384 1.088 . . . . 0.0 110.265 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 t -102.77 130.66 49.81 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.539 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -83.16 130.32 35.09 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.9 mp -117.26 123.46 46.64 Favored 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -84.72 125.19 32.31 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -56.92 103.77 0.13 Allowed 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 172.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 89' ' ' ILE . 22.9 t -80.03 -78.27 0.17 Allowed 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 125.346 1.654 . . . . 0.0 109.971 -172.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -116.23 78.64 1.21 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.694 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.59 ' N ' HG12 ' A' ' 89' ' ' ILE . 14.0 ttt180 63.78 24.74 13.9 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.22 -140.76 5.6 Favored Glycine 0 N--CA 1.409 -3.106 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.456 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.637 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 89.1 m-85 -125.67 -85.85 0.62 Allowed 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 114.481 -0.86 . . . . 0.0 112.083 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.39 52.89 0.19 Allowed Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.109 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HA ' HG23 ' A' ' 47' ' ' VAL . 29.8 p90 -160.9 150.5 17.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.0 p -112.03 136.42 51.42 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.0 0.905 . . . . 0.0 109.242 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 4.5 p -125.27 148.4 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.608 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.702 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 10.8 m -114.98 164.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 124.492 1.117 . . . . 0.0 113.283 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.96 -124.62 6.55 Favored Glycine 0 C--O 1.284 3.249 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.132 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.527 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.34 53.67 5.74 Favored Glycine 1 CA--C 1.443 -4.425 0 O-C-N 127.235 2.374 . . . . 0.0 112.173 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 51.3 t0 -86.14 -47.89 9.08 Favored 'General case' 1 C--N 1.244 -4.012 0 CA-C-N 113.276 -1.462 . . . . 0.0 109.241 -176.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.8 pt-20 -158.93 174.51 3.98 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.032 -164.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 24.8 Cg_exo -75.46 59.61 5.53 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 124.662 3.575 . . . . 0.0 108.021 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -178.58 -23.7 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.348 -2.205 . . . . 0.0 109.324 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 9.7 tp10 -131.23 120.54 23.4 Favored 'General case' 0 C--O 1.257 1.488 0 C-N-CA 122.997 0.519 . . . . 0.0 110.022 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.51 166.18 14.36 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 127.258 2.223 . . . . 0.0 110.261 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -96.85 145.25 26.03 Favored 'General case' 0 C--O 1.175 -2.844 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.648 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 14.9 tt0 -135.03 147.7 49.72 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 118.866 0.757 . . . . 0.0 109.928 -177.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 29' ' ' PHE . 34.7 mm -79.5 114.9 20.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.531 -0.731 . . . . 0.0 110.188 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -98.46 -22.05 16.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.434 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 37.6 m -155.72 127.14 7.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.7 tp -86.01 112.11 20.91 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.437 HG23 ' HA ' ' A' ' 29' ' ' PHE . 29.7 t -87.47 104.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.62 145.85 27.16 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.098 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 86.16 3.87 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.438 1.711 . . . . 0.0 109.74 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.705 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.44 163.08 36.95 Favored Glycine 0 C--O 1.212 -1.264 0 CA-C-O 117.773 -1.571 . . . . 0.0 110.21 171.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.637 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 22.1 Cg_endo -72.48 -25.48 17.92 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 CA-C-N 121.732 2.766 . . . . 0.0 110.458 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.39 -43.69 98.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.428 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.49 75.37 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.449 1.119 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 69.7 mt -72.18 -40.88 67.61 Favored 'General case' 0 N--CA 1.396 -3.169 0 CA-C-N 112.401 -2.181 . . . . 0.0 114.704 -171.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.24 -24.99 46.69 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.42 27.03 71.16 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-N 113.543 -1.662 . . . . 0.0 115.416 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -110.65 -0.71 17.08 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.789 0.804 . . . . 0.0 110.437 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.4 ' HE3' HD12 ' A' ' 97' ' ' LEU . 42.8 ttm -129.28 126.97 40.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -142.69 144.93 32.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 m -45.14 114.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.234 1.414 . . . . 0.0 111.284 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.9 -36.95 1.96 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.61 145.21 50.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.8 0.81 . . . . 0.0 111.981 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 41' ' ' LEU 0.258 0.2 OUTLIER -110.33 126.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.27 -175.571 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.43 116.47 15.79 Favored 'Isoleucine or valine' 0 C--O 1.294 3.441 0 C-N-CA 125.673 1.589 . . . . 0.0 110.649 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 37.5 t -103.22 -58.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.99 -177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 20.4 m -136.87 157.87 45.76 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.055 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.61 104.1 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 0.0 112.519 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.06 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 125.766 1.627 . . . . 0.0 112.079 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -131.98 -12.09 3.3 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.0 0.429 . . . . 0.0 110.838 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -89.68 134.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.759 0.79 . . . . 0.0 110.382 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 45.1 t -80.88 80.03 7.43 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.604 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.23 -5.81 8.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.245 1.022 . . . . 0.0 108.504 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.527 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . 44.6 tp -56.35 111.11 0.89 Allowed 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.789 -1.551 . . . . 0.0 107.174 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.96 91.68 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.886 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.29 145.13 37.63 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 39.8 m -73.53 141.82 46.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.434 ' O ' HG11 ' A' ' 81' ' ' VAL . 56.7 t-80 -51.28 -40.47 59.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.72 -176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.18 85.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.092 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.3 -48.6 22.44 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.769 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.06 -43.14 97.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.651 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 77' ' ' HIS . 13.8 p -63.18 -37.85 80.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.436 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.83 90.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.22 -50.8 33.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-O 122.161 0.982 . . . . 0.0 109.383 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 9.0 m-85 -64.68 -35.13 80.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.799 -175.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -85.49 -21.42 28.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.67 0.272 . . . . 0.0 110.933 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 m -90.82 -2.52 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.967 -0.458 . . . . 0.0 111.409 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.622 HD11 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -47.65 142.43 6.59 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 89.0 Cg_endo -98.84 156.66 0.68 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 124.035 3.157 . . . . 0.0 112.575 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.59 HG12 ' N ' ' A' ' 25' ' ' ARG . 64.3 mt -69.01 142.39 16.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 124.414 1.086 . . . . 0.0 110.628 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.9 74.41 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.138 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.454 ' C ' ' HD2' ' A' ' 22' ' ' LYS . . . -101.05 -172.94 2.26 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -149.9 138.37 20.67 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -167.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.6 m -149.63 149.41 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 C-N-CA 122.846 0.458 . . . . 0.0 110.734 172.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.79 109.44 21.39 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.51 1.131 . . . . 0.0 108.327 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.7 mm? -90.44 113.42 25.35 Favored 'General case' 0 C--N 1.275 -2.667 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.54 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 40.3 mt-10 -88.39 106.36 18.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 174.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.4 HD12 ' HE3' ' A' ' 58' ' ' MET . 1.6 pt? -132.61 158.61 41.8 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.893 0.378 . . . . 0.0 110.442 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.6 t -116.19 125.16 51.89 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.45 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 16.7 tpp85 -98.22 142.62 29.67 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . 149.33 -9.4 0.93 Allowed Glycine 0 C--N 1.303 -1.3 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.105 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 C--N 1.31 -1.152 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 11.5 pt-20 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' THR . . . . . 0.414 ' HB ' HG11 ' A' ' 31' ' ' VAL . 29.4 m -113.3 131.52 55.9 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.42 ' HA ' HG23 ' A' ' 30' ' ' THR . 33.4 tt0 -102.84 120.9 41.41 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 22.7 m . . . . . 0 N--CA 1.432 -1.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.383 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.042 0.448 . . . . 0.0 109.883 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.638 ' O ' HD22 ' A' ' 73' ' ' LEU . 13.3 ptm180 49.69 27.81 2.37 Favored 'General case' 0 N--CA 1.515 2.82 0 C-N-CA 126.499 1.919 . . . . 0.0 113.026 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.738 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.8 m-80 -96.33 115.28 65.53 Favored Pre-proline 1 C--N 1.22 -5.044 0 CA-C-N 112.894 -1.957 . . . . 0.0 112.283 174.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.315 26.7 Cg_exo -62.48 -34.66 75.19 Favored 'Trans proline' 0 CA--C 1.475 -2.465 0 CA-C-O 124.201 1.667 . . . . 0.0 108.301 173.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -65.16 -28.26 69.29 Favored 'General case' 1 N--CA 1.344 -5.738 0 CA-C-N 109.855 -3.339 . . . . 0.0 111.69 -175.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.3 pt-20 -80.59 -33.11 36.25 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.0 128.75 37.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.696 1.236 . . . . 0.0 110.361 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -83.08 -172.24 4.02 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.33 -169.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 77.32 -135.17 15.95 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.963 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -114.45 139.2 49.72 Favored 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 124.072 0.949 . . . . 0.0 109.309 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.34 114.86 28.89 Favored 'General case' 0 C--N 1.26 -3.283 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -131.65 152.3 36.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.188 -175.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . 0.501 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 18.7 t60 -126.73 102.81 7.22 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -130.96 146.83 52.49 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.711 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -81.08 133.7 35.52 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 122.713 0.405 . . . . 0.0 111.695 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.54 125.7 48.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -85.36 119.65 25.96 Favored 'General case' 0 N--CA 1.395 -3.176 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.135 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.546 ' HG3' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -52.32 101.29 0.04 OUTLIER 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 89' ' ' ILE . 11.1 t -83.08 -94.71 0.06 Allowed 'General case' 0 N--CA 1.411 -2.391 0 O-C-N 124.816 1.323 . . . . 0.0 109.628 -176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -96.03 73.93 3.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.562 ' N ' HG12 ' A' ' 89' ' ' ILE . 32.0 ttt180 59.98 40.75 18.49 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.425 1.49 . . . . 0.0 111.909 176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 163.68 -138.05 5.1 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.726 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 83.8 m-85 -121.91 -84.09 0.66 Allowed 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.786 -0.207 . . . . 0.0 111.321 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.52 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.56 53.43 0.13 Allowed Glycine 0 C--N 1.291 -1.949 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.998 -171.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.429 ' HA ' HG21 ' A' ' 47' ' ' VAL . 30.7 p90 -161.23 143.24 12.03 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 20.0 p -106.06 135.69 47.07 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.793 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 0.9 OUTLIER -114.08 163.22 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.559 -168.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 44' ' ' LYS . 2.7 m -121.46 133.31 68.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.173 0 C-N-CA 124.293 1.037 . . . . 0.0 109.689 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.18 -130.96 9.6 Favored Glycine 0 C--O 1.279 2.946 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.123 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.77 62.26 1.01 Allowed Glycine 0 CA--C 1.453 -3.817 0 O-C-N 126.462 1.919 . . . . 0.0 110.837 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 8.5 t70 -110.8 -36.1 5.79 Favored 'General case' 0 C--N 1.249 -3.795 0 CA-C-N 113.735 -1.232 . . . . 0.0 109.719 -170.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.5 pt-20 -158.3 174.71 3.78 Favored Pre-proline 0 CA--C 1.481 -1.686 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.227 -169.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 73.1 Cg_exo -60.15 -30.43 91.32 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 122.617 2.211 . . . . 0.0 109.516 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.85 -39.37 79.96 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.889 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.67 119.78 37.88 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -88.97 165.95 14.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.876 2.07 . . . . 0.0 108.538 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 5.9 mp -89.27 144.17 26.29 Favored 'General case' 0 C--O 1.18 -2.597 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.689 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.85 169.4 17.14 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.8 mm -113.54 126.1 70.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 -173.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -102.28 -20.31 14.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.496 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.6 m -155.75 126.92 7.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.186 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -78.6 108.99 12.4 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 89.3 t -84.86 126.42 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.5 144.55 55.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.331 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 82.68 2.83 1.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 125.205 1.566 . . . . 0.0 110.071 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.7 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.11 160.3 38.39 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.726 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.34 -25.3 18.59 Favored 'Trans proline' 0 C--O 1.18 -2.398 0 CA-C-N 121.092 2.446 . . . . 0.0 109.62 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.18 94.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.523 175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.94 68.9 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 122.655 1.217 . . . . 0.0 109.8 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 52.1 mt -72.54 -50.07 28.2 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.356 -2.202 . . . . 0.0 115.9 -172.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.51 -21.43 41.91 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.4 -169.59 54.87 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.395 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt 58.5 30.29 19.54 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 112.784 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' MET . . . . . 0.655 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.5 tmt? -159.83 131.97 6.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 171.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -147.85 160.27 42.95 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.477 0.656 . . . . 0.0 112.26 -169.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -54.69 119.91 6.0 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.386 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.54 4.1 15.81 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.867 -1.158 . . . . 0.0 112.752 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.556 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 p30 -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.214 171.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 6.5 p -100.42 117.87 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.398 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 50.4 mm -74.59 111.41 10.38 Favored 'Isoleucine or valine' 0 C--O 1.301 3.794 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.277 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 58.6 t -89.18 -58.09 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.476 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -160.55 173.64 15.23 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.031 -0.418 . . . . 0.0 110.852 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG13 ' CG2' ' A' ' 72' ' ' VAL . 11.1 p -140.5 121.33 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.378 30.0 p-10 33.03 -89.84 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -92.5 -34.09 14.22 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -93.09 130.87 38.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.227 1.013 . . . . 0.0 112.719 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 t -84.7 90.16 7.66 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 67' ' ' VAL . 40.8 t -78.89 -0.34 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 122.857 1.313 . . . . 0.0 109.039 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 6' ' ' ARG . 20.8 tp -68.1 111.47 4.49 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.363 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.5 43.04 93.28 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.792 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.42 137.8 32.05 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.481 ' HB ' ' CG ' ' A' ' 79' ' ' GLN . 35.9 m -69.55 143.87 53.26 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -47.49 -49.18 26.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.147 0.885 . . . . 0.0 112.548 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.83 71.95 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.684 0.754 . . . . 0.0 110.97 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.481 ' CG ' ' HB ' ' A' ' 76' ' ' THR . 14.1 mm-40 -80.1 -50.0 10.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.854 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -42.27 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.427 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.7 p -63.07 -35.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -43.77 98.28 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.9 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.59 -50.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 122.196 0.998 . . . . 0.0 109.357 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -67.25 -28.69 68.25 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.41 -1.723 . . . . 0.0 112.759 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 78.7 mm-40 -88.49 -17.26 30.72 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 p -94.86 -13.6 25.34 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -52.02 154.8 3.61 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 177.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -95.45 148.14 1.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.093 3.195 . . . . 0.0 112.325 -176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.562 HG12 ' N ' ' A' ' 25' ' ' ARG . 50.6 mt -65.26 124.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.897 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.65 11.28 44.59 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-O 119.746 -0.475 . . . . 0.0 113.354 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.06 -178.09 4.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.033 0.916 . . . . 0.0 111.626 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 t -139.29 150.51 45.51 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 110.496 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.5 m -151.39 156.66 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.149 0.98 . . . . 0.0 110.854 174.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.501 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 23.6 m-20 -105.21 107.33 18.26 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 13.5 tp -94.33 125.92 39.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.26 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HB3' ' HD1' ' A' ' 17' ' ' HIS . 9.8 pt-20 -108.74 113.8 27.06 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.887 0.851 . . . . 0.0 108.789 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.556 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.7 pt? -142.13 155.5 45.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.324 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 63' ' ' VAL . 58.8 m -113.58 107.11 15.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.573 0.702 . . . . 0.0 109.33 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.655 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 4.9 ttp-105 -85.83 133.67 33.96 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.152 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.31 40.23 0.97 Allowed Glycine 0 C--N 1.283 -2.369 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.812 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 . . . . . 0 N--CA 1.409 -2.488 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.183 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 32.8 mt-10 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.429 0.633 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 7.8 m -88.65 110.2 20.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.442 ' HA ' HG23 ' A' ' 30' ' ' THR . 21.1 mt-30 -84.26 120.93 26.81 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 27' ' ' PHE . 12.9 m . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.742 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . 0.41 ' O ' ' HE2' ' A' ' 1' ' ' LYS . . . 54.86 53.45 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.791 1.236 . . . . 0.0 111.882 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -84.94 86.35 7.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.617 ' HA2' ' O ' ' A' ' 122' ' ' ASP . . . -118.46 29.22 6.47 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.79 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.41 ' HE2' ' O ' ' A' ' -2' ' ' ALA . 0.0 OUTLIER -117.34 155.13 50.3 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -175.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.39 119.86 6.89 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.603 1.535 . . . . 0.0 112.008 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -69.64 144.64 52.88 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.404 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.474 ' CZ ' ' HA ' ' A' ' 38' ' ' ASP . 10.6 t80 -145.59 140.47 27.42 Favored 'General case' 0 C--N 1.269 -2.931 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.507 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.386 15.0 t -156.72 -52.78 0.08 Allowed 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.147 161.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 5' ' ' THR . 18.2 ptt-85 155.18 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.736 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.6 t-20 -55.86 111.88 3.67 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 112.779 -2.01 . . . . 0.0 112.913 -175.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.2 Cg_exo -63.96 -27.16 66.38 Favored 'Trans proline' 0 CA--C 1.476 -2.407 0 C-N-CA 121.234 1.289 . . . . 0.0 109.997 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -85.4 -14.92 44.78 Favored 'General case' 1 N--CA 1.358 -5.063 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.652 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.736 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.4 pt-20 -72.69 -36.2 67.83 Favored 'General case' 0 C--N 1.376 1.752 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.453 ' CD2' ' HH ' ' A' ' 101' ' ' TYR . 87.0 mt -59.99 136.0 57.88 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.16 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -98.34 177.49 5.35 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.648 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.6 -99.71 2.48 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.765 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -145.79 128.22 15.94 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.408 0.623 . . . . 0.0 109.352 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.73 115.21 29.8 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -126.12 152.41 33.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.058 -175.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.686 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 14.7 t-160 -127.33 99.89 5.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.3 t -124.2 141.3 52.17 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.047 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.502 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -86.71 131.14 34.22 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.685 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.54 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.7 mp -115.02 123.35 48.85 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -86.22 115.44 23.78 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.539 ' HG3' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -45.17 102.35 0.03 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 123.95 0.9 . . . . 0.0 109.234 169.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -123.14 135.93 54.56 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 125.274 1.609 . . . . 0.0 108.939 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m 55.12 28.62 11.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.068 0.947 . . . . 0.0 113.143 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.734 ' N ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 77.5 102.91 0.07 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.632 1.573 . . . . 0.0 108.368 176.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.55 -137.32 13.53 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.289 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.636 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.6 m-85 -124.29 -82.76 0.64 Allowed 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.525 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 119.64 56.02 0.25 Allowed Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.432 ' CD1' HD12 ' A' ' 43' ' ' ILE . 28.2 p90 -160.9 143.65 12.79 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.444 HG22 ' CB ' ' B' ' 160' ' ' GLN . 40.0 p -107.99 134.94 50.19 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-O 122.134 0.969 . . . . 0.0 109.199 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 2.2 p -135.55 136.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.957 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.044 -169.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 15.2 m -115.39 131.82 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.261 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.522 ' HA2' ' CB ' ' B' ' 156' ' ' ARG . . . 137.1 -145.35 17.13 Favored Glycine 0 CA--C 1.457 -3.57 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.419 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 48.39 70.11 0.82 Allowed Glycine 0 CA--C 1.464 -3.137 0 O-C-N 126.599 1.999 . . . . 0.0 112.031 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -116.93 -29.25 6.06 Favored 'General case' 0 C--N 1.259 -3.332 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.296 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.6 pt-20 -159.21 174.23 4.23 Favored Pre-proline 0 CA--C 1.467 -2.242 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.579 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.445 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 77.1 Cg_exo -61.72 -25.83 79.23 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 122.435 2.09 . . . . 0.0 109.388 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.474 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 19.5 t70 -84.01 -21.39 31.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.347 -2.206 . . . . 0.0 112.306 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -122.75 119.41 30.58 Favored 'General case' 0 C--O 1.264 1.837 0 O-C-N 121.492 -0.755 . . . . 0.0 110.471 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.0 165.67 12.74 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.249 2.22 . . . . 0.0 108.495 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.3 mp -93.08 146.47 23.62 Favored 'General case' 0 C--O 1.183 -2.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.583 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.0 tt0 -137.18 144.49 42.93 Favored 'General case' 0 C--O 1.191 -2.006 0 CA-C-N 118.56 0.618 . . . . 0.0 110.318 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 HD12 ' CD1' ' A' ' 29' ' ' PHE . 23.4 mm -79.94 119.63 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 O-C-N 121.829 -0.544 . . . . 0.0 109.848 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HD2' ' OG ' ' A' ' 45' ' ' SER . 1.2 pptp? -103.28 -19.79 14.34 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.951 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 44' ' ' LYS . 45.6 m -161.14 128.16 4.08 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 1.5 pp -87.63 128.35 35.28 Favored 'General case' 0 N--CA 1.395 -3.183 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.725 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.525 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.6 t -80.2 127.51 39.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 86.8 mt -64.5 133.99 53.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.496 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.6 t70 84.73 11.08 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.385 1.678 . . . . 0.0 109.608 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.597 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.93 155.57 23.17 Favored Glycine 0 CA--C 1.487 -1.702 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.572 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.5 Cg_endo -72.02 -25.32 19.64 Favored 'Trans proline' 0 N--CA 1.425 -2.556 0 CA-C-N 121.266 2.533 . . . . 0.0 110.486 -170.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.85 85.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.62 88.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 122.861 1.315 . . . . 0.0 109.879 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 87.4 mt -72.42 -45.73 58.36 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 112.785 -2.007 . . . . 0.0 114.459 -174.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -68.78 -24.69 64.45 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.74 3.2 9.43 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-N 114.186 -1.37 . . . . 0.0 115.893 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -110.44 19.42 18.8 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.996 1.379 . . . . 0.0 109.802 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ttt -146.67 133.21 19.77 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.528 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 44.4 mt-10 -140.43 162.11 36.11 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.354 0.662 . . . . 0.0 109.738 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.0 m -57.02 119.01 5.56 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.51 -18.5 5.73 Favored Glycine 0 C--N 1.302 -1.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.47 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.539 ' OD1' ' HB2' ' A' ' 99' ' ' ARG . 11.1 m-20 -67.79 136.63 54.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -101.38 130.35 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 43.3 mm -82.22 111.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.299 3.702 0 C-N-CA 123.343 0.657 . . . . 0.0 109.856 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 60.4 t -91.85 -57.92 3.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 126.346 2.279 . . . . 0.0 108.764 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -157.74 170.96 21.19 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.925 -0.484 . . . . 0.0 111.24 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -152.67 120.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.018 0.437 . . . . 0.0 112.145 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.18 58.63 5.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.907 1.283 . . . . 0.0 111.258 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.26 -30.09 0.2 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.504 -1.68 . . . . 0.0 113.033 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 m -65.83 127.12 30.73 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 121.444 0.64 . . . . 0.0 111.14 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.9 t -79.05 78.24 5.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.233 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.499 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 87.2 t -83.89 5.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 122.786 1.279 . . . . 0.0 109.49 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 6' ' ' ARG . 13.3 tp -66.62 110.13 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.92 45.0 95.73 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.205 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.499 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 1.7 t60 -79.72 147.99 31.7 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.5 m -74.87 143.57 43.78 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 117.73 -1.128 . . . . 0.0 108.821 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -48.07 -49.28 32.16 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.246 0.93 . . . . 0.0 112.33 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.7 71.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 124.063 0.852 . . . . 0.0 110.988 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -80.28 -48.57 12.83 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.125 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.8 -43.14 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.603 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.7 p -64.53 -35.97 76.06 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -42.99 85.89 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.261 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -72.25 -50.65 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 CA-C-O 122.474 1.131 . . . . 0.0 109.528 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.66 -29.67 69.75 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.049 -1.887 . . . . 0.0 113.327 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.603 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 mp0 -86.71 -25.18 24.88 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 p -85.57 -22.36 28.1 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.539 HD11 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -52.43 151.35 7.6 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.4 Cg_endo -102.49 159.54 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.242 3.961 . . . . 0.0 112.302 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.734 HG12 ' N ' ' A' ' 25' ' ' ARG . 26.9 mt -67.96 131.21 33.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.297 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.03 11.4 34.43 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.961 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -103.39 176.88 5.0 Favored 'General case' 0 C--O 1.202 -1.444 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.496 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.502 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 30.1 t -134.57 148.32 50.44 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.082 -0.386 . . . . 0.0 110.675 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.07 149.75 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 C-N-CA 124.104 0.961 . . . . 0.0 111.169 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.686 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.9 m-20 -100.23 111.75 24.04 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.526 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.54 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.32 125.09 35.97 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.937 0.399 . . . . 0.0 110.315 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.474 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 35.2 mt-10 -104.27 105.45 15.59 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.43 157.29 45.36 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.254 -172.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.9 t -131.7 120.09 22.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.344 0.592 . . . . 0.0 109.739 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 19.4 ttp85 -114.98 158.62 21.8 Favored 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 124.086 0.955 . . . . 0.0 109.858 -174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.22 -15.34 2.54 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.453 ' HH ' ' CD2' ' A' ' 11' ' ' LEU . 89.7 m-85 -91.33 112.27 53.18 Favored Pre-proline 0 N--CA 1.432 -1.34 0 CA-C-N 113.989 -1.105 . . . . 0.0 108.222 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -75.75 142.78 26.05 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 121.391 1.394 . . . . 0.0 110.961 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.71 109.61 6.46 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -94.92 -79.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.626 2.217 . . . . 0.0 113.829 -176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.1 150.52 24.37 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.452 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.5 m-20 -78.65 126.04 83.36 Favored Pre-proline 0 CA--C 1.48 -1.743 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -173.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.1 Cg_endo -97.7 12.04 0.94 Allowed 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 123.096 2.53 . . . . 0.0 107.003 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.424 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 24.4 t70 -91.67 -17.79 24.96 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 112.935 -1.939 . . . . 0.0 108.428 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.03 108.4 51.78 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.054 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 108' ' ' ASP . 45.9 Cg_exo -70.89 -159.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.587 2.858 . . . . 0.0 114.197 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 76.43 26.87 0.86 Allowed 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.347 1.859 . . . . 0.0 112.773 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.8 m -166.96 154.85 9.5 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -75.85 113.87 13.82 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -79.58 104.38 10.14 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.461 0.648 . . . . 0.0 112.034 -165.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.8 99.0 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 170.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.0 t -75.85 142.23 42.23 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.0 m -102.52 114.56 28.86 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.622 HG21 ' O ' ' A' ' 119' ' ' ALA . 9.1 p -92.97 140.7 15.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.755 -171.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.622 ' O ' HG21 ' A' ' 118' ' ' VAL . . . -90.97 166.15 13.18 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.495 ' HB ' ' O ' ' A' ' 119' ' ' ALA . 2.3 mp 74.04 22.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 125.149 2.404 . . . . 0.0 108.028 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp -92.96 148.62 21.85 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-N 112.691 -2.05 . . . . 0.0 106.942 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.617 ' O ' ' HA2' ' A' ' 0' ' ' GLY . 6.6 m-20 -74.49 121.31 21.3 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-O 121.078 0.466 . . . . 0.0 109.881 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.3 mmpt? -105.3 57.72 0.68 Allowed 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.445 ' HG3' ' HB3' ' A' ' 122' ' ' ASP . 25.6 mt-10 -82.52 147.65 56.57 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 C-N-CA 122.747 2.298 . . . . 0.0 111.836 179.056 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' B' ' 151' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 1.5 p -88.34 148.21 24.38 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.1 t -119.87 -58.11 1.91 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.67 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -77.1 85.49 3.59 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.924 -0.485 . . . . 0.0 111.983 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 10.3 t -156.58 113.52 3.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.111 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.522 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . 8.6 ptp180 -73.22 125.38 27.64 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.722 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.548 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 23.4 mmt180 -89.34 142.76 27.37 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.137 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.58 110.75 12.65 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 124.245 0.965 . . . . 0.0 109.042 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 8.5 m -115.67 89.01 3.0 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.444 ' CB ' HG22 ' A' ' 30' ' ' THR . 5.1 pm0 -76.97 114.06 15.34 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.263 0.554 . . . . 0.0 110.631 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.427 -1.593 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.63 -175.074 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.217 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 54.93 64.35 1.83 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.17 0.988 . . . . 0.0 110.677 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -74.29 69.6 1.6 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.005 0.907 . . . . 0.0 112.845 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -127.93 37.79 2.23 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' B' ' 151' ' ' ARG . 0.8 OUTLIER -87.24 148.79 45.64 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.797 -0.701 . . . . 0.0 110.009 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.76 125.41 17.15 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.635 2.223 . . . . 0.0 110.197 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -59.04 126.9 29.62 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.835 -1.529 . . . . 0.0 114.391 -170.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 38' ' ' ASP . 33.7 t80 -148.68 133.39 17.86 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.742 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.461 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 8.8 t -167.07 30.31 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.078 0 O-C-N 124.141 0.901 . . . . 0.0 109.604 166.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.526 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 47.67 41.12 13.22 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 124.049 1.881 . . . . 0.0 112.107 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.78 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -111.42 114.81 52.64 Favored Pre-proline 0 C--N 1.248 -3.845 0 CA-C-N 112.82 -1.991 . . . . 0.0 112.98 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.469 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.305 14.6 Cg_exo -57.53 -36.06 98.72 Favored 'Trans proline' 0 CA--C 1.48 -2.203 0 CA-C-O 123.948 1.562 . . . . 0.0 109.076 172.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -73.94 -15.87 61.11 Favored 'General case' 1 N--CA 1.344 -5.737 0 CA-C-N 110.626 -2.988 . . . . 0.0 112.403 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.1 pt-20 -80.85 -30.42 35.66 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.469 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.6 mt -66.76 137.22 56.48 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.473 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -82.86 179.86 7.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.453 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.55 -129.73 9.47 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.619 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 144.98 50.49 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 122.757 0.423 . . . . 0.0 110.362 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -113.03 112.26 23.57 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.418 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -127.08 152.54 35.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.229 -175.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.82 108.13 14.01 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -131.96 147.17 52.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.682 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -92.8 140.82 29.12 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.952 0.501 . . . . 0.0 111.368 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.541 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.0 OUTLIER -122.14 127.4 50.04 Favored 'General case' 0 C--O 1.258 1.512 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -85.88 113.95 22.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.659 ' HG3' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -42.35 106.07 0.06 Allowed 'General case' 0 CA--C 1.475 -1.921 0 C-N-CA 125.441 1.496 . . . . 0.0 112.267 172.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -120.34 129.91 54.19 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.607 ' C ' HG12 ' A' ' 89' ' ' ILE . 10.9 m 61.16 -165.22 0.22 Allowed 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -84.57 61.03 6.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.636 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.41 -121.0 1.05 Allowed Glycine 0 N--CA 1.406 -3.313 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.284 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.525 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 76.4 m-85 -135.28 -101.02 0.22 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.921 -1.14 . . . . 0.0 112.032 -168.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.26 57.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' HA ' HG23 ' A' ' 47' ' ' VAL . 50.7 p90 -160.55 143.58 13.28 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -101.35 135.31 43.04 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 117.792 -1.563 . . . . 0.0 109.932 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG13 ' O ' ' B' ' 159' ' ' THR . 11.3 p -126.0 143.42 39.57 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.516 -170.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 5.7 m -115.65 132.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.837 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' B' ' 156' ' ' ARG . . . 127.22 -144.36 15.02 Favored Glycine 0 C--N 1.277 -2.727 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.264 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.453 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.76 63.52 2.48 Favored Glycine 0 CA--C 1.457 -3.592 0 O-C-N 126.483 1.931 . . . . 0.0 111.946 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.468 ' CG ' ' HG1' ' B' ' 155' ' ' THR . 8.5 t70 -105.18 -42.48 5.27 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.322 -0.939 . . . . 0.0 108.514 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.1 pt-20 -160.03 172.61 5.75 Favored Pre-proline 0 CA--C 1.472 -2.026 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.324 -170.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 18.7 Cg_exo -76.01 64.53 6.91 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.152 3.235 . . . . 0.0 108.57 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . 28.1 t0 -172.83 -47.27 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 111.789 -2.46 . . . . 0.0 107.373 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' OE2' ' HA ' ' B' ' 154' ' ' ARG . 6.2 tp10 -105.11 119.32 38.75 Favored 'General case' 0 C--O 1.273 2.335 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.423 ' CD1' HD11 ' A' ' 73' ' ' LEU . 9.8 m-85 -93.12 166.22 12.45 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 128.682 2.793 . . . . 0.0 108.905 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.453 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.1 mp -96.37 145.87 25.25 Favored 'General case' 0 C--O 1.172 -3.016 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.421 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 40.4 tt0 -139.78 144.34 37.34 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 118.488 0.586 . . . . 0.0 110.093 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 HD11 ' N ' ' A' ' 43' ' ' ILE . 1.2 mp -81.82 118.42 29.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 O-C-N 121.913 -0.492 . . . . 0.0 109.683 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -98.75 -24.39 15.04 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.432 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -152.37 127.99 10.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.644 -0.66 . . . . 0.0 109.673 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.0 pp -86.97 116.51 25.08 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' HA ' ' A' ' 29' ' ' PHE . 67.0 t -87.91 134.73 27.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.273 -173.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 95.7 mt -60.24 142.54 54.39 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.7 t70 79.87 3.42 2.06 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.784 1.302 . . . . 0.0 110.558 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.658 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -95.05 155.74 21.57 Favored Glycine 0 CA--C 1.489 -1.571 0 CA-C-O 118.362 -1.243 . . . . 0.0 110.45 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.525 ' HD3' ' C ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -71.89 -25.64 19.71 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 CA-C-N 120.931 2.365 . . . . 0.0 111.062 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.8 97.12 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.9 74.45 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.542 1.163 . . . . 0.0 109.954 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 79.7 mt -71.58 -40.3 70.0 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-N 112.933 -1.94 . . . . 0.0 114.165 -172.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.77 -24.58 58.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.94 -3.98 11.49 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.997 -1.456 . . . . 0.0 115.893 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -94.08 -42.58 8.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.449 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 22.5 ttt -82.12 133.84 35.29 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -139.76 168.74 19.12 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.094 0.949 . . . . 0.0 112.073 -169.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 43' ' ' ILE . 20.7 m -64.16 126.23 27.08 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.383 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.09 -9.93 12.01 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.618 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 18.9 m-20 -78.37 144.17 36.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.327 0.1 OUTLIER -115.48 119.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.544 0.688 . . . . 0.0 111.094 171.086 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.67 113.76 4.77 Favored 'Isoleucine or valine' 0 C--O 1.299 3.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.215 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 87.6 t -102.39 -54.96 6.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 112.254 -2.248 . . . . 0.0 110.203 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.452 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.9 t -143.65 158.22 43.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.388 -0.82 . . . . 0.0 110.213 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.15 112.1 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.03 0.443 . . . . 0.0 111.641 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 71.24 -66.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.137 1.375 . . . . 0.0 111.875 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.66 -37.61 0.1 Allowed 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.844 1.658 . . . . 0.0 109.035 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -67.71 127.69 33.7 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.781 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.3 t -85.69 90.3 7.98 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.52 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 9.7 p -80.26 4.09 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 122.701 1.239 . . . . 0.0 109.928 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 HD11 ' CD1' ' A' ' 40' ' ' PHE . 19.6 tp -67.43 111.79 4.27 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.563 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.78 37.54 88.74 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.528 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.52 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -82.49 148.22 28.25 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 83.2 m -78.77 143.22 36.32 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.776 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -47.26 -50.55 21.15 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.288 0.949 . . . . 0.0 113.096 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.12 74.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.845 0.716 . . . . 0.0 110.702 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -75.68 -50.41 15.49 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.0 p -62.02 -45.25 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.667 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.57 -36.0 76.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.416 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -59.08 -47.88 83.62 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.486 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -72.46 -49.96 38.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.385 0 CA-C-O 122.18 0.991 . . . . 0.0 110.121 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -61.41 -40.44 94.42 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.529 -1.668 . . . . 0.0 113.141 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.63 -14.07 46.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -91.76 -2.21 57.05 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.119 0.485 . . . . 0.0 110.824 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.659 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.2 mt -53.35 140.51 44.97 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.051 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -97.82 150.78 0.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.618 2.879 . . . . 0.0 113.042 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.607 HG12 ' C ' ' A' ' 24' ' ' SER . 23.6 mt -67.59 135.89 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.432 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.6 12.43 58.23 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.222 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.513 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -108.5 -170.63 1.71 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.147 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.0 t -150.04 142.17 24.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.499 HG22 ' HE3' ' A' ' 22' ' ' LYS . 27.4 m -145.51 155.35 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.818 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.775 173.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.05 113.81 27.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 124.929 1.393 . . . . 0.0 109.197 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.541 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.7 mm? -91.12 120.32 31.97 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.517 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 20.4 mt-10 -98.71 110.21 22.84 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.406 HD12 ' HG3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.49 156.52 45.74 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.046 -170.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 63.3 m -109.99 125.91 53.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.606 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.477 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 tpp85 -102.82 153.52 20.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.98 -5.77 7.84 Favored Glycine 0 CA--C 1.486 -1.72 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.938 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -89.16 113.45 56.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 13.0 Cg_exo -72.28 150.21 52.58 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.065 1.843 . . . . 0.0 109.796 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -96.47 103.99 16.15 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 86.2 Cg_endo -86.7 26.38 0.63 Allowed 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.122 2.548 . . . . 0.0 114.039 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.437 ' O ' HD13 ' A' ' 103' ' ' LEU . 52.1 p90 -162.04 169.43 21.02 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 23.9 t70 -91.27 130.97 37.93 Favored Pre-proline 0 CA--C 1.474 -1.974 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 174.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 108' ' ' ASP . 18.0 Cg_endo -103.73 7.2 0.34 Allowed 'Trans proline' 0 N--CA 1.413 -3.216 0 C-N-CA 123.249 2.632 . . . . 0.0 111.303 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.443 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 24.6 t70 -89.8 -36.8 14.92 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.26 131.27 80.83 Favored Pre-proline 0 N--CA 1.442 -0.864 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.413 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.262 0.0 OUTLIER -37.18 89.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.359 1 C-N-CA 126.04 4.493 . . . . 0.0 117.22 176.503 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -126.9 86.24 2.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 118.054 -1.458 . . . . 0.0 110.297 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.0 t -80.4 -177.07 6.0 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.264 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 114.06 6.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.715 0.769 . . . . 0.0 112.987 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -77.05 115.45 16.86 Favored 'General case' 0 N--CA 1.399 -3.011 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 166.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.6 p -112.01 122.34 66.13 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -165.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 t -97.01 144.29 27.05 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.9 m -149.91 143.17 25.09 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.081 0.467 . . . . 0.0 110.132 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.08 101.22 12.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.35 72.83 5.97 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.15 0.976 . . . . 0.0 110.44 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.6 mm -143.15 -35.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.1 mt -89.48 -177.09 5.24 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.791 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -80.33 90.01 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -36.09 114.74 0.3 Allowed 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 112.471 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -89.08 117.33 68.14 Favored Pre-proline 0 C--N 1.286 -2.181 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.027 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo . . . . . 0 C--N 1.351 0.664 0 C-N-CA 123.156 2.57 . . . . 0.0 112.802 -177.959 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HB3' ' A' ' 1' ' ' LYS . 94.4 mtt180 . . . . . 0 C--O 1.212 -0.92 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 40.5 m -155.58 -32.37 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.459 1.027 . . . . 0.0 113.384 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 18.0 m -82.53 121.76 27.19 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 121.457 0.646 . . . . 0.0 112.171 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.426 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 45.8 mmt-85 -130.64 42.93 3.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 17.0 p -63.38 -48.27 78.6 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.835 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.409 ' HA ' ' HA2' ' A' ' 33' ' ' GLY 0.348 9.6 ptp180 50.07 95.47 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 176.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 13.4 mmt180 -81.89 156.4 24.82 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.102 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' B' ' 158' ' ' GLU . 0.1 OUTLIER -95.49 83.34 3.79 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.182 0.991 . . . . 0.0 110.714 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.552 ' O ' HG13 ' A' ' 31' ' ' VAL . 7.4 m -75.83 107.82 8.27 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.95 93.94 9.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.704 -0.622 . . . . 0.0 110.629 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.717 -177.386 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.623 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -142.6 141.25 31.93 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.1 mmt 64.69 33.38 10.55 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.374 1.069 . . . . 0.0 113.599 178.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -97.91 43.5 1.94 Allowed Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.79 143.5 28.76 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.86 145.68 32.31 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.609 -1.727 . . . . 0.0 107.609 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -68.3 117.73 10.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 112.2 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.555 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 32.5 t80 -147.5 134.56 20.36 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.303 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.613 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 8.8 t -173.92 41.29 0.01 OUTLIER 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 124.32 1.013 . . . . 0.0 109.605 168.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.613 ' HG2' ' O ' ' A' ' 5' ' ' THR . 10.2 ptm180 56.02 13.47 1.16 Allowed 'General case' 0 N--CA 1.516 2.842 0 C-N-CA 126.423 1.889 . . . . 0.0 113.653 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.737 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.7 m-80 -93.8 115.03 64.59 Favored Pre-proline 0 C--N 1.251 -3.712 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.288 10.8 Cg_exo -62.06 -29.69 81.71 Favored 'Trans proline' 0 CA--C 1.475 -2.444 0 N-CA-C 108.019 -1.57 . . . . 0.0 108.019 170.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 t -69.79 -25.68 63.91 Favored 'General case' 1 N--CA 1.354 -5.255 0 CA-C-N 111.271 -2.695 . . . . 0.0 110.962 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.737 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.0 pt-20 -78.27 -31.26 48.96 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.01 133.92 55.35 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.547 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 176.08 6.72 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.803 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.23 -116.19 5.44 Favored Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.324 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.405 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.4 156.42 48.21 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -122.07 112.47 18.28 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -119.85 152.22 22.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-O 121.209 0.528 . . . . 0.0 110.737 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.611 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.3 t-160 -133.26 99.64 4.6 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 14.9 t -126.27 142.09 51.66 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.677 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.564 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -86.84 133.36 33.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.019 0.928 . . . . 0.0 111.637 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -115.45 127.34 55.26 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -88.06 103.94 16.19 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.58 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.53 118.23 1.03 Allowed 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 19.3 t -92.51 -137.05 0.17 Allowed 'General case' 0 N--CA 1.403 -2.785 0 O-C-N 126.104 2.128 . . . . 0.0 106.717 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -63.84 83.29 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.402 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 60.69 27.99 17.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.395 1.878 . . . . 0.0 112.009 174.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.45 -139.48 5.41 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.69 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.7 m-85 -124.66 -87.84 0.61 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.92 52.54 0.11 Allowed Glycine 0 C--N 1.295 -1.72 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.037 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.479 ' CD1' HD12 ' A' ' 43' ' ' ILE . 42.2 p90 -160.96 141.94 11.61 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 172.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.6 p -107.62 138.04 44.57 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 19.3 m -124.89 159.29 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -167.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.526 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.9 m -115.87 133.7 61.48 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 C-N-CA 124.516 1.127 . . . . 0.0 109.968 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HG3' ' B' ' 156' ' ' ARG . . . 116.18 -143.91 18.24 Favored Glycine 0 C--N 1.278 -2.689 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.467 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.531 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.77 58.09 4.34 Favored Glycine 0 CA--C 1.452 -3.87 0 O-C-N 126.115 1.714 . . . . 0.0 111.228 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' HG2' ' B' ' 157' ' ' ARG . 6.3 t70 -102.67 -35.49 8.67 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.328 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.9 pt-20 -158.45 168.44 12.44 Favored Pre-proline 0 CA--C 1.469 -2.151 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.404 -169.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -75.94 58.18 5.39 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 124.298 3.332 . . . . 0.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.555 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 6.1 t70 -170.81 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 112.085 -2.325 . . . . 0.0 106.732 -173.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.42 118.73 34.55 Favored 'General case' 0 C--O 1.272 2.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.279 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.18 165.96 13.65 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 127.976 2.51 . . . . 0.0 108.348 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.531 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.9 mp -95.76 144.38 26.2 Favored 'General case' 0 C--O 1.175 -2.858 0 C-N-CA 118.506 -1.277 . . . . 0.0 109.639 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 36.5 tt0 -130.1 156.28 44.8 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 29' ' ' PHE . 12.6 mm -90.01 127.27 42.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.67 -19.86 13.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.509 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.479 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.0 m -155.73 127.28 7.3 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 tp -83.14 114.96 21.69 Favored 'General case' 0 N--CA 1.402 -2.84 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 58.4 t -86.99 122.71 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.19 146.17 50.93 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 84.37 3.03 0.79 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.489 1.743 . . . . 0.0 109.795 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.691 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -86.91 158.98 31.06 Favored Glycine 0 C--O 1.207 -1.579 0 CA-C-O 117.872 -1.516 . . . . 0.0 109.576 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.6 Cg_endo -72.59 -25.17 17.92 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 CA-C-N 121.725 2.762 . . . . 0.0 110.633 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.38 -42.2 98.83 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.241 174.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.36 82.12 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.668 1.223 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.691 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 82.6 mt -71.67 -44.74 63.73 Favored 'General case' 0 N--CA 1.405 -2.715 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.517 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.16 -19.61 50.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.36 1.076 . . . . 0.0 108.242 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.98 27.92 65.39 Favored Glycine 0 CA--C 1.48 -2.097 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.593 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 26.4 tptp -102.06 -13.08 17.66 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.331 -173.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.464 ' HG2' HD13 ' A' ' 97' ' ' LEU . 67.5 mtp -123.11 144.31 49.4 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.43 141.39 25.9 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -45.16 114.14 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.726 1.21 . . . . 0.0 111.332 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.6 -18.77 5.12 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.461 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.64 146.51 45.2 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.515 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.288 1.2 p -117.87 116.18 50.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.964 174.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.08 120.02 25.25 Favored 'Isoleucine or valine' 0 C--O 1.284 2.882 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.692 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 37.4 t -99.12 -34.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-N 112.334 -2.212 . . . . 0.0 110.138 -177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -170.62 169.49 7.16 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.9 p -155.17 115.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.403 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 63.3 t30 37.43 76.59 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.14 1.776 . . . . 0.0 113.918 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 70.89 -18.93 0.24 Allowed 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.76 122.53 33.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.39 77.2 8.29 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 122.023 0.916 . . . . 0.0 110.134 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.94 -0.91 4.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.426 1.108 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.508 HD21 ' O ' ' A' ' 6' ' ' ARG . 30.7 tp -59.04 110.52 1.06 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 170.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.59 48.77 84.54 Favored Glycine 0 N--CA 1.431 -1.641 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.298 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -89.17 141.14 28.78 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 24.0 m -74.04 144.09 45.22 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.247 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -46.72 -47.54 20.53 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.135 0.879 . . . . 0.0 113.103 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.901 0.857 . . . . 0.0 111.081 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 79.2 mm-40 -78.51 -49.75 12.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.651 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.7 p -64.46 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.387 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.93 -44.64 98.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -72.79 -27.04 61.75 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.27 -1.372 . . . . 0.0 113.276 -175.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -73.02 -51.21 27.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 122.03 0.919 . . . . 0.0 109.003 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.46 -39.09 92.3 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.703 -1.59 . . . . 0.0 112.755 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' B' ' 161' ' ' VAL . 14.2 mm100 -85.65 -20.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -96.17 4.96 52.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.211 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.58 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 3.1 mt -48.47 147.08 4.35 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.302 1.041 . . . . 0.0 112.709 170.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -94.27 150.56 2.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.246 2.631 . . . . 0.0 111.436 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 23' ' ' SER . 24.8 mt -68.75 143.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.305 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.52 12.06 70.4 Favored Glycine 0 CA--C 1.497 -1.052 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.483 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.71 -176.34 3.71 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.274 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.564 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.7 t -147.03 142.68 27.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.255 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 4.7 m -151.98 144.24 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 O-C-N 124.2 0.938 . . . . 0.0 111.002 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.611 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 2.5 m-20 -97.79 117.73 32.76 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.696 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 3.2 mm? -90.67 121.98 33.05 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -91.05 108.18 19.7 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.464 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -141.61 147.74 38.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.062 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.28 136.77 44.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.841 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 18.4 tpp85 -114.08 149.98 34.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.24 3.95 6.61 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -107.44 142.35 24.94 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 122.788 0.435 . . . . 0.0 111.389 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.531 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 68.9 Cg_endo -90.72 179.0 1.85 Allowed 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.453 2.102 . . . . 0.0 109.303 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 92.15 3.45 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 93.3 Cg_endo -88.6 40.89 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.414 2.743 . . . . 0.0 111.325 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -168.23 145.94 4.21 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.426 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.5 t70 -108.26 132.09 21.32 Favored Pre-proline 0 CA--C 1.475 -1.936 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 19.2 Cg_endo -103.07 5.84 0.39 Allowed 'Trans proline' 0 N--CA 1.413 -3.236 0 C-N-CA 123.422 2.748 . . . . 0.0 111.282 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.419 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 34.0 t70 -100.53 -34.72 9.8 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.07 143.18 72.9 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.279 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -37.56 -28.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 1 C-N-CA 126.615 4.877 . . . . 0.0 117.613 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.77 81.38 2.72 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-O 121.6 0.714 . . . . 0.0 111.114 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.3 t -69.8 -131.28 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.974 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.578 172.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB3' ' CD ' ' B' ' 157' ' ' ARG . 5.1 p -54.98 133.85 48.61 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.551 0.74 . . . . 0.0 112.434 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 155' ' ' THR . 48.4 mt -89.65 105.02 17.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.574 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -123.55 107.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 t -79.87 151.44 30.2 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.238 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.3 m -93.88 103.29 15.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.868 0.842 . . . . 0.0 109.94 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.4 p -133.71 135.07 55.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.96 76.31 7.91 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.651 0.738 . . . . 0.0 112.424 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.6 mm -117.17 -56.78 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.8 mt -97.47 140.52 31.78 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.892 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.0 99.55 10.49 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -61.19 134.41 56.98 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.715 1.245 . . . . 0.0 112.695 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.407 ' CD ' ' H ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -92.8 145.6 30.58 Favored Pre-proline 0 C--N 1.258 -3.381 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.121 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 CA--C 1.547 1.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.919 179.819 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.448 ' HG2' ' H ' ' B' ' 152' ' ' SER 0.266 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.234 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.448 ' H ' ' HG2' ' B' ' 151' ' ' ARG . 16.6 m -78.68 9.54 4.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.701 0.762 . . . . 0.0 112.709 -171.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -81.71 -16.0 52.61 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 124.52 1.128 . . . . 0.0 109.894 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 71.07 -63.0 0.44 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.222 1.409 . . . . 0.0 113.531 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.2 m 67.13 -67.31 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.182 1.393 . . . . 0.0 110.675 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.423 ' HG3' ' N ' ' A' ' 33' ' ' GLY . 20.8 ttm180 69.22 110.07 0.05 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.535 ' HG2' ' OD2' ' A' ' 35' ' ' ASP . 8.0 mmm180 -111.13 165.66 11.72 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.286 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.2 mp0 -99.63 85.48 3.13 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.042 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.41 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 14.3 m -81.44 128.29 33.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -98.47 124.91 43.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.44 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.027 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.94 71.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.958 0.885 . . . . 0.0 108.686 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.1 ptp -123.19 169.37 11.32 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.909 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 88.87 31.83 11.88 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.66 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 135.55 67.57 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.3 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.43 145.96 66.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.514 2.143 . . . . 0.0 109.805 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.95 135.03 57.67 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.251 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' O ' ' HB ' ' A' ' 5' ' ' THR . 22.6 t80 -146.88 134.99 21.57 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.936 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.594 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.5 t 179.96 39.78 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 O-C-N 125.071 1.482 . . . . 0.0 110.357 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 5' ' ' THR . 31.1 ptt180 54.67 15.53 1.1 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 126.159 1.784 . . . . 0.0 113.559 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.806 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.9 m-80 -94.62 114.22 62.94 Favored Pre-proline 1 C--N 1.242 -4.065 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.269 7.2 Cg_exo -58.36 -29.97 89.78 Favored 'Trans proline' 0 CA--C 1.483 -2.034 0 C-N-CA 121.552 1.501 . . . . 0.0 109.336 170.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -72.99 -25.43 60.98 Favored 'General case' 1 N--CA 1.365 -4.721 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.313 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.806 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -76.02 -34.54 59.69 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -55.07 130.61 42.51 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 122.406 1.098 . . . . 0.0 111.748 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.17 170.88 12.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.282 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.67 -109.65 3.05 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.045 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -147.33 145.13 29.22 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 123.082 0.553 . . . . 0.0 110.646 -176.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -110.22 111.45 22.77 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.401 HD11 ' N ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -124.07 147.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.005 0.907 . . . . 0.0 112.152 -177.17 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -118.05 99.79 7.12 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -129.69 137.02 50.39 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.562 0.696 . . . . 0.0 111.588 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -73.36 133.54 43.83 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.07 0.948 . . . . 0.0 112.008 -176.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.401 HD22 ' HB2' ' A' ' 52' ' ' ALA . 1.5 tp -124.49 134.41 53.04 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -93.66 114.72 27.09 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.555 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.633 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -42.71 99.5 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 125.0 1.32 . . . . 0.0 111.099 168.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.3 m -118.48 125.44 49.9 Favored 'General case' 0 N--CA 1.417 -2.092 0 O-C-N 125.527 1.767 . . . . 0.0 107.655 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 58.46 47.7 13.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.777 0.799 . . . . 0.0 111.035 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.425 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.7 mpt_? 84.7 -62.74 0.08 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 126.635 1.974 . . . . 0.0 111.702 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . -100.29 -115.06 3.74 Favored Glycine 0 N--CA 1.406 -3.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.211 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.636 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 81.2 m-85 -129.97 -84.5 0.54 Allowed 'General case' 0 N--CA 1.397 -3.12 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.002 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 134.26 53.86 0.07 OUTLIER Glycine 0 C--N 1.295 -1.73 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.008 -170.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.459 ' HA ' HG23 ' A' ' 47' ' ' VAL . 44.0 p90 -161.64 142.85 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.412 HG23 ' HB2' ' B' ' 160' ' ' GLN . 76.9 p -104.24 135.12 46.31 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.823 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 1.0 OUTLIER -115.77 162.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.791 -171.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' B' ' 156' ' ' ARG . 6.8 m -137.0 132.31 47.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 C-N-CA 123.505 0.722 . . . . 0.0 109.237 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' B' ' 156' ' ' ARG . . . 131.91 -147.85 18.84 Favored Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.46 60.64 3.59 Favored Glycine 0 CA--C 1.462 -3.263 0 O-C-N 126.352 1.854 . . . . 0.0 113.085 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -106.03 -24.23 12.44 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 114.348 -0.926 . . . . 0.0 109.148 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -158.49 172.06 6.63 Favored Pre-proline 0 C--O 1.196 -1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.426 -173.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -67.54 -15.34 44.8 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 123.117 2.545 . . . . 0.0 109.439 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -92.6 -24.04 18.83 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.995 -178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.628 ' OE1' ' HD3' ' B' ' 154' ' ' ARG . 35.3 tt0 -123.22 117.93 26.45 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -84.61 165.54 17.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.253 2.221 . . . . 0.0 108.619 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.513 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -91.37 144.72 25.29 Favored 'General case' 0 C--O 1.183 -2.441 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.085 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 16.3 tt0 -128.07 169.49 14.0 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.3 mm -112.9 135.68 51.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 107' ' ' PRO . 21.6 pttp -114.54 -13.64 12.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -159.75 127.98 4.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.512 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 3.7 pp -90.92 119.28 30.99 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.459 HG23 ' HA ' ' A' ' 29' ' ' PHE . 92.4 t -75.67 126.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-O 121.142 0.496 . . . . 0.0 109.711 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.63 135.02 56.45 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.4 t70 87.47 2.2 0.41 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 125.422 1.701 . . . . 0.0 110.255 -173.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.39 159.54 37.07 Favored Glycine 0 C--O 1.208 -1.5 0 CA-C-O 118.175 -1.347 . . . . 0.0 110.887 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -72.46 -25.52 17.96 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 121.307 2.554 . . . . 0.0 110.155 -170.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.595 ' HB3' ' SD ' ' A' ' 58' ' ' MET . . . -67.4 -43.11 82.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.476 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.35 76.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.499 1.143 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 95.2 mt -71.86 -39.7 69.5 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.926 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.97 -17.26 47.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 122.554 1.168 . . . . 0.0 109.773 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.84 46.38 76.44 Favored Glycine 0 CA--C 1.494 -1.233 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.106 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.2 tpmt? -126.9 6.34 6.62 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.588 0.709 . . . . 0.0 110.956 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.595 ' SD ' ' HB3' ' A' ' 52' ' ' ALA . 1.8 tmt? -147.93 150.57 34.3 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.512 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 10.8 pt-20 -136.02 166.95 22.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.275 1.036 . . . . 0.0 111.152 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.465 ' N ' HD23 ' A' ' 46' ' ' LEU . 69.0 m -68.75 119.62 13.42 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.39 -25.69 4.77 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.59 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.566 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.2 m-20 -54.99 150.71 9.87 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.179 0.514 . . . . 0.0 111.625 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.267 0.8 OUTLIER -115.15 120.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 175.344 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.453 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.4 mm -78.03 119.35 26.7 Favored 'Isoleucine or valine' 0 C--O 1.302 3.82 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.496 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.9 t -100.63 -52.87 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.112 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 p -164.1 174.06 11.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.683 0.278 . . . . 0.0 111.543 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.95 152.6 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' CB ' ' H ' ' A' ' 94' ' ' ASP . 3.8 t30 -26.66 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.526 1.53 . . . . 0.0 112.725 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 t70 85.03 -52.42 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.26 1.824 . . . . 0.0 114.11 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -93.95 127.19 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.384 1.088 . . . . 0.0 113.322 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.15 89.37 5.99 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.605 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.27 9.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 122.408 1.099 . . . . 0.0 109.599 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.591 HD23 ' O ' ' A' ' 6' ' ' ARG . 23.6 tp -64.18 110.19 2.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.89 43.61 87.46 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.979 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.2 150.53 38.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -77.42 143.1 38.87 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.675 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' O ' HG11 ' A' ' 81' ' ' VAL . 73.0 t60 -47.7 -49.99 26.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.871 0.759 . . . . 0.0 112.191 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.84 75.29 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.829 0.706 . . . . 0.0 110.944 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -76.65 -50.4 13.83 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.881 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.31 -44.49 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.367 -178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 77' ' ' HIS . 10.9 p -64.79 -36.07 76.66 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.669 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.3 tmmm? -60.63 -45.84 92.52 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.733 178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -73.12 -50.32 32.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.394 1.092 . . . . 0.0 109.425 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.29 -28.69 69.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.467 -1.697 . . . . 0.0 113.306 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 15.6 mm-40 -88.19 -17.47 30.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 p -95.63 -4.07 45.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.499 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -61.99 154.52 68.3 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.959 0.409 . . . . 0.0 111.212 174.093 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 35.6 Cg_endo -102.86 153.57 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.778 3.652 . . . . 0.0 112.704 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.425 HG12 ' H ' ' A' ' 25' ' ' ARG . 59.9 mt -65.58 128.86 29.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.014 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.4 10.7 33.09 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.613 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.08 177.06 5.2 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.432 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.561 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 31.3 t -140.0 150.84 44.93 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 123.427 0.691 . . . . 0.0 110.155 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.8 m -155.55 164.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 124.894 1.278 . . . . 0.0 109.96 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.416 ' H ' ' CB ' ' A' ' 68' ' ' ASN . 14.5 m-20 -107.38 107.7 18.71 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.73 122.19 34.05 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -103.28 110.67 22.73 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -141.51 156.76 45.71 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 -175.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 84.7 m -111.5 126.41 54.93 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.566 ' HD3' ' OD1' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -97.3 146.11 25.45 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.17 -19.66 2.86 Favored Glycine 0 CA--C 1.491 -1.453 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.825 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -88.88 128.55 51.76 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-O 120.752 0.311 . . . . 0.0 110.82 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -89.42 177.62 2.72 Favored 'Trans proline' 0 N--CA 1.441 -1.614 0 C-N-CA 122.508 2.139 . . . . 0.0 110.59 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.59 81.06 39.63 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.78 59.18 1.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.704 2.936 . . . . 0.0 109.192 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -158.83 159.09 34.68 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 12.8 m-20 -82.96 130.78 56.21 Favored Pre-proline 0 CA--C 1.485 -1.554 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.188 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.3 Cg_endo -96.12 11.55 1.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.364 2.709 . . . . 0.0 106.484 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.445 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 27.2 t70 -106.31 -10.48 16.36 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 112.106 -2.315 . . . . 0.0 108.926 -175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -99.61 108.91 53.34 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.11 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 108' ' ' ASP . 17.4 Cg_exo -83.18 -140.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 124.177 3.251 . . . . 0.0 112.914 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 10.7 m120 100.33 -72.88 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 128.706 2.802 . . . . 0.0 114.137 169.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -178.29 172.46 1.53 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.487 ' OG ' ' HA ' ' B' ' 157' ' ' ARG . 69.2 m -93.77 109.99 21.64 Favored 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -75.31 136.93 40.85 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.389 177.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.71 106.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.879 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.9 t -96.2 148.72 22.43 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 p -144.77 171.42 14.44 Favored 'General case' 0 C--N 1.26 -3.32 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -94.32 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -145.8 79.16 1.55 Allowed 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.832 -174.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.1 -30.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.865 1.317 . . . . 0.0 107.656 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -17.06 17.17 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.532 -1.667 . . . . 0.0 111.199 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -155.69 94.61 1.58 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -132.59 129.27 38.75 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.94 -174.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.46 121.01 59.62 Favored Pre-proline 0 N--CA 1.412 -2.357 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.096 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 122.879 2.386 . . . . 0.0 112.433 -177.217 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.491 ' HD3' ' H ' ' B' ' 152' ' ' SER . 5.1 tpp180 . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.491 ' H ' ' HD3' ' B' ' 151' ' ' ARG . 17.2 m 82.16 -45.88 0.17 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.497 1.519 . . . . 0.0 110.845 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -87.8 133.15 33.93 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.628 ' HD3' ' OE1' ' A' ' 39' ' ' GLU . 10.0 tpp180 -115.28 122.14 45.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 22.2 m -114.6 -51.1 2.76 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.885 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.492 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 69.5 mtp180 61.45 72.04 0.53 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.73 0.776 . . . . 0.0 110.161 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.487 ' HA ' ' OG ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -77.18 127.1 32.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.812 -177.096 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 37.7 tt0 -72.99 110.97 7.68 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.243 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.444 ' HB ' HG21 ' A' ' 31' ' ' VAL . 12.3 m -115.23 97.89 6.46 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.412 ' HB2' HG23 ' A' ' 30' ' ' THR . 4.0 pm0 -76.95 120.4 22.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.842 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.547 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -84.38 -46.92 11.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.364 0.602 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 56.4 ttp -132.08 151.54 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . 112.33 14.72 10.38 Favored Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.871 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.483 ' HB2' ' HZ3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER -101.91 157.06 34.41 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.12 169.42 13.65 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 122.011 1.808 . . . . 0.0 110.666 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -66.92 134.36 51.87 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.524 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -146.76 140.11 25.61 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.297 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.361 12.1 t -154.61 -49.04 0.09 Allowed 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.798 161.342 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.444 ' O ' HD13 ' A' ' 73' ' ' LEU . 8.7 ptm85 153.88 -29.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 125.64 1.576 . . . . 0.0 107.44 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.77 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 21.5 t30 -57.78 114.43 8.43 Favored Pre-proline 0 C--N 1.266 -3.058 0 CA-C-N 112.145 -2.298 . . . . 0.0 114.136 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.259 7.2 Cg_exo -58.86 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.469 -2.737 0 C-N-CA 122.818 2.345 . . . . 0.0 110.666 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.416 ' HB2' ' OD1' ' A' ' 7' ' ' ASN . 71.4 m -79.58 -12.65 59.84 Favored 'General case' 1 N--CA 1.348 -5.53 0 CA-C-N 112.464 -2.153 . . . . 0.0 112.257 -173.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.77 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -78.45 -35.5 46.7 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -54.52 129.9 37.82 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.693 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -77.14 179.47 6.29 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.372 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.0 -114.84 4.16 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.962 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.592 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.59 154.22 46.43 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.084 0.554 . . . . 0.0 110.289 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -119.43 115.62 24.46 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.04 140.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.599 0.714 . . . . 0.0 111.234 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.735 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.1 t60 -124.77 99.59 6.23 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -112.8 133.62 54.71 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.562 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -75.68 137.27 40.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -125.95 121.59 33.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -77.91 123.06 26.31 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.642 ' N ' ' HZ1' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -52.1 108.33 0.28 Allowed 'General case' 0 CA--C 1.471 -2.085 0 C-N-CA 123.905 0.882 . . . . 0.0 112.151 174.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.1 t -83.49 -148.38 0.09 Allowed 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 126.754 2.534 . . . . 0.0 108.389 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -61.62 76.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.477 ' HD3' ' O ' ' A' ' 87' ' ' ILE . 23.7 mmt180 67.04 48.08 1.29 Allowed 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.43 1.11 . . . . 0.0 110.938 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.92 -123.05 1.45 Allowed Glycine 0 N--CA 1.4 -3.732 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.679 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.687 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.8 m-85 -130.47 -83.99 0.53 Allowed 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.068 -1.066 . . . . 0.0 110.637 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.551 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.78 49.89 0.12 Allowed Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.239 -171.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 27' ' ' PHE . 28.4 p90 -161.35 142.72 11.52 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 16.5 p -104.09 136.3 43.98 Favored 'General case' 0 C--N 1.259 -3.352 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 22.9 m -123.6 157.89 29.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 3.2 m -115.35 174.58 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 C-N-CA 125.281 1.432 . . . . 0.0 111.029 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.92 -130.4 9.89 Favored Glycine 0 CA--C 1.481 -2.089 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 29.92 59.46 0.2 Allowed Glycine 0 CA--C 1.473 -2.579 0 C-N-CA 127.523 2.487 . . . . 0.0 113.81 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.52 -28.44 7.85 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 114.166 -1.017 . . . . 0.0 108.505 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -158.37 169.97 9.7 Favored Pre-proline 0 CA--C 1.47 -2.111 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.959 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -61.91 -26.54 79.08 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.459 2.106 . . . . 0.0 109.6 -178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.47 -29.95 59.77 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 112.504 -2.135 . . . . 0.0 111.729 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -122.11 119.09 30.31 Favored 'General case' 0 C--O 1.27 2.165 0 O-C-N 121.77 -0.581 . . . . 0.0 110.739 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -85.97 166.11 16.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.941 2.496 . . . . 0.0 109.547 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.494 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.1 mp -88.33 145.57 25.76 Favored 'General case' 0 C--O 1.178 -2.702 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.846 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.4 tt0 -135.54 158.94 43.13 Favored 'General case' 0 C--O 1.18 -2.569 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 62' ' ' ASP . 18.9 mm -87.95 127.74 40.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.47 -22.83 13.59 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 48.8 m -155.04 126.94 7.57 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -83.53 106.39 15.22 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.9 t -85.36 135.8 24.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.87 0.843 . . . . 0.0 110.974 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.48 141.7 57.81 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.584 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.7 t70 78.94 4.6 2.38 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.722 1.249 . . . . 0.0 110.903 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.651 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.73 159.5 36.44 Favored Glycine 0 C--O 1.201 -1.955 0 CA-C-O 118.085 -1.397 . . . . 0.0 109.897 173.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.687 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.48 -24.54 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.825 0 CA-C-N 121.438 2.619 . . . . 0.0 109.678 -173.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.64 78.66 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.405 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.06 -48.24 63.26 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.572 1.177 . . . . 0.0 109.289 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 77.8 mt -72.08 -43.59 64.6 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 112.461 -2.154 . . . . 0.0 115.558 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.436 ' OD1' ' HE3' ' A' ' 57' ' ' LYS . 5.0 t0 -83.26 -20.75 33.92 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -140.89 19.04 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 119.913 -1.136 . . . . 0.0 110.87 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HE3' ' OD1' ' A' ' 55' ' ' ASP 0.344 0.0 OUTLIER 53.36 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.472 1.909 . . . . 0.0 115.42 -176.704 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 39.8 ttm -68.83 141.37 55.15 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 109.282 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -151.0 144.47 24.92 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 m -45.38 114.73 0.79 Allowed 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 124.635 1.209 . . . . 0.0 110.869 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.3 -30.42 3.03 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.501 ' O ' HG12 ' A' ' 43' ' ' ILE 0.375 0.9 OUTLIER -69.16 143.29 54.12 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.669 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.548 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -103.2 118.27 49.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.131 -174.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 mt -74.9 123.24 30.14 Favored 'Isoleucine or valine' 1 C--O 1.307 4.101 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 58.5 t -99.9 -45.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 111.498 -2.592 . . . . 0.0 110.105 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -160.27 170.67 20.62 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.356 -0.84 . . . . 0.0 112.016 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.93 112.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.184 0.516 . . . . 0.0 112.109 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 65.9 -48.04 0.4 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.489 2.316 . . . . 0.0 115.57 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.49 -39.86 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 125.605 1.562 . . . . 0.0 109.347 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 m -71.44 134.35 46.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.625 -175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.2 t -84.28 84.44 7.63 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.541 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -86.27 17.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 123.763 1.744 . . . . 0.0 109.796 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD13 ' O ' ' A' ' 6' ' ' ARG . 12.5 tp -71.72 110.83 6.53 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.48 -1.691 . . . . 0.0 106.459 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.46 36.72 92.97 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.471 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -77.16 128.29 34.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.9 m -62.58 145.82 53.45 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.208 0.943 . . . . 0.0 110.439 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -45.59 -51.42 12.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.189 0.596 . . . . 0.0 112.47 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.97 78.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 124.299 0.999 . . . . 0.0 110.538 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 74.5 mm-40 -76.03 -50.15 15.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.318 -175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.488 HG21 HD22 ' A' ' 41' ' ' LEU . 14.5 p -65.06 -42.24 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.827 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.85 -36.38 76.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -62.15 -41.5 98.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.243 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.0 -50.41 32.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 122.502 1.144 . . . . 0.0 109.717 -177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 7.5 m-85 -66.65 -35.59 80.54 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.446 -1.707 . . . . 0.0 112.969 -174.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -85.58 -13.51 48.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.2 t -77.73 -23.75 49.3 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.589 HD12 ' CE2' ' A' ' 27' ' ' PHE . 2.0 mt -48.37 136.62 12.13 Favored Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 86.0 Cg_endo -99.13 153.45 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.212 3.274 . . . . 0.0 112.398 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 25' ' ' ARG . 41.1 mt -68.6 140.59 18.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.107 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.51 12.31 61.28 Favored Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.012 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.483 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -105.9 -169.77 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.501 -171.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.401 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.1 p -149.27 138.46 21.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -169.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.488 HG23 ' HE2' ' A' ' 22' ' ' LYS . 27.3 m -145.56 156.13 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.735 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 31.7 m-20 -99.46 106.96 19.06 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 9.8 tp -95.96 125.94 40.85 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.015 0.436 . . . . 0.0 110.942 -174.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -107.74 115.2 29.72 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.639 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.21 157.68 44.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.235 0.541 . . . . 0.0 111.382 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.0 m -117.89 140.01 50.32 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.0 tpp85 -110.08 132.22 54.36 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.97 -30.21 0.14 Allowed Glycine 0 C--N 1.296 -1.671 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -93.65 141.6 24.04 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.56 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 43.3 Cg_endo -96.95 -162.88 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.953 2.436 . . . . 0.0 109.151 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.65 85.87 3.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 80.9 Cg_endo -91.79 50.96 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.492 2.795 . . . . 0.0 114.039 -170.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -172.95 164.26 4.97 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 4.4 m-20 -99.37 132.54 23.11 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.0 Cg_exo -92.74 0.45 3.79 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.136 2.557 . . . . 0.0 108.21 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.43 -27.51 63.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.995 -1.911 . . . . 0.0 109.04 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -83.58 131.02 53.69 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.35 -166.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.571 2.847 . . . . 0.0 114.869 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 m120 88.69 131.47 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 127.483 2.313 . . . . 0.0 110.651 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -67.69 -133.66 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.808 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' B' ' 157' ' ' ARG . 4.9 m -72.85 99.26 2.62 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.664 -1.272 . . . . 0.0 109.279 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.612 ' O ' ' HA ' ' B' ' 155' ' ' THR . 0.0 OUTLIER -93.64 132.99 37.44 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.828 175.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.42 131.48 39.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-O 120.974 0.416 . . . . 0.0 109.886 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 t -133.83 146.01 50.24 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.0 t -97.11 121.56 39.13 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.37 103.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -130.78 74.47 1.6 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.66 0.743 . . . . 0.0 109.056 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.2 mm -83.9 -55.77 6.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 122' ' ' ASP 0.449 4.3 pp 71.42 -56.51 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 165.464 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.459 ' N ' HD12 ' A' ' 121' ' ' LEU . 17.1 t70 -174.52 128.77 0.34 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.95 90.95 3.43 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.297 0.57 . . . . 0.0 111.156 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.47 142.73 24.99 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.273 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 122.413 2.075 . . . . 0.0 112.479 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.418 ' NH2' ' HG2' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -162.52 29.74 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.919 0.781 . . . . 0.0 112.781 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 62.7 m 57.05 43.26 24.67 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.136 0.97 . . . . 0.0 112.582 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -122.54 128.05 50.27 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 23.8 m 68.09 53.09 0.64 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -113.4 152.01 30.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.763 -171.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 0.0 OUTLIER -124.52 173.29 8.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.67 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 43.8 mt-10 -105.36 151.12 24.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 111.072 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -150.49 119.55 6.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.468 ' HA ' HG21 ' A' ' 30' ' ' THR . 29.3 tt0 -84.07 130.53 34.86 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 29' ' ' PHE . 10.7 m . . . . . 0 N--CA 1.407 -2.611 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -142.7 31.79 1.45 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.632 0.729 . . . . 0.0 109.566 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.37 60.06 5.87 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.659 0.742 . . . . 0.0 111.629 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -103.29 40.32 2.48 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.77 150.2 43.0 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.32 135.46 22.56 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.275 1.316 . . . . 0.0 110.755 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -101.91 130.5 48.43 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.381 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -146.97 143.03 28.15 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.881 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.415 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.355 12.9 t -157.67 -44.79 0.06 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.261 162.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.475 ' O ' HD23 ' A' ' 73' ' ' LEU . 15.6 ptm180 152.77 -19.45 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 126.667 1.987 . . . . 0.0 108.379 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.808 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.1 m-80 -66.42 118.46 53.87 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -171.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.307 21.4 Cg_exo -62.48 -35.87 69.01 Favored 'Trans proline' 0 CA--C 1.467 -2.844 0 N-CA-C 107.734 -1.679 . . . . 0.0 107.734 172.257 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m -66.78 -23.64 66.1 Favored 'General case' 1 N--CA 1.333 -6.297 0 CA-C-N 109.925 -3.307 . . . . 0.0 112.236 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.808 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.7 pt-20 -79.48 -30.9 42.24 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.1 mt -59.12 133.95 56.56 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.385 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -81.26 168.57 18.33 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.453 -1.703 . . . . 0.0 113.887 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 90.85 -114.61 4.49 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.61 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -140.8 146.51 37.72 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.551 1.14 . . . . 0.0 110.118 -178.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -113.56 116.91 30.26 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 154.47 40.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 123.403 0.681 . . . . 0.0 112.358 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.45 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.1 p-80 -126.71 112.5 15.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.263 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.488 ' OG1' ' HE2' ' A' ' 57' ' ' LYS . 7.5 t -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.308 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.42 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -85.07 136.61 33.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.2 mp -124.66 129.04 49.77 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 69.9 ttt180 -86.95 112.64 22.0 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.516 ' HG2' HG23 ' A' ' 87' ' ' ILE . 2.1 mptp? -36.12 111.26 0.13 Allowed 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 125.225 1.41 . . . . 0.0 111.579 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -89.0 -143.19 0.14 Allowed 'General case' 0 N--CA 1.415 -2.194 0 O-C-N 125.48 1.738 . . . . 0.0 108.186 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -58.89 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.438 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.8 mtp180 57.29 40.27 27.91 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 125.474 1.51 . . . . 0.0 112.486 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.75 -130.72 2.21 Favored Glycine 0 N--CA 1.406 -3.313 0 CA-C-N 113.49 -1.686 . . . . 0.0 108.956 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.4 m-85 -134.61 -75.58 0.46 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.07 46.53 0.2 Allowed Glycine 0 C--N 1.294 -1.765 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.239 -169.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.448 ' CD1' HD11 ' A' ' 43' ' ' ILE . 45.0 p90 -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 172.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.492 ' CG2' ' HG3' ' B' ' 160' ' ' GLN . 69.9 p -108.39 136.23 48.37 Favored 'General case' 0 C--N 1.271 -2.814 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.259 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.495 HG22 HD23 ' A' ' 41' ' ' LEU . 1.1 m -114.9 162.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 11.4 m -125.36 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.63 -132.03 10.03 Favored Glycine 0 C--O 1.27 2.4 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.244 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.555 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.95 45.27 7.53 Favored Glycine 0 CA--C 1.458 -3.472 0 C-N-CA 126.245 1.878 . . . . 0.0 112.594 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' HB2' ' B' ' 156' ' ' ARG . 18.6 t70 -95.12 -22.2 18.03 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-O 121.296 0.57 . . . . 0.0 110.612 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 39' ' ' GLU . 7.2 pt-20 -157.28 171.3 7.63 Favored Pre-proline 0 N--CA 1.413 -2.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 -168.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 51.5 Cg_exo -64.02 -36.28 49.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.874 1.716 . . . . 0.0 108.201 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.16 -27.24 66.25 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.982 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.425 ' N ' ' HG3' ' A' ' 36' ' ' GLU . 41.0 tt0 -125.5 117.69 24.16 Favored 'General case' 0 C--O 1.267 1.988 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.372 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -84.22 165.26 18.53 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 126.669 2.481 . . . . 0.0 108.25 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.4 mp -86.43 144.53 27.25 Favored 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.708 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -128.88 164.78 22.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.4 mm -107.04 123.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 118.795 0.725 . . . . 0.0 110.963 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' HA ' ' CD2' ' A' ' 103' ' ' LEU . 17.9 pttm -100.93 -26.69 13.65 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 123.436 0.46 . . . . 0.0 111.954 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.439 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 44.3 m -149.87 126.99 11.26 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.646 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.16 113.15 15.84 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 85.0 t -87.04 121.51 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.7 mt -67.4 142.73 56.62 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.33 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.429 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 34.9 t70 82.91 5.99 0.87 Allowed 'General case' 0 C--O 1.216 -0.668 0 O-C-N 125.103 1.502 . . . . 0.0 109.579 -172.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.638 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -88.81 165.4 33.34 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-O 118.113 -1.382 . . . . 0.0 110.175 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.672 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 27.9 Cg_endo -72.41 -25.47 18.17 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.338 2.569 . . . . 0.0 110.547 -170.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.441 ' HB1' HD21 ' A' ' 20' ' ' LEU . . . -68.66 -37.08 79.36 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.871 175.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.64 65.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 122.81 1.29 . . . . 0.0 109.264 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 81.2 mt -72.4 -46.19 56.35 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.537 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.48 -26.71 58.43 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.89 -165.88 51.43 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HE2' ' OG1' ' A' ' 18' ' ' THR . 6.2 ttpm? 72.81 -49.95 0.7 Allowed 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.429 ' HG2' HD13 ' A' ' 97' ' ' LEU . 1.5 tmt? -87.21 133.02 33.7 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.14 166.85 24.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.543 0.687 . . . . 0.0 111.359 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -58.12 129.89 44.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.438 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.86 -6.27 25.76 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.132 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.577 ' O ' HG12 ' A' ' 43' ' ' ILE . 14.8 m-20 -79.91 129.35 34.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 2.7 p -98.11 115.93 39.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.852 173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.3 mm -71.03 113.78 7.9 Favored 'Isoleucine or valine' 0 C--O 1.294 3.432 0 C-N-CA 125.078 1.351 . . . . 0.0 110.669 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.4 t -103.22 -54.72 6.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.687 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.8 t -144.92 160.27 41.58 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.077 -0.389 . . . . 0.0 110.159 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 p -146.31 105.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.487 ' CB ' HG12 ' A' ' 93' ' ' VAL . 27.6 t-20 65.97 -65.58 0.18 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.718 1.607 . . . . 0.0 114.341 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.22 -39.64 0.25 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 124.98 1.312 . . . . 0.0 108.884 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.5 m -70.04 127.33 32.48 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.304 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.2 t -87.26 87.23 7.38 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p -77.11 2.25 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 122.496 1.141 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 6' ' ' ARG . 22.9 tp -63.75 111.6 2.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.226 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.451 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 68.35 27.78 73.59 Favored Glycine 0 N--CA 1.425 -2.073 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.95 138.3 46.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.409 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 62.1 m -71.05 143.01 50.86 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.569 ' CG ' ' HA ' ' B' ' 156' ' ' ARG . 51.1 t-80 -49.08 -45.05 42.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -174.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.94 81.37 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.656 0.598 . . . . 0.0 110.471 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.409 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 73.4 mm-40 -69.32 -56.0 8.81 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.276 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.421 HG22 HD22 ' A' ' 41' ' ' LEU . 5.4 p -61.25 -47.36 93.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.598 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.1 p -62.7 -35.9 72.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.618 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -41.18 96.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 123.152 0.283 . . . . 0.0 111.418 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -51.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 122.401 1.096 . . . . 0.0 108.741 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -64.01 -30.26 71.35 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.236 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.598 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 tp-100 -85.96 -23.22 27.01 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.4 p -94.98 2.91 55.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.587 . . . . 0.0 111.511 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.516 HG23 ' HG2' ' A' ' 22' ' ' LYS . 7.0 mt -48.13 143.52 6.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.791 1.236 . . . . 0.0 114.081 173.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 39.8 Cg_endo -95.75 142.86 1.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.632 2.888 . . . . 0.0 110.467 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.438 HG12 ' H ' ' A' ' 25' ' ' ARG . 39.0 mt -68.45 142.97 15.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.835 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.66 72.34 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.068 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -98.65 -171.41 2.11 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.615 -171.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.42 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.7 p -147.85 138.24 22.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -168.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 68' ' ' ASN . 1.3 m -151.24 155.72 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.834 174.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.36 109.76 21.86 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.726 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.9 mm? -90.66 113.72 25.85 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 46.7 mt-10 -92.19 107.83 19.5 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.429 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -139.48 153.8 47.6 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 120.926 0.393 . . . . 0.0 110.545 -172.375 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.5 t -113.87 126.73 55.51 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.485 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.475 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 21.5 tpp85 -96.92 137.91 35.28 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.13 1.92 Allowed Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.772 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -79.87 134.91 56.12 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.274 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.493 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 83.4 Cg_endo -88.92 175.63 3.5 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.86 1.707 . . . . 0.0 109.643 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.435 ' CD2' ' HA ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER -112.6 86.41 8.45 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 10.5 Cg_endo -85.8 46.31 1.67 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.302 2.668 . . . . 0.0 111.12 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -156.27 176.89 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -103.44 132.36 21.16 Favored Pre-proline 0 C--N 1.288 -2.094 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 108' ' ' ASP . 16.6 Cg_endo -102.55 5.2 0.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.626 0 C-N-CA 123.495 2.796 . . . . 0.0 110.757 -172.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.442 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 17.5 t70 -96.8 -32.6 12.04 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.516 -176.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -45.82 130.3 6.86 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 126.202 1.801 . . . . 0.0 111.641 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -16.34 -94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.656 1 C-N-CA 127.645 5.563 . . . . 0.0 117.621 -177.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.642 ' N ' HD21 ' A' ' 111' ' ' ASN . 0.6 OUTLIER 65.2 88.46 0.1 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.904 1.682 . . . . 0.0 112.62 175.199 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -87.32 -158.74 0.46 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.854 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.534 ' HA ' ' CG2' ' B' ' 155' ' ' THR . 9.2 m -70.01 102.05 1.93 Allowed 'General case' 0 N--CA 1.414 -2.256 0 O-C-N 121.937 -0.477 . . . . 0.0 110.591 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' H ' HG21 ' B' ' 155' ' ' THR . 33.5 mt -77.63 105.24 8.67 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.22 132.54 65.48 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-O 121.254 0.55 . . . . 0.0 111.498 -173.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -80.46 142.03 34.67 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.6 p -86.13 91.15 8.34 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.697 0.761 . . . . 0.0 112.162 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -105.14 101.49 12.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.933 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 122' ' ' ASP . . . -135.59 79.71 1.79 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.2 -174.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.03 -14.24 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.72 -19.78 18.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.73 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.526 ' C ' ' HD3' ' A' ' 123' ' ' LYS . 8.6 t70 -88.5 -160.86 0.68 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.96 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' HD3' ' C ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER 38.99 38.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.852 2.061 . . . . 0.0 113.311 -176.789 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -73.81 111.23 11.4 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.066 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.433 -2.031 0 C-N-CA 122.819 2.346 . . . . 0.0 109.838 174.745 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -95.41 73.34 3.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.5 m -67.88 -87.36 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 43.07 32.64 0.45 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.384 1.088 . . . . 0.0 112.111 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 113' ' ' SER . 0.9 OUTLIER -83.54 -171.19 3.44 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 126.333 1.853 . . . . 0.0 112.026 -175.376 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.569 ' HA ' ' CG ' ' A' ' 77' ' ' HIS . 6.7 ptm180 -152.7 146.43 25.12 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.518 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 24.6 mmm180 72.4 -57.78 0.61 Allowed 'General case' 0 C--N 1.37 1.467 0 CA-C-N 120.314 1.416 . . . . 0.0 110.823 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.457 ' HB3' HE22 ' B' ' 160' ' ' GLN . 48.2 mm-40 -80.37 85.61 5.83 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.927 1.291 . . . . 0.0 113.44 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.402 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.43 93.28 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.422 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.492 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.7 mp0 -82.38 110.05 17.18 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.166 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.477 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 78.52 1.18 2.6 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.676 1.59 . . . . 0.0 114.687 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 95.7 mmm 52.34 62.66 2.58 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.311 1.444 . . . . 0.0 113.846 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -90.43 11.74 70.4 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.22 140.24 22.69 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.88 146.85 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.505 2.137 . . . . 0.0 110.822 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -93.05 128.49 38.95 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.151 0.501 . . . . 0.0 110.629 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -147.46 129.39 15.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.333 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.645 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.5 t -166.41 26.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.15 166.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.698 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.3 ptm180 57.21 19.14 4.67 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.921 2.088 . . . . 0.0 112.789 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.746 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.5 114.24 58.84 Favored Pre-proline 1 C--N 1.231 -4.549 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.081 176.451 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 10.5 Cg_exo -58.0 -29.49 86.92 Favored 'Trans proline' 0 CA--C 1.48 -2.214 0 C-N-CA 121.528 1.485 . . . . 0.0 109.278 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -71.46 -24.27 61.98 Favored 'General case' 1 N--CA 1.366 -4.658 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.671 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -79.33 -31.62 43.16 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.1 129.74 41.19 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.745 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -80.23 179.19 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.031 -1.895 . . . . 0.0 113.231 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.01 -126.59 8.01 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.845 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -128.54 146.87 50.71 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.91 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.18 116.87 28.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 153.39 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.736 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.638 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.8 t-160 -125.31 111.44 15.19 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.6 t -128.42 151.49 49.31 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 -178.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.93 136.34 42.94 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 2.4 mp -117.59 116.48 27.18 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -86.47 106.78 17.72 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.601 ' HD2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -36.86 117.72 0.53 Allowed 'General case' 0 CA--C 1.472 -2.035 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 25.2 t -87.87 -152.95 0.22 Allowed 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 126.236 2.21 . . . . 0.0 108.306 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.2 m -65.61 80.43 0.06 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' N ' HG12 ' A' ' 89' ' ' ILE . 24.4 mmt180 71.44 73.88 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.47 1.108 . . . . 0.0 111.392 174.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.48 -131.9 10.13 Favored Glycine 0 N--CA 1.405 -3.372 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.886 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.634 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.9 m-85 -129.08 -78.9 0.56 Allowed 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.437 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.597 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.64 55.41 0.18 Allowed Glycine 0 C--N 1.285 -2.265 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -170.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.458 ' CD1' HD13 ' A' ' 43' ' ' ILE . 19.3 p90 -162.2 146.5 12.28 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.0 p -108.31 135.04 50.29 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.219 1.009 . . . . 0.0 109.577 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 3.2 p -131.59 144.11 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.96 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.256 -167.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 20.0 m -120.42 132.54 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 124.317 1.047 . . . . 0.0 111.347 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 132.77 -139.19 10.73 Favored Glycine 0 N--CA 1.396 -3.997 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.51 44.37 5.2 Favored Glycine 0 C--O 1.18 -3.278 0 O-C-N 125.898 1.587 . . . . 0.0 110.184 -177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.655 ' OD2' ' HB2' ' B' ' 156' ' ' ARG . 15.9 t70 -82.44 -41.97 19.15 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 113.252 -1.474 . . . . 0.0 107.875 -172.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -160.28 170.88 7.89 Favored Pre-proline 0 CA--C 1.48 -1.712 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 -176.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -73.74 59.08 4.12 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 124.49 3.46 . . . . 0.0 108.842 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -166.88 -39.46 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 111.871 -2.422 . . . . 0.0 108.257 -172.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.21 122.23 38.67 Favored 'General case' 0 C--O 1.27 2.147 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.978 -178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.28 166.06 14.02 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 128.673 2.789 . . . . 0.0 109.937 -174.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -90.39 144.81 25.46 Favored 'General case' 0 C--O 1.168 -3.221 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.184 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 2.6 tt0 -138.53 145.33 40.59 Favored 'General case' 0 C--O 1.185 -2.34 0 CA-C-N 118.67 0.668 . . . . 0.0 109.575 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 ' O ' HD23 ' A' ' 103' ' ' LEU . 37.0 mm -88.27 121.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.99 0 O-C-N 121.477 -0.765 . . . . 0.0 111.855 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.537 ' O ' ' HB3' ' A' ' 107' ' ' PRO . 46.5 mtmt -101.39 -19.35 15.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.889 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.508 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 58.5 m -150.47 127.3 11.02 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.185 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 tp -84.02 109.15 17.42 Favored 'General case' 0 N--CA 1.386 -3.636 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.597 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.5 t -83.05 121.57 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.64 150.42 48.77 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.396 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 76.47 12.13 2.63 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 125.012 1.445 . . . . 0.0 109.59 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.639 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.45 160.83 27.06 Favored Glycine 0 C--O 1.201 -1.962 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.671 171.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 3.8 Cg_endo -71.97 -25.21 19.9 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 CA-C-N 121.672 2.736 . . . . 0.0 109.931 -172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.85 -45.15 93.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.99 174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.29 -45.51 80.14 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.367 1.079 . . . . 0.0 110.432 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.639 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.7 mt -72.18 -35.69 69.06 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.795 -172.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.473 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.7 t70 -83.57 -23.83 31.82 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.67 69.57 Favored Glycine 0 CA--C 1.492 -1.351 0 CA-C-N 113.219 -1.809 . . . . 0.0 113.287 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.488 ' HB2' ' HZ3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -99.72 -15.62 18.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.963 -0.618 . . . . 0.0 111.142 -173.481 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.444 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 35.5 ttm -122.98 139.73 53.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -147.41 164.0 34.72 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.478 0.656 . . . . 0.0 109.469 -175.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.435 HG21 ' C ' ' A' ' 44' ' ' LYS . 8.5 m -54.2 117.91 3.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.914 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.94 -1.67 9.19 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.583 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.603 ' CG ' HD12 ' A' ' 97' ' ' LEU . 1.2 p30 -102.25 156.61 17.46 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.664 -0.903 . . . . 0.0 112.667 172.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -113.18 122.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.748 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.05 116.69 19.44 Favored 'Isoleucine or valine' 0 C--O 1.304 3.964 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.14 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.6 t -99.4 -53.84 7.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.758 -176.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.4 m -143.44 161.83 37.39 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.131 -0.981 . . . . 0.0 112.189 -176.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.19 97.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.896 0.855 . . . . 0.0 112.501 -175.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 65.12 -84.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.769 1.628 . . . . 0.0 112.918 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.34 -7.23 3.77 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.295 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.5 m -98.72 133.16 43.44 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.479 0.657 . . . . 0.0 109.336 -178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 t -87.65 82.79 7.31 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.9 p -75.81 -3.08 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.774 1.274 . . . . 0.0 109.471 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.698 HD21 ' O ' ' A' ' 6' ' ' ARG . 22.4 tp -64.23 111.03 2.41 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.384 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 38.87 96.76 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.644 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.44 149.92 31.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.7 m -73.24 141.92 47.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.5 ' O ' HG13 ' A' ' 81' ' ' VAL . 39.6 t-80 -52.89 -47.89 67.57 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 118.893 0.77 . . . . 0.0 112.026 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.75 -35.4 68.57 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -76.2 -50.47 14.42 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.277 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 77' ' ' HIS . 6.6 p -61.12 -44.42 98.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 123.312 0.382 . . . . 0.0 111.531 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 77' ' ' HIS . 14.8 p -64.02 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.686 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.27 -42.86 87.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.52 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -72.89 -51.04 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.32 1.057 . . . . 0.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -65.01 -30.58 71.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 113.506 -1.679 . . . . 0.0 113.51 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -85.95 -22.76 27.22 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 122.112 -0.368 . . . . 0.0 111.88 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.0 m -79.33 -14.82 58.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.808 0.337 . . . . 0.0 110.95 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.517 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.7 mt -47.94 135.67 11.18 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.0 Cg_endo -99.58 156.46 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.35 3.367 . . . . 0.0 111.43 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.57 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -68.02 138.53 22.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.816 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.46 55.83 Favored Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.554 -1.308 . . . . 0.0 112.079 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.39 -175.37 3.19 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.058 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.517 ' N ' ' HE3' ' A' ' 22' ' ' LYS . 11.4 p -148.22 136.82 21.58 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 m -154.16 147.84 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 124.02 0.928 . . . . 0.0 111.229 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.638 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 1.9 m-20 -105.22 108.13 19.49 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 124.272 1.029 . . . . 0.0 109.519 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.8 mm? -91.43 124.25 35.48 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.349 0.595 . . . . 0.0 111.715 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -97.31 119.0 35.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.9 pt? -142.7 159.06 42.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 60.4 m -120.49 108.52 14.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.131 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.28 144.5 28.06 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.776 0.831 . . . . 0.0 108.807 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.99 14.84 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.574 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -88.5 127.09 57.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.574 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 25.4 Cg_endo -60.64 151.92 72.58 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.633 2.222 . . . . 0.0 113.86 -173.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.47 HD23 ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -110.37 76.83 1.13 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.01 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 22.0 Cg_endo -92.67 37.69 0.23 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.863 2.376 . . . . 0.0 109.736 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.456 ' CD2' ' HD2' ' A' ' 104' ' ' PRO . 57.6 m-85 -138.22 149.98 46.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.432 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 17.7 t70 -79.38 136.38 56.52 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.537 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.3 Cg_endo -91.35 -8.3 3.27 Favored 'Trans proline' 0 N--CA 1.411 -3.324 0 C-N-CA 123.381 2.721 . . . . 0.0 110.533 -171.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.83 -29.06 16.16 Favored 'General case' 0 N--CA 1.38 -3.94 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.021 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.87 109.15 0.98 Allowed Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 127.621 2.368 . . . . 0.0 115.683 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -90.83 -146.64 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 124.204 3.27 . . . . 0.0 110.584 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 m120 76.81 87.31 0.08 Allowed 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 126.415 1.886 . . . . 0.0 112.795 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.488 ' OG1' ' HG3' ' B' ' 154' ' ' ARG . 12.1 t -129.54 160.82 32.04 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.944 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.601 ' O ' ' HA ' ' B' ' 155' ' ' THR . 26.6 m -137.04 101.07 4.45 Favored 'General case' 0 N--CA 1.383 -3.8 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 170.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -80.94 122.0 26.71 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.66 109.75 24.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.8 t -74.1 148.35 41.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.8 m -99.62 134.04 43.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.242 0.544 . . . . 0.0 112.088 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.89 123.11 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.021 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.46 83.53 2.63 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.315 0.579 . . . . 0.0 111.607 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.1 mm -98.32 -39.01 7.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -130.55 170.99 13.53 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.511 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.92 72.96 0.5 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.919 1.343 . . . . 0.0 112.62 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 131.83 54.18 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -80.04 116.87 64.4 Favored Pre-proline 0 C--N 1.289 -2.051 0 O-C-N 123.547 0.53 . . . . 0.0 110.991 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.436 -1.864 0 C-N-CA 122.564 2.176 . . . . 0.0 109.859 174.147 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 121.124 0.488 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.1 m -159.29 -60.57 0.07 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.1 p -152.33 116.36 4.9 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.488 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 6.1 tpp180 -131.7 72.15 1.49 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.603 0.716 . . . . 0.0 109.332 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.601 ' HA ' ' O ' ' A' ' 113' ' ' SER . 12.8 p -110.16 -10.89 14.64 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.239 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.655 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 3.5 mpt_? -141.44 -148.75 0.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 33' ' ' GLY 0.327 83.8 mtt180 82.01 -68.47 0.08 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . 0.256 10.7 pt-20 -84.05 96.02 8.76 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -172.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.444 ' HB ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -100.86 120.65 40.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -99.75 115.59 29.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 21.8 m . . . . . 0 N--CA 1.434 -1.242 0 O-C-N 123.38 0.425 . . . . 0.0 109.973 -175.261 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.0 -29.72 58.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.889 0.376 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -97.8 55.23 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.991 0.9 . . . . 0.0 109.481 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.461 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . -107.12 36.12 4.6 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.961 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 160.56 26.5 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.2 35.84 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.904 1.736 . . . . 0.0 110.141 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -81.5 131.05 35.26 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.592 -172.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 38' ' ' ASP . 24.3 t80 -148.13 134.22 19.29 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.66 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -171.11 35.72 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.153 167.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.582 ' O ' HD21 ' A' ' 73' ' ' LEU . 28.8 ptt180 50.64 26.83 2.64 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.994 2.118 . . . . 0.0 113.662 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.771 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 9.8 m-80 -103.18 114.56 65.01 Favored Pre-proline 1 C--N 1.236 -4.362 0 CA-C-N 113.588 -1.642 . . . . 0.0 114.264 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 11.9 Cg_exo -55.95 -33.93 90.53 Favored 'Trans proline' 0 CA--C 1.479 -2.227 0 C-N-CA 121.583 1.522 . . . . 0.0 109.197 168.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 t -65.97 -26.73 67.7 Favored 'General case' 1 N--CA 1.371 -4.378 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.648 -177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.771 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -77.81 -31.95 52.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.08 133.94 55.94 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.254 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HE2' ' O ' ' A' ' 100' ' ' GLY . 17.1 ptmt -82.53 -177.52 6.72 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.579 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 84.73 -112.63 3.66 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.479 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 4.6 ptmt -146.46 149.13 33.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.017 0.927 . . . . 0.0 109.565 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.37 116.11 28.41 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -131.15 152.44 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.44 0.638 . . . . 0.0 111.846 -177.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.73 110.69 12.88 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.027 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -129.53 142.6 50.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -73.44 133.86 43.82 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.424 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.3 128.01 53.74 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -82.96 108.33 16.2 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.331 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.538 ' CG ' HG21 ' A' ' 87' ' ' ILE . 2.4 mptp? -40.04 106.34 0.05 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 124.144 0.978 . . . . 0.0 111.136 170.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -127.38 141.58 51.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 125.131 1.52 . . . . 0.0 110.141 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 54.73 32.63 17.82 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.477 1.511 . . . . 0.0 114.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.576 ' HD3' ' O ' ' A' ' 87' ' ' ILE . 23.9 mmt180 73.79 53.89 0.11 Allowed 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 122.63 1.205 . . . . 0.0 109.605 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.26 -120.45 1.17 Allowed Glycine 0 N--CA 1.401 -3.7 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.696 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.0 m-85 -135.48 -78.52 0.43 Allowed 'General case' 0 C--N 1.275 -2.649 0 C-N-CA 122.743 0.417 . . . . 0.0 111.763 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.96 48.56 0.12 Allowed Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.728 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.404 ' HA ' HG21 ' A' ' 47' ' ' VAL . 50.9 p90 -161.47 143.53 11.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.508 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 37.9 p -105.11 135.48 46.38 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.598 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.79 147.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.107 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.63 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 15.2 m -120.32 135.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.867 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.37 -131.25 8.28 Favored Glycine 0 C--N 1.281 -2.522 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.523 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 36.82 60.08 1.03 Allowed Glycine 0 CA--C 1.479 -2.182 0 C-N-CA 126.647 2.07 . . . . 0.0 113.99 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -115.76 -18.68 10.75 Favored 'General case' 0 C--N 1.25 -3.742 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.712 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.35 168.43 12.49 Favored Pre-proline 0 CA--C 1.466 -2.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -61.38 -38.52 63.74 Favored 'Trans proline' 0 CA--C 1.49 -1.708 0 C-N-CA 122.074 1.85 . . . . 0.0 108.513 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . 29.1 t70 -73.15 -12.06 60.75 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 111.961 -2.381 . . . . 0.0 111.709 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 32.2 tt0 -132.34 118.18 19.09 Favored 'General case' 0 C--O 1.279 2.61 0 O-C-N 121.823 -0.548 . . . . 0.0 111.74 174.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -85.76 166.19 16.29 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.748 2.819 . . . . 0.0 107.981 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.523 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -91.2 145.17 24.89 Favored 'General case' 0 C--O 1.17 -3.129 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.891 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.4 tt0 -128.91 160.44 32.64 Favored 'General case' 0 C--O 1.169 -3.146 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' N ' HD13 ' A' ' 43' ' ' ILE . 1.2 mp -105.65 127.19 60.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.497 ' HG3' ' CG2' ' A' ' 32' ' ' VAL 0.305 42.1 mtmt -113.28 -7.94 13.52 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.926 172.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.508 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 73.1 m -149.69 127.51 11.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.632 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.89 117.69 24.06 Favored 'General case' 0 N--CA 1.404 -2.77 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.491 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 86.4 t -88.29 128.55 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.05 145.99 41.9 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 81.44 5.72 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 125.501 1.75 . . . . 0.0 108.502 -171.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.575 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.45 159.52 38.82 Favored Glycine 0 C--O 1.204 -1.758 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.42 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.696 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 19.9 Cg_endo -72.8 -25.78 16.55 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 120.853 2.327 . . . . 0.0 109.971 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -45.23 90.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.428 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.24 -50.94 63.89 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.681 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.575 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.5 mt -71.48 -36.5 71.18 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 112.688 -2.051 . . . . 0.0 114.854 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -79.75 -19.7 48.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.0 108.751 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.54 42.97 99.87 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.827 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.99 -25.47 2.52 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.035 -0.583 . . . . 0.0 111.485 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.481 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 1.6 tmt? -120.24 146.03 46.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -142.9 166.99 23.14 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.557 1.17 . . . . 0.0 113.498 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.4 m -63.57 123.04 17.8 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 113.807 -1.542 . . . . 0.0 107.469 171.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.21 -11.23 10.71 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.965 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.473 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 15.0 m-20 -74.34 157.9 34.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -128.22 123.81 61.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 49.2 mm -73.93 113.18 11.76 Favored 'Isoleucine or valine' 0 C--O 1.3 3.733 0 C-N-CA 125.041 1.336 . . . . 0.0 110.683 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.9 t -105.4 -54.79 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 126.019 2.074 . . . . 0.0 110.673 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.438 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 40.3 t -147.56 158.33 43.95 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.959 -0.463 . . . . 0.0 110.943 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.91 89.52 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 CA-C-O 122.22 1.01 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.435 43.6 p30 42.15 -89.12 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -171.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -93.53 -30.95 14.74 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.827 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.7 m -91.25 131.11 36.98 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.085 0.945 . . . . 0.0 110.962 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.7 t -88.69 86.63 7.03 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.253 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.51 1.59 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 122.54 1.162 . . . . 0.0 109.628 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.582 HD21 ' O ' ' A' ' 6' ' ' ARG . 28.7 tp -60.68 111.7 1.72 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.999 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.43 38.6 95.04 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.41 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.415 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -81.07 133.23 35.44 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -62.36 145.29 54.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.509 ' HB2' ' HE ' ' B' ' 157' ' ' ARG . 2.6 t60 -45.61 -51.89 11.46 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.622 0.646 . . . . 0.0 112.19 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.92 72.65 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 124.102 0.877 . . . . 0.0 111.186 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -80.55 -47.36 14.32 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.489 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 12.0 p -65.17 -42.28 93.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 77' ' ' HIS . 14.3 p -65.87 -37.79 80.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.676 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -58.86 -45.16 90.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.307 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.1 mt -73.75 -51.21 25.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-O 122.174 0.988 . . . . 0.0 109.615 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.92 -29.48 69.9 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.098 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -86.32 -23.81 26.11 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -80.25 -12.0 59.67 Favored 'General case' 0 C--O 1.249 1.062 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.813 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.576 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 6.7 mt -47.69 139.98 8.41 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.8 1.24 . . . . 0.0 113.5 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.5 Cg_endo -99.0 145.11 0.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.894 3.062 . . . . 0.0 111.333 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.459 HG12 ' H ' ' A' ' 25' ' ' ARG . 37.7 mt -68.3 142.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.45 11.32 57.27 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.431 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -105.43 -177.03 3.25 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.828 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.438 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.8 p -148.95 145.89 27.59 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 0.2 OUTLIER -153.37 158.41 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 C-N-CA 123.754 0.822 . . . . 0.0 111.038 174.323 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -96.55 107.5 19.93 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.45 114.04 26.0 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.438 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 30.3 mt-10 -97.7 111.75 23.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.411 HD13 ' CG ' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.07 157.46 45.27 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.799 -173.383 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.0 t -112.55 130.2 56.1 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.481 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 21.6 tpp85 -103.17 152.38 21.52 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' O ' ' HE2' ' A' ' 12' ' ' LYS . . . 110.9 8.18 24.43 Favored Glycine 0 CA--C 1.493 -1.283 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.366 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -90.21 118.78 69.1 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.452 ' C ' ' HD3' ' A' ' 104' ' ' PRO . 51.5 Cg_endo -69.24 153.88 70.63 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.395 2.063 . . . . 0.0 115.079 -172.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.63 73.64 4.32 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.3 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.452 ' HD3' ' C ' ' A' ' 102' ' ' PRO . 7.5 Cg_endo -89.06 -3.31 6.17 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.54 2.16 . . . . 0.0 110.906 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.8 137.91 53.81 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.438 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -78.46 154.06 79.01 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 -171.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -102.02 3.13 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.603 2.869 . . . . 0.0 108.115 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.08 -54.17 4.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.83 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.59 137.58 82.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.866 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -56.9 -155.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.503 3.469 . . . . 0.0 115.428 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 m120 82.23 122.59 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 125.805 1.642 . . . . 0.0 110.232 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 m -66.21 -32.49 73.95 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.233 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.472 ' HA ' ' OG1' ' B' ' 155' ' ' THR . 0.0 OUTLIER -85.92 115.98 23.87 Favored 'General case' 0 C--N 1.257 -3.438 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.054 176.848 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' B' ' 155' ' ' THR . 12.0 mt -100.39 104.29 15.71 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 m -110.95 133.05 57.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.034 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.2 t -103.2 142.34 34.34 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.8 m -78.03 119.59 21.67 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.502 ' O ' ' HE2' ' A' ' 123' ' ' LYS . 3.3 p -93.28 99.95 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 122.459 1.123 . . . . 0.0 110.673 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.73 73.1 0.99 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.461 HG22 ' HA2' ' A' ' 0' ' ' GLY . 47.5 mm -136.95 -44.73 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.23 135.74 54.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 170.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -81.89 85.98 6.58 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.156 0.979 . . . . 0.0 112.124 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.554 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -106.85 109.84 21.84 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 171.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.81 99.92 7.57 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.039 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 3.4 Cg_endo . . . . . 0 N--CA 1.439 -1.712 0 C-N-CA 122.877 2.384 . . . . 0.0 111.23 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.7 t -100.14 -55.47 2.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.168 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.9 m -106.61 157.11 17.93 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.199 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -127.12 22.71 6.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.765 . . . . 0.0 109.85 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 1.7 t -137.52 120.87 16.98 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.111 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 10.2 mmt180 -63.34 136.28 57.56 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 3.3 tmm_? -90.32 144.23 26.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -101.91 125.43 48.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.919 -0.488 . . . . 0.0 110.555 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 23.2 m -132.51 117.73 18.38 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.504 ' HA ' HG21 ' A' ' 30' ' ' THR . 53.9 tt0 -79.62 122.41 26.48 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.354 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 N--CA 1.408 -2.569 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.665 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -91.24 -0.75 57.74 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 121.08 0.467 . . . . 0.0 111.899 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.0 ttt -124.46 44.06 2.85 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.86 3.44 87.0 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.288 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -92.46 146.45 32.47 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.32 123.23 11.49 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.092 1.861 . . . . 0.0 110.19 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.09 155.5 26.26 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 113.075 -1.875 . . . . 0.0 113.286 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -145.42 132.26 20.11 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.155 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -161.77 29.64 0.12 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 167.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 61.13 36.1 18.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.585 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.789 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -121.86 120.11 28.67 Favored Pre-proline 0 C--N 1.268 -2.95 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 16.3 Cg_exo -62.92 -32.93 76.55 Favored 'Trans proline' 0 CA--C 1.473 -2.528 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 172.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -71.09 -22.25 62.13 Favored 'General case' 1 N--CA 1.365 -4.708 0 CA-C-N 111.899 -2.41 . . . . 0.0 110.97 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.789 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.2 pt-20 -77.07 -36.62 55.7 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.409 ' CD2' ' HH ' ' A' ' 101' ' ' TYR . 95.9 mt -54.28 131.31 41.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.271 0.982 . . . . 0.0 111.146 176.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -86.06 169.16 13.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.048 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.57 -108.24 3.65 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.249 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 144.88 29.95 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 122.834 0.453 . . . . 0.0 110.911 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -111.19 122.08 46.95 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.465 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -135.57 152.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.26 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.649 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.1 t60 -128.27 101.49 6.26 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -117.66 137.02 52.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.15 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -79.17 133.6 36.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.115 -0.366 . . . . 0.0 110.273 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -118.02 119.46 34.87 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -81.25 104.64 11.86 Favored 'General case' 0 N--CA 1.403 -2.797 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.88 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.585 ' CG ' HG23 ' A' ' 87' ' ' ILE . 1.9 mptp? -33.41 106.76 0.04 OUTLIER 'General case' 0 CA--C 1.483 -1.632 0 C-N-CA 125.357 1.463 . . . . 0.0 112.112 174.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 t -81.65 -150.78 0.08 Allowed 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 125.983 2.052 . . . . 0.0 108.283 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -61.69 83.25 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.41 ' H ' HG12 ' A' ' 89' ' ' ILE . 27.2 mtp85 58.31 44.26 18.82 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.852 1.261 . . . . 0.0 113.66 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.6 -133.91 3.83 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.624 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.4 m-85 -129.77 -77.79 0.55 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.604 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.62 52.1 0.16 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.741 -171.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.495 ' CD2' HD12 ' A' ' 43' ' ' ILE . 37.2 p90 -161.64 142.6 11.0 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.473 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.4 p -106.25 136.56 45.75 Favored 'General case' 0 C--N 1.265 -3.074 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.269 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 17.5 m -123.39 158.02 28.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.887 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG11 ' HD2' ' A' ' 44' ' ' LYS . 8.9 m -121.53 133.06 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.854 0 C-N-CA 124.334 1.053 . . . . 0.0 109.599 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.64 -142.06 13.34 Favored Glycine 0 CA--C 1.455 -3.708 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.009 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.431 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.45 57.07 1.5 Allowed Glycine 0 CA--C 1.458 -3.475 0 O-C-N 127.136 2.316 . . . . 0.0 111.385 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -104.72 -32.16 9.0 Favored 'General case' 0 C--N 1.251 -3.676 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -137.76 170.68 9.93 Favored Pre-proline 0 N--CA 1.405 -2.701 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.102 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 32.0 Cg_exo -71.81 -8.72 23.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.296 2.664 . . . . 0.0 108.709 174.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -111.67 -10.66 14.07 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.837 1.655 . . . . 0.0 110.811 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.82 120.18 30.99 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 121.999 -0.438 . . . . 0.0 109.989 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -87.32 165.45 15.62 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 127.444 2.297 . . . . 0.0 110.61 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 5.5 mp -93.15 145.24 24.56 Favored 'General case' 0 C--O 1.176 -2.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.304 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 37.0 tt0 -133.92 155.91 49.06 Favored 'General case' 0 C--O 1.162 -3.515 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 HD12 ' CD2' ' A' ' 29' ' ' PHE . 12.2 mm -87.27 126.38 41.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 118.88 0.764 . . . . 0.0 109.243 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.437 ' HD2' HG11 ' A' ' 32' ' ' VAL . 20.9 ptmt -102.09 -23.46 14.07 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 123.137 0.273 . . . . 0.0 110.317 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 38.7 m -151.49 126.43 9.74 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.88 108.96 19.0 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.604 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 79.8 t -85.76 127.63 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 121.87 0.843 . . . . 0.0 111.661 -173.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.52 85.33 4.6 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.459 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t70 165.12 -22.52 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 125.115 1.509 . . . . 0.0 109.822 -170.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.57 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -99.55 166.28 20.6 Favored Glycine 0 CA--C 1.48 -2.116 0 CA-C-N 115.456 -0.793 . . . . 0.0 114.045 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 6.1 Cg_endo -67.72 -23.85 41.71 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.142 1.895 . . . . 0.0 111.077 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' HB2' ' HB2' ' A' ' 58' ' ' MET . . . -58.35 -52.34 66.01 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.971 0.909 . . . . 0.0 111.395 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.552 ' HB1' ' CD2' ' A' ' 54' ' ' LEU . . . -73.74 -37.15 65.18 Favored 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 122.879 1.324 . . . . 0.0 110.049 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.57 HD23 ' O ' ' A' ' 50' ' ' GLY . 1.0 OUTLIER -71.25 -38.44 71.92 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 111.755 -2.475 . . . . 0.0 111.175 -170.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.87 -26.07 37.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.564 1.173 . . . . 0.0 108.049 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.73 86.06 Favored Glycine 0 CA--C 1.481 -2.076 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.429 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -122.08 0.67 9.68 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.694 -174.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.61 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 67.3 mtp -128.04 159.2 35.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.42 164.16 30.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.476 0.655 . . . . 0.0 110.719 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -71.24 116.73 11.9 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 131.36 -23.89 4.24 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.456 ' O ' HG12 ' A' ' 43' ' ' ILE . 7.3 m-20 -58.16 140.96 51.86 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 120.716 0.294 . . . . 0.0 110.62 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.323 0.2 OUTLIER -109.17 115.96 50.85 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-O 121.578 0.704 . . . . 0.0 111.891 174.23 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.465 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.8 mm -68.82 114.62 5.88 Favored 'Isoleucine or valine' 0 C--O 1.301 3.777 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.791 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.1 t -95.83 -58.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 112.361 -2.199 . . . . 0.0 110.1 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.5 m -158.31 173.32 16.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.0 -0.438 . . . . 0.0 110.471 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.1 p -145.55 153.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.413 ' HB3' HG13 ' A' ' 93' ' ' VAL . 9.8 t30 -31.31 113.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.01 1.324 . . . . 0.0 111.782 172.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 75.04 -38.9 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.98 1.712 . . . . 0.0 115.231 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -100.2 122.66 43.38 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.894 0.854 . . . . 0.0 111.497 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.4 t -83.56 83.38 7.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.973 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.55 -2.62 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.346 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -66.77 110.48 3.28 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.623 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.12 28.51 70.13 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.74 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.428 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.05 140.97 43.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 122.017 -0.696 . . . . 0.0 109.693 178.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 m -74.78 143.61 43.93 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 117.526 -1.225 . . . . 0.0 108.044 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -47.84 -49.46 29.17 Favored 'General case' 0 CA--C 1.485 -1.52 0 CA-C-N 118.952 0.796 . . . . 0.0 111.7 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.05 74.33 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 124.758 1.286 . . . . 0.0 111.084 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -75.23 -53.37 8.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -61.65 -42.66 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.579 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 8.9 p -62.49 -45.34 99.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 C-N-CA 121.264 -0.174 . . . . 0.0 110.532 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -57.12 -41.51 79.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.697 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -72.65 -50.23 35.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.161 0.981 . . . . 0.0 108.912 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.95 -29.1 70.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.453 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.7 pt20 -86.69 -24.01 25.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -93.08 2.81 56.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.585 HG23 ' CG ' ' A' ' 22' ' ' LYS . 4.3 mt -51.19 144.04 15.95 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.964 1.306 . . . . 0.0 113.618 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -92.74 140.43 1.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.517 2.811 . . . . 0.0 111.048 176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.41 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.9 mt -68.49 138.91 21.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.47 12.52 62.77 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.493 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -101.48 -171.47 1.99 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.648 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.526 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.5 t -148.88 144.39 26.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.855 -0.528 . . . . 0.0 112.187 -171.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.441 HG12 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -152.95 154.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 C-N-CA 124.221 1.008 . . . . 0.0 110.25 173.463 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 5.5 m-20 -99.74 107.7 19.83 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.9 tp -99.73 115.24 29.04 Favored 'General case' 0 C--N 1.269 -2.929 0 CA-C-O 120.803 0.335 . . . . 0.0 110.166 -174.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -103.3 123.8 47.46 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.421 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.4 OUTLIER -141.52 163.26 33.4 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.705 -173.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.2 t -116.69 128.33 55.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.61 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 22.2 tpp85 -103.66 152.49 21.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.88 -43.03 1.26 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.409 ' HH ' ' CD2' ' A' ' 11' ' ' LEU . 84.9 m-85 -67.74 135.96 92.49 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 114.644 -0.778 . . . . 0.0 109.342 174.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.422 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 47.6 Cg_endo -97.38 -161.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 122.72 2.28 . . . . 0.0 109.014 172.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.65 81.0 11.07 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 86.9 Cg_endo -91.83 7.46 3.25 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 123.282 2.655 . . . . 0.0 114.475 -170.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -144.92 121.63 11.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.447 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 8.9 m-20 -79.24 125.98 82.35 Favored Pre-proline 0 CA--C 1.481 -1.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.1 Cg_exo -95.05 -0.95 2.55 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 123.059 2.506 . . . . 0.0 107.337 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.84 -37.32 67.47 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.042 -1.89 . . . . 0.0 107.654 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.55 123.86 89.82 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.18 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.05 -175.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 123.657 2.905 . . . . 0.0 115.647 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 80.71 43.48 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.7 2.0 . . . . 0.0 110.761 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 55.8 m -94.68 138.31 32.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.643 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.0 m -124.29 102.44 7.69 Favored 'General case' 0 N--CA 1.395 -3.213 0 C-N-CA 123.815 0.846 . . . . 0.0 111.127 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' B' ' 157' ' ' ARG . 1.8 mm? -77.27 123.84 27.02 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.07 0.462 . . . . 0.0 110.02 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 12.2 m -111.03 133.33 56.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.3 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 t -71.19 142.53 50.65 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -87.05 149.8 24.48 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.4 t -93.59 100.12 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.419 ' N ' HD11 ' A' ' 120' ' ' ILE . . . -148.53 74.06 1.26 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 119' ' ' ALA . 4.3 mp -121.23 -16.45 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.766 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 pp -108.14 -166.01 1.09 Allowed 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.841 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -54.07 103.97 0.09 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.365 1.079 . . . . 0.0 112.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -113.4 101.3 9.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.707 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -76.85 118.1 69.46 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.439 -1.72 0 C-N-CA 122.086 1.858 . . . . 0.0 112.523 -177.725 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 . . . . . 0 CA--C 1.505 -0.778 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 23.1 t 62.98 -167.13 0.22 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.082 0.864 . . . . 0.0 112.251 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.5 m -156.93 52.58 0.5 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 125.861 1.664 . . . . 0.0 106.733 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 70.12 85.97 0.13 Allowed 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 125.137 1.375 . . . . 0.0 109.996 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.9 -156.65 0.33 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 174.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 73.9 mtt180 78.76 130.16 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.052 0.941 . . . . 0.0 112.901 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' B' ' 158' ' ' GLU . 22.5 tpt180 -109.34 141.65 41.38 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.4 pm0 -75.25 116.83 16.41 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-O 121.816 0.817 . . . . 0.0 110.374 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.499 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 18.1 m -105.4 110.21 22.47 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.456 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.1 mp0 -85.17 104.44 15.05 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.7 m . . . . . 0 N--CA 1.428 -1.546 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.439 -177.66 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.846 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -90.66 -36.61 14.28 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 66.5 mtt -114.39 -177.29 3.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.274 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 91.41 28.96 13.07 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.5 157.31 54.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.81 133.52 34.17 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.695 1.597 . . . . 0.0 108.508 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -88.23 154.97 20.01 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 8.9 t80 -148.65 134.35 18.83 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.153 -1.84 . . . . 0.0 110.116 175.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.499 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 15.0 t -174.14 26.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 124.439 1.096 . . . . 0.0 109.478 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.499 ' HG2' ' O ' ' A' ' 5' ' ' THR . 33.2 ptt180 56.97 14.03 1.74 Allowed 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 127.486 2.314 . . . . 0.0 114.889 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.699 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 14.4 m-80 -92.6 124.7 58.24 Favored Pre-proline 1 C--N 1.241 -4.135 0 CA-C-N 114.18 -1.373 . . . . 0.0 113.109 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.272 11.3 Cg_exo -60.35 -32.57 94.21 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 122.046 1.83 . . . . 0.0 108.781 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -68.72 -22.86 64.31 Favored 'General case' 1 N--CA 1.367 -4.59 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.219 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.6 pt-20 -79.34 -38.5 35.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.43 130.06 44.58 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.509 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -77.34 177.95 7.54 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.153 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.25 -122.65 6.55 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.321 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' A' ' 99' ' ' ARG . 13.4 mmmm -107.8 149.61 28.01 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 123.473 0.709 . . . . 0.0 109.317 -177.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.51 111.25 16.59 Favored 'General case' 1 C--N 1.241 -4.121 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 151.99 36.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.952 0.882 . . . . 0.0 112.854 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.566 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.2 t60 -132.95 103.45 6.07 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -128.66 140.15 51.9 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.238 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -73.54 135.2 43.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.495 177.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.84 120.87 37.73 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.401 ' C ' ' HZ2' ' A' ' 22' ' ' LYS . 24.3 ttm180 -72.73 124.29 25.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.116 0.484 . . . . 0.0 109.9 -176.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.651 ' N ' ' HZ2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -57.56 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 123.59 0.756 . . . . 0.0 110.989 171.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -107.93 126.11 52.3 Favored 'General case' 0 N--CA 1.405 -2.707 0 O-C-N 126.187 2.179 . . . . 0.0 108.09 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.5 m 47.15 56.34 6.96 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.297 1.439 . . . . 0.0 113.974 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.645 ' N ' HG12 ' A' ' 89' ' ' ILE . 19.9 mmt180 68.31 42.71 1.62 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.248 0.547 . . . . 0.0 112.123 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.9 -124.43 1.48 Allowed Glycine 0 N--CA 1.403 -3.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.235 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.624 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -132.74 -87.06 0.45 Allowed 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 114.367 -0.916 . . . . 0.0 111.753 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.473 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 123.9 52.28 0.2 Allowed Glycine 0 C--N 1.289 -2.062 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -167.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.468 ' CD1' HD13 ' A' ' 43' ' ' ILE . 18.0 p90 -160.71 143.72 13.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.503 HG21 ' HA ' ' B' ' 160' ' ' GLN . 17.3 p -107.45 135.14 49.44 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 122.173 0.987 . . . . 0.0 109.68 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.704 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 3.5 p -130.46 137.61 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.753 -169.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 4.6 m -114.49 154.1 15.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 125.03 1.332 . . . . 0.0 113.545 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.86 -127.88 9.37 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.547 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 40.53 74.66 0.14 Allowed Glycine 1 CA--C 1.449 -4.068 0 O-C-N 126.648 2.028 . . . . 0.0 113.194 178.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -130.75 -20.44 2.86 Favored 'General case' 0 C--N 1.259 -3.333 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.169 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 7.7 pt-20 -156.68 170.92 8.1 Favored Pre-proline 0 N--CA 1.415 -2.203 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.031 -166.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 75.8 Cg_exo -61.14 -38.13 69.43 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 122.649 2.233 . . . . 0.0 108.895 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 13.1 t70 -72.22 -25.3 61.6 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.88 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -127.36 118.83 24.89 Favored 'General case' 0 C--O 1.274 2.367 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.134 -177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.584 ' CD1' HD11 ' A' ' 73' ' ' LEU . 3.1 m-85 -87.27 165.67 15.49 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 128.134 2.574 . . . . 0.0 108.795 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 6.1 mp -89.27 147.01 24.36 Favored 'General case' 0 C--O 1.18 -2.582 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.077 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' OE1' HD22 ' A' ' 103' ' ' LEU . 6.6 tt0 -136.04 144.99 45.55 Favored 'General case' 0 C--O 1.175 -2.844 0 CA-C-N 118.698 0.681 . . . . 0.0 109.163 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 62' ' ' ASP . 34.4 mm -83.25 117.81 29.75 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 O-C-N 121.599 -0.688 . . . . 0.0 111.081 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.56 -18.95 19.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -159.6 127.84 4.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 pp -82.31 117.04 22.09 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.473 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 90.3 t -83.45 129.24 37.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.1 142.05 54.8 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.117 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 80.09 5.29 1.84 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.58 1.175 . . . . 0.0 109.744 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.724 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -93.31 160.38 24.7 Favored Glycine 0 CA--C 1.484 -1.904 0 CA-C-O 118.153 -1.359 . . . . 0.0 109.886 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 32.1 Cg_endo -72.01 -25.21 19.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.95 2.375 . . . . 0.0 110.208 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -61.03 -49.25 78.16 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.468 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.91 86.53 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.134 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.724 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.0 mt -72.06 -38.3 69.5 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 112.921 -1.945 . . . . 0.0 114.55 -172.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.505 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 12.9 t70 -71.75 -27.26 62.86 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.66 2.72 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.887 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.505 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 17.3 ptpt -77.32 -34.34 55.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.824 1.312 . . . . 0.0 112.549 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.551 ' SD ' ' HB1' ' A' ' 52' ' ' ALA . 1.0 OUTLIER -79.44 139.04 37.78 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.76 167.94 21.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.458 1.123 . . . . 0.0 112.242 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.2 m -61.23 135.37 57.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.573 173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.87 -16.03 43.77 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' O ' HG12 ' A' ' 43' ' ' ILE . 10.4 m-20 -66.47 132.99 49.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.268 0.2 OUTLIER -101.13 120.71 51.05 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.759 176.094 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -73.0 115.62 14.08 Favored 'Isoleucine or valine' 0 C--O 1.302 3.848 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.15 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.8 t -102.2 -58.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 126.395 2.309 . . . . 0.0 109.814 -176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 13.4 m -146.3 172.06 14.05 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 13.7 p -144.43 154.78 14.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -34.18 112.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 64.36 15.59 9.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.2 1.4 . . . . 0.0 114.045 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.1 m -142.18 125.15 16.17 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.477 1.132 . . . . 0.0 112.493 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.5 108.94 14.54 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.231 -1.35 . . . . 0.0 107.967 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 41.1 t -86.04 -2.71 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 40' ' ' PHE . 2.6 mm? -66.92 123.28 19.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.205 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 36' ' ' GLU . . . 81.46 9.44 85.81 Favored Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.832 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.555 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.8 111.03 10.73 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 92.1 m -62.0 149.73 40.02 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.23 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -47.55 -43.79 25.44 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.97 0.804 . . . . 0.0 111.713 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -36.01 82.49 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 82' ' ' LYS . 27.5 mm-40 -79.32 -48.27 14.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.291 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 14.9 p -63.87 -40.74 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.137 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.51 -36.27 76.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 4.5 tmmm? -57.2 -47.97 79.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.44 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.2 mt -72.94 -50.28 33.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 CA-C-O 122.283 1.039 . . . . 0.0 109.883 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.508 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 5.4 m-85 -63.96 -38.04 89.62 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.308 -1.769 . . . . 0.0 114.017 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 -86.2 -19.87 29.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.117 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.8 m -75.6 -17.62 59.97 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.653 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.571 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.8 mt -44.74 135.68 4.65 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.463 1.105 . . . . 0.0 113.459 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 74.0 Cg_endo -97.79 154.42 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.179 3.253 . . . . 0.0 112.127 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.645 HG12 ' N ' ' A' ' 25' ' ' ARG . 7.3 mt -69.05 143.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.263 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.24 11.93 71.5 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.832 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.479 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -105.45 -170.5 1.76 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.88 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.9 p -149.66 138.29 20.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.581 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 27.5 m -133.47 152.3 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.373 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.07 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.566 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -94.23 107.32 19.26 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.08 123.3 45.71 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.335 0.588 . . . . 0.0 109.995 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.1 tt0 -103.17 115.14 30.0 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.444 HD12 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.92 159.13 42.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.584 -175.402 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.3 t -122.57 140.06 53.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.467 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 20.1 tpp85 -110.64 142.2 42.85 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.71 -18.19 1.63 Allowed Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.914 -1.136 . . . . 0.0 111.89 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -97.45 112.39 61.03 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.4 131.08 9.36 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 N-CA-C 106.144 -2.291 . . . . 0.0 106.144 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.483 HD22 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -41.08 100.14 0.22 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 124.98 1.312 . . . . 0.0 109.72 -176.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.15 23.47 0.84 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.525 2.817 . . . . 0.0 113.927 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.419 ' O ' HD13 ' A' ' 103' ' ' LEU . 47.7 p90 -162.38 156.74 21.66 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 m-20 -103.05 127.99 28.65 Favored Pre-proline 0 C--N 1.273 -2.747 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -93.55 1.61 3.32 Favored 'Trans proline' 0 N--CA 1.431 -2.19 0 C-N-CA 122.884 2.389 . . . . 0.0 107.636 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.83 -20.1 28.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.298 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.422 ' CG ' ' HD2' ' A' ' 110' ' ' PRO . 32.0 t70 -93.8 159.19 35.15 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.655 1.982 . . . . 0.0 106.121 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 109' ' ' ASP . 16.9 Cg_exo -45.66 -165.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 124.718 3.612 . . . . 0.0 117.588 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 68.81 66.35 0.3 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.447 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 t -86.82 177.79 7.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 113.043 -1.889 . . . . 0.0 111.208 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.488 ' HB2' ' CB ' ' B' ' 157' ' ' ARG . 33.5 t -87.21 101.59 13.65 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.776 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.539 HD21 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -89.44 124.1 34.17 Favored 'General case' 0 N--CA 1.382 -3.826 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.41 HG23 HG21 ' B' ' 155' ' ' THR . 48.3 t -92.67 105.74 17.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -71.34 141.8 50.42 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 m -109.17 89.26 2.94 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.44 100.87 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.263 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.016 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.1 73.02 0.83 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.4 mm -126.61 -3.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 164.33 27.25 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.181 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.12 134.33 43.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 101.87 14.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.174 -177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.11 110.93 41.84 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 CA--C 1.534 0.514 0 C-N-CA 122.716 2.277 . . . . 0.0 112.088 -178.444 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.485 ' H1 ' ' CD ' ' A' ' 36' ' ' GLU . 10.7 ptp180 . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p 61.88 16.6 8.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.695 1.598 . . . . 0.0 114.459 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' SER . . . . . 0.433 ' C ' ' HD2' ' B' ' 154' ' ' ARG 0.255 58.3 m -88.49 -104.07 0.08 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.174 175.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.49 ' O ' HD11 ' A' ' 114' ' ' LEU . 5.5 mpt_? -135.76 -83.39 0.39 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 118.3 -1.36 . . . . 0.0 114.615 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.41 HG21 HG23 ' A' ' 115' ' ' VAL . 14.3 m -88.67 12.98 13.31 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.565 0.698 . . . . 0.0 112.662 -165.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.469 ' HD2' ' O ' ' B' ' 156' ' ' ARG . 0.0 OUTLIER -52.07 109.81 0.42 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.53 1.132 . . . . 0.0 113.813 177.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.488 ' CB ' ' HB2' ' A' ' 113' ' ' SER . 17.5 ttp180 175.54 -153.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.704 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.1 pm0 -82.77 142.4 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 17.9 m -114.11 109.76 18.94 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 102.527 -3.138 . . . . 0.0 102.527 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.503 ' HA ' HG21 ' A' ' 30' ' ' THR . 46.9 tt0 -86.94 96.07 10.13 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.564 0.697 . . . . 0.0 111.078 -174.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 20.0 m . . . . . 0 N--CA 1.418 -2.036 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.205 -173.61 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.995 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.42 97.19 1.58 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 94.7 mmm 66.5 71.37 0.39 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.348 1.059 . . . . 0.0 112.705 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -88.95 4.75 84.87 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.69 148.02 43.41 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.31 141.95 40.21 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 121.582 1.521 . . . . 0.0 109.945 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -104.65 143.25 33.33 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.256 0.551 . . . . 0.0 112.258 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -146.93 133.3 19.59 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.067 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.424 HG23 ' OE1' ' A' ' 10' ' ' GLU . 13.6 t -168.76 37.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.181 0 O-C-N 124.438 1.086 . . . . 0.0 108.36 166.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.611 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.0 ptt180 46.15 36.12 2.99 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 126.249 1.82 . . . . 0.0 112.974 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.777 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -108.14 111.54 61.85 Favored Pre-proline 1 C--N 1.219 -5.096 0 CA-C-N 112.29 -2.232 . . . . 0.0 113.645 178.783 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.299 17.3 Cg_exo -58.13 -36.44 97.9 Favored 'Trans proline' 0 CA--C 1.478 -2.306 0 C-N-CA 121.757 1.638 . . . . 0.0 109.355 172.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 m -66.01 -26.65 67.63 Favored 'General case' 1 N--CA 1.36 -4.941 0 CA-C-N 111.284 -2.689 . . . . 0.0 112.571 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.777 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.1 pt-20 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.7 131.58 48.38 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -80.94 -175.18 5.24 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.097 -1.411 . . . . 0.0 113.365 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.2 -119.77 4.95 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.468 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.17 157.87 45.11 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 123.821 0.848 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.93 111.11 16.67 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.27 135.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.264 0.554 . . . . 0.0 111.378 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.419 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 21.6 t60 -112.66 99.65 8.1 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.442 ' CB ' ' HG2' ' A' ' 57' ' ' LYS . 10.6 t -118.34 140.16 50.26 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.298 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -81.24 130.41 35.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.1 mp -115.73 132.56 56.6 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -92.13 119.57 31.91 Favored 'General case' 0 N--CA 1.387 -3.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.484 ' HG3' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -53.21 99.97 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 166.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.522 ' O ' HG23 ' A' ' 89' ' ' ILE . 70.9 m -87.25 -54.89 4.06 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 124.509 1.131 . . . . 0.0 113.365 -167.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -144.89 70.8 1.28 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.455 ' N ' HG12 ' A' ' 89' ' ' ILE . 29.2 mmt180 67.78 78.8 0.23 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 104.63 -141.31 15.26 Favored Glycine 0 N--CA 1.411 -3.017 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.063 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.701 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.4 m-85 -119.3 -82.33 0.64 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.325 -0.938 . . . . 0.0 111.562 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.24 50.34 0.2 Allowed Glycine 0 C--N 1.291 -1.948 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.995 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CD2' HD11 ' A' ' 43' ' ' ILE . 46.2 p90 -161.59 143.35 11.52 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.1 p -104.73 146.21 29.27 Favored 'General case' 0 C--N 1.256 -3.46 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.71 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 43' ' ' ILE . 29.9 m -128.26 157.2 40.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG11 ' HD2' ' A' ' 44' ' ' LYS . 10.5 m -119.74 132.59 69.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 C-N-CA 124.959 1.304 . . . . 0.0 110.205 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 124.88 -144.25 15.08 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.485 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.57 61.56 3.24 Favored Glycine 0 CA--C 1.466 -2.986 0 O-C-N 125.93 1.606 . . . . 0.0 112.048 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.68 -32.7 6.57 Favored 'General case' 0 C--N 1.261 -3.274 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.403 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.03 170.43 8.93 Favored Pre-proline 0 CA--C 1.478 -1.791 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.633 -171.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.92 63.29 8.11 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.968 3.112 . . . . 0.0 107.76 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.78 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 111.822 -2.445 . . . . 0.0 106.851 -172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.33 119.52 39.27 Favored 'General case' 0 C--O 1.269 2.122 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.357 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' O ' ' HA3' ' A' ' 33' ' ' GLY . 37.7 m-85 -95.09 164.91 12.68 Favored 'General case' 0 N--CA 1.508 2.427 0 C-N-CA 127.858 2.463 . . . . 0.0 108.408 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.496 ' O ' HG21 ' A' ' 63' ' ' VAL . 4.7 mp -96.3 144.83 26.12 Favored 'General case' 0 C--O 1.169 -3.151 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.609 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 tt0 -134.49 151.34 51.07 Favored 'General case' 0 C--O 1.168 -3.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 62' ' ' ASP . 11.6 mm -78.46 126.6 38.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HD2' HG11 ' A' ' 32' ' ' VAL . 10.3 ptmm? -105.35 -22.21 13.08 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 122.342 0.257 . . . . 0.0 111.188 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 15.9 m -156.03 126.91 6.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.3 tp -83.29 114.77 21.62 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 57.4 t -90.45 119.88 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.63 144.0 55.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.319 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 83.49 8.02 0.65 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 125.412 1.695 . . . . 0.0 109.702 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.627 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.16 158.11 27.62 Favored Glycine 0 C--O 1.203 -1.817 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 172.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 58.5 Cg_endo -73.22 -25.37 15.84 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 CA-C-N 121.852 2.826 . . . . 0.0 110.112 -170.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.84 94.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.189 174.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.31 66.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-O 122.621 1.2 . . . . 0.0 110.076 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 89.1 mt -71.4 -48.07 52.1 Favored 'General case' 0 N--CA 1.395 -3.191 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.875 -172.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.9 t70 -70.52 -28.29 64.83 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.07 26.97 70.74 Favored Glycine 0 CA--C 1.487 -1.707 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.828 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -90.62 -20.53 22.45 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.457 -0.871 . . . . 0.0 109.563 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 66.3 mtp -125.72 152.35 45.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.872 -174.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.37 167.34 26.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.603 0.716 . . . . 0.0 111.882 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.404 HG22 ' C ' ' A' ' 44' ' ' LYS . 7.3 m -60.4 116.52 4.35 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.56 -42.03 1.43 Allowed Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.559 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.3 148.94 50.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.302 0.3 OUTLIER -110.51 119.15 58.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -172.403 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.1 mm -64.83 115.03 2.78 Favored 'Isoleucine or valine' 0 C--O 1.302 3.842 0 C-N-CA 126.478 1.911 . . . . 0.0 110.765 178.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.0 t -98.49 -58.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.183 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.9 m -154.9 173.35 16.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.306 -0.871 . . . . 0.0 112.147 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 9.8 p -140.97 159.32 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -31.96 105.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.396 1.478 . . . . 0.0 114.76 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.95 33.78 9.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.772 1.629 . . . . 0.0 112.224 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.459 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 15.5 m -140.61 120.71 13.76 Favored 'General case' 0 N--CA 1.421 -1.901 0 O-C-N 121.424 -0.797 . . . . 0.0 109.371 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 24.1 t -81.58 77.07 8.47 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.516 -177.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 91.2 t -74.08 -8.0 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 123.173 1.463 . . . . 0.0 108.62 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 6' ' ' ARG . 24.7 tp -64.89 111.13 2.68 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.138 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.71 74.01 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.477 -176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -74.6 139.78 43.89 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 30.7 m -72.84 145.08 47.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 117.458 -1.258 . . . . 0.0 108.381 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.412 ' O ' HG13 ' A' ' 81' ' ' VAL . 70.3 t60 -47.33 -48.44 25.3 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.276 0.944 . . . . 0.0 112.216 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.44 70.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.816 0.698 . . . . 0.0 110.843 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 64.8 mm-40 -80.14 -49.4 11.74 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.835 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.2 p -63.72 -42.68 96.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.445 -178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.633 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.5 p -65.33 -36.05 76.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.834 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 38.6 ttpt -55.26 -48.19 74.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.436 0.294 . . . . 0.0 111.428 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -72.27 -50.26 37.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 122.706 1.241 . . . . 0.0 109.515 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.34 -28.27 68.54 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.024 -1.898 . . . . 0.0 112.792 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.633 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.1 mp0 -86.65 -22.93 25.84 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 p -90.0 -18.48 25.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.484 HD13 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -54.47 151.41 14.27 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -102.84 163.05 0.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.874 3.716 . . . . 0.0 112.283 -177.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 23' ' ' SER . 64.4 mt -67.92 131.91 32.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.931 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.28 10.97 46.74 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.79 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.88 -179.2 4.09 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 118.456 1.128 . . . . 0.0 111.82 -175.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.431 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 17.2 t -138.68 153.62 48.56 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 109.94 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.3 m -153.89 151.16 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 C-N-CA 124.341 1.057 . . . . 0.0 110.391 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.536 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 14.8 m-20 -95.57 107.59 19.78 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.04 116.39 31.88 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.29 125.05 52.72 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.396 0.617 . . . . 0.0 110.77 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 2.1 pt? -141.95 163.21 33.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.656 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 78.7 m -109.57 124.4 51.07 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.328 0.585 . . . . 0.0 110.662 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 6.7 tpp85 -98.95 147.31 25.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.32 -28.88 2.44 Favored Glycine 0 CA--C 1.486 -1.773 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -86.58 135.08 36.54 Favored Pre-proline 0 N--CA 1.429 -1.502 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.404 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.582 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 72.0 Cg_endo -98.05 -162.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.615 2.21 . . . . 0.0 107.223 168.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.98 98.96 3.13 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 7.3 Cg_exo -74.01 -8.62 21.36 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.217 2.611 . . . . 0.0 112.012 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -151.62 139.9 20.35 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.55 149.07 71.03 Favored Pre-proline 0 CA--C 1.485 -1.532 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -95.91 10.41 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 123.415 2.743 . . . . 0.0 108.448 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.42 -32.64 32.61 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 113.353 -1.748 . . . . 0.0 108.606 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.24 121.84 85.37 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.127 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.8 -164.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 124.52 3.48 . . . . 0.0 116.068 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 m120 84.61 13.02 0.27 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.318 2.247 . . . . 0.0 113.393 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t 42.88 -142.67 0.11 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.243 1.417 . . . . 0.0 111.575 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.9 m -60.74 101.88 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.424 ' O ' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -97.9 136.72 37.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-O 121.681 0.753 . . . . 0.0 112.819 -178.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 m -117.36 131.99 68.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.9 t -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.9 m -105.2 89.58 3.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 122.434 1.111 . . . . 0.0 108.786 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.435 HG21 HG12 ' A' ' 120' ' ' ILE . 7.1 p -96.3 132.64 40.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.103 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.06 74.34 5.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.592 0.71 . . . . 0.0 112.783 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 118' ' ' VAL . 33.0 mm -132.37 13.97 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.439 ' H ' HD21 ' A' ' 121' ' ' LEU . 1.5 pt? -82.81 -71.08 0.51 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.712 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -159.98 115.86 2.42 Favored 'General case' 0 C--N 1.258 -3.376 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -121.49 143.54 49.2 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 120.906 0.384 . . . . 0.0 110.076 -169.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -81.6 133.26 52.98 Favored Pre-proline 0 C--N 1.286 -2.165 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.444 -1.431 0 C-N-CA 122.13 1.887 . . . . 0.0 111.187 177.114 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . 0.274 58.6 p 63.95 -97.05 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.56 1.544 . . . . 0.0 115.029 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -72.55 70.26 0.91 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.191 0.996 . . . . 0.0 113.176 -175.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -131.67 3.64 4.18 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.367 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 11.4 m -84.06 55.32 3.26 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.381 1.086 . . . . 0.0 108.836 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -90.12 128.54 36.35 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.856 -174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -99.73 142.3 31.39 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.41 132.96 36.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.297 0.57 . . . . 0.0 111.468 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 15.0 m -132.78 122.82 25.08 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -92.77 110.77 22.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.839 -177.769 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.367 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -151.81 -79.94 0.11 Allowed 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.12 0.96 . . . . 0.0 112.997 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.4 ttt -58.29 118.29 5.35 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . 0.466 ' C ' ' HD3' ' A' ' 1' ' ' LYS . . . 103.61 -7.57 50.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.183 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.466 ' HD3' ' C ' ' A' ' 0' ' ' GLY . 0.0 OUTLIER -143.07 174.01 4.02 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -177.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.02 155.58 9.86 Favored 'Trans proline' 0 N--CA 1.435 -1.916 0 N-CA-C 108.017 -1.57 . . . . 0.0 108.017 165.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -94.11 137.96 32.71 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -141.31 132.05 25.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.057 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 33.0 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.025 165.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 41.81 42.86 2.33 Favored 'General case' 0 C--N 1.372 1.558 0 C-N-CA 126.527 1.931 . . . . 0.0 113.189 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.804 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.6 m-80 -112.5 119.45 43.44 Favored Pre-proline 1 C--N 1.223 -4.893 0 CA-C-N 112.412 -2.177 . . . . 0.0 113.315 176.263 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.317 24.1 Cg_exo -60.71 -37.33 79.74 Favored 'Trans proline' 0 CA--C 1.474 -2.491 0 C-N-CA 121.788 1.659 . . . . 0.0 108.436 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.1 m -64.8 -23.62 67.3 Favored 'General case' 1 N--CA 1.346 -5.653 0 CA-C-N 109.848 -3.342 . . . . 0.0 112.432 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.804 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.9 pt-20 -80.97 -34.59 32.99 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.9 mt -55.79 129.98 41.57 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 122.772 1.273 . . . . 0.0 112.052 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.84 173.74 7.85 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 112.801 -1.999 . . . . 0.0 112.376 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.576 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 78.01 -121.35 5.7 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.525 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.67 155.52 49.55 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.916 0.486 . . . . 0.0 109.914 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.33 111.63 20.37 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.41 152.88 37.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-O 121.484 0.659 . . . . 0.0 111.961 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -125.91 113.79 17.67 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.664 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.443 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 11.2 t -125.48 137.3 53.96 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.269 0.557 . . . . 0.0 110.633 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -74.82 131.35 40.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.561 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.46 126.31 53.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.45 105.46 17.63 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.551 ' CG ' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -39.8 113.97 0.39 Allowed 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 175.754 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.8 t -89.26 -149.65 0.19 Allowed 'General case' 0 N--CA 1.406 -2.628 0 O-C-N 126.182 2.176 . . . . 0.0 107.951 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -61.96 80.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.468 ' N ' HG12 ' A' ' 89' ' ' ILE . 17.4 mmm180 65.54 56.9 0.91 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.59 -131.55 5.22 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.149 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.658 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -130.0 -83.64 0.55 Allowed 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.305 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.574 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 135.03 53.18 0.07 OUTLIER Glycine 0 C--N 1.297 -1.595 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.877 -170.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.447 ' CD1' HD11 ' A' ' 43' ' ' ILE . 35.4 p90 -162.39 152.11 16.09 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.527 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.3 p -112.03 144.07 42.0 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.051 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 76.1 t -113.45 149.38 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.072 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 42' ' ' GLN . 1.2 m -119.87 129.76 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.47 -132.7 9.15 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.511 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 33.46 59.98 0.5 Allowed Glycine 1 CA--C 1.445 -4.327 0 O-C-N 126.215 1.773 . . . . 0.0 111.391 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.55 -29.6 9.55 Favored 'General case' 0 C--N 1.252 -3.67 0 CA-C-N 113.933 -1.134 . . . . 0.0 109.214 -170.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -159.15 173.78 4.65 Favored Pre-proline 0 CA--C 1.483 -1.606 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.655 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 73.6 Cg_exo -62.22 -25.95 77.24 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.907 2.405 . . . . 0.0 109.921 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.66 -22.76 27.75 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.996 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.44 119.98 31.61 Favored 'General case' 0 C--O 1.264 1.849 0 O-C-N 121.735 -0.603 . . . . 0.0 110.368 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -86.62 164.87 16.58 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.766 2.026 . . . . 0.0 110.805 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.8 mp -89.16 144.82 25.84 Favored 'General case' 0 C--O 1.183 -2.398 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.2 tt0 -138.76 158.73 43.68 Favored 'General case' 0 C--O 1.188 -2.16 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.447 HD11 ' CD1' ' A' ' 29' ' ' PHE . 32.0 mm -92.6 124.15 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 122.527 0.331 . . . . 0.0 110.216 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -104.85 -18.93 14.05 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 123.452 0.47 . . . . 0.0 110.404 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.527 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 54.4 m -154.94 127.63 8.03 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.904 0.383 . . . . 0.0 110.539 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.2 tp -81.14 106.72 13.35 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.574 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.1 t -79.82 115.02 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.95 143.52 57.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.614 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.44 ' HA ' HD23 ' A' ' 54' ' ' LEU . 33.1 t70 79.43 14.69 1.01 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 125.252 1.595 . . . . 0.0 109.51 -172.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -97.18 165.27 22.73 Favored Glycine 0 C--O 1.207 -1.579 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.5 Cg_endo -72.51 -25.12 18.22 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 121.816 2.808 . . . . 0.0 110.772 -169.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.458 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.81 -45.41 89.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.77 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.36 -46.08 71.05 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 124.637 1.175 . . . . 0.0 110.301 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 92.2 mt -71.66 -34.01 69.36 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.506 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.482 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 14.1 t70 -77.91 -27.6 49.54 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.59 29.33 69.83 Favored Glycine 0 CA--C 1.484 -1.898 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.336 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 5.0 tppp? -97.12 -50.81 4.45 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.209 -0.995 . . . . 0.0 111.349 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.475 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 62.7 mtp -88.86 158.34 18.14 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.352 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.78 159.0 43.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 m -62.98 118.68 8.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.28 -31.18 3.05 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' O ' HG12 ' A' ' 43' ' ' ILE . 9.1 m-20 -53.25 140.43 26.59 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.018 0.481 . . . . 0.0 111.615 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.5 OUTLIER -107.8 114.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.175 0.512 . . . . 0.0 111.497 175.805 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.48 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -70.25 116.5 11.58 Favored 'Isoleucine or valine' 0 C--O 1.298 3.641 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.166 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.3 t -99.57 -59.17 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.395 -176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 p -151.79 166.21 32.07 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.452 -175.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.95 110.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.88 ' ND2' ' HB ' ' A' ' 93' ' ' VAL . 14.7 m-80 43.13 65.21 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 76.46 -38.05 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.663 1.585 . . . . 0.0 112.869 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 m -59.23 122.74 14.61 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.728 0.775 . . . . 0.0 110.382 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -83.33 76.75 9.88 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.602 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 43.8 t -77.93 -7.18 10.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.635 176.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.2 tp -69.43 110.7 4.86 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 76.84 32.68 48.97 Favored Glycine 0 N--CA 1.411 -2.974 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.959 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -88.78 137.26 32.48 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.456 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 38.1 m -72.35 144.18 48.35 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 117.942 -1.028 . . . . 0.0 108.838 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CD2' ' HD3' ' B' ' 157' ' ' ARG . 67.2 t60 -47.71 -50.86 23.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 119.046 0.839 . . . . 0.0 112.849 -176.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.7 72.15 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.64 0.587 . . . . 0.0 110.969 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.456 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 33.5 mm-40 -75.95 -52.46 10.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.362 0.601 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -64.43 -43.49 96.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.811 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.8 p -63.57 -35.84 74.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.413 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.83 95.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.905 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.2 -50.54 35.73 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 122.383 1.087 . . . . 0.0 109.455 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.13 -34.87 79.43 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.83 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 72.0 mm-40 -85.9 -15.2 42.47 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -82.72 -16.43 48.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.225 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.551 HG23 ' CG ' ' A' ' 22' ' ' LYS . 5.5 mt -43.8 138.82 3.04 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 53.4 Cg_endo -95.96 148.06 1.28 Allowed 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 123.478 2.786 . . . . 0.0 110.858 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' SER . 20.2 mt -67.54 139.86 20.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.72 57.08 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.851 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.96 -176.65 3.5 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.007 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 5.9 p -149.39 138.13 21.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.909 -0.495 . . . . 0.0 111.828 -173.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.88 ' HB ' ' ND2' ' A' ' 68' ' ' ASN . 2.5 m -153.36 143.18 14.54 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 C-N-CA 122.645 0.378 . . . . 0.0 111.953 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.674 ' N ' HD22 ' A' ' 68' ' ' ASN . 19.9 m-20 -78.07 106.98 10.3 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 125.865 1.666 . . . . 0.0 107.749 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.4 tp -96.12 118.75 33.33 Favored 'General case' 0 C--N 1.26 -3.307 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.6 116.51 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.425 HD12 ' HG2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -141.94 159.98 41.12 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 -175.12 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 73.8 m -112.82 127.45 56.17 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.532 0.682 . . . . 0.0 110.631 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.576 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 22.7 tpp85 -97.2 146.01 25.5 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.36 -32.24 2.18 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.799 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -77.2 125.18 86.91 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.641 0.257 . . . . 0.0 110.472 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.579 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 86.5 Cg_endo -85.73 -175.48 1.9 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 121.991 1.794 . . . . 0.0 109.785 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.99 89.82 5.92 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 9.4 Cg_exo -74.54 -15.4 21.99 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.747 2.298 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -100.74 166.44 10.87 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.416 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.5 m-20 -111.91 150.33 42.19 Favored Pre-proline 0 C--N 1.268 -2.958 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.6 Cg_endo -96.77 12.44 1.08 Allowed 'Trans proline' 0 N--CA 1.426 -2.496 0 C-N-CA 124.063 3.175 . . . . 0.0 106.771 -179.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -115.47 1.84 13.74 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 112.34 -2.209 . . . . 0.0 107.665 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -116.25 145.22 34.55 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.39 -172.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -18.75 -88.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 126.91 5.074 . . . . 0.0 117.98 175.388 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.3 m120 57.05 71.58 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 126.268 1.827 . . . . 0.0 112.741 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.4 t -83.88 -161.34 0.52 Allowed 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.2 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.485 ' HA ' HG23 ' B' ' 155' ' ' THR . 6.7 p -61.63 115.42 3.93 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.12 0.486 . . . . 0.0 112.195 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.49 105.59 15.42 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.24 126.8 52.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.245 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 t -127.02 152.13 47.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m -72.21 115.8 11.88 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.813 0.816 . . . . 0.0 111.307 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.98 147.11 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.319 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.32 110.84 20.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.584 0.706 . . . . 0.0 109.661 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 mt -126.02 -51.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -102.29 160.08 14.84 Favored 'General case' 0 CA--C 1.482 -1.656 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.358 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -82.05 89.98 6.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.521 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 72.7 mmtt -74.3 134.02 42.58 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.208 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.66 107.51 24.71 Favored Pre-proline 0 C--N 1.262 -3.208 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.673 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 66.7 Cg_endo . . . . . 0 N--CA 1.436 -1.855 0 C-N-CA 122.859 2.373 . . . . 0.0 111.71 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.436 ' HB3' HG22 ' A' ' 76' ' ' THR . 19.4 m -79.05 41.06 0.43 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.612 1.165 . . . . 0.0 113.986 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -158.84 159.57 35.2 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' B' ' 155' ' ' THR . 0.0 OUTLIER 69.57 144.7 0.05 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 124.4 1.062 . . . . 0.0 112.632 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' B' ' 154' ' ' ARG 0.267 13.2 m 111.73 -45.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.292 1.837 . . . . 0.0 113.888 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.414 ' CA ' ' HE ' ' B' ' 156' ' ' ARG . 0.1 OUTLIER 69.52 90.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -174.065 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.429 ' HD3' ' CD2' ' A' ' 77' ' ' HIS . 46.9 mtt180 -92.31 152.12 19.95 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -164.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -93.43 104.6 16.73 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.334 -179.117 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 19.9 m -94.69 101.55 13.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -83.88 122.57 28.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.312 -1.027 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.4 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.207 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -87.04 135.51 33.25 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -178.77 4.13 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 107.76 20.24 8.61 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.536 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 146.49 34.76 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.31 139.9 85.44 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 C-N-CA 122.407 2.071 . . . . 0.0 111.997 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -107.94 144.12 35.64 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.807 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 8.7 t80 -147.37 139.51 24.42 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.612 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.383 9.9 t -156.82 -54.08 0.08 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.51 162.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.498 ' O ' HD11 ' A' ' 73' ' ' LEU . 18.0 ptt180 157.88 -33.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.739 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 20.2 t30 -53.94 111.45 2.83 Favored Pre-proline 0 C--N 1.269 -2.904 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.637 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.274 7.6 Cg_exo -57.4 -36.54 98.82 Favored 'Trans proline' 0 CA--C 1.463 -3.035 0 C-N-CA 122.921 2.414 . . . . 0.0 111.241 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.1 m -77.94 -9.32 59.03 Favored 'General case' 1 N--CA 1.347 -5.611 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.424 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.739 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.3 pt-20 -80.23 -36.56 34.58 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.3 mt -57.23 134.51 55.99 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.941 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.62 170.8 16.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.153 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 93.87 -117.01 5.37 Favored Glycine 0 N--CA 1.424 -2.106 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.052 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.473 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -150.38 145.78 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 110.465 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.92 112.49 24.18 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 152.49 37.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.471 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 p-80 -123.48 116.38 23.12 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.396 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -122.46 140.98 52.11 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.631 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -73.77 132.73 42.92 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.978 178.777 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.04 127.39 54.86 Favored 'General case' 0 C--O 1.256 1.435 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -86.87 105.84 17.33 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.702 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.536 ' CG ' HG23 ' A' ' 87' ' ' ILE . 1.6 mptm? -36.65 108.74 0.08 Allowed 'General case' 0 C--O 1.257 1.495 0 C-N-CA 125.115 1.366 . . . . 0.0 112.38 173.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 t -124.32 142.42 51.29 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 125.034 1.459 . . . . 0.0 108.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 m 52.56 39.4 27.98 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.46 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 67.52 35.15 4.3 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.013 1.325 . . . . 0.0 110.989 176.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.31 -120.95 0.83 Allowed Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.5 m-85 -137.92 -93.25 0.21 Allowed 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 153.03 54.46 0.01 OUTLIER Glycine 0 C--N 1.292 -1.916 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' HA ' HG22 ' A' ' 47' ' ' VAL . 44.7 p90 -160.64 166.48 28.82 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.509 HG21 ' HA ' ' B' ' 160' ' ' GLN . 29.3 p -120.51 136.23 54.83 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 121.192 -0.942 . . . . 0.0 109.126 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.67 140.09 47.52 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.687 -170.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 6.8 m -115.24 169.05 6.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.101 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.783 ' O ' ' HB3' ' B' ' 157' ' ' ARG . . . 84.8 -125.79 7.35 Favored Glycine 0 C--O 1.191 -2.558 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.459 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 31.89 58.5 0.36 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 125.87 1.7 . . . . 0.0 113.863 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.57 -32.11 5.98 Favored 'General case' 1 C--N 1.233 -4.494 0 CA-C-N 113.033 -1.583 . . . . 0.0 109.431 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -158.6 172.24 6.39 Favored Pre-proline 0 CA--C 1.466 -2.274 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.397 -174.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 50.0 Cg_exo -63.83 -26.02 67.65 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.206 1.937 . . . . 0.0 108.914 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.483 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 9.8 t70 -71.43 -35.47 70.95 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.638 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.87 119.11 26.94 Favored 'General case' 0 C--O 1.275 2.415 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.188 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.497 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 8.6 m-85 -82.46 166.03 19.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.849 2.46 . . . . 0.0 110.699 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.565 ' HG ' ' NH2' ' B' ' 157' ' ' ARG . 3.9 mp -85.36 145.42 27.5 Favored 'General case' 0 C--O 1.187 -2.214 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.122 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.2 tt0 -145.04 148.38 33.64 Favored 'General case' 0 C--O 1.191 -1.977 0 CA-C-N 118.817 0.735 . . . . 0.0 109.264 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.4 mm -81.7 123.26 37.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -103.41 -19.96 14.24 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.053 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.473 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.2 m -155.31 127.74 7.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.11 111.3 18.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.2 t -86.67 121.47 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.0 145.42 55.42 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.542 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 t70 84.41 6.03 0.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 125.56 1.788 . . . . 0.0 109.319 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.609 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.72 158.51 25.2 Favored Glycine 0 C--O 1.2 -1.995 0 CA-C-O 118.322 -1.266 . . . . 0.0 110.66 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.3 Cg_endo -72.13 -25.11 19.49 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 CA-C-N 120.858 2.329 . . . . 0.0 110.192 -171.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB3' ' HB2' ' A' ' 58' ' ' MET . . . -62.43 -46.81 86.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.977 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.64 81.76 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.609 1.164 . . . . 0.0 110.753 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.5 mt -71.92 -41.58 67.71 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 113.336 -1.756 . . . . 0.0 114.378 -174.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.8 -25.09 61.02 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.78 -0.32 86.42 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 117.941 1.937 . . . . 0.0 117.941 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -94.47 -49.54 5.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 120.348 2.074 . . . . 0.0 114.03 -176.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.431 ' HG2' HD12 ' A' ' 97' ' ' LEU . 65.8 mtp -64.62 139.46 58.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.187 0.304 . . . . 0.0 110.894 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.27 167.12 18.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.343 0.592 . . . . 0.0 110.939 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -60.83 128.19 35.29 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.54 -35.03 4.02 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.455 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.561 ' O ' HG12 ' A' ' 43' ' ' ILE . 3.5 m-20 -52.78 129.07 28.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.383 0.673 . . . . 0.0 110.613 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.255 0.8 OUTLIER -93.4 116.23 34.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.335 0.588 . . . . 0.0 112.184 -179.161 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.8 mm -72.77 115.52 13.6 Favored 'Isoleucine or valine' 0 C--O 1.295 3.476 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.829 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.7 t -98.45 -56.69 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 112.293 -2.23 . . . . 0.0 110.54 -175.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.4 m -157.66 174.66 15.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.699 -0.626 . . . . 0.0 110.98 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.9 p -140.02 159.78 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.63 ' OD1' HG13 ' A' ' 93' ' ' VAL . 28.4 p-10 -29.22 109.86 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.524 1.129 . . . . 0.0 113.31 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 69.8 -37.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.995 1.318 . . . . 0.0 113.729 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.0 m -82.67 124.35 30.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.076 0.941 . . . . 0.0 111.865 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.82 78.72 9.83 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.985 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.44 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 23.8 t -77.17 3.71 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.302 1.049 . . . . 0.0 109.068 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 6' ' ' ARG . 12.1 tp -65.74 111.55 3.28 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.514 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 62.96 37.9 95.7 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.589 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -74.13 137.85 43.5 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.433 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 47.3 m -72.76 146.96 46.01 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.527 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.554 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 1.2 t60 -44.43 -49.63 9.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.236 0.614 . . . . 0.0 112.045 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.81 80.35 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 123.748 0.655 . . . . 0.0 111.102 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.433 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 25.6 mm-40 -75.33 -53.41 8.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 11.7 p -59.72 -44.59 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.725 -177.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.531 HG13 ' O ' ' A' ' 77' ' ' HIS . 11.7 p -69.48 -36.13 69.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.062 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 3.7 tmmm? -59.96 -44.07 94.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.7 -50.68 37.31 Favored 'Isoleucine or valine' 0 C--O 1.262 1.729 0 CA-C-O 122.507 1.146 . . . . 0.0 108.895 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 13.2 m-85 -66.18 -33.76 76.49 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.398 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.82 -19.21 32.84 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.349 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.3 m -84.08 -10.01 58.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.069 0.461 . . . . 0.0 110.879 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.536 HG23 ' CG ' ' A' ' 22' ' ' LYS . 6.1 mt -49.78 138.07 18.0 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 68.7 Cg_endo -101.58 149.16 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.209 3.273 . . . . 0.0 111.254 175.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.46 HG12 ' H ' ' A' ' 25' ' ' ARG . 22.8 mt -68.4 143.25 15.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.052 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.19 11.42 57.44 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.458 ' HB1' ' HG2' ' A' ' 22' ' ' LYS . . . -107.09 -173.36 2.27 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.547 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.526 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 31.1 t -149.52 151.94 34.73 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -169.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.63 HG13 ' OD1' ' A' ' 68' ' ' ASN . 1.1 m -157.12 153.72 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 C-N-CA 124.206 1.002 . . . . 0.0 111.245 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.02 107.49 19.54 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.412 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.7 tp -96.03 116.57 29.16 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.55 113.96 25.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 HD12 ' HG2' ' A' ' 58' ' ' MET . 1.4 pt? -141.48 157.8 44.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.1 t -111.63 123.58 50.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.497 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 14.7 tpp85 -92.12 143.06 26.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.15 -36.16 1.41 Allowed Glycine 0 C--N 1.294 -1.769 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -88.32 129.04 51.01 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -104.56 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.696 2.264 . . . . 0.0 110.815 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.99 79.64 6.24 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.404 ' HD2' ' CD2' ' A' ' 105' ' ' PHE . 57.6 Cg_endo -87.98 5.37 5.42 Favored 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.783 2.322 . . . . 0.0 110.96 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.404 ' CD2' ' HD2' ' A' ' 104' ' ' PRO . 52.7 p90 -138.41 172.14 13.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.438 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.7 m-20 -126.88 146.39 57.24 Favored Pre-proline 0 C--N 1.291 -1.97 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.561 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.0 Cg_endo -92.32 1.25 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.965 3.11 . . . . 0.0 107.345 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -86.46 -30.5 21.98 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 112.419 -2.173 . . . . 0.0 107.366 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.68 143.85 34.37 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.437 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.03 -163.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.679 2.919 . . . . 0.0 115.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' B' ' 152' ' ' SER . 11.6 m120 71.82 32.86 1.83 Allowed 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.901 -175.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 m -171.11 135.14 0.97 Allowed 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' B' ' 154' ' ' ARG . 71.0 m -103.61 116.09 31.71 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 121.329 0.585 . . . . 0.0 111.401 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.439 HD11 ' O ' ' B' ' 156' ' ' ARG . 1.0 OUTLIER -92.95 116.17 28.8 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.838 175.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.23 122.57 67.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 t -71.27 151.41 44.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.554 ' HB2' ' NE2' ' A' ' 77' ' ' HIS . 32.7 t -84.26 108.12 16.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.88 123.48 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.38 76.46 1.03 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.0 mm -88.0 -35.05 7.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.68 177.4 6.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.346 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 71.98 4.97 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -172.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.83 49.15 1.79 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.793 -1.549 . . . . 0.0 107.921 169.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.72 118.39 70.5 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.416 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.544 0.999 0 C-N-CA 123.454 2.769 . . . . 0.0 112.979 178.765 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 46.6 m -75.92 93.15 3.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.089 0.471 . . . . 0.0 111.468 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 19.9 m -77.94 121.42 24.15 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 113' ' ' SER . 79.9 mtm180 -69.94 -14.88 62.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.57 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.2 p -148.85 97.57 2.73 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.771 0.828 . . . . 0.0 110.141 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.439 ' O ' HD11 ' A' ' 114' ' ' LEU . 34.4 ttm180 -103.53 115.5 30.63 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.783 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.82 151.85 40.43 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.228 -0.897 . . . . 0.0 113.343 -171.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -113.82 130.37 56.48 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 126.685 1.994 . . . . 0.0 107.844 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.71 ' OG1' ' HD3' ' B' ' 157' ' ' ARG . 54.4 m -147.33 117.02 7.09 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.509 ' HA ' HG21 ' A' ' 30' ' ' THR . 9.8 tt0 -91.51 109.22 20.51 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.475 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.276 -2.596 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.305 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -85.01 100.11 11.45 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.231 0.538 . . . . 0.0 109.857 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.7 mmt -128.26 153.37 47.03 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.486 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 89.76 21.87 38.4 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.147 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.454 ' HB2' ' HZ3' ' A' ' 1' ' ' LYS . 0.0 OUTLIER -94.49 150.98 38.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 116.696 0.248 . . . . 0.0 110.397 178.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 127.83 17.77 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 121.941 1.761 . . . . 0.0 110.461 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -101.21 131.37 47.24 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.541 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -148.37 132.12 16.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.815 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.584 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.3 t -169.96 34.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.862 0.726 . . . . 0.0 109.495 168.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 5' ' ' THR . 12.8 ptm180 53.23 16.43 0.81 Allowed 'General case' 0 N--CA 1.518 2.933 0 C-N-CA 127.12 2.168 . . . . 0.0 113.686 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.719 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.78 110.28 36.26 Favored Pre-proline 0 C--N 1.257 -3.426 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.793 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.263 7.7 Cg_exo -58.38 -31.86 94.91 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 121.225 1.283 . . . . 0.0 109.114 171.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -72.74 -19.52 61.37 Favored 'General case' 1 N--CA 1.361 -4.9 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.851 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.719 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.8 pt-20 -79.77 -31.53 40.9 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.442 HD21 ' CE2' ' A' ' 40' ' ' PHE . 86.7 mt -63.46 137.55 58.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.649 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.84 174.0 7.47 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.652 -174.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.83 -115.52 5.33 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.382 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.38 149.15 46.75 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.54 115.55 23.03 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.417 HD11 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -134.89 153.13 34.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 -176.222 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -129.44 123.64 32.11 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.59 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.432 ' HB ' ' HD3' ' A' ' 57' ' ' LYS . 15.2 t -127.89 133.05 49.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.292 0.568 . . . . 0.0 111.758 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -81.86 128.3 33.89 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.464 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.5 mp -111.06 127.97 55.72 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -87.49 108.26 18.95 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.67 ' HE2' ' N ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -40.48 108.43 0.09 Allowed 'General case' 0 CA--C 1.462 -2.434 0 C-N-CA 125.857 1.663 . . . . 0.0 112.246 175.148 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -87.54 -143.21 0.12 Allowed 'General case' 0 N--CA 1.401 -2.896 0 O-C-N 126.598 2.436 . . . . 0.0 107.298 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -67.01 82.6 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.13 24.34 13.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 112.063 176.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -130.33 1.68 Allowed Glycine 0 C--O 1.276 2.78 0 C-N-CA 118.588 -1.768 . . . . 0.0 113.692 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.581 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 78.8 m-85 -133.83 -91.65 0.35 Allowed 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.33 53.15 0.1 Allowed Glycine 0 C--N 1.306 -1.089 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -169.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' HA ' HG22 ' A' ' 47' ' ' VAL . 32.8 p90 -162.0 145.86 12.27 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -108.13 135.87 48.76 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 42' ' ' GLN . 1.9 p -123.41 140.4 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 CA-C-N 113.403 -1.726 . . . . 0.0 111.02 -171.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 5.5 m -124.02 133.65 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 C-N-CA 124.677 1.191 . . . . 0.0 110.691 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 -140.78 12.2 Favored Glycine 0 CA--C 1.461 -3.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.46 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.4 55.86 2.47 Favored Glycine 0 CA--C 1.45 -3.977 0 O-C-N 126.695 2.056 . . . . 0.0 112.101 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.24 -31.62 15.36 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.639 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.7 167.69 13.92 Favored Pre-proline 0 CA--C 1.48 -1.724 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.484 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -77.76 64.45 8.16 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 124.189 3.259 . . . . 0.0 107.805 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.15 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.065 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 8.5 tp10 -107.35 119.97 40.85 Favored 'General case' 0 C--O 1.267 1.992 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CE2' HD21 ' A' ' 11' ' ' LEU . 20.5 m-85 -84.32 164.37 19.03 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 127.804 2.442 . . . . 0.0 111.778 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.9 mp -90.45 147.89 23.12 Favored 'General case' 0 C--O 1.201 -1.473 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.9 tt0 -139.63 155.27 47.53 Favored 'General case' 0 C--O 1.184 -2.367 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.7 mm -100.3 123.47 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.588 -0.695 . . . . 0.0 110.811 -178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.433 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . 56.7 pttt -102.62 -23.59 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 123.357 0.411 . . . . 0.0 112.02 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 m -151.88 127.05 9.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.48 108.17 19.25 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 62.9 t -85.82 134.35 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.494 0.664 . . . . 0.0 110.197 -173.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.15 140.92 57.53 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.189 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HA ' HD22 ' A' ' 54' ' ' LEU . 34.0 t70 80.54 5.29 1.65 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.238 1.415 . . . . 0.0 110.996 -176.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.702 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -81.62 159.36 40.32 Favored Glycine 0 C--O 1.203 -1.817 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.558 173.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 13.5 Cg_endo -72.0 -25.09 19.94 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 CA-C-N 121.559 2.68 . . . . 0.0 109.855 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB1' HD21 ' A' ' 20' ' ' LEU . . . -64.97 -42.37 94.62 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.64 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.43 76.99 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.767 1.27 . . . . 0.0 109.782 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.702 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 65.9 mt -72.11 -46.91 54.79 Favored 'General case' 0 C--N 1.267 -3.007 0 CA-C-N 112.64 -2.073 . . . . 0.0 115.188 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.76 -24.65 56.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.05 -155.94 33.6 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.007 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.7 tttp 70.25 -58.79 0.53 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.135 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 26.9 ttt -77.65 137.64 38.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.639 0.776 . . . . 0.0 109.076 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -152.16 143.69 23.47 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.741 0.416 . . . . 0.0 109.941 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 m -45.81 116.38 1.19 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.215 1.006 . . . . 0.0 110.811 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.78 -11.04 7.05 Favored Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.57 145.45 56.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 3.4 m -106.99 132.65 53.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 117.961 -1.496 . . . . 0.0 107.213 168.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.272 5.8 mt -83.74 119.55 33.16 Favored 'Isoleucine or valine' 1 C--O 1.31 4.267 0 CA-C-O 121.564 0.697 . . . . 0.0 112.599 -178.531 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 ' HA ' HD13 ' A' ' 73' ' ' LEU . 93.7 t -109.23 -50.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 O-C-N 127.356 2.91 . . . . 0.0 112.382 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 95' ' ' LEU . 29.2 m -145.48 158.63 43.81 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.491 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.41 HG12 ' HB ' ' A' ' 70' ' ' THR . 5.2 p -135.23 86.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.447 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.482 37.3 p30 54.93 -90.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.361 2.265 . . . . 0.0 114.761 -171.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -89.59 -37.65 14.52 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.609 0.719 . . . . 0.0 110.172 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.41 ' HB ' HG12 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -77.91 127.84 33.0 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.842 -172.297 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.98 96.68 10.35 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 14.5 p -90.67 -1.11 9.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.783 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 65' ' ' VAL . 17.4 tp -69.56 112.0 5.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.43 27.33 43.93 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.599 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -81.42 150.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 63.3 m -76.48 142.47 40.94 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 117.824 -1.084 . . . . 0.0 108.764 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.7 t-80 -48.27 -48.66 35.47 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.061 0.846 . . . . 0.0 112.894 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.49 69.55 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.303 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -80.55 -46.23 16.11 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.014 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 HG23 HD22 ' A' ' 41' ' ' LEU . 7.6 p -61.92 -43.73 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.917 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.3 -35.93 74.1 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.559 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.81 -46.69 81.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.733 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.5 -50.69 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.208 1.004 . . . . 0.0 109.362 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -62.26 -36.28 81.58 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.479 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.57 -20.04 32.12 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.699 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 t -80.8 -13.08 59.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.625 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.6 mt -48.67 134.11 13.79 Favored Pre-proline 0 CA--C 1.565 1.558 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 88.3 Cg_endo -99.95 157.63 0.53 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.233 3.288 . . . . 0.0 112.286 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 23' ' ' SER . 22.7 mt -68.97 142.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 123.656 0.782 . . . . 0.0 110.425 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.99 13.27 69.51 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.206 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -109.94 -170.19 1.61 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.486 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.479 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.4 t -149.95 148.88 29.61 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.917 -0.489 . . . . 0.0 112.281 -172.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.536 HG21 ' HE3' ' A' ' 22' ' ' LYS . 6.5 m -155.24 145.92 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 124.844 1.258 . . . . 0.0 110.05 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 68' ' ' ASN . 7.0 m-20 -95.9 107.75 20.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.682 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.6 mm? -92.06 120.87 33.08 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.092 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.77 122.44 38.55 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 63' ' ' VAL . 1.8 mm? -116.51 151.57 35.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.891 0.744 . . . . 0.0 109.737 -179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 8.3 t -117.92 111.51 19.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 168.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 13.4 tpp85 -100.28 158.01 16.19 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.4 -15.52 6.38 Favored Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.77 125.79 49.83 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 113.889 -1.156 . . . . 0.0 108.165 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.588 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 84.6 Cg_endo -85.61 -172.2 1.07 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 121.828 1.685 . . . . 0.0 109.696 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.3 83.83 1.57 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.588 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 16.4 Cg_exo -67.77 -52.46 0.54 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.259 1.973 . . . . 0.0 110.138 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -105.43 120.38 41.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.8 m-20 -79.36 148.46 70.54 Favored Pre-proline 0 CA--C 1.468 -2.196 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.7 Cg_endo -93.59 9.13 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.759 2.973 . . . . 0.0 107.537 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.34 -31.75 43.11 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 112.394 -2.185 . . . . 0.0 106.193 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.1 142.13 92.61 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.583 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.85 178.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.664 3.576 . . . . 0.0 117.154 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 81.72 -38.33 0.12 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.81 2.044 . . . . 0.0 114.417 174.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 38.8 m 68.63 -73.6 0.09 Allowed 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.517 1.127 . . . . 0.0 111.329 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 50.9 m -76.06 102.55 5.72 Favored 'General case' 0 C--N 1.26 -3.324 0 C-N-CA 125.641 1.576 . . . . 0.0 107.938 175.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.3 mt -97.54 103.87 15.84 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.514 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.8 t -104.65 112.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 t -91.89 150.85 20.83 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.4 p -94.58 122.74 37.47 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.99 100.48 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -133.69 80.7 1.88 Allowed 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.742 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.51 -18.11 6.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.37 151.73 42.24 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.018 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.73 2.45 4.36 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.456 1.122 . . . . 0.0 112.307 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -83.62 81.48 8.73 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.988 -175.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -98.12 117.72 64.59 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.032 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.438 -1.753 0 C-N-CA 122.523 2.149 . . . . 0.0 111.362 177.042 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 14.5 m -88.95 109.29 20.12 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 33.4 m -58.27 129.33 41.49 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -84.97 -14.01 48.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.824 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 7.0 m -169.5 169.78 8.64 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -179.55 142.2 0.17 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 75.2 mtm180 -131.48 161.45 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.135 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 15.0 pt-20 -102.45 112.55 25.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.466 ' HB ' HG12 ' A' ' 31' ' ' VAL . 11.0 m -93.04 124.16 36.82 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 172.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -106.11 101.89 11.34 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.724 -0.61 . . . . 0.0 109.977 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.722 -172.062 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.72 150.37 24.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' MET . . . . . 0.4 ' SD ' ' HB2' ' A' ' 1' ' ' LYS . 13.8 tpt -134.29 83.49 2.04 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.646 0.736 . . . . 0.0 111.265 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -120.57 25.42 7.28 Favored Glycine 0 C--N 1.301 -1.399 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 172.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.463 ' N ' ' HD2' ' A' ' 1' ' ' LYS . 3.7 mptp? -77.41 142.62 67.4 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.155 -1.023 . . . . 0.0 110.049 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.55 159.94 42.11 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.865 2.376 . . . . 0.0 113.376 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -105.5 135.78 46.26 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.848 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.406 ' O ' ' HB ' ' A' ' 5' ' ' THR . 28.8 t80 -147.57 134.44 20.16 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 4' ' ' PHE . 14.9 t -169.41 35.92 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.914 0.759 . . . . 0.0 112.019 168.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.544 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 6.8 tpt180 61.75 30.97 18.57 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.413 1.578 . . . . 0.0 109.97 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.78 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -120.29 108.18 38.35 Favored Pre-proline 0 C--N 1.263 -3.193 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -177.632 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.276 8.0 Cg_exo -55.22 -30.19 70.33 Favored 'Trans proline' 0 CA--C 1.486 -1.882 0 C-N-CA 121.527 1.485 . . . . 0.0 110.289 169.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -75.36 -23.01 57.1 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.601 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -73.99 -33.23 63.75 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.419 HD12 ' SG ' ' A' ' 98' ' ' CYS . 74.8 mt -62.09 133.28 55.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.785 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' HB3' ' HZ1' ' A' ' 12' ' ' LYS . 0.2 OUTLIER -80.31 175.81 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.451 -1.704 . . . . 0.0 113.672 -171.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 87.94 -132.0 10.95 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.47 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.512 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.39 142.8 51.01 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 123.819 0.848 . . . . 0.0 109.331 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -107.22 116.15 31.42 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -133.67 151.94 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.66 -177.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.565 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 13.2 t-160 -123.31 105.23 9.68 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -124.18 136.9 54.51 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.158 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.643 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -78.12 129.84 35.66 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.331 0.653 . . . . 0.0 110.324 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -117.31 120.17 37.39 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 176.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -84.77 103.1 13.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.531 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.97 115.07 0.36 Allowed 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 176.344 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -88.52 -148.31 0.16 Allowed 'General case' 0 N--CA 1.41 -2.431 0 O-C-N 126.241 2.213 . . . . 0.0 108.056 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -62.69 83.79 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' N ' HG12 ' A' ' 89' ' ' ILE . 22.2 mmt180 67.35 49.61 1.03 Allowed 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 124.964 1.306 . . . . 0.0 112.492 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.32 -123.16 2.22 Favored Glycine 0 N--CA 1.401 -3.682 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.685 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.693 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 64.1 m-85 -125.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.261 -3.265 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.471 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.47 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.26 49.64 0.18 Allowed Glycine 0 C--N 1.292 -1.867 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.052 -172.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 27' ' ' PHE . 28.3 p90 -161.16 142.26 11.52 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 73.9 p -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.506 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 11.0 m -125.7 159.16 33.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.885 -170.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 ' CD ' ' A' ' 44' ' ' LYS . 4.2 m -120.53 131.59 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 C-N-CA 124.07 0.948 . . . . 0.0 110.519 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.563 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 130.58 -137.24 9.36 Favored Glycine 0 C--O 1.291 3.701 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.527 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.484 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.83 61.86 3.21 Favored Glycine 1 CA--C 1.436 -4.886 0 O-C-N 127.109 2.299 . . . . 0.0 110.953 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 76' ' ' THR . 13.5 t0 -99.19 -48.66 4.76 Favored 'General case' 0 C--N 1.248 -3.833 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 5.9 pt-20 -160.35 175.97 2.84 Favored Pre-proline 0 C--N 1.287 -2.14 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.661 -170.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 32.2 Cg_exo -72.42 64.89 3.68 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.154 3.236 . . . . 0.0 107.97 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 1.8 t70 -171.66 -41.49 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.498 -2.137 . . . . 0.0 108.637 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.87 120.09 28.36 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.204 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -88.61 166.1 14.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 128.242 2.617 . . . . 0.0 108.114 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -89.77 144.13 26.23 Favored 'General case' 0 C--O 1.166 -3.329 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.903 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 tt0 -130.59 156.28 45.12 Favored 'General case' 0 C--O 1.17 -3.089 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 13.3 mm -93.05 128.9 44.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 CA-C-N 119.161 0.891 . . . . 0.0 109.823 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' CD ' HG12 ' A' ' 32' ' ' VAL . 4.5 ptmm? -107.82 -23.96 11.86 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.535 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 39.7 m -151.61 126.96 9.95 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.686 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.1 112.33 18.37 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 57.6 t -89.93 122.56 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.05 146.3 54.84 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.605 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 83.05 4.27 0.94 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 125.055 1.472 . . . . 0.0 109.771 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.646 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.98 158.77 36.93 Favored Glycine 0 C--O 1.205 -1.673 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.541 173.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.693 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.9 Cg_endo -72.17 -25.26 19.18 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 CA-C-N 121.549 2.674 . . . . 0.0 109.716 -171.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.411 ' HB3' ' SD ' ' A' ' 58' ' ' MET . . . -60.65 -48.18 82.93 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.88 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.89 82.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.163 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 83.9 mt -72.07 -39.51 68.96 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.975 -172.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.45 -21.07 45.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.42 40.97 98.35 Favored Glycine 0 CA--C 1.49 -1.503 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.753 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -141.95 27.54 1.8 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.185 0.993 . . . . 0.0 110.315 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.646 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.7 tmt? -160.24 137.49 9.4 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.634 ' HG2' ' NE ' ' A' ' 99' ' ' ARG . 7.9 pt-20 -154.95 160.07 40.86 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 119.309 0.959 . . . . 0.0 112.336 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -53.72 123.15 11.47 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.519 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.56 -1.09 21.93 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.954 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.526 ' CB ' ' HA ' ' A' ' 99' ' ' ARG . 3.1 p30 -100.94 161.92 13.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.432 172.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.701 HG11 ' SG ' ' A' ' 98' ' ' CYS 0.342 0.2 OUTLIER -118.31 125.3 74.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -179.093 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.4 mm -69.77 114.17 6.71 Favored 'Isoleucine or valine' 0 C--O 1.303 3.914 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.605 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' C ' ' HG ' ' A' ' 66' ' ' SER . 88.2 t -93.59 -58.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 112.471 -2.15 . . . . 0.0 110.007 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 65' ' ' VAL . 67.5 m -162.22 173.96 13.54 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.99 -0.444 . . . . 0.0 110.871 -175.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.0 p -143.68 156.64 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -30.18 111.28 0.07 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.8 1.64 . . . . 0.0 113.033 170.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.5 t70 75.39 -27.2 0.19 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.63 1.572 . . . . 0.0 113.677 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 m -112.44 116.24 29.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.979 0.895 . . . . 0.0 111.403 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.3 t -82.75 96.0 8.04 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.47 0.09 4.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.431 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 tp -65.07 110.99 2.69 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.256 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.26 80.62 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.433 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.411 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -74.03 145.4 44.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 44.2 m -76.69 142.83 40.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.216 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.422 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.7 t60 -48.08 -49.22 32.4 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 118.993 0.815 . . . . 0.0 112.537 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.06 75.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 124.298 0.999 . . . . 0.0 110.517 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 68.1 mm-40 -77.95 -49.96 13.11 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.012 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -63.59 -43.92 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.444 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.422 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.8 p -63.78 -40.26 88.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.228 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -58.45 -44.21 89.14 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.825 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.28 -48.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 122.057 0.932 . . . . 0.0 109.977 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.52 -32.24 73.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.958 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.81 -16.64 38.13 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.877 0.37 . . . . 0.0 110.968 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.4 t -77.81 -23.45 49.07 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.531 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.6 mt -50.28 139.36 19.23 Favored Pre-proline 0 N--CA 1.434 -1.261 0 C-N-CA 124.382 1.073 . . . . 0.0 113.292 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -99.69 158.5 0.56 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 124.185 3.257 . . . . 0.0 111.422 176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 23' ' ' SER . 23.6 mt -68.32 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.245 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.72 12.61 60.56 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.561 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.02 -175.27 2.9 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.281 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.643 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 13.2 t -148.22 139.2 23.18 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.886 -0.509 . . . . 0.0 112.338 -172.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.9 m -151.64 158.98 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.063 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.565 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 8.2 m-20 -102.87 108.01 19.06 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 tp -100.79 120.96 40.88 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.455 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 12.6 pt-20 -103.16 124.4 48.51 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD11 ' NH1' ' A' ' 99' ' ' ARG . 4.2 pp -141.64 165.31 27.83 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.407 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.701 ' SG ' HG11 ' A' ' 63' ' ' VAL . 3.0 p -118.73 113.42 21.12 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.458 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -90.38 137.32 32.45 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.484 -173.724 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.94 23.79 5.44 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.599 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -95.32 127.56 41.79 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.451 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 17.9 Cg_endo -58.2 134.24 60.5 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.339 2.026 . . . . 0.0 113.206 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.61 77.18 3.22 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 176.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 74.4 Cg_endo -89.98 32.92 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.755 2.303 . . . . 0.0 112.455 -173.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 162.19 35.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.497 ' OD2' ' HB3' ' A' ' 108' ' ' ASP . 21.3 t70 -90.15 136.88 28.26 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 10.2 Cg_endo -97.45 3.23 1.56 Allowed 'Trans proline' 0 N--CA 1.412 -3.279 0 C-N-CA 123.139 2.559 . . . . 0.0 111.098 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.497 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 11.7 t70 -87.95 -48.3 7.89 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -49.06 122.16 11.34 Favored Pre-proline 0 C--O 1.235 0.329 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -34.9 82.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.428 1 C-N-CA 126.858 5.038 . . . . 0.0 118.577 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.05 37.06 4.11 Favored 'General case' 0 C--N 1.272 -2.788 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.538 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.5 m -73.99 -38.14 64.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.145 -178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.3 t -117.57 105.54 12.18 Favored 'General case' 1 C--N 1.242 -4.104 0 CA-C-N 112.972 -1.922 . . . . 0.0 107.901 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.509 ' N ' ' HA ' ' B' ' 155' ' ' THR . 31.1 mt -75.55 104.46 6.12 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.05 102.18 12.64 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.345 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.246 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.1 t -96.33 142.97 27.82 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.3 m -87.62 135.39 33.38 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.56 134.94 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.07 85.51 5.53 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 121.498 0.666 . . . . 0.0 111.387 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.82 -43.33 13.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.13 -171.24 3.46 Favored 'General case' 0 C--O 1.25 1.129 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.468 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.04 67.74 9.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.488 1.137 . . . . 0.0 111.999 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -96.69 73.75 2.7 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.553 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -97.61 102.48 13.17 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 122.808 2.338 . . . . 0.0 112.572 -176.061 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' SER . . . . . 0.493 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 16.9 m -63.96 96.02 0.13 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.502 1.121 . . . . 0.0 111.523 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -150.11 97.64 2.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.538 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 55.57 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.951 2.1 . . . . 0.0 115.572 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.509 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 80.9 p 56.15 50.74 12.96 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.003 1.721 . . . . 0.0 112.833 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -123.83 -153.69 0.57 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.563 ' HA ' ' H ' ' A' ' 33' ' ' GLY 0.352 97.4 mtt180 79.47 -74.41 0.06 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 44' ' ' LYS . 9.0 tp10 -62.87 98.07 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.067 0.854 . . . . 0.0 111.815 -174.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.506 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 4.8 m -115.01 102.78 10.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -86.28 95.22 9.55 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 9.1 m . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.427 -174.153 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.673 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.17 63.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.411 0.624 . . . . 0.0 109.738 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -177.56 6.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.907 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 94.99 -1.63 65.37 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.992 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -127.29 143.83 48.57 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.82 137.48 38.4 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.297 1.998 . . . . 0.0 110.789 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -109.18 141.41 41.46 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.59 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.636 ' CZ ' ' HA ' ' A' ' 38' ' ' ASP . 11.4 t80 -147.46 142.72 27.28 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.452 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.32 12.6 t -157.57 -48.14 0.07 Allowed 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.264 161.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.475 ' O ' HD21 ' A' ' 73' ' ' LEU . 26.7 ptt180 156.39 -30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.29 1.836 . . . . 0.0 106.276 177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.739 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 39.4 t-20 -40.6 107.68 0.49 Allowed Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.414 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.261 9.6 Cg_exo -61.67 -32.95 87.16 Favored 'Trans proline' 0 CA--C 1.465 -2.932 0 C-N-CA 121.918 1.745 . . . . 0.0 110.374 -178.608 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -80.04 -18.92 48.88 Favored 'General case' 1 N--CA 1.338 -6.046 0 CA-C-N 111.972 -2.376 . . . . 0.0 111.726 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.739 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.2 pt-20 -73.24 -36.22 66.4 Favored 'General case' 0 C--N 1.379 1.859 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.594 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 85.3 mt -54.94 129.37 37.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.785 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.9 -162.58 0.55 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.26 -171.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 65.92 -102.0 0.66 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.003 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.471 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 149.06 32.93 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 123.259 0.624 . . . . 0.0 109.861 178.564 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.64 110.98 21.46 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.18 153.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.708 -177.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 26.8 p-80 -132.05 107.59 8.76 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.928 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -122.51 132.18 54.2 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -76.29 136.26 39.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.43 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.562 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.0 130.53 54.78 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.199 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -82.89 124.23 30.14 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.511 ' HZ1' ' HA ' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -53.28 109.46 0.44 Allowed 'General case' 0 CA--C 1.466 -2.257 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 173.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.7 t -85.14 -146.18 0.1 Allowed 'General case' 0 N--CA 1.413 -2.306 0 O-C-N 126.624 2.453 . . . . 0.0 107.82 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 m -64.12 84.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.0 mpt_? 59.86 43.99 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 125.698 1.599 . . . . 0.0 111.353 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.24 -127.0 1.8 Allowed Glycine 1 N--CA 1.394 -4.143 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.935 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.691 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m-85 -133.68 -82.57 0.46 Allowed 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 114.349 -0.926 . . . . 0.0 111.356 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.524 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.33 54.76 0.18 Allowed Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -169.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.442 ' HA ' HG22 ' A' ' 47' ' ' VAL . 18.8 p90 -161.32 148.77 15.04 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -113.08 136.66 52.46 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.909 0.861 . . . . 0.0 109.154 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' B' ' 159' ' ' THR . 6.2 p -128.63 150.54 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.523 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.472 -167.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.76 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 12.3 m -114.33 154.3 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 124.829 1.252 . . . . 0.0 113.106 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.23 -123.91 6.8 Favored Glycine 0 C--O 1.291 3.706 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.94 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.502 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.64 47.79 3.06 Favored Glycine 0 CA--C 1.47 -2.781 0 O-C-N 126.455 1.914 . . . . 0.0 112.081 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' B' ' 156' ' ' ARG . 6.1 t70 -95.4 -29.31 14.5 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -173.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . 13.2 mt-10 -140.95 172.64 5.86 Favored Pre-proline 0 N--CA 1.41 -2.442 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.062 -169.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.518 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_exo -73.66 -8.4 21.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.532 2.822 . . . . 0.0 108.149 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.636 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 17.6 t70 -108.03 -9.13 15.69 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.047 -1.888 . . . . 0.0 110.183 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA2' ' A' ' 34' ' ' GLY . 30.0 tt0 -131.24 119.41 21.77 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.639 -0.663 . . . . 0.0 110.9 -179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 8.4 m-85 -86.57 166.18 15.62 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.428 2.291 . . . . 0.0 110.232 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.8 mp -93.77 146.38 23.91 Favored 'General case' 0 C--O 1.181 -2.535 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.468 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 28.7 tt0 -138.48 144.92 40.26 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-N 118.803 0.729 . . . . 0.0 109.949 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' CD1' ' A' ' 29' ' ' PHE . 27.0 mm -80.28 120.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.743 0 O-C-N 121.498 -0.751 . . . . 0.0 110.734 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' CD ' ' HB2' ' A' ' 107' ' ' PRO . 44.1 pttt -100.75 -22.0 15.01 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 123.473 0.483 . . . . 0.0 111.544 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.7 m -158.46 127.48 5.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.9 pp -84.44 121.07 27.05 Favored 'General case' 0 N--CA 1.402 -2.872 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.524 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.7 t -85.0 129.3 37.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.63 138.59 58.53 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.434 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 t70 81.65 8.04 1.02 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.777 1.298 . . . . 0.0 110.766 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.679 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.1 161.12 27.66 Favored Glycine 0 C--O 1.21 -1.395 0 CA-C-O 117.894 -1.504 . . . . 0.0 109.798 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.691 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.3 Cg_endo -72.13 -24.74 19.9 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 CA-C-N 121.501 2.651 . . . . 0.0 110.271 -169.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -49.94 75.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.188 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.44 80.76 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.961 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 74.3 mt -71.77 -40.31 69.36 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-N 112.745 -2.025 . . . . 0.0 115.46 -172.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.07 -21.58 56.59 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.696 1.236 . . . . 0.0 107.785 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.76 30.98 73.99 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 112.894 -1.957 . . . . 0.0 114.022 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.07 -1.27 3.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.742 0.782 . . . . 0.0 111.058 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.451 ' HG2' HD13 ' A' ' 97' ' ' LEU . 1.5 tmt? -132.5 125.41 30.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.19 167.53 21.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.702 0.763 . . . . 0.0 112.122 -167.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.7 m -56.35 119.93 6.8 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.778 174.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.43 5.85 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 26.7 m-20 -72.18 135.36 46.12 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.1 OUTLIER -104.77 120.2 54.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 CA-C-O 121.519 0.676 . . . . 0.0 110.837 173.254 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.89 111.75 4.09 Favored 'Isoleucine or valine' 0 C--O 1.299 3.679 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.595 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 91.8 t -93.61 -58.25 3.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.53 0 O-C-N 126.315 2.259 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -151.43 171.06 18.11 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.833 -0.542 . . . . 0.0 110.102 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 7.7 p -146.87 114.4 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 93' ' ' VAL 0.4 0.2 OUTLIER 31.23 66.88 0.14 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.951 1.3 . . . . 0.0 114.146 -171.31 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.44 -37.43 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.283 1.433 . . . . 0.0 114.102 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.4 m -57.81 121.99 11.8 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.446 0.641 . . . . 0.0 110.754 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 36.0 t -80.88 78.73 7.64 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.32 -169.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.503 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 56.0 t -80.83 0.23 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 123.325 1.536 . . . . 0.0 108.851 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.475 HD21 ' O ' ' A' ' 6' ' ' ARG . 17.1 tp -67.68 110.74 3.86 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 65.62 43.02 95.15 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.486 -174.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.503 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -87.58 141.89 28.27 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.295 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.6 m -68.77 141.73 55.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.54 ' HB3' ' HD3' ' B' ' 156' ' ' ARG . 6.4 t60 -54.17 -38.35 65.47 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.428 1.091 . . . . 0.0 112.079 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.7 90.23 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.109 0.881 . . . . 0.0 110.067 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.47 -48.84 18.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.811 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 HG13 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.09 -43.0 97.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.883 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.2 p -65.46 -36.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.263 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -42.16 97.45 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.378 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.51 -50.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 122.394 1.092 . . . . 0.0 108.991 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.63 -33.63 76.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.411 -1.722 . . . . 0.0 113.706 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -85.71 -22.66 27.72 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 m -83.28 -10.94 58.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.418 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.59 HD13 ' CE2' ' A' ' 27' ' ' PHE . 1.5 mt -46.74 136.58 7.69 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.357 1.063 . . . . 0.0 113.823 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.3 Cg_endo -97.28 150.65 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.798 2.999 . . . . 0.0 112.08 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 25' ' ' ARG . 17.8 mt -68.05 142.02 16.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.519 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.31 11.48 64.49 Favored Glycine 0 CA--C 1.485 -1.831 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.162 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -105.37 -170.1 1.7 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.77 -171.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.448 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 24.3 t -149.86 146.07 26.91 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 17.2 m -150.6 153.9 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 C-N-CA 123.483 0.713 . . . . 0.0 109.725 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.532 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 19.7 t70 -100.81 112.68 25.15 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.562 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.0 mm? -90.8 113.76 25.98 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.501 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 38.3 tt0 -94.97 109.21 21.26 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD13 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.48 159.34 42.43 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 0.0 112.359 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.594 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 t -110.27 122.98 48.95 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.471 ' HB3' ' CG ' ' A' ' 14' ' ' LYS . 17.3 tpp85 -104.21 147.22 27.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.51 -13.92 4.24 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.064 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.53 114.06 62.51 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-O 120.509 0.195 . . . . 0.0 110.852 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.576 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 3.7 Cg_exo -76.89 163.73 30.8 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.001 1.801 . . . . 0.0 111.176 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.2 81.83 1.78 Allowed Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.513 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.576 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 58.0 Cg_endo -96.47 52.12 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.691 2.927 . . . . 0.0 108.598 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -161.98 140.63 9.31 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 14.3 t70 -91.24 120.63 68.41 Favored Pre-proline 0 N--CA 1.413 -2.312 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 108' ' ' ASP . 28.4 Cg_endo -103.01 10.0 0.36 Allowed 'Trans proline' 0 C--N 1.284 -2.827 0 C-N-CA 123.376 2.717 . . . . 0.0 109.998 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.457 ' N ' ' HD2' ' A' ' 107' ' ' PRO . 13.7 t70 -100.26 -29.56 12.38 Favored 'General case' 0 N--CA 1.395 -3.224 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -63.35 122.47 76.0 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.982 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.267 0.0 OUTLIER -40.34 88.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.204 1 C-N-CA 125.912 4.408 . . . . 0.0 117.704 174.346 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -124.25 32.04 5.62 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 117.722 -1.591 . . . . 0.0 109.927 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.1 t -171.13 174.13 4.75 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.63 ' O ' ' HA ' ' B' ' 155' ' ' THR . 64.3 m -141.95 109.47 5.66 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.63 106.36 7.16 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.65 131.52 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 166.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 t -72.84 144.89 47.3 Favored 'General case' 0 C--N 1.279 -2.471 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.375 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 p -105.04 117.87 35.09 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.54 106.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.161 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.18 74.02 0.85 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.784 0.802 . . . . 0.0 112.109 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.09 -10.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 1.8 pt? -118.79 -166.82 1.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.303 -171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.75 102.66 1.96 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.619 0.723 . . . . 0.0 109.447 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 121' ' ' LEU . 31.7 mmmt -99.24 92.52 5.48 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.41 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.7 119.29 75.3 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.84 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 N--CA 1.445 -1.355 0 C-N-CA 122.422 2.082 . . . . 0.0 111.313 179.944 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 5.1 p -166.89 164.28 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.164 0.507 . . . . 0.0 112.106 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 42.3 m -151.28 -44.28 0.11 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -142.26 45.85 1.64 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.445 0.64 . . . . 0.0 111.032 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.63 ' HA ' ' O ' ' A' ' 113' ' ' SER . 10.2 p -126.38 0.8 7.0 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.923 0.868 . . . . 0.0 110.213 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.54 ' HD3' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -129.93 -140.76 0.23 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -170.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.76 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.6 ttm180 75.65 -12.4 0.99 Allowed 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -135.96 88.97 2.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 119.449 1.022 . . . . 0.0 111.907 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.54 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 5.3 m -89.68 125.87 35.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -109.54 115.34 29.74 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 31.7 m . . . . . 0 N--CA 1.426 -1.651 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.402 -173.401 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.41 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -82.16 58.02 3.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.547 0.689 . . . . 0.0 110.789 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 87.1 mmm -117.24 50.27 1.11 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.702 0.763 . . . . 0.0 111.39 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -88.92 27.03 7.67 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 150.75 74.97 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.99 138.42 40.23 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.656 1.57 . . . . 0.0 110.0 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -99.61 147.92 24.86 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.177 -174.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -147.95 130.78 16.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.458 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 15.1 t -168.02 33.63 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.93 165.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.572 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 45.55 42.75 8.39 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 123.991 1.853 . . . . 0.0 112.606 178.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.794 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.8 OUTLIER -115.2 114.02 43.41 Favored Pre-proline 1 C--N 1.242 -4.085 0 CA-C-N 113.083 -1.871 . . . . 0.0 114.186 178.367 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.9 Cg_exo -56.72 -30.52 84.53 Favored 'Trans proline' 0 CA--C 1.481 -2.154 0 C-N-CA 121.314 1.343 . . . . 0.0 109.693 168.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -79.54 -13.22 59.69 Favored 'General case' 1 N--CA 1.362 -4.857 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.485 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.794 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -81.38 -32.11 32.99 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' HA ' ' A' ' 8' ' ' PRO . 79.2 mt -61.81 143.32 56.49 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.896 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.72 -179.33 7.09 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.426 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.2 -128.36 9.38 Favored Glycine 0 N--CA 1.432 -1.603 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.833 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.489 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 2.4 ptmm? -127.53 151.62 48.65 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 123.882 0.873 . . . . 0.0 110.847 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.84 119.32 37.6 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.02 152.82 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 121.647 0.737 . . . . 0.0 111.923 -177.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.456 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.5 p-80 -135.35 105.08 6.11 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.476 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -115.83 140.19 49.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.277 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.551 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -74.15 131.89 41.71 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.461 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.4 tp -117.12 121.67 41.93 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.89 114.53 21.25 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.48 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.648 ' N ' ' HZ1' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -48.42 111.49 0.46 Allowed 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 125.108 1.363 . . . . 0.0 112.802 177.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 22.8 t -88.17 -144.28 0.14 Allowed 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 127.159 2.787 . . . . 0.0 107.327 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 p -62.56 84.27 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.3 mpt_? 59.88 29.85 19.4 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 126.414 1.886 . . . . 0.0 112.215 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.42 -123.05 1.02 Allowed Glycine 0 N--CA 1.412 -2.94 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.173 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.701 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 76.3 m-85 -130.88 -90.45 0.45 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.055 -1.073 . . . . 0.0 111.324 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.591 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 128.07 54.99 0.12 Allowed Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.002 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.434 ' HA ' HG21 ' A' ' 47' ' ' VAL . 38.4 p90 -161.52 142.95 11.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HA ' ' B' ' 160' ' ' GLN . 25.5 p -105.68 136.04 46.01 Favored 'General case' 0 C--N 1.284 -2.283 0 O-C-N 121.336 -0.852 . . . . 0.0 109.497 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.479 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 14.4 m -125.78 160.01 33.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.724 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 25.2 m -124.04 132.49 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 174.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 129.77 -139.73 11.18 Favored Glycine 0 N--CA 1.41 -3.091 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.068 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.506 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.41 48.52 8.55 Favored Glycine 1 CA--C 1.443 -4.413 0 C-N-CA 125.754 1.645 . . . . 0.0 111.204 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' B' ' 156' ' ' ARG . 35.3 t70 -88.99 -32.64 17.52 Favored 'General case' 0 C--N 1.252 -3.669 0 CA-C-N 114.566 -0.817 . . . . 0.0 109.712 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -158.67 167.9 13.49 Favored Pre-proline 0 N--CA 1.415 -2.21 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.464 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -77.46 51.15 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.409 3.406 . . . . 0.0 109.916 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -162.79 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.194 -2.275 . . . . 0.0 108.257 -171.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' OE2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 tt0 -111.78 120.15 41.0 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.48 165.67 16.96 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 128.29 2.636 . . . . 0.0 109.282 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 3.9 mp -95.06 146.14 24.48 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.003 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 1.2 tm0? -131.79 151.58 51.57 Favored 'General case' 0 C--O 1.169 -3.147 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 62' ' ' ASP . 8.2 mm -90.54 122.34 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 118.827 0.74 . . . . 0.0 109.237 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HA ' ' CD2' ' A' ' 103' ' ' LEU . 53.6 pttt -106.02 -18.18 14.11 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.765 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.464 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.9 m -156.34 127.74 7.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.023 0.439 . . . . 0.0 111.326 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.01 121.28 21.74 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 97.2 t -92.98 123.44 45.07 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.88 148.93 48.4 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.708 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.3 t70 80.6 4.71 1.67 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.982 1.426 . . . . 0.0 109.743 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.662 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.5 164.63 31.91 Favored Glycine 0 C--O 1.209 -1.468 0 CA-C-O 117.893 -1.504 . . . . 0.0 110.544 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.701 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 10.1 Cg_endo -72.5 -25.72 17.61 Favored 'Trans proline' 0 C--O 1.191 -1.868 0 CA-C-N 121.639 2.719 . . . . 0.0 110.482 -171.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.24 87.53 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.676 0.751 . . . . 0.0 109.408 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.39 68.06 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 122.536 1.16 . . . . 0.0 109.252 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.4 mt -72.13 -50.0 31.43 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 112.619 -2.082 . . . . 0.0 115.522 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.01 -24.52 55.29 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.77 45.62 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.086 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 69.85 -61.37 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.366 1.466 . . . . 0.0 112.637 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.403 ' HG2' HD12 ' A' ' 97' ' ' LEU . 1.3 tmt? -77.7 136.24 38.16 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -146.02 167.05 24.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.151 0.5 . . . . 0.0 111.107 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.8 m -58.24 128.04 35.11 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.6 -13.28 10.89 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.521 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.49 ' O ' HG12 ' A' ' 43' ' ' ILE . 24.8 m-20 -75.65 161.49 29.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 10.4 m -123.31 133.95 67.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 40.1 mm -81.0 109.22 15.14 Favored 'Isoleucine or valine' 0 C--O 1.302 3.866 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.9 t -95.84 -56.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 O-C-N 126.225 2.203 . . . . 0.0 109.717 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -156.44 173.23 17.21 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.518 -0.739 . . . . 0.0 110.054 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 p -145.68 120.84 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.252 4.8 p-10 16.58 84.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.542 1.937 . . . . 0.0 115.216 -172.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 74.73 -37.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.403 1.481 . . . . 0.0 113.09 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.6 m -66.46 125.25 25.11 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-O 121.922 0.867 . . . . 0.0 110.195 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 47.3 t -89.14 91.41 8.78 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.542 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.1 t -86.46 3.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.76 1.267 . . . . 0.0 108.767 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.1 tp -76.38 111.08 11.45 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.78 38.36 60.82 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.846 -173.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.17 145.92 29.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.4 m -75.43 142.31 43.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 117.468 -1.253 . . . . 0.0 107.691 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 62.2 t60 -48.58 -48.04 39.19 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 119.211 0.914 . . . . 0.0 112.815 -176.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -36.13 76.23 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 124.367 1.042 . . . . 0.0 110.536 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -75.0 -51.56 13.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.666 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -63.93 -44.08 97.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.6 p -60.47 -42.13 90.11 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.535 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.26 -39.13 92.23 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -71.5 -46.59 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 122.187 0.994 . . . . 0.0 108.402 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.0 -28.89 69.22 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.745 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.09 -23.77 26.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.6 t -92.55 -2.64 56.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.38 0.61 . . . . 0.0 110.163 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.58 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -54.49 138.26 60.25 Favored Pre-proline 0 N--CA 1.424 -1.754 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.787 173.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -93.39 149.27 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.239 2.626 . . . . 0.0 111.794 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.417 HG12 ' H ' ' A' ' 25' ' ' ARG . 26.3 mt -67.86 141.81 17.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.46 12.37 63.01 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.637 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.467 ' HB2' ' HG2' ' A' ' 22' ' ' LYS . . . -106.89 -169.06 1.49 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.804 -171.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.551 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 27.9 t -148.14 148.1 30.21 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.841 -0.537 . . . . 0.0 112.218 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 18.3 m -146.58 161.15 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.014 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.553 173.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -107.41 107.75 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.6 tp -92.01 114.09 26.53 Favored 'General case' 0 C--N 1.253 -3.591 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.976 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -90.76 107.63 19.31 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -141.47 161.72 37.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.481 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.4 ' HB2' HG21 ' A' ' 63' ' ' VAL . 74.4 m -124.27 123.49 40.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.966 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.503 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 18.9 tpp85 -93.35 147.17 23.16 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.442 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . 137.54 5.64 1.71 Allowed Glycine 0 C--N 1.296 -1.661 0 C-N-CA 119.101 -1.523 . . . . 0.0 112.586 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -105.93 99.94 25.31 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 116.714 0.257 . . . . 0.0 110.469 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 100' ' ' GLY . 18.0 Cg_exo -66.74 132.21 28.03 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 121.949 1.766 . . . . 0.0 107.732 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.429 ' CD2' ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -69.94 104.86 0.9 Allowed Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -95.48 41.45 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.018 2.479 . . . . 0.0 111.578 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.418 ' O ' HD12 ' A' ' 103' ' ' LEU . 31.5 t80 -167.0 168.43 13.83 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.4 m-20 -79.33 140.26 56.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -93.14 0.54 3.56 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.018 2.479 . . . . 0.0 107.421 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.06 -33.77 44.35 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.435 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -51.41 114.42 5.02 Favored Pre-proline 0 C--O 1.246 0.894 0 CA-C-N 113.184 -1.826 . . . . 0.0 112.108 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -62.06 -153.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 124.094 3.196 . . . . 0.0 113.293 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.82 70.8 0.43 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.239 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.1 m -78.53 -149.37 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.429 179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.1 102.52 0.08 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 119.215 0.916 . . . . 0.0 111.936 -173.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.681 ' O ' ' HA ' ' B' ' 155' ' ' THR . 0.0 OUTLIER -74.82 119.53 19.14 Favored 'General case' 1 N--CA 1.379 -4.004 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.566 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' B' ' 154' ' ' ARG . 9.7 p -123.45 114.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-O 122.112 0.958 . . . . 0.0 109.763 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 t -102.18 146.28 28.2 Favored 'General case' 0 N--CA 1.391 -3.393 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -120.06 137.29 54.2 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.71 108.45 23.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.43 73.92 1.48 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.686 0.755 . . . . 0.0 112.102 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.38 -30.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 122.546 1.165 . . . . 0.0 108.355 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.95 -132.43 0.33 Allowed 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.12 107.56 3.24 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.874 1.321 . . . . 0.0 110.129 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -121.06 41.22 3.37 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.52 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -76.04 125.44 88.04 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 123.007 2.472 . . . . 0.0 112.659 -175.928 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -79.45 89.22 5.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 24.8 m 74.63 154.38 0.15 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.73 1.212 . . . . 0.0 112.266 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -147.03 -71.25 0.23 Allowed 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.885 178.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.681 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 2.0 t -158.35 143.13 16.23 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.427 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 ptm180 -159.96 155.66 25.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.27 1.395 . . . . 0.0 112.211 -175.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' GLY 0.414 23.3 ptt180 62.05 -62.89 0.1 Allowed 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 174.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -73.57 87.02 1.61 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 123.008 0.523 . . . . 0.0 109.824 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.479 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 2.9 m -100.06 113.89 26.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' THR . 55.0 tt0 -88.66 104.8 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 29' ' ' PHE . 10.1 m . . . . . 0 N--CA 1.418 -2.062 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.096 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.17 90.9 1.6 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.383 0.673 . . . . 0.0 110.404 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.32 20.88 17.6 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -71.87 -19.75 78.38 Favored Glycine 0 C--N 1.318 -0.439 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.52 141.75 24.29 Favored Pre-proline 0 N--CA 1.424 -1.765 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -76.43 171.29 18.34 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.755 2.303 . . . . 0.0 109.005 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -57.33 112.95 1.55 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.22 1.01 . . . . 0.0 109.149 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HZ ' ' O ' ' A' ' 37' ' ' PRO . 4.1 t80 -147.0 144.17 28.97 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.128 -172.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.335 8.9 t -156.45 -53.77 0.08 Allowed 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.104 163.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.571 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.2 ptm180 164.03 -30.12 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.699 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.6 t-20 -46.07 108.66 0.85 Allowed Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.846 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.1 -27.35 73.38 Favored 'Trans proline' 0 CA--C 1.469 -2.755 0 C-N-CA 121.565 1.51 . . . . 0.0 110.882 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -81.83 -19.71 40.52 Favored 'General case' 1 N--CA 1.354 -5.235 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.031 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.699 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.9 pt-20 -75.26 -34.41 61.37 Favored 'General case' 0 C--N 1.372 1.571 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.5 132.86 49.55 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.921 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -80.06 171.16 15.46 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.772 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 97.42 -123.49 7.82 Favored Glycine 0 N--CA 1.417 -2.569 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.271 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -135.72 141.38 44.88 Favored 'General case' 0 C--N 1.282 -2.349 0 C-N-CA 123.479 0.712 . . . . 0.0 109.55 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -108.83 111.64 23.48 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.44 152.13 23.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.564 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.1 t60 -131.84 99.71 4.85 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -114.22 145.57 41.54 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.759 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -84.88 134.68 34.27 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.432 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -117.23 119.98 36.84 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -81.49 110.95 17.36 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.541 ' HG3' HD13 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.19 104.4 0.04 OUTLIER 'General case' 0 CA--C 1.465 -2.3 0 O-C-N 123.85 0.719 . . . . 0.0 109.398 170.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 65.1 m -92.34 -117.32 0.08 Allowed 'General case' 0 N--CA 1.388 -3.534 0 O-C-N 125.125 1.515 . . . . 0.0 109.953 -176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.6 m -78.81 79.53 5.21 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 119.907 1.23 . . . . 0.0 113.079 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.451 ' HD3' ' O ' ' A' ' 87' ' ' ILE . 16.8 mmt180 62.84 51.19 3.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.143 0.973 . . . . 0.0 111.322 173.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.85 -124.78 2.93 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.697 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 74.5 m-85 -127.79 -81.33 0.59 Allowed 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.516 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.5 51.41 0.1 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.456 -172.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.529 ' CD2' HD11 ' A' ' 43' ' ' ILE . 27.4 p90 -162.05 146.81 12.71 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.96 0.904 . . . . 0.0 108.715 174.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 HG23 ' HA ' ' B' ' 160' ' ' GLN . 68.0 p -109.92 136.14 49.68 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.891 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 15.4 m -117.45 168.45 9.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.193 -168.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG12 ' HG2' ' A' ' 44' ' ' LYS . 5.7 m -127.38 133.06 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 125.482 1.513 . . . . 0.0 109.739 173.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.672 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 115.87 -135.6 12.3 Favored Glycine 0 C--N 1.273 -2.951 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.811 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.452 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 38.66 50.8 2.48 Favored Glycine 0 CA--C 1.461 -3.299 0 O-C-N 126.214 1.773 . . . . 0.0 111.142 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.55 ' OD1' ' HD2' ' B' ' 156' ' ' ARG . 36.0 t0 -95.75 -36.05 11.31 Favored 'General case' 0 C--N 1.251 -3.69 0 CA-C-N 113.324 -1.438 . . . . 0.0 110.361 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -158.82 173.65 4.79 Favored Pre-proline 0 N--CA 1.411 -2.38 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.756 -172.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' O ' ' HZ ' ' A' ' 4' ' ' PHE . 52.0 Cg_exo -66.42 -13.89 41.81 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 123.012 2.475 . . . . 0.0 109.538 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.77 -14.55 24.6 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.234 -1.803 . . . . 0.0 111.826 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -139.25 120.28 14.56 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 111.301 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 14.5 m-85 -79.97 166.04 22.0 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 127.412 2.285 . . . . 0.0 111.569 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.541 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 4.6 mp -88.41 146.04 25.46 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.638 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 tt0 -142.38 154.71 44.86 Favored 'General case' 0 C--O 1.181 -2.539 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.529 HD11 ' CD2' ' A' ' 29' ' ' PHE . 18.9 mm -93.22 127.01 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 118.914 0.779 . . . . 0.0 109.065 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -105.49 -21.21 13.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.1 m -157.24 128.43 6.79 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.76 123.07 27.36 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 123.714 0.806 . . . . 0.0 108.83 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.516 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.3 t -94.96 111.82 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.9 145.43 52.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.902 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.5 t70 86.01 3.05 0.56 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 125.824 1.953 . . . . 0.0 109.098 -171.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.653 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.43 159.97 34.09 Favored Glycine 0 C--O 1.204 -1.773 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.072 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 34.2 Cg_endo -72.61 -25.85 17.11 Favored 'Trans proline' 0 N--CA 1.435 -1.929 0 CA-C-N 121.148 2.474 . . . . 0.0 110.515 -171.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.28 -46.04 91.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.737 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.91 85.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.501 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.653 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.1 mt -72.0 -40.09 68.77 Favored 'General case' 0 N--CA 1.405 -2.699 0 CA-C-N 113.384 -1.734 . . . . 0.0 114.832 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -75.05 -24.7 58.3 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.24 15.38 65.45 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 113.296 -1.775 . . . . 0.0 115.486 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.05 22.37 7.96 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.8 1.286 . . . . 0.0 109.805 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.8 ttt -140.17 128.69 22.83 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.38 149.32 30.67 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -167.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.2 m -44.75 117.52 1.33 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.643 1.177 . . . . 0.0 110.819 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.11 -7.56 8.66 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.532 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.63 150.33 39.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -108.36 129.7 62.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.5 mm -84.93 115.93 27.61 Favored 'Isoleucine or valine' 0 C--O 1.302 3.83 0 CA-C-O 121.701 0.762 . . . . 0.0 109.26 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.24 -58.21 3.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.81 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.727 -177.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -155.59 166.74 32.61 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.899 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 p -152.9 115.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' CB ' HG11 ' A' ' 93' ' ' VAL . 16.3 t-20 51.33 52.41 14.88 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.945 1.298 . . . . 0.0 111.78 173.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 69.33 -6.76 0.91 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.889 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.4 m -81.06 126.48 31.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.2 t -82.45 73.82 9.46 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.955 0.883 . . . . 0.0 110.595 -172.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.494 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 80.0 t -79.55 -4.11 6.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 122.66 1.219 . . . . 0.0 109.202 177.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD21 ' O ' ' A' ' 6' ' ' ARG . 13.6 tp -66.93 112.03 4.1 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.456 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 70.92 37.01 65.12 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.418 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -82.61 147.17 28.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.56 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 87.7 m -76.24 143.28 41.09 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 117.599 -1.191 . . . . 0.0 109.171 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.536 ' NE2' ' HA ' ' B' ' 154' ' ' ARG . 83.2 t60 -46.77 -47.66 20.76 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.336 0.971 . . . . 0.0 113.164 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' O ' ' HB3' ' A' ' 82' ' ' LYS . . . -63.53 -32.25 73.65 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.474 0.654 . . . . 0.0 110.821 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.422 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 32.0 mm-40 -77.82 -49.91 13.36 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.15 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.46 HG23 HD21 ' A' ' 41' ' ' LEU . 7.4 p -61.35 -44.75 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.148 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.62 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 11.6 p -60.85 -45.13 98.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.416 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -60.18 -38.75 84.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.3 mt -73.12 -48.28 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-O 122.502 1.144 . . . . 0.0 108.909 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.108 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.62 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.8 pt20 -86.71 -24.46 25.18 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.769 -0.582 . . . . 0.0 111.798 174.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -75.46 -26.22 58.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.541 HD13 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -59.61 152.23 57.68 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.4 Cg_endo -102.25 159.51 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.063 3.842 . . . . 0.0 111.942 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.543 ' HA ' ' O ' ' A' ' 23' ' ' SER . 45.4 mt -67.78 131.01 33.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.97 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.45 10.88 40.19 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 119.773 -0.46 . . . . 0.0 113.981 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 22' ' ' LYS . . . -99.35 -176.43 3.29 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.578 1.189 . . . . 0.0 111.902 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.561 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.2 t -140.99 145.39 35.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.704 -0.623 . . . . 0.0 111.75 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.43 157.64 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 C-N-CA 123.964 0.905 . . . . 0.0 111.486 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.486 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 4.2 m-20 -104.56 107.11 17.88 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.413 HD22 HD21 ' A' ' 20' ' ' LEU . 15.4 tp -99.53 121.51 41.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-O 121.123 0.487 . . . . 0.0 111.608 -172.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HG2' ' HD1' ' A' ' 17' ' ' HIS . 47.1 mt-10 -98.02 114.47 26.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.52 148.12 40.57 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.113 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.0 t -117.64 120.1 36.99 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.3 tpp85 -95.18 139.87 30.89 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.84 -28.35 1.03 Allowed Glycine 0 C--N 1.3 -1.444 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.306 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.18 98.67 6.86 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.554 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 95.6 Cg_endo -79.31 -175.34 2.69 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.664 2.243 . . . . 0.0 111.36 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.67 101.06 6.14 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 3.0 Cg_exo -78.51 -0.83 11.06 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.359 2.706 . . . . 0.0 111.52 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.93 163.75 32.11 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.446 ' C ' ' H ' ' A' ' 108' ' ' ASP . 6.0 m-20 -98.3 144.39 28.01 Favored Pre-proline 0 C--N 1.282 -2.332 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -93.58 16.66 1.18 Allowed 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 123.566 2.844 . . . . 0.0 107.267 -177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 106' ' ' ASP . 27.7 t70 -84.35 -24.02 29.92 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-N 112.009 -2.36 . . . . 0.0 107.239 178.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.22 135.67 95.15 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.281 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -92.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 1 C-N-CA 127.142 5.228 . . . . 0.0 117.854 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 49.45 57.56 6.37 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 125.814 1.646 . . . . 0.0 111.59 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 m -61.21 134.81 57.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.406 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.4 p -73.57 101.24 3.52 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -172.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -91.12 131.89 36.4 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 171.144 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.401 HG21 ' O ' ' B' ' 154' ' ' ARG . 12.0 p -102.12 124.1 55.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.96 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.0 t -135.81 133.44 37.88 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 -173.9 3.0 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.402 HG22 ' CG2' ' A' ' 76' ' ' THR . 33.6 t -112.74 100.39 10.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.77 73.99 0.99 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.918 0.866 . . . . 0.0 110.163 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.86 -60.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.14 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.1 mt -84.8 178.81 7.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.939 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -78.16 71.83 4.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.519 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HB3' ' HZ3' ' A' ' 123' ' ' LYS . 0.2 OUTLIER -136.36 120.91 18.25 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.932 178.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.57 132.07 25.87 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.701 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 123.153 2.568 . . . . 0.0 112.526 179.694 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 17.9 m -72.8 58.39 0.45 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.154 0.581 . . . . 0.0 111.738 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -76.17 60.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.879 0.847 . . . . 0.0 112.047 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.536 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 18.6 mtp180 -136.25 34.64 2.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 5.9 t -100.64 13.68 33.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.25 -1.796 . . . . 0.0 110.888 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.55 ' HD2' ' OD1' ' A' ' 35' ' ' ASP . 15.9 mmt85 73.04 147.5 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.746 1.218 . . . . 0.0 107.812 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.672 ' HA ' ' O ' ' A' ' 33' ' ' GLY . 49.3 mtp85 72.99 -71.76 0.13 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.851 0.75 . . . . 0.0 112.773 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 41.4 tt0 -73.29 108.67 6.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 120.826 0.346 . . . . 0.0 110.183 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 6.7 m -123.39 133.66 54.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.418 ' HA ' HG23 ' A' ' 30' ' ' THR . 0.7 OUTLIER -100.02 116.58 32.39 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 12.2 m . . . . . 0 N--CA 1.419 -1.975 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.178 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.907 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -89.88 71.42 7.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.0 mtp -125.74 42.62 3.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.026 0.917 . . . . 0.0 109.831 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -87.48 1.18 85.75 Favored Glycine 0 C--N 1.315 -0.598 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.063 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -104.09 160.77 24.97 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.54 119.64 6.7 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.394 1.396 . . . . 0.0 110.429 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -109.13 145.3 35.95 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 113.644 -1.616 . . . . 0.0 112.249 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -147.16 135.15 21.39 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.098 174.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.666 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 13.5 t -167.68 38.81 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.333 1.053 . . . . 0.0 108.787 166.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.666 ' HG2' ' O ' ' A' ' 5' ' ' THR . 5.7 ptm180 60.13 12.5 3.29 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 127.264 2.225 . . . . 0.0 113.413 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.786 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 12.0 m-80 -97.39 115.25 65.71 Favored Pre-proline 0 C--N 1.251 -3.686 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.289 13.2 Cg_exo -61.06 -30.17 88.93 Favored 'Trans proline' 0 CA--C 1.483 -2.069 0 N-CA-C 107.906 -1.613 . . . . 0.0 107.906 170.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 t -68.66 -25.6 64.89 Favored 'General case' 1 N--CA 1.363 -4.815 0 CA-C-N 110.993 -2.822 . . . . 0.0 111.003 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.786 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.3 pt-20 -80.3 -33.79 37.32 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.72 135.29 57.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.655 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HE3' ' O ' ' A' ' 100' ' ' GLY . 45.8 pttt -78.66 166.01 23.0 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.337 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 98.82 -122.98 7.74 Favored Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.514 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.0 147.07 46.04 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 124.712 1.205 . . . . 0.0 110.014 -177.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.5 123.4 49.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.6 152.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.542 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 43.5 p-80 -126.11 100.49 6.35 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 122.384 1.088 . . . . 0.0 110.265 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 t -102.77 130.66 49.81 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.539 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -83.16 130.32 35.09 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.079 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.427 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 1.9 mp -117.26 123.46 46.64 Favored 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -84.72 125.19 32.31 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -56.92 103.77 0.13 Allowed 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 172.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.581 ' O ' HG22 ' A' ' 89' ' ' ILE . 22.9 t -80.03 -78.27 0.17 Allowed 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 125.346 1.654 . . . . 0.0 109.971 -172.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -116.23 78.64 1.21 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.694 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.59 ' N ' HG12 ' A' ' 89' ' ' ILE . 14.0 ttt180 63.78 24.74 13.9 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.22 -140.76 5.6 Favored Glycine 0 N--CA 1.409 -3.106 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.456 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.637 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 89.1 m-85 -125.67 -85.85 0.62 Allowed 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 114.481 -0.86 . . . . 0.0 112.083 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.39 52.89 0.19 Allowed Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.109 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.437 ' HA ' HG23 ' A' ' 47' ' ' VAL . 29.8 p90 -160.9 150.5 17.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.0 p -112.03 136.42 51.42 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.0 0.905 . . . . 0.0 109.242 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 4.5 p -125.27 148.4 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.608 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.702 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 10.8 m -114.98 164.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 124.492 1.117 . . . . 0.0 113.283 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.96 -124.62 6.55 Favored Glycine 0 C--O 1.284 3.249 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.132 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.527 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.34 53.67 5.74 Favored Glycine 1 CA--C 1.443 -4.425 0 O-C-N 127.235 2.374 . . . . 0.0 112.173 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 51.3 t0 -86.14 -47.89 9.08 Favored 'General case' 1 C--N 1.244 -4.012 0 CA-C-N 113.276 -1.462 . . . . 0.0 109.241 -176.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.438 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.8 pt-20 -158.93 174.51 3.98 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.032 -164.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 24.8 Cg_exo -75.46 59.61 5.53 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 124.662 3.575 . . . . 0.0 108.021 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -178.58 -23.7 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.348 -2.205 . . . . 0.0 109.324 -169.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 9.7 tp10 -131.23 120.54 23.4 Favored 'General case' 0 C--O 1.257 1.488 0 C-N-CA 122.997 0.519 . . . . 0.0 110.022 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.51 166.18 14.36 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 127.258 2.223 . . . . 0.0 110.261 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -96.85 145.25 26.03 Favored 'General case' 0 C--O 1.175 -2.844 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.648 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 14.9 tt0 -135.03 147.7 49.72 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 118.866 0.757 . . . . 0.0 109.928 -177.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' CD1' ' A' ' 29' ' ' PHE . 34.7 mm -79.5 114.9 20.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.531 -0.731 . . . . 0.0 110.188 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -98.46 -22.05 16.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.434 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 37.6 m -155.72 127.14 7.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.7 tp -86.01 112.11 20.91 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.437 HG23 ' HA ' ' A' ' 29' ' ' PHE . 29.7 t -87.47 104.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.62 145.85 27.16 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.098 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 86.16 3.87 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.438 1.711 . . . . 0.0 109.74 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.705 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.44 163.08 36.95 Favored Glycine 0 C--O 1.212 -1.264 0 CA-C-O 117.773 -1.571 . . . . 0.0 110.21 171.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.637 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 22.1 Cg_endo -72.48 -25.48 17.92 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 CA-C-N 121.732 2.766 . . . . 0.0 110.458 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.39 -43.69 98.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.428 175.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.49 75.37 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.449 1.119 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.705 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 69.7 mt -72.18 -40.88 67.61 Favored 'General case' 0 N--CA 1.396 -3.169 0 CA-C-N 112.401 -2.181 . . . . 0.0 114.704 -171.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.24 -24.99 46.69 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.42 27.03 71.16 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-N 113.543 -1.662 . . . . 0.0 115.416 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -110.65 -0.71 17.08 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.789 0.804 . . . . 0.0 110.437 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.4 ' HE3' HD12 ' A' ' 97' ' ' LEU . 42.8 ttm -129.28 126.97 40.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -142.69 144.93 32.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 m -45.14 114.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.234 1.414 . . . . 0.0 111.284 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.9 -36.95 1.96 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.61 145.21 50.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.8 0.81 . . . . 0.0 111.981 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 41' ' ' LEU 0.258 0.2 OUTLIER -110.33 126.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.27 -175.571 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.43 116.47 15.79 Favored 'Isoleucine or valine' 0 C--O 1.294 3.441 0 C-N-CA 125.673 1.589 . . . . 0.0 110.649 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 37.5 t -103.22 -58.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.99 -177.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.437 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 20.4 m -136.87 157.87 45.76 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.055 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.9 p -137.61 104.1 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 0.0 112.519 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.06 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 125.766 1.627 . . . . 0.0 112.079 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -131.98 -12.09 3.3 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.0 0.429 . . . . 0.0 110.838 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -89.68 134.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.759 0.79 . . . . 0.0 110.382 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 45.1 t -80.88 80.03 7.43 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.604 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.23 -5.81 8.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.245 1.022 . . . . 0.0 108.504 176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.527 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . 44.6 tp -56.35 111.11 0.89 Allowed 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.789 -1.551 . . . . 0.0 107.174 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.88 37.96 91.68 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.886 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.29 145.13 37.63 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 39.8 m -73.53 141.82 46.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.434 ' O ' HG11 ' A' ' 81' ' ' VAL . 56.7 t-80 -51.28 -40.47 59.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.72 -176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.18 85.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.092 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -75.3 -48.6 22.44 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.769 -177.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.06 -43.14 97.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.651 -178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.434 HG11 ' O ' ' A' ' 77' ' ' HIS . 13.8 p -63.18 -37.85 80.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.436 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.83 90.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.22 -50.8 33.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-O 122.161 0.982 . . . . 0.0 109.383 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.417 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 9.0 m-85 -64.68 -35.13 80.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.799 -175.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -85.49 -21.42 28.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.67 0.272 . . . . 0.0 110.933 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 m -90.82 -2.52 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.967 -0.458 . . . . 0.0 111.409 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.622 HD11 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -47.65 142.43 6.59 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 89.0 Cg_endo -98.84 156.66 0.68 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 124.035 3.157 . . . . 0.0 112.575 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.59 HG12 ' N ' ' A' ' 25' ' ' ARG . 64.3 mt -69.01 142.39 16.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 124.414 1.086 . . . . 0.0 110.628 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.9 74.41 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.138 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.454 ' C ' ' HD2' ' A' ' 22' ' ' LYS . . . -101.05 -172.94 2.26 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -149.9 138.37 20.67 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -167.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.6 m -149.63 149.41 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 C-N-CA 122.846 0.458 . . . . 0.0 110.734 172.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.79 109.44 21.39 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.51 1.131 . . . . 0.0 108.327 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.7 mm? -90.44 113.42 25.35 Favored 'General case' 0 C--N 1.275 -2.667 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.54 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 40.3 mt-10 -88.39 106.36 18.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 174.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.4 HD12 ' HE3' ' A' ' 58' ' ' MET . 1.6 pt? -132.61 158.61 41.8 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.893 0.378 . . . . 0.0 110.442 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.6 t -116.19 125.16 51.89 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.45 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 16.7 tpp85 -98.22 142.62 29.67 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.453 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . 149.33 -9.4 0.93 Allowed Glycine 0 C--N 1.303 -1.3 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.105 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -108.29 92.14 9.23 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.97 129.68 20.09 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 106.146 -2.29 . . . . 0.0 106.146 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -38.96 97.59 0.14 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 125.174 1.546 . . . . 0.0 112.384 -172.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -95.99 -2.21 2.02 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.887 2.391 . . . . 0.0 113.229 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.66 157.52 42.53 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 17.0 t70 -91.76 135.12 27.95 Favored Pre-proline 0 CA--C 1.48 -1.718 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 26.7 Cg_endo -104.92 12.84 0.22 Allowed 'Trans proline' 0 N--CA 1.418 -2.934 0 C-N-CA 123.366 2.711 . . . . 0.0 110.888 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.31 -32.4 9.58 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.751 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -35.42 127.21 0.58 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 127.297 2.239 . . . . 0.0 113.079 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -23.09 -137.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.215 1 C-N-CA 128.748 6.299 . . . . 0.0 119.85 -173.158 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 153' ' ' SER . 0.8 OUTLIER 75.35 -34.55 0.26 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 125.971 1.708 . . . . 0.0 112.955 -178.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 m 73.08 161.72 0.25 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.504 1.122 . . . . 0.0 110.104 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.1 t -122.57 128.01 50.18 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.5 ' HG ' ' HA ' ' B' ' 154' ' ' ARG . 8.6 mt -76.77 104.21 7.15 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.84 109.73 29.57 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.157 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.462 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.8 t -70.58 151.52 44.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 m -81.64 89.9 6.27 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.364 1.078 . . . . 0.0 108.572 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.42 135.12 42.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.9 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -141.99 98.77 3.39 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.226 1.012 . . . . 0.0 110.029 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.9 mt -100.15 7.64 8.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 124.301 2.0 . . . . 0.0 106.054 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.48 146.95 31.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 112.525 -2.125 . . . . 0.0 107.113 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 t70 76.61 -5.59 2.16 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.04 1.336 . . . . 0.0 112.511 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.8 mttm -126.52 148.98 49.64 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -98.06 117.88 64.43 Favored Pre-proline 0 C--N 1.28 -2.445 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.977 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.445 -1.344 0 C-N-CA 122.639 2.226 . . . . 0.0 110.661 172.45 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.567 ' HD2' ' O ' ' B' ' 151' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.218 0.533 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 18.6 t -123.05 138.52 54.66 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' SER . . . . . 0.468 ' HA ' ' NH1' ' B' ' 154' ' ' ARG . 63.2 m 65.52 -176.95 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.302 1.002 . . . . 0.0 109.513 -174.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . 0.5 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -128.12 -175.38 3.48 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 121.446 -0.784 . . . . 0.0 112.735 -176.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.476 ' HA ' ' N ' ' A' ' 114' ' ' LEU . 3.1 m -61.18 -23.31 65.49 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.126 0.965 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.461 ' HG2' ' CB ' ' B' ' 154' ' ' ARG . 10.1 mmt85 -46.58 105.11 0.06 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 128.167 2.587 . . . . 0.0 111.652 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 32' ' ' VAL 0.262 12.6 ptm180 161.24 -52.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.322 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 11.5 pt-20 -155.15 130.51 9.68 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' THR . . . . . 0.414 ' HB ' HG11 ' A' ' 31' ' ' VAL . 29.4 m -113.3 131.52 55.9 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.42 ' HA ' HG23 ' A' ' 30' ' ' THR . 33.4 tt0 -102.84 120.9 41.41 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.417 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 22.7 m . . . . . 0 N--CA 1.432 -1.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.383 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.246 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -163.96 159.86 21.29 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 62.9 mtt 64.97 -167.67 0.22 Allowed 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.875 0.735 . . . . 0.0 111.484 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 101.7 3.63 52.51 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.11 158.28 32.44 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -68.94 124.63 11.63 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.094 1.196 . . . . 0.0 108.994 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -99.8 130.36 45.99 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.127 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -148.21 136.58 21.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.869 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.9 t -178.05 33.47 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.709 1.204 . . . . 0.0 109.883 168.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.638 ' O ' HD22 ' A' ' 73' ' ' LEU . 13.3 ptm180 49.69 27.81 2.37 Favored 'General case' 0 N--CA 1.515 2.82 0 C-N-CA 126.499 1.919 . . . . 0.0 113.026 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.738 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.8 m-80 -96.33 115.28 65.53 Favored Pre-proline 1 C--N 1.22 -5.044 0 CA-C-N 112.894 -1.957 . . . . 0.0 112.283 174.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.315 26.7 Cg_exo -62.48 -34.66 75.19 Favored 'Trans proline' 0 CA--C 1.475 -2.465 0 CA-C-O 124.201 1.667 . . . . 0.0 108.301 173.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -65.16 -28.26 69.29 Favored 'General case' 1 N--CA 1.344 -5.738 0 CA-C-N 109.855 -3.339 . . . . 0.0 111.69 -175.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.738 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.3 pt-20 -80.59 -33.11 36.25 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.0 128.75 37.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.696 1.236 . . . . 0.0 110.361 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.7 ptmm? -83.08 -172.24 4.02 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.33 -169.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 77.32 -135.17 15.95 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.963 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -114.45 139.2 49.72 Favored 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 124.072 0.949 . . . . 0.0 109.309 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.34 114.86 28.89 Favored 'General case' 0 C--N 1.26 -3.283 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.415 HD11 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -131.65 152.3 36.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.188 -175.13 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . 0.501 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 18.7 t60 -126.73 102.81 7.22 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -130.96 146.83 52.49 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.711 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -81.08 133.7 35.52 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 122.713 0.405 . . . . 0.0 111.695 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.54 125.7 48.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -85.36 119.65 25.96 Favored 'General case' 0 N--CA 1.395 -3.176 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.135 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.546 ' HG3' HD11 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -52.32 101.29 0.04 OUTLIER 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 89' ' ' ILE . 11.1 t -83.08 -94.71 0.06 Allowed 'General case' 0 N--CA 1.411 -2.391 0 O-C-N 124.816 1.323 . . . . 0.0 109.628 -176.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -96.03 73.93 3.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.562 ' N ' HG12 ' A' ' 89' ' ' ILE . 32.0 ttt180 59.98 40.75 18.49 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.425 1.49 . . . . 0.0 111.909 176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 163.68 -138.05 5.1 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.726 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 83.8 m-85 -121.91 -84.09 0.66 Allowed 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.786 -0.207 . . . . 0.0 111.321 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.52 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.56 53.43 0.13 Allowed Glycine 0 C--N 1.291 -1.949 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.998 -171.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.429 ' HA ' HG21 ' A' ' 47' ' ' VAL . 30.7 p90 -161.23 143.24 12.03 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.496 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 20.0 p -106.06 135.69 47.07 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.793 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.742 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 0.9 OUTLIER -114.08 163.22 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.559 -168.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 44' ' ' LYS . 2.7 m -121.46 133.31 68.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.173 0 C-N-CA 124.293 1.037 . . . . 0.0 109.689 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.18 -130.96 9.6 Favored Glycine 0 C--O 1.279 2.946 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.123 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.482 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.77 62.26 1.01 Allowed Glycine 0 CA--C 1.453 -3.817 0 O-C-N 126.462 1.919 . . . . 0.0 110.837 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.583 ' OD2' ' HB3' ' B' ' 156' ' ' ARG . 8.5 t70 -110.8 -36.1 5.79 Favored 'General case' 0 C--N 1.249 -3.795 0 CA-C-N 113.735 -1.232 . . . . 0.0 109.719 -170.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.5 pt-20 -158.3 174.71 3.78 Favored Pre-proline 0 CA--C 1.481 -1.686 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.227 -169.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 73.1 Cg_exo -60.15 -30.43 91.32 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 122.617 2.211 . . . . 0.0 109.516 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.85 -39.37 79.96 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.889 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.67 119.78 37.88 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -88.97 165.95 14.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.876 2.07 . . . . 0.0 108.538 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 64' ' ' ILE . 5.9 mp -89.27 144.17 26.29 Favored 'General case' 0 C--O 1.18 -2.597 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.689 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.85 169.4 17.14 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.8 mm -113.54 126.1 70.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 -173.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HG2' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -102.28 -20.31 14.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.496 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.6 m -155.75 126.92 7.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.186 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -78.6 108.99 12.4 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 89.3 t -84.86 126.42 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.5 144.55 55.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.331 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 82.68 2.83 1.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 125.205 1.566 . . . . 0.0 110.071 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.7 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.11 160.3 38.39 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.726 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.34 -25.3 18.59 Favored 'Trans proline' 0 C--O 1.18 -2.398 0 CA-C-N 121.092 2.446 . . . . 0.0 109.62 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.69 -44.18 94.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.523 175.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.94 68.9 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 122.655 1.217 . . . . 0.0 109.8 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.7 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 52.1 mt -72.54 -50.07 28.2 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.356 -2.202 . . . . 0.0 115.9 -172.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.51 -21.43 41.91 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.4 -169.59 54.87 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.395 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt 58.5 30.29 19.54 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 112.784 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' MET . . . . . 0.655 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.5 tmt? -159.83 131.97 6.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 171.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -147.85 160.27 42.95 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.477 0.656 . . . . 0.0 112.26 -169.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -54.69 119.91 6.0 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.386 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.54 4.1 15.81 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.867 -1.158 . . . . 0.0 112.752 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.556 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 p30 -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.214 171.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 6.5 p -100.42 117.87 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.398 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 50.4 mm -74.59 111.41 10.38 Favored 'Isoleucine or valine' 0 C--O 1.301 3.794 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.277 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 58.6 t -89.18 -58.09 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.476 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -160.55 173.64 15.23 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.031 -0.418 . . . . 0.0 110.852 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG13 ' CG2' ' A' ' 72' ' ' VAL . 11.1 p -140.5 121.33 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.378 30.0 p-10 33.03 -89.84 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -92.5 -34.09 14.22 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -93.09 130.87 38.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.227 1.013 . . . . 0.0 112.719 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 t -84.7 90.16 7.66 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.412 ' CG2' HG13 ' A' ' 67' ' ' VAL . 40.8 t -78.89 -0.34 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 122.857 1.313 . . . . 0.0 109.039 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.638 HD22 ' O ' ' A' ' 6' ' ' ARG . 20.8 tp -68.1 111.47 4.49 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.363 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.5 43.04 93.28 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.792 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.42 137.8 32.05 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.481 ' HB ' ' CG ' ' A' ' 79' ' ' GLN . 35.9 m -69.55 143.87 53.26 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.457 ' CG ' ' HA ' ' B' ' 156' ' ' ARG . 19.1 t60 -47.49 -49.18 26.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.147 0.885 . . . . 0.0 112.548 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.83 71.95 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.684 0.754 . . . . 0.0 110.97 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.481 ' CG ' ' HB ' ' A' ' 76' ' ' THR . 14.1 mm-40 -80.1 -50.0 10.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.854 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.71 -42.27 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.427 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.527 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.7 p -63.07 -35.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -43.77 98.28 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.9 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.59 -50.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 122.196 0.998 . . . . 0.0 109.357 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -67.25 -28.69 68.25 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.41 -1.723 . . . . 0.0 112.759 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 78.7 mm-40 -88.49 -17.26 30.72 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 p -94.86 -13.6 25.34 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -52.02 154.8 3.61 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 177.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -95.45 148.14 1.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.093 3.195 . . . . 0.0 112.325 -176.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.562 HG12 ' N ' ' A' ' 25' ' ' ARG . 50.6 mt -65.26 124.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.897 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.65 11.28 44.59 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-O 119.746 -0.475 . . . . 0.0 113.354 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.06 -178.09 4.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.033 0.916 . . . . 0.0 111.626 -173.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 t -139.29 150.51 45.51 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 110.496 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.5 m -151.39 156.66 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.149 0.98 . . . . 0.0 110.854 174.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.501 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 23.6 m-20 -105.21 107.33 18.26 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 13.5 tp -94.33 125.92 39.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.26 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.43 ' HB3' ' HD1' ' A' ' 17' ' ' HIS . 9.8 pt-20 -108.74 113.8 27.06 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.887 0.851 . . . . 0.0 108.789 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.556 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.7 pt? -142.13 155.5 45.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.324 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' CYS . . . . . 0.468 ' O ' HG13 ' A' ' 63' ' ' VAL . 58.8 m -113.58 107.11 15.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.573 0.702 . . . . 0.0 109.33 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.655 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 4.9 ttp-105 -85.83 133.67 33.96 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.152 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.31 40.23 0.97 Allowed Glycine 0 C--N 1.283 -2.369 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.812 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -108.14 125.79 31.19 Favored Pre-proline 0 N--CA 1.409 -2.488 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.554 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 35.7 Cg_exo -59.29 138.35 84.04 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.318 2.012 . . . . 0.0 112.814 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 105' ' ' PHE . 0.3 OUTLIER -98.14 91.62 1.22 Allowed Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 48.5 Cg_endo -88.58 20.44 1.14 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.087 2.524 . . . . 0.0 113.675 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' O ' HD12 ' A' ' 103' ' ' LEU . 95.0 m-85 -142.42 179.07 7.16 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.1 m-20 -79.64 146.48 65.22 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.7 Cg_endo -97.48 9.2 1.22 Allowed 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 123.772 2.981 . . . . 0.0 107.126 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.1 -25.76 10.96 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.929 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.28 113.7 28.23 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.474 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.02 153.06 76.14 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 C-N-CA 123.792 2.994 . . . . 0.0 113.694 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.4 ' HB3' HD22 ' A' ' 114' ' ' LEU . 8.8 m120 164.38 68.31 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 129.6 3.16 . . . . 0.0 109.683 165.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 57.2 m -85.11 -40.6 16.58 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.604 1.192 . . . . 0.0 110.331 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.505 ' HA ' HG23 ' B' ' 155' ' ' THR . 10.2 t -91.89 99.04 11.97 Favored 'General case' 0 C--N 1.251 -3.701 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.393 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.502 ' H ' ' HA ' ' B' ' 155' ' ' THR . 57.1 mt -123.34 104.99 9.46 Favored 'General case' 0 N--CA 1.416 -2.175 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.05 123.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.5 t -71.03 144.62 50.35 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.2 t -110.61 156.24 21.24 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.11 101.41 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-O 122.023 0.916 . . . . 0.0 110.397 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.53 73.67 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.8 mm -110.4 -9.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.861 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.3 mt -130.49 163.94 25.91 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.052 0.453 . . . . 0.0 111.647 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -98.94 101.81 13.33 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.464 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -93.1 135.59 34.14 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.693 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -90.54 111.74 49.21 Favored Pre-proline 0 C--N 1.269 -2.894 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.957 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.462 -0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.439 -175.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.8 t -95.97 111.39 23.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -144.98 119.22 9.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.364 0.602 . . . . 0.0 111.738 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -90.25 151.31 21.58 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' THR . . . . . 0.505 HG23 ' HA ' ' A' ' 113' ' ' SER . 27.1 p 62.63 139.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.647 1.179 . . . . 0.0 114.132 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.583 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 48.7 mtm180 -153.44 165.4 35.93 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 75.25 -77.58 0.05 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.068 0.547 . . . . 0.0 111.897 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' GLU . . . . . 0.742 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 32.8 mt-10 -86.59 91.11 8.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.429 0.633 . . . . 0.0 112.239 -173.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 7.8 m -88.65 110.2 20.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.442 ' HA ' HG23 ' A' ' 30' ' ' THR . 21.1 mt-30 -84.26 120.93 26.81 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.404 HG21 ' HB2' ' A' ' 27' ' ' PHE . 12.9 m . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.386 15.0 t . . . . . 0 N--CA 1.417 -2.084 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.147 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' THR . 18.2 ptt-85 155.18 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.745 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.6 t-20 -55.86 111.88 3.67 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 112.779 -2.01 . . . . 0.0 112.913 -175.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.2 Cg_exo -63.96 -27.16 66.38 Favored 'Trans proline' 0 CA--C 1.476 -2.407 0 C-N-CA 121.234 1.289 . . . . 0.0 109.997 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -85.4 -14.92 44.78 Favored 'General case' 1 N--CA 1.358 -5.063 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.652 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.4 pt-20 -72.69 -36.2 67.83 Favored 'General case' 0 C--N 1.376 1.752 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.0 mt -59.99 136.0 57.88 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.16 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -98.34 177.49 5.35 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.648 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.6 -99.71 2.48 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.765 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -145.79 128.22 15.94 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.408 0.623 . . . . 0.0 109.352 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.73 115.21 29.8 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -126.12 152.41 33.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.058 -175.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.691 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 14.7 t-160 -127.33 99.89 5.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 HG22 HD21 ' A' ' 97' ' ' LEU . 15.3 t -124.2 141.3 52.17 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.047 -172.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -86.71 131.14 34.22 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.685 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.7 mp -115.02 123.35 48.85 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -86.22 115.44 23.78 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -45.17 102.35 0.03 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 123.95 0.9 . . . . 0.0 109.234 169.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -123.14 135.93 54.56 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 125.274 1.609 . . . . 0.0 108.939 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m 55.12 28.62 11.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.068 0.947 . . . . 0.0 113.143 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.744 ' N ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 77.5 102.91 0.07 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.632 1.573 . . . . 0.0 108.368 176.637 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.55 -137.32 13.53 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.289 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.649 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.6 m-85 -124.29 -82.76 0.64 Allowed 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.54 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 119.64 56.02 0.25 Allowed Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.455 ' HA ' ' H ' ' A' ' 47' ' ' VAL . 28.2 p90 -160.9 143.65 12.79 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' CB ' ' B' ' 160' ' ' GLN . 40.0 p -107.99 134.94 50.19 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-O 122.134 0.969 . . . . 0.0 109.199 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.584 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 2.2 p -135.55 136.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.957 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.044 -169.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.2 m -115.39 131.82 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.261 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.1 -145.35 17.13 Favored Glycine 0 CA--C 1.457 -3.57 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 48.39 70.11 0.82 Allowed Glycine 0 CA--C 1.464 -3.137 0 O-C-N 126.599 1.999 . . . . 0.0 112.031 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -116.93 -29.25 6.06 Favored 'General case' 0 C--N 1.259 -3.332 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.296 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.6 pt-20 -159.21 174.23 4.23 Favored Pre-proline 0 CA--C 1.467 -2.242 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.579 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 77.1 Cg_exo -61.72 -25.83 79.23 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 122.435 2.09 . . . . 0.0 109.388 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -84.01 -21.39 31.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.347 -2.206 . . . . 0.0 112.306 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -122.75 119.41 30.58 Favored 'General case' 0 C--O 1.264 1.837 0 O-C-N 121.492 -0.755 . . . . 0.0 110.471 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.0 165.67 12.74 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.249 2.22 . . . . 0.0 108.495 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.3 mp -93.08 146.47 23.62 Favored 'General case' 0 C--O 1.183 -2.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.583 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 63' ' ' VAL . 15.0 tt0 -137.18 144.49 42.93 Favored 'General case' 0 C--O 1.191 -2.006 0 CA-C-N 118.56 0.618 . . . . 0.0 110.318 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.445 HD12 ' CD1' ' A' ' 29' ' ' PHE . 23.4 mm -79.94 119.63 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 O-C-N 121.829 -0.544 . . . . 0.0 109.848 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 32' ' ' VAL . 1.2 pptp? -103.28 -19.79 14.34 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.951 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.418 ' OG ' ' HD2' ' A' ' 44' ' ' LYS . 45.6 m -161.14 128.16 4.08 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 59' ' ' GLU . 1.5 pp -87.63 128.35 35.28 Favored 'General case' 0 N--CA 1.395 -3.183 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.725 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.54 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.6 t -80.2 127.51 39.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 86.8 mt -64.5 133.99 53.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.6 t70 84.73 11.08 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.385 1.678 . . . . 0.0 109.608 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.93 155.57 23.17 Favored Glycine 0 CA--C 1.487 -1.702 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.572 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.5 Cg_endo -72.02 -25.32 19.64 Favored 'Trans proline' 0 N--CA 1.425 -2.556 0 CA-C-N 121.266 2.533 . . . . 0.0 110.486 -170.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.85 85.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.62 88.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 122.861 1.315 . . . . 0.0 109.879 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 87.4 mt -72.42 -45.73 58.36 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 112.785 -2.007 . . . . 0.0 114.459 -174.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -68.78 -24.69 64.45 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.74 3.2 9.43 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-N 114.186 -1.37 . . . . 0.0 115.893 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -110.44 19.42 18.8 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.996 1.379 . . . . 0.0 109.802 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ttt -146.67 133.21 19.77 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.613 ' HA ' HD23 ' A' ' 46' ' ' LEU . 44.4 mt-10 -140.43 162.11 36.11 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.354 0.662 . . . . 0.0 109.738 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.0 m -57.02 119.01 5.56 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.51 -18.5 5.73 Favored Glycine 0 C--N 1.302 -1.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.47 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' A' ' 99' ' ' ARG . 11.1 m-20 -67.79 136.63 54.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HG3' ' A' ' 42' ' ' GLN . 1.8 m -101.38 130.35 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 43.3 mm -82.22 111.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.299 3.702 0 C-N-CA 123.343 0.657 . . . . 0.0 109.856 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 60.4 t -91.85 -57.92 3.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 126.346 2.279 . . . . 0.0 108.764 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -157.74 170.96 21.19 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.925 -0.484 . . . . 0.0 111.24 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -152.67 120.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.018 0.437 . . . . 0.0 112.145 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 50.18 58.63 5.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.907 1.283 . . . . 0.0 111.258 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.26 -30.09 0.2 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.504 -1.68 . . . . 0.0 113.033 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 m -65.83 127.12 30.73 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 121.444 0.64 . . . . 0.0 111.14 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.9 t -79.05 78.24 5.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.233 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 87.2 t -83.89 5.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 122.786 1.279 . . . . 0.0 109.49 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.463 HD13 HG13 ' A' ' 65' ' ' VAL . 13.3 tp -66.62 110.13 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.92 45.0 95.73 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.205 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 1.7 t60 -79.72 147.99 31.7 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.5 m -74.87 143.57 43.78 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 117.73 -1.128 . . . . 0.0 108.821 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -48.07 -49.28 32.16 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.246 0.93 . . . . 0.0 112.33 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.7 71.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 124.063 0.852 . . . . 0.0 110.988 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 81.0 mm-40 -80.28 -48.57 12.83 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.125 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 41' ' ' LEU . 7.3 p -63.8 -43.14 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.7 p -64.53 -35.97 76.06 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -42.99 85.89 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.261 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -72.25 -50.65 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 CA-C-O 122.474 1.131 . . . . 0.0 109.528 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.66 -29.67 69.75 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.049 -1.887 . . . . 0.0 113.327 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 mp0 -86.71 -25.18 24.88 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 p -85.57 -22.36 28.1 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -52.43 151.35 7.6 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.4 Cg_endo -102.49 159.54 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.242 3.961 . . . . 0.0 112.302 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.744 HG12 ' N ' ' A' ' 25' ' ' ARG . 26.9 mt -67.96 131.21 33.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.297 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.03 11.4 34.43 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.961 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -103.39 176.88 5.0 Favored 'General case' 0 C--O 1.202 -1.444 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.496 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.492 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 30.1 t -134.57 148.32 50.44 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.082 -0.386 . . . . 0.0 110.675 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 22' ' ' LYS . 3.2 m -149.07 149.75 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 C-N-CA 124.104 0.961 . . . . 0.0 111.169 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.691 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.9 m-20 -100.23 111.75 24.04 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.526 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.32 125.09 35.97 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.937 0.399 . . . . 0.0 110.315 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 35.2 mt-10 -104.27 105.45 15.59 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 18' ' ' THR . 0.4 OUTLIER -141.43 157.29 45.36 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.254 -172.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.9 t -131.7 120.09 22.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.344 0.592 . . . . 0.0 109.739 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 19.4 ttp85 -114.98 158.62 21.8 Favored 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 124.086 0.955 . . . . 0.0 109.858 -174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.22 -15.34 2.54 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 113.989 -1.105 . . . . 0.0 108.222 177.978 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 8.5 m -115.67 89.01 3.0 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.496 ' CB ' HG22 ' A' ' 30' ' ' THR . 5.1 pm0 -76.97 114.06 15.34 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.263 0.554 . . . . 0.0 110.631 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.2 m . . . . . 0 N--CA 1.427 -1.593 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.63 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.432 -1.345 0 CA-C-O 121.585 0.707 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 47.67 41.12 13.22 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 124.049 1.881 . . . . 0.0 112.107 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.787 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 4.6 m-20 -111.42 114.81 52.64 Favored Pre-proline 0 C--N 1.248 -3.845 0 CA-C-N 112.82 -1.991 . . . . 0.0 112.98 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.305 14.6 Cg_exo -57.53 -36.06 98.72 Favored 'Trans proline' 0 CA--C 1.48 -2.203 0 CA-C-O 123.948 1.562 . . . . 0.0 109.076 172.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -73.94 -15.87 61.11 Favored 'General case' 1 N--CA 1.344 -5.737 0 CA-C-N 110.626 -2.988 . . . . 0.0 112.403 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.787 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.1 pt-20 -80.85 -30.42 35.66 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.6 mt -66.76 137.22 56.48 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.473 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -82.86 179.86 7.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.453 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.55 -129.73 9.47 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.619 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 144.98 50.49 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 122.757 0.423 . . . . 0.0 110.362 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -113.03 112.26 23.57 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.08 152.54 35.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.229 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.82 108.13 14.01 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -131.96 147.17 52.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.682 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -92.8 140.82 29.12 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.952 0.501 . . . . 0.0 111.368 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -122.14 127.4 50.04 Favored 'General case' 0 C--O 1.258 1.512 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -85.88 113.95 22.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.81 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -42.35 106.07 0.06 Allowed 'General case' 0 CA--C 1.475 -1.921 0 C-N-CA 125.441 1.496 . . . . 0.0 112.267 172.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -120.34 129.91 54.19 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.623 ' C ' HG12 ' A' ' 89' ' ' ILE . 10.9 m 61.16 -165.22 0.22 Allowed 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -84.57 61.03 6.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.636 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.41 -121.0 1.05 Allowed Glycine 0 N--CA 1.406 -3.313 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.284 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 87' ' ' ILE . 76.4 m-85 -135.28 -101.02 0.22 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.921 -1.14 . . . . 0.0 112.032 -168.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.26 57.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.518 ' HA ' HG23 ' A' ' 47' ' ' VAL . 50.7 p90 -160.55 143.58 13.28 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -101.35 135.31 43.04 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 117.792 -1.563 . . . . 0.0 109.932 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 159' ' ' THR . 11.3 p -126.0 143.42 39.57 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.516 -170.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -115.65 132.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.837 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.22 -144.36 15.02 Favored Glycine 0 C--N 1.277 -2.727 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.264 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.561 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.76 63.52 2.48 Favored Glycine 0 CA--C 1.457 -3.592 0 O-C-N 126.483 1.931 . . . . 0.0 111.946 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 76' ' ' THR . 8.5 t70 -105.18 -42.48 5.27 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.322 -0.939 . . . . 0.0 108.514 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.1 pt-20 -160.03 172.61 5.75 Favored Pre-proline 0 CA--C 1.472 -2.026 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.324 -170.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 18.7 Cg_exo -76.01 64.53 6.91 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.152 3.235 . . . . 0.0 108.57 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -172.83 -47.27 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 111.789 -2.46 . . . . 0.0 107.373 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -105.11 119.32 38.75 Favored 'General case' 0 C--O 1.273 2.335 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.947 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.12 166.22 12.45 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 128.682 2.793 . . . . 0.0 108.905 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.561 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.1 mp -96.37 145.87 25.25 Favored 'General case' 0 C--O 1.172 -3.016 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.421 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 40.4 tt0 -139.78 144.34 37.34 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 118.488 0.586 . . . . 0.0 110.093 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.2 mp -81.82 118.42 29.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 O-C-N 121.913 -0.492 . . . . 0.0 109.683 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -98.75 -24.39 15.04 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.432 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -152.37 127.99 10.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.644 -0.66 . . . . 0.0 109.673 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 60' ' ' THR . 3.0 pp -86.97 116.51 25.08 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 29' ' ' PHE . 67.0 t -87.91 134.73 27.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.273 -173.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 95.7 mt -60.24 142.54 54.39 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.7 t70 79.87 3.42 2.06 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.784 1.302 . . . . 0.0 110.558 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -95.05 155.74 21.57 Favored Glycine 0 CA--C 1.489 -1.571 0 CA-C-O 118.362 -1.243 . . . . 0.0 110.45 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.627 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 18.1 Cg_endo -71.89 -25.64 19.71 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 CA-C-N 120.931 2.365 . . . . 0.0 111.062 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.8 97.12 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.9 74.45 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.542 1.163 . . . . 0.0 109.954 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 79.7 mt -71.58 -40.3 70.0 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-N 112.933 -1.94 . . . . 0.0 114.165 -172.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.77 -24.58 58.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.94 -3.98 11.49 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.997 -1.456 . . . . 0.0 115.893 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -94.08 -42.58 8.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.431 ' HG3' HD11 ' A' ' 97' ' ' LEU . 22.5 ttt -82.12 133.84 35.29 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -139.76 168.74 19.12 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.094 0.949 . . . . 0.0 112.073 -169.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.459 ' H ' HD23 ' A' ' 46' ' ' LEU . 20.7 m -64.16 126.23 27.08 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.383 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.09 -9.93 12.01 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.618 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 18.9 m-20 -78.37 144.17 36.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.327 0.1 OUTLIER -115.48 119.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.544 0.688 . . . . 0.0 111.094 171.086 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 43' ' ' ILE . 40.7 mm -68.67 113.76 4.77 Favored 'Isoleucine or valine' 0 C--O 1.299 3.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.215 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG13 HD13 ' A' ' 73' ' ' LEU . 87.6 t -102.39 -54.96 6.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 112.254 -2.248 . . . . 0.0 110.203 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.9 t -143.65 158.22 43.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.388 -0.82 . . . . 0.0 110.213 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.15 112.1 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.03 0.443 . . . . 0.0 111.641 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.425 ' HB2' HG12 ' A' ' 93' ' ' VAL . 2.3 t30 71.24 -66.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.137 1.375 . . . . 0.0 111.875 175.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.66 -37.61 0.1 Allowed 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.844 1.658 . . . . 0.0 109.035 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -67.71 127.69 33.7 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.781 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.3 t -85.69 90.3 7.98 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.526 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 9.7 p -80.26 4.09 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 122.701 1.239 . . . . 0.0 109.928 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.641 HD13 HG13 ' A' ' 65' ' ' VAL . 19.6 tp -67.43 111.79 4.27 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.563 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.78 37.54 88.74 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.528 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -82.49 148.22 28.25 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 83.2 m -78.77 143.22 36.32 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.776 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 83.2 t60 -47.26 -50.55 21.15 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.288 0.949 . . . . 0.0 113.096 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.12 74.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.845 0.716 . . . . 0.0 110.702 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 34.3 mm-40 -75.68 -50.41 15.49 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 41' ' ' LEU . 7.0 p -62.02 -45.25 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.667 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.57 -36.0 76.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.416 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -59.08 -47.88 83.62 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.486 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -72.46 -49.96 38.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.385 0 CA-C-O 122.18 0.991 . . . . 0.0 110.121 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HB3' HG11 ' B' ' 161' ' ' VAL . 7.2 m-85 -61.41 -40.44 94.42 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.529 -1.668 . . . . 0.0 113.141 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.63 -14.07 46.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -91.76 -2.21 57.05 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.119 0.485 . . . . 0.0 110.824 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.753 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.2 mt -53.35 140.51 44.97 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.051 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 83.6 Cg_endo -97.82 150.78 0.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.618 2.879 . . . . 0.0 113.042 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.623 HG12 ' C ' ' A' ' 24' ' ' SER . 23.6 mt -67.59 135.89 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.432 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.6 12.43 58.23 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.222 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -108.5 -170.63 1.71 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.147 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.409 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.0 t -150.04 142.17 24.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.81 HG22 ' HE3' ' A' ' 22' ' ' LYS . 27.4 m -145.51 155.35 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.818 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.775 173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.05 113.81 27.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 124.929 1.393 . . . . 0.0 109.197 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.7 mm? -91.12 120.32 31.97 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 20.4 mt-10 -98.71 110.21 22.84 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.431 HD11 ' HG3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.49 156.52 45.74 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.046 -170.139 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 63.3 m -109.99 125.91 53.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.606 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 tpp85 -102.82 153.52 20.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.98 -5.77 7.84 Favored Glycine 0 CA--C 1.486 -1.72 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.938 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.1 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 158' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.565 0 CA-C-O 122.182 0.991 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.537 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.4 m -75.83 107.82 8.27 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.95 93.94 9.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.704 -0.622 . . . . 0.0 110.629 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 m . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.717 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 8.8 t . . . . . 0 N--CA 1.419 -1.995 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 5' ' ' THR . 10.2 ptm180 56.02 13.47 1.16 Allowed 'General case' 0 N--CA 1.516 2.842 0 C-N-CA 126.423 1.889 . . . . 0.0 113.653 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.7 m-80 -93.8 115.03 64.59 Favored Pre-proline 0 C--N 1.251 -3.712 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.288 10.8 Cg_exo -62.06 -29.69 81.71 Favored 'Trans proline' 0 CA--C 1.475 -2.444 0 N-CA-C 108.019 -1.57 . . . . 0.0 108.019 170.816 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 t -69.79 -25.68 63.91 Favored 'General case' 1 N--CA 1.354 -5.255 0 CA-C-N 111.271 -2.695 . . . . 0.0 110.962 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.0 pt-20 -78.27 -31.26 48.96 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 86.9 mt -63.01 133.92 55.35 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.547 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 176.08 6.72 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.803 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.23 -116.19 5.44 Favored Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.324 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.4 156.42 48.21 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -122.07 112.47 18.28 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -119.85 152.22 22.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-O 121.209 0.528 . . . . 0.0 110.737 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.605 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.3 t-160 -133.26 99.64 4.6 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 14.9 t -126.27 142.09 51.66 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.677 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -86.84 133.36 33.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.019 0.928 . . . . 0.0 111.637 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -115.45 127.34 55.26 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -88.06 103.94 16.19 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.687 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.53 118.23 1.03 Allowed 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 19.3 t -92.51 -137.05 0.17 Allowed 'General case' 0 N--CA 1.403 -2.785 0 O-C-N 126.104 2.128 . . . . 0.0 106.717 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -63.84 83.29 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.505 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 60.69 27.99 17.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.395 1.878 . . . . 0.0 112.009 174.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.45 -139.48 5.41 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.69 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.601 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.7 m-85 -124.66 -87.84 0.61 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.92 52.54 0.11 Allowed Glycine 0 C--N 1.295 -1.72 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.037 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 42.2 p90 -160.96 141.94 11.61 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 172.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.6 p -107.62 138.04 44.57 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 41' ' ' LEU . 19.3 m -124.89 159.29 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -167.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.9 m -115.87 133.7 61.48 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 C-N-CA 124.516 1.127 . . . . 0.0 109.968 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.18 -143.91 18.24 Favored Glycine 0 C--N 1.278 -2.689 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.467 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.77 58.09 4.34 Favored Glycine 0 CA--C 1.452 -3.87 0 O-C-N 126.115 1.714 . . . . 0.0 111.228 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 76' ' ' THR . 6.3 t70 -102.67 -35.49 8.67 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.328 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.9 pt-20 -158.45 168.44 12.44 Favored Pre-proline 0 CA--C 1.469 -2.151 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.404 -169.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -75.94 58.18 5.39 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 124.298 3.332 . . . . 0.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.81 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 112.085 -2.325 . . . . 0.0 106.732 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.42 118.73 34.55 Favored 'General case' 0 C--O 1.272 2.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.279 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.18 165.96 13.65 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 127.976 2.51 . . . . 0.0 108.348 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.9 mp -95.76 144.38 26.2 Favored 'General case' 0 C--O 1.175 -2.858 0 C-N-CA 118.506 -1.277 . . . . 0.0 109.639 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 36.5 tt0 -130.1 156.28 44.8 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' A' ' 29' ' ' PHE . 12.6 mm -90.01 127.27 42.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.67 -19.86 13.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.509 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.0 m -155.73 127.28 7.3 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 tp -83.14 114.96 21.69 Favored 'General case' 0 N--CA 1.402 -2.84 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.493 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 58.4 t -86.99 122.71 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.19 146.17 50.93 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 84.37 3.03 0.79 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.489 1.743 . . . . 0.0 109.795 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.658 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -86.91 158.98 31.06 Favored Glycine 0 C--O 1.207 -1.579 0 CA-C-O 117.872 -1.516 . . . . 0.0 109.576 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.6 Cg_endo -72.59 -25.17 17.92 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 CA-C-N 121.725 2.762 . . . . 0.0 110.633 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.38 -42.2 98.83 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.241 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.36 82.12 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.668 1.223 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 82.6 mt -71.67 -44.74 63.73 Favored 'General case' 0 N--CA 1.405 -2.715 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.517 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.16 -19.61 50.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.36 1.076 . . . . 0.0 108.242 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.98 27.92 65.39 Favored Glycine 0 CA--C 1.48 -2.097 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.593 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 26.4 tptp -102.06 -13.08 17.66 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.331 -173.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.619 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 67.5 mtp -123.11 144.31 49.4 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.43 141.39 25.9 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -45.16 114.14 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.726 1.21 . . . . 0.0 111.332 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.6 -18.77 5.12 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.461 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CB ' HD12 ' A' ' 97' ' ' LEU . 5.0 m-20 -60.64 146.51 45.2 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.288 1.2 p -117.87 116.18 50.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.964 174.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.08 120.02 25.25 Favored 'Isoleucine or valine' 0 C--O 1.284 2.882 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.692 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.434 HG11 ' HG3' ' A' ' 8' ' ' PRO . 37.4 t -99.12 -34.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-N 112.334 -2.212 . . . . 0.0 110.138 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -170.62 169.49 7.16 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 95' ' ' LEU . 6.9 p -155.17 115.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 63.3 t30 37.43 76.59 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.14 1.776 . . . . 0.0 113.918 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 70.89 -18.93 0.24 Allowed 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.76 122.53 33.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.39 77.2 8.29 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 122.023 0.916 . . . . 0.0 110.134 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.94 -0.91 4.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.426 1.108 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 6' ' ' ARG . 30.7 tp -59.04 110.52 1.06 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 170.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.59 48.77 84.54 Favored Glycine 0 N--CA 1.431 -1.641 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.298 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -89.17 141.14 28.78 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.541 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 24.0 m -74.04 144.09 45.22 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.247 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.431 ' HA ' HG12 ' A' ' 80' ' ' VAL . 73.2 t60 -46.72 -47.54 20.53 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.135 0.879 . . . . 0.0 113.103 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.901 0.857 . . . . 0.0 111.081 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 79.2 mm-40 -78.51 -49.75 12.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.651 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 41' ' ' LEU . 12.7 p -64.46 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.93 -44.64 98.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -72.79 -27.04 61.75 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.27 -1.372 . . . . 0.0 113.276 -175.361 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -73.02 -51.21 27.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 122.03 0.919 . . . . 0.0 109.003 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.46 -39.09 92.3 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.703 -1.59 . . . . 0.0 112.755 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' B' ' 161' ' ' VAL . 14.2 mm100 -85.65 -20.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -96.17 4.96 52.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.211 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.687 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 3.1 mt -48.47 147.08 4.35 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.302 1.041 . . . . 0.0 112.709 170.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -94.27 150.56 2.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.246 2.631 . . . . 0.0 111.436 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.505 HG12 ' H ' ' A' ' 25' ' ' ARG . 24.8 mt -68.75 143.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.305 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.52 12.06 70.4 Favored Glycine 0 CA--C 1.497 -1.052 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.483 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.71 -176.34 3.71 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.274 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.556 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.7 t -147.03 142.68 27.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.255 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 4.7 m -151.98 144.24 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 O-C-N 124.2 0.938 . . . . 0.0 111.002 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 2.5 m-20 -97.79 117.73 32.76 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.696 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 3.2 mm? -90.67 121.98 33.05 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -91.05 108.18 19.7 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.577 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -141.61 147.74 38.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.062 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.28 136.77 44.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.841 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 18.4 tpp85 -114.08 149.98 34.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.24 3.95 6.61 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' A' ' 11' ' ' LEU . 65.3 m-85 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 122.788 0.435 . . . . 0.0 111.389 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.2 mp0 . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 14.3 m -81.44 128.29 33.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.43 ' HA ' HG22 ' A' ' 30' ' ' THR . 50.6 mt-30 -98.47 124.91 43.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.458 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.5 t . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 121.031 0.443 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 5' ' ' THR . 31.1 ptt180 54.67 15.53 1.1 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 126.159 1.784 . . . . 0.0 113.559 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.81 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.9 m-80 -94.62 114.22 62.94 Favored Pre-proline 1 C--N 1.242 -4.065 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.269 7.2 Cg_exo -58.36 -29.97 89.78 Favored 'Trans proline' 0 CA--C 1.483 -2.034 0 C-N-CA 121.552 1.501 . . . . 0.0 109.336 170.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -72.99 -25.43 60.98 Favored 'General case' 1 N--CA 1.365 -4.721 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.313 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -76.02 -34.54 59.69 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -55.07 130.61 42.51 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 122.406 1.098 . . . . 0.0 111.748 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.17 170.88 12.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.282 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.67 -109.65 3.05 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.045 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -147.33 145.13 29.22 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 123.082 0.553 . . . . 0.0 110.646 -176.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -110.22 111.45 22.77 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.005 0.907 . . . . 0.0 112.152 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -118.05 99.79 7.12 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -129.69 137.02 50.39 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.562 0.696 . . . . 0.0 111.588 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -73.36 133.54 43.83 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.07 0.948 . . . . 0.0 112.008 -176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 tp -124.49 134.41 53.04 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -93.66 114.72 27.09 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.555 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -42.71 99.5 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 125.0 1.32 . . . . 0.0 111.099 168.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.3 m -118.48 125.44 49.9 Favored 'General case' 0 N--CA 1.417 -2.092 0 O-C-N 125.527 1.767 . . . . 0.0 107.655 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 58.46 47.7 13.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.777 0.799 . . . . 0.0 111.035 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.546 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.7 mpt_? 84.7 -62.74 0.08 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 126.635 1.974 . . . . 0.0 111.702 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . -100.29 -115.06 3.74 Favored Glycine 0 N--CA 1.406 -3.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.211 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.635 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 81.2 m-85 -129.97 -84.5 0.54 Allowed 'General case' 0 N--CA 1.397 -3.12 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.002 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 134.26 53.86 0.07 OUTLIER Glycine 0 C--N 1.295 -1.73 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.008 -170.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' HD12 ' A' ' 43' ' ' ILE . 44.0 p90 -161.64 142.85 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.517 HG22 ' HB2' ' B' ' 160' ' ' GLN . 76.9 p -104.24 135.12 46.31 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.823 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 159' ' ' THR . 1.0 OUTLIER -115.77 162.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.791 -171.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.0 132.31 47.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 C-N-CA 123.505 0.722 . . . . 0.0 109.237 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.91 -147.85 18.84 Favored Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.46 60.64 3.59 Favored Glycine 0 CA--C 1.462 -3.263 0 O-C-N 126.352 1.854 . . . . 0.0 113.085 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -106.03 -24.23 12.44 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 114.348 -0.926 . . . . 0.0 109.148 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 3.0 pt-20 -158.49 172.06 6.63 Favored Pre-proline 0 C--O 1.196 -1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.426 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -67.54 -15.34 44.8 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 123.117 2.545 . . . . 0.0 109.439 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 21.5 t70 -92.6 -24.04 18.83 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.995 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.22 117.93 26.45 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -84.61 165.54 17.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.253 2.221 . . . . 0.0 108.619 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -91.37 144.72 25.29 Favored 'General case' 0 C--O 1.183 -2.441 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.085 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 16.3 tt0 -128.07 169.49 14.0 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.3 mm -112.9 135.68 51.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' C ' HG23 ' A' ' 60' ' ' THR . 21.6 pttp -114.54 -13.64 12.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -159.75 127.98 4.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 3.7 pp -90.92 119.28 30.99 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' H ' ' HA ' ' A' ' 29' ' ' PHE . 92.4 t -75.67 126.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-O 121.142 0.496 . . . . 0.0 109.711 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.63 135.02 56.45 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.4 t70 87.47 2.2 0.41 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 125.422 1.701 . . . . 0.0 110.255 -173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.39 159.54 37.07 Favored Glycine 0 C--O 1.208 -1.5 0 CA-C-O 118.175 -1.347 . . . . 0.0 110.887 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.635 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -72.46 -25.52 17.96 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 121.307 2.554 . . . . 0.0 110.155 -170.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -67.4 -43.11 82.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.476 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.35 76.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.499 1.143 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 95.2 mt -71.86 -39.7 69.5 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.926 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.97 -17.26 47.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 122.554 1.168 . . . . 0.0 109.773 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.84 46.38 76.44 Favored Glycine 0 CA--C 1.494 -1.233 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.106 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.2 tpmt? -126.9 6.34 6.62 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.588 0.709 . . . . 0.0 110.956 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.613 ' SD ' ' HB1' ' A' ' 52' ' ' ALA . 1.8 tmt? -147.93 150.57 34.3 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 10.8 pt-20 -136.02 166.95 22.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.275 1.036 . . . . 0.0 111.152 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.495 ' N ' HD23 ' A' ' 46' ' ' LEU . 69.0 m -68.75 119.62 13.42 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.39 -25.69 4.77 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.59 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.575 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.2 m-20 -54.99 150.71 9.87 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.179 0.514 . . . . 0.0 111.625 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.267 0.8 OUTLIER -115.15 120.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 175.344 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.4 mm -78.03 119.35 26.7 Favored 'Isoleucine or valine' 0 C--O 1.302 3.82 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.496 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 73' ' ' LEU . 47.9 t -100.63 -52.87 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.112 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 p -164.1 174.06 11.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.683 0.278 . . . . 0.0 111.543 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.95 152.6 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.582 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 10.3 t-20 -26.66 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.526 1.53 . . . . 0.0 112.725 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 t70 85.03 -52.42 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.26 1.824 . . . . 0.0 114.11 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -93.95 127.19 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.384 1.088 . . . . 0.0 113.322 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.15 89.37 5.99 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.605 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.27 9.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 122.408 1.099 . . . . 0.0 109.599 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 6' ' ' ARG . 23.6 tp -64.18 110.19 2.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.89 43.61 87.46 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.979 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.2 150.53 38.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -77.42 143.1 38.87 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.675 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.469 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.0 t60 -47.7 -49.99 26.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.871 0.759 . . . . 0.0 112.191 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.84 75.29 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.829 0.706 . . . . 0.0 110.944 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -76.65 -50.4 13.83 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.881 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 41' ' ' LEU . 7.2 p -63.31 -44.49 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.367 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.9 p -64.79 -36.07 76.66 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.669 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.3 tmmm? -60.63 -45.84 92.52 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.733 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -73.12 -50.32 32.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.394 1.092 . . . . 0.0 109.425 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.29 -28.69 69.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.467 -1.697 . . . . 0.0 113.306 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 15.6 mm-40 -88.19 -17.47 30.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 p -95.63 -4.07 45.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -61.99 154.52 68.3 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.959 0.409 . . . . 0.0 111.212 174.093 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 35.6 Cg_endo -102.86 153.57 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.778 3.652 . . . . 0.0 112.704 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 25' ' ' ARG . 59.9 mt -65.58 128.86 29.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.014 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.4 10.7 33.09 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.613 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.08 177.06 5.2 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.432 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 31.3 t -140.0 150.84 44.93 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 123.427 0.691 . . . . 0.0 110.155 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.8 m -155.55 164.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 124.894 1.278 . . . . 0.0 109.96 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.582 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 14.5 m-20 -107.38 107.7 18.71 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.73 122.19 34.05 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -103.28 110.67 22.73 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' A' ' 62' ' ' ASP . 1.1 pt? -141.51 156.76 45.71 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 84.7 m -111.5 126.41 54.93 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.3 146.11 25.45 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.17 -19.66 2.86 Favored Glycine 0 CA--C 1.491 -1.453 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.825 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 120.752 0.311 . . . . 0.0 110.82 176.446 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 37.7 tt0 . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.643 ' HB ' HG22 ' A' ' 31' ' ' VAL . 12.3 m -115.23 97.89 6.46 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.517 ' HB2' HG22 ' A' ' 30' ' ' THR . 4.0 pm0 -76.95 120.4 22.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.6 m . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.361 12.1 t . . . . . 0 N--CA 1.415 -2.215 0 CA-C-O 119.402 -0.332 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.444 ' HB2' HD21 ' A' ' 73' ' ' LEU . 8.7 ptm85 153.88 -29.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 125.64 1.576 . . . . 0.0 107.44 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 21.5 t30 -57.78 114.43 8.43 Favored Pre-proline 0 C--N 1.266 -3.058 0 CA-C-N 112.145 -2.298 . . . . 0.0 114.136 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.259 7.2 Cg_exo -58.86 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.469 -2.737 0 C-N-CA 122.818 2.345 . . . . 0.0 110.666 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.4 m -79.58 -12.65 59.84 Favored 'General case' 1 N--CA 1.348 -5.53 0 CA-C-N 112.464 -2.153 . . . . 0.0 112.257 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -78.45 -35.5 46.7 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -54.52 129.9 37.82 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.693 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -77.14 179.47 6.29 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.372 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.0 -114.84 4.16 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.962 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.59 154.22 46.43 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.084 0.554 . . . . 0.0 110.289 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -119.43 115.62 24.46 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.04 140.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.599 0.714 . . . . 0.0 111.234 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.737 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.1 t60 -124.77 99.59 6.23 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -112.8 133.62 54.71 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.562 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 92' ' ' SER . 0.6 OUTLIER -75.68 137.27 40.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -125.95 121.59 33.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -77.91 123.06 26.31 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.764 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -52.1 108.33 0.28 Allowed 'General case' 0 CA--C 1.471 -2.085 0 C-N-CA 123.905 0.882 . . . . 0.0 112.151 174.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.1 t -83.49 -148.38 0.09 Allowed 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 126.754 2.534 . . . . 0.0 108.389 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -61.62 76.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.7 mmt180 67.04 48.08 1.29 Allowed 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.43 1.11 . . . . 0.0 110.938 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.92 -123.05 1.45 Allowed Glycine 0 N--CA 1.4 -3.732 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.679 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.695 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.8 m-85 -130.47 -83.99 0.53 Allowed 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.068 -1.066 . . . . 0.0 110.637 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.78 49.89 0.12 Allowed Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.239 -171.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.494 ' HA ' HG23 ' A' ' 47' ' ' VAL . 28.4 p90 -161.35 142.72 11.52 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' HA ' ' B' ' 160' ' ' GLN . 16.5 p -104.09 136.3 43.98 Favored 'General case' 0 C--N 1.259 -3.352 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 22.9 m -123.6 157.89 29.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG13 ' HG2' ' A' ' 44' ' ' LYS . 3.2 m -115.35 174.58 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 C-N-CA 125.281 1.432 . . . . 0.0 111.029 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.92 -130.4 9.89 Favored Glycine 0 CA--C 1.481 -2.089 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 29.92 59.46 0.2 Allowed Glycine 0 CA--C 1.473 -2.579 0 C-N-CA 127.523 2.487 . . . . 0.0 113.81 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.52 -28.44 7.85 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 114.166 -1.017 . . . . 0.0 108.505 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -158.37 169.97 9.7 Favored Pre-proline 0 CA--C 1.47 -2.111 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.959 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 57.6 Cg_exo -61.91 -26.54 79.08 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.459 2.106 . . . . 0.0 109.6 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.47 -29.95 59.77 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 112.504 -2.135 . . . . 0.0 111.729 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -122.11 119.09 30.31 Favored 'General case' 0 C--O 1.27 2.165 0 O-C-N 121.77 -0.581 . . . . 0.0 110.739 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 22.8 m-85 -85.97 166.11 16.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.941 2.496 . . . . 0.0 109.547 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.792 HD21 HG21 ' A' ' 80' ' ' VAL . 6.1 mp -88.33 145.57 25.76 Favored 'General case' 0 C--O 1.178 -2.702 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.846 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.4 tt0 -135.54 158.94 43.13 Favored 'General case' 0 C--O 1.18 -2.569 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 62' ' ' ASP . 18.9 mm -87.95 127.74 40.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.586 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.47 -22.83 13.59 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 48.8 m -155.04 126.94 7.57 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 53' ' ' ALA . 3.2 tm? -83.53 106.39 15.22 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 92.9 t -85.36 135.8 24.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.87 0.843 . . . . 0.0 110.974 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.48 141.7 57.81 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.584 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.7 t70 78.94 4.6 2.38 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.722 1.249 . . . . 0.0 110.903 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.73 159.5 36.44 Favored Glycine 0 C--O 1.201 -1.955 0 CA-C-O 118.085 -1.397 . . . . 0.0 109.897 173.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.48 -24.54 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.825 0 CA-C-N 121.438 2.619 . . . . 0.0 109.678 -173.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.64 78.66 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.405 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -69.06 -48.24 63.26 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.572 1.177 . . . . 0.0 109.289 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 77.8 mt -72.08 -43.59 64.6 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 112.461 -2.154 . . . . 0.0 115.558 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' HE3' ' A' ' 57' ' ' LYS . 5.0 t0 -83.26 -20.75 33.92 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -140.89 19.04 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 119.913 -1.136 . . . . 0.0 110.87 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HE3' ' OD1' ' A' ' 55' ' ' ASP 0.344 0.0 OUTLIER 53.36 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.472 1.909 . . . . 0.0 115.42 -176.704 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.424 ' HE1' HD23 ' A' ' 95' ' ' LEU . 39.8 ttm -68.83 141.37 55.15 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 109.282 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -151.0 144.47 24.92 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 m -45.38 114.73 0.79 Allowed 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 124.635 1.209 . . . . 0.0 110.869 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.3 -30.42 3.03 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 43' ' ' ILE 0.375 0.9 OUTLIER -69.16 143.29 54.12 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.669 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -103.2 118.27 49.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.131 -174.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 mt -74.9 123.24 30.14 Favored 'Isoleucine or valine' 1 C--O 1.307 4.101 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG13 HD13 ' A' ' 73' ' ' LEU . 58.5 t -99.9 -45.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 111.498 -2.592 . . . . 0.0 110.105 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -160.27 170.67 20.62 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.356 -0.84 . . . . 0.0 112.016 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.93 112.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.184 0.516 . . . . 0.0 112.109 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 65.9 -48.04 0.4 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.489 2.316 . . . . 0.0 115.57 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.49 -39.86 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 125.605 1.562 . . . . 0.0 109.347 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.408 HG21 HD13 ' A' ' 83' ' ' ILE . 6.7 m -71.44 134.35 46.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.625 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.2 t -84.28 84.44 7.63 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.541 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -86.27 17.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 123.763 1.744 . . . . 0.0 109.796 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 65' ' ' VAL . 12.5 tp -71.72 110.83 6.53 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.48 -1.691 . . . . 0.0 106.459 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 61.46 36.72 92.97 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.998 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -77.16 128.29 34.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 36.9 m -62.58 145.82 53.45 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.208 0.943 . . . . 0.0 110.439 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -45.59 -51.42 12.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.189 0.596 . . . . 0.0 112.47 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.97 78.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 124.299 0.999 . . . . 0.0 110.538 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 74.5 mm-40 -76.03 -50.15 15.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.318 -175.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.792 HG21 HD21 ' A' ' 41' ' ' LEU . 14.5 p -65.06 -42.24 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.827 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.85 -36.38 76.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -62.15 -41.5 98.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.243 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 70' ' ' THR . 75.7 mt -73.0 -50.41 32.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 122.502 1.144 . . . . 0.0 109.717 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 7.5 m-85 -66.65 -35.59 80.54 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.446 -1.707 . . . . 0.0 112.969 -174.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -85.58 -13.51 48.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.2 t -77.73 -23.75 49.3 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.612 HD12 ' CE2' ' A' ' 27' ' ' PHE . 2.0 mt -48.37 136.62 12.13 Favored Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 86.0 Cg_endo -99.13 153.45 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.212 3.274 . . . . 0.0 112.398 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 25' ' ' ARG . 41.1 mt -68.6 140.59 18.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.107 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.51 12.31 61.28 Favored Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.012 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.9 -169.77 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.501 -171.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 11.1 p -149.27 138.46 21.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -169.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.764 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.3 m -145.56 156.13 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.737 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 31.7 m-20 -99.46 106.96 19.06 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.424 HD23 ' HE1' ' A' ' 58' ' ' MET . 9.8 tp -95.96 125.94 40.85 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.015 0.436 . . . . 0.0 110.942 -174.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -107.74 115.2 29.72 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.639 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.21 157.68 44.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.235 0.541 . . . . 0.0 111.382 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.0 m -117.89 140.01 50.32 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.717 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.0 tpp85 -110.08 132.22 54.36 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.97 -30.21 0.14 Allowed Glycine 0 C--N 1.296 -1.671 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.408 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 43.8 mt-10 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.304 0.573 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -150.49 119.55 6.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.537 ' HA ' HG22 ' A' ' 30' ' ' THR . 29.3 tt0 -84.07 130.53 34.86 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 27' ' ' PHE . 10.7 m . . . . . 0 N--CA 1.407 -2.611 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.355 12.9 t . . . . . 0 N--CA 1.423 -1.78 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.513 ' HB2' HD21 ' A' ' 73' ' ' LEU . 15.6 ptm180 152.77 -19.45 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 126.667 1.987 . . . . 0.0 108.379 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.815 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 7.9 m120 -66.42 118.46 53.87 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -171.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.307 21.4 Cg_exo -62.48 -35.87 69.01 Favored 'Trans proline' 0 CA--C 1.467 -2.844 0 N-CA-C 107.734 -1.679 . . . . 0.0 107.734 172.257 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m -66.78 -23.64 66.1 Favored 'General case' 1 N--CA 1.333 -6.297 0 CA-C-N 109.925 -3.307 . . . . 0.0 112.236 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.815 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.7 pt-20 -79.48 -30.9 42.24 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.1 mt -59.12 133.95 56.56 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.385 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -81.26 168.57 18.33 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.453 -1.703 . . . . 0.0 113.887 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 90.85 -114.61 4.49 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.61 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.594 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -140.8 146.51 37.72 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.551 1.14 . . . . 0.0 110.118 -178.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -113.56 116.91 30.26 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 154.47 40.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 123.403 0.681 . . . . 0.0 112.358 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.1 p-80 -126.71 112.5 15.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.263 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 58' ' ' MET . 7.5 t -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.308 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -85.07 136.61 33.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -124.66 129.04 49.77 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 69.9 ttt180 -86.95 112.64 22.0 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.1 mptp? -36.12 111.26 0.13 Allowed 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 125.225 1.41 . . . . 0.0 111.579 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -89.0 -143.19 0.14 Allowed 'General case' 0 N--CA 1.415 -2.194 0 O-C-N 125.48 1.738 . . . . 0.0 108.186 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -58.89 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.8 mtp180 57.29 40.27 27.91 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 125.474 1.51 . . . . 0.0 112.486 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.75 -130.72 2.21 Favored Glycine 0 N--CA 1.406 -3.313 0 CA-C-N 113.49 -1.686 . . . . 0.0 108.956 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.679 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.4 m-85 -134.61 -75.58 0.46 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.07 46.53 0.2 Allowed Glycine 0 C--N 1.294 -1.765 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.239 -169.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 45.0 p90 -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 172.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' B' ' 160' ' ' GLN . 69.9 p -108.39 136.23 48.37 Favored 'General case' 0 C--N 1.271 -2.814 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.259 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.646 HG21 HD23 ' A' ' 41' ' ' LEU . 1.1 m -114.9 162.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.36 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.63 -132.03 10.03 Favored Glycine 0 C--O 1.27 2.4 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.244 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.675 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.95 45.27 7.53 Favored Glycine 0 CA--C 1.458 -3.472 0 C-N-CA 126.245 1.878 . . . . 0.0 112.594 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.12 -22.2 18.03 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-O 121.296 0.57 . . . . 0.0 110.612 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 39' ' ' GLU . 7.2 pt-20 -157.28 171.3 7.63 Favored Pre-proline 0 N--CA 1.413 -2.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 -168.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 51.5 Cg_exo -64.02 -36.28 49.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.874 1.716 . . . . 0.0 108.201 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.16 -27.24 66.25 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.982 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 41.0 tt0 -125.5 117.69 24.16 Favored 'General case' 0 C--O 1.267 1.988 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.372 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -84.22 165.26 18.53 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 126.669 2.481 . . . . 0.0 108.25 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.675 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.4 mp -86.43 144.53 27.25 Favored 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.708 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -128.88 164.78 22.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.4 mm -107.04 123.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 118.795 0.725 . . . . 0.0 110.963 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -100.93 -26.69 13.65 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 123.436 0.46 . . . . 0.0 111.954 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 44.3 m -149.87 126.99 11.26 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.646 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.16 113.15 15.84 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 85.0 t -87.04 121.51 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.7 mt -67.4 142.73 56.62 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.33 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 34.9 t70 82.91 5.99 0.87 Allowed 'General case' 0 C--O 1.216 -0.668 0 O-C-N 125.103 1.502 . . . . 0.0 109.579 -172.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -88.81 165.4 33.34 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-O 118.113 -1.382 . . . . 0.0 110.175 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 27.9 Cg_endo -72.41 -25.47 18.17 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.338 2.569 . . . . 0.0 110.547 -170.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -68.66 -37.08 79.36 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.871 175.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.64 65.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 122.81 1.29 . . . . 0.0 109.264 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 81.2 mt -72.4 -46.19 56.35 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.537 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.48 -26.71 58.43 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.89 -165.88 51.43 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 18' ' ' THR . 6.2 ttpm? 72.81 -49.95 0.7 Allowed 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -87.21 133.02 33.7 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.14 166.85 24.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.543 0.687 . . . . 0.0 111.359 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -58.12 129.89 44.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.438 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.86 -6.27 25.76 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.132 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 43' ' ' ILE . 14.8 m-20 -79.91 129.35 34.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 2.7 p -98.11 115.93 39.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.852 173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.3 mm -71.03 113.78 7.9 Favored 'Isoleucine or valine' 0 C--O 1.294 3.432 0 C-N-CA 125.078 1.351 . . . . 0.0 110.669 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.4 t -103.22 -54.72 6.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.687 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.8 t -144.92 160.27 41.58 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.077 -0.389 . . . . 0.0 110.159 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 95' ' ' LEU . 5.3 p -146.31 105.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.454 ' CB ' HG12 ' A' ' 93' ' ' VAL . 27.6 t-20 65.97 -65.58 0.18 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.718 1.607 . . . . 0.0 114.341 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.22 -39.64 0.25 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 124.98 1.312 . . . . 0.0 108.884 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.5 m -70.04 127.33 32.48 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.304 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.2 t -87.26 87.23 7.38 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 66' ' ' SER . 10.1 p -77.11 2.25 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 122.496 1.141 . . . . 0.0 109.591 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 6' ' ' ARG . 22.9 tp -63.75 111.6 2.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.226 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 68.35 27.78 73.59 Favored Glycine 0 N--CA 1.425 -2.073 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.95 138.3 46.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 62.1 m -71.05 143.01 50.86 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.42 ' O ' HG12 ' A' ' 81' ' ' VAL . 51.1 t-80 -49.08 -45.05 42.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -174.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.94 81.37 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.656 0.598 . . . . 0.0 110.471 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 73.4 mm-40 -69.32 -56.0 8.81 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.276 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 41' ' ' LEU . 5.4 p -61.25 -47.36 93.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.611 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.1 p -62.7 -35.9 72.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.618 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -41.18 96.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 123.152 0.283 . . . . 0.0 111.418 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -51.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 122.401 1.096 . . . . 0.0 108.741 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -64.01 -30.26 71.35 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.236 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.611 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 tp-100 -85.96 -23.22 27.01 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.4 p -94.98 2.91 55.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.587 . . . . 0.0 111.511 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.465 HD13 ' HG3' ' A' ' 22' ' ' LYS . 7.0 mt -48.13 143.52 6.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.791 1.236 . . . . 0.0 114.081 173.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 39.8 Cg_endo -95.75 142.86 1.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.632 2.888 . . . . 0.0 110.467 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.566 HG12 ' H ' ' A' ' 25' ' ' ARG . 39.0 mt -68.45 142.97 15.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.835 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.66 72.34 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.068 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -98.65 -171.41 2.11 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.615 -171.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.446 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.7 p -147.85 138.24 22.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -168.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG13 ' HE2' ' A' ' 22' ' ' LYS . 1.3 m -151.24 155.72 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.834 174.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.36 109.76 21.86 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.726 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.9 mm? -90.66 113.72 25.85 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 46.7 mt-10 -92.19 107.83 19.5 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -139.48 153.8 47.6 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 120.926 0.393 . . . . 0.0 110.545 -172.375 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.5 t -113.87 126.73 55.51 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.485 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.594 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 21.5 tpp85 -96.92 137.91 35.28 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.13 1.92 Allowed Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.772 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.422 -1.861 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.274 176.487 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.544 ' HB3' HE22 ' B' ' 160' ' ' GLN . 48.2 mm-40 . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.474 ' HB ' HG22 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.43 93.28 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.544 HE22 ' HB3' ' B' ' 158' ' ' GLU . 2.7 mp0 -82.38 110.05 17.18 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 27' ' ' PHE . 14.2 m . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.5 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.709 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.3 ptm180 57.21 19.14 4.67 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.921 2.088 . . . . 0.0 112.789 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.75 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.5 m-20 -88.5 114.24 58.84 Favored Pre-proline 1 C--N 1.231 -4.549 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.081 176.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 10.5 Cg_exo -58.0 -29.49 86.92 Favored 'Trans proline' 0 CA--C 1.48 -2.214 0 C-N-CA 121.528 1.485 . . . . 0.0 109.278 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -71.46 -24.27 61.98 Favored 'General case' 1 N--CA 1.366 -4.658 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.671 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.75 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -79.33 -31.62 43.16 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.1 129.74 41.19 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.745 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -80.23 179.19 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.031 -1.895 . . . . 0.0 113.231 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.01 -126.59 8.01 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.845 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -128.54 146.87 50.71 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.91 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.18 116.87 28.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 153.39 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.736 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.649 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.8 t-160 -125.31 111.44 15.19 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 97' ' ' LEU . 12.6 t -128.42 151.49 49.31 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.93 136.34 42.94 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 2.4 mp -117.59 116.48 27.18 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -86.47 106.78 17.72 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.86 117.72 0.53 Allowed 'General case' 0 CA--C 1.472 -2.035 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 25.2 t -87.87 -152.95 0.22 Allowed 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 126.236 2.21 . . . . 0.0 108.306 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.4 ' HA ' HG12 ' A' ' 89' ' ' ILE . 23.2 m -65.61 80.43 0.06 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.588 ' N ' HG12 ' A' ' 89' ' ' ILE . 24.4 mmt180 71.44 73.88 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.47 1.108 . . . . 0.0 111.392 174.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.48 -131.9 10.13 Favored Glycine 0 N--CA 1.405 -3.372 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.886 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.645 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.9 m-85 -129.08 -78.9 0.56 Allowed 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.437 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.608 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.64 55.41 0.18 Allowed Glycine 0 C--N 1.285 -2.265 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -170.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 43' ' ' ILE . 19.3 p90 -162.2 146.5 12.28 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.0 p -108.31 135.04 50.29 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.219 1.009 . . . . 0.0 109.577 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 3.2 p -131.59 144.11 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.96 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.256 -167.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 44' ' ' LYS . 20.0 m -120.42 132.54 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 124.317 1.047 . . . . 0.0 111.347 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.77 -139.19 10.73 Favored Glycine 0 N--CA 1.396 -3.997 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 42.51 44.37 5.2 Favored Glycine 0 C--O 1.18 -3.278 0 O-C-N 125.898 1.587 . . . . 0.0 110.184 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 15.9 t70 -82.44 -41.97 19.15 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 113.252 -1.474 . . . . 0.0 107.875 -172.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 4.1 pt-20 -160.28 170.88 7.89 Favored Pre-proline 0 CA--C 1.48 -1.712 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -73.74 59.08 4.12 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 124.49 3.46 . . . . 0.0 108.842 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t70 -166.88 -39.46 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 111.871 -2.422 . . . . 0.0 108.257 -172.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 37.2 tt0 -122.21 122.23 38.67 Favored 'General case' 0 C--O 1.27 2.147 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.978 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.28 166.06 14.02 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 128.673 2.789 . . . . 0.0 109.937 -174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -90.39 144.81 25.46 Favored 'General case' 0 C--O 1.168 -3.221 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.184 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 2.6 tt0 -138.53 145.33 40.59 Favored 'General case' 0 C--O 1.185 -2.34 0 CA-C-N 118.67 0.668 . . . . 0.0 109.575 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 29' ' ' PHE . 37.0 mm -88.27 121.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.99 0 O-C-N 121.477 -0.765 . . . . 0.0 111.855 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' C ' HG23 ' A' ' 60' ' ' THR . 46.5 mtmt -101.39 -19.35 15.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.889 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 58.5 m -150.47 127.3 11.02 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.185 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 tp -84.02 109.15 17.42 Favored 'General case' 0 N--CA 1.386 -3.636 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.608 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.5 t -83.05 121.57 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.64 150.42 48.77 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.396 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 76.47 12.13 2.63 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 125.012 1.445 . . . . 0.0 109.59 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.45 160.83 27.06 Favored Glycine 0 C--O 1.201 -1.962 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.671 171.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 3.8 Cg_endo -71.97 -25.21 19.9 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 CA-C-N 121.672 2.736 . . . . 0.0 109.931 -172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 58' ' ' MET . . . -62.85 -45.15 93.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.99 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.29 -45.51 80.14 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.367 1.079 . . . . 0.0 110.432 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.7 mt -72.18 -35.69 69.06 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.795 -172.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.7 t70 -83.57 -23.83 31.82 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.67 69.57 Favored Glycine 0 CA--C 1.492 -1.351 0 CA-C-N 113.219 -1.809 . . . . 0.0 113.287 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -99.72 -15.62 18.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.963 -0.618 . . . . 0.0 111.142 -173.481 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.548 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 35.5 ttm -122.98 139.73 53.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB2' ' HE ' ' A' ' 99' ' ' ARG . 34.9 mt-10 -147.41 164.0 34.72 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.478 0.656 . . . . 0.0 109.469 -175.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 44' ' ' LYS . 8.5 m -54.2 117.91 3.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.914 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.94 -1.67 9.19 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.583 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.621 ' CG ' HD12 ' A' ' 97' ' ' LEU . 1.2 p30 -102.25 156.61 17.46 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.664 -0.903 . . . . 0.0 112.667 172.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -113.18 122.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.748 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.05 116.69 19.44 Favored 'Isoleucine or valine' 0 C--O 1.304 3.964 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.14 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 73' ' ' LEU . 47.6 t -99.4 -53.84 7.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.758 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.413 ' HA ' HG12 ' A' ' 72' ' ' VAL . 50.4 m -143.44 161.83 37.39 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.131 -0.981 . . . . 0.0 112.189 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.6 p -142.19 97.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.896 0.855 . . . . 0.0 112.501 -175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 93' ' ' VAL . 41.8 t-20 65.12 -84.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.769 1.628 . . . . 0.0 112.918 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.34 -7.23 3.77 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.295 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.448 ' HB ' HG13 ' A' ' 67' ' ' VAL . 77.5 m -98.72 133.16 43.44 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.479 0.657 . . . . 0.0 109.336 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 t -87.65 82.79 7.31 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.514 ' HB ' HG12 ' A' ' 67' ' ' VAL . 9.9 p -75.81 -3.08 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.774 1.274 . . . . 0.0 109.471 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 6' ' ' ARG . 22.4 tp -64.23 111.03 2.41 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.384 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 38.87 96.76 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.644 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.44 149.92 31.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.7 m -73.24 141.92 47.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.548 ' HA ' HG12 ' A' ' 80' ' ' VAL . 39.6 t-80 -52.89 -47.89 67.57 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 118.893 0.77 . . . . 0.0 112.026 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.75 -35.4 68.57 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -76.2 -50.47 14.42 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.277 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 77' ' ' HIS . 6.6 p -61.12 -44.42 98.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 123.312 0.382 . . . . 0.0 111.531 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.8 p -64.02 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.686 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.9 tmmm? -58.27 -42.86 87.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.52 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -72.89 -51.04 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.32 1.057 . . . . 0.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -65.01 -30.58 71.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 113.506 -1.679 . . . . 0.0 113.51 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.95 -22.76 27.22 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 122.112 -0.368 . . . . 0.0 111.88 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.0 m -79.33 -14.82 58.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.808 0.337 . . . . 0.0 110.95 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 22' ' ' LYS . 4.7 mt -47.94 135.67 11.18 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.0 Cg_endo -99.58 156.46 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.35 3.367 . . . . 0.0 111.43 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -68.02 138.53 22.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.816 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.46 55.83 Favored Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.554 -1.308 . . . . 0.0 112.079 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -97.39 -175.37 3.19 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.058 -172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.538 ' N ' ' HE3' ' A' ' 22' ' ' LYS . 11.4 p -148.22 136.82 21.58 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 68' ' ' ASN . 10.0 m -154.16 147.84 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 124.02 0.928 . . . . 0.0 111.229 175.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 1.9 m-20 -105.22 108.13 19.49 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 124.272 1.029 . . . . 0.0 109.519 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.8 mm? -91.43 124.25 35.48 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.349 0.595 . . . . 0.0 111.715 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -97.31 119.0 35.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.621 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.9 pt? -142.7 159.06 42.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 60.4 m -120.49 108.52 14.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.131 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.545 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.28 144.5 28.06 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.776 0.831 . . . . 0.0 108.807 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.99 14.84 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.574 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . 0.256 10.7 pt-20 . . . . . 0 C--O 1.244 0.773 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.497 ' HB ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -100.86 120.65 40.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 30' ' ' THR . 25.2 tt0 -99.75 115.59 29.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 27' ' ' PHE . 21.8 m . . . . . 0 N--CA 1.434 -1.242 0 O-C-N 123.38 0.425 . . . . 0.0 109.973 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.427 -1.577 0 CA-C-O 121.621 0.724 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.587 ' O ' HD21 ' A' ' 73' ' ' LEU . 28.8 ptt180 50.64 26.83 2.64 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.994 2.118 . . . . 0.0 113.662 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.775 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 9.8 m-80 -103.18 114.56 65.01 Favored Pre-proline 1 C--N 1.236 -4.362 0 CA-C-N 113.588 -1.642 . . . . 0.0 114.264 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.281 11.9 Cg_exo -55.95 -33.93 90.53 Favored 'Trans proline' 0 CA--C 1.479 -2.227 0 C-N-CA 121.583 1.522 . . . . 0.0 109.197 168.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 t -65.97 -26.73 67.7 Favored 'General case' 1 N--CA 1.371 -4.378 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.648 -177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.775 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -77.81 -31.95 52.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.08 133.94 55.94 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.254 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 100' ' ' GLY . 17.1 ptmt -82.53 -177.52 6.72 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.579 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 84.73 -112.63 3.66 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.479 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 4.6 ptmt -146.46 149.13 33.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.017 0.927 . . . . 0.0 109.565 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.37 116.11 28.41 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.15 152.44 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.44 0.638 . . . . 0.0 111.846 -177.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.73 110.69 12.88 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.027 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -129.53 142.6 50.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -73.44 133.86 43.82 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.3 128.01 53.74 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -82.96 108.33 16.2 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.331 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.4 mptp? -40.04 106.34 0.05 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 124.144 0.978 . . . . 0.0 111.136 170.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -127.38 141.58 51.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 125.131 1.52 . . . . 0.0 110.141 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 54.73 32.63 17.82 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.477 1.511 . . . . 0.0 114.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.596 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.9 mmt180 73.79 53.89 0.11 Allowed 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 122.63 1.205 . . . . 0.0 109.605 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.26 -120.45 1.17 Allowed Glycine 0 N--CA 1.401 -3.7 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.711 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.0 m-85 -135.48 -78.52 0.43 Allowed 'General case' 0 C--N 1.275 -2.649 0 C-N-CA 122.743 0.417 . . . . 0.0 111.763 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.499 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.96 48.56 0.12 Allowed Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.728 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -161.47 143.53 11.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.561 HG22 ' HA ' ' B' ' 160' ' ' GLN . 37.9 p -105.11 135.48 46.38 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.598 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.79 147.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.107 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.511 ' CG2' ' HG3' ' A' ' 44' ' ' LYS . 15.2 m -120.32 135.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.867 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.37 -131.25 8.28 Favored Glycine 0 C--N 1.281 -2.522 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 36.82 60.08 1.03 Allowed Glycine 0 CA--C 1.479 -2.182 0 C-N-CA 126.647 2.07 . . . . 0.0 113.99 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -115.76 -18.68 10.75 Favored 'General case' 0 C--N 1.25 -3.742 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.712 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.35 168.43 12.49 Favored Pre-proline 0 CA--C 1.466 -2.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -61.38 -38.52 63.74 Favored 'Trans proline' 0 CA--C 1.49 -1.708 0 C-N-CA 122.074 1.85 . . . . 0.0 108.513 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.15 -12.06 60.75 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 111.961 -2.381 . . . . 0.0 111.709 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -132.34 118.18 19.09 Favored 'General case' 0 C--O 1.279 2.61 0 O-C-N 121.823 -0.548 . . . . 0.0 111.74 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -85.76 166.19 16.29 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.748 2.819 . . . . 0.0 107.981 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -91.2 145.17 24.89 Favored 'General case' 0 C--O 1.17 -3.129 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.891 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.4 tt0 -128.91 160.44 32.64 Favored 'General case' 0 C--O 1.169 -3.146 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.485 HG12 ' CE ' ' A' ' 58' ' ' MET . 1.2 mp -105.65 127.19 60.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HG3' ' CG2' ' A' ' 32' ' ' VAL 0.305 42.1 mtmt -113.28 -7.94 13.52 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.926 172.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 73.1 m -149.69 127.51 11.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.632 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.89 117.69 24.06 Favored 'General case' 0 N--CA 1.404 -2.77 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 86.4 t -88.29 128.55 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.05 145.99 41.9 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 81.44 5.72 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 125.501 1.75 . . . . 0.0 108.502 -171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.45 159.52 38.82 Favored Glycine 0 C--O 1.204 -1.758 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.42 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 19.9 Cg_endo -72.8 -25.78 16.55 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 120.853 2.327 . . . . 0.0 109.971 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -45.23 90.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.428 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.24 -50.94 63.89 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.681 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.5 mt -71.48 -36.5 71.18 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 112.688 -2.051 . . . . 0.0 114.854 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -79.75 -19.7 48.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.0 108.751 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.54 42.97 99.87 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.827 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.99 -25.47 2.52 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.035 -0.583 . . . . 0.0 111.485 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.485 ' CE ' HG12 ' A' ' 43' ' ' ILE . 1.6 tmt? -120.24 146.03 46.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -142.9 166.99 23.14 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.557 1.17 . . . . 0.0 113.498 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.401 HG23 ' C ' ' A' ' 44' ' ' LYS . 28.4 m -63.57 123.04 17.8 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 113.807 -1.542 . . . . 0.0 107.469 171.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.21 -11.23 10.71 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.965 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 15.0 m-20 -74.34 157.9 34.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -128.22 123.81 61.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 49.2 mm -73.93 113.18 11.76 Favored 'Isoleucine or valine' 0 C--O 1.3 3.733 0 C-N-CA 125.041 1.336 . . . . 0.0 110.683 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.9 t -105.4 -54.79 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 126.019 2.074 . . . . 0.0 110.673 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 40.3 t -147.56 158.33 43.95 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.959 -0.463 . . . . 0.0 110.943 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.91 89.52 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 CA-C-O 122.22 1.01 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 93' ' ' VAL 0.435 43.6 p30 42.15 -89.12 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -171.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -93.53 -30.95 14.74 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.827 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.7 m -91.25 131.11 36.98 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.085 0.945 . . . . 0.0 110.962 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.7 t -88.69 86.63 7.03 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.253 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.51 1.59 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 122.54 1.162 . . . . 0.0 109.628 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 6' ' ' ARG . 28.7 tp -60.68 111.7 1.72 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.999 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.43 38.6 95.04 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.41 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -81.07 133.23 35.44 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -62.36 145.29 54.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.447 ' O ' HG12 ' A' ' 81' ' ' VAL . 2.6 t60 -45.61 -51.89 11.46 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.622 0.646 . . . . 0.0 112.19 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.92 72.65 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 124.102 0.877 . . . . 0.0 111.186 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -80.55 -47.36 14.32 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.489 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 41' ' ' LEU . 12.0 p -65.17 -42.28 93.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.3 p -65.87 -37.79 80.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.676 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -58.86 -45.16 90.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.307 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.1 mt -73.75 -51.21 25.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-O 122.174 0.988 . . . . 0.0 109.615 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.92 -29.48 69.9 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.098 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -86.32 -23.81 26.11 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -80.25 -12.0 59.67 Favored 'General case' 0 C--O 1.249 1.062 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.813 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.593 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 6.7 mt -47.69 139.98 8.41 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.8 1.24 . . . . 0.0 113.5 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -99.0 145.11 0.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.894 3.062 . . . . 0.0 111.333 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 ' H ' ' A' ' 25' ' ' ARG . 37.7 mt -68.3 142.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.45 11.32 57.27 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -105.43 -177.03 3.25 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.828 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.8 p -148.95 145.89 27.59 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -153.37 158.41 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 C-N-CA 123.754 0.822 . . . . 0.0 111.038 174.323 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -96.55 107.5 19.93 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' LEU . 12.8 tp -94.45 114.04 26.0 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 30.3 mt-10 -97.7 111.75 23.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.07 157.46 45.27 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.799 -173.383 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.0 t -112.55 130.2 56.1 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 21.6 tpp85 -103.17 152.38 21.52 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 12' ' ' LYS . . . 110.9 8.18 24.43 Favored Glycine 0 CA--C 1.493 -1.283 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.366 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.421 -1.921 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.779 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 CA--C 1.548 0.888 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 23.2 m -132.51 117.73 18.38 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.561 ' HA ' HG22 ' A' ' 30' ' ' THR . 53.9 tt0 -79.62 122.41 26.48 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.354 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 N--CA 1.408 -2.569 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.419 -2.001 0 CA-C-O 121.692 0.758 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 61.13 36.1 18.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.585 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.799 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.2 m-20 -121.86 120.11 28.67 Favored Pre-proline 0 C--N 1.268 -2.95 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.28 16.3 Cg_exo -62.92 -32.93 76.55 Favored 'Trans proline' 0 CA--C 1.473 -2.528 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 172.366 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -71.09 -22.25 62.13 Favored 'General case' 1 N--CA 1.365 -4.708 0 CA-C-N 111.899 -2.41 . . . . 0.0 110.97 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.799 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.2 pt-20 -77.07 -36.62 55.7 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.28 131.31 41.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.271 0.982 . . . . 0.0 111.146 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -86.06 169.16 13.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.048 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.57 -108.24 3.65 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.249 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.551 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 144.88 29.95 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 122.834 0.453 . . . . 0.0 110.911 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -111.19 122.08 46.95 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -135.57 152.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.26 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.1 t60 -128.27 101.49 6.26 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -117.66 137.02 52.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.15 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -79.17 133.6 36.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.115 -0.366 . . . . 0.0 110.273 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -118.02 119.46 34.87 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -81.25 104.64 11.86 Favored 'General case' 0 N--CA 1.403 -2.797 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.88 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.703 ' HE2' HG13 ' A' ' 93' ' ' VAL . 1.9 mptp? -33.41 106.76 0.04 OUTLIER 'General case' 0 CA--C 1.483 -1.632 0 C-N-CA 125.357 1.463 . . . . 0.0 112.112 174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 t -81.65 -150.78 0.08 Allowed 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 125.983 2.052 . . . . 0.0 108.283 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -61.69 83.25 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' H ' HG12 ' A' ' 89' ' ' ILE . 27.2 mtp85 58.31 44.26 18.82 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.852 1.261 . . . . 0.0 113.66 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.6 -133.91 3.83 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.619 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.4 m-85 -129.77 -77.79 0.55 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.62 52.1 0.16 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.741 -171.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 43' ' ' ILE . 37.2 p90 -161.64 142.6 11.0 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.4 p -106.25 136.56 45.75 Favored 'General case' 0 C--N 1.265 -3.074 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.269 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 17.5 m -123.39 158.02 28.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.887 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 44' ' ' LYS . 8.9 m -121.53 133.06 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.854 0 C-N-CA 124.334 1.053 . . . . 0.0 109.599 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.64 -142.06 13.34 Favored Glycine 0 CA--C 1.455 -3.708 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.009 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.45 57.07 1.5 Allowed Glycine 0 CA--C 1.458 -3.475 0 O-C-N 127.136 2.316 . . . . 0.0 111.385 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -104.72 -32.16 9.0 Favored 'General case' 0 C--N 1.251 -3.676 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -137.76 170.68 9.93 Favored Pre-proline 0 N--CA 1.405 -2.701 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.102 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 32.0 Cg_exo -71.81 -8.72 23.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.296 2.664 . . . . 0.0 108.709 174.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -111.67 -10.66 14.07 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.837 1.655 . . . . 0.0 110.811 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.82 120.18 30.99 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 121.999 -0.438 . . . . 0.0 109.989 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -87.32 165.45 15.62 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 127.444 2.297 . . . . 0.0 110.61 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.5 mp -93.15 145.24 24.56 Favored 'General case' 0 C--O 1.176 -2.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.304 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 37.0 tt0 -133.92 155.91 49.06 Favored 'General case' 0 C--O 1.162 -3.515 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 29' ' ' PHE . 12.2 mm -87.27 126.38 41.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 118.88 0.764 . . . . 0.0 109.243 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' HG13 ' A' ' 32' ' ' VAL . 20.9 ptmt -102.09 -23.46 14.07 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 123.137 0.273 . . . . 0.0 110.317 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.472 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 38.7 m -151.49 126.43 9.74 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.88 108.96 19.0 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 79.8 t -85.76 127.63 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 121.87 0.843 . . . . 0.0 111.661 -173.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.52 85.33 4.6 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.459 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 54' ' ' LEU . 5.7 t70 165.12 -22.52 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 125.115 1.509 . . . . 0.0 109.822 -170.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -99.55 166.28 20.6 Favored Glycine 0 CA--C 1.48 -2.116 0 CA-C-N 115.456 -0.793 . . . . 0.0 114.045 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.631 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 6.1 Cg_endo -67.72 -23.85 41.71 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.142 1.895 . . . . 0.0 111.077 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -58.35 -52.34 66.01 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.971 0.909 . . . . 0.0 111.395 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.688 ' HB3' HD23 ' A' ' 54' ' ' LEU . . . -73.74 -37.15 65.18 Favored 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 122.879 1.324 . . . . 0.0 110.049 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -71.25 -38.44 71.92 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 111.755 -2.475 . . . . 0.0 111.175 -170.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.87 -26.07 37.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.564 1.173 . . . . 0.0 108.049 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.73 86.06 Favored Glycine 0 CA--C 1.481 -2.076 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.429 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -122.08 0.67 9.68 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.694 -174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.611 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 67.3 mtp -128.04 159.2 35.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.42 164.16 30.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.476 0.655 . . . . 0.0 110.719 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -71.24 116.73 11.9 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 131.36 -23.89 4.24 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 7.3 m-20 -58.16 140.96 51.86 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 120.716 0.294 . . . . 0.0 110.62 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.323 0.2 OUTLIER -109.17 115.96 50.85 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-O 121.578 0.704 . . . . 0.0 111.891 174.23 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.8 mm -68.82 114.62 5.88 Favored 'Isoleucine or valine' 0 C--O 1.301 3.777 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.791 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.613 HG13 HD13 ' A' ' 73' ' ' LEU . 65.1 t -95.83 -58.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 112.361 -2.199 . . . . 0.0 110.1 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.5 m -158.31 173.32 16.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.0 -0.438 . . . . 0.0 110.471 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 72' ' ' VAL . 9.1 p -145.55 153.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 2.0 t-20 -31.31 113.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.01 1.324 . . . . 0.0 111.782 172.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 75.04 -38.9 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.98 1.712 . . . . 0.0 115.231 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -100.2 122.66 43.38 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.894 0.854 . . . . 0.0 111.497 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.4 t -83.56 83.38 7.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.973 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 67' ' ' VAL . 78.8 t -72.55 -2.62 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.346 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -66.77 110.48 3.28 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.12 28.51 70.13 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.74 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.05 140.97 43.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 122.017 -0.696 . . . . 0.0 109.693 178.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 m -74.78 143.61 43.93 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 117.526 -1.225 . . . . 0.0 108.044 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -47.84 -49.46 29.17 Favored 'General case' 0 CA--C 1.485 -1.52 0 CA-C-N 118.952 0.796 . . . . 0.0 111.7 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.05 74.33 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 124.758 1.286 . . . . 0.0 111.084 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -75.23 -53.37 8.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -61.65 -42.66 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.579 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 8.9 p -62.49 -45.34 99.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 C-N-CA 121.264 -0.174 . . . . 0.0 110.532 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.1 tmmm? -57.12 -41.51 79.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.697 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -72.65 -50.23 35.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.161 0.981 . . . . 0.0 108.912 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.95 -29.1 70.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.453 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 14.0 pt20 -86.69 -24.01 25.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -93.08 2.81 56.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.564 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 4.3 mt -51.19 144.04 15.95 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.964 1.306 . . . . 0.0 113.618 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 29.9 Cg_endo -92.74 140.43 1.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.517 2.811 . . . . 0.0 111.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.9 mt -68.49 138.91 21.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.47 12.52 62.77 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -101.48 -171.47 1.99 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.648 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.5 t -148.88 144.39 26.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.855 -0.528 . . . . 0.0 112.187 -171.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.703 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -152.95 154.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 C-N-CA 124.221 1.008 . . . . 0.0 110.25 173.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.654 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 5.5 m-20 -99.74 107.7 19.83 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.46 HD22 HD22 ' A' ' 20' ' ' LEU . 12.9 tp -99.73 115.24 29.04 Favored 'General case' 0 C--N 1.269 -2.929 0 CA-C-O 120.803 0.335 . . . . 0.0 110.166 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -103.3 123.8 47.46 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.4 OUTLIER -141.52 163.26 33.4 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.705 -173.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.2 t -116.69 128.33 55.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.611 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 22.2 tpp85 -103.66 152.49 21.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.88 -43.03 1.26 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 . . . . . 0 C--N 1.297 -1.686 0 CA-C-N 114.644 -0.778 . . . . 0.0 109.342 174.953 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.4 pm0 . . . . . 0 N--CA 1.414 -2.245 0 CA-C-O 121.816 0.817 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 18.1 m -105.4 110.21 22.47 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.465 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.1 mp0 -85.17 104.44 15.05 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.428 -1.546 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.439 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 15.0 t . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' THR . 33.2 ptt180 56.97 14.03 1.74 Allowed 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 127.486 2.314 . . . . 0.0 114.889 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.713 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 14.4 m-80 -92.6 124.7 58.24 Favored Pre-proline 1 C--N 1.241 -4.135 0 CA-C-N 114.18 -1.373 . . . . 0.0 113.109 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.272 11.3 Cg_exo -60.35 -32.57 94.21 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 122.046 1.83 . . . . 0.0 108.781 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -68.72 -22.86 64.31 Favored 'General case' 1 N--CA 1.367 -4.59 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.219 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.6 pt-20 -79.34 -38.5 35.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.43 130.06 44.58 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.509 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -77.34 177.95 7.54 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.153 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.25 -122.65 6.55 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.321 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ARG . 13.4 mmmm -107.8 149.61 28.01 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 123.473 0.709 . . . . 0.0 109.317 -177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.51 111.25 16.59 Favored 'General case' 1 C--N 1.241 -4.121 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 151.99 36.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.952 0.882 . . . . 0.0 112.854 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.2 t60 -132.95 103.45 6.07 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -128.66 140.15 51.9 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.238 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -73.54 135.2 43.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.495 177.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.84 120.87 37.73 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -72.73 124.29 25.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.116 0.484 . . . . 0.0 109.9 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.661 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -57.56 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 123.59 0.756 . . . . 0.0 110.989 171.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -107.93 126.11 52.3 Favored 'General case' 0 N--CA 1.405 -2.707 0 O-C-N 126.187 2.179 . . . . 0.0 108.09 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' ILE . 3.5 m 47.15 56.34 6.96 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.297 1.439 . . . . 0.0 113.974 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.663 ' N ' HG12 ' A' ' 89' ' ' ILE . 19.9 mmt180 68.31 42.71 1.62 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.248 0.547 . . . . 0.0 112.123 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.9 -124.43 1.48 Allowed Glycine 0 N--CA 1.403 -3.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.235 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.648 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -132.74 -87.06 0.45 Allowed 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 114.367 -0.916 . . . . 0.0 111.753 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.482 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 123.9 52.28 0.2 Allowed Glycine 0 C--N 1.289 -2.062 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -167.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.483 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.0 p90 -160.71 143.72 13.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' HA ' ' B' ' 160' ' ' GLN . 17.3 p -107.45 135.14 49.44 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 122.173 0.987 . . . . 0.0 109.68 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 3.5 p -130.46 137.61 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.753 -169.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 44' ' ' LYS . 4.6 m -114.49 154.1 15.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 125.03 1.332 . . . . 0.0 113.545 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.86 -127.88 9.37 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.701 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 40.53 74.66 0.14 Allowed Glycine 1 CA--C 1.449 -4.068 0 O-C-N 126.648 2.028 . . . . 0.0 113.194 178.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -130.75 -20.44 2.86 Favored 'General case' 0 C--N 1.259 -3.333 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.169 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 7.7 pt-20 -156.68 170.92 8.1 Favored Pre-proline 0 N--CA 1.415 -2.203 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.031 -166.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 75.8 Cg_exo -61.14 -38.13 69.43 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 122.649 2.233 . . . . 0.0 108.895 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.22 -25.3 61.6 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.88 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 25.7 tt0 -127.36 118.83 24.89 Favored 'General case' 0 C--O 1.274 2.367 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.134 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.576 ' CD1' HD12 ' A' ' 73' ' ' LEU . 3.1 m-85 -87.27 165.67 15.49 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 128.134 2.574 . . . . 0.0 108.795 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.701 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.1 mp -89.27 147.01 24.36 Favored 'General case' 0 C--O 1.18 -2.582 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.077 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 6.6 tt0 -136.04 144.99 45.55 Favored 'General case' 0 C--O 1.175 -2.844 0 CA-C-N 118.698 0.681 . . . . 0.0 109.163 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 62' ' ' ASP . 34.4 mm -83.25 117.81 29.75 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 O-C-N 121.599 -0.688 . . . . 0.0 111.081 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -96.56 -18.95 19.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.226 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -159.6 127.84 4.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 60' ' ' THR . 3.4 pp -82.31 117.04 22.09 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 90.3 t -83.45 129.24 37.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.1 142.05 54.8 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.117 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 80.09 5.29 1.84 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.58 1.175 . . . . 0.0 109.744 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.686 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -93.31 160.38 24.7 Favored Glycine 0 CA--C 1.484 -1.904 0 CA-C-O 118.153 -1.359 . . . . 0.0 109.886 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.648 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 32.1 Cg_endo -72.01 -25.21 19.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.95 2.375 . . . . 0.0 110.208 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -61.03 -49.25 78.16 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.468 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.91 86.53 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.134 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.0 mt -72.06 -38.3 69.5 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 112.921 -1.945 . . . . 0.0 114.55 -172.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 12.9 t70 -71.75 -27.26 62.86 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.66 2.72 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.887 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 17.3 ptpt -77.32 -34.34 55.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.824 1.312 . . . . 0.0 112.549 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -79.44 139.04 37.78 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.76 167.94 21.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.458 1.123 . . . . 0.0 112.242 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.442 ' H ' HD23 ' A' ' 46' ' ' LEU . 18.2 m -61.23 135.37 57.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.573 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.87 -16.03 43.77 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.551 ' O ' HG12 ' A' ' 43' ' ' ILE . 10.4 m-20 -66.47 132.99 49.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.268 0.2 OUTLIER -101.13 120.71 51.05 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.759 176.094 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -73.0 115.62 14.08 Favored 'Isoleucine or valine' 0 C--O 1.302 3.848 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.15 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 73' ' ' LEU . 72.8 t -102.2 -58.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 126.395 2.309 . . . . 0.0 109.814 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 13.4 m -146.3 172.06 14.05 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.43 154.78 14.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -34.18 112.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 64.36 15.59 9.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.2 1.4 . . . . 0.0 114.045 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.1 m -142.18 125.15 16.17 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.477 1.132 . . . . 0.0 112.493 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.5 108.94 14.54 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.231 -1.35 . . . . 0.0 107.967 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 41.1 t -86.04 -2.71 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 40' ' ' PHE . 2.6 mm? -66.92 123.28 19.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.205 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 36' ' ' GLU . . . 81.46 9.44 85.81 Favored Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.832 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.8 111.03 10.73 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 92.1 m -62.0 149.73 40.02 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.23 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -47.55 -43.79 25.44 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.97 0.804 . . . . 0.0 111.713 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -36.01 82.49 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 27.5 mm-40 -79.32 -48.27 14.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.291 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 14.9 p -63.87 -40.74 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.137 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.51 -36.27 76.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 4.5 tmmm? -57.2 -47.97 79.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.44 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.2 mt -72.94 -50.28 33.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 CA-C-O 122.283 1.039 . . . . 0.0 109.883 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 5.4 m-85 -63.96 -38.04 89.62 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.308 -1.769 . . . . 0.0 114.017 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 12.4 mm-40 -86.2 -19.87 29.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.117 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.8 m -75.6 -17.62 59.97 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.653 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.8 mt -44.74 135.68 4.65 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.463 1.105 . . . . 0.0 113.459 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 74.0 Cg_endo -97.79 154.42 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.179 3.253 . . . . 0.0 112.127 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' N ' ' A' ' 25' ' ' ARG . 7.3 mt -69.05 143.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.263 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.24 11.93 71.5 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.832 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.511 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.45 -170.5 1.76 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.88 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 36.9 p -149.66 138.29 20.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.5 m -133.47 152.3 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.373 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.07 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -94.23 107.32 19.26 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.08 123.3 45.71 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.335 0.588 . . . . 0.0 109.995 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.1 tt0 -103.17 115.14 30.0 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.92 159.13 42.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.584 -175.402 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.3 t -122.57 140.06 53.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 20.1 tpp85 -110.64 142.2 42.85 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.71 -18.19 1.63 Allowed Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.914 -1.136 . . . . 0.0 111.89 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.958 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.1 pm0 . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 17.9 m -114.11 109.76 18.94 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 102.527 -3.138 . . . . 0.0 102.527 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.558 ' HA ' HG22 ' A' ' 30' ' ' THR . 46.9 tt0 -86.94 96.07 10.13 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.564 0.697 . . . . 0.0 111.078 -174.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.0 m . . . . . 0 N--CA 1.418 -2.036 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.205 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 10' ' ' GLU . 13.6 t . . . . . 0 N--CA 1.428 -1.533 0 CA-C-O 122.273 1.035 . . . . 0.0 108.36 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.0 ptt180 46.15 36.12 2.99 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 126.249 1.82 . . . . 0.0 112.974 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.783 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -108.14 111.54 61.85 Favored Pre-proline 1 C--N 1.219 -5.096 0 CA-C-N 112.29 -2.232 . . . . 0.0 113.645 178.783 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.299 17.3 Cg_exo -58.13 -36.44 97.9 Favored 'Trans proline' 0 CA--C 1.478 -2.306 0 C-N-CA 121.757 1.638 . . . . 0.0 109.355 172.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 m -66.01 -26.65 67.63 Favored 'General case' 1 N--CA 1.36 -4.941 0 CA-C-N 111.284 -2.689 . . . . 0.0 112.571 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.1 pt-20 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.7 131.58 48.38 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -80.94 -175.18 5.24 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.097 -1.411 . . . . 0.0 113.365 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.2 -119.77 4.95 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.468 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.17 157.87 45.11 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 123.821 0.848 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.93 111.11 16.67 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.27 135.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.264 0.554 . . . . 0.0 111.378 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.444 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 21.6 t60 -112.66 99.65 8.1 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.458 ' CB ' ' HG2' ' A' ' 57' ' ' LYS . 10.6 t -118.34 140.16 50.26 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.298 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -81.24 130.41 35.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.1 mp -115.73 132.56 56.6 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -92.13 119.57 31.91 Favored 'General case' 0 N--CA 1.387 -3.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -53.21 99.97 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 166.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 89' ' ' ILE . 70.9 m -87.25 -54.89 4.06 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 124.509 1.131 . . . . 0.0 113.365 -167.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -144.89 70.8 1.28 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' N ' HG12 ' A' ' 89' ' ' ILE . 29.2 mmt180 67.78 78.8 0.23 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 104.63 -141.31 15.26 Favored Glycine 0 N--CA 1.411 -3.017 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.063 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.706 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.4 m-85 -119.3 -82.33 0.64 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.325 -0.938 . . . . 0.0 111.562 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.52 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.24 50.34 0.2 Allowed Glycine 0 C--N 1.291 -1.948 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.995 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 43' ' ' ILE . 46.2 p90 -161.59 143.35 11.52 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.454 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.1 p -104.73 146.21 29.27 Favored 'General case' 0 C--N 1.256 -3.46 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.71 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 43' ' ' ILE . 29.9 m -128.26 157.2 40.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.499 HG13 ' HD2' ' A' ' 44' ' ' LYS . 10.5 m -119.74 132.59 69.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 C-N-CA 124.959 1.304 . . . . 0.0 110.205 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 124.88 -144.25 15.08 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.57 61.56 3.24 Favored Glycine 0 CA--C 1.466 -2.986 0 O-C-N 125.93 1.606 . . . . 0.0 112.048 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.68 -32.7 6.57 Favored 'General case' 0 C--N 1.261 -3.274 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.403 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.03 170.43 8.93 Favored Pre-proline 0 CA--C 1.478 -1.791 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.633 -171.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.92 63.29 8.11 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.968 3.112 . . . . 0.0 107.76 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.78 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 111.822 -2.445 . . . . 0.0 106.851 -172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.33 119.52 39.27 Favored 'General case' 0 C--O 1.269 2.122 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.357 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.433 ' O ' ' HA3' ' A' ' 33' ' ' GLY . 37.7 m-85 -95.09 164.91 12.68 Favored 'General case' 0 N--CA 1.508 2.427 0 C-N-CA 127.858 2.463 . . . . 0.0 108.408 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -96.3 144.83 26.12 Favored 'General case' 0 C--O 1.169 -3.151 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.609 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 tt0 -134.49 151.34 51.07 Favored 'General case' 0 C--O 1.168 -3.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.573 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.6 mm -78.46 126.6 38.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' HG13 ' A' ' 32' ' ' VAL . 10.3 ptmm? -105.35 -22.21 13.08 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 122.342 0.257 . . . . 0.0 111.188 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 15.9 m -156.03 126.91 6.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.3 tp -83.29 114.77 21.62 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 57.4 t -90.45 119.88 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.63 144.0 55.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.319 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 83.49 8.02 0.65 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 125.412 1.695 . . . . 0.0 109.702 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.6 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.16 158.11 27.62 Favored Glycine 0 C--O 1.203 -1.817 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 172.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 58.5 Cg_endo -73.22 -25.37 15.84 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 CA-C-N 121.852 2.826 . . . . 0.0 110.112 -170.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -64.16 -39.84 94.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.189 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.31 66.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-O 122.621 1.2 . . . . 0.0 110.076 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 89.1 mt -71.4 -48.07 52.1 Favored 'General case' 0 N--CA 1.395 -3.191 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.875 -172.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.9 t70 -70.52 -28.29 64.83 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.07 26.97 70.74 Favored Glycine 0 CA--C 1.487 -1.707 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.828 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -90.62 -20.53 22.45 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.457 -0.871 . . . . 0.0 109.563 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.562 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 66.3 mtp -125.72 152.35 45.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.872 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.37 167.34 26.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.603 0.716 . . . . 0.0 111.882 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 44' ' ' LYS . 7.3 m -60.4 116.52 4.35 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.56 -42.03 1.43 Allowed Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.3 148.94 50.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.302 0.3 OUTLIER -110.51 119.15 58.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -172.403 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.1 mm -64.83 115.03 2.78 Favored 'Isoleucine or valine' 0 C--O 1.302 3.842 0 C-N-CA 126.478 1.911 . . . . 0.0 110.765 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 93.0 t -98.49 -58.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.183 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.9 m -154.9 173.35 16.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.306 -0.871 . . . . 0.0 112.147 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 9.8 p -140.97 159.32 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -31.96 105.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.396 1.478 . . . . 0.0 114.76 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.95 33.78 9.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.772 1.629 . . . . 0.0 112.224 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.473 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 15.5 m -140.61 120.71 13.76 Favored 'General case' 0 N--CA 1.421 -1.901 0 O-C-N 121.424 -0.797 . . . . 0.0 109.371 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 24.1 t -81.58 77.07 8.47 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.516 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 91.2 t -74.08 -8.0 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 123.173 1.463 . . . . 0.0 108.62 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 6' ' ' ARG . 24.7 tp -64.89 111.13 2.68 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.138 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.71 74.01 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.477 -176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -74.6 139.78 43.89 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 30.7 m -72.84 145.08 47.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 117.458 -1.258 . . . . 0.0 108.381 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.439 ' HA ' HG12 ' A' ' 80' ' ' VAL . 70.3 t60 -47.33 -48.44 25.3 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.276 0.944 . . . . 0.0 112.216 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.44 70.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.816 0.698 . . . . 0.0 110.843 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 64.8 mm-40 -80.14 -49.4 11.74 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.835 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 41' ' ' LEU . 8.2 p -63.72 -42.68 96.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.445 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.5 p -65.33 -36.05 76.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.834 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 38.6 ttpt -55.26 -48.19 74.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.436 0.294 . . . . 0.0 111.428 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -72.27 -50.26 37.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 122.706 1.241 . . . . 0.0 109.515 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.34 -28.27 68.54 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.024 -1.898 . . . . 0.0 112.792 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.1 mp0 -86.65 -22.93 25.84 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 p -90.0 -18.48 25.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -54.47 151.41 14.27 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -102.84 163.05 0.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.874 3.716 . . . . 0.0 112.283 -177.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 23' ' ' SER . 64.4 mt -67.92 131.91 32.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.931 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.28 10.97 46.74 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.79 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.88 -179.2 4.09 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 118.456 1.128 . . . . 0.0 111.82 -175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 17.2 t -138.68 153.62 48.56 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 109.94 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.3 m -153.89 151.16 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 C-N-CA 124.341 1.057 . . . . 0.0 110.391 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 14.8 m-20 -95.57 107.59 19.78 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.04 116.39 31.88 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.29 125.05 52.72 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.396 0.617 . . . . 0.0 110.77 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 2.1 pt? -141.95 163.21 33.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.656 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 78.7 m -109.57 124.4 51.07 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.328 0.585 . . . . 0.0 110.662 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.578 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 6.7 tpp85 -98.95 147.31 25.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.32 -28.88 2.44 Favored Glycine 0 CA--C 1.486 -1.773 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 N--CA 1.429 -1.502 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.404 175.697 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.429 -1.487 0 CA-C-O 121.297 0.57 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 15.0 m -132.78 122.82 25.08 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.454 ' HA ' HG22 ' A' ' 30' ' ' THR . 2.3 mp0 -92.77 110.77 22.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 29' ' ' PHE . 13.9 m . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.839 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.425 -1.699 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 41.81 42.86 2.33 Favored 'General case' 0 C--N 1.372 1.558 0 C-N-CA 126.527 1.931 . . . . 0.0 113.189 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.813 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.6 m-80 -112.5 119.45 43.44 Favored Pre-proline 1 C--N 1.223 -4.893 0 CA-C-N 112.412 -2.177 . . . . 0.0 113.315 176.263 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.317 24.1 Cg_exo -60.71 -37.33 79.74 Favored 'Trans proline' 0 CA--C 1.474 -2.491 0 C-N-CA 121.788 1.659 . . . . 0.0 108.436 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.1 m -64.8 -23.62 67.3 Favored 'General case' 1 N--CA 1.346 -5.653 0 CA-C-N 109.848 -3.342 . . . . 0.0 112.432 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.813 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.9 pt-20 -80.97 -34.59 32.99 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.9 mt -55.79 129.98 41.57 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 122.772 1.273 . . . . 0.0 112.052 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.84 173.74 7.85 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 112.801 -1.999 . . . . 0.0 112.376 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 78.01 -121.35 5.7 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.597 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.67 155.52 49.55 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.916 0.486 . . . . 0.0 109.914 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.33 111.63 20.37 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.41 152.88 37.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-O 121.484 0.659 . . . . 0.0 111.961 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -125.91 113.79 17.67 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.664 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 11.2 t -125.48 137.3 53.96 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.269 0.557 . . . . 0.0 110.633 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -74.82 131.35 40.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.561 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.46 126.31 53.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.45 105.46 17.63 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -39.8 113.97 0.39 Allowed 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 175.754 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.8 t -89.26 -149.65 0.19 Allowed 'General case' 0 N--CA 1.406 -2.628 0 O-C-N 126.182 2.176 . . . . 0.0 107.951 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -61.96 80.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 89' ' ' ILE . 17.4 mmm180 65.54 56.9 0.91 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.59 -131.55 5.22 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.149 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.669 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -130.0 -83.64 0.55 Allowed 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.305 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.578 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 135.03 53.18 0.07 OUTLIER Glycine 0 C--N 1.297 -1.595 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.877 -170.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 43' ' ' ILE . 35.4 p90 -162.39 152.11 16.09 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.3 p -112.03 144.07 42.0 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.051 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 76.1 t -113.45 149.38 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.072 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 42' ' ' GLN . 1.2 m -119.87 129.76 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.47 -132.7 9.15 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.613 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 33.46 59.98 0.5 Allowed Glycine 1 CA--C 1.445 -4.327 0 O-C-N 126.215 1.773 . . . . 0.0 111.391 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.55 -29.6 9.55 Favored 'General case' 0 C--N 1.252 -3.67 0 CA-C-N 113.933 -1.134 . . . . 0.0 109.214 -170.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -159.15 173.78 4.65 Favored Pre-proline 0 CA--C 1.483 -1.606 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.655 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 73.6 Cg_exo -62.22 -25.95 77.24 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.907 2.405 . . . . 0.0 109.921 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.66 -22.76 27.75 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.996 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.44 119.98 31.61 Favored 'General case' 0 C--O 1.264 1.849 0 O-C-N 121.735 -0.603 . . . . 0.0 110.368 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -86.62 164.87 16.58 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.766 2.026 . . . . 0.0 110.805 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.664 HD21 HG21 ' A' ' 80' ' ' VAL . 6.8 mp -89.16 144.82 25.84 Favored 'General case' 0 C--O 1.183 -2.398 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.2 tt0 -138.76 158.73 43.68 Favored 'General case' 0 C--O 1.188 -2.16 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 29' ' ' PHE . 32.0 mm -92.6 124.15 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 122.527 0.331 . . . . 0.0 110.216 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -104.85 -18.93 14.05 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 123.452 0.47 . . . . 0.0 110.404 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 54.4 m -154.94 127.63 8.03 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.904 0.383 . . . . 0.0 110.539 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.2 tp -81.14 106.72 13.35 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.1 t -79.82 115.02 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.95 143.52 57.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.614 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.507 ' HA ' HD21 ' A' ' 54' ' ' LEU . 33.1 t70 79.43 14.69 1.01 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 125.252 1.595 . . . . 0.0 109.51 -172.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -97.18 165.27 22.73 Favored Glycine 0 C--O 1.207 -1.579 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.5 Cg_endo -72.51 -25.12 18.22 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 121.816 2.808 . . . . 0.0 110.772 -169.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.81 -45.41 89.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.77 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.36 -46.08 71.05 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 124.637 1.175 . . . . 0.0 110.301 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 92.2 mt -71.66 -34.01 69.36 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.506 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 14.1 t70 -77.91 -27.6 49.54 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.59 29.33 69.83 Favored Glycine 0 CA--C 1.484 -1.898 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.336 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.493 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 5.0 tppp? -97.12 -50.81 4.45 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.209 -0.995 . . . . 0.0 111.349 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.61 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 62.7 mtp -88.86 158.34 18.14 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.352 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.78 159.0 43.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 m -62.98 118.68 8.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.28 -31.18 3.05 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' HD12 ' A' ' 97' ' ' LEU . 9.1 m-20 -53.25 140.43 26.59 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.018 0.481 . . . . 0.0 111.615 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.5 OUTLIER -107.8 114.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.175 0.512 . . . . 0.0 111.497 175.805 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -70.25 116.5 11.58 Favored 'Isoleucine or valine' 0 C--O 1.298 3.641 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.166 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG13 HD13 ' A' ' 73' ' ' LEU . 88.3 t -99.57 -59.17 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.395 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 p -151.79 166.21 32.07 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.452 -175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.95 110.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.925 HD22 ' H ' ' A' ' 94' ' ' ASP . 10.8 m120 43.13 65.21 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 76.46 -38.05 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.663 1.585 . . . . 0.0 112.869 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 m -59.23 122.74 14.61 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.728 0.775 . . . . 0.0 110.382 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -83.33 76.75 9.88 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.602 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 75' ' ' HIS . 43.8 t -77.93 -7.18 10.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.635 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.512 HD13 HG13 ' A' ' 65' ' ' VAL . 16.2 tp -69.43 110.7 4.86 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 76.84 32.68 48.97 Favored Glycine 0 N--CA 1.411 -2.974 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.959 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -88.78 137.26 32.48 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 38.1 m -72.35 144.18 48.35 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 117.942 -1.028 . . . . 0.0 108.838 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -47.71 -50.86 23.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 119.046 0.839 . . . . 0.0 112.849 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.7 72.15 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.64 0.587 . . . . 0.0 110.969 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 33.5 mm-40 -75.95 -52.46 10.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.362 0.601 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.664 HG21 HD21 ' A' ' 41' ' ' LEU . 7.2 p -64.43 -43.49 96.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.811 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.57 -35.84 74.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.413 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.83 95.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.905 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.2 -50.54 35.73 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 122.383 1.087 . . . . 0.0 109.455 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.13 -34.87 79.43 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.83 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -85.9 -15.2 42.47 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -82.72 -16.43 48.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.225 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.606 HG23 ' HG2' ' A' ' 22' ' ' LYS . 5.5 mt -43.8 138.82 3.04 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 53.4 Cg_endo -95.96 148.06 1.28 Allowed 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 123.478 2.786 . . . . 0.0 110.858 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.49 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -67.54 139.86 20.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.72 57.08 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.851 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.96 -176.65 3.5 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.007 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.44 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 5.9 p -149.39 138.13 21.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.909 -0.495 . . . . 0.0 111.828 -173.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.722 ' HB ' ' OD1' ' A' ' 68' ' ' ASN . 2.5 m -153.36 143.18 14.54 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 C-N-CA 122.645 0.378 . . . . 0.0 111.953 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.925 ' H ' HD22 ' A' ' 68' ' ' ASN . 19.9 m-20 -78.07 106.98 10.3 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 125.865 1.666 . . . . 0.0 107.749 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.4 tp -96.12 118.75 33.33 Favored 'General case' 0 C--N 1.26 -3.307 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.6 116.51 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -141.94 159.98 41.12 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 -175.12 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 73.8 m -112.82 127.45 56.17 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.532 0.682 . . . . 0.0 110.631 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.597 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 22.7 tpp85 -97.2 146.01 25.5 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.36 -32.24 2.18 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.799 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 C--N 1.311 -1.079 0 CA-C-O 120.641 0.257 . . . . 0.0 110.472 177.299 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.413 -2.317 0 CA-C-O 121.548 0.689 . . . . 0.0 111.334 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 19.9 m -94.69 101.55 13.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.44 ' HA ' HG22 ' A' ' 30' ' ' THR . 73.3 mt-30 -83.88 122.57 28.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.312 -1.027 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.4 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 7' ' ' ASN 0.383 9.9 t . . . . . 0 N--CA 1.421 -1.909 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.51 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' A' ' 40' ' ' PHE . 18.0 ptt180 157.88 -33.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.74 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 20.2 t30 -53.94 111.45 2.83 Favored Pre-proline 0 C--N 1.269 -2.904 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.637 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.274 7.6 Cg_exo -57.4 -36.54 98.82 Favored 'Trans proline' 0 CA--C 1.463 -3.035 0 C-N-CA 122.921 2.414 . . . . 0.0 111.241 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.1 m -77.94 -9.32 59.03 Favored 'General case' 1 N--CA 1.347 -5.611 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.424 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.74 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.3 pt-20 -80.23 -36.56 34.58 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.3 mt -57.23 134.51 55.99 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.941 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.62 170.8 16.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.153 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 93.87 -117.01 5.37 Favored Glycine 0 N--CA 1.424 -2.106 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.052 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -150.38 145.78 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 110.465 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.92 112.49 24.18 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 152.49 37.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.471 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 p-80 -123.48 116.38 23.12 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.396 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -122.46 140.98 52.11 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.631 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -73.77 132.73 42.92 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.978 178.777 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.04 127.39 54.86 Favored 'General case' 0 C--O 1.256 1.435 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -86.87 105.84 17.33 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.702 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.767 ' HE3' HG13 ' A' ' 93' ' ' VAL . 1.6 mptm? -36.65 108.74 0.08 Allowed 'General case' 0 C--O 1.257 1.495 0 C-N-CA 125.115 1.366 . . . . 0.0 112.38 173.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 t -124.32 142.42 51.29 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 125.034 1.459 . . . . 0.0 108.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 m 52.56 39.4 27.98 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 67.52 35.15 4.3 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.013 1.325 . . . . 0.0 110.989 176.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.31 -120.95 0.83 Allowed Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.602 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.5 m-85 -137.92 -93.25 0.21 Allowed 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 50' ' ' GLY . . . 153.03 54.46 0.01 OUTLIER Glycine 0 C--N 1.292 -1.916 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 44.7 p90 -160.64 166.48 28.82 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.575 HG22 ' HA ' ' B' ' 160' ' ' GLN . 29.3 p -120.51 136.23 54.83 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 121.192 -0.942 . . . . 0.0 109.126 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.67 140.09 47.52 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.687 -170.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.8 m -115.24 169.05 6.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.101 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.8 -125.79 7.35 Favored Glycine 0 C--O 1.191 -2.558 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 31.89 58.5 0.36 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 125.87 1.7 . . . . 0.0 113.863 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.57 -32.11 5.98 Favored 'General case' 1 C--N 1.233 -4.494 0 CA-C-N 113.033 -1.583 . . . . 0.0 109.431 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -158.6 172.24 6.39 Favored Pre-proline 0 CA--C 1.466 -2.274 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.397 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 50.0 Cg_exo -63.83 -26.02 67.65 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.206 1.937 . . . . 0.0 108.914 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.43 -35.47 70.95 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.638 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.87 119.11 26.94 Favored 'General case' 0 C--O 1.275 2.415 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.188 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 8.6 m-85 -82.46 166.03 19.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.849 2.46 . . . . 0.0 110.699 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.769 HD21 HG21 ' A' ' 80' ' ' VAL . 3.9 mp -85.36 145.42 27.5 Favored 'General case' 0 C--O 1.187 -2.214 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.122 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.2 tt0 -145.04 148.38 33.64 Favored 'General case' 0 C--O 1.191 -1.977 0 CA-C-N 118.817 0.735 . . . . 0.0 109.264 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.4 mm -81.7 123.26 37.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' C ' HG23 ' A' ' 60' ' ' THR . 42.8 pttt -103.41 -19.96 14.24 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.053 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.2 m -155.31 127.74 7.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.11 111.3 18.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.2 t -86.67 121.47 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.0 145.42 55.42 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.542 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 t70 84.41 6.03 0.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 125.56 1.788 . . . . 0.0 109.319 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.72 158.51 25.2 Favored Glycine 0 C--O 1.2 -1.995 0 CA-C-O 118.322 -1.266 . . . . 0.0 110.66 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.3 Cg_endo -72.13 -25.11 19.49 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 CA-C-N 120.858 2.329 . . . . 0.0 110.192 -171.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -62.43 -46.81 86.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.977 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.64 81.76 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.609 1.164 . . . . 0.0 110.753 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.5 mt -71.92 -41.58 67.71 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 113.336 -1.756 . . . . 0.0 114.378 -174.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.8 -25.09 61.02 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.78 -0.32 86.42 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 117.941 1.937 . . . . 0.0 117.941 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -94.47 -49.54 5.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 120.348 2.074 . . . . 0.0 114.03 -176.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.601 ' HG2' HD11 ' A' ' 97' ' ' LEU . 65.8 mtp -64.62 139.46 58.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.187 0.304 . . . . 0.0 110.894 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.27 167.12 18.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.343 0.592 . . . . 0.0 110.939 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 44' ' ' LYS . 25.7 m -60.83 128.19 35.29 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.54 -35.03 4.02 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.455 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 43' ' ' ILE . 3.5 m-20 -52.78 129.07 28.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.383 0.673 . . . . 0.0 110.613 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.255 0.8 OUTLIER -93.4 116.23 34.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.335 0.588 . . . . 0.0 112.184 -179.161 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.8 mm -72.77 115.52 13.6 Favored 'Isoleucine or valine' 0 C--O 1.295 3.476 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.829 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 73' ' ' LEU . 98.7 t -98.45 -56.69 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 112.293 -2.23 . . . . 0.0 110.54 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.4 m -157.66 174.66 15.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.699 -0.626 . . . . 0.0 110.98 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.471 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.9 p -140.02 159.78 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.521 ' OD1' HG12 ' A' ' 93' ' ' VAL . 28.4 p-10 -29.22 109.86 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.524 1.129 . . . . 0.0 113.31 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 69.8 -37.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.995 1.318 . . . . 0.0 113.729 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.0 m -82.67 124.35 30.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.076 0.941 . . . . 0.0 111.865 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.82 78.72 9.83 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.985 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 23.8 t -77.17 3.71 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.302 1.049 . . . . 0.0 109.068 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.651 HD13 HG13 ' A' ' 65' ' ' VAL . 12.1 tp -65.74 111.55 3.28 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.514 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 62.96 37.9 95.7 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.589 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -74.13 137.85 43.5 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 47.3 m -72.76 146.96 46.01 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.527 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.537 ' O ' HG12 ' A' ' 81' ' ' VAL . 1.2 t60 -44.43 -49.63 9.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.236 0.614 . . . . 0.0 112.045 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.81 80.35 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 123.748 0.655 . . . . 0.0 111.102 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 25.6 mm-40 -75.33 -53.41 8.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 41' ' ' LEU . 11.7 p -59.72 -44.59 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.725 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.7 p -69.48 -36.13 69.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.062 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 3.7 tmmm? -59.96 -44.07 94.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.7 -50.68 37.31 Favored 'Isoleucine or valine' 0 C--O 1.262 1.729 0 CA-C-O 122.507 1.146 . . . . 0.0 108.895 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 13.2 m-85 -66.18 -33.76 76.49 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.398 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.82 -19.21 32.84 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.349 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.3 m -84.08 -10.01 58.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.069 0.461 . . . . 0.0 110.879 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 22' ' ' LYS . 6.1 mt -49.78 138.07 18.0 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -101.58 149.16 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.209 3.273 . . . . 0.0 111.254 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.535 HG12 ' H ' ' A' ' 25' ' ' ARG . 22.8 mt -68.4 143.25 15.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.052 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.19 11.42 57.44 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.427 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -107.09 -173.36 2.27 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.547 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.567 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 31.1 t -149.52 151.94 34.73 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -169.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HE3' ' A' ' 22' ' ' LYS . 1.1 m -157.12 153.72 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 C-N-CA 124.206 1.002 . . . . 0.0 111.245 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.02 107.49 19.54 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.7 tp -96.03 116.57 29.16 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.55 113.96 25.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.601 HD11 ' HG2' ' A' ' 58' ' ' MET . 1.4 pt? -141.48 157.8 44.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.1 t -111.63 123.58 50.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.588 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.7 tpp85 -92.12 143.06 26.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.15 -36.16 1.41 Allowed Glycine 0 C--N 1.294 -1.769 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.09 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 N--CA 1.438 -1.025 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.457 HG22 HG13 ' B' ' 161' ' ' VAL . 54.4 m -147.33 117.02 7.09 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.575 ' HA ' HG22 ' A' ' 30' ' ' THR . 62.8 tt0 -91.51 109.22 20.51 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.276 -2.596 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.305 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.605 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.3 t . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 5' ' ' THR . 12.8 ptm180 53.23 16.43 0.81 Allowed 'General case' 0 N--CA 1.518 2.933 0 C-N-CA 127.12 2.168 . . . . 0.0 113.686 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.729 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.78 110.28 36.26 Favored Pre-proline 0 C--N 1.257 -3.426 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.793 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.263 7.7 Cg_exo -58.38 -31.86 94.91 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 121.225 1.283 . . . . 0.0 109.114 171.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -72.74 -19.52 61.37 Favored 'General case' 1 N--CA 1.361 -4.9 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.851 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.8 pt-20 -79.77 -31.53 40.9 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 40' ' ' PHE . 86.7 mt -63.46 137.55 58.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.649 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.84 174.0 7.47 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.652 -174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.83 -115.52 5.33 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.382 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.38 149.15 46.75 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.54 115.55 23.03 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -134.89 153.13 34.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 -176.222 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -129.44 123.64 32.11 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.59 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.483 HG21 ' HB2' ' A' ' 58' ' ' MET . 15.2 t -127.89 133.05 49.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.292 0.568 . . . . 0.0 111.758 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -81.86 128.3 33.89 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 mp -111.06 127.97 55.72 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -87.49 108.26 18.95 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.693 ' HG3' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -40.48 108.43 0.09 Allowed 'General case' 0 CA--C 1.462 -2.434 0 C-N-CA 125.857 1.663 . . . . 0.0 112.246 175.148 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -87.54 -143.21 0.12 Allowed 'General case' 0 N--CA 1.401 -2.896 0 O-C-N 126.598 2.436 . . . . 0.0 107.298 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -67.01 82.6 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER 64.13 24.34 13.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 112.063 176.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -130.33 1.68 Allowed Glycine 0 C--O 1.276 2.78 0 C-N-CA 118.588 -1.768 . . . . 0.0 113.692 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.6 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 78.8 m-85 -133.83 -91.65 0.35 Allowed 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.511 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.33 53.15 0.1 Allowed Glycine 0 C--N 1.306 -1.089 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -169.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 32.8 p90 -162.0 145.86 12.27 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -108.13 135.87 48.76 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG13 ' HB ' ' B' ' 159' ' ' THR . 1.9 p -123.41 140.4 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 CA-C-N 113.403 -1.726 . . . . 0.0 111.02 -171.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.5 m -124.02 133.65 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 C-N-CA 124.677 1.191 . . . . 0.0 110.691 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 -140.78 12.2 Favored Glycine 0 CA--C 1.461 -3.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.4 55.86 2.47 Favored Glycine 0 CA--C 1.45 -3.977 0 O-C-N 126.695 2.056 . . . . 0.0 112.101 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.24 -31.62 15.36 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.639 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 4.7 pt-20 -158.7 167.69 13.92 Favored Pre-proline 0 CA--C 1.48 -1.724 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.484 -171.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' GLU . 15.0 Cg_exo -77.76 64.45 8.16 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 124.189 3.259 . . . . 0.0 107.805 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.15 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.065 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.35 119.97 40.85 Favored 'General case' 0 C--O 1.267 1.992 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 11' ' ' LEU . 20.5 m-85 -84.32 164.37 19.03 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 127.804 2.442 . . . . 0.0 111.778 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -90.45 147.89 23.12 Favored 'General case' 0 C--O 1.201 -1.473 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.9 tt0 -139.63 155.27 47.53 Favored 'General case' 0 C--O 1.184 -2.367 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 29' ' ' PHE . 44.7 mm -100.3 123.47 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.588 -0.695 . . . . 0.0 110.811 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -102.62 -23.59 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 123.357 0.411 . . . . 0.0 112.02 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 m -151.88 127.05 9.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.48 108.17 19.25 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.511 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 62.9 t -85.82 134.35 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.494 0.664 . . . . 0.0 110.197 -173.115 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.15 140.92 57.53 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.189 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 80.54 5.29 1.65 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.238 1.415 . . . . 0.0 110.996 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.68 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -81.62 159.36 40.32 Favored Glycine 0 C--O 1.203 -1.817 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.558 173.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 13.5 Cg_endo -72.0 -25.09 19.94 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 CA-C-N 121.559 2.68 . . . . 0.0 109.855 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -64.97 -42.37 94.62 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.64 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.43 76.99 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.767 1.27 . . . . 0.0 109.782 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 65.9 mt -72.11 -46.91 54.79 Favored 'General case' 0 C--N 1.267 -3.007 0 CA-C-N 112.64 -2.073 . . . . 0.0 115.188 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.76 -24.65 56.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.05 -155.94 33.6 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.007 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.7 tttp 70.25 -58.79 0.53 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.135 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 18' ' ' THR . 26.9 ttt -77.65 137.64 38.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.639 0.776 . . . . 0.0 109.076 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -152.16 143.69 23.47 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.741 0.416 . . . . 0.0 109.941 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 m -45.81 116.38 1.19 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.215 1.006 . . . . 0.0 110.811 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.78 -11.04 7.05 Favored Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.57 145.45 56.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 3.4 m -106.99 132.65 53.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 117.961 -1.496 . . . . 0.0 107.213 168.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.272 5.8 mt -83.74 119.55 33.16 Favored 'Isoleucine or valine' 1 C--O 1.31 4.267 0 CA-C-O 121.564 0.697 . . . . 0.0 112.599 -178.531 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 73' ' ' LEU . 93.7 t -109.23 -50.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 O-C-N 127.356 2.91 . . . . 0.0 112.382 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 72' ' ' VAL . 29.2 m -145.48 158.63 43.81 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.491 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG13 ' HB ' ' A' ' 70' ' ' THR . 5.2 p -135.23 86.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.482 37.3 p30 54.93 -90.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.361 2.265 . . . . 0.0 114.761 -171.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -89.59 -37.65 14.52 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.609 0.719 . . . . 0.0 110.172 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HB ' HG13 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -77.91 127.84 33.0 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.842 -172.297 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.98 96.68 10.35 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 14.5 p -90.67 -1.11 9.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.783 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 65' ' ' VAL . 17.4 tp -69.56 112.0 5.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.43 27.33 43.93 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.599 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -81.42 150.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 63.3 m -76.48 142.47 40.94 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 117.824 -1.084 . . . . 0.0 108.764 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.7 t-80 -48.27 -48.66 35.47 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.061 0.846 . . . . 0.0 112.894 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.49 69.55 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.303 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 29.3 mm-40 -80.55 -46.23 16.11 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 HD21 ' A' ' 41' ' ' LEU . 7.6 p -61.92 -43.73 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.917 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.3 -35.93 74.1 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.559 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.81 -46.69 81.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.733 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.5 -50.69 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.208 1.004 . . . . 0.0 109.362 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -62.26 -36.28 81.58 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.479 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.57 -20.04 32.12 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.699 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 t -80.8 -13.08 59.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.693 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.6 mt -48.67 134.11 13.79 Favored Pre-proline 0 CA--C 1.565 1.558 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 88.3 Cg_endo -99.95 157.63 0.53 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.233 3.288 . . . . 0.0 112.286 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' SER . 22.7 mt -68.97 142.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 123.656 0.782 . . . . 0.0 110.425 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.99 13.27 69.51 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.206 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -109.94 -170.19 1.61 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.486 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.459 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.4 t -149.95 148.88 29.61 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.917 -0.489 . . . . 0.0 112.281 -172.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.639 HG22 ' HE3' ' A' ' 22' ' ' LYS . 6.5 m -155.24 145.92 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 124.844 1.258 . . . . 0.0 110.05 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.5 ' H ' ' HB3' ' A' ' 68' ' ' ASN . 7.0 m-20 -95.9 107.75 20.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.682 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.6 mm? -92.06 120.87 33.08 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.092 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.77 122.44 38.55 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.51 151.57 35.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.891 0.744 . . . . 0.0 109.737 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 63' ' ' VAL . 8.3 t -117.92 111.51 19.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 168.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 13.4 tpp85 -100.28 158.01 16.19 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.4 -15.52 6.38 Favored Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.42 -1.938 0 CA-C-N 113.889 -1.156 . . . . 0.0 108.165 176.692 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 15.0 pt-20 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.523 ' HB ' HG13 ' A' ' 31' ' ' VAL . 11.0 m -93.04 124.16 36.82 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 172.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -106.11 101.89 11.34 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.724 -0.61 . . . . 0.0 109.977 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.722 -172.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.584 0.706 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 6.8 tpt180 61.75 30.97 18.57 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.413 1.578 . . . . 0.0 109.97 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.781 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.9 m-20 -120.29 108.18 38.35 Favored Pre-proline 0 C--N 1.263 -3.193 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.276 8.0 Cg_exo -55.22 -30.19 70.33 Favored 'Trans proline' 0 CA--C 1.486 -1.882 0 C-N-CA 121.527 1.485 . . . . 0.0 110.289 169.521 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -75.36 -23.01 57.1 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.601 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.781 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -73.99 -33.23 63.75 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 74.8 mt -62.09 133.28 55.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.785 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.31 175.81 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.451 -1.704 . . . . 0.0 113.672 -171.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 87.94 -132.0 10.95 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.47 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.608 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.39 142.8 51.01 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 123.819 0.848 . . . . 0.0 109.331 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -107.22 116.15 31.42 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -133.67 151.94 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.66 -177.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 13.2 t-160 -123.31 105.23 9.68 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -124.18 136.9 54.51 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.158 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.65 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -78.12 129.84 35.66 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.331 0.653 . . . . 0.0 110.324 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -117.31 120.17 37.39 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 176.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -84.77 103.1 13.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.97 115.07 0.36 Allowed 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 176.344 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -88.52 -148.31 0.16 Allowed 'General case' 0 N--CA 1.41 -2.431 0 O-C-N 126.241 2.213 . . . . 0.0 108.056 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -62.69 83.79 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.547 ' H ' HG12 ' A' ' 89' ' ' ILE . 22.2 mmt180 67.35 49.61 1.03 Allowed 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 124.964 1.306 . . . . 0.0 112.492 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.32 -123.16 2.22 Favored Glycine 0 N--CA 1.401 -3.682 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.685 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.694 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 64.1 m-85 -125.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.261 -3.265 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.471 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.479 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.26 49.64 0.18 Allowed Glycine 0 C--N 1.292 -1.867 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.052 -172.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 27' ' ' PHE . 28.3 p90 -161.16 142.26 11.52 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 73.9 p -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 11.0 m -125.7 159.16 33.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.885 -170.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.496 HG13 ' CD ' ' A' ' 44' ' ' LYS . 4.2 m -120.53 131.59 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 C-N-CA 124.07 0.948 . . . . 0.0 110.519 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.58 -137.24 9.36 Favored Glycine 0 C--O 1.291 3.701 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.527 174.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.83 61.86 3.21 Favored Glycine 1 CA--C 1.436 -4.886 0 O-C-N 127.109 2.299 . . . . 0.0 110.953 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 76' ' ' THR . 13.5 t0 -99.19 -48.66 4.76 Favored 'General case' 0 C--N 1.248 -3.833 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 5.9 pt-20 -160.35 175.97 2.84 Favored Pre-proline 0 C--N 1.287 -2.14 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.661 -170.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 32.2 Cg_exo -72.42 64.89 3.68 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.154 3.236 . . . . 0.0 107.97 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 1.8 t70 -171.66 -41.49 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.498 -2.137 . . . . 0.0 108.637 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.87 120.09 28.36 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.204 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -88.61 166.1 14.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 128.242 2.617 . . . . 0.0 108.114 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -89.77 144.13 26.23 Favored 'General case' 0 C--O 1.166 -3.329 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.903 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 tt0 -130.59 156.28 45.12 Favored 'General case' 0 C--O 1.17 -3.089 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.421 HD11 HG12 ' A' ' 64' ' ' ILE . 13.3 mm -93.05 128.9 44.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 CA-C-N 119.161 0.891 . . . . 0.0 109.823 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CD ' HG13 ' A' ' 32' ' ' VAL . 4.5 ptmm? -107.82 -23.96 11.86 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 39.7 m -151.61 126.96 9.95 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.686 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.1 112.33 18.37 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 57.6 t -89.93 122.56 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.05 146.3 54.84 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.605 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 83.05 4.27 0.94 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 125.055 1.472 . . . . 0.0 109.771 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.98 158.77 36.93 Favored Glycine 0 C--O 1.205 -1.673 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.541 173.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.9 Cg_endo -72.17 -25.26 19.18 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 CA-C-N 121.549 2.674 . . . . 0.0 109.716 -171.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -60.65 -48.18 82.93 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.88 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.89 82.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.163 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 83.9 mt -72.07 -39.51 68.96 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.975 -172.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.45 -21.07 45.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.42 40.97 98.35 Favored Glycine 0 CA--C 1.49 -1.503 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.753 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -141.95 27.54 1.8 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.185 0.993 . . . . 0.0 110.315 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.647 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.7 tmt? -160.24 137.49 9.4 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HG2' ' NE ' ' A' ' 99' ' ' ARG . 7.9 pt-20 -154.95 160.07 40.86 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 119.309 0.959 . . . . 0.0 112.336 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -53.72 123.15 11.47 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.519 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.56 -1.09 21.93 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.954 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.1 p30 -100.94 161.92 13.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.432 172.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.727 HG13 ' SG ' ' A' ' 98' ' ' CYS 0.342 0.2 OUTLIER -118.31 125.3 74.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -179.093 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.421 HG12 HD11 ' A' ' 43' ' ' ILE . 47.4 mm -69.77 114.17 6.71 Favored 'Isoleucine or valine' 0 C--O 1.303 3.914 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.605 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.67 HG13 HD13 ' A' ' 73' ' ' LEU . 88.2 t -93.59 -58.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 112.471 -2.15 . . . . 0.0 110.007 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -162.22 173.96 13.54 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.99 -0.444 . . . . 0.0 110.871 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.0 p -143.68 156.64 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 3.1 t-20 -30.18 111.28 0.07 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.8 1.64 . . . . 0.0 113.033 170.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.5 t70 75.39 -27.2 0.19 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.63 1.572 . . . . 0.0 113.677 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 m -112.44 116.24 29.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.979 0.895 . . . . 0.0 111.403 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.3 t -82.75 96.0 8.04 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.47 0.09 4.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.431 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.67 HD13 HG13 ' A' ' 65' ' ' VAL . 15.2 tp -65.07 110.99 2.69 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.256 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.26 80.62 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.433 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -74.03 145.4 44.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 44.2 m -76.69 142.83 40.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.216 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.432 ' O ' HG12 ' A' ' 81' ' ' VAL . 55.9 t-80 -48.08 -49.22 32.4 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 118.993 0.815 . . . . 0.0 112.537 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.06 75.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 124.298 0.999 . . . . 0.0 110.517 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 68.1 mm-40 -77.95 -49.96 13.11 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.012 -176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -63.59 -43.92 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.444 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.8 p -63.78 -40.26 88.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.228 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' SER . 4.6 tmmm? -58.45 -44.21 89.14 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.825 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.28 -48.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 122.057 0.932 . . . . 0.0 109.977 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.52 -32.24 73.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.958 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.81 -16.64 38.13 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.877 0.37 . . . . 0.0 110.968 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 27.4 t -77.81 -23.45 49.07 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.617 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.6 mt -50.28 139.36 19.23 Favored Pre-proline 0 N--CA 1.434 -1.261 0 C-N-CA 124.382 1.073 . . . . 0.0 113.292 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 71.7 Cg_endo -99.69 158.5 0.56 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 124.185 3.257 . . . . 0.0 111.422 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.547 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.6 mt -68.32 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.245 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.72 12.61 60.56 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.561 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -100.02 -175.27 2.9 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.281 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.65 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 13.2 t -148.22 139.2 23.18 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.886 -0.509 . . . . 0.0 112.338 -172.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.9 m -151.64 158.98 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.063 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.559 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 8.2 m-20 -102.87 108.01 19.06 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD22 HD22 ' A' ' 20' ' ' LEU . 12.5 tp -100.79 120.96 40.88 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 12.6 pt-20 -103.16 124.4 48.51 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 58' ' ' MET . 4.2 pp -141.64 165.31 27.83 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.407 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.727 ' SG ' HG13 ' A' ' 63' ' ' VAL . 3.0 p -118.73 113.42 21.12 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.458 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -90.38 137.32 32.45 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.484 -173.724 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.94 23.79 5.44 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.599 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.6 t80 . . . . . 0 C--N 1.303 -1.421 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.584 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.448 0.642 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 4.8 m -115.01 102.78 10.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.436 ' HA ' HG22 ' A' ' 30' ' ' THR . 77.3 mt-30 -86.28 95.22 9.55 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.58 HG23 ' HB2' ' A' ' 27' ' ' PHE . 9.1 m . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.427 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 7' ' ' ASN 0.32 12.6 t . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' HD21 ' A' ' 73' ' ' LEU . 26.7 ptt180 156.39 -30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.29 1.836 . . . . 0.0 106.276 177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 39.4 t-20 -40.6 107.68 0.49 Allowed Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.414 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.261 9.6 Cg_exo -61.67 -32.95 87.16 Favored 'Trans proline' 0 CA--C 1.465 -2.932 0 C-N-CA 121.918 1.745 . . . . 0.0 110.374 -178.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -80.04 -18.92 48.88 Favored 'General case' 1 N--CA 1.338 -6.046 0 CA-C-N 111.972 -2.376 . . . . 0.0 111.726 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.2 pt-20 -73.24 -36.22 66.4 Favored 'General case' 0 C--N 1.379 1.859 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 85.3 mt -54.94 129.37 37.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.785 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.9 -162.58 0.55 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.26 -171.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 65.92 -102.0 0.66 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.003 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 149.06 32.93 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 123.259 0.624 . . . . 0.0 109.861 178.564 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 8' ' ' PRO . 2.5 t80 -112.64 110.98 21.46 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.18 153.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.708 -177.158 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 26.8 p-80 -132.05 107.59 8.76 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.928 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -122.51 132.18 54.2 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -76.29 136.26 39.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.43 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.0 130.53 54.78 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.199 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -82.89 124.23 30.14 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 109.46 0.44 Allowed 'General case' 0 CA--C 1.466 -2.257 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 173.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.7 t -85.14 -146.18 0.1 Allowed 'General case' 0 N--CA 1.413 -2.306 0 O-C-N 126.624 2.453 . . . . 0.0 107.82 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 m -64.12 84.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.0 mpt_? 59.86 43.99 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 125.698 1.599 . . . . 0.0 111.353 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.24 -127.0 1.8 Allowed Glycine 1 N--CA 1.394 -4.143 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.935 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.7 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m-85 -133.68 -82.57 0.46 Allowed 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 114.349 -0.926 . . . . 0.0 111.356 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.53 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.33 54.76 0.18 Allowed Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -169.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.8 p90 -161.32 148.77 15.04 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -113.08 136.66 52.46 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.909 0.861 . . . . 0.0 109.154 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 6.2 p -128.63 150.54 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.523 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.472 -167.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 42' ' ' GLN . 12.3 m -114.33 154.3 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 124.829 1.252 . . . . 0.0 113.106 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.23 -123.91 6.8 Favored Glycine 0 C--O 1.291 3.706 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.94 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.64 47.79 3.06 Favored Glycine 0 CA--C 1.47 -2.781 0 O-C-N 126.455 1.914 . . . . 0.0 112.081 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -95.4 -29.31 14.5 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . 13.2 mt-10 -140.95 172.64 5.86 Favored Pre-proline 0 N--CA 1.41 -2.442 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.062 -169.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_exo -73.66 -8.4 21.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.532 2.822 . . . . 0.0 108.149 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.03 -9.13 15.69 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.047 -1.888 . . . . 0.0 110.183 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -131.24 119.41 21.77 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.639 -0.663 . . . . 0.0 110.9 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 8.4 m-85 -86.57 166.18 15.62 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.428 2.291 . . . . 0.0 110.232 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.8 mp -93.77 146.38 23.91 Favored 'General case' 0 C--O 1.181 -2.535 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.468 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 28.7 tt0 -138.48 144.92 40.26 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-N 118.803 0.729 . . . . 0.0 109.949 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 29' ' ' PHE . 27.0 mm -80.28 120.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.743 0 O-C-N 121.498 -0.751 . . . . 0.0 110.734 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 60' ' ' THR . 44.1 pttt -100.75 -22.0 15.01 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 123.473 0.483 . . . . 0.0 111.544 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.7 m -158.46 127.48 5.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 60' ' ' THR . 2.9 pp -84.44 121.07 27.05 Favored 'General case' 0 N--CA 1.402 -2.872 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.7 t -85.0 129.3 37.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.63 138.59 58.53 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.434 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 t70 81.65 8.04 1.02 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.777 1.298 . . . . 0.0 110.766 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.654 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.1 161.12 27.66 Favored Glycine 0 C--O 1.21 -1.395 0 CA-C-O 117.894 -1.504 . . . . 0.0 109.798 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.3 Cg_endo -72.13 -24.74 19.9 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 CA-C-N 121.501 2.651 . . . . 0.0 110.271 -169.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -49.94 75.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.188 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.44 80.76 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.961 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 74.3 mt -71.77 -40.31 69.36 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-N 112.745 -2.025 . . . . 0.0 115.46 -172.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.07 -21.58 56.59 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.696 1.236 . . . . 0.0 107.785 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.76 30.98 73.99 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 112.894 -1.957 . . . . 0.0 114.022 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.07 -1.27 3.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.742 0.782 . . . . 0.0 111.058 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -132.5 125.41 30.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.19 167.53 21.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.702 0.763 . . . . 0.0 112.122 -167.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.489 ' H ' HD23 ' A' ' 46' ' ' LEU . 4.7 m -56.35 119.93 6.8 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.778 174.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.43 5.85 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 26.7 m-20 -72.18 135.36 46.12 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.1 OUTLIER -104.77 120.2 54.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 CA-C-O 121.519 0.676 . . . . 0.0 110.837 173.254 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.89 111.75 4.09 Favored 'Isoleucine or valine' 0 C--O 1.299 3.679 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.595 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.581 HG13 HD13 ' A' ' 73' ' ' LEU . 91.8 t -93.61 -58.25 3.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.53 0 O-C-N 126.315 2.259 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -151.43 171.06 18.11 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.833 -0.542 . . . . 0.0 110.102 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 7.7 p -146.87 114.4 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 93' ' ' VAL 0.4 0.2 OUTLIER 31.23 66.88 0.14 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.951 1.3 . . . . 0.0 114.146 -171.31 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.44 -37.43 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.283 1.433 . . . . 0.0 114.102 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.4 m -57.81 121.99 11.8 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.446 0.641 . . . . 0.0 110.754 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 36.0 t -80.88 78.73 7.64 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.32 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 56.0 t -80.83 0.23 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 123.325 1.536 . . . . 0.0 108.851 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -67.68 110.74 3.86 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 65.62 43.02 95.15 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.486 -174.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -87.58 141.89 28.27 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.295 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.6 m -68.77 141.73 55.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.543 ' HA ' HG12 ' A' ' 80' ' ' VAL . 6.4 t60 -54.17 -38.35 65.47 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.428 1.091 . . . . 0.0 112.079 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.7 90.23 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.109 0.881 . . . . 0.0 110.067 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.47 -48.84 18.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.811 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.09 -43.0 97.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.883 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.2 p -65.46 -36.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.263 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -42.16 97.45 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.378 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.51 -50.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 122.394 1.092 . . . . 0.0 108.991 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.63 -33.63 76.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.411 -1.722 . . . . 0.0 113.706 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.71 -22.66 27.72 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 m -83.28 -10.94 58.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.418 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.5 mt -46.74 136.58 7.69 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.357 1.063 . . . . 0.0 113.823 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.3 Cg_endo -97.28 150.65 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.798 2.999 . . . . 0.0 112.08 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' ARG . 17.8 mt -68.05 142.02 16.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.519 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.31 11.48 64.49 Favored Glycine 0 CA--C 1.485 -1.831 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.162 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.37 -170.1 1.7 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.77 -171.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.44 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 24.3 t -149.86 146.07 26.91 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.734 HG22 ' HE2' ' A' ' 22' ' ' LYS . 17.2 m -150.6 153.9 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 C-N-CA 123.483 0.713 . . . . 0.0 109.725 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 19.7 t70 -100.81 112.68 25.15 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.0 mm? -90.8 113.76 25.98 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 38.3 tt0 -94.97 109.21 21.26 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.48 159.34 42.43 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 0.0 112.359 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 t -110.27 122.98 48.95 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 17.3 tpp85 -104.21 147.22 27.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.51 -13.92 4.24 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.064 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 120.509 0.195 . . . . 0.0 110.852 177.13 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 C--O 1.237 0.422 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.556 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 5.3 m -89.68 125.87 35.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.54 115.34 29.74 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 27' ' ' PHE . 31.7 m . . . . . 0 N--CA 1.426 -1.651 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.402 -173.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 15.1 t . . . . . 0 N--CA 1.425 -1.682 0 CA-C-O 122.307 1.051 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 45.55 42.75 8.39 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 123.991 1.853 . . . . 0.0 112.606 178.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.801 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.8 m-20 -115.2 114.02 43.41 Favored Pre-proline 1 C--N 1.242 -4.085 0 CA-C-N 113.083 -1.871 . . . . 0.0 114.186 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.9 Cg_exo -56.72 -30.52 84.53 Favored 'Trans proline' 0 CA--C 1.481 -2.154 0 C-N-CA 121.314 1.343 . . . . 0.0 109.693 168.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -79.54 -13.22 59.69 Favored 'General case' 1 N--CA 1.362 -4.857 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.485 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -81.38 -32.11 32.99 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 63' ' ' VAL . 79.2 mt -61.81 143.32 56.49 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.896 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.72 -179.33 7.09 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.426 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.2 -128.36 9.38 Favored Glycine 0 N--CA 1.432 -1.603 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.833 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 2.4 ptmm? -127.53 151.62 48.65 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 123.882 0.873 . . . . 0.0 110.847 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.84 119.32 37.6 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.404 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -138.02 152.82 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 121.647 0.737 . . . . 0.0 111.923 -177.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.5 p-80 -135.35 105.08 6.11 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.476 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -115.83 140.19 49.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.277 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.15 131.89 41.71 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.4 tp -117.12 121.67 41.93 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.89 114.53 21.25 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.48 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.778 ' HA ' ' HZ2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -48.42 111.49 0.46 Allowed 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 125.108 1.363 . . . . 0.0 112.802 177.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 22.8 t -88.17 -144.28 0.14 Allowed 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 127.159 2.787 . . . . 0.0 107.327 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 p -62.56 84.27 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.555 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.3 mpt_? 59.88 29.85 19.4 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 126.414 1.886 . . . . 0.0 112.215 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.42 -123.05 1.02 Allowed Glycine 0 N--CA 1.412 -2.94 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.173 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.712 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 76.3 m-85 -130.88 -90.45 0.45 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.055 -1.073 . . . . 0.0 111.324 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.602 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 128.07 54.99 0.12 Allowed Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.002 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' O ' HG22 ' B' ' 161' ' ' VAL . 38.4 p90 -161.52 142.95 11.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.55 HG22 ' HA ' ' B' ' 160' ' ' GLN . 25.5 p -105.68 136.04 46.01 Favored 'General case' 0 C--N 1.284 -2.283 0 O-C-N 121.336 -0.852 . . . . 0.0 109.497 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 14.4 m -125.78 160.01 33.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.724 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 44' ' ' LYS . 25.2 m -124.04 132.49 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 174.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA2' ' OE2' ' A' ' 39' ' ' GLU . . . 129.77 -139.73 11.18 Favored Glycine 0 N--CA 1.41 -3.091 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.068 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.644 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.41 48.52 8.55 Favored Glycine 1 CA--C 1.443 -4.413 0 C-N-CA 125.754 1.645 . . . . 0.0 111.204 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.99 -32.64 17.52 Favored 'General case' 0 C--N 1.252 -3.669 0 CA-C-N 114.566 -0.817 . . . . 0.0 109.712 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -158.67 167.9 13.49 Favored Pre-proline 0 N--CA 1.415 -2.21 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.464 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 16.6 Cg_exo -77.46 51.15 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.409 3.406 . . . . 0.0 109.916 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -162.79 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.194 -2.275 . . . . 0.0 108.257 -171.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' OE2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 tt0 -111.78 120.15 41.0 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.48 165.67 16.96 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 128.29 2.636 . . . . 0.0 109.282 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.644 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 3.9 mp -95.06 146.14 24.48 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.003 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 1.2 tm0? -131.79 151.58 51.57 Favored 'General case' 0 C--O 1.169 -3.147 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 62' ' ' ASP . 8.2 mm -90.54 122.34 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 118.827 0.74 . . . . 0.0 109.237 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HD3' HG13 ' A' ' 32' ' ' VAL . 53.6 pttt -106.02 -18.18 14.11 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.765 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.9 m -156.34 127.74 7.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.023 0.439 . . . . 0.0 111.326 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.01 121.28 21.74 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.602 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 97.2 t -92.98 123.44 45.07 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.88 148.93 48.4 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.708 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.3 t70 80.6 4.71 1.67 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.982 1.426 . . . . 0.0 109.743 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.633 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.5 164.63 31.91 Favored Glycine 0 C--O 1.209 -1.468 0 CA-C-O 117.893 -1.504 . . . . 0.0 110.544 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 10.1 Cg_endo -72.5 -25.72 17.61 Favored 'Trans proline' 0 C--O 1.191 -1.868 0 CA-C-N 121.639 2.719 . . . . 0.0 110.482 -171.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.24 87.53 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.676 0.751 . . . . 0.0 109.408 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.39 68.06 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 122.536 1.16 . . . . 0.0 109.252 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.4 mt -72.13 -50.0 31.43 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 112.619 -2.082 . . . . 0.0 115.522 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.01 -24.52 55.29 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.77 45.62 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.086 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 69.85 -61.37 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.366 1.466 . . . . 0.0 112.637 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.535 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.3 tmt? -77.7 136.24 38.16 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -146.02 167.05 24.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.151 0.5 . . . . 0.0 111.107 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.8 m -58.24 128.04 35.11 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.6 -13.28 10.89 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.521 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 43' ' ' ILE . 24.8 m-20 -75.65 161.49 29.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 11' ' ' LEU . 10.4 m -123.31 133.95 67.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 40.1 mm -81.0 109.22 15.14 Favored 'Isoleucine or valine' 0 C--O 1.302 3.866 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 73' ' ' LEU . 86.9 t -95.84 -56.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 O-C-N 126.225 2.203 . . . . 0.0 109.717 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -156.44 173.23 17.21 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.518 -0.739 . . . . 0.0 110.054 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.5 p -145.68 120.84 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.252 4.8 p-10 16.58 84.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.542 1.937 . . . . 0.0 115.216 -172.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 74.73 -37.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.403 1.481 . . . . 0.0 113.09 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.6 m -66.46 125.25 25.11 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-O 121.922 0.867 . . . . 0.0 110.195 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 47.3 t -89.14 91.41 8.78 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.542 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 67' ' ' VAL . 57.1 t -86.46 3.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.76 1.267 . . . . 0.0 108.767 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 65' ' ' VAL . 13.1 tp -76.38 111.08 11.45 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.78 38.36 60.82 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.846 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -82.17 145.92 29.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.673 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.4 m -75.43 142.31 43.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 117.468 -1.253 . . . . 0.0 107.691 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.405 ' O ' HG12 ' A' ' 81' ' ' VAL . 62.2 t60 -48.58 -48.04 39.19 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 119.211 0.914 . . . . 0.0 112.815 -176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -36.13 76.23 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 124.367 1.042 . . . . 0.0 110.536 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -75.0 -51.56 13.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.666 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.4 p -63.93 -44.08 97.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.6 p -60.47 -42.13 90.11 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.535 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 35.4 ttpt -65.26 -39.13 92.23 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -71.5 -46.59 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 122.187 0.994 . . . . 0.0 108.402 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.0 -28.89 69.22 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.745 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.09 -23.77 26.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.6 t -92.55 -2.64 56.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.38 0.61 . . . . 0.0 110.163 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.605 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -54.49 138.26 60.25 Favored Pre-proline 0 N--CA 1.424 -1.754 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.787 173.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -93.39 149.27 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.239 2.626 . . . . 0.0 111.794 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG12 ' H ' ' A' ' 25' ' ' ARG . 26.3 mt -67.86 141.81 17.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.46 12.37 63.01 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.637 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.589 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -106.89 -169.06 1.49 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.804 -171.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.547 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 27.9 t -148.14 148.1 30.21 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.841 -0.537 . . . . 0.0 112.218 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.3 m -146.58 161.15 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.014 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.553 173.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -107.41 107.75 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.6 tp -92.01 114.09 26.53 Favored 'General case' 0 C--N 1.253 -3.591 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.976 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -90.76 107.63 19.31 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.47 161.72 37.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.481 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.507 ' HB2' HG22 ' A' ' 63' ' ' VAL . 74.4 m -124.27 123.49 40.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.966 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' CG ' ' A' ' 14' ' ' LYS . 18.9 tpp85 -93.35 147.17 23.16 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.54 5.64 1.71 Allowed Glycine 0 C--N 1.296 -1.661 0 C-N-CA 119.101 -1.523 . . . . 0.0 112.586 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 116.714 0.257 . . . . 0.0 110.469 176.412 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.476 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 2.9 m -100.06 113.89 26.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 30' ' ' THR . 55.0 tt0 -88.66 104.8 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 29' ' ' PHE . 10.1 m . . . . . 0 N--CA 1.418 -2.062 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.096 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 7' ' ' ASN 0.335 8.9 t . . . . . 0 N--CA 1.418 -2.038 0 CA-C-O 120.553 0.216 . . . . 0.0 111.104 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.2 ptm180 164.03 -30.12 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.6 t-20 -46.07 108.66 0.85 Allowed Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.846 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.1 -27.35 73.38 Favored 'Trans proline' 0 CA--C 1.469 -2.755 0 C-N-CA 121.565 1.51 . . . . 0.0 110.882 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -81.83 -19.71 40.52 Favored 'General case' 1 N--CA 1.354 -5.235 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.031 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.703 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.9 pt-20 -75.26 -34.41 61.37 Favored 'General case' 0 C--N 1.372 1.571 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.5 132.86 49.55 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.921 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -80.06 171.16 15.46 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.772 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 97.42 -123.49 7.82 Favored Glycine 0 N--CA 1.417 -2.569 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.271 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -135.72 141.38 44.88 Favored 'General case' 0 C--N 1.282 -2.349 0 C-N-CA 123.479 0.712 . . . . 0.0 109.55 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -108.83 111.64 23.48 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.44 152.13 23.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.564 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.1 t60 -131.84 99.71 4.85 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -114.22 145.57 41.54 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.759 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -84.88 134.68 34.27 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -117.23 119.98 36.84 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -81.49 110.95 17.36 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.19 104.4 0.04 OUTLIER 'General case' 0 CA--C 1.465 -2.3 0 O-C-N 123.85 0.719 . . . . 0.0 109.398 170.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 65.1 m -92.34 -117.32 0.08 Allowed 'General case' 0 N--CA 1.388 -3.534 0 O-C-N 125.125 1.515 . . . . 0.0 109.953 -176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.6 m -78.81 79.53 5.21 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 119.907 1.23 . . . . 0.0 113.079 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' H ' HG12 ' A' ' 89' ' ' ILE . 16.8 mmt180 62.84 51.19 3.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.143 0.973 . . . . 0.0 111.322 173.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.85 -124.78 2.93 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.692 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 74.5 m-85 -127.79 -81.33 0.59 Allowed 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.5 51.41 0.1 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.456 -172.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 43' ' ' ILE . 27.4 p90 -162.05 146.81 12.71 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.96 0.904 . . . . 0.0 108.715 174.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.0 p -109.92 136.14 49.68 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.891 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 15.4 m -117.45 168.45 9.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.193 -168.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.7 m -127.38 133.06 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 125.482 1.513 . . . . 0.0 109.739 173.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.87 -135.6 12.3 Favored Glycine 0 C--N 1.273 -2.951 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.811 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 38.66 50.8 2.48 Favored Glycine 0 CA--C 1.461 -3.299 0 O-C-N 126.214 1.773 . . . . 0.0 111.142 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -95.75 -36.05 11.31 Favored 'General case' 0 C--N 1.251 -3.69 0 CA-C-N 113.324 -1.438 . . . . 0.0 110.361 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.1 pt-20 -158.82 173.65 4.79 Favored Pre-proline 0 N--CA 1.411 -2.38 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.756 -172.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 52.0 Cg_exo -66.42 -13.89 41.81 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 123.012 2.475 . . . . 0.0 109.538 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.77 -14.55 24.6 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.234 -1.803 . . . . 0.0 111.826 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -139.25 120.28 14.56 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 111.301 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 14.5 m-85 -79.97 166.04 22.0 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 127.412 2.285 . . . . 0.0 111.569 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.892 HD21 HG21 ' A' ' 80' ' ' VAL . 4.6 mp -88.41 146.04 25.46 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.638 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 tt0 -142.38 154.71 44.86 Favored 'General case' 0 C--O 1.181 -2.539 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 29' ' ' PHE . 18.9 mm -93.22 127.01 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 118.914 0.779 . . . . 0.0 109.065 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -105.49 -21.21 13.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.1 m -157.24 128.43 6.79 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.76 123.07 27.36 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 123.714 0.806 . . . . 0.0 108.83 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.3 t -94.96 111.82 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.9 145.43 52.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.902 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.5 t70 86.01 3.05 0.56 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 125.824 1.953 . . . . 0.0 109.098 -171.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.43 159.97 34.09 Favored Glycine 0 C--O 1.204 -1.773 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.072 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 34.2 Cg_endo -72.61 -25.85 17.11 Favored 'Trans proline' 0 N--CA 1.435 -1.929 0 CA-C-N 121.148 2.474 . . . . 0.0 110.515 -171.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.28 -46.04 91.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.737 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.91 85.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.501 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.1 mt -72.0 -40.09 68.77 Favored 'General case' 0 N--CA 1.405 -2.699 0 CA-C-N 113.384 -1.734 . . . . 0.0 114.832 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -75.05 -24.7 58.3 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.24 15.38 65.45 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 113.296 -1.775 . . . . 0.0 115.486 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.05 22.37 7.96 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.8 1.286 . . . . 0.0 109.805 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.8 ttt -140.17 128.69 22.83 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.38 149.32 30.67 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -167.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.2 m -44.75 117.52 1.33 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.643 1.177 . . . . 0.0 110.819 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.11 -7.56 8.66 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.532 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.63 150.33 39.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -108.36 129.7 62.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.5 mm -84.93 115.93 27.61 Favored 'Isoleucine or valine' 0 C--O 1.302 3.83 0 CA-C-O 121.701 0.762 . . . . 0.0 109.26 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 73' ' ' LEU . 95.3 t -96.24 -58.21 3.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.81 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.727 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -155.59 166.74 32.61 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.899 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 95' ' ' LEU . 8.1 p -152.9 115.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 51.33 52.41 14.88 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.945 1.298 . . . . 0.0 111.78 173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 69.33 -6.76 0.91 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.889 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.4 m -81.06 126.48 31.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.2 t -82.45 73.82 9.46 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.955 0.883 . . . . 0.0 110.595 -172.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 80.0 t -79.55 -4.11 6.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 122.66 1.219 . . . . 0.0 109.202 177.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 6' ' ' ARG . 13.6 tp -66.93 112.03 4.1 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 70.92 37.01 65.12 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.418 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -82.61 147.17 28.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.56 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 87.7 m -76.24 143.28 41.09 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 117.599 -1.191 . . . . 0.0 109.171 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HA ' HG12 ' A' ' 80' ' ' VAL . 83.2 t60 -46.77 -47.66 20.76 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.336 0.971 . . . . 0.0 113.164 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 82' ' ' LYS . . . -63.53 -32.25 73.65 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.474 0.654 . . . . 0.0 110.821 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.511 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 32.0 mm-40 -77.82 -49.91 13.36 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.15 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -61.35 -44.75 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.148 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 11.6 p -60.85 -45.13 98.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.416 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -60.18 -38.75 84.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.3 mt -73.12 -48.28 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-O 122.502 1.144 . . . . 0.0 108.909 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.108 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 14.1 pt20 -86.71 -24.46 25.18 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.769 -0.582 . . . . 0.0 111.798 174.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -75.46 -26.22 58.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.584 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -59.61 152.23 57.68 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.4 Cg_endo -102.25 159.51 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.063 3.842 . . . . 0.0 111.942 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' SER . 45.4 mt -67.78 131.01 33.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.97 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.45 10.88 40.19 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 119.773 -0.46 . . . . 0.0 113.981 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -99.35 -176.43 3.29 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.578 1.189 . . . . 0.0 111.902 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.555 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.2 t -140.99 145.39 35.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.704 -0.623 . . . . 0.0 111.75 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.43 157.64 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 C-N-CA 123.964 0.905 . . . . 0.0 111.486 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.506 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 4.2 m-20 -104.56 107.11 17.88 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.481 HD22 HD22 ' A' ' 20' ' ' LEU . 15.4 tp -99.53 121.51 41.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-O 121.123 0.487 . . . . 0.0 111.608 -172.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.02 114.47 26.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.52 148.12 40.57 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.113 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.0 t -117.64 120.1 36.99 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.642 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.3 tpp85 -95.18 139.87 30.89 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.84 -28.35 1.03 Allowed Glycine 0 C--N 1.3 -1.444 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.306 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.306 -1.292 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.457 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 41.4 tt0 . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 120.826 0.346 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 6.7 m -123.39 133.66 54.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.507 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.7 OUTLIER -100.02 116.58 32.39 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.2 m . . . . . 0 N--CA 1.419 -1.975 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.664 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 13.5 t . . . . . 0 N--CA 1.426 -1.644 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 5' ' ' THR . 5.7 ptm180 60.13 12.5 3.29 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 127.264 2.225 . . . . 0.0 113.413 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.792 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 12.0 m-80 -97.39 115.25 65.71 Favored Pre-proline 0 C--N 1.251 -3.686 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.289 13.2 Cg_exo -61.06 -30.17 88.93 Favored 'Trans proline' 0 CA--C 1.483 -2.069 0 N-CA-C 107.906 -1.613 . . . . 0.0 107.906 170.016 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 t -68.66 -25.6 64.89 Favored 'General case' 1 N--CA 1.363 -4.815 0 CA-C-N 110.993 -2.822 . . . . 0.0 111.003 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.3 pt-20 -80.3 -33.79 37.32 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.72 135.29 57.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.655 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 100' ' ' GLY . 45.8 pttt -78.66 166.01 23.0 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.337 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 98.82 -122.98 7.74 Favored Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.514 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.0 147.07 46.04 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 124.712 1.205 . . . . 0.0 110.014 -177.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.5 123.4 49.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -135.6 152.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 43.5 p-80 -126.11 100.49 6.35 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 122.384 1.088 . . . . 0.0 110.265 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 t -102.77 130.66 49.81 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.539 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -83.16 130.32 35.09 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.079 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.9 mp -117.26 123.46 46.64 Favored 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -84.72 125.19 32.31 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.682 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -56.92 103.77 0.13 Allowed 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 172.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.03 -78.27 0.17 Allowed 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 125.346 1.654 . . . . 0.0 109.971 -172.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -116.23 78.64 1.21 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.694 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.625 ' N ' HG12 ' A' ' 89' ' ' ILE . 14.0 ttt180 63.78 24.74 13.9 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.22 -140.76 5.6 Favored Glycine 0 N--CA 1.409 -3.106 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.456 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.634 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 89.1 m-85 -125.67 -85.85 0.62 Allowed 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 114.481 -0.86 . . . . 0.0 112.083 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.39 52.89 0.19 Allowed Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.109 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 43' ' ' ILE . 29.8 p90 -160.9 150.5 17.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HA ' ' B' ' 160' ' ' GLN . 36.0 p -112.03 136.42 51.42 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.0 0.905 . . . . 0.0 109.242 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 4.5 p -125.27 148.4 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.608 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.702 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 42' ' ' GLN . 10.8 m -114.98 164.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 124.492 1.117 . . . . 0.0 113.283 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.96 -124.62 6.55 Favored Glycine 0 C--O 1.284 3.249 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.132 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.34 53.67 5.74 Favored Glycine 1 CA--C 1.443 -4.425 0 O-C-N 127.235 2.374 . . . . 0.0 112.173 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 51.3 t0 -86.14 -47.89 9.08 Favored 'General case' 1 C--N 1.244 -4.012 0 CA-C-N 113.276 -1.462 . . . . 0.0 109.241 -176.198 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.8 pt-20 -158.93 174.51 3.98 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.032 -164.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 24.8 Cg_exo -75.46 59.61 5.53 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 124.662 3.575 . . . . 0.0 108.021 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 22.9 t70 -178.58 -23.7 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.348 -2.205 . . . . 0.0 109.324 -169.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 9.7 tp10 -131.23 120.54 23.4 Favored 'General case' 0 C--O 1.257 1.488 0 C-N-CA 122.997 0.519 . . . . 0.0 110.022 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.51 166.18 14.36 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 127.258 2.223 . . . . 0.0 110.261 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.639 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -96.85 145.25 26.03 Favored 'General case' 0 C--O 1.175 -2.844 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.648 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 14.9 tt0 -135.03 147.7 49.72 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 118.866 0.757 . . . . 0.0 109.928 -177.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 29' ' ' PHE . 34.7 mm -79.5 114.9 20.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.531 -0.731 . . . . 0.0 110.188 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -98.46 -22.05 16.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 37.6 m -155.72 127.14 7.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.7 tp -86.01 112.11 20.91 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.47 104.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.62 145.85 27.16 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.098 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 86.16 3.87 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.438 1.711 . . . . 0.0 109.74 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.666 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.44 163.08 36.95 Favored Glycine 0 C--O 1.212 -1.264 0 CA-C-O 117.773 -1.571 . . . . 0.0 110.21 171.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 22.1 Cg_endo -72.48 -25.48 17.92 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 CA-C-N 121.732 2.766 . . . . 0.0 110.458 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -62.39 -43.69 98.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.428 175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.49 75.37 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.449 1.119 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 69.7 mt -72.18 -40.88 67.61 Favored 'General case' 0 N--CA 1.396 -3.169 0 CA-C-N 112.401 -2.181 . . . . 0.0 114.704 -171.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.24 -24.99 46.69 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.42 27.03 71.16 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-N 113.543 -1.662 . . . . 0.0 115.416 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -110.65 -0.71 17.08 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.789 0.804 . . . . 0.0 110.437 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.421 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 42.8 ttm -129.28 126.97 40.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -142.69 144.93 32.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 m -45.14 114.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.234 1.414 . . . . 0.0 111.284 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.9 -36.95 1.96 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.61 145.21 50.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.8 0.81 . . . . 0.0 111.981 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.258 0.2 OUTLIER -110.33 126.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.27 -175.571 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.43 116.47 15.79 Favored 'Isoleucine or valine' 0 C--O 1.294 3.441 0 C-N-CA 125.673 1.589 . . . . 0.0 110.649 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 37.5 t -103.22 -58.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.99 -177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 20.4 m -136.87 157.87 45.76 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.055 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 5.9 p -137.61 104.1 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 0.0 112.519 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.06 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 125.766 1.627 . . . . 0.0 112.079 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -131.98 -12.09 3.3 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.0 0.429 . . . . 0.0 110.838 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -89.68 134.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.759 0.79 . . . . 0.0 110.382 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 45.1 t -80.88 80.03 7.43 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.604 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 67' ' ' VAL . 7.5 p -77.23 -5.81 8.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.245 1.022 . . . . 0.0 108.504 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . 44.6 tp -56.35 111.11 0.89 Allowed 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.789 -1.551 . . . . 0.0 107.174 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 58.88 37.96 91.68 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.886 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.29 145.13 37.63 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 39.8 m -73.53 141.82 46.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.495 ' HA ' HG12 ' A' ' 80' ' ' VAL . 56.7 t-80 -51.28 -40.47 59.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.72 -176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.18 85.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.092 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 80.7 mm-40 -75.3 -48.6 22.44 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.769 -177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.06 -43.14 97.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.651 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 77' ' ' HIS . 13.8 p -63.18 -37.85 80.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.436 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.83 90.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.22 -50.8 33.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-O 122.161 0.982 . . . . 0.0 109.383 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 9.0 m-85 -64.68 -35.13 80.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.799 -175.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -85.49 -21.42 28.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.67 0.272 . . . . 0.0 110.933 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 m -90.82 -2.52 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.967 -0.458 . . . . 0.0 111.409 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -47.65 142.43 6.59 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.84 156.66 0.68 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 124.035 3.157 . . . . 0.0 112.575 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' N ' ' A' ' 25' ' ' ARG . 64.3 mt -69.01 142.39 16.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 124.414 1.086 . . . . 0.0 110.628 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.9 74.41 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.138 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.603 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -101.05 -172.94 2.26 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -149.9 138.37 20.67 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -167.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.682 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.6 m -149.63 149.41 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 C-N-CA 122.846 0.458 . . . . 0.0 110.734 172.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.79 109.44 21.39 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.51 1.131 . . . . 0.0 108.327 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.7 mm? -90.44 113.42 25.35 Favored 'General case' 0 C--N 1.275 -2.667 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.54 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 40.3 mt-10 -88.39 106.36 18.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 174.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' ILE . 1.6 pt? -132.61 158.61 41.8 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.893 0.378 . . . . 0.0 110.442 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.6 t -116.19 125.16 51.89 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 16.7 tpp85 -98.22 142.62 29.67 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . 149.33 -9.4 0.93 Allowed Glycine 0 C--N 1.303 -1.3 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.105 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 C--N 1.31 -1.152 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 11.5 pt-20 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 31' ' ' VAL . 29.4 m -113.3 131.52 55.9 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' THR . 33.4 tt0 -102.84 120.9 41.41 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 22.7 m . . . . . 0 N--CA 1.432 -1.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.383 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.9 t . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.042 0.448 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.649 ' O ' HD21 ' A' ' 73' ' ' LEU . 13.3 ptm180 49.69 27.81 2.37 Favored 'General case' 0 N--CA 1.515 2.82 0 C-N-CA 126.499 1.919 . . . . 0.0 113.026 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.746 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.8 m-80 -96.33 115.28 65.53 Favored Pre-proline 1 C--N 1.22 -5.044 0 CA-C-N 112.894 -1.957 . . . . 0.0 112.283 174.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.315 26.7 Cg_exo -62.48 -34.66 75.19 Favored 'Trans proline' 0 CA--C 1.475 -2.465 0 CA-C-O 124.201 1.667 . . . . 0.0 108.301 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -65.16 -28.26 69.29 Favored 'General case' 1 N--CA 1.344 -5.738 0 CA-C-N 109.855 -3.339 . . . . 0.0 111.69 -175.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.3 pt-20 -80.59 -33.11 36.25 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.0 128.75 37.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.696 1.236 . . . . 0.0 110.361 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 10.7 ptmm? -83.08 -172.24 4.02 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.33 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 77.32 -135.17 15.95 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.963 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -114.45 139.2 49.72 Favored 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 124.072 0.949 . . . . 0.0 109.309 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.34 114.86 28.89 Favored 'General case' 0 C--N 1.26 -3.283 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -131.65 152.3 36.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.188 -175.13 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . 0.522 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 18.7 t60 -126.73 102.81 7.22 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -130.96 146.83 52.49 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.711 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -81.08 133.7 35.52 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 122.713 0.405 . . . . 0.0 111.695 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.54 125.7 48.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.052 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -85.36 119.65 25.96 Favored 'General case' 0 N--CA 1.395 -3.176 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.135 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -52.32 101.29 0.04 OUTLIER 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 89' ' ' ILE . 11.1 t -83.08 -94.71 0.06 Allowed 'General case' 0 N--CA 1.411 -2.391 0 O-C-N 124.816 1.323 . . . . 0.0 109.628 -176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -96.03 73.93 3.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.578 ' N ' HG12 ' A' ' 89' ' ' ILE . 32.0 ttt180 59.98 40.75 18.49 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.425 1.49 . . . . 0.0 111.909 176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 163.68 -138.05 5.1 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.735 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 83.8 m-85 -121.91 -84.09 0.66 Allowed 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.786 -0.207 . . . . 0.0 111.321 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.56 53.43 0.13 Allowed Glycine 0 C--N 1.291 -1.949 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.998 -171.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 43' ' ' ILE . 30.7 p90 -161.23 143.24 12.03 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' HA ' ' B' ' 160' ' ' GLN . 20.0 p -106.06 135.69 47.07 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.793 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 0.9 OUTLIER -114.08 163.22 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.559 -168.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 44' ' ' LYS . 2.7 m -121.46 133.31 68.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.173 0 C-N-CA 124.293 1.037 . . . . 0.0 109.689 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.18 -130.96 9.6 Favored Glycine 0 C--O 1.279 2.946 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.123 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.568 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.77 62.26 1.01 Allowed Glycine 0 CA--C 1.453 -3.817 0 O-C-N 126.462 1.919 . . . . 0.0 110.837 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 8.5 t70 -110.8 -36.1 5.79 Favored 'General case' 0 C--N 1.249 -3.795 0 CA-C-N 113.735 -1.232 . . . . 0.0 109.719 -170.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.5 pt-20 -158.3 174.71 3.78 Favored Pre-proline 0 CA--C 1.481 -1.686 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.227 -169.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 73.1 Cg_exo -60.15 -30.43 91.32 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 122.617 2.211 . . . . 0.0 109.516 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.85 -39.37 79.96 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.889 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.67 119.78 37.88 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -88.97 165.95 14.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.876 2.07 . . . . 0.0 108.538 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -89.27 144.17 26.29 Favored 'General case' 0 C--O 1.18 -2.597 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.689 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.562 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -133.85 169.4 17.14 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 29' ' ' PHE . 36.8 mm -113.54 126.1 70.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 -173.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.609 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -102.28 -20.31 14.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.6 m -155.75 126.92 7.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.186 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -78.6 108.99 12.4 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 89.3 t -84.86 126.42 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.5 144.55 55.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.331 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 82.68 2.83 1.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 125.205 1.566 . . . . 0.0 110.071 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.682 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.11 160.3 38.39 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.34 -25.3 18.59 Favored 'Trans proline' 0 C--O 1.18 -2.398 0 CA-C-N 121.092 2.446 . . . . 0.0 109.62 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -63.69 -44.18 94.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.523 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.94 68.9 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 122.655 1.217 . . . . 0.0 109.8 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 52.1 mt -72.54 -50.07 28.2 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.356 -2.202 . . . . 0.0 115.9 -172.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.51 -21.43 41.91 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.4 -169.59 54.87 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.395 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt 58.5 30.29 19.54 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 112.784 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' MET . . . . . 0.672 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.5 tmt? -159.83 131.97 6.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 171.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -147.85 160.27 42.95 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.477 0.656 . . . . 0.0 112.26 -169.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -54.69 119.91 6.0 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.386 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.54 4.1 15.81 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.867 -1.158 . . . . 0.0 112.752 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 p30 -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.214 171.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 6.5 p -100.42 117.87 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.398 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 50.4 mm -74.59 111.41 10.38 Favored 'Isoleucine or valine' 0 C--O 1.301 3.794 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.277 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 73' ' ' LEU . 58.6 t -89.18 -58.09 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.476 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -160.55 173.64 15.23 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.031 -0.418 . . . . 0.0 110.852 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.1 p -140.5 121.33 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.378 30.0 p-10 33.03 -89.84 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -92.5 -34.09 14.22 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -93.09 130.87 38.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.227 1.013 . . . . 0.0 112.719 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 t -84.7 90.16 7.66 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 41' ' ' LEU . 40.8 t -78.89 -0.34 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 122.857 1.313 . . . . 0.0 109.039 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 6' ' ' ARG . 20.8 tp -68.1 111.47 4.49 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.363 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.5 43.04 93.28 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.792 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -92.42 137.8 32.05 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.9 m -69.55 143.87 53.26 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -47.49 -49.18 26.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.147 0.885 . . . . 0.0 112.548 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.83 71.95 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.684 0.754 . . . . 0.0 110.97 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 14.1 mm-40 -80.1 -50.0 10.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.854 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.711 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -64.71 -42.27 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.427 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.7 p -63.07 -35.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -43.77 98.28 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.9 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.59 -50.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 122.196 0.998 . . . . 0.0 109.357 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -67.25 -28.69 68.25 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.41 -1.723 . . . . 0.0 112.759 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 78.7 mm-40 -88.49 -17.26 30.72 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 p -94.86 -13.6 25.34 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.665 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -52.02 154.8 3.61 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 177.338 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -95.45 148.14 1.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.093 3.195 . . . . 0.0 112.325 -176.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.578 HG12 ' N ' ' A' ' 25' ' ' ARG . 50.6 mt -65.26 124.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.897 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.65 11.28 44.59 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-O 119.746 -0.475 . . . . 0.0 113.354 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -93.06 -178.09 4.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.033 0.916 . . . . 0.0 111.626 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 t -139.29 150.51 45.51 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 110.496 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.566 HG22 ' HE2' ' A' ' 22' ' ' LYS . 2.5 m -151.39 156.66 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.149 0.98 . . . . 0.0 110.854 174.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.522 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 23.6 m-20 -105.21 107.33 18.26 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 20' ' ' LEU . 13.5 tp -94.33 125.92 39.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.26 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 9.8 pt-20 -108.74 113.8 27.06 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.887 0.851 . . . . 0.0 108.789 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.554 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.7 pt? -142.13 155.5 45.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.324 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 63' ' ' VAL . 58.8 m -113.58 107.11 15.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.573 0.702 . . . . 0.0 109.33 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.672 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 4.9 ttp-105 -85.83 133.67 33.96 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.152 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.31 40.23 0.97 Allowed Glycine 0 C--N 1.283 -2.369 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.812 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 . . . . . 0 N--CA 1.409 -2.488 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.183 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 158' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 32.8 mt-10 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.429 0.633 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 159' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 31' ' ' VAL . 7.8 m -88.65 110.2 20.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' THR . 69.7 mt-30 -84.26 120.93 26.81 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.9 m . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.742 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . 0.425 ' O ' ' HE2' ' A' ' 1' ' ' LYS . . . 54.86 53.45 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.791 1.236 . . . . 0.0 111.882 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -84.94 86.35 7.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 122' ' ' ASP . . . -118.46 29.22 6.47 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.79 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' -2' ' ' ALA . 0.0 OUTLIER -117.34 155.13 50.3 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -175.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.39 119.86 6.89 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.603 1.535 . . . . 0.0 112.008 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -69.64 144.64 52.88 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.404 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.528 ' CE2' ' HA ' ' A' ' 38' ' ' ASP . 10.6 t80 -145.59 140.47 27.42 Favored 'General case' 0 C--N 1.269 -2.931 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.507 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.386 15.0 t -156.72 -52.78 0.08 Allowed 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.147 161.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' THR . 18.2 ptt-85 155.18 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.745 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.6 t-20 -55.86 111.88 3.67 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 112.779 -2.01 . . . . 0.0 112.913 -175.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.2 Cg_exo -63.96 -27.16 66.38 Favored 'Trans proline' 0 CA--C 1.476 -2.407 0 C-N-CA 121.234 1.289 . . . . 0.0 109.997 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -85.4 -14.92 44.78 Favored 'General case' 1 N--CA 1.358 -5.063 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.652 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.4 pt-20 -72.69 -36.2 67.83 Favored 'General case' 0 C--N 1.376 1.752 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.0 mt -59.99 136.0 57.88 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.16 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -98.34 177.49 5.35 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.648 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.6 -99.71 2.48 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.765 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -145.79 128.22 15.94 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.408 0.623 . . . . 0.0 109.352 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.73 115.21 29.8 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -126.12 152.41 33.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.058 -175.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.691 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 14.7 t-160 -127.33 99.89 5.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 HG22 HD21 ' A' ' 97' ' ' LEU . 15.3 t -124.2 141.3 52.17 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.047 -172.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -86.71 131.14 34.22 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.685 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.7 mp -115.02 123.35 48.85 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -86.22 115.44 23.78 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -45.17 102.35 0.03 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 123.95 0.9 . . . . 0.0 109.234 169.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -123.14 135.93 54.56 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 125.274 1.609 . . . . 0.0 108.939 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m 55.12 28.62 11.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.068 0.947 . . . . 0.0 113.143 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.744 ' N ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 77.5 102.91 0.07 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.632 1.573 . . . . 0.0 108.368 176.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.55 -137.32 13.53 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.289 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.649 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.6 m-85 -124.29 -82.76 0.64 Allowed 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.54 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 119.64 56.02 0.25 Allowed Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' HA ' ' H ' ' A' ' 47' ' ' VAL . 28.2 p90 -160.9 143.65 12.79 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' CB ' ' B' ' 160' ' ' GLN . 40.0 p -107.99 134.94 50.19 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-O 122.134 0.969 . . . . 0.0 109.199 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.584 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 2.2 p -135.55 136.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.957 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.044 -169.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 15.2 m -115.39 131.82 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.261 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' B' ' 156' ' ' ARG . . . 137.1 -145.35 17.13 Favored Glycine 0 CA--C 1.457 -3.57 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 48.39 70.11 0.82 Allowed Glycine 0 CA--C 1.464 -3.137 0 O-C-N 126.599 1.999 . . . . 0.0 112.031 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -116.93 -29.25 6.06 Favored 'General case' 0 C--N 1.259 -3.332 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.296 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.6 pt-20 -159.21 174.23 4.23 Favored Pre-proline 0 CA--C 1.467 -2.242 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.579 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 77.1 Cg_exo -61.72 -25.83 79.23 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 122.435 2.09 . . . . 0.0 109.388 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 19.5 t70 -84.01 -21.39 31.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.347 -2.206 . . . . 0.0 112.306 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -122.75 119.41 30.58 Favored 'General case' 0 C--O 1.264 1.837 0 O-C-N 121.492 -0.755 . . . . 0.0 110.471 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.0 165.67 12.74 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.249 2.22 . . . . 0.0 108.495 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.3 mp -93.08 146.47 23.62 Favored 'General case' 0 C--O 1.183 -2.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.583 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 63' ' ' VAL . 15.0 tt0 -137.18 144.49 42.93 Favored 'General case' 0 C--O 1.191 -2.006 0 CA-C-N 118.56 0.618 . . . . 0.0 110.318 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.445 HD12 ' CD1' ' A' ' 29' ' ' PHE . 23.4 mm -79.94 119.63 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 O-C-N 121.829 -0.544 . . . . 0.0 109.848 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 32' ' ' VAL . 1.2 pptp? -103.28 -19.79 14.34 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.951 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.418 ' OG ' ' HD2' ' A' ' 44' ' ' LYS . 45.6 m -161.14 128.16 4.08 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 59' ' ' GLU . 1.5 pp -87.63 128.35 35.28 Favored 'General case' 0 N--CA 1.395 -3.183 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.725 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.54 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.6 t -80.2 127.51 39.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 86.8 mt -64.5 133.99 53.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.6 t70 84.73 11.08 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.385 1.678 . . . . 0.0 109.608 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.93 155.57 23.17 Favored Glycine 0 CA--C 1.487 -1.702 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.572 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.5 Cg_endo -72.02 -25.32 19.64 Favored 'Trans proline' 0 N--CA 1.425 -2.556 0 CA-C-N 121.266 2.533 . . . . 0.0 110.486 -170.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.85 85.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.62 88.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 122.861 1.315 . . . . 0.0 109.879 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 87.4 mt -72.42 -45.73 58.36 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 112.785 -2.007 . . . . 0.0 114.459 -174.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -68.78 -24.69 64.45 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.74 3.2 9.43 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-N 114.186 -1.37 . . . . 0.0 115.893 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -110.44 19.42 18.8 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.996 1.379 . . . . 0.0 109.802 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ttt -146.67 133.21 19.77 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.613 ' HA ' HD23 ' A' ' 46' ' ' LEU . 44.4 mt-10 -140.43 162.11 36.11 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.354 0.662 . . . . 0.0 109.738 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.0 m -57.02 119.01 5.56 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.51 -18.5 5.73 Favored Glycine 0 C--N 1.302 -1.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.47 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' A' ' 99' ' ' ARG . 11.1 m-20 -67.79 136.63 54.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HG3' ' A' ' 42' ' ' GLN . 1.8 m -101.38 130.35 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 43.3 mm -82.22 111.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.299 3.702 0 C-N-CA 123.343 0.657 . . . . 0.0 109.856 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 60.4 t -91.85 -57.92 3.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 126.346 2.279 . . . . 0.0 108.764 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -157.74 170.96 21.19 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.925 -0.484 . . . . 0.0 111.24 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -152.67 120.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.018 0.437 . . . . 0.0 112.145 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.2 t30 50.18 58.63 5.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.907 1.283 . . . . 0.0 111.258 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.26 -30.09 0.2 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.504 -1.68 . . . . 0.0 113.033 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 m -65.83 127.12 30.73 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 121.444 0.64 . . . . 0.0 111.14 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.9 t -79.05 78.24 5.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.233 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 87.2 t -83.89 5.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 122.786 1.279 . . . . 0.0 109.49 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.463 HD13 HG13 ' A' ' 65' ' ' VAL . 13.3 tp -66.62 110.13 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.92 45.0 95.73 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.205 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 1.7 t60 -79.72 147.99 31.7 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.5 m -74.87 143.57 43.78 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 117.73 -1.128 . . . . 0.0 108.821 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -48.07 -49.28 32.16 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.246 0.93 . . . . 0.0 112.33 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.7 71.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 124.063 0.852 . . . . 0.0 110.988 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 81.0 mm-40 -80.28 -48.57 12.83 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.125 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 41' ' ' LEU . 7.3 p -63.8 -43.14 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.7 p -64.53 -35.97 76.06 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -42.99 85.89 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.261 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -72.25 -50.65 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 CA-C-O 122.474 1.131 . . . . 0.0 109.528 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.66 -29.67 69.75 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.049 -1.887 . . . . 0.0 113.327 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 mp0 -86.71 -25.18 24.88 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 p -85.57 -22.36 28.1 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -52.43 151.35 7.6 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.4 Cg_endo -102.49 159.54 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.242 3.961 . . . . 0.0 112.302 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.744 HG12 ' N ' ' A' ' 25' ' ' ARG . 26.9 mt -67.96 131.21 33.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.297 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.03 11.4 34.43 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.961 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -103.39 176.88 5.0 Favored 'General case' 0 C--O 1.202 -1.444 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.496 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.492 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 30.1 t -134.57 148.32 50.44 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.082 -0.386 . . . . 0.0 110.675 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 22' ' ' LYS . 3.2 m -149.07 149.75 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 C-N-CA 124.104 0.961 . . . . 0.0 111.169 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.691 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.9 m-20 -100.23 111.75 24.04 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.526 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.32 125.09 35.97 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.937 0.399 . . . . 0.0 110.315 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 35.2 mt-10 -104.27 105.45 15.59 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 18' ' ' THR . 0.4 OUTLIER -141.43 157.29 45.36 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.254 -172.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.9 t -131.7 120.09 22.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.344 0.592 . . . . 0.0 109.739 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 19.4 ttp85 -114.98 158.62 21.8 Favored 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 124.086 0.955 . . . . 0.0 109.858 -174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.22 -15.34 2.54 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -91.33 112.27 53.18 Favored Pre-proline 0 N--CA 1.432 -1.34 0 CA-C-N 113.989 -1.105 . . . . 0.0 108.222 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' HD13 ' A' ' 120' ' ' ILE . 45.7 Cg_endo -75.75 142.78 26.05 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 121.391 1.394 . . . . 0.0 110.961 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.71 109.61 6.46 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HG3' ' HA ' ' A' ' 118' ' ' VAL . 11.2 Cg_endo -94.92 -79.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.626 2.217 . . . . 0.0 113.829 -176.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.1 150.52 24.37 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.5 m-20 -78.65 126.04 83.36 Favored Pre-proline 0 CA--C 1.48 -1.743 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -173.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.1 Cg_endo -97.7 12.04 0.94 Allowed 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 123.096 2.53 . . . . 0.0 107.003 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 24.4 t70 -91.67 -17.79 24.96 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 112.935 -1.939 . . . . 0.0 108.428 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.03 108.4 51.78 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.054 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 108' ' ' ASP . 45.9 Cg_exo -70.89 -159.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.587 2.858 . . . . 0.0 114.197 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 76.43 26.87 0.86 Allowed 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.347 1.859 . . . . 0.0 112.773 176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.8 m -166.96 154.85 9.5 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -75.85 113.87 13.82 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -79.58 104.38 10.14 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.461 0.648 . . . . 0.0 112.034 -165.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.8 99.0 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 170.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.0 t -75.85 142.23 42.23 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.0 m -102.52 114.56 28.86 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 119' ' ' ALA . 9.1 p -92.97 140.7 15.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.755 -171.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -90.97 166.15 13.18 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 119' ' ' ALA . 2.3 mp 74.04 22.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 125.149 2.404 . . . . 0.0 108.028 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp -92.96 148.62 21.85 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-N 112.691 -2.05 . . . . 0.0 106.942 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.627 ' O ' ' HA2' ' A' ' 0' ' ' GLY . 6.6 m-20 -74.49 121.31 21.3 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-O 121.078 0.466 . . . . 0.0 109.881 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.3 mmpt? -105.3 57.72 0.68 Allowed 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 122' ' ' ASP . 25.6 mt-10 -82.52 147.65 56.57 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 C-N-CA 122.747 2.298 . . . . 0.0 111.836 179.056 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' B' ' 151' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 1.5 p -88.34 148.21 24.38 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.1 t -119.87 -58.11 1.91 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.67 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -77.1 85.49 3.59 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.924 -0.485 . . . . 0.0 111.983 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 10.3 t -156.58 113.52 3.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.111 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.538 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . 8.6 ptp180 -73.22 125.38 27.64 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.722 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 23.4 mmt180 -89.34 142.76 27.37 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.137 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.58 110.75 12.65 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 124.245 0.965 . . . . 0.0 109.042 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 8.5 m -115.67 89.01 3.0 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.496 ' CB ' HG22 ' A' ' 30' ' ' THR . 5.1 pm0 -76.97 114.06 15.34 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.263 0.554 . . . . 0.0 110.631 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.2 m . . . . . 0 N--CA 1.427 -1.593 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.63 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.217 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 54.93 64.35 1.83 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.17 0.988 . . . . 0.0 110.677 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -74.29 69.6 1.6 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.005 0.907 . . . . 0.0 112.845 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -127.93 37.79 2.23 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 151' ' ' ARG . 0.8 OUTLIER -87.24 148.79 45.64 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.797 -0.701 . . . . 0.0 110.009 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.76 125.41 17.15 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.635 2.223 . . . . 0.0 110.197 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -59.04 126.9 29.62 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.835 -1.529 . . . . 0.0 114.391 -170.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 38' ' ' ASP . 33.7 t80 -148.68 133.39 17.86 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.742 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -167.07 30.31 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.078 0 O-C-N 124.141 0.901 . . . . 0.0 109.604 166.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 47.67 41.12 13.22 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 124.049 1.881 . . . . 0.0 112.107 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.787 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 4.6 m-20 -111.42 114.81 52.64 Favored Pre-proline 0 C--N 1.248 -3.845 0 CA-C-N 112.82 -1.991 . . . . 0.0 112.98 176.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.305 14.6 Cg_exo -57.53 -36.06 98.72 Favored 'Trans proline' 0 CA--C 1.48 -2.203 0 CA-C-O 123.948 1.562 . . . . 0.0 109.076 172.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -73.94 -15.87 61.11 Favored 'General case' 1 N--CA 1.344 -5.737 0 CA-C-N 110.626 -2.988 . . . . 0.0 112.403 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.787 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.1 pt-20 -80.85 -30.42 35.66 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.6 mt -66.76 137.22 56.48 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.473 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -82.86 179.86 7.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.453 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.55 -129.73 9.47 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.619 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 144.98 50.49 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 122.757 0.423 . . . . 0.0 110.362 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -113.03 112.26 23.57 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.08 152.54 35.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.229 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.82 108.13 14.01 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -131.96 147.17 52.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.682 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -92.8 140.82 29.12 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.952 0.501 . . . . 0.0 111.368 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -122.14 127.4 50.04 Favored 'General case' 0 C--O 1.258 1.512 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -85.88 113.95 22.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.81 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -42.35 106.07 0.06 Allowed 'General case' 0 CA--C 1.475 -1.921 0 C-N-CA 125.441 1.496 . . . . 0.0 112.267 172.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -120.34 129.91 54.19 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.623 ' C ' HG12 ' A' ' 89' ' ' ILE . 10.9 m 61.16 -165.22 0.22 Allowed 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -84.57 61.03 6.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.636 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.41 -121.0 1.05 Allowed Glycine 0 N--CA 1.406 -3.313 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.284 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 87' ' ' ILE . 76.4 m-85 -135.28 -101.02 0.22 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.921 -1.14 . . . . 0.0 112.032 -168.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.26 57.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.518 ' HA ' HG23 ' A' ' 47' ' ' VAL . 50.7 p90 -160.55 143.58 13.28 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -101.35 135.31 43.04 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 117.792 -1.563 . . . . 0.0 109.932 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 159' ' ' THR . 11.3 p -126.0 143.42 39.57 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.516 -170.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 5.7 m -115.65 132.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.837 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 156' ' ' ARG . . . 127.22 -144.36 15.02 Favored Glycine 0 C--N 1.277 -2.727 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.264 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.561 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.76 63.52 2.48 Favored Glycine 0 CA--C 1.457 -3.592 0 O-C-N 126.483 1.931 . . . . 0.0 111.946 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 76' ' ' THR . 8.5 t70 -105.18 -42.48 5.27 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.322 -0.939 . . . . 0.0 108.514 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.1 pt-20 -160.03 172.61 5.75 Favored Pre-proline 0 CA--C 1.472 -2.026 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.324 -170.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 18.7 Cg_exo -76.01 64.53 6.91 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.152 3.235 . . . . 0.0 108.57 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . 28.1 t0 -172.83 -47.27 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 111.789 -2.46 . . . . 0.0 107.373 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' B' ' 154' ' ' ARG . 6.2 tp10 -105.11 119.32 38.75 Favored 'General case' 0 C--O 1.273 2.335 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.12 166.22 12.45 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 128.682 2.793 . . . . 0.0 108.905 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.561 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.1 mp -96.37 145.87 25.25 Favored 'General case' 0 C--O 1.172 -3.016 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.421 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 40.4 tt0 -139.78 144.34 37.34 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 118.488 0.586 . . . . 0.0 110.093 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.2 mp -81.82 118.42 29.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 O-C-N 121.913 -0.492 . . . . 0.0 109.683 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -98.75 -24.39 15.04 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.432 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -152.37 127.99 10.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.644 -0.66 . . . . 0.0 109.673 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 60' ' ' THR . 3.0 pp -86.97 116.51 25.08 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 29' ' ' PHE . 67.0 t -87.91 134.73 27.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.273 -173.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 95.7 mt -60.24 142.54 54.39 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.7 t70 79.87 3.42 2.06 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.784 1.302 . . . . 0.0 110.558 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -95.05 155.74 21.57 Favored Glycine 0 CA--C 1.489 -1.571 0 CA-C-O 118.362 -1.243 . . . . 0.0 110.45 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.627 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 18.1 Cg_endo -71.89 -25.64 19.71 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 CA-C-N 120.931 2.365 . . . . 0.0 111.062 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.8 97.12 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.9 74.45 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.542 1.163 . . . . 0.0 109.954 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 79.7 mt -71.58 -40.3 70.0 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-N 112.933 -1.94 . . . . 0.0 114.165 -172.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.77 -24.58 58.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.94 -3.98 11.49 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.997 -1.456 . . . . 0.0 115.893 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -94.08 -42.58 8.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.431 ' HG3' HD11 ' A' ' 97' ' ' LEU . 22.5 ttt -82.12 133.84 35.29 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -139.76 168.74 19.12 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.094 0.949 . . . . 0.0 112.073 -169.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.459 ' H ' HD23 ' A' ' 46' ' ' LEU . 20.7 m -64.16 126.23 27.08 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.383 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.09 -9.93 12.01 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.618 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 18.9 m-20 -78.37 144.17 36.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.327 0.1 OUTLIER -115.48 119.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.544 0.688 . . . . 0.0 111.094 171.086 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 43' ' ' ILE . 40.7 mm -68.67 113.76 4.77 Favored 'Isoleucine or valine' 0 C--O 1.299 3.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.215 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG13 HD13 ' A' ' 73' ' ' LEU . 87.6 t -102.39 -54.96 6.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 112.254 -2.248 . . . . 0.0 110.203 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.9 t -143.65 158.22 43.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.388 -0.82 . . . . 0.0 110.213 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.15 112.1 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.03 0.443 . . . . 0.0 111.641 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.425 ' HB2' HG12 ' A' ' 93' ' ' VAL . 2.3 t30 71.24 -66.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.137 1.375 . . . . 0.0 111.875 175.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.66 -37.61 0.1 Allowed 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.844 1.658 . . . . 0.0 109.035 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -67.71 127.69 33.7 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.781 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.3 t -85.69 90.3 7.98 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.526 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 9.7 p -80.26 4.09 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 122.701 1.239 . . . . 0.0 109.928 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.641 HD13 HG13 ' A' ' 65' ' ' VAL . 19.6 tp -67.43 111.79 4.27 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.563 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.78 37.54 88.74 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.528 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -82.49 148.22 28.25 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 83.2 m -78.77 143.22 36.32 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.776 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 83.2 t60 -47.26 -50.55 21.15 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.288 0.949 . . . . 0.0 113.096 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.12 74.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.845 0.716 . . . . 0.0 110.702 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 34.3 mm-40 -75.68 -50.41 15.49 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 41' ' ' LEU . 7.0 p -62.02 -45.25 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.667 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.57 -36.0 76.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.416 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -59.08 -47.88 83.62 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.486 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -72.46 -49.96 38.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.385 0 CA-C-O 122.18 0.991 . . . . 0.0 110.121 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HB3' HG11 ' B' ' 161' ' ' VAL . 7.2 m-85 -61.41 -40.44 94.42 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.529 -1.668 . . . . 0.0 113.141 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.63 -14.07 46.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -91.76 -2.21 57.05 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.119 0.485 . . . . 0.0 110.824 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.753 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.2 mt -53.35 140.51 44.97 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.051 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 83.6 Cg_endo -97.82 150.78 0.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.618 2.879 . . . . 0.0 113.042 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.623 HG12 ' C ' ' A' ' 24' ' ' SER . 23.6 mt -67.59 135.89 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.432 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.6 12.43 58.23 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.222 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -108.5 -170.63 1.71 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.147 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.409 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.0 t -150.04 142.17 24.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.81 HG22 ' HE3' ' A' ' 22' ' ' LYS . 27.4 m -145.51 155.35 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.818 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.775 173.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.05 113.81 27.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 124.929 1.393 . . . . 0.0 109.197 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.7 mm? -91.12 120.32 31.97 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 20.4 mt-10 -98.71 110.21 22.84 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.431 HD11 ' HG3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.49 156.52 45.74 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.046 -170.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 63.3 m -109.99 125.91 53.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.606 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 tpp85 -102.82 153.52 20.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.98 -5.77 7.84 Favored Glycine 0 CA--C 1.486 -1.72 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.938 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -89.16 113.45 56.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 13.0 Cg_exo -72.28 150.21 52.58 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.065 1.843 . . . . 0.0 109.796 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -96.47 103.99 16.15 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 86.2 Cg_endo -86.7 26.38 0.63 Allowed 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.122 2.548 . . . . 0.0 114.039 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.444 ' O ' HD12 ' A' ' 103' ' ' LEU . 52.1 p90 -162.04 169.43 21.02 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 23.9 t70 -91.27 130.97 37.93 Favored Pre-proline 0 CA--C 1.474 -1.974 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 174.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 18.0 Cg_endo -103.73 7.2 0.34 Allowed 'Trans proline' 0 N--CA 1.413 -3.216 0 C-N-CA 123.249 2.632 . . . . 0.0 111.303 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.8 -36.8 14.92 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.26 131.27 80.83 Favored Pre-proline 0 N--CA 1.442 -0.864 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.413 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.262 0.0 OUTLIER -37.18 89.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.359 1 C-N-CA 126.04 4.493 . . . . 0.0 117.22 176.503 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -126.9 86.24 2.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 118.054 -1.458 . . . . 0.0 110.297 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.0 t -80.4 -177.07 6.0 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.264 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 114.06 6.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.715 0.769 . . . . 0.0 112.987 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' B' ' 155' ' ' THR . 0.0 OUTLIER -77.05 115.45 16.86 Favored 'General case' 0 N--CA 1.399 -3.011 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 166.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HA ' HG22 ' B' ' 155' ' ' THR . 11.6 p -112.01 122.34 66.13 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -165.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 t -97.01 144.29 27.05 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.9 m -149.91 143.17 25.09 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.081 0.467 . . . . 0.0 110.132 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.08 101.22 12.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.35 72.83 5.97 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.15 0.976 . . . . 0.0 110.44 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.6 mm -143.15 -35.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' A' ' 123' ' ' LYS . 90.1 mt -89.48 -177.09 5.24 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.791 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -80.33 90.01 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -36.09 114.74 0.3 Allowed 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 112.471 -178.686 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 11.1 tp10 -89.08 117.33 68.14 Favored Pre-proline 0 C--N 1.286 -2.181 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.027 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 12.3 Cg_exo . . . . . 0 C--N 1.351 0.664 0 C-N-CA 123.156 2.57 . . . . 0.0 112.802 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 1' ' ' LYS . 94.4 mtt180 . . . . . 0 C--O 1.212 -0.92 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 40.5 m -155.58 -32.37 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.459 1.027 . . . . 0.0 113.384 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 18.0 m -82.53 121.76 27.19 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 121.457 0.646 . . . . 0.0 112.171 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.42 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 45.8 mmt-85 -130.64 42.93 3.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 17.0 p -63.38 -48.27 78.6 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.835 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.45 ' HA ' ' HA2' ' A' ' 33' ' ' GLY 0.348 9.6 ptp180 50.07 95.47 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 176.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 13.4 mmt180 -81.89 156.4 24.82 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.102 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 158' ' ' GLU . 0.1 OUTLIER -95.49 83.34 3.79 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.182 0.991 . . . . 0.0 110.714 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.537 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.4 m -75.83 107.82 8.27 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -88.95 93.94 9.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.704 -0.622 . . . . 0.0 110.629 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 m . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.717 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.623 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -142.6 141.25 31.93 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' MET . . . . . 0.412 ' HA ' ' HE2' ' A' ' 1' ' ' LYS . 24.1 mmt 64.69 33.38 10.55 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.374 1.069 . . . . 0.0 113.599 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -97.91 43.5 1.94 Allowed Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' -1' ' ' MET . 0.0 OUTLIER -111.79 143.5 28.76 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.86 145.68 32.31 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.609 -1.727 . . . . 0.0 107.609 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -68.3 117.73 10.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 112.2 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 32.5 t80 -147.5 134.56 20.36 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.303 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 8.8 t -173.92 41.29 0.01 OUTLIER 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 124.32 1.013 . . . . 0.0 109.605 168.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 5' ' ' THR . 10.2 ptm180 56.02 13.47 1.16 Allowed 'General case' 0 N--CA 1.516 2.842 0 C-N-CA 126.423 1.889 . . . . 0.0 113.653 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.7 m-80 -93.8 115.03 64.59 Favored Pre-proline 0 C--N 1.251 -3.712 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.288 10.8 Cg_exo -62.06 -29.69 81.71 Favored 'Trans proline' 0 CA--C 1.475 -2.444 0 N-CA-C 108.019 -1.57 . . . . 0.0 108.019 170.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 t -69.79 -25.68 63.91 Favored 'General case' 1 N--CA 1.354 -5.255 0 CA-C-N 111.271 -2.695 . . . . 0.0 110.962 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.0 pt-20 -78.27 -31.26 48.96 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 86.9 mt -63.01 133.92 55.35 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.547 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 176.08 6.72 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.803 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.23 -116.19 5.44 Favored Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.324 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.4 156.42 48.21 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -122.07 112.47 18.28 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -119.85 152.22 22.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-O 121.209 0.528 . . . . 0.0 110.737 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.605 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.3 t-160 -133.26 99.64 4.6 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 14.9 t -126.27 142.09 51.66 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.677 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -86.84 133.36 33.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.019 0.928 . . . . 0.0 111.637 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -115.45 127.34 55.26 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -88.06 103.94 16.19 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.687 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.53 118.23 1.03 Allowed 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 19.3 t -92.51 -137.05 0.17 Allowed 'General case' 0 N--CA 1.403 -2.785 0 O-C-N 126.104 2.128 . . . . 0.0 106.717 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -63.84 83.29 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.505 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 60.69 27.99 17.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.395 1.878 . . . . 0.0 112.009 174.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.45 -139.48 5.41 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.69 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.601 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.7 m-85 -124.66 -87.84 0.61 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.92 52.54 0.11 Allowed Glycine 0 C--N 1.295 -1.72 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.037 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 42.2 p90 -160.96 141.94 11.61 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 172.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.6 p -107.62 138.04 44.57 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 41' ' ' LEU . 19.3 m -124.89 159.29 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -167.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.9 m -115.87 133.7 61.48 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 C-N-CA 124.516 1.127 . . . . 0.0 109.968 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' B' ' 156' ' ' ARG . . . 116.18 -143.91 18.24 Favored Glycine 0 C--N 1.278 -2.689 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.467 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.77 58.09 4.34 Favored Glycine 0 CA--C 1.452 -3.87 0 O-C-N 126.115 1.714 . . . . 0.0 111.228 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD2' ' HG2' ' B' ' 157' ' ' ARG . 6.3 t70 -102.67 -35.49 8.67 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.328 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.9 pt-20 -158.45 168.44 12.44 Favored Pre-proline 0 CA--C 1.469 -2.151 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.404 -169.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -75.94 58.18 5.39 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 124.298 3.332 . . . . 0.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.546 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 6.1 t70 -170.81 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 112.085 -2.325 . . . . 0.0 106.732 -173.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.42 118.73 34.55 Favored 'General case' 0 C--O 1.272 2.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.279 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.18 165.96 13.65 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 127.976 2.51 . . . . 0.0 108.348 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.9 mp -95.76 144.38 26.2 Favored 'General case' 0 C--O 1.175 -2.858 0 C-N-CA 118.506 -1.277 . . . . 0.0 109.639 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 36.5 tt0 -130.1 156.28 44.8 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' A' ' 29' ' ' PHE . 12.6 mm -90.01 127.27 42.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.67 -19.86 13.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.509 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.0 m -155.73 127.28 7.3 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 tp -83.14 114.96 21.69 Favored 'General case' 0 N--CA 1.402 -2.84 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.493 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 58.4 t -86.99 122.71 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.19 146.17 50.93 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 84.37 3.03 0.79 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.489 1.743 . . . . 0.0 109.795 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.658 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -86.91 158.98 31.06 Favored Glycine 0 C--O 1.207 -1.579 0 CA-C-O 117.872 -1.516 . . . . 0.0 109.576 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.6 Cg_endo -72.59 -25.17 17.92 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 CA-C-N 121.725 2.762 . . . . 0.0 110.633 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.38 -42.2 98.83 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.241 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.36 82.12 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.668 1.223 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 82.6 mt -71.67 -44.74 63.73 Favored 'General case' 0 N--CA 1.405 -2.715 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.517 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.16 -19.61 50.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.36 1.076 . . . . 0.0 108.242 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.98 27.92 65.39 Favored Glycine 0 CA--C 1.48 -2.097 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.593 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 26.4 tptp -102.06 -13.08 17.66 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.331 -173.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.619 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 67.5 mtp -123.11 144.31 49.4 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.43 141.39 25.9 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -45.16 114.14 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.726 1.21 . . . . 0.0 111.332 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.6 -18.77 5.12 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.461 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CB ' HD12 ' A' ' 97' ' ' LEU . 5.0 m-20 -60.64 146.51 45.2 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.288 1.2 p -117.87 116.18 50.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.964 174.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.08 120.02 25.25 Favored 'Isoleucine or valine' 0 C--O 1.284 2.882 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.692 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.434 HG11 ' HG3' ' A' ' 8' ' ' PRO . 37.4 t -99.12 -34.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-N 112.334 -2.212 . . . . 0.0 110.138 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -170.62 169.49 7.16 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 95' ' ' LEU . 6.9 p -155.17 115.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 63.3 t30 37.43 76.59 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.14 1.776 . . . . 0.0 113.918 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 70.89 -18.93 0.24 Allowed 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.76 122.53 33.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.39 77.2 8.29 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 122.023 0.916 . . . . 0.0 110.134 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.94 -0.91 4.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.426 1.108 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 6' ' ' ARG . 30.7 tp -59.04 110.52 1.06 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 170.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.59 48.77 84.54 Favored Glycine 0 N--CA 1.431 -1.641 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.298 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -89.17 141.14 28.78 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.541 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 24.0 m -74.04 144.09 45.22 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.247 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.431 ' HA ' HG12 ' A' ' 80' ' ' VAL . 73.2 t60 -46.72 -47.54 20.53 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.135 0.879 . . . . 0.0 113.103 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.901 0.857 . . . . 0.0 111.081 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 79.2 mm-40 -78.51 -49.75 12.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.651 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 41' ' ' LEU . 12.7 p -64.46 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.93 -44.64 98.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -72.79 -27.04 61.75 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.27 -1.372 . . . . 0.0 113.276 -175.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -73.02 -51.21 27.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 122.03 0.919 . . . . 0.0 109.003 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.46 -39.09 92.3 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.703 -1.59 . . . . 0.0 112.755 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' B' ' 161' ' ' VAL . 14.2 mm100 -85.65 -20.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -96.17 4.96 52.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.211 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.687 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 3.1 mt -48.47 147.08 4.35 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.302 1.041 . . . . 0.0 112.709 170.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -94.27 150.56 2.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.246 2.631 . . . . 0.0 111.436 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.505 HG12 ' H ' ' A' ' 25' ' ' ARG . 24.8 mt -68.75 143.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.305 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.52 12.06 70.4 Favored Glycine 0 CA--C 1.497 -1.052 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.483 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.71 -176.34 3.71 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.274 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.556 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.7 t -147.03 142.68 27.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.255 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 4.7 m -151.98 144.24 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 O-C-N 124.2 0.938 . . . . 0.0 111.002 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 2.5 m-20 -97.79 117.73 32.76 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.696 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 3.2 mm? -90.67 121.98 33.05 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -91.05 108.18 19.7 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.577 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -141.61 147.74 38.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.062 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.28 136.77 44.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.841 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 18.4 tpp85 -114.08 149.98 34.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.24 3.95 6.61 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' A' ' 11' ' ' LEU . 65.3 m-85 -107.44 142.35 24.94 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 122.788 0.435 . . . . 0.0 111.389 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 68.9 Cg_endo -90.72 179.0 1.85 Allowed 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.453 2.102 . . . . 0.0 109.303 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 92.15 3.45 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 93.3 Cg_endo -88.6 40.89 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.414 2.743 . . . . 0.0 111.325 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -168.23 145.94 4.21 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.5 t70 -108.26 132.09 21.32 Favored Pre-proline 0 CA--C 1.475 -1.936 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 19.2 Cg_endo -103.07 5.84 0.39 Allowed 'Trans proline' 0 N--CA 1.413 -3.236 0 C-N-CA 123.422 2.748 . . . . 0.0 111.282 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -100.53 -34.72 9.8 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.07 143.18 72.9 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.279 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -37.56 -28.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 1 C-N-CA 126.615 4.877 . . . . 0.0 117.613 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -75.77 81.38 2.72 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-O 121.6 0.714 . . . . 0.0 111.114 -176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.3 t -69.8 -131.28 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.974 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.578 172.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HB3' ' CD ' ' B' ' 157' ' ' ARG . 5.1 p -54.98 133.85 48.61 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.551 0.74 . . . . 0.0 112.434 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' B' ' 155' ' ' THR . 48.4 mt -89.65 105.02 17.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.574 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -123.55 107.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 t -79.87 151.44 30.2 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.238 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.3 m -93.88 103.29 15.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.868 0.842 . . . . 0.0 109.94 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 120' ' ' ILE . 6.4 p -133.71 135.07 55.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.96 76.31 7.91 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.651 0.738 . . . . 0.0 112.424 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 118' ' ' VAL . 49.6 mm -117.17 -56.78 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.8 mt -97.47 140.52 31.78 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.892 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.0 99.55 10.49 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -61.19 134.41 56.98 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.715 1.245 . . . . 0.0 112.695 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -92.8 145.6 30.58 Favored Pre-proline 0 C--N 1.258 -3.381 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.121 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 CA--C 1.547 1.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.919 179.819 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.473 ' HG2' ' H ' ' B' ' 152' ' ' SER 0.266 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.234 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.473 ' H ' ' HG2' ' B' ' 151' ' ' ARG . 16.6 m -78.68 9.54 4.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.701 0.762 . . . . 0.0 112.709 -171.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -81.71 -16.0 52.61 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 124.52 1.128 . . . . 0.0 109.894 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 71.07 -63.0 0.44 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.222 1.409 . . . . 0.0 113.531 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.2 m 67.13 -67.31 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.182 1.393 . . . . 0.0 110.675 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 33' ' ' GLY . 20.8 ttm180 69.22 110.07 0.05 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.545 ' HG2' ' OD2' ' A' ' 35' ' ' ASP . 8.0 mmm180 -111.13 165.66 11.72 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.286 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.2 mp0 -99.63 85.48 3.13 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.042 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 14.3 m -81.44 128.29 33.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.43 ' HA ' HG22 ' A' ' 30' ' ' THR . 50.6 mt-30 -98.47 124.91 43.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.458 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.027 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.94 71.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.958 0.885 . . . . 0.0 108.686 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.1 ptp -123.19 169.37 11.32 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.909 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 88.87 31.83 11.88 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.66 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 135.55 67.57 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.3 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.43 145.96 66.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.514 2.143 . . . . 0.0 109.805 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.95 135.03 57.67 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.251 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 22.6 t80 -146.88 134.99 21.57 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.936 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.5 t 179.96 39.78 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 O-C-N 125.071 1.482 . . . . 0.0 110.357 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 5' ' ' THR . 31.1 ptt180 54.67 15.53 1.1 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 126.159 1.784 . . . . 0.0 113.559 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.81 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.9 m-80 -94.62 114.22 62.94 Favored Pre-proline 1 C--N 1.242 -4.065 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.269 7.2 Cg_exo -58.36 -29.97 89.78 Favored 'Trans proline' 0 CA--C 1.483 -2.034 0 C-N-CA 121.552 1.501 . . . . 0.0 109.336 170.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -72.99 -25.43 60.98 Favored 'General case' 1 N--CA 1.365 -4.721 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.313 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -76.02 -34.54 59.69 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -55.07 130.61 42.51 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 122.406 1.098 . . . . 0.0 111.748 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.17 170.88 12.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.282 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.67 -109.65 3.05 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.045 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -147.33 145.13 29.22 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 123.082 0.553 . . . . 0.0 110.646 -176.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -110.22 111.45 22.77 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.005 0.907 . . . . 0.0 112.152 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -118.05 99.79 7.12 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -129.69 137.02 50.39 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.562 0.696 . . . . 0.0 111.588 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -73.36 133.54 43.83 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.07 0.948 . . . . 0.0 112.008 -176.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 tp -124.49 134.41 53.04 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -93.66 114.72 27.09 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.555 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -42.71 99.5 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 125.0 1.32 . . . . 0.0 111.099 168.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.3 m -118.48 125.44 49.9 Favored 'General case' 0 N--CA 1.417 -2.092 0 O-C-N 125.527 1.767 . . . . 0.0 107.655 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 58.46 47.7 13.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.777 0.799 . . . . 0.0 111.035 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.546 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.7 mpt_? 84.7 -62.74 0.08 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 126.635 1.974 . . . . 0.0 111.702 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . -100.29 -115.06 3.74 Favored Glycine 0 N--CA 1.406 -3.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.211 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.635 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 81.2 m-85 -129.97 -84.5 0.54 Allowed 'General case' 0 N--CA 1.397 -3.12 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.002 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 134.26 53.86 0.07 OUTLIER Glycine 0 C--N 1.295 -1.73 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.008 -170.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' HD12 ' A' ' 43' ' ' ILE . 44.0 p90 -161.64 142.85 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.517 HG22 ' HB2' ' B' ' 160' ' ' GLN . 76.9 p -104.24 135.12 46.31 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.823 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 159' ' ' THR . 1.0 OUTLIER -115.77 162.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.791 -171.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' B' ' 156' ' ' ARG . 6.8 m -137.0 132.31 47.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 C-N-CA 123.505 0.722 . . . . 0.0 109.237 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' B' ' 156' ' ' ARG . . . 131.91 -147.85 18.84 Favored Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.46 60.64 3.59 Favored Glycine 0 CA--C 1.462 -3.263 0 O-C-N 126.352 1.854 . . . . 0.0 113.085 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -106.03 -24.23 12.44 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 114.348 -0.926 . . . . 0.0 109.148 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 3.0 pt-20 -158.49 172.06 6.63 Favored Pre-proline 0 C--O 1.196 -1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.426 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -67.54 -15.34 44.8 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 123.117 2.545 . . . . 0.0 109.439 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 21.5 t70 -92.6 -24.04 18.83 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.995 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.64 ' OE1' ' HD3' ' B' ' 154' ' ' ARG . 35.3 tt0 -123.22 117.93 26.45 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -84.61 165.54 17.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.253 2.221 . . . . 0.0 108.619 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -91.37 144.72 25.29 Favored 'General case' 0 C--O 1.183 -2.441 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.085 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 16.3 tt0 -128.07 169.49 14.0 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.3 mm -112.9 135.68 51.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 107' ' ' PRO . 21.6 pttp -114.54 -13.64 12.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -159.75 127.98 4.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 3.7 pp -90.92 119.28 30.99 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' H ' ' HA ' ' A' ' 29' ' ' PHE . 92.4 t -75.67 126.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-O 121.142 0.496 . . . . 0.0 109.711 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.63 135.02 56.45 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.4 t70 87.47 2.2 0.41 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 125.422 1.701 . . . . 0.0 110.255 -173.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.39 159.54 37.07 Favored Glycine 0 C--O 1.208 -1.5 0 CA-C-O 118.175 -1.347 . . . . 0.0 110.887 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.635 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -72.46 -25.52 17.96 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 121.307 2.554 . . . . 0.0 110.155 -170.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -67.4 -43.11 82.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.476 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.35 76.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.499 1.143 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 95.2 mt -71.86 -39.7 69.5 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.926 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.97 -17.26 47.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 122.554 1.168 . . . . 0.0 109.773 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.84 46.38 76.44 Favored Glycine 0 CA--C 1.494 -1.233 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.106 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.2 tpmt? -126.9 6.34 6.62 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.588 0.709 . . . . 0.0 110.956 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.613 ' SD ' ' HB1' ' A' ' 52' ' ' ALA . 1.8 tmt? -147.93 150.57 34.3 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 10.8 pt-20 -136.02 166.95 22.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.275 1.036 . . . . 0.0 111.152 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.495 ' N ' HD23 ' A' ' 46' ' ' LEU . 69.0 m -68.75 119.62 13.42 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.39 -25.69 4.77 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.59 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.575 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.2 m-20 -54.99 150.71 9.87 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.179 0.514 . . . . 0.0 111.625 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.267 0.8 OUTLIER -115.15 120.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 175.344 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.4 mm -78.03 119.35 26.7 Favored 'Isoleucine or valine' 0 C--O 1.302 3.82 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.496 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 73' ' ' LEU . 47.9 t -100.63 -52.87 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.112 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 p -164.1 174.06 11.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.683 0.278 . . . . 0.0 111.543 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.95 152.6 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.582 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 10.3 t-20 -26.66 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.526 1.53 . . . . 0.0 112.725 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 t70 85.03 -52.42 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.26 1.824 . . . . 0.0 114.11 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -93.95 127.19 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.384 1.088 . . . . 0.0 113.322 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.15 89.37 5.99 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.605 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.27 9.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 122.408 1.099 . . . . 0.0 109.599 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 6' ' ' ARG . 23.6 tp -64.18 110.19 2.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.89 43.61 87.46 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.979 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.2 150.53 38.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -77.42 143.1 38.87 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.675 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.469 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.0 t60 -47.7 -49.99 26.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.871 0.759 . . . . 0.0 112.191 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.84 75.29 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.829 0.706 . . . . 0.0 110.944 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -76.65 -50.4 13.83 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.881 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 41' ' ' LEU . 7.2 p -63.31 -44.49 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.367 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.9 p -64.79 -36.07 76.66 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.669 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.3 tmmm? -60.63 -45.84 92.52 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.733 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -73.12 -50.32 32.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.394 1.092 . . . . 0.0 109.425 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.29 -28.69 69.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.467 -1.697 . . . . 0.0 113.306 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 15.6 mm-40 -88.19 -17.47 30.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 p -95.63 -4.07 45.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -61.99 154.52 68.3 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.959 0.409 . . . . 0.0 111.212 174.093 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 35.6 Cg_endo -102.86 153.57 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.778 3.652 . . . . 0.0 112.704 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 25' ' ' ARG . 59.9 mt -65.58 128.86 29.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.014 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.4 10.7 33.09 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.613 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.08 177.06 5.2 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.432 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 31.3 t -140.0 150.84 44.93 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 123.427 0.691 . . . . 0.0 110.155 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.8 m -155.55 164.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 124.894 1.278 . . . . 0.0 109.96 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.582 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 14.5 m-20 -107.38 107.7 18.71 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.73 122.19 34.05 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -103.28 110.67 22.73 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' A' ' 62' ' ' ASP . 1.1 pt? -141.51 156.76 45.71 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 84.7 m -111.5 126.41 54.93 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.3 146.11 25.45 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.17 -19.66 2.86 Favored Glycine 0 CA--C 1.491 -1.453 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.825 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -88.88 128.55 51.76 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-O 120.752 0.311 . . . . 0.0 110.82 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -89.42 177.62 2.72 Favored 'Trans proline' 0 N--CA 1.441 -1.614 0 C-N-CA 122.508 2.139 . . . . 0.0 110.59 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -121.59 81.06 39.63 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.78 59.18 1.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.704 2.936 . . . . 0.0 109.192 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -158.83 159.09 34.68 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 12.8 m-20 -82.96 130.78 56.21 Favored Pre-proline 0 CA--C 1.485 -1.554 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.188 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.3 Cg_endo -96.12 11.55 1.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.364 2.709 . . . . 0.0 106.484 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.435 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 27.2 t70 -106.31 -10.48 16.36 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 112.106 -2.315 . . . . 0.0 108.926 -175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -99.61 108.91 53.34 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.11 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 108' ' ' ASP . 17.4 Cg_exo -83.18 -140.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 124.177 3.251 . . . . 0.0 112.914 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 67.7 m-20 100.33 -72.88 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 128.706 2.802 . . . . 0.0 114.137 169.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -178.29 172.46 1.53 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' B' ' 157' ' ' ARG . 69.2 m -93.77 109.99 21.64 Favored 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.583 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -75.31 136.93 40.85 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.389 177.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.71 106.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.879 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.9 t -96.2 148.72 22.43 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 p -144.77 171.42 14.44 Favored 'General case' 0 C--N 1.26 -3.32 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -94.32 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 123' ' ' LYS . . . -145.8 79.16 1.55 Allowed 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.832 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.1 -30.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.865 1.317 . . . . 0.0 107.656 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -17.06 17.17 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.532 -1.667 . . . . 0.0 111.199 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -155.69 94.61 1.58 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HB3' ' HB1' ' A' ' 119' ' ' ALA . 17.8 pttp -132.59 129.27 38.75 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.94 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.1 OUTLIER -97.46 121.01 59.62 Favored Pre-proline 0 N--CA 1.412 -2.357 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.096 177.302 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 122.879 2.386 . . . . 0.0 112.433 -177.217 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.552 ' HD3' ' H ' ' B' ' 152' ' ' SER . 5.1 tpp180 . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.552 ' H ' ' HD3' ' B' ' 151' ' ' ARG . 17.2 m 82.16 -45.88 0.17 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.497 1.519 . . . . 0.0 110.845 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -87.8 133.15 33.93 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' A' ' 39' ' ' GLU . 10.0 tpp180 -115.28 122.14 45.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 22.2 m -114.6 -51.1 2.76 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.885 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.538 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 69.5 mtp180 61.45 72.04 0.53 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.73 0.776 . . . . 0.0 110.161 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.501 ' HA ' ' OG ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -77.18 127.1 32.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.812 -177.096 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 37.7 tt0 -72.99 110.97 7.68 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.243 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.643 ' HB ' HG22 ' A' ' 31' ' ' VAL . 12.3 m -115.23 97.89 6.46 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.517 ' HB2' HG22 ' A' ' 30' ' ' THR . 4.0 pm0 -76.95 120.4 22.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.6 m . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.547 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -84.38 -46.92 11.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.364 0.602 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 56.4 ttp -132.08 151.54 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . 112.33 14.72 10.38 Favored Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.871 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.428 ' HG2' ' NH2' ' B' ' 151' ' ' ARG . 0.0 OUTLIER -101.91 157.06 34.41 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.12 169.42 13.65 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 122.011 1.808 . . . . 0.0 110.666 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -66.92 134.36 51.87 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.524 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 38' ' ' ASP . 16.3 t80 -146.76 140.11 25.61 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.297 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.361 12.1 t -154.61 -49.04 0.09 Allowed 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.798 161.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.444 ' HB2' HD21 ' A' ' 73' ' ' LEU . 8.7 ptm85 153.88 -29.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 125.64 1.576 . . . . 0.0 107.44 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 21.5 t30 -57.78 114.43 8.43 Favored Pre-proline 0 C--N 1.266 -3.058 0 CA-C-N 112.145 -2.298 . . . . 0.0 114.136 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.259 7.2 Cg_exo -58.86 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.469 -2.737 0 C-N-CA 122.818 2.345 . . . . 0.0 110.666 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.4 m -79.58 -12.65 59.84 Favored 'General case' 1 N--CA 1.348 -5.53 0 CA-C-N 112.464 -2.153 . . . . 0.0 112.257 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -78.45 -35.5 46.7 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -54.52 129.9 37.82 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.693 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -77.14 179.47 6.29 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.372 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.0 -114.84 4.16 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.962 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.59 154.22 46.43 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.084 0.554 . . . . 0.0 110.289 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -119.43 115.62 24.46 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.04 140.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.599 0.714 . . . . 0.0 111.234 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.737 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.1 t60 -124.77 99.59 6.23 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -112.8 133.62 54.71 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.562 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 92' ' ' SER . 0.6 OUTLIER -75.68 137.27 40.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -125.95 121.59 33.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -77.91 123.06 26.31 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.764 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -52.1 108.33 0.28 Allowed 'General case' 0 CA--C 1.471 -2.085 0 C-N-CA 123.905 0.882 . . . . 0.0 112.151 174.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.1 t -83.49 -148.38 0.09 Allowed 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 126.754 2.534 . . . . 0.0 108.389 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -61.62 76.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.7 mmt180 67.04 48.08 1.29 Allowed 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.43 1.11 . . . . 0.0 110.938 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.92 -123.05 1.45 Allowed Glycine 0 N--CA 1.4 -3.732 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.679 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.695 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.8 m-85 -130.47 -83.99 0.53 Allowed 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.068 -1.066 . . . . 0.0 110.637 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.78 49.89 0.12 Allowed Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.239 -171.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.494 ' HA ' HG23 ' A' ' 47' ' ' VAL . 28.4 p90 -161.35 142.72 11.52 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' HA ' ' B' ' 160' ' ' GLN . 16.5 p -104.09 136.3 43.98 Favored 'General case' 0 C--N 1.259 -3.352 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 22.9 m -123.6 157.89 29.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 3.2 m -115.35 174.58 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 C-N-CA 125.281 1.432 . . . . 0.0 111.029 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' B' ' 156' ' ' ARG . . . 85.92 -130.4 9.89 Favored Glycine 0 CA--C 1.481 -2.089 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 29.92 59.46 0.2 Allowed Glycine 0 CA--C 1.473 -2.579 0 C-N-CA 127.523 2.487 . . . . 0.0 113.81 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.52 -28.44 7.85 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 114.166 -1.017 . . . . 0.0 108.505 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -158.37 169.97 9.7 Favored Pre-proline 0 CA--C 1.47 -2.111 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.959 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 57.6 Cg_exo -61.91 -26.54 79.08 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.459 2.106 . . . . 0.0 109.6 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.445 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 18.6 t70 -75.47 -29.95 59.77 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 112.504 -2.135 . . . . 0.0 111.729 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -122.11 119.09 30.31 Favored 'General case' 0 C--O 1.27 2.165 0 O-C-N 121.77 -0.581 . . . . 0.0 110.739 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 22.8 m-85 -85.97 166.11 16.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.941 2.496 . . . . 0.0 109.547 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.792 HD21 HG21 ' A' ' 80' ' ' VAL . 6.1 mp -88.33 145.57 25.76 Favored 'General case' 0 C--O 1.178 -2.702 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.846 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.4 tt0 -135.54 158.94 43.13 Favored 'General case' 0 C--O 1.18 -2.569 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 62' ' ' ASP . 18.9 mm -87.95 127.74 40.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.586 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.47 -22.83 13.59 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 48.8 m -155.04 126.94 7.57 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 53' ' ' ALA . 3.2 tm? -83.53 106.39 15.22 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 92.9 t -85.36 135.8 24.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.87 0.843 . . . . 0.0 110.974 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.48 141.7 57.81 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.584 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.7 t70 78.94 4.6 2.38 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.722 1.249 . . . . 0.0 110.903 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.73 159.5 36.44 Favored Glycine 0 C--O 1.201 -1.955 0 CA-C-O 118.085 -1.397 . . . . 0.0 109.897 173.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.48 -24.54 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.825 0 CA-C-N 121.438 2.619 . . . . 0.0 109.678 -173.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.64 78.66 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.405 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -69.06 -48.24 63.26 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.572 1.177 . . . . 0.0 109.289 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 77.8 mt -72.08 -43.59 64.6 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 112.461 -2.154 . . . . 0.0 115.558 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' HE3' ' A' ' 57' ' ' LYS . 5.0 t0 -83.26 -20.75 33.92 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -140.89 19.04 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 119.913 -1.136 . . . . 0.0 110.87 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HE3' ' OD1' ' A' ' 55' ' ' ASP 0.344 0.0 OUTLIER 53.36 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.472 1.909 . . . . 0.0 115.42 -176.704 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.424 ' HE1' HD23 ' A' ' 95' ' ' LEU . 39.8 ttm -68.83 141.37 55.15 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 109.282 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -151.0 144.47 24.92 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 m -45.38 114.73 0.79 Allowed 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 124.635 1.209 . . . . 0.0 110.869 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.3 -30.42 3.03 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 43' ' ' ILE 0.375 0.9 OUTLIER -69.16 143.29 54.12 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.669 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -103.2 118.27 49.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.131 -174.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 mt -74.9 123.24 30.14 Favored 'Isoleucine or valine' 1 C--O 1.307 4.101 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG13 HD13 ' A' ' 73' ' ' LEU . 58.5 t -99.9 -45.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 111.498 -2.592 . . . . 0.0 110.105 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -160.27 170.67 20.62 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.356 -0.84 . . . . 0.0 112.016 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.93 112.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.184 0.516 . . . . 0.0 112.109 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 65.9 -48.04 0.4 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.489 2.316 . . . . 0.0 115.57 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.49 -39.86 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 125.605 1.562 . . . . 0.0 109.347 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.408 HG21 HD13 ' A' ' 83' ' ' ILE . 6.7 m -71.44 134.35 46.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.625 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.2 t -84.28 84.44 7.63 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.541 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -86.27 17.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 123.763 1.744 . . . . 0.0 109.796 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 65' ' ' VAL . 12.5 tp -71.72 110.83 6.53 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.48 -1.691 . . . . 0.0 106.459 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 61.46 36.72 92.97 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.998 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -77.16 128.29 34.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 36.9 m -62.58 145.82 53.45 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.208 0.943 . . . . 0.0 110.439 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -45.59 -51.42 12.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.189 0.596 . . . . 0.0 112.47 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.97 78.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 124.299 0.999 . . . . 0.0 110.538 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 74.5 mm-40 -76.03 -50.15 15.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.318 -175.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.792 HG21 HD21 ' A' ' 41' ' ' LEU . 14.5 p -65.06 -42.24 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.827 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.85 -36.38 76.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -62.15 -41.5 98.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.243 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 70' ' ' THR . 75.7 mt -73.0 -50.41 32.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 122.502 1.144 . . . . 0.0 109.717 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 7.5 m-85 -66.65 -35.59 80.54 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.446 -1.707 . . . . 0.0 112.969 -174.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -85.58 -13.51 48.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.2 t -77.73 -23.75 49.3 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.612 HD12 ' CE2' ' A' ' 27' ' ' PHE . 2.0 mt -48.37 136.62 12.13 Favored Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 86.0 Cg_endo -99.13 153.45 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.212 3.274 . . . . 0.0 112.398 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 25' ' ' ARG . 41.1 mt -68.6 140.59 18.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.107 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.51 12.31 61.28 Favored Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.012 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.9 -169.77 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.501 -171.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 11.1 p -149.27 138.46 21.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -169.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.764 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.3 m -145.56 156.13 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.737 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 31.7 m-20 -99.46 106.96 19.06 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.424 HD23 ' HE1' ' A' ' 58' ' ' MET . 9.8 tp -95.96 125.94 40.85 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.015 0.436 . . . . 0.0 110.942 -174.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -107.74 115.2 29.72 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.639 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.21 157.68 44.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.235 0.541 . . . . 0.0 111.382 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.0 m -117.89 140.01 50.32 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.717 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.0 tpp85 -110.08 132.22 54.36 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.97 -30.21 0.14 Allowed Glycine 0 C--N 1.296 -1.671 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -93.65 141.6 24.04 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.57 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 43.3 Cg_endo -96.95 -162.88 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.953 2.436 . . . . 0.0 109.151 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.65 85.87 3.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 80.9 Cg_endo -91.79 50.96 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.492 2.795 . . . . 0.0 114.039 -170.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -172.95 164.26 4.97 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 4.4 m-20 -99.37 132.54 23.11 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.0 Cg_exo -92.74 0.45 3.79 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.136 2.557 . . . . 0.0 108.21 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.43 -27.51 63.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.995 -1.911 . . . . 0.0 109.04 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -83.58 131.02 53.69 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.35 -166.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.571 2.847 . . . . 0.0 114.869 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 88.69 131.47 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 127.483 2.313 . . . . 0.0 110.651 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -67.69 -133.66 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.808 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' B' ' 157' ' ' ARG . 4.9 m -72.85 99.26 2.62 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.664 -1.272 . . . . 0.0 109.279 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -93.64 132.99 37.44 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.828 175.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.42 131.48 39.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-O 120.974 0.416 . . . . 0.0 109.886 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 t -133.83 146.01 50.24 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.0 t -97.11 121.56 39.13 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.37 103.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.432 ' HA ' ' HA3' ' A' ' 0' ' ' GLY . . . -130.78 74.47 1.6 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.66 0.743 . . . . 0.0 109.056 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.2 mm -83.9 -55.77 6.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 122' ' ' ASP 0.449 4.3 pp 71.42 -56.51 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 165.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.459 ' N ' HD12 ' A' ' 121' ' ' LEU . 17.1 t70 -174.52 128.77 0.34 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.95 90.95 3.43 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.297 0.57 . . . . 0.0 111.156 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.47 142.73 24.99 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.273 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 122.413 2.075 . . . . 0.0 112.479 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.428 ' NH2' ' HG2' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -162.52 29.74 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.919 0.781 . . . . 0.0 112.781 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 62.7 m 57.05 43.26 24.67 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.136 0.97 . . . . 0.0 112.582 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -122.54 128.05 50.27 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 23.8 m 68.09 53.09 0.64 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -113.4 152.01 30.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.763 -171.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.631 ' C ' ' HD2' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -124.52 173.29 8.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 43.8 mt-10 -105.36 151.12 24.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 111.072 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -150.49 119.55 6.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.537 ' HA ' HG22 ' A' ' 30' ' ' THR . 29.3 tt0 -84.07 130.53 34.86 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 27' ' ' PHE . 10.7 m . . . . . 0 N--CA 1.407 -2.611 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -142.7 31.79 1.45 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.632 0.729 . . . . 0.0 109.566 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.37 60.06 5.87 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.659 0.742 . . . . 0.0 111.629 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -103.29 40.32 2.48 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.77 150.2 43.0 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.32 135.46 22.56 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.275 1.316 . . . . 0.0 110.755 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' HE2' ' HA ' ' A' ' 11' ' ' LEU . 30.5 p90 -101.91 130.5 48.43 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.381 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -146.97 143.03 28.15 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.881 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.355 12.9 t -157.67 -44.79 0.06 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.261 162.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.513 ' HB2' HD21 ' A' ' 73' ' ' LEU . 15.6 ptm180 152.77 -19.45 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 126.667 1.987 . . . . 0.0 108.379 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.815 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 7.9 m120 -66.42 118.46 53.87 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -171.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.307 21.4 Cg_exo -62.48 -35.87 69.01 Favored 'Trans proline' 0 CA--C 1.467 -2.844 0 N-CA-C 107.734 -1.679 . . . . 0.0 107.734 172.257 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m -66.78 -23.64 66.1 Favored 'General case' 1 N--CA 1.333 -6.297 0 CA-C-N 109.925 -3.307 . . . . 0.0 112.236 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.815 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.7 pt-20 -79.48 -30.9 42.24 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.1 mt -59.12 133.95 56.56 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.385 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -81.26 168.57 18.33 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.453 -1.703 . . . . 0.0 113.887 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 90.85 -114.61 4.49 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.61 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.594 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -140.8 146.51 37.72 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.551 1.14 . . . . 0.0 110.118 -178.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -113.56 116.91 30.26 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 154.47 40.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 123.403 0.681 . . . . 0.0 112.358 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.1 p-80 -126.71 112.5 15.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.263 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 58' ' ' MET . 7.5 t -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.308 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -85.07 136.61 33.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -124.66 129.04 49.77 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 69.9 ttt180 -86.95 112.64 22.0 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.1 mptp? -36.12 111.26 0.13 Allowed 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 125.225 1.41 . . . . 0.0 111.579 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -89.0 -143.19 0.14 Allowed 'General case' 0 N--CA 1.415 -2.194 0 O-C-N 125.48 1.738 . . . . 0.0 108.186 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -58.89 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.8 mtp180 57.29 40.27 27.91 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 125.474 1.51 . . . . 0.0 112.486 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.75 -130.72 2.21 Favored Glycine 0 N--CA 1.406 -3.313 0 CA-C-N 113.49 -1.686 . . . . 0.0 108.956 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.679 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.4 m-85 -134.61 -75.58 0.46 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.07 46.53 0.2 Allowed Glycine 0 C--N 1.294 -1.765 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.239 -169.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 45.0 p90 -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 172.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' B' ' 160' ' ' GLN . 69.9 p -108.39 136.23 48.37 Favored 'General case' 0 C--N 1.271 -2.814 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.259 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.646 HG21 HD23 ' A' ' 41' ' ' LEU . 1.1 m -114.9 162.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 11.4 m -125.36 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 115.63 -132.03 10.03 Favored Glycine 0 C--O 1.27 2.4 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.244 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.675 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.95 45.27 7.53 Favored Glycine 0 CA--C 1.458 -3.472 0 C-N-CA 126.245 1.878 . . . . 0.0 112.594 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' B' ' 156' ' ' ARG . 18.6 t70 -95.12 -22.2 18.03 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-O 121.296 0.57 . . . . 0.0 110.612 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 39' ' ' GLU . 7.2 pt-20 -157.28 171.3 7.63 Favored Pre-proline 0 N--CA 1.413 -2.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 -168.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 51.5 Cg_exo -64.02 -36.28 49.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.874 1.716 . . . . 0.0 108.201 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.16 -27.24 66.25 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.982 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 41.0 tt0 -125.5 117.69 24.16 Favored 'General case' 0 C--O 1.267 1.988 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.372 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -84.22 165.26 18.53 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 126.669 2.481 . . . . 0.0 108.25 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.675 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.4 mp -86.43 144.53 27.25 Favored 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.708 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -128.88 164.78 22.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.4 mm -107.04 123.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 118.795 0.725 . . . . 0.0 110.963 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HA ' HD21 ' A' ' 103' ' ' LEU . 17.9 pttm -100.93 -26.69 13.65 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 123.436 0.46 . . . . 0.0 111.954 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 44.3 m -149.87 126.99 11.26 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.646 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.16 113.15 15.84 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 85.0 t -87.04 121.51 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.7 mt -67.4 142.73 56.62 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.33 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 34.9 t70 82.91 5.99 0.87 Allowed 'General case' 0 C--O 1.216 -0.668 0 O-C-N 125.103 1.502 . . . . 0.0 109.579 -172.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -88.81 165.4 33.34 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-O 118.113 -1.382 . . . . 0.0 110.175 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 27.9 Cg_endo -72.41 -25.47 18.17 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.338 2.569 . . . . 0.0 110.547 -170.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -68.66 -37.08 79.36 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.871 175.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.64 65.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 122.81 1.29 . . . . 0.0 109.264 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 81.2 mt -72.4 -46.19 56.35 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.537 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.48 -26.71 58.43 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.89 -165.88 51.43 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 18' ' ' THR . 6.2 ttpm? 72.81 -49.95 0.7 Allowed 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -87.21 133.02 33.7 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.14 166.85 24.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.543 0.687 . . . . 0.0 111.359 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -58.12 129.89 44.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.438 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.86 -6.27 25.76 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.132 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 43' ' ' ILE . 14.8 m-20 -79.91 129.35 34.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 2.7 p -98.11 115.93 39.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.852 173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.3 mm -71.03 113.78 7.9 Favored 'Isoleucine or valine' 0 C--O 1.294 3.432 0 C-N-CA 125.078 1.351 . . . . 0.0 110.669 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.4 t -103.22 -54.72 6.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.687 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.8 t -144.92 160.27 41.58 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.077 -0.389 . . . . 0.0 110.159 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 95' ' ' LEU . 5.3 p -146.31 105.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.454 ' CB ' HG12 ' A' ' 93' ' ' VAL . 27.6 t-20 65.97 -65.58 0.18 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.718 1.607 . . . . 0.0 114.341 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.22 -39.64 0.25 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 124.98 1.312 . . . . 0.0 108.884 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.5 m -70.04 127.33 32.48 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.304 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.2 t -87.26 87.23 7.38 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 66' ' ' SER . 10.1 p -77.11 2.25 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 122.496 1.141 . . . . 0.0 109.591 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 6' ' ' ARG . 22.9 tp -63.75 111.6 2.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.226 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 68.35 27.78 73.59 Favored Glycine 0 N--CA 1.425 -2.073 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.95 138.3 46.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 62.1 m -71.05 143.01 50.86 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.522 ' CG ' ' HA ' ' B' ' 156' ' ' ARG . 51.1 t-80 -49.08 -45.05 42.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -174.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.94 81.37 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.656 0.598 . . . . 0.0 110.471 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 73.4 mm-40 -69.32 -56.0 8.81 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.276 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 41' ' ' LEU . 5.4 p -61.25 -47.36 93.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.611 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.1 p -62.7 -35.9 72.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.618 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -41.18 96.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 123.152 0.283 . . . . 0.0 111.418 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -51.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 122.401 1.096 . . . . 0.0 108.741 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -64.01 -30.26 71.35 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.236 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.611 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 tp-100 -85.96 -23.22 27.01 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.4 p -94.98 2.91 55.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.587 . . . . 0.0 111.511 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.465 HD13 ' HG3' ' A' ' 22' ' ' LYS . 7.0 mt -48.13 143.52 6.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.791 1.236 . . . . 0.0 114.081 173.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 39.8 Cg_endo -95.75 142.86 1.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.632 2.888 . . . . 0.0 110.467 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.566 HG12 ' H ' ' A' ' 25' ' ' ARG . 39.0 mt -68.45 142.97 15.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.835 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.66 72.34 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.068 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -98.65 -171.41 2.11 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.615 -171.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.446 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.7 p -147.85 138.24 22.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -168.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG13 ' HE2' ' A' ' 22' ' ' LYS . 1.3 m -151.24 155.72 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.834 174.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.36 109.76 21.86 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.726 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.9 mm? -90.66 113.72 25.85 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 46.7 mt-10 -92.19 107.83 19.5 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -139.48 153.8 47.6 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 120.926 0.393 . . . . 0.0 110.545 -172.375 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.5 t -113.87 126.73 55.51 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.485 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.594 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 21.5 tpp85 -96.92 137.91 35.28 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.13 1.92 Allowed Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.772 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -79.87 134.91 56.12 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.274 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 83.4 Cg_endo -88.92 175.63 3.5 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.86 1.707 . . . . 0.0 109.643 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER -112.6 86.41 8.45 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 10.5 Cg_endo -85.8 46.31 1.67 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.302 2.668 . . . . 0.0 111.12 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -156.27 176.89 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -103.44 132.36 21.16 Favored Pre-proline 0 C--N 1.288 -2.094 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 16.6 Cg_endo -102.55 5.2 0.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.626 0 C-N-CA 123.495 2.796 . . . . 0.0 110.757 -172.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -96.8 -32.6 12.04 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.516 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -45.82 130.3 6.86 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 126.202 1.801 . . . . 0.0 111.641 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -16.34 -94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.656 1 C-N-CA 127.645 5.563 . . . . 0.0 117.621 -177.854 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.423 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 1.9 m-20 65.2 88.46 0.1 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.904 1.682 . . . . 0.0 112.62 175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -87.32 -158.74 0.46 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.854 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.568 ' HA ' ' CG2' ' B' ' 155' ' ' THR . 9.2 m -70.01 102.05 1.93 Allowed 'General case' 0 N--CA 1.414 -2.256 0 O-C-N 121.937 -0.477 . . . . 0.0 110.591 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' B' ' 155' ' ' THR . 33.5 mt -77.63 105.24 8.67 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.22 132.54 65.48 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-O 121.254 0.55 . . . . 0.0 111.498 -173.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -80.46 142.03 34.67 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.6 p -86.13 91.15 8.34 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.697 0.761 . . . . 0.0 112.162 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -105.14 101.49 12.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.933 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 122' ' ' ASP . . . -135.59 79.71 1.79 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.2 -174.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.03 -14.24 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.72 -19.78 18.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.73 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.542 ' C ' ' HD3' ' A' ' 123' ' ' LYS . 8.6 t70 -88.5 -160.86 0.68 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.96 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.542 ' HD3' ' C ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER 38.99 38.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.852 2.061 . . . . 0.0 113.311 -176.789 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -73.81 111.23 11.4 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.066 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.433 -2.031 0 C-N-CA 122.819 2.346 . . . . 0.0 109.838 174.745 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -95.41 73.34 3.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.5 m -67.88 -87.36 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 43.07 32.64 0.45 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.384 1.088 . . . . 0.0 112.111 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 113' ' ' SER . 0.9 OUTLIER -83.54 -171.19 3.44 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 126.333 1.853 . . . . 0.0 112.026 -175.376 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.522 ' HA ' ' CG ' ' A' ' 77' ' ' HIS . 6.7 ptm180 -152.7 146.43 25.12 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 24.6 mmm180 72.4 -57.78 0.61 Allowed 'General case' 0 C--N 1.37 1.467 0 CA-C-N 120.314 1.416 . . . . 0.0 110.823 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.544 ' HB3' HE22 ' B' ' 160' ' ' GLN . 48.2 mm-40 -80.37 85.61 5.83 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.927 1.291 . . . . 0.0 113.44 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.474 ' HB ' HG22 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.43 93.28 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.544 HE22 ' HB3' ' B' ' 158' ' ' GLU . 2.7 mp0 -82.38 110.05 17.18 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 27' ' ' PHE . 14.2 m . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.477 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 78.52 1.18 2.6 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.676 1.59 . . . . 0.0 114.687 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 95.7 mmm 52.34 62.66 2.58 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.311 1.444 . . . . 0.0 113.846 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -90.43 11.74 70.4 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.22 140.24 22.69 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.88 146.85 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.505 2.137 . . . . 0.0 110.822 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -93.05 128.49 38.95 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.151 0.501 . . . . 0.0 110.629 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -147.46 129.39 15.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.333 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.5 t -166.41 26.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.15 166.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.709 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.3 ptm180 57.21 19.14 4.67 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.921 2.088 . . . . 0.0 112.789 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.75 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.5 m-20 -88.5 114.24 58.84 Favored Pre-proline 1 C--N 1.231 -4.549 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.081 176.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 10.5 Cg_exo -58.0 -29.49 86.92 Favored 'Trans proline' 0 CA--C 1.48 -2.214 0 C-N-CA 121.528 1.485 . . . . 0.0 109.278 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -71.46 -24.27 61.98 Favored 'General case' 1 N--CA 1.366 -4.658 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.671 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.75 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -79.33 -31.62 43.16 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.1 129.74 41.19 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.745 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -80.23 179.19 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.031 -1.895 . . . . 0.0 113.231 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.01 -126.59 8.01 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.845 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -128.54 146.87 50.71 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.91 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.18 116.87 28.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 153.39 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.736 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.649 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.8 t-160 -125.31 111.44 15.19 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 97' ' ' LEU . 12.6 t -128.42 151.49 49.31 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.93 136.34 42.94 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 2.4 mp -117.59 116.48 27.18 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -86.47 106.78 17.72 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.86 117.72 0.53 Allowed 'General case' 0 CA--C 1.472 -2.035 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 25.2 t -87.87 -152.95 0.22 Allowed 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 126.236 2.21 . . . . 0.0 108.306 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.4 ' HA ' HG12 ' A' ' 89' ' ' ILE . 23.2 m -65.61 80.43 0.06 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.588 ' N ' HG12 ' A' ' 89' ' ' ILE . 24.4 mmt180 71.44 73.88 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.47 1.108 . . . . 0.0 111.392 174.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.48 -131.9 10.13 Favored Glycine 0 N--CA 1.405 -3.372 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.886 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.645 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.9 m-85 -129.08 -78.9 0.56 Allowed 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.437 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.608 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.64 55.41 0.18 Allowed Glycine 0 C--N 1.285 -2.265 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -170.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 43' ' ' ILE . 19.3 p90 -162.2 146.5 12.28 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.0 p -108.31 135.04 50.29 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.219 1.009 . . . . 0.0 109.577 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 3.2 p -131.59 144.11 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.96 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.256 -167.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 20.0 m -120.42 132.54 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 124.317 1.047 . . . . 0.0 111.347 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 132.77 -139.19 10.73 Favored Glycine 0 N--CA 1.396 -3.997 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 42.51 44.37 5.2 Favored Glycine 0 C--O 1.18 -3.278 0 O-C-N 125.898 1.587 . . . . 0.0 110.184 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.666 ' OD2' ' HB2' ' B' ' 156' ' ' ARG . 15.9 t70 -82.44 -41.97 19.15 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 113.252 -1.474 . . . . 0.0 107.875 -172.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 4.1 pt-20 -160.28 170.88 7.89 Favored Pre-proline 0 CA--C 1.48 -1.712 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -73.74 59.08 4.12 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 124.49 3.46 . . . . 0.0 108.842 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t70 -166.88 -39.46 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 111.871 -2.422 . . . . 0.0 108.257 -172.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 37.2 tt0 -122.21 122.23 38.67 Favored 'General case' 0 C--O 1.27 2.147 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.978 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.28 166.06 14.02 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 128.673 2.789 . . . . 0.0 109.937 -174.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -90.39 144.81 25.46 Favored 'General case' 0 C--O 1.168 -3.221 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.184 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 2.6 tt0 -138.53 145.33 40.59 Favored 'General case' 0 C--O 1.185 -2.34 0 CA-C-N 118.67 0.668 . . . . 0.0 109.575 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 29' ' ' PHE . 37.0 mm -88.27 121.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.99 0 O-C-N 121.477 -0.765 . . . . 0.0 111.855 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 107' ' ' PRO . 46.5 mtmt -101.39 -19.35 15.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.889 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 58.5 m -150.47 127.3 11.02 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.185 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 tp -84.02 109.15 17.42 Favored 'General case' 0 N--CA 1.386 -3.636 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.608 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.5 t -83.05 121.57 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.64 150.42 48.77 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.396 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 76.47 12.13 2.63 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 125.012 1.445 . . . . 0.0 109.59 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.45 160.83 27.06 Favored Glycine 0 C--O 1.201 -1.962 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.671 171.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 3.8 Cg_endo -71.97 -25.21 19.9 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 CA-C-N 121.672 2.736 . . . . 0.0 109.931 -172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 58' ' ' MET . . . -62.85 -45.15 93.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.99 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.29 -45.51 80.14 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.367 1.079 . . . . 0.0 110.432 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.7 mt -72.18 -35.69 69.06 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.795 -172.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.7 t70 -83.57 -23.83 31.82 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.67 69.57 Favored Glycine 0 CA--C 1.492 -1.351 0 CA-C-N 113.219 -1.809 . . . . 0.0 113.287 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -99.72 -15.62 18.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.963 -0.618 . . . . 0.0 111.142 -173.481 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.548 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 35.5 ttm -122.98 139.73 53.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB2' ' HE ' ' A' ' 99' ' ' ARG . 34.9 mt-10 -147.41 164.0 34.72 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.478 0.656 . . . . 0.0 109.469 -175.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 44' ' ' LYS . 8.5 m -54.2 117.91 3.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.914 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.94 -1.67 9.19 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.583 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.621 ' CG ' HD12 ' A' ' 97' ' ' LEU . 1.2 p30 -102.25 156.61 17.46 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.664 -0.903 . . . . 0.0 112.667 172.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -113.18 122.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.748 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.05 116.69 19.44 Favored 'Isoleucine or valine' 0 C--O 1.304 3.964 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.14 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 73' ' ' LEU . 47.6 t -99.4 -53.84 7.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.758 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.413 ' HA ' HG12 ' A' ' 72' ' ' VAL . 50.4 m -143.44 161.83 37.39 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.131 -0.981 . . . . 0.0 112.189 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.6 p -142.19 97.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.896 0.855 . . . . 0.0 112.501 -175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 93' ' ' VAL . 41.8 t-20 65.12 -84.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.769 1.628 . . . . 0.0 112.918 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.34 -7.23 3.77 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.295 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.448 ' HB ' HG13 ' A' ' 67' ' ' VAL . 77.5 m -98.72 133.16 43.44 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.479 0.657 . . . . 0.0 109.336 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 t -87.65 82.79 7.31 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.514 ' HB ' HG12 ' A' ' 67' ' ' VAL . 9.9 p -75.81 -3.08 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.774 1.274 . . . . 0.0 109.471 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 6' ' ' ARG . 22.4 tp -64.23 111.03 2.41 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.384 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 38.87 96.76 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.644 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.44 149.92 31.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.7 m -73.24 141.92 47.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.565 ' HB2' ' HB3' ' B' ' 156' ' ' ARG . 39.6 t-80 -52.89 -47.89 67.57 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 118.893 0.77 . . . . 0.0 112.026 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.75 -35.4 68.57 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -76.2 -50.47 14.42 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.277 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 77' ' ' HIS . 6.6 p -61.12 -44.42 98.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 123.312 0.382 . . . . 0.0 111.531 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.8 p -64.02 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.686 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.9 tmmm? -58.27 -42.86 87.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.52 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -72.89 -51.04 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.32 1.057 . . . . 0.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -65.01 -30.58 71.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 113.506 -1.679 . . . . 0.0 113.51 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.95 -22.76 27.22 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 122.112 -0.368 . . . . 0.0 111.88 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.0 m -79.33 -14.82 58.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.808 0.337 . . . . 0.0 110.95 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 22' ' ' LYS . 4.7 mt -47.94 135.67 11.18 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.0 Cg_endo -99.58 156.46 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.35 3.367 . . . . 0.0 111.43 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -68.02 138.53 22.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.816 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.46 55.83 Favored Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.554 -1.308 . . . . 0.0 112.079 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -97.39 -175.37 3.19 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.058 -172.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.538 ' N ' ' HE3' ' A' ' 22' ' ' LYS . 11.4 p -148.22 136.82 21.58 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 68' ' ' ASN . 10.0 m -154.16 147.84 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 124.02 0.928 . . . . 0.0 111.229 175.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 1.9 m-20 -105.22 108.13 19.49 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 124.272 1.029 . . . . 0.0 109.519 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.8 mm? -91.43 124.25 35.48 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.349 0.595 . . . . 0.0 111.715 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -97.31 119.0 35.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.621 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.9 pt? -142.7 159.06 42.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 60.4 m -120.49 108.52 14.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.131 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.545 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.28 144.5 28.06 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.776 0.831 . . . . 0.0 108.807 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.99 14.84 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.574 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -88.5 127.09 57.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.593 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 25.4 Cg_endo -60.64 151.92 72.58 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.633 2.222 . . . . 0.0 113.86 -173.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -110.37 76.83 1.13 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.01 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 22.0 Cg_endo -92.67 37.69 0.23 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.863 2.376 . . . . 0.0 109.736 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CD2' ' HD2' ' A' ' 104' ' ' PRO . 57.6 m-85 -138.22 149.98 46.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 17.7 t70 -79.38 136.38 56.52 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.559 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.3 Cg_endo -91.35 -8.3 3.27 Favored 'Trans proline' 0 N--CA 1.411 -3.324 0 C-N-CA 123.381 2.721 . . . . 0.0 110.533 -171.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.83 -29.06 16.16 Favored 'General case' 0 N--CA 1.38 -3.94 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.021 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.87 109.15 0.98 Allowed Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 127.621 2.368 . . . . 0.0 115.683 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -90.83 -146.64 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 124.204 3.27 . . . . 0.0 110.584 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 m120 76.81 87.31 0.08 Allowed 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 126.415 1.886 . . . . 0.0 112.795 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.505 ' OG1' ' HG3' ' B' ' 154' ' ' ARG . 12.1 t -129.54 160.82 32.04 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.944 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' B' ' 155' ' ' THR . 26.6 m -137.04 101.07 4.45 Favored 'General case' 0 N--CA 1.383 -3.8 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 170.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -80.94 122.0 26.71 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.66 109.75 24.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.8 t -74.1 148.35 41.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.8 m -99.62 134.04 43.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.242 0.544 . . . . 0.0 112.088 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.89 123.11 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.021 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.46 83.53 2.63 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.315 0.579 . . . . 0.0 111.607 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.1 mm -98.32 -39.01 7.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -130.55 170.99 13.53 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.511 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.92 72.96 0.5 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.919 1.343 . . . . 0.0 112.62 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 131.83 54.18 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -80.04 116.87 64.4 Favored Pre-proline 0 C--N 1.289 -2.051 0 O-C-N 123.547 0.53 . . . . 0.0 110.991 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.436 -1.864 0 C-N-CA 122.564 2.176 . . . . 0.0 109.859 174.147 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 121.124 0.488 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.1 m -159.29 -60.57 0.07 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.1 p -152.33 116.36 4.9 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.505 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 6.1 tpp180 -131.7 72.15 1.49 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.603 0.716 . . . . 0.0 109.332 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 113' ' ' SER . 12.8 p -110.16 -10.89 14.64 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.239 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.666 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 3.5 mpt_? -141.44 -148.75 0.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' GLY 0.327 83.8 mtt180 82.01 -68.47 0.08 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . 0.256 10.7 pt-20 -84.05 96.02 8.76 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -172.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.497 ' HB ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -100.86 120.65 40.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 30' ' ' THR . 25.2 tt0 -99.75 115.59 29.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 27' ' ' PHE . 21.8 m . . . . . 0 N--CA 1.434 -1.242 0 O-C-N 123.38 0.425 . . . . 0.0 109.973 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.0 -29.72 58.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.889 0.376 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -97.8 55.23 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.991 0.9 . . . . 0.0 109.481 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . -107.12 36.12 4.6 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.961 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 160.56 26.5 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.2 35.84 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.904 1.736 . . . . 0.0 110.141 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -81.5 131.05 35.26 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.592 -172.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' CG ' ' HA ' ' A' ' 38' ' ' ASP . 24.3 t80 -148.13 134.22 19.29 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.66 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -171.11 35.72 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.153 167.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.587 ' O ' HD21 ' A' ' 73' ' ' LEU . 28.8 ptt180 50.64 26.83 2.64 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.994 2.118 . . . . 0.0 113.662 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.775 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 9.8 m-80 -103.18 114.56 65.01 Favored Pre-proline 1 C--N 1.236 -4.362 0 CA-C-N 113.588 -1.642 . . . . 0.0 114.264 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.281 11.9 Cg_exo -55.95 -33.93 90.53 Favored 'Trans proline' 0 CA--C 1.479 -2.227 0 C-N-CA 121.583 1.522 . . . . 0.0 109.197 168.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 t -65.97 -26.73 67.7 Favored 'General case' 1 N--CA 1.371 -4.378 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.648 -177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.775 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -77.81 -31.95 52.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.08 133.94 55.94 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.254 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 100' ' ' GLY . 17.1 ptmt -82.53 -177.52 6.72 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.579 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 84.73 -112.63 3.66 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.479 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 4.6 ptmt -146.46 149.13 33.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.017 0.927 . . . . 0.0 109.565 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.37 116.11 28.41 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.15 152.44 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.44 0.638 . . . . 0.0 111.846 -177.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.73 110.69 12.88 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.027 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -129.53 142.6 50.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -73.44 133.86 43.82 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.3 128.01 53.74 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -82.96 108.33 16.2 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.331 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.4 mptp? -40.04 106.34 0.05 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 124.144 0.978 . . . . 0.0 111.136 170.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -127.38 141.58 51.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 125.131 1.52 . . . . 0.0 110.141 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 54.73 32.63 17.82 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.477 1.511 . . . . 0.0 114.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.596 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.9 mmt180 73.79 53.89 0.11 Allowed 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 122.63 1.205 . . . . 0.0 109.605 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.26 -120.45 1.17 Allowed Glycine 0 N--CA 1.401 -3.7 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.711 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.0 m-85 -135.48 -78.52 0.43 Allowed 'General case' 0 C--N 1.275 -2.649 0 C-N-CA 122.743 0.417 . . . . 0.0 111.763 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.499 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.96 48.56 0.12 Allowed Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.728 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -161.47 143.53 11.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.561 HG22 ' HA ' ' B' ' 160' ' ' GLN . 37.9 p -105.11 135.48 46.38 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.598 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.79 147.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.107 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 15.2 m -120.32 135.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.867 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.37 -131.25 8.28 Favored Glycine 0 C--N 1.281 -2.522 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 36.82 60.08 1.03 Allowed Glycine 0 CA--C 1.479 -2.182 0 C-N-CA 126.647 2.07 . . . . 0.0 113.99 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -115.76 -18.68 10.75 Favored 'General case' 0 C--N 1.25 -3.742 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.712 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.35 168.43 12.49 Favored Pre-proline 0 CA--C 1.466 -2.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -61.38 -38.52 63.74 Favored 'Trans proline' 0 CA--C 1.49 -1.708 0 C-N-CA 122.074 1.85 . . . . 0.0 108.513 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 29.1 t70 -73.15 -12.06 60.75 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 111.961 -2.381 . . . . 0.0 111.709 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -132.34 118.18 19.09 Favored 'General case' 0 C--O 1.279 2.61 0 O-C-N 121.823 -0.548 . . . . 0.0 111.74 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -85.76 166.19 16.29 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.748 2.819 . . . . 0.0 107.981 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -91.2 145.17 24.89 Favored 'General case' 0 C--O 1.17 -3.129 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.891 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.4 tt0 -128.91 160.44 32.64 Favored 'General case' 0 C--O 1.169 -3.146 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.485 HG12 ' CE ' ' A' ' 58' ' ' MET . 1.2 mp -105.65 127.19 60.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HG3' ' CG2' ' A' ' 32' ' ' VAL 0.305 42.1 mtmt -113.28 -7.94 13.52 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.926 172.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 73.1 m -149.69 127.51 11.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.632 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.89 117.69 24.06 Favored 'General case' 0 N--CA 1.404 -2.77 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 86.4 t -88.29 128.55 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.05 145.99 41.9 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 81.44 5.72 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 125.501 1.75 . . . . 0.0 108.502 -171.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.45 159.52 38.82 Favored Glycine 0 C--O 1.204 -1.758 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.42 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 19.9 Cg_endo -72.8 -25.78 16.55 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 120.853 2.327 . . . . 0.0 109.971 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -45.23 90.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.428 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.24 -50.94 63.89 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.681 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.5 mt -71.48 -36.5 71.18 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 112.688 -2.051 . . . . 0.0 114.854 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -79.75 -19.7 48.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.0 108.751 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.54 42.97 99.87 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.827 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.99 -25.47 2.52 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.035 -0.583 . . . . 0.0 111.485 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.485 ' CE ' HG12 ' A' ' 43' ' ' ILE . 1.6 tmt? -120.24 146.03 46.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -142.9 166.99 23.14 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.557 1.17 . . . . 0.0 113.498 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.401 HG23 ' C ' ' A' ' 44' ' ' LYS . 28.4 m -63.57 123.04 17.8 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 113.807 -1.542 . . . . 0.0 107.469 171.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.21 -11.23 10.71 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.965 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 15.0 m-20 -74.34 157.9 34.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -128.22 123.81 61.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 49.2 mm -73.93 113.18 11.76 Favored 'Isoleucine or valine' 0 C--O 1.3 3.733 0 C-N-CA 125.041 1.336 . . . . 0.0 110.683 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.9 t -105.4 -54.79 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 126.019 2.074 . . . . 0.0 110.673 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 40.3 t -147.56 158.33 43.95 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.959 -0.463 . . . . 0.0 110.943 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.91 89.52 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 CA-C-O 122.22 1.01 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 93' ' ' VAL 0.435 43.6 p30 42.15 -89.12 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -171.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -93.53 -30.95 14.74 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.827 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.7 m -91.25 131.11 36.98 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.085 0.945 . . . . 0.0 110.962 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.7 t -88.69 86.63 7.03 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.253 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.51 1.59 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 122.54 1.162 . . . . 0.0 109.628 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 6' ' ' ARG . 28.7 tp -60.68 111.7 1.72 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.999 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.43 38.6 95.04 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.41 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -81.07 133.23 35.44 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -62.36 145.29 54.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.505 ' HB2' ' HE ' ' B' ' 157' ' ' ARG . 2.6 t60 -45.61 -51.89 11.46 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.622 0.646 . . . . 0.0 112.19 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.92 72.65 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 124.102 0.877 . . . . 0.0 111.186 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -80.55 -47.36 14.32 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.489 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 41' ' ' LEU . 12.0 p -65.17 -42.28 93.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.3 p -65.87 -37.79 80.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.676 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -58.86 -45.16 90.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.307 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.1 mt -73.75 -51.21 25.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-O 122.174 0.988 . . . . 0.0 109.615 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.92 -29.48 69.9 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.098 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -86.32 -23.81 26.11 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -80.25 -12.0 59.67 Favored 'General case' 0 C--O 1.249 1.062 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.813 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.593 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 6.7 mt -47.69 139.98 8.41 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.8 1.24 . . . . 0.0 113.5 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -99.0 145.11 0.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.894 3.062 . . . . 0.0 111.333 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 ' H ' ' A' ' 25' ' ' ARG . 37.7 mt -68.3 142.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.45 11.32 57.27 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -105.43 -177.03 3.25 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.828 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.8 p -148.95 145.89 27.59 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -153.37 158.41 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 C-N-CA 123.754 0.822 . . . . 0.0 111.038 174.323 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -96.55 107.5 19.93 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' LEU . 12.8 tp -94.45 114.04 26.0 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 30.3 mt-10 -97.7 111.75 23.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.07 157.46 45.27 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.799 -173.383 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.0 t -112.55 130.2 56.1 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 21.6 tpp85 -103.17 152.38 21.52 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 12' ' ' LYS . . . 110.9 8.18 24.43 Favored Glycine 0 CA--C 1.493 -1.283 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.366 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -90.21 118.78 69.1 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' C ' ' HD3' ' A' ' 104' ' ' PRO . 51.5 Cg_endo -69.24 153.88 70.63 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.395 2.063 . . . . 0.0 115.079 -172.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.63 73.64 4.32 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.3 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 102' ' ' PRO . 7.5 Cg_endo -89.06 -3.31 6.17 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.54 2.16 . . . . 0.0 110.906 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.8 137.91 53.81 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.438 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 m-20 -78.46 154.06 79.01 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 -171.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 10.0 Cg_endo -102.02 3.13 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.603 2.869 . . . . 0.0 108.115 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.08 -54.17 4.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.83 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.59 137.58 82.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.866 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -56.9 -155.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.503 3.469 . . . . 0.0 115.428 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 82.23 122.59 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 125.805 1.642 . . . . 0.0 110.232 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 m -66.21 -32.49 73.95 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.233 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' B' ' 155' ' ' THR . 0.0 OUTLIER -85.92 115.98 23.87 Favored 'General case' 0 C--N 1.257 -3.438 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.054 176.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 155' ' ' THR . 12.0 mt -100.39 104.29 15.71 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 m -110.95 133.05 57.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.034 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.2 t -103.2 142.34 34.34 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.8 m -78.03 119.59 21.67 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.515 ' O ' ' HE2' ' A' ' 123' ' ' LYS . 3.3 p -93.28 99.95 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 122.459 1.123 . . . . 0.0 110.673 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.73 73.1 0.99 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 0' ' ' GLY . 47.5 mm -136.95 -44.73 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.23 135.74 54.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 170.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -81.89 85.98 6.58 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.156 0.979 . . . . 0.0 112.124 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.556 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -106.85 109.84 21.84 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 171.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.81 99.92 7.57 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.039 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 3.4 Cg_endo . . . . . 0 N--CA 1.439 -1.712 0 C-N-CA 122.877 2.384 . . . . 0.0 111.23 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.7 t -100.14 -55.47 2.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.168 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.9 m -106.61 157.11 17.93 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.199 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -127.12 22.71 6.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.765 . . . . 0.0 109.85 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 113' ' ' SER . 1.7 t -137.52 120.87 16.98 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.111 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 10.2 mmt180 -63.34 136.28 57.56 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 3.3 tmm_? -90.32 144.23 26.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -101.91 125.43 48.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.919 -0.488 . . . . 0.0 110.555 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 23.2 m -132.51 117.73 18.38 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.561 ' HA ' HG22 ' A' ' 30' ' ' THR . 53.9 tt0 -79.62 122.41 26.48 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.354 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 N--CA 1.408 -2.569 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -91.24 -0.75 57.74 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 121.08 0.467 . . . . 0.0 111.899 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.0 ttt -124.46 44.06 2.85 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.86 3.44 87.0 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.288 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -92.46 146.45 32.47 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.32 123.23 11.49 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.092 1.861 . . . . 0.0 110.19 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.09 155.5 26.26 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 113.075 -1.875 . . . . 0.0 113.286 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -145.42 132.26 20.11 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.155 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -161.77 29.64 0.12 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 167.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 61.13 36.1 18.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.585 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.799 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.2 m-20 -121.86 120.11 28.67 Favored Pre-proline 0 C--N 1.268 -2.95 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.28 16.3 Cg_exo -62.92 -32.93 76.55 Favored 'Trans proline' 0 CA--C 1.473 -2.528 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 172.366 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -71.09 -22.25 62.13 Favored 'General case' 1 N--CA 1.365 -4.708 0 CA-C-N 111.899 -2.41 . . . . 0.0 110.97 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.799 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.2 pt-20 -77.07 -36.62 55.7 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.28 131.31 41.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.271 0.982 . . . . 0.0 111.146 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -86.06 169.16 13.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.048 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.57 -108.24 3.65 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.249 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.551 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 144.88 29.95 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 122.834 0.453 . . . . 0.0 110.911 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -111.19 122.08 46.95 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -135.57 152.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.26 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.1 t60 -128.27 101.49 6.26 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -117.66 137.02 52.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.15 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -79.17 133.6 36.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.115 -0.366 . . . . 0.0 110.273 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -118.02 119.46 34.87 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -81.25 104.64 11.86 Favored 'General case' 0 N--CA 1.403 -2.797 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.88 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.703 ' HE2' HG13 ' A' ' 93' ' ' VAL . 1.9 mptp? -33.41 106.76 0.04 OUTLIER 'General case' 0 CA--C 1.483 -1.632 0 C-N-CA 125.357 1.463 . . . . 0.0 112.112 174.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 t -81.65 -150.78 0.08 Allowed 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 125.983 2.052 . . . . 0.0 108.283 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -61.69 83.25 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' H ' HG12 ' A' ' 89' ' ' ILE . 27.2 mtp85 58.31 44.26 18.82 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.852 1.261 . . . . 0.0 113.66 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.6 -133.91 3.83 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.619 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.4 m-85 -129.77 -77.79 0.55 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.62 52.1 0.16 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.741 -171.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 43' ' ' ILE . 37.2 p90 -161.64 142.6 11.0 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.4 p -106.25 136.56 45.75 Favored 'General case' 0 C--N 1.265 -3.074 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.269 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 17.5 m -123.39 158.02 28.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.887 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 44' ' ' LYS . 8.9 m -121.53 133.06 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.854 0 C-N-CA 124.334 1.053 . . . . 0.0 109.599 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' B' ' 156' ' ' ARG . . . 130.64 -142.06 13.34 Favored Glycine 0 CA--C 1.455 -3.708 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.009 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.45 57.07 1.5 Allowed Glycine 0 CA--C 1.458 -3.475 0 O-C-N 127.136 2.316 . . . . 0.0 111.385 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -104.72 -32.16 9.0 Favored 'General case' 0 C--N 1.251 -3.676 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -137.76 170.68 9.93 Favored Pre-proline 0 N--CA 1.405 -2.701 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.102 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 32.0 Cg_exo -71.81 -8.72 23.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.296 2.664 . . . . 0.0 108.709 174.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -111.67 -10.66 14.07 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.837 1.655 . . . . 0.0 110.811 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.82 120.18 30.99 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 121.999 -0.438 . . . . 0.0 109.989 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -87.32 165.45 15.62 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 127.444 2.297 . . . . 0.0 110.61 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.5 mp -93.15 145.24 24.56 Favored 'General case' 0 C--O 1.176 -2.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.304 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 37.0 tt0 -133.92 155.91 49.06 Favored 'General case' 0 C--O 1.162 -3.515 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 29' ' ' PHE . 12.2 mm -87.27 126.38 41.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 118.88 0.764 . . . . 0.0 109.243 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' HG13 ' A' ' 32' ' ' VAL . 20.9 ptmt -102.09 -23.46 14.07 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 123.137 0.273 . . . . 0.0 110.317 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.472 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 38.7 m -151.49 126.43 9.74 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.88 108.96 19.0 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 79.8 t -85.76 127.63 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 121.87 0.843 . . . . 0.0 111.661 -173.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.52 85.33 4.6 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.459 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 54' ' ' LEU . 5.7 t70 165.12 -22.52 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 125.115 1.509 . . . . 0.0 109.822 -170.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -99.55 166.28 20.6 Favored Glycine 0 CA--C 1.48 -2.116 0 CA-C-N 115.456 -0.793 . . . . 0.0 114.045 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.631 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 6.1 Cg_endo -67.72 -23.85 41.71 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.142 1.895 . . . . 0.0 111.077 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -58.35 -52.34 66.01 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.971 0.909 . . . . 0.0 111.395 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.688 ' HB3' HD23 ' A' ' 54' ' ' LEU . . . -73.74 -37.15 65.18 Favored 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 122.879 1.324 . . . . 0.0 110.049 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -71.25 -38.44 71.92 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 111.755 -2.475 . . . . 0.0 111.175 -170.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.87 -26.07 37.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.564 1.173 . . . . 0.0 108.049 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.73 86.06 Favored Glycine 0 CA--C 1.481 -2.076 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.429 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -122.08 0.67 9.68 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.694 -174.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.611 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 67.3 mtp -128.04 159.2 35.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.42 164.16 30.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.476 0.655 . . . . 0.0 110.719 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -71.24 116.73 11.9 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 131.36 -23.89 4.24 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 7.3 m-20 -58.16 140.96 51.86 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 120.716 0.294 . . . . 0.0 110.62 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.323 0.2 OUTLIER -109.17 115.96 50.85 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-O 121.578 0.704 . . . . 0.0 111.891 174.23 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.8 mm -68.82 114.62 5.88 Favored 'Isoleucine or valine' 0 C--O 1.301 3.777 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.791 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.613 HG13 HD13 ' A' ' 73' ' ' LEU . 65.1 t -95.83 -58.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 112.361 -2.199 . . . . 0.0 110.1 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.5 m -158.31 173.32 16.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.0 -0.438 . . . . 0.0 110.471 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 72' ' ' VAL . 9.1 p -145.55 153.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 2.0 t-20 -31.31 113.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.01 1.324 . . . . 0.0 111.782 172.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 75.04 -38.9 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.98 1.712 . . . . 0.0 115.231 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -100.2 122.66 43.38 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.894 0.854 . . . . 0.0 111.497 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.4 t -83.56 83.38 7.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.973 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 67' ' ' VAL . 78.8 t -72.55 -2.62 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.346 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -66.77 110.48 3.28 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.12 28.51 70.13 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.74 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.05 140.97 43.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 122.017 -0.696 . . . . 0.0 109.693 178.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 m -74.78 143.61 43.93 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 117.526 -1.225 . . . . 0.0 108.044 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -47.84 -49.46 29.17 Favored 'General case' 0 CA--C 1.485 -1.52 0 CA-C-N 118.952 0.796 . . . . 0.0 111.7 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.05 74.33 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 124.758 1.286 . . . . 0.0 111.084 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -75.23 -53.37 8.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -61.65 -42.66 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.579 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 8.9 p -62.49 -45.34 99.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 C-N-CA 121.264 -0.174 . . . . 0.0 110.532 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.1 tmmm? -57.12 -41.51 79.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.697 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -72.65 -50.23 35.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.161 0.981 . . . . 0.0 108.912 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.95 -29.1 70.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.453 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 14.0 pt20 -86.69 -24.01 25.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -93.08 2.81 56.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.564 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 4.3 mt -51.19 144.04 15.95 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.964 1.306 . . . . 0.0 113.618 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 29.9 Cg_endo -92.74 140.43 1.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.517 2.811 . . . . 0.0 111.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.9 mt -68.49 138.91 21.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.47 12.52 62.77 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -101.48 -171.47 1.99 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.648 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.5 t -148.88 144.39 26.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.855 -0.528 . . . . 0.0 112.187 -171.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.703 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -152.95 154.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 C-N-CA 124.221 1.008 . . . . 0.0 110.25 173.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 5.5 m-20 -99.74 107.7 19.83 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.46 HD22 HD22 ' A' ' 20' ' ' LEU . 12.9 tp -99.73 115.24 29.04 Favored 'General case' 0 C--N 1.269 -2.929 0 CA-C-O 120.803 0.335 . . . . 0.0 110.166 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -103.3 123.8 47.46 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.4 OUTLIER -141.52 163.26 33.4 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.705 -173.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.2 t -116.69 128.33 55.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.611 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 22.2 tpp85 -103.66 152.49 21.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.88 -43.03 1.26 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -67.74 135.96 92.49 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 114.644 -0.778 . . . . 0.0 109.342 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 47.6 Cg_endo -97.38 -161.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 122.72 2.28 . . . . 0.0 109.014 172.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.65 81.0 11.07 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 86.9 Cg_endo -91.83 7.46 3.25 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 123.282 2.655 . . . . 0.0 114.475 -170.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -144.92 121.63 11.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 8.9 m-20 -79.24 125.98 82.35 Favored Pre-proline 0 CA--C 1.481 -1.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.1 Cg_exo -95.05 -0.95 2.55 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 123.059 2.506 . . . . 0.0 107.337 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.84 -37.32 67.47 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.042 -1.89 . . . . 0.0 107.654 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.55 123.86 89.82 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.18 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.05 -175.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 123.657 2.905 . . . . 0.0 115.647 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 80.71 43.48 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.7 2.0 . . . . 0.0 110.761 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.427 HG23 ' O ' ' B' ' 154' ' ' ARG . 55.8 m -94.68 138.31 32.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.643 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.0 m -124.29 102.44 7.69 Favored 'General case' 0 N--CA 1.395 -3.213 0 C-N-CA 123.815 0.846 . . . . 0.0 111.127 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' B' ' 157' ' ' ARG . 1.8 mm? -77.27 123.84 27.02 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.07 0.462 . . . . 0.0 110.02 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG22 ' CG2' ' B' ' 155' ' ' THR . 12.2 m -111.03 133.33 56.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.3 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 t -71.19 142.53 50.65 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -87.05 149.8 24.48 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.4 t -93.59 100.12 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' N ' HD12 ' A' ' 120' ' ' ILE . . . -148.53 74.06 1.26 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 119' ' ' ALA . 4.3 mp -121.23 -16.45 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.766 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 pp -108.14 -166.01 1.09 Allowed 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.841 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -54.07 103.97 0.09 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.365 1.079 . . . . 0.0 112.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -113.4 101.3 9.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.707 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -76.85 118.1 69.46 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.439 -1.72 0 C-N-CA 122.086 1.858 . . . . 0.0 112.523 -177.725 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 . . . . . 0 CA--C 1.505 -0.778 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 23.1 t 62.98 -167.13 0.22 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.082 0.864 . . . . 0.0 112.251 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.5 m -156.93 52.58 0.5 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 125.861 1.664 . . . . 0.0 106.733 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 112' ' ' THR . 98.5 mtt180 70.12 85.97 0.13 Allowed 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 125.137 1.375 . . . . 0.0 109.996 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.4 ' CG2' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -86.9 -156.65 0.33 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 174.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.422 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 73.9 mtt180 78.76 130.16 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.052 0.941 . . . . 0.0 112.901 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.649 ' HB2' HD11 ' A' ' 114' ' ' LEU . 22.5 tpt180 -109.34 141.65 41.38 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.4 pm0 -75.25 116.83 16.41 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-O 121.816 0.817 . . . . 0.0 110.374 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 18.1 m -105.4 110.21 22.47 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.465 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.1 mp0 -85.17 104.44 15.05 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.428 -1.546 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.439 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.846 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -90.66 -36.61 14.28 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 66.5 mtt -114.39 -177.29 3.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.274 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 91.41 28.96 13.07 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.5 157.31 54.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.81 133.52 34.17 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.695 1.597 . . . . 0.0 108.508 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -88.23 154.97 20.01 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 8.9 t80 -148.65 134.35 18.83 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.153 -1.84 . . . . 0.0 110.116 175.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 15.0 t -174.14 26.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 124.439 1.096 . . . . 0.0 109.478 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' THR . 33.2 ptt180 56.97 14.03 1.74 Allowed 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 127.486 2.314 . . . . 0.0 114.889 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.713 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 14.4 m-80 -92.6 124.7 58.24 Favored Pre-proline 1 C--N 1.241 -4.135 0 CA-C-N 114.18 -1.373 . . . . 0.0 113.109 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.272 11.3 Cg_exo -60.35 -32.57 94.21 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 122.046 1.83 . . . . 0.0 108.781 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -68.72 -22.86 64.31 Favored 'General case' 1 N--CA 1.367 -4.59 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.219 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.6 pt-20 -79.34 -38.5 35.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.43 130.06 44.58 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.509 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -77.34 177.95 7.54 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.153 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.25 -122.65 6.55 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.321 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ARG . 13.4 mmmm -107.8 149.61 28.01 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 123.473 0.709 . . . . 0.0 109.317 -177.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.51 111.25 16.59 Favored 'General case' 1 C--N 1.241 -4.121 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 151.99 36.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.952 0.882 . . . . 0.0 112.854 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.2 t60 -132.95 103.45 6.07 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -128.66 140.15 51.9 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.238 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -73.54 135.2 43.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.495 177.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.84 120.87 37.73 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -72.73 124.29 25.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.116 0.484 . . . . 0.0 109.9 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.661 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -57.56 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 123.59 0.756 . . . . 0.0 110.989 171.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -107.93 126.11 52.3 Favored 'General case' 0 N--CA 1.405 -2.707 0 O-C-N 126.187 2.179 . . . . 0.0 108.09 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' ILE . 3.5 m 47.15 56.34 6.96 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.297 1.439 . . . . 0.0 113.974 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.663 ' N ' HG12 ' A' ' 89' ' ' ILE . 19.9 mmt180 68.31 42.71 1.62 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.248 0.547 . . . . 0.0 112.123 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.9 -124.43 1.48 Allowed Glycine 0 N--CA 1.403 -3.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.235 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.648 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -132.74 -87.06 0.45 Allowed 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 114.367 -0.916 . . . . 0.0 111.753 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 123.9 52.28 0.2 Allowed Glycine 0 C--N 1.289 -2.062 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -167.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.483 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.0 p90 -160.71 143.72 13.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' HA ' ' B' ' 160' ' ' GLN . 17.3 p -107.45 135.14 49.44 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 122.173 0.987 . . . . 0.0 109.68 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 3.5 p -130.46 137.61 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.753 -169.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 44' ' ' LYS . 4.6 m -114.49 154.1 15.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 125.03 1.332 . . . . 0.0 113.545 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.86 -127.88 9.37 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.701 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 40.53 74.66 0.14 Allowed Glycine 1 CA--C 1.449 -4.068 0 O-C-N 126.648 2.028 . . . . 0.0 113.194 178.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -130.75 -20.44 2.86 Favored 'General case' 0 C--N 1.259 -3.333 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.169 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 7.7 pt-20 -156.68 170.92 8.1 Favored Pre-proline 0 N--CA 1.415 -2.203 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.031 -166.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 75.8 Cg_exo -61.14 -38.13 69.43 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 122.649 2.233 . . . . 0.0 108.895 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 13.1 t70 -72.22 -25.3 61.6 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.88 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 25.7 tt0 -127.36 118.83 24.89 Favored 'General case' 0 C--O 1.274 2.367 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.134 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.576 ' CD1' HD12 ' A' ' 73' ' ' LEU . 3.1 m-85 -87.27 165.67 15.49 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 128.134 2.574 . . . . 0.0 108.795 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.701 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.1 mp -89.27 147.01 24.36 Favored 'General case' 0 C--O 1.18 -2.582 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.077 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 6.6 tt0 -136.04 144.99 45.55 Favored 'General case' 0 C--O 1.175 -2.844 0 CA-C-N 118.698 0.681 . . . . 0.0 109.163 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 62' ' ' ASP . 34.4 mm -83.25 117.81 29.75 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 O-C-N 121.599 -0.688 . . . . 0.0 111.081 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -96.56 -18.95 19.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.226 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -159.6 127.84 4.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 60' ' ' THR . 3.4 pp -82.31 117.04 22.09 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 90.3 t -83.45 129.24 37.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.1 142.05 54.8 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.117 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 80.09 5.29 1.84 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.58 1.175 . . . . 0.0 109.744 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.686 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -93.31 160.38 24.7 Favored Glycine 0 CA--C 1.484 -1.904 0 CA-C-O 118.153 -1.359 . . . . 0.0 109.886 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.648 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 32.1 Cg_endo -72.01 -25.21 19.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.95 2.375 . . . . 0.0 110.208 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -61.03 -49.25 78.16 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.468 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.91 86.53 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.134 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.0 mt -72.06 -38.3 69.5 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 112.921 -1.945 . . . . 0.0 114.55 -172.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 12.9 t70 -71.75 -27.26 62.86 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.66 2.72 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.887 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 17.3 ptpt -77.32 -34.34 55.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.824 1.312 . . . . 0.0 112.549 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -79.44 139.04 37.78 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.76 167.94 21.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.458 1.123 . . . . 0.0 112.242 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.442 ' H ' HD23 ' A' ' 46' ' ' LEU . 18.2 m -61.23 135.37 57.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.573 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.87 -16.03 43.77 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.551 ' O ' HG12 ' A' ' 43' ' ' ILE . 10.4 m-20 -66.47 132.99 49.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.268 0.2 OUTLIER -101.13 120.71 51.05 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.759 176.094 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -73.0 115.62 14.08 Favored 'Isoleucine or valine' 0 C--O 1.302 3.848 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.15 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 73' ' ' LEU . 72.8 t -102.2 -58.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 126.395 2.309 . . . . 0.0 109.814 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 13.4 m -146.3 172.06 14.05 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.43 154.78 14.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -34.18 112.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 64.36 15.59 9.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.2 1.4 . . . . 0.0 114.045 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.1 m -142.18 125.15 16.17 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.477 1.132 . . . . 0.0 112.493 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.5 108.94 14.54 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.231 -1.35 . . . . 0.0 107.967 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 41.1 t -86.04 -2.71 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 40' ' ' PHE . 2.6 mm? -66.92 123.28 19.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.205 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 36' ' ' GLU . . . 81.46 9.44 85.81 Favored Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.832 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.8 111.03 10.73 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 92.1 m -62.0 149.73 40.02 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.23 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -47.55 -43.79 25.44 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.97 0.804 . . . . 0.0 111.713 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -36.01 82.49 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 27.5 mm-40 -79.32 -48.27 14.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.291 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 14.9 p -63.87 -40.74 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.137 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.51 -36.27 76.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 4.5 tmmm? -57.2 -47.97 79.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.44 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.2 mt -72.94 -50.28 33.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 CA-C-O 122.283 1.039 . . . . 0.0 109.883 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 5.4 m-85 -63.96 -38.04 89.62 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.308 -1.769 . . . . 0.0 114.017 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 12.4 mm-40 -86.2 -19.87 29.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.117 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.8 m -75.6 -17.62 59.97 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.653 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.8 mt -44.74 135.68 4.65 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.463 1.105 . . . . 0.0 113.459 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 74.0 Cg_endo -97.79 154.42 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.179 3.253 . . . . 0.0 112.127 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' N ' ' A' ' 25' ' ' ARG . 7.3 mt -69.05 143.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.263 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.24 11.93 71.5 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.832 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.45 -170.5 1.76 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.88 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 36.9 p -149.66 138.29 20.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.5 m -133.47 152.3 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.373 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.07 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.585 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -94.23 107.32 19.26 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.08 123.3 45.71 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.335 0.588 . . . . 0.0 109.995 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.1 tt0 -103.17 115.14 30.0 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.92 159.13 42.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.584 -175.402 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.3 t -122.57 140.06 53.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 20.1 tpp85 -110.64 142.2 42.85 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . 146.71 -18.19 1.63 Allowed Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.914 -1.136 . . . . 0.0 111.89 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -97.45 112.39 61.03 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 100' ' ' GLY . 4.3 Cg_exo -79.4 131.08 9.36 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 N-CA-C 106.144 -2.291 . . . . 0.0 106.144 168.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -41.08 100.14 0.22 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 124.98 1.312 . . . . 0.0 109.72 -176.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.15 23.47 0.84 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.525 2.817 . . . . 0.0 113.927 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 103' ' ' LEU . 47.7 p90 -162.38 156.74 21.66 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 m-20 -103.05 127.99 28.65 Favored Pre-proline 0 C--N 1.273 -2.747 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -93.55 1.61 3.32 Favored 'Trans proline' 0 N--CA 1.431 -2.19 0 C-N-CA 122.884 2.389 . . . . 0.0 107.636 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.83 -20.1 28.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.298 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.427 ' CG ' ' HD2' ' A' ' 110' ' ' PRO . 32.0 t70 -93.8 159.19 35.15 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.655 1.982 . . . . 0.0 106.121 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 109' ' ' ASP . 16.9 Cg_exo -45.66 -165.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 124.718 3.612 . . . . 0.0 117.588 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 68.81 66.35 0.3 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.447 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 t -86.82 177.79 7.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 113.043 -1.889 . . . . 0.0 111.208 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.621 ' HB2' ' HB2' ' B' ' 157' ' ' ARG . 33.5 t -87.21 101.59 13.65 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.776 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.688 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -89.44 124.1 34.17 Favored 'General case' 0 N--CA 1.382 -3.826 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.539 HG22 HG23 ' B' ' 155' ' ' THR . 48.3 t -92.67 105.74 17.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -71.34 141.8 50.42 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 m -109.17 89.26 2.94 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.44 100.87 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.263 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.016 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.1 73.02 0.83 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.4 mm -126.61 -3.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 164.33 27.25 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.181 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.12 134.33 43.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 101.87 14.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.174 -177.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.11 110.93 41.84 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 CA--C 1.534 0.514 0 C-N-CA 122.716 2.277 . . . . 0.0 112.088 -178.444 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p 61.88 16.6 8.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.695 1.598 . . . . 0.0 114.459 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' SER . . . . . 0.426 ' C ' ' HD2' ' B' ' 154' ' ' ARG 0.255 58.3 m -88.49 -104.07 0.08 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.174 175.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' B' ' 153' ' ' SER . 5.5 mpt_? -135.76 -83.39 0.39 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 118.3 -1.36 . . . . 0.0 114.615 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 115' ' ' VAL . 14.3 m -88.67 12.98 13.31 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.565 0.698 . . . . 0.0 112.662 -165.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' B' ' 156' ' ' ARG . 0.0 OUTLIER -52.07 109.81 0.42 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.53 1.132 . . . . 0.0 113.813 177.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 17.5 ttp180 175.54 -153.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.1 pm0 -82.77 142.4 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 17.9 m -114.11 109.76 18.94 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 102.527 -3.138 . . . . 0.0 102.527 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.558 ' HA ' HG22 ' A' ' 30' ' ' THR . 46.9 tt0 -86.94 96.07 10.13 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.564 0.697 . . . . 0.0 111.078 -174.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.0 m . . . . . 0 N--CA 1.418 -2.036 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.205 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.995 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.42 97.19 1.58 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 94.7 mmm 66.5 71.37 0.39 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.348 1.059 . . . . 0.0 112.705 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -88.95 4.75 84.87 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.69 148.02 43.41 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.31 141.95 40.21 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 121.582 1.521 . . . . 0.0 109.945 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -104.65 143.25 33.33 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.256 0.551 . . . . 0.0 112.258 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -146.93 133.3 19.59 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.067 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 10' ' ' GLU . 13.6 t -168.76 37.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.181 0 O-C-N 124.438 1.086 . . . . 0.0 108.36 166.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.0 ptt180 46.15 36.12 2.99 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 126.249 1.82 . . . . 0.0 112.974 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.783 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -108.14 111.54 61.85 Favored Pre-proline 1 C--N 1.219 -5.096 0 CA-C-N 112.29 -2.232 . . . . 0.0 113.645 178.783 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.299 17.3 Cg_exo -58.13 -36.44 97.9 Favored 'Trans proline' 0 CA--C 1.478 -2.306 0 C-N-CA 121.757 1.638 . . . . 0.0 109.355 172.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 m -66.01 -26.65 67.63 Favored 'General case' 1 N--CA 1.36 -4.941 0 CA-C-N 111.284 -2.689 . . . . 0.0 112.571 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.1 pt-20 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.7 131.58 48.38 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -80.94 -175.18 5.24 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.097 -1.411 . . . . 0.0 113.365 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.2 -119.77 4.95 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.468 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.17 157.87 45.11 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 123.821 0.848 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.93 111.11 16.67 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.27 135.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.264 0.554 . . . . 0.0 111.378 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.444 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 21.6 t60 -112.66 99.65 8.1 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.458 ' CB ' ' HG2' ' A' ' 57' ' ' LYS . 10.6 t -118.34 140.16 50.26 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.298 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -81.24 130.41 35.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.1 mp -115.73 132.56 56.6 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -92.13 119.57 31.91 Favored 'General case' 0 N--CA 1.387 -3.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -53.21 99.97 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 166.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 89' ' ' ILE . 70.9 m -87.25 -54.89 4.06 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 124.509 1.131 . . . . 0.0 113.365 -167.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -144.89 70.8 1.28 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' N ' HG12 ' A' ' 89' ' ' ILE . 29.2 mmt180 67.78 78.8 0.23 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 104.63 -141.31 15.26 Favored Glycine 0 N--CA 1.411 -3.017 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.063 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.706 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.4 m-85 -119.3 -82.33 0.64 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.325 -0.938 . . . . 0.0 111.562 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.52 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.24 50.34 0.2 Allowed Glycine 0 C--N 1.291 -1.948 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.995 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 43' ' ' ILE . 46.2 p90 -161.59 143.35 11.52 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.454 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.1 p -104.73 146.21 29.27 Favored 'General case' 0 C--N 1.256 -3.46 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.71 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 43' ' ' ILE . 29.9 m -128.26 157.2 40.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.499 HG13 ' HD2' ' A' ' 44' ' ' LYS . 10.5 m -119.74 132.59 69.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 C-N-CA 124.959 1.304 . . . . 0.0 110.205 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 124.88 -144.25 15.08 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.57 61.56 3.24 Favored Glycine 0 CA--C 1.466 -2.986 0 O-C-N 125.93 1.606 . . . . 0.0 112.048 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.68 -32.7 6.57 Favored 'General case' 0 C--N 1.261 -3.274 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.403 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.03 170.43 8.93 Favored Pre-proline 0 CA--C 1.478 -1.791 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.633 -171.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.92 63.29 8.11 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.968 3.112 . . . . 0.0 107.76 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.78 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 111.822 -2.445 . . . . 0.0 106.851 -172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.33 119.52 39.27 Favored 'General case' 0 C--O 1.269 2.122 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.357 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.433 ' O ' ' HA3' ' A' ' 33' ' ' GLY . 37.7 m-85 -95.09 164.91 12.68 Favored 'General case' 0 N--CA 1.508 2.427 0 C-N-CA 127.858 2.463 . . . . 0.0 108.408 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -96.3 144.83 26.12 Favored 'General case' 0 C--O 1.169 -3.151 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.609 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 tt0 -134.49 151.34 51.07 Favored 'General case' 0 C--O 1.168 -3.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.6 mm -78.46 126.6 38.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' HG13 ' A' ' 32' ' ' VAL . 10.3 ptmm? -105.35 -22.21 13.08 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 122.342 0.257 . . . . 0.0 111.188 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 15.9 m -156.03 126.91 6.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.3 tp -83.29 114.77 21.62 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 57.4 t -90.45 119.88 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.63 144.0 55.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.319 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 83.49 8.02 0.65 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 125.412 1.695 . . . . 0.0 109.702 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.6 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.16 158.11 27.62 Favored Glycine 0 C--O 1.203 -1.817 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 172.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 58.5 Cg_endo -73.22 -25.37 15.84 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 CA-C-N 121.852 2.826 . . . . 0.0 110.112 -170.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -64.16 -39.84 94.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.189 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.31 66.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-O 122.621 1.2 . . . . 0.0 110.076 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 89.1 mt -71.4 -48.07 52.1 Favored 'General case' 0 N--CA 1.395 -3.191 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.875 -172.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.9 t70 -70.52 -28.29 64.83 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.07 26.97 70.74 Favored Glycine 0 CA--C 1.487 -1.707 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.828 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -90.62 -20.53 22.45 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.457 -0.871 . . . . 0.0 109.563 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.562 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 66.3 mtp -125.72 152.35 45.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.872 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.37 167.34 26.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.603 0.716 . . . . 0.0 111.882 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 44' ' ' LYS . 7.3 m -60.4 116.52 4.35 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.56 -42.03 1.43 Allowed Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.3 148.94 50.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.302 0.3 OUTLIER -110.51 119.15 58.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -172.403 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.1 mm -64.83 115.03 2.78 Favored 'Isoleucine or valine' 0 C--O 1.302 3.842 0 C-N-CA 126.478 1.911 . . . . 0.0 110.765 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 93.0 t -98.49 -58.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.183 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.9 m -154.9 173.35 16.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.306 -0.871 . . . . 0.0 112.147 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 9.8 p -140.97 159.32 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -31.96 105.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.396 1.478 . . . . 0.0 114.76 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.95 33.78 9.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.772 1.629 . . . . 0.0 112.224 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.473 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 15.5 m -140.61 120.71 13.76 Favored 'General case' 0 N--CA 1.421 -1.901 0 O-C-N 121.424 -0.797 . . . . 0.0 109.371 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 24.1 t -81.58 77.07 8.47 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.516 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 91.2 t -74.08 -8.0 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 123.173 1.463 . . . . 0.0 108.62 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 6' ' ' ARG . 24.7 tp -64.89 111.13 2.68 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.138 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.71 74.01 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.477 -176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -74.6 139.78 43.89 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 30.7 m -72.84 145.08 47.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 117.458 -1.258 . . . . 0.0 108.381 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.439 ' HA ' HG12 ' A' ' 80' ' ' VAL . 70.3 t60 -47.33 -48.44 25.3 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.276 0.944 . . . . 0.0 112.216 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.44 70.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.816 0.698 . . . . 0.0 110.843 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 64.8 mm-40 -80.14 -49.4 11.74 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.835 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 41' ' ' LEU . 8.2 p -63.72 -42.68 96.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.445 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.5 p -65.33 -36.05 76.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.834 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 38.6 ttpt -55.26 -48.19 74.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.436 0.294 . . . . 0.0 111.428 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -72.27 -50.26 37.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 122.706 1.241 . . . . 0.0 109.515 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.34 -28.27 68.54 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.024 -1.898 . . . . 0.0 112.792 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.1 mp0 -86.65 -22.93 25.84 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 p -90.0 -18.48 25.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -54.47 151.41 14.27 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -102.84 163.05 0.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.874 3.716 . . . . 0.0 112.283 -177.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 23' ' ' SER . 64.4 mt -67.92 131.91 32.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.931 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.28 10.97 46.74 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.79 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.88 -179.2 4.09 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 118.456 1.128 . . . . 0.0 111.82 -175.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 17.2 t -138.68 153.62 48.56 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 109.94 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.3 m -153.89 151.16 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 C-N-CA 124.341 1.057 . . . . 0.0 110.391 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 14.8 m-20 -95.57 107.59 19.78 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.04 116.39 31.88 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.29 125.05 52.72 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.396 0.617 . . . . 0.0 110.77 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 2.1 pt? -141.95 163.21 33.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.656 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 78.7 m -109.57 124.4 51.07 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.328 0.585 . . . . 0.0 110.662 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.578 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 6.7 tpp85 -98.95 147.31 25.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.32 -28.88 2.44 Favored Glycine 0 CA--C 1.486 -1.773 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -86.58 135.08 36.54 Favored Pre-proline 0 N--CA 1.429 -1.502 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.404 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.568 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 72.0 Cg_endo -98.05 -162.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.615 2.21 . . . . 0.0 107.223 168.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.98 98.96 3.13 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 7.3 Cg_exo -74.01 -8.62 21.36 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.217 2.611 . . . . 0.0 112.012 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -151.62 139.9 20.35 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.55 149.07 71.03 Favored Pre-proline 0 CA--C 1.485 -1.532 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -95.91 10.41 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 123.415 2.743 . . . . 0.0 108.448 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.42 -32.64 32.61 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 113.353 -1.748 . . . . 0.0 108.606 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.24 121.84 85.37 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.127 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.8 -164.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 124.52 3.48 . . . . 0.0 116.068 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 84.61 13.02 0.27 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.318 2.247 . . . . 0.0 113.393 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t 42.88 -142.67 0.11 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.243 1.417 . . . . 0.0 111.575 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.493 ' HB3' HG22 ' B' ' 155' ' ' THR . 5.9 m -60.74 101.88 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.678 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -97.9 136.72 37.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-O 121.681 0.753 . . . . 0.0 112.819 -178.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 m -117.36 131.99 68.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.9 t -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.9 m -105.2 89.58 3.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 122.434 1.111 . . . . 0.0 108.786 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 120' ' ' ILE . 7.1 p -96.3 132.64 40.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.103 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -79.06 74.34 5.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.592 0.71 . . . . 0.0 112.783 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 118' ' ' VAL . 33.0 mm -132.37 13.97 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.5 pt? -82.81 -71.08 0.51 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.712 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 32.2 t70 -159.98 115.86 2.42 Favored 'General case' 0 C--N 1.258 -3.376 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.492 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 36.7 mtpt -121.49 143.54 49.2 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 120.906 0.384 . . . . 0.0 110.076 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -81.6 133.26 52.98 Favored Pre-proline 0 C--N 1.286 -2.165 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.444 -1.431 0 C-N-CA 122.13 1.887 . . . . 0.0 111.187 177.114 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . 0.274 58.6 p 63.95 -97.05 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.56 1.544 . . . . 0.0 115.029 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -72.55 70.26 0.91 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.191 0.996 . . . . 0.0 113.176 -175.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -131.67 3.64 4.18 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.367 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 113' ' ' SER . 11.4 m -84.06 55.32 3.26 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.381 1.086 . . . . 0.0 108.836 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -90.12 128.54 36.35 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.856 -174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -99.73 142.3 31.39 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.41 132.96 36.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.297 0.57 . . . . 0.0 111.468 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 15.0 m -132.78 122.82 25.08 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.454 ' HA ' HG22 ' A' ' 30' ' ' THR . 2.3 mp0 -92.77 110.77 22.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 29' ' ' PHE . 13.9 m . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.839 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.367 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -151.81 -79.94 0.11 Allowed 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.12 0.96 . . . . 0.0 112.997 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.4 ttt -58.29 118.29 5.35 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . 0.46 ' C ' ' HD3' ' A' ' 1' ' ' LYS . . . 103.61 -7.57 50.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.183 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.46 ' HD3' ' C ' ' A' ' 0' ' ' GLY . 0.0 OUTLIER -143.07 174.01 4.02 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -177.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.02 155.58 9.86 Favored 'Trans proline' 0 N--CA 1.435 -1.916 0 N-CA-C 108.017 -1.57 . . . . 0.0 108.017 165.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.419 ' HE1' ' HA ' ' A' ' 11' ' ' LEU . 12.1 p90 -94.11 137.96 32.71 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -141.31 132.05 25.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.057 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 33.0 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.025 165.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 41.81 42.86 2.33 Favored 'General case' 0 C--N 1.372 1.558 0 C-N-CA 126.527 1.931 . . . . 0.0 113.189 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.813 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.6 m-80 -112.5 119.45 43.44 Favored Pre-proline 1 C--N 1.223 -4.893 0 CA-C-N 112.412 -2.177 . . . . 0.0 113.315 176.263 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.317 24.1 Cg_exo -60.71 -37.33 79.74 Favored 'Trans proline' 0 CA--C 1.474 -2.491 0 C-N-CA 121.788 1.659 . . . . 0.0 108.436 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.1 m -64.8 -23.62 67.3 Favored 'General case' 1 N--CA 1.346 -5.653 0 CA-C-N 109.848 -3.342 . . . . 0.0 112.432 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.813 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.9 pt-20 -80.97 -34.59 32.99 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' HA ' ' HE1' ' A' ' 3' ' ' PHE . 98.9 mt -55.79 129.98 41.57 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 122.772 1.273 . . . . 0.0 112.052 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.84 173.74 7.85 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 112.801 -1.999 . . . . 0.0 112.376 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 78.01 -121.35 5.7 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.597 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.67 155.52 49.55 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.916 0.486 . . . . 0.0 109.914 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.33 111.63 20.37 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.41 152.88 37.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-O 121.484 0.659 . . . . 0.0 111.961 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -125.91 113.79 17.67 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.664 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 11.2 t -125.48 137.3 53.96 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.269 0.557 . . . . 0.0 110.633 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -74.82 131.35 40.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.561 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.46 126.31 53.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.45 105.46 17.63 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -39.8 113.97 0.39 Allowed 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 175.754 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.8 t -89.26 -149.65 0.19 Allowed 'General case' 0 N--CA 1.406 -2.628 0 O-C-N 126.182 2.176 . . . . 0.0 107.951 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -61.96 80.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 89' ' ' ILE . 17.4 mmm180 65.54 56.9 0.91 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.59 -131.55 5.22 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.149 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.669 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -130.0 -83.64 0.55 Allowed 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.305 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.578 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 135.03 53.18 0.07 OUTLIER Glycine 0 C--N 1.297 -1.595 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.877 -170.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 43' ' ' ILE . 35.4 p90 -162.39 152.11 16.09 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.3 p -112.03 144.07 42.0 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.051 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 76.1 t -113.45 149.38 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.072 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 42' ' ' GLN . 1.2 m -119.87 129.76 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.47 -132.7 9.15 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.613 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 33.46 59.98 0.5 Allowed Glycine 1 CA--C 1.445 -4.327 0 O-C-N 126.215 1.773 . . . . 0.0 111.391 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.55 -29.6 9.55 Favored 'General case' 0 C--N 1.252 -3.67 0 CA-C-N 113.933 -1.134 . . . . 0.0 109.214 -170.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -159.15 173.78 4.65 Favored Pre-proline 0 CA--C 1.483 -1.606 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.655 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 73.6 Cg_exo -62.22 -25.95 77.24 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.907 2.405 . . . . 0.0 109.921 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.66 -22.76 27.75 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.996 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.44 119.98 31.61 Favored 'General case' 0 C--O 1.264 1.849 0 O-C-N 121.735 -0.603 . . . . 0.0 110.368 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -86.62 164.87 16.58 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.766 2.026 . . . . 0.0 110.805 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD21 HG21 ' A' ' 80' ' ' VAL . 6.8 mp -89.16 144.82 25.84 Favored 'General case' 0 C--O 1.183 -2.398 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.2 tt0 -138.76 158.73 43.68 Favored 'General case' 0 C--O 1.188 -2.16 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 29' ' ' PHE . 32.0 mm -92.6 124.15 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 122.527 0.331 . . . . 0.0 110.216 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -104.85 -18.93 14.05 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 123.452 0.47 . . . . 0.0 110.404 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 54.4 m -154.94 127.63 8.03 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.904 0.383 . . . . 0.0 110.539 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.2 tp -81.14 106.72 13.35 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.1 t -79.82 115.02 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.95 143.52 57.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.614 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.507 ' HA ' HD21 ' A' ' 54' ' ' LEU . 33.1 t70 79.43 14.69 1.01 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 125.252 1.595 . . . . 0.0 109.51 -172.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -97.18 165.27 22.73 Favored Glycine 0 C--O 1.207 -1.579 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.5 Cg_endo -72.51 -25.12 18.22 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 121.816 2.808 . . . . 0.0 110.772 -169.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.81 -45.41 89.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.77 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.36 -46.08 71.05 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 124.637 1.175 . . . . 0.0 110.301 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 92.2 mt -71.66 -34.01 69.36 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.506 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 14.1 t70 -77.91 -27.6 49.54 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.59 29.33 69.83 Favored Glycine 0 CA--C 1.484 -1.898 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.336 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 5.0 tppp? -97.12 -50.81 4.45 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.209 -0.995 . . . . 0.0 111.349 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.61 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 62.7 mtp -88.86 158.34 18.14 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.352 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.78 159.0 43.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 m -62.98 118.68 8.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.28 -31.18 3.05 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' HD12 ' A' ' 97' ' ' LEU . 9.1 m-20 -53.25 140.43 26.59 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.018 0.481 . . . . 0.0 111.615 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.5 OUTLIER -107.8 114.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.175 0.512 . . . . 0.0 111.497 175.805 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -70.25 116.5 11.58 Favored 'Isoleucine or valine' 0 C--O 1.298 3.641 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.166 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG13 HD13 ' A' ' 73' ' ' LEU . 88.3 t -99.57 -59.17 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.395 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 p -151.79 166.21 32.07 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.452 -175.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.95 110.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.925 HD22 ' H ' ' A' ' 94' ' ' ASP . 10.8 m120 43.13 65.21 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 76.46 -38.05 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.663 1.585 . . . . 0.0 112.869 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 m -59.23 122.74 14.61 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.728 0.775 . . . . 0.0 110.382 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -83.33 76.75 9.88 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.602 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 75' ' ' HIS . 43.8 t -77.93 -7.18 10.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.635 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.512 HD13 HG13 ' A' ' 65' ' ' VAL . 16.2 tp -69.43 110.7 4.86 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 76.84 32.68 48.97 Favored Glycine 0 N--CA 1.411 -2.974 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.959 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -88.78 137.26 32.48 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 38.1 m -72.35 144.18 48.35 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 117.942 -1.028 . . . . 0.0 108.838 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' ' HD3' ' B' ' 157' ' ' ARG . 67.2 t60 -47.71 -50.86 23.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 119.046 0.839 . . . . 0.0 112.849 -176.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.7 72.15 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.64 0.587 . . . . 0.0 110.969 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 33.5 mm-40 -75.95 -52.46 10.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.362 0.601 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.664 HG21 HD21 ' A' ' 41' ' ' LEU . 7.2 p -64.43 -43.49 96.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.811 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.57 -35.84 74.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.413 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.83 95.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.905 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.2 -50.54 35.73 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 122.383 1.087 . . . . 0.0 109.455 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.13 -34.87 79.43 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.83 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -85.9 -15.2 42.47 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -82.72 -16.43 48.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.225 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.606 HG23 ' HG2' ' A' ' 22' ' ' LYS . 5.5 mt -43.8 138.82 3.04 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 53.4 Cg_endo -95.96 148.06 1.28 Allowed 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 123.478 2.786 . . . . 0.0 110.858 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.49 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -67.54 139.86 20.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.72 57.08 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.851 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.96 -176.65 3.5 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.007 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.44 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 5.9 p -149.39 138.13 21.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.909 -0.495 . . . . 0.0 111.828 -173.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.722 ' HB ' ' OD1' ' A' ' 68' ' ' ASN . 2.5 m -153.36 143.18 14.54 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 C-N-CA 122.645 0.378 . . . . 0.0 111.953 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.925 ' H ' HD22 ' A' ' 68' ' ' ASN . 19.9 m-20 -78.07 106.98 10.3 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 125.865 1.666 . . . . 0.0 107.749 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.4 tp -96.12 118.75 33.33 Favored 'General case' 0 C--N 1.26 -3.307 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.6 116.51 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -141.94 159.98 41.12 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 -175.12 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 73.8 m -112.82 127.45 56.17 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.532 0.682 . . . . 0.0 110.631 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.597 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 22.7 tpp85 -97.2 146.01 25.5 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.36 -32.24 2.18 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.799 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -77.2 125.18 86.91 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.641 0.257 . . . . 0.0 110.472 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.59 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 86.5 Cg_endo -85.73 -175.48 1.9 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 121.991 1.794 . . . . 0.0 109.785 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.99 89.82 5.92 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 9.4 Cg_exo -74.54 -15.4 21.99 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.747 2.298 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -100.74 166.44 10.87 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 109' ' ' ASP . 6.5 m-20 -111.91 150.33 42.19 Favored Pre-proline 0 C--N 1.268 -2.958 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -96.77 12.44 1.08 Allowed 'Trans proline' 0 N--CA 1.426 -2.496 0 C-N-CA 124.063 3.175 . . . . 0.0 106.771 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -115.47 1.84 13.74 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 112.34 -2.209 . . . . 0.0 107.665 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 106' ' ' ASP . 27.1 t70 -116.25 145.22 34.55 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.39 -172.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -18.75 -88.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 126.91 5.074 . . . . 0.0 117.98 175.388 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 32.7 m-20 57.05 71.58 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 126.268 1.827 . . . . 0.0 112.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.4 t -83.88 -161.34 0.52 Allowed 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.2 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.513 ' HA ' HG23 ' B' ' 155' ' ' THR . 6.7 p -61.63 115.42 3.93 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.12 0.486 . . . . 0.0 112.195 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.49 105.59 15.42 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.24 126.8 52.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.245 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 t -127.02 152.13 47.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m -72.21 115.8 11.88 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.813 0.816 . . . . 0.0 111.307 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.98 147.11 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.319 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.32 110.84 20.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.584 0.706 . . . . 0.0 109.661 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 mt -126.02 -51.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -102.29 160.08 14.84 Favored 'General case' 0 CA--C 1.482 -1.656 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.358 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -82.05 89.98 6.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.521 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 72.7 mmtt -74.3 134.02 42.58 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.208 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -92.66 107.51 24.71 Favored Pre-proline 0 C--N 1.262 -3.208 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.673 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 66.7 Cg_endo . . . . . 0 N--CA 1.436 -1.855 0 C-N-CA 122.859 2.373 . . . . 0.0 111.71 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 76' ' ' THR . 19.4 m -79.05 41.06 0.43 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.612 1.165 . . . . 0.0 113.986 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -158.84 159.57 35.2 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' B' ' 155' ' ' THR . 0.0 OUTLIER 69.57 144.7 0.05 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 124.4 1.062 . . . . 0.0 112.632 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 113' ' ' SER 0.267 13.2 m 111.73 -45.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.292 1.837 . . . . 0.0 113.888 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.422 ' CA ' ' HE ' ' B' ' 156' ' ' ARG . 0.1 OUTLIER 69.52 90.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -174.065 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.445 ' HD3' ' CD2' ' A' ' 77' ' ' HIS . 46.9 mtt180 -92.31 152.12 19.95 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -164.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -93.43 104.6 16.73 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.334 -179.117 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 19.9 m -94.69 101.55 13.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.44 ' HA ' HG22 ' A' ' 30' ' ' THR . 73.3 mt-30 -83.88 122.57 28.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.312 -1.027 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.4 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.207 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -87.04 135.51 33.25 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -178.77 4.13 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 107.76 20.24 8.61 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.536 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 146.49 34.76 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.31 139.9 85.44 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 C-N-CA 122.407 2.071 . . . . 0.0 111.997 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -107.94 144.12 35.64 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.807 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 8.7 t80 -147.37 139.51 24.42 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.612 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 7' ' ' ASN 0.383 9.9 t -156.82 -54.08 0.08 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.51 162.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' A' ' 40' ' ' PHE . 18.0 ptt180 157.88 -33.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.74 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 20.2 t30 -53.94 111.45 2.83 Favored Pre-proline 0 C--N 1.269 -2.904 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.637 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.274 7.6 Cg_exo -57.4 -36.54 98.82 Favored 'Trans proline' 0 CA--C 1.463 -3.035 0 C-N-CA 122.921 2.414 . . . . 0.0 111.241 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.1 m -77.94 -9.32 59.03 Favored 'General case' 1 N--CA 1.347 -5.611 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.424 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.74 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.3 pt-20 -80.23 -36.56 34.58 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.3 mt -57.23 134.51 55.99 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.941 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.62 170.8 16.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.153 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 93.87 -117.01 5.37 Favored Glycine 0 N--CA 1.424 -2.106 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.052 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -150.38 145.78 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 110.465 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.92 112.49 24.18 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 152.49 37.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.471 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 p-80 -123.48 116.38 23.12 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.396 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -122.46 140.98 52.11 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.631 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -73.77 132.73 42.92 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.978 178.777 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.04 127.39 54.86 Favored 'General case' 0 C--O 1.256 1.435 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -86.87 105.84 17.33 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.702 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.767 ' HE3' HG13 ' A' ' 93' ' ' VAL . 1.6 mptm? -36.65 108.74 0.08 Allowed 'General case' 0 C--O 1.257 1.495 0 C-N-CA 125.115 1.366 . . . . 0.0 112.38 173.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 t -124.32 142.42 51.29 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 125.034 1.459 . . . . 0.0 108.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 m 52.56 39.4 27.98 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 67.52 35.15 4.3 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.013 1.325 . . . . 0.0 110.989 176.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.31 -120.95 0.83 Allowed Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.602 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.5 m-85 -137.92 -93.25 0.21 Allowed 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 50' ' ' GLY . . . 153.03 54.46 0.01 OUTLIER Glycine 0 C--N 1.292 -1.916 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 44.7 p90 -160.64 166.48 28.82 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.575 HG22 ' HA ' ' B' ' 160' ' ' GLN . 29.3 p -120.51 136.23 54.83 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 121.192 -0.942 . . . . 0.0 109.126 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.67 140.09 47.52 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.687 -170.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 6.8 m -115.24 169.05 6.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.101 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.794 ' O ' ' HB3' ' B' ' 157' ' ' ARG . . . 84.8 -125.79 7.35 Favored Glycine 0 C--O 1.191 -2.558 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 31.89 58.5 0.36 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 125.87 1.7 . . . . 0.0 113.863 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.57 -32.11 5.98 Favored 'General case' 1 C--N 1.233 -4.494 0 CA-C-N 113.033 -1.583 . . . . 0.0 109.431 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -158.6 172.24 6.39 Favored Pre-proline 0 CA--C 1.466 -2.274 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.397 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 50.0 Cg_exo -63.83 -26.02 67.65 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.206 1.937 . . . . 0.0 108.914 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.521 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 9.8 t70 -71.43 -35.47 70.95 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.638 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.87 119.11 26.94 Favored 'General case' 0 C--O 1.275 2.415 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.188 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 8.6 m-85 -82.46 166.03 19.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.849 2.46 . . . . 0.0 110.699 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.769 HD21 HG21 ' A' ' 80' ' ' VAL . 3.9 mp -85.36 145.42 27.5 Favored 'General case' 0 C--O 1.187 -2.214 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.122 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.2 tt0 -145.04 148.38 33.64 Favored 'General case' 0 C--O 1.191 -1.977 0 CA-C-N 118.817 0.735 . . . . 0.0 109.264 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.4 mm -81.7 123.26 37.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' C ' HG23 ' A' ' 60' ' ' THR . 42.8 pttt -103.41 -19.96 14.24 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.053 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.2 m -155.31 127.74 7.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.11 111.3 18.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.2 t -86.67 121.47 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.0 145.42 55.42 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.542 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 t70 84.41 6.03 0.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 125.56 1.788 . . . . 0.0 109.319 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.72 158.51 25.2 Favored Glycine 0 C--O 1.2 -1.995 0 CA-C-O 118.322 -1.266 . . . . 0.0 110.66 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.3 Cg_endo -72.13 -25.11 19.49 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 CA-C-N 120.858 2.329 . . . . 0.0 110.192 -171.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -62.43 -46.81 86.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.977 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.64 81.76 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.609 1.164 . . . . 0.0 110.753 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.5 mt -71.92 -41.58 67.71 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 113.336 -1.756 . . . . 0.0 114.378 -174.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.8 -25.09 61.02 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.78 -0.32 86.42 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 117.941 1.937 . . . . 0.0 117.941 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -94.47 -49.54 5.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 120.348 2.074 . . . . 0.0 114.03 -176.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.601 ' HG2' HD11 ' A' ' 97' ' ' LEU . 65.8 mtp -64.62 139.46 58.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.187 0.304 . . . . 0.0 110.894 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.27 167.12 18.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.343 0.592 . . . . 0.0 110.939 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 44' ' ' LYS . 25.7 m -60.83 128.19 35.29 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.54 -35.03 4.02 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.455 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 43' ' ' ILE . 3.5 m-20 -52.78 129.07 28.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.383 0.673 . . . . 0.0 110.613 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.255 0.8 OUTLIER -93.4 116.23 34.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.335 0.588 . . . . 0.0 112.184 -179.161 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.8 mm -72.77 115.52 13.6 Favored 'Isoleucine or valine' 0 C--O 1.295 3.476 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.829 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 73' ' ' LEU . 98.7 t -98.45 -56.69 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 112.293 -2.23 . . . . 0.0 110.54 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.4 m -157.66 174.66 15.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.699 -0.626 . . . . 0.0 110.98 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.471 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.9 p -140.02 159.78 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.521 ' OD1' HG12 ' A' ' 93' ' ' VAL . 28.4 p-10 -29.22 109.86 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.524 1.129 . . . . 0.0 113.31 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 69.8 -37.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.995 1.318 . . . . 0.0 113.729 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.0 m -82.67 124.35 30.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.076 0.941 . . . . 0.0 111.865 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.82 78.72 9.83 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.985 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 23.8 t -77.17 3.71 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.302 1.049 . . . . 0.0 109.068 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD13 HG13 ' A' ' 65' ' ' VAL . 12.1 tp -65.74 111.55 3.28 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.514 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 62.96 37.9 95.7 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.589 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -74.13 137.85 43.5 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 47.3 m -72.76 146.96 46.01 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.527 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.573 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 1.2 t60 -44.43 -49.63 9.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.236 0.614 . . . . 0.0 112.045 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.81 80.35 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 123.748 0.655 . . . . 0.0 111.102 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 25.6 mm-40 -75.33 -53.41 8.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 41' ' ' LEU . 11.7 p -59.72 -44.59 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.725 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.7 p -69.48 -36.13 69.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.062 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 3.7 tmmm? -59.96 -44.07 94.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.7 -50.68 37.31 Favored 'Isoleucine or valine' 0 C--O 1.262 1.729 0 CA-C-O 122.507 1.146 . . . . 0.0 108.895 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 13.2 m-85 -66.18 -33.76 76.49 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.398 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.82 -19.21 32.84 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.349 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.3 m -84.08 -10.01 58.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.069 0.461 . . . . 0.0 110.879 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 22' ' ' LYS . 6.1 mt -49.78 138.07 18.0 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -101.58 149.16 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.209 3.273 . . . . 0.0 111.254 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.535 HG12 ' H ' ' A' ' 25' ' ' ARG . 22.8 mt -68.4 143.25 15.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.052 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.19 11.42 57.44 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.427 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -107.09 -173.36 2.27 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.547 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.567 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 31.1 t -149.52 151.94 34.73 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -169.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HE3' ' A' ' 22' ' ' LYS . 1.1 m -157.12 153.72 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 C-N-CA 124.206 1.002 . . . . 0.0 111.245 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.02 107.49 19.54 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.7 tp -96.03 116.57 29.16 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.55 113.96 25.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.601 HD11 ' HG2' ' A' ' 58' ' ' MET . 1.4 pt? -141.48 157.8 44.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.1 t -111.63 123.58 50.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.588 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.7 tpp85 -92.12 143.06 26.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.15 -36.16 1.41 Allowed Glycine 0 C--N 1.294 -1.769 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -88.32 129.04 51.01 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -104.56 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.696 2.264 . . . . 0.0 110.815 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.99 79.64 6.24 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD2' ' CD2' ' A' ' 105' ' ' PHE . 57.6 Cg_endo -87.98 5.37 5.42 Favored 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.783 2.322 . . . . 0.0 110.96 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.406 ' CD2' ' HD2' ' A' ' 104' ' ' PRO . 52.7 p90 -138.41 172.14 13.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.7 m-20 -126.88 146.39 57.24 Favored Pre-proline 0 C--N 1.291 -1.97 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.561 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.0 Cg_endo -92.32 1.25 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.965 3.11 . . . . 0.0 107.345 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -86.46 -30.5 21.98 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 112.419 -2.173 . . . . 0.0 107.366 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.68 143.85 34.37 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.437 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.03 -163.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.679 2.919 . . . . 0.0 115.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' B' ' 152' ' ' SER . 65.6 m-20 71.82 32.86 1.83 Allowed 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.901 -175.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 m -171.11 135.14 0.97 Allowed 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' B' ' 154' ' ' ARG . 71.0 m -103.61 116.09 31.71 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 121.329 0.585 . . . . 0.0 111.401 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.439 HD13 ' O ' ' B' ' 156' ' ' ARG . 1.0 OUTLIER -92.95 116.17 28.8 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.838 175.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.23 122.57 67.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 t -71.27 151.41 44.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.573 ' HB2' ' NE2' ' A' ' 77' ' ' HIS . 32.7 t -84.26 108.12 16.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.88 123.48 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.38 76.46 1.03 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.0 mm -88.0 -35.05 7.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.68 177.4 6.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.346 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 71.98 4.97 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -172.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.83 49.15 1.79 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.793 -1.549 . . . . 0.0 107.921 169.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.72 118.39 70.5 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.416 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.544 0.999 0 C-N-CA 123.454 2.769 . . . . 0.0 112.979 178.765 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 46.6 m -75.92 93.15 3.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.089 0.471 . . . . 0.0 111.468 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 19.9 m -77.94 121.42 24.15 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' SER . 79.9 mtm180 -69.94 -14.88 62.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.57 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.2 p -148.85 97.57 2.73 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.771 0.828 . . . . 0.0 110.141 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.439 ' O ' HD13 ' A' ' 114' ' ' LEU . 34.4 ttm180 -103.53 115.5 30.63 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.794 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.82 151.85 40.43 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.228 -0.897 . . . . 0.0 113.343 -171.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -113.82 130.37 56.48 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 126.685 1.994 . . . . 0.0 107.844 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.72 ' OG1' ' HD3' ' B' ' 157' ' ' ARG . 54.4 m -147.33 117.02 7.09 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.575 ' HA ' HG22 ' A' ' 30' ' ' THR . 62.8 tt0 -91.51 109.22 20.51 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.276 -2.596 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.305 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -85.01 100.11 11.45 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.231 0.538 . . . . 0.0 109.857 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.7 mmt -128.26 153.37 47.03 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.486 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 89.76 21.87 38.4 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.147 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 150.98 38.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 116.696 0.248 . . . . 0.0 110.397 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 127.83 17.77 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 121.941 1.761 . . . . 0.0 110.461 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -101.21 131.37 47.24 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.541 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -148.37 132.12 16.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.815 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.605 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.3 t -169.96 34.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.862 0.726 . . . . 0.0 109.495 168.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 5' ' ' THR . 12.8 ptm180 53.23 16.43 0.81 Allowed 'General case' 0 N--CA 1.518 2.933 0 C-N-CA 127.12 2.168 . . . . 0.0 113.686 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.729 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.78 110.28 36.26 Favored Pre-proline 0 C--N 1.257 -3.426 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.793 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.263 7.7 Cg_exo -58.38 -31.86 94.91 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 121.225 1.283 . . . . 0.0 109.114 171.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -72.74 -19.52 61.37 Favored 'General case' 1 N--CA 1.361 -4.9 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.851 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.8 pt-20 -79.77 -31.53 40.9 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 40' ' ' PHE . 86.7 mt -63.46 137.55 58.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.649 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.84 174.0 7.47 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.652 -174.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.83 -115.52 5.33 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.382 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.38 149.15 46.75 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.54 115.55 23.03 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -134.89 153.13 34.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 -176.222 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -129.44 123.64 32.11 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.59 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.483 HG21 ' HB2' ' A' ' 58' ' ' MET . 15.2 t -127.89 133.05 49.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.292 0.568 . . . . 0.0 111.758 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -81.86 128.3 33.89 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 mp -111.06 127.97 55.72 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -87.49 108.26 18.95 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.693 ' HG3' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -40.48 108.43 0.09 Allowed 'General case' 0 CA--C 1.462 -2.434 0 C-N-CA 125.857 1.663 . . . . 0.0 112.246 175.148 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -87.54 -143.21 0.12 Allowed 'General case' 0 N--CA 1.401 -2.896 0 O-C-N 126.598 2.436 . . . . 0.0 107.298 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -67.01 82.6 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER 64.13 24.34 13.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 112.063 176.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -130.33 1.68 Allowed Glycine 0 C--O 1.276 2.78 0 C-N-CA 118.588 -1.768 . . . . 0.0 113.692 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.6 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 78.8 m-85 -133.83 -91.65 0.35 Allowed 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.33 53.15 0.1 Allowed Glycine 0 C--N 1.306 -1.089 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -169.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 32.8 p90 -162.0 145.86 12.27 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -108.13 135.87 48.76 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG13 ' HB ' ' B' ' 159' ' ' THR . 1.9 p -123.41 140.4 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 CA-C-N 113.403 -1.726 . . . . 0.0 111.02 -171.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 5.5 m -124.02 133.65 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 C-N-CA 124.677 1.191 . . . . 0.0 110.691 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 -140.78 12.2 Favored Glycine 0 CA--C 1.461 -3.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.4 55.86 2.47 Favored Glycine 0 CA--C 1.45 -3.977 0 O-C-N 126.695 2.056 . . . . 0.0 112.101 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.24 -31.62 15.36 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.639 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 4.7 pt-20 -158.7 167.69 13.92 Favored Pre-proline 0 CA--C 1.48 -1.724 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.484 -171.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' GLU . 15.0 Cg_exo -77.76 64.45 8.16 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 124.189 3.259 . . . . 0.0 107.805 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.15 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.065 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.35 119.97 40.85 Favored 'General case' 0 C--O 1.267 1.992 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 11' ' ' LEU . 20.5 m-85 -84.32 164.37 19.03 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 127.804 2.442 . . . . 0.0 111.778 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -90.45 147.89 23.12 Favored 'General case' 0 C--O 1.201 -1.473 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.9 tt0 -139.63 155.27 47.53 Favored 'General case' 0 C--O 1.184 -2.367 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 29' ' ' PHE . 44.7 mm -100.3 123.47 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.588 -0.695 . . . . 0.0 110.811 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . 56.7 pttt -102.62 -23.59 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 123.357 0.411 . . . . 0.0 112.02 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 m -151.88 127.05 9.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.48 108.17 19.25 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.511 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 62.9 t -85.82 134.35 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.494 0.664 . . . . 0.0 110.197 -173.115 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.15 140.92 57.53 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.189 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 80.54 5.29 1.65 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.238 1.415 . . . . 0.0 110.996 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.68 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -81.62 159.36 40.32 Favored Glycine 0 C--O 1.203 -1.817 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.558 173.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 13.5 Cg_endo -72.0 -25.09 19.94 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 CA-C-N 121.559 2.68 . . . . 0.0 109.855 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -64.97 -42.37 94.62 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.64 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.43 76.99 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.767 1.27 . . . . 0.0 109.782 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 65.9 mt -72.11 -46.91 54.79 Favored 'General case' 0 C--N 1.267 -3.007 0 CA-C-N 112.64 -2.073 . . . . 0.0 115.188 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.76 -24.65 56.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.05 -155.94 33.6 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.007 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.7 tttp 70.25 -58.79 0.53 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.135 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 18' ' ' THR . 26.9 ttt -77.65 137.64 38.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.639 0.776 . . . . 0.0 109.076 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -152.16 143.69 23.47 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.741 0.416 . . . . 0.0 109.941 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 m -45.81 116.38 1.19 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.215 1.006 . . . . 0.0 110.811 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.78 -11.04 7.05 Favored Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.57 145.45 56.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 3.4 m -106.99 132.65 53.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 117.961 -1.496 . . . . 0.0 107.213 168.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.272 5.8 mt -83.74 119.55 33.16 Favored 'Isoleucine or valine' 1 C--O 1.31 4.267 0 CA-C-O 121.564 0.697 . . . . 0.0 112.599 -178.531 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 73' ' ' LEU . 93.7 t -109.23 -50.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 O-C-N 127.356 2.91 . . . . 0.0 112.382 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 72' ' ' VAL . 29.2 m -145.48 158.63 43.81 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.491 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG13 ' HB ' ' A' ' 70' ' ' THR . 5.2 p -135.23 86.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.482 37.3 p30 54.93 -90.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.361 2.265 . . . . 0.0 114.761 -171.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -89.59 -37.65 14.52 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.609 0.719 . . . . 0.0 110.172 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HB ' HG13 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -77.91 127.84 33.0 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.842 -172.297 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.98 96.68 10.35 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 14.5 p -90.67 -1.11 9.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.783 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 65' ' ' VAL . 17.4 tp -69.56 112.0 5.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.43 27.33 43.93 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.599 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -81.42 150.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 63.3 m -76.48 142.47 40.94 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 117.824 -1.084 . . . . 0.0 108.764 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.7 t-80 -48.27 -48.66 35.47 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.061 0.846 . . . . 0.0 112.894 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.49 69.55 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.303 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 29.3 mm-40 -80.55 -46.23 16.11 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 HD21 ' A' ' 41' ' ' LEU . 7.6 p -61.92 -43.73 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.917 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.3 -35.93 74.1 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.559 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.81 -46.69 81.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.733 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.5 -50.69 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.208 1.004 . . . . 0.0 109.362 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -62.26 -36.28 81.58 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.479 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.57 -20.04 32.12 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.699 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 t -80.8 -13.08 59.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.693 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.6 mt -48.67 134.11 13.79 Favored Pre-proline 0 CA--C 1.565 1.558 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 88.3 Cg_endo -99.95 157.63 0.53 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.233 3.288 . . . . 0.0 112.286 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' SER . 22.7 mt -68.97 142.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 123.656 0.782 . . . . 0.0 110.425 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.99 13.27 69.51 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.206 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -109.94 -170.19 1.61 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.486 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.459 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.4 t -149.95 148.88 29.61 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.917 -0.489 . . . . 0.0 112.281 -172.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.639 HG22 ' HE3' ' A' ' 22' ' ' LYS . 6.5 m -155.24 145.92 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 124.844 1.258 . . . . 0.0 110.05 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.5 ' H ' ' HB3' ' A' ' 68' ' ' ASN . 7.0 m-20 -95.9 107.75 20.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.682 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.6 mm? -92.06 120.87 33.08 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.092 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.77 122.44 38.55 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.51 151.57 35.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.891 0.744 . . . . 0.0 109.737 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 63' ' ' VAL . 8.3 t -117.92 111.51 19.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 168.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 13.4 tpp85 -100.28 158.01 16.19 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.4 -15.52 6.38 Favored Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.77 125.79 49.83 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 113.889 -1.156 . . . . 0.0 108.165 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.6 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 84.6 Cg_endo -85.61 -172.2 1.07 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 121.828 1.685 . . . . 0.0 109.696 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.3 83.83 1.57 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 16.4 Cg_exo -67.77 -52.46 0.54 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.259 1.973 . . . . 0.0 110.138 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -105.43 120.38 41.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.8 m-20 -79.36 148.46 70.54 Favored Pre-proline 0 CA--C 1.468 -2.196 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 44' ' ' LYS . 2.7 Cg_endo -93.59 9.13 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.759 2.973 . . . . 0.0 107.537 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.34 -31.75 43.11 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 112.394 -2.185 . . . . 0.0 106.193 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.1 142.13 92.61 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.583 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.85 178.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.664 3.576 . . . . 0.0 117.154 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 81.72 -38.33 0.12 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.81 2.044 . . . . 0.0 114.417 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 38.8 m 68.63 -73.6 0.09 Allowed 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.517 1.127 . . . . 0.0 111.329 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB3' HG23 ' B' ' 155' ' ' THR . 50.9 m -76.06 102.55 5.72 Favored 'General case' 0 C--N 1.26 -3.324 0 C-N-CA 125.641 1.576 . . . . 0.0 107.938 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.3 mt -97.54 103.87 15.84 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.514 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.8 t -104.65 112.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 t -91.89 150.85 20.83 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.4 p -94.58 122.74 37.47 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.99 100.48 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -133.69 80.7 1.88 Allowed 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.742 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.51 -18.11 6.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.37 151.73 42.24 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.018 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.73 2.45 4.36 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.456 1.122 . . . . 0.0 112.307 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 29.3 ttpp -83.62 81.48 8.73 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.988 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -98.12 117.72 64.59 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.032 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.438 -1.753 0 C-N-CA 122.523 2.149 . . . . 0.0 111.362 177.042 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 14.5 m -88.95 109.29 20.12 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 33.4 m -58.27 129.33 41.49 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -84.97 -14.01 48.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.824 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.435 HG22 ' H ' ' B' ' 156' ' ' ARG . 7.0 m -169.5 169.78 8.64 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 169.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.435 ' H ' HG22 ' B' ' 155' ' ' THR . 39.2 ptt180 -179.55 142.2 0.17 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 75.2 mtm180 -131.48 161.45 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.135 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 15.0 pt-20 -102.45 112.55 25.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.523 ' HB ' HG13 ' A' ' 31' ' ' VAL . 11.0 m -93.04 124.16 36.82 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 172.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -106.11 101.89 11.34 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.724 -0.61 . . . . 0.0 109.977 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.722 -172.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.72 150.37 24.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 1' ' ' LYS . 13.8 tpt -134.29 83.49 2.04 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.646 0.736 . . . . 0.0 111.265 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -120.57 25.42 7.28 Favored Glycine 0 C--N 1.301 -1.399 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 172.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 1' ' ' LYS . 3.7 mptp? -77.41 142.62 67.4 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.155 -1.023 . . . . 0.0 110.049 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.55 159.94 42.11 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.865 2.376 . . . . 0.0 113.376 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -105.5 135.78 46.26 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.848 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.57 134.44 20.16 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -169.41 35.92 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.914 0.759 . . . . 0.0 112.019 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 6.8 tpt180 61.75 30.97 18.57 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.413 1.578 . . . . 0.0 109.97 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.781 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.9 m-20 -120.29 108.18 38.35 Favored Pre-proline 0 C--N 1.263 -3.193 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.276 8.0 Cg_exo -55.22 -30.19 70.33 Favored 'Trans proline' 0 CA--C 1.486 -1.882 0 C-N-CA 121.527 1.485 . . . . 0.0 110.289 169.521 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -75.36 -23.01 57.1 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.601 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.781 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -73.99 -33.23 63.75 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 74.8 mt -62.09 133.28 55.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.785 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.31 175.81 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.451 -1.704 . . . . 0.0 113.672 -171.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 87.94 -132.0 10.95 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.47 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.608 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.39 142.8 51.01 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 123.819 0.848 . . . . 0.0 109.331 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -107.22 116.15 31.42 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -133.67 151.94 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.66 -177.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 13.2 t-160 -123.31 105.23 9.68 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -124.18 136.9 54.51 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.158 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.65 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -78.12 129.84 35.66 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.331 0.653 . . . . 0.0 110.324 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -117.31 120.17 37.39 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 176.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -84.77 103.1 13.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.97 115.07 0.36 Allowed 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 176.344 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -88.52 -148.31 0.16 Allowed 'General case' 0 N--CA 1.41 -2.431 0 O-C-N 126.241 2.213 . . . . 0.0 108.056 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -62.69 83.79 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.547 ' H ' HG12 ' A' ' 89' ' ' ILE . 22.2 mmt180 67.35 49.61 1.03 Allowed 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 124.964 1.306 . . . . 0.0 112.492 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.32 -123.16 2.22 Favored Glycine 0 N--CA 1.401 -3.682 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.685 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.694 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 64.1 m-85 -125.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.261 -3.265 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.471 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.26 49.64 0.18 Allowed Glycine 0 C--N 1.292 -1.867 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.052 -172.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 27' ' ' PHE . 28.3 p90 -161.16 142.26 11.52 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 73.9 p -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 11.0 m -125.7 159.16 33.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.885 -170.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG13 ' CD ' ' A' ' 44' ' ' LYS . 4.2 m -120.53 131.59 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 C-N-CA 124.07 0.948 . . . . 0.0 110.519 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.694 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 130.58 -137.24 9.36 Favored Glycine 0 C--O 1.291 3.701 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.527 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.83 61.86 3.21 Favored Glycine 1 CA--C 1.436 -4.886 0 O-C-N 127.109 2.299 . . . . 0.0 110.953 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 76' ' ' THR . 13.5 t0 -99.19 -48.66 4.76 Favored 'General case' 0 C--N 1.248 -3.833 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 5.9 pt-20 -160.35 175.97 2.84 Favored Pre-proline 0 C--N 1.287 -2.14 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.661 -170.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 32.2 Cg_exo -72.42 64.89 3.68 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.154 3.236 . . . . 0.0 107.97 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 1.8 t70 -171.66 -41.49 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.498 -2.137 . . . . 0.0 108.637 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.87 120.09 28.36 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.204 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -88.61 166.1 14.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 128.242 2.617 . . . . 0.0 108.114 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -89.77 144.13 26.23 Favored 'General case' 0 C--O 1.166 -3.329 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.903 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 tt0 -130.59 156.28 45.12 Favored 'General case' 0 C--O 1.17 -3.089 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.421 HD11 HG12 ' A' ' 64' ' ' ILE . 13.3 mm -93.05 128.9 44.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 CA-C-N 119.161 0.891 . . . . 0.0 109.823 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CD ' HG13 ' A' ' 32' ' ' VAL . 4.5 ptmm? -107.82 -23.96 11.86 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 39.7 m -151.61 126.96 9.95 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.686 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.1 112.33 18.37 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 57.6 t -89.93 122.56 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.05 146.3 54.84 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.605 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 83.05 4.27 0.94 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 125.055 1.472 . . . . 0.0 109.771 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.98 158.77 36.93 Favored Glycine 0 C--O 1.205 -1.673 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.541 173.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.9 Cg_endo -72.17 -25.26 19.18 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 CA-C-N 121.549 2.674 . . . . 0.0 109.716 -171.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -60.65 -48.18 82.93 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.88 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.89 82.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.163 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 83.9 mt -72.07 -39.51 68.96 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.975 -172.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.45 -21.07 45.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.42 40.97 98.35 Favored Glycine 0 CA--C 1.49 -1.503 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.753 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -141.95 27.54 1.8 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.185 0.993 . . . . 0.0 110.315 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.647 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.7 tmt? -160.24 137.49 9.4 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HG2' ' NE ' ' A' ' 99' ' ' ARG . 7.9 pt-20 -154.95 160.07 40.86 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 119.309 0.959 . . . . 0.0 112.336 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -53.72 123.15 11.47 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.519 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.56 -1.09 21.93 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.954 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.1 p30 -100.94 161.92 13.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.432 172.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.727 HG13 ' SG ' ' A' ' 98' ' ' CYS 0.342 0.2 OUTLIER -118.31 125.3 74.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -179.093 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.421 HG12 HD11 ' A' ' 43' ' ' ILE . 47.4 mm -69.77 114.17 6.71 Favored 'Isoleucine or valine' 0 C--O 1.303 3.914 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.605 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.67 HG13 HD13 ' A' ' 73' ' ' LEU . 88.2 t -93.59 -58.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 112.471 -2.15 . . . . 0.0 110.007 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -162.22 173.96 13.54 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.99 -0.444 . . . . 0.0 110.871 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.0 p -143.68 156.64 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 3.1 t-20 -30.18 111.28 0.07 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.8 1.64 . . . . 0.0 113.033 170.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.5 t70 75.39 -27.2 0.19 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.63 1.572 . . . . 0.0 113.677 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 m -112.44 116.24 29.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.979 0.895 . . . . 0.0 111.403 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.3 t -82.75 96.0 8.04 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.47 0.09 4.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.431 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.67 HD13 HG13 ' A' ' 65' ' ' VAL . 15.2 tp -65.07 110.99 2.69 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.256 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.26 80.62 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.433 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -74.03 145.4 44.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 44.2 m -76.69 142.83 40.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.216 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.432 ' O ' HG12 ' A' ' 81' ' ' VAL . 55.9 t-80 -48.08 -49.22 32.4 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 118.993 0.815 . . . . 0.0 112.537 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.06 75.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 124.298 0.999 . . . . 0.0 110.517 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 68.1 mm-40 -77.95 -49.96 13.11 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.012 -176.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -63.59 -43.92 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.444 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.8 p -63.78 -40.26 88.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.228 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' SER . 4.6 tmmm? -58.45 -44.21 89.14 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.825 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.28 -48.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 122.057 0.932 . . . . 0.0 109.977 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.52 -32.24 73.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.958 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.81 -16.64 38.13 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.877 0.37 . . . . 0.0 110.968 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 27.4 t -77.81 -23.45 49.07 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.617 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.6 mt -50.28 139.36 19.23 Favored Pre-proline 0 N--CA 1.434 -1.261 0 C-N-CA 124.382 1.073 . . . . 0.0 113.292 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 71.7 Cg_endo -99.69 158.5 0.56 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 124.185 3.257 . . . . 0.0 111.422 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.547 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.6 mt -68.32 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.245 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.72 12.61 60.56 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.561 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -100.02 -175.27 2.9 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.281 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.65 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 13.2 t -148.22 139.2 23.18 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.886 -0.509 . . . . 0.0 112.338 -172.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.9 m -151.64 158.98 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.063 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.559 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 8.2 m-20 -102.87 108.01 19.06 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD22 HD22 ' A' ' 20' ' ' LEU . 12.5 tp -100.79 120.96 40.88 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 12.6 pt-20 -103.16 124.4 48.51 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 58' ' ' MET . 4.2 pp -141.64 165.31 27.83 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.407 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.727 ' SG ' HG13 ' A' ' 63' ' ' VAL . 3.0 p -118.73 113.42 21.12 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.458 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -90.38 137.32 32.45 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.484 -173.724 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.94 23.79 5.44 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.599 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -95.32 127.56 41.79 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 17.9 Cg_endo -58.2 134.24 60.5 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.339 2.026 . . . . 0.0 113.206 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.61 77.18 3.22 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 176.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 74.4 Cg_endo -89.98 32.92 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.755 2.303 . . . . 0.0 112.455 -173.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 162.19 35.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 108' ' ' ASP . 21.3 t70 -90.15 136.88 28.26 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 10.2 Cg_endo -97.45 3.23 1.56 Allowed 'Trans proline' 0 N--CA 1.412 -3.279 0 C-N-CA 123.139 2.559 . . . . 0.0 111.098 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 11.7 t70 -87.95 -48.3 7.89 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -49.06 122.16 11.34 Favored Pre-proline 0 C--O 1.235 0.329 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -34.9 82.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.428 1 C-N-CA 126.858 5.038 . . . . 0.0 118.577 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.05 37.06 4.11 Favored 'General case' 0 C--N 1.272 -2.788 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.538 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.45 HG23 ' HG2' ' B' ' 158' ' ' GLU . 54.5 m -73.99 -38.14 64.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.145 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.3 t -117.57 105.54 12.18 Favored 'General case' 1 C--N 1.242 -4.104 0 CA-C-N 112.972 -1.922 . . . . 0.0 107.901 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' H ' ' HA ' ' B' ' 155' ' ' THR . 31.1 mt -75.55 104.46 6.12 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.05 102.18 12.64 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.345 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.246 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.1 t -96.33 142.97 27.82 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.3 m -87.62 135.39 33.38 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.56 134.94 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.07 85.51 5.53 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 121.498 0.666 . . . . 0.0 111.387 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.82 -43.33 13.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.13 -171.24 3.46 Favored 'General case' 0 C--O 1.25 1.129 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.468 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.04 67.74 9.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.488 1.137 . . . . 0.0 111.999 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -96.69 73.75 2.7 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.553 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -97.61 102.48 13.17 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 122.808 2.338 . . . . 0.0 112.572 -176.061 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 152' ' ' SER . . . . . 0.491 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 16.9 m -63.96 96.02 0.13 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.502 1.121 . . . . 0.0 111.523 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -150.11 97.64 2.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.538 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 55.57 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.951 2.1 . . . . 0.0 115.572 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.554 ' HA ' ' H ' ' A' ' 114' ' ' LEU . 80.9 p 56.15 50.74 12.96 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.003 1.721 . . . . 0.0 112.833 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -123.83 -153.69 0.57 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.694 ' HA ' ' H ' ' A' ' 33' ' ' GLY 0.352 97.4 mtt180 79.47 -74.41 0.06 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 112' ' ' THR . 9.0 tp10 -62.87 98.07 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.067 0.854 . . . . 0.0 111.815 -174.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 4.8 m -115.01 102.78 10.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.436 ' HA ' HG22 ' A' ' 30' ' ' THR . 77.3 mt-30 -86.28 95.22 9.55 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.58 HG23 ' HB2' ' A' ' 27' ' ' PHE . 9.1 m . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.427 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.673 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.17 63.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.411 0.624 . . . . 0.0 109.738 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -177.56 6.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.907 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 94.99 -1.63 65.37 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.992 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -127.29 143.83 48.57 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.82 137.48 38.4 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.297 1.998 . . . . 0.0 110.789 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -109.18 141.41 41.46 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.59 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.658 ' CZ ' ' HA ' ' A' ' 38' ' ' ASP . 11.4 t80 -147.46 142.72 27.28 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 7' ' ' ASN 0.32 12.6 t -157.57 -48.14 0.07 Allowed 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.264 161.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' HD21 ' A' ' 73' ' ' LEU . 26.7 ptt180 156.39 -30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.29 1.836 . . . . 0.0 106.276 177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 39.4 t-20 -40.6 107.68 0.49 Allowed Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.414 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.261 9.6 Cg_exo -61.67 -32.95 87.16 Favored 'Trans proline' 0 CA--C 1.465 -2.932 0 C-N-CA 121.918 1.745 . . . . 0.0 110.374 -178.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -80.04 -18.92 48.88 Favored 'General case' 1 N--CA 1.338 -6.046 0 CA-C-N 111.972 -2.376 . . . . 0.0 111.726 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.2 pt-20 -73.24 -36.22 66.4 Favored 'General case' 0 C--N 1.379 1.859 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 85.3 mt -54.94 129.37 37.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.785 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.9 -162.58 0.55 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.26 -171.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 65.92 -102.0 0.66 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.003 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 149.06 32.93 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 123.259 0.624 . . . . 0.0 109.861 178.564 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 8' ' ' PRO . 2.5 t80 -112.64 110.98 21.46 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.18 153.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.708 -177.158 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 26.8 p-80 -132.05 107.59 8.76 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.928 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -122.51 132.18 54.2 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -76.29 136.26 39.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.43 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.0 130.53 54.78 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.199 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -82.89 124.23 30.14 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 109.46 0.44 Allowed 'General case' 0 CA--C 1.466 -2.257 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 173.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.7 t -85.14 -146.18 0.1 Allowed 'General case' 0 N--CA 1.413 -2.306 0 O-C-N 126.624 2.453 . . . . 0.0 107.82 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 m -64.12 84.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.0 mpt_? 59.86 43.99 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 125.698 1.599 . . . . 0.0 111.353 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.24 -127.0 1.8 Allowed Glycine 1 N--CA 1.394 -4.143 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.935 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.7 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m-85 -133.68 -82.57 0.46 Allowed 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 114.349 -0.926 . . . . 0.0 111.356 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.33 54.76 0.18 Allowed Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -169.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.8 p90 -161.32 148.77 15.04 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -113.08 136.66 52.46 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.909 0.861 . . . . 0.0 109.154 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 6.2 p -128.63 150.54 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.523 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.472 -167.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.758 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 12.3 m -114.33 154.3 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 124.829 1.252 . . . . 0.0 113.106 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 87.23 -123.91 6.8 Favored Glycine 0 C--O 1.291 3.706 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.94 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.64 47.79 3.06 Favored Glycine 0 CA--C 1.47 -2.781 0 O-C-N 126.455 1.914 . . . . 0.0 112.081 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' B' ' 156' ' ' ARG . 6.1 t70 -95.4 -29.31 14.5 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -173.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . 13.2 mt-10 -140.95 172.64 5.86 Favored Pre-proline 0 N--CA 1.41 -2.442 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.062 -169.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_exo -73.66 -8.4 21.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.532 2.822 . . . . 0.0 108.149 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.658 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 17.6 t70 -108.03 -9.13 15.69 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.047 -1.888 . . . . 0.0 110.183 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -131.24 119.41 21.77 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.639 -0.663 . . . . 0.0 110.9 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 8.4 m-85 -86.57 166.18 15.62 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.428 2.291 . . . . 0.0 110.232 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.8 mp -93.77 146.38 23.91 Favored 'General case' 0 C--O 1.181 -2.535 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.468 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 28.7 tt0 -138.48 144.92 40.26 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-N 118.803 0.729 . . . . 0.0 109.949 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 29' ' ' PHE . 27.0 mm -80.28 120.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.743 0 O-C-N 121.498 -0.751 . . . . 0.0 110.734 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CD ' ' HB2' ' A' ' 107' ' ' PRO . 44.1 pttt -100.75 -22.0 15.01 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 123.473 0.483 . . . . 0.0 111.544 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.7 m -158.46 127.48 5.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 60' ' ' THR . 2.9 pp -84.44 121.07 27.05 Favored 'General case' 0 N--CA 1.402 -2.872 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.7 t -85.0 129.3 37.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.63 138.59 58.53 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.434 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 t70 81.65 8.04 1.02 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.777 1.298 . . . . 0.0 110.766 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.654 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.1 161.12 27.66 Favored Glycine 0 C--O 1.21 -1.395 0 CA-C-O 117.894 -1.504 . . . . 0.0 109.798 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.3 Cg_endo -72.13 -24.74 19.9 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 CA-C-N 121.501 2.651 . . . . 0.0 110.271 -169.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -49.94 75.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.188 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.44 80.76 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.961 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 74.3 mt -71.77 -40.31 69.36 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-N 112.745 -2.025 . . . . 0.0 115.46 -172.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.07 -21.58 56.59 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.696 1.236 . . . . 0.0 107.785 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.76 30.98 73.99 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 112.894 -1.957 . . . . 0.0 114.022 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.07 -1.27 3.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.742 0.782 . . . . 0.0 111.058 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -132.5 125.41 30.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.19 167.53 21.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.702 0.763 . . . . 0.0 112.122 -167.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.489 ' H ' HD23 ' A' ' 46' ' ' LEU . 4.7 m -56.35 119.93 6.8 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.778 174.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.43 5.85 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 26.7 m-20 -72.18 135.36 46.12 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.1 OUTLIER -104.77 120.2 54.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 CA-C-O 121.519 0.676 . . . . 0.0 110.837 173.254 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.89 111.75 4.09 Favored 'Isoleucine or valine' 0 C--O 1.299 3.679 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.595 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.581 HG13 HD13 ' A' ' 73' ' ' LEU . 91.8 t -93.61 -58.25 3.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.53 0 O-C-N 126.315 2.259 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -151.43 171.06 18.11 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.833 -0.542 . . . . 0.0 110.102 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 7.7 p -146.87 114.4 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 93' ' ' VAL 0.4 0.2 OUTLIER 31.23 66.88 0.14 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.951 1.3 . . . . 0.0 114.146 -171.31 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.44 -37.43 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.283 1.433 . . . . 0.0 114.102 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.4 m -57.81 121.99 11.8 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.446 0.641 . . . . 0.0 110.754 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 36.0 t -80.88 78.73 7.64 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.32 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 56.0 t -80.83 0.23 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 123.325 1.536 . . . . 0.0 108.851 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -67.68 110.74 3.86 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 65.62 43.02 95.15 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.486 -174.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -87.58 141.89 28.27 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.295 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.6 m -68.77 141.73 55.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.645 ' HB3' ' HD3' ' B' ' 156' ' ' ARG . 6.4 t60 -54.17 -38.35 65.47 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.428 1.091 . . . . 0.0 112.079 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.7 90.23 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.109 0.881 . . . . 0.0 110.067 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.47 -48.84 18.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.811 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.09 -43.0 97.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.883 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.2 p -65.46 -36.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.263 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -42.16 97.45 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.378 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.51 -50.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 122.394 1.092 . . . . 0.0 108.991 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.63 -33.63 76.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.411 -1.722 . . . . 0.0 113.706 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -85.71 -22.66 27.72 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 m -83.28 -10.94 58.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.418 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.5 mt -46.74 136.58 7.69 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.357 1.063 . . . . 0.0 113.823 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.3 Cg_endo -97.28 150.65 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.798 2.999 . . . . 0.0 112.08 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' ARG . 17.8 mt -68.05 142.02 16.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.519 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.31 11.48 64.49 Favored Glycine 0 CA--C 1.485 -1.831 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.162 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.37 -170.1 1.7 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.77 -171.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.44 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 24.3 t -149.86 146.07 26.91 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.734 HG22 ' HE2' ' A' ' 22' ' ' LYS . 17.2 m -150.6 153.9 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 C-N-CA 123.483 0.713 . . . . 0.0 109.725 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 19.7 t70 -100.81 112.68 25.15 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.0 mm? -90.8 113.76 25.98 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 38.3 tt0 -94.97 109.21 21.26 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.48 159.34 42.43 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 0.0 112.359 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 t -110.27 122.98 48.95 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 17.3 tpp85 -104.21 147.22 27.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.51 -13.92 4.24 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.064 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.53 114.06 62.51 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-O 120.509 0.195 . . . . 0.0 110.852 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.598 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 3.7 Cg_exo -76.89 163.73 30.8 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.001 1.801 . . . . 0.0 111.176 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.2 81.83 1.78 Allowed Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.513 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 58.0 Cg_endo -96.47 52.12 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.691 2.927 . . . . 0.0 108.598 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -161.98 140.63 9.31 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 14.3 t70 -91.24 120.63 68.41 Favored Pre-proline 0 N--CA 1.413 -2.312 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 28.4 Cg_endo -103.01 10.0 0.36 Allowed 'Trans proline' 0 C--N 1.284 -2.827 0 C-N-CA 123.376 2.717 . . . . 0.0 109.998 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.26 -29.56 12.38 Favored 'General case' 0 N--CA 1.395 -3.224 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -63.35 122.47 76.0 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.982 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.267 0.0 OUTLIER -40.34 88.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.204 1 C-N-CA 125.912 4.408 . . . . 0.0 117.704 174.346 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -124.25 32.04 5.62 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 117.722 -1.591 . . . . 0.0 109.927 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.1 t -171.13 174.13 4.75 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' B' ' 155' ' ' THR . 64.3 m -141.95 109.47 5.66 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.63 106.36 7.16 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.65 131.52 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 166.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 t -72.84 144.89 47.3 Favored 'General case' 0 C--N 1.279 -2.471 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.375 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 p -105.04 117.87 35.09 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.54 106.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.161 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.18 74.02 0.85 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.784 0.802 . . . . 0.0 112.109 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.09 -10.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 1.8 pt? -118.79 -166.82 1.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.303 -171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.75 102.66 1.96 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.619 0.723 . . . . 0.0 109.447 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 121' ' ' LEU . 31.7 mmmt -99.24 92.52 5.48 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.41 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.7 119.29 75.3 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.84 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 N--CA 1.445 -1.355 0 C-N-CA 122.422 2.082 . . . . 0.0 111.313 179.944 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 5.1 p -166.89 164.28 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.164 0.507 . . . . 0.0 112.106 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 42.3 m -151.28 -44.28 0.11 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -142.26 45.85 1.64 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.445 0.64 . . . . 0.0 111.032 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 113' ' ' SER . 10.2 p -126.38 0.8 7.0 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.923 0.868 . . . . 0.0 110.213 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.645 ' HD3' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -129.93 -140.76 0.23 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -170.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.758 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.6 ttm180 75.65 -12.4 0.99 Allowed 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -135.96 88.97 2.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 119.449 1.022 . . . . 0.0 111.907 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.556 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 5.3 m -89.68 125.87 35.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -109.54 115.34 29.74 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 27' ' ' PHE . 31.7 m . . . . . 0 N--CA 1.426 -1.651 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.402 -173.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.41 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -82.16 58.02 3.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.547 0.689 . . . . 0.0 110.789 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 87.1 mmm -117.24 50.27 1.11 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.702 0.763 . . . . 0.0 111.39 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -88.92 27.03 7.67 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 150.75 74.97 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.99 138.42 40.23 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.656 1.57 . . . . 0.0 110.0 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -99.61 147.92 24.86 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.177 -174.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -147.95 130.78 16.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 15.1 t -168.02 33.63 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.93 165.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 45.55 42.75 8.39 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 123.991 1.853 . . . . 0.0 112.606 178.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.801 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.8 m-20 -115.2 114.02 43.41 Favored Pre-proline 1 C--N 1.242 -4.085 0 CA-C-N 113.083 -1.871 . . . . 0.0 114.186 178.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.9 Cg_exo -56.72 -30.52 84.53 Favored 'Trans proline' 0 CA--C 1.481 -2.154 0 C-N-CA 121.314 1.343 . . . . 0.0 109.693 168.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -79.54 -13.22 59.69 Favored 'General case' 1 N--CA 1.362 -4.857 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.485 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -81.38 -32.11 32.99 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 63' ' ' VAL . 79.2 mt -61.81 143.32 56.49 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.896 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.72 -179.33 7.09 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.426 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.2 -128.36 9.38 Favored Glycine 0 N--CA 1.432 -1.603 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.833 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 2.4 ptmm? -127.53 151.62 48.65 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 123.882 0.873 . . . . 0.0 110.847 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.84 119.32 37.6 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -138.02 152.82 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 121.647 0.737 . . . . 0.0 111.923 -177.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.5 p-80 -135.35 105.08 6.11 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.476 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -115.83 140.19 49.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.277 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.15 131.89 41.71 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.4 tp -117.12 121.67 41.93 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.89 114.53 21.25 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.48 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.778 ' HA ' ' HZ2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -48.42 111.49 0.46 Allowed 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 125.108 1.363 . . . . 0.0 112.802 177.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 22.8 t -88.17 -144.28 0.14 Allowed 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 127.159 2.787 . . . . 0.0 107.327 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 p -62.56 84.27 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.555 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.3 mpt_? 59.88 29.85 19.4 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 126.414 1.886 . . . . 0.0 112.215 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.42 -123.05 1.02 Allowed Glycine 0 N--CA 1.412 -2.94 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.173 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.712 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 76.3 m-85 -130.88 -90.45 0.45 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.055 -1.073 . . . . 0.0 111.324 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.602 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 128.07 54.99 0.12 Allowed Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.002 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' O ' HG22 ' B' ' 161' ' ' VAL . 38.4 p90 -161.52 142.95 11.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.55 HG22 ' HA ' ' B' ' 160' ' ' GLN . 25.5 p -105.68 136.04 46.01 Favored 'General case' 0 C--N 1.284 -2.283 0 O-C-N 121.336 -0.852 . . . . 0.0 109.497 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 14.4 m -125.78 160.01 33.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.724 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 25.2 m -124.04 132.49 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 174.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 129.77 -139.73 11.18 Favored Glycine 0 N--CA 1.41 -3.091 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.068 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.644 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.41 48.52 8.55 Favored Glycine 1 CA--C 1.443 -4.413 0 C-N-CA 125.754 1.645 . . . . 0.0 111.204 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' B' ' 156' ' ' ARG . 35.3 t70 -88.99 -32.64 17.52 Favored 'General case' 0 C--N 1.252 -3.669 0 CA-C-N 114.566 -0.817 . . . . 0.0 109.712 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -158.67 167.9 13.49 Favored Pre-proline 0 N--CA 1.415 -2.21 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.464 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 16.6 Cg_exo -77.46 51.15 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.409 3.406 . . . . 0.0 109.916 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -162.79 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.194 -2.275 . . . . 0.0 108.257 -171.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' OE2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 tt0 -111.78 120.15 41.0 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.48 165.67 16.96 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 128.29 2.636 . . . . 0.0 109.282 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.644 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 3.9 mp -95.06 146.14 24.48 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.003 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 1.2 tm0? -131.79 151.58 51.57 Favored 'General case' 0 C--O 1.169 -3.147 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 62' ' ' ASP . 8.2 mm -90.54 122.34 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 118.827 0.74 . . . . 0.0 109.237 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HA ' HD21 ' A' ' 103' ' ' LEU . 53.6 pttt -106.02 -18.18 14.11 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.765 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.9 m -156.34 127.74 7.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.023 0.439 . . . . 0.0 111.326 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.01 121.28 21.74 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.602 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 97.2 t -92.98 123.44 45.07 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.88 148.93 48.4 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.708 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.3 t70 80.6 4.71 1.67 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.982 1.426 . . . . 0.0 109.743 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.633 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.5 164.63 31.91 Favored Glycine 0 C--O 1.209 -1.468 0 CA-C-O 117.893 -1.504 . . . . 0.0 110.544 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 10.1 Cg_endo -72.5 -25.72 17.61 Favored 'Trans proline' 0 C--O 1.191 -1.868 0 CA-C-N 121.639 2.719 . . . . 0.0 110.482 -171.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.24 87.53 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.676 0.751 . . . . 0.0 109.408 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.39 68.06 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 122.536 1.16 . . . . 0.0 109.252 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.4 mt -72.13 -50.0 31.43 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 112.619 -2.082 . . . . 0.0 115.522 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.01 -24.52 55.29 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.77 45.62 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.086 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 69.85 -61.37 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.366 1.466 . . . . 0.0 112.637 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.535 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.3 tmt? -77.7 136.24 38.16 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -146.02 167.05 24.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.151 0.5 . . . . 0.0 111.107 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.8 m -58.24 128.04 35.11 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.6 -13.28 10.89 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.521 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 43' ' ' ILE . 24.8 m-20 -75.65 161.49 29.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 11' ' ' LEU . 10.4 m -123.31 133.95 67.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 40.1 mm -81.0 109.22 15.14 Favored 'Isoleucine or valine' 0 C--O 1.302 3.866 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 73' ' ' LEU . 86.9 t -95.84 -56.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 O-C-N 126.225 2.203 . . . . 0.0 109.717 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -156.44 173.23 17.21 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.518 -0.739 . . . . 0.0 110.054 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.5 p -145.68 120.84 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.252 4.8 p-10 16.58 84.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.542 1.937 . . . . 0.0 115.216 -172.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 74.73 -37.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.403 1.481 . . . . 0.0 113.09 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.6 m -66.46 125.25 25.11 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-O 121.922 0.867 . . . . 0.0 110.195 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 47.3 t -89.14 91.41 8.78 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.542 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 67' ' ' VAL . 57.1 t -86.46 3.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.76 1.267 . . . . 0.0 108.767 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 65' ' ' VAL . 13.1 tp -76.38 111.08 11.45 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.78 38.36 60.82 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.846 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -82.17 145.92 29.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.4 m -75.43 142.31 43.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 117.468 -1.253 . . . . 0.0 107.691 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HD2' HG23 ' B' ' 155' ' ' THR . 62.2 t60 -48.58 -48.04 39.19 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 119.211 0.914 . . . . 0.0 112.815 -176.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -36.13 76.23 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 124.367 1.042 . . . . 0.0 110.536 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -75.0 -51.56 13.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.666 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.4 p -63.93 -44.08 97.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.6 p -60.47 -42.13 90.11 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.535 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 35.4 ttpt -65.26 -39.13 92.23 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -71.5 -46.59 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 122.187 0.994 . . . . 0.0 108.402 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.0 -28.89 69.22 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.745 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.09 -23.77 26.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.6 t -92.55 -2.64 56.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.38 0.61 . . . . 0.0 110.163 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.605 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -54.49 138.26 60.25 Favored Pre-proline 0 N--CA 1.424 -1.754 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.787 173.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -93.39 149.27 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.239 2.626 . . . . 0.0 111.794 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG12 ' H ' ' A' ' 25' ' ' ARG . 26.3 mt -67.86 141.81 17.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.46 12.37 63.01 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.637 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.589 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -106.89 -169.06 1.49 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.804 -171.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.547 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 27.9 t -148.14 148.1 30.21 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.841 -0.537 . . . . 0.0 112.218 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.3 m -146.58 161.15 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.014 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.553 173.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -107.41 107.75 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.6 tp -92.01 114.09 26.53 Favored 'General case' 0 C--N 1.253 -3.591 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.976 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -90.76 107.63 19.31 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.47 161.72 37.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.481 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.507 ' HB2' HG22 ' A' ' 63' ' ' VAL . 74.4 m -124.27 123.49 40.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.966 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' CG ' ' A' ' 14' ' ' LYS . 18.9 tpp85 -93.35 147.17 23.16 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . 137.54 5.64 1.71 Allowed Glycine 0 C--N 1.296 -1.661 0 C-N-CA 119.101 -1.523 . . . . 0.0 112.586 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -105.93 99.94 25.31 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 116.714 0.257 . . . . 0.0 110.469 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 100' ' ' GLY . 18.0 Cg_exo -66.74 132.21 28.03 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 121.949 1.766 . . . . 0.0 107.732 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.641 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -69.94 104.86 0.9 Allowed Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -95.48 41.45 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.018 2.479 . . . . 0.0 111.578 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.43 ' O ' HD12 ' A' ' 103' ' ' LEU . 31.5 t80 -167.0 168.43 13.83 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.4 m-20 -79.33 140.26 56.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -93.14 0.54 3.56 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.018 2.479 . . . . 0.0 107.421 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.06 -33.77 44.35 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.435 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -51.41 114.42 5.02 Favored Pre-proline 0 C--O 1.246 0.894 0 CA-C-N 113.184 -1.826 . . . . 0.0 112.108 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -62.06 -153.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 124.094 3.196 . . . . 0.0 113.293 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 65.82 70.8 0.43 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.239 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 113' ' ' SER . 3.1 m -78.53 -149.37 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' HG22 ' A' ' 112' ' ' THR . 0.3 OUTLIER -56.1 102.52 0.08 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 119.215 0.916 . . . . 0.0 111.936 -173.373 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' B' ' 155' ' ' THR . 0.0 OUTLIER -74.82 119.53 19.14 Favored 'General case' 1 N--CA 1.379 -4.004 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.566 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' B' ' 154' ' ' ARG . 9.7 p -123.45 114.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-O 122.112 0.958 . . . . 0.0 109.763 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 t -102.18 146.28 28.2 Favored 'General case' 0 N--CA 1.391 -3.393 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -120.06 137.29 54.2 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.71 108.45 23.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.43 73.92 1.48 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.686 0.755 . . . . 0.0 112.102 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.38 -30.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 122.546 1.165 . . . . 0.0 108.355 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.95 -132.43 0.33 Allowed 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.12 107.56 3.24 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.874 1.321 . . . . 0.0 110.129 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -121.06 41.22 3.37 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.52 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 37.6 mt-10 -76.04 125.44 88.04 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 32.5 Cg_exo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 123.007 2.472 . . . . 0.0 112.659 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -79.45 89.22 5.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 24.8 m 74.63 154.38 0.15 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.73 1.212 . . . . 0.0 112.266 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -147.03 -71.25 0.23 Allowed 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.885 178.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 2.0 t -158.35 143.13 16.23 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.446 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 ptm180 -159.96 155.66 25.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.27 1.395 . . . . 0.0 112.211 -175.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' GLY 0.414 23.3 ptt180 62.05 -62.89 0.1 Allowed 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 174.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -73.57 87.02 1.61 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 123.008 0.523 . . . . 0.0 109.824 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.476 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 2.9 m -100.06 113.89 26.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 30' ' ' THR . 55.0 tt0 -88.66 104.8 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 29' ' ' PHE . 10.1 m . . . . . 0 N--CA 1.418 -2.062 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.096 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.17 90.9 1.6 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.383 0.673 . . . . 0.0 110.404 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.32 20.88 17.6 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -71.87 -19.75 78.38 Favored Glycine 0 C--N 1.318 -0.439 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.52 141.75 24.29 Favored Pre-proline 0 N--CA 1.424 -1.765 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -76.43 171.29 18.34 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.755 2.303 . . . . 0.0 109.005 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -57.33 112.95 1.55 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.22 1.01 . . . . 0.0 109.149 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HZ ' ' O ' ' A' ' 37' ' ' PRO . 4.1 t80 -147.0 144.17 28.97 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.128 -172.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 7' ' ' ASN 0.335 8.9 t -156.45 -53.77 0.08 Allowed 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.104 163.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.2 ptm180 164.03 -30.12 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.6 t-20 -46.07 108.66 0.85 Allowed Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.846 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.1 -27.35 73.38 Favored 'Trans proline' 0 CA--C 1.469 -2.755 0 C-N-CA 121.565 1.51 . . . . 0.0 110.882 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -81.83 -19.71 40.52 Favored 'General case' 1 N--CA 1.354 -5.235 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.031 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.703 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.9 pt-20 -75.26 -34.41 61.37 Favored 'General case' 0 C--N 1.372 1.571 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.5 132.86 49.55 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.921 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -80.06 171.16 15.46 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.772 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 97.42 -123.49 7.82 Favored Glycine 0 N--CA 1.417 -2.569 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.271 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -135.72 141.38 44.88 Favored 'General case' 0 C--N 1.282 -2.349 0 C-N-CA 123.479 0.712 . . . . 0.0 109.55 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -108.83 111.64 23.48 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.44 152.13 23.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.564 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.1 t60 -131.84 99.71 4.85 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -114.22 145.57 41.54 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.759 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -84.88 134.68 34.27 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -117.23 119.98 36.84 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -81.49 110.95 17.36 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.19 104.4 0.04 OUTLIER 'General case' 0 CA--C 1.465 -2.3 0 O-C-N 123.85 0.719 . . . . 0.0 109.398 170.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 65.1 m -92.34 -117.32 0.08 Allowed 'General case' 0 N--CA 1.388 -3.534 0 O-C-N 125.125 1.515 . . . . 0.0 109.953 -176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.6 m -78.81 79.53 5.21 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 119.907 1.23 . . . . 0.0 113.079 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' H ' HG12 ' A' ' 89' ' ' ILE . 16.8 mmt180 62.84 51.19 3.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.143 0.973 . . . . 0.0 111.322 173.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.85 -124.78 2.93 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.692 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 74.5 m-85 -127.79 -81.33 0.59 Allowed 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.5 51.41 0.1 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.456 -172.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 43' ' ' ILE . 27.4 p90 -162.05 146.81 12.71 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.96 0.904 . . . . 0.0 108.715 174.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.0 p -109.92 136.14 49.68 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.891 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 15.4 m -117.45 168.45 9.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.193 -168.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.7 m -127.38 133.06 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 125.482 1.513 . . . . 0.0 109.739 173.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.651 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 115.87 -135.6 12.3 Favored Glycine 0 C--N 1.273 -2.951 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.811 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 38.66 50.8 2.48 Favored Glycine 0 CA--C 1.461 -3.299 0 O-C-N 126.214 1.773 . . . . 0.0 111.142 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.554 ' OD1' ' HD2' ' B' ' 156' ' ' ARG . 36.0 t0 -95.75 -36.05 11.31 Favored 'General case' 0 C--N 1.251 -3.69 0 CA-C-N 113.324 -1.438 . . . . 0.0 110.361 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.1 pt-20 -158.82 173.65 4.79 Favored Pre-proline 0 N--CA 1.411 -2.38 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.756 -172.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 52.0 Cg_exo -66.42 -13.89 41.81 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 123.012 2.475 . . . . 0.0 109.538 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.77 -14.55 24.6 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.234 -1.803 . . . . 0.0 111.826 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -139.25 120.28 14.56 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 111.301 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 14.5 m-85 -79.97 166.04 22.0 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 127.412 2.285 . . . . 0.0 111.569 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.892 HD21 HG21 ' A' ' 80' ' ' VAL . 4.6 mp -88.41 146.04 25.46 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.638 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 tt0 -142.38 154.71 44.86 Favored 'General case' 0 C--O 1.181 -2.539 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 29' ' ' PHE . 18.9 mm -93.22 127.01 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 118.914 0.779 . . . . 0.0 109.065 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -105.49 -21.21 13.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.1 m -157.24 128.43 6.79 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.76 123.07 27.36 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 123.714 0.806 . . . . 0.0 108.83 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.3 t -94.96 111.82 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.9 145.43 52.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.902 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.5 t70 86.01 3.05 0.56 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 125.824 1.953 . . . . 0.0 109.098 -171.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.43 159.97 34.09 Favored Glycine 0 C--O 1.204 -1.773 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.072 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 34.2 Cg_endo -72.61 -25.85 17.11 Favored 'Trans proline' 0 N--CA 1.435 -1.929 0 CA-C-N 121.148 2.474 . . . . 0.0 110.515 -171.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.28 -46.04 91.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.737 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.91 85.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.501 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.1 mt -72.0 -40.09 68.77 Favored 'General case' 0 N--CA 1.405 -2.699 0 CA-C-N 113.384 -1.734 . . . . 0.0 114.832 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -75.05 -24.7 58.3 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.24 15.38 65.45 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 113.296 -1.775 . . . . 0.0 115.486 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.05 22.37 7.96 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.8 1.286 . . . . 0.0 109.805 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.8 ttt -140.17 128.69 22.83 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.38 149.32 30.67 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -167.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.2 m -44.75 117.52 1.33 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.643 1.177 . . . . 0.0 110.819 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.11 -7.56 8.66 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.532 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.63 150.33 39.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -108.36 129.7 62.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.5 mm -84.93 115.93 27.61 Favored 'Isoleucine or valine' 0 C--O 1.302 3.83 0 CA-C-O 121.701 0.762 . . . . 0.0 109.26 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 73' ' ' LEU . 95.3 t -96.24 -58.21 3.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.81 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.727 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -155.59 166.74 32.61 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.899 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 95' ' ' LEU . 8.1 p -152.9 115.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 51.33 52.41 14.88 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.945 1.298 . . . . 0.0 111.78 173.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 69.33 -6.76 0.91 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.889 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.4 m -81.06 126.48 31.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.2 t -82.45 73.82 9.46 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.955 0.883 . . . . 0.0 110.595 -172.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 80.0 t -79.55 -4.11 6.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 122.66 1.219 . . . . 0.0 109.202 177.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 6' ' ' ARG . 13.6 tp -66.93 112.03 4.1 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 70.92 37.01 65.12 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.418 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -82.61 147.17 28.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.56 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 87.7 m -76.24 143.28 41.09 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 117.599 -1.191 . . . . 0.0 109.171 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.52 ' NE2' ' HA ' ' B' ' 154' ' ' ARG . 83.2 t60 -46.77 -47.66 20.76 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.336 0.971 . . . . 0.0 113.164 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 82' ' ' LYS . . . -63.53 -32.25 73.65 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.474 0.654 . . . . 0.0 110.821 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.511 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 32.0 mm-40 -77.82 -49.91 13.36 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.15 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -61.35 -44.75 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.148 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 11.6 p -60.85 -45.13 98.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.416 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -60.18 -38.75 84.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.3 mt -73.12 -48.28 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-O 122.502 1.144 . . . . 0.0 108.909 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.108 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 14.1 pt20 -86.71 -24.46 25.18 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.769 -0.582 . . . . 0.0 111.798 174.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -75.46 -26.22 58.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.584 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -59.61 152.23 57.68 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.4 Cg_endo -102.25 159.51 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.063 3.842 . . . . 0.0 111.942 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' SER . 45.4 mt -67.78 131.01 33.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.97 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.45 10.88 40.19 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 119.773 -0.46 . . . . 0.0 113.981 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -99.35 -176.43 3.29 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.578 1.189 . . . . 0.0 111.902 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.555 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.2 t -140.99 145.39 35.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.704 -0.623 . . . . 0.0 111.75 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.43 157.64 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 C-N-CA 123.964 0.905 . . . . 0.0 111.486 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.506 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 4.2 m-20 -104.56 107.11 17.88 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.481 HD22 HD22 ' A' ' 20' ' ' LEU . 15.4 tp -99.53 121.51 41.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-O 121.123 0.487 . . . . 0.0 111.608 -172.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.02 114.47 26.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.52 148.12 40.57 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.113 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.0 t -117.64 120.1 36.99 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.642 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.3 tpp85 -95.18 139.87 30.89 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.84 -28.35 1.03 Allowed Glycine 0 C--N 1.3 -1.444 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.306 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.18 98.67 6.86 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 95.6 Cg_endo -79.31 -175.34 2.69 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.664 2.243 . . . . 0.0 111.36 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.67 101.06 6.14 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 3.0 Cg_exo -78.51 -0.83 11.06 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.359 2.706 . . . . 0.0 111.52 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.93 163.75 32.11 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.0 m-20 -98.3 144.39 28.01 Favored Pre-proline 0 C--N 1.282 -2.332 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.1 Cg_endo -93.58 16.66 1.18 Allowed 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 123.566 2.844 . . . . 0.0 107.267 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.35 -24.02 29.92 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-N 112.009 -2.36 . . . . 0.0 107.239 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.22 135.67 95.15 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.281 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -92.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 1 C-N-CA 127.142 5.228 . . . . 0.0 117.854 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 49.45 57.56 6.37 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 125.814 1.646 . . . . 0.0 111.59 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 m -61.21 134.81 57.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.406 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.4 p -73.57 101.24 3.52 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -172.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -91.12 131.89 36.4 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 171.144 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 154' ' ' ARG . 12.0 p -102.12 124.1 55.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.96 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.0 t -135.81 133.44 37.88 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 -173.9 3.0 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG21 ' CG2' ' A' ' 76' ' ' THR . 33.6 t -112.74 100.39 10.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.77 73.99 0.99 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.918 0.866 . . . . 0.0 110.163 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.86 -60.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.14 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.1 mt -84.8 178.81 7.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.939 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -78.16 71.83 4.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.519 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.36 120.91 18.25 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.932 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.57 132.07 25.87 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.701 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 123.153 2.568 . . . . 0.0 112.526 179.694 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 17.9 m -72.8 58.39 0.45 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.154 0.581 . . . . 0.0 111.738 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -76.17 60.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.879 0.847 . . . . 0.0 112.047 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.52 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 18.6 mtp180 -136.25 34.64 2.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 5.9 t -100.64 13.68 33.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.25 -1.796 . . . . 0.0 110.888 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.554 ' HD2' ' OD1' ' A' ' 35' ' ' ASP . 15.9 mmt85 73.04 147.5 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.746 1.218 . . . . 0.0 107.812 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.651 ' HA ' ' H ' ' A' ' 33' ' ' GLY . 49.3 mtp85 72.99 -71.76 0.13 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.851 0.75 . . . . 0.0 112.773 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 41.4 tt0 -73.29 108.67 6.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 120.826 0.346 . . . . 0.0 110.183 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 6.7 m -123.39 133.66 54.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.507 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.7 OUTLIER -100.02 116.58 32.39 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.2 m . . . . . 0 N--CA 1.419 -1.975 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.907 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -89.88 71.42 7.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.0 mtp -125.74 42.62 3.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.026 0.917 . . . . 0.0 109.831 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -87.48 1.18 85.75 Favored Glycine 0 C--N 1.315 -0.598 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.063 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -104.09 160.77 24.97 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.54 119.64 6.7 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.394 1.396 . . . . 0.0 110.429 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -109.13 145.3 35.95 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 113.644 -1.616 . . . . 0.0 112.249 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -147.16 135.15 21.39 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.098 174.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.664 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 13.5 t -167.68 38.81 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.333 1.053 . . . . 0.0 108.787 166.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 5' ' ' THR . 5.7 ptm180 60.13 12.5 3.29 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 127.264 2.225 . . . . 0.0 113.413 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.792 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 12.0 m-80 -97.39 115.25 65.71 Favored Pre-proline 0 C--N 1.251 -3.686 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.289 13.2 Cg_exo -61.06 -30.17 88.93 Favored 'Trans proline' 0 CA--C 1.483 -2.069 0 N-CA-C 107.906 -1.613 . . . . 0.0 107.906 170.016 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 t -68.66 -25.6 64.89 Favored 'General case' 1 N--CA 1.363 -4.815 0 CA-C-N 110.993 -2.822 . . . . 0.0 111.003 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.3 pt-20 -80.3 -33.79 37.32 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.72 135.29 57.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.655 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 100' ' ' GLY . 45.8 pttt -78.66 166.01 23.0 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.337 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 98.82 -122.98 7.74 Favored Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.514 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.0 147.07 46.04 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 124.712 1.205 . . . . 0.0 110.014 -177.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.5 123.4 49.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -135.6 152.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 43.5 p-80 -126.11 100.49 6.35 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 122.384 1.088 . . . . 0.0 110.265 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 t -102.77 130.66 49.81 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.539 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -83.16 130.32 35.09 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.079 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.9 mp -117.26 123.46 46.64 Favored 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -84.72 125.19 32.31 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.682 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -56.92 103.77 0.13 Allowed 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 172.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.03 -78.27 0.17 Allowed 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 125.346 1.654 . . . . 0.0 109.971 -172.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -116.23 78.64 1.21 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.694 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.625 ' N ' HG12 ' A' ' 89' ' ' ILE . 14.0 ttt180 63.78 24.74 13.9 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.22 -140.76 5.6 Favored Glycine 0 N--CA 1.409 -3.106 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.456 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.634 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 89.1 m-85 -125.67 -85.85 0.62 Allowed 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 114.481 -0.86 . . . . 0.0 112.083 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.39 52.89 0.19 Allowed Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.109 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 43' ' ' ILE . 29.8 p90 -160.9 150.5 17.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HA ' ' B' ' 160' ' ' GLN . 36.0 p -112.03 136.42 51.42 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.0 0.905 . . . . 0.0 109.242 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 4.5 p -125.27 148.4 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.608 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.702 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 10.8 m -114.98 164.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 124.492 1.117 . . . . 0.0 113.283 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.96 -124.62 6.55 Favored Glycine 0 C--O 1.284 3.249 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.132 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.34 53.67 5.74 Favored Glycine 1 CA--C 1.443 -4.425 0 O-C-N 127.235 2.374 . . . . 0.0 112.173 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 51.3 t0 -86.14 -47.89 9.08 Favored 'General case' 1 C--N 1.244 -4.012 0 CA-C-N 113.276 -1.462 . . . . 0.0 109.241 -176.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.8 pt-20 -158.93 174.51 3.98 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.032 -164.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 24.8 Cg_exo -75.46 59.61 5.53 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 124.662 3.575 . . . . 0.0 108.021 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 22.9 t70 -178.58 -23.7 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.348 -2.205 . . . . 0.0 109.324 -169.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 9.7 tp10 -131.23 120.54 23.4 Favored 'General case' 0 C--O 1.257 1.488 0 C-N-CA 122.997 0.519 . . . . 0.0 110.022 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.51 166.18 14.36 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 127.258 2.223 . . . . 0.0 110.261 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.639 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -96.85 145.25 26.03 Favored 'General case' 0 C--O 1.175 -2.844 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.648 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 14.9 tt0 -135.03 147.7 49.72 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 118.866 0.757 . . . . 0.0 109.928 -177.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 29' ' ' PHE . 34.7 mm -79.5 114.9 20.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.531 -0.731 . . . . 0.0 110.188 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -98.46 -22.05 16.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 37.6 m -155.72 127.14 7.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.7 tp -86.01 112.11 20.91 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.47 104.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.62 145.85 27.16 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.098 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 86.16 3.87 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.438 1.711 . . . . 0.0 109.74 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.666 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.44 163.08 36.95 Favored Glycine 0 C--O 1.212 -1.264 0 CA-C-O 117.773 -1.571 . . . . 0.0 110.21 171.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 22.1 Cg_endo -72.48 -25.48 17.92 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 CA-C-N 121.732 2.766 . . . . 0.0 110.458 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -62.39 -43.69 98.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.428 175.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.49 75.37 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.449 1.119 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 69.7 mt -72.18 -40.88 67.61 Favored 'General case' 0 N--CA 1.396 -3.169 0 CA-C-N 112.401 -2.181 . . . . 0.0 114.704 -171.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.24 -24.99 46.69 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.42 27.03 71.16 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-N 113.543 -1.662 . . . . 0.0 115.416 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -110.65 -0.71 17.08 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.789 0.804 . . . . 0.0 110.437 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.421 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 42.8 ttm -129.28 126.97 40.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -142.69 144.93 32.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 m -45.14 114.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.234 1.414 . . . . 0.0 111.284 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.9 -36.95 1.96 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.61 145.21 50.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.8 0.81 . . . . 0.0 111.981 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.258 0.2 OUTLIER -110.33 126.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.27 -175.571 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.43 116.47 15.79 Favored 'Isoleucine or valine' 0 C--O 1.294 3.441 0 C-N-CA 125.673 1.589 . . . . 0.0 110.649 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 37.5 t -103.22 -58.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.99 -177.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 20.4 m -136.87 157.87 45.76 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.055 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 5.9 p -137.61 104.1 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 0.0 112.519 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.06 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 125.766 1.627 . . . . 0.0 112.079 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -131.98 -12.09 3.3 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.0 0.429 . . . . 0.0 110.838 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -89.68 134.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.759 0.79 . . . . 0.0 110.382 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 45.1 t -80.88 80.03 7.43 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.604 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 67' ' ' VAL . 7.5 p -77.23 -5.81 8.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.245 1.022 . . . . 0.0 108.504 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . 44.6 tp -56.35 111.11 0.89 Allowed 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.789 -1.551 . . . . 0.0 107.174 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 58.88 37.96 91.68 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.886 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.29 145.13 37.63 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 39.8 m -73.53 141.82 46.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.495 ' HA ' HG12 ' A' ' 80' ' ' VAL . 56.7 t-80 -51.28 -40.47 59.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.72 -176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.18 85.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.092 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 80.7 mm-40 -75.3 -48.6 22.44 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.769 -177.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.06 -43.14 97.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.651 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 77' ' ' HIS . 13.8 p -63.18 -37.85 80.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.436 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.83 90.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.22 -50.8 33.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-O 122.161 0.982 . . . . 0.0 109.383 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 9.0 m-85 -64.68 -35.13 80.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.799 -175.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -85.49 -21.42 28.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.67 0.272 . . . . 0.0 110.933 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 m -90.82 -2.52 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.967 -0.458 . . . . 0.0 111.409 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -47.65 142.43 6.59 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.84 156.66 0.68 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 124.035 3.157 . . . . 0.0 112.575 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' N ' ' A' ' 25' ' ' ARG . 64.3 mt -69.01 142.39 16.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 124.414 1.086 . . . . 0.0 110.628 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.9 74.41 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.138 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.603 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -101.05 -172.94 2.26 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -149.9 138.37 20.67 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -167.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.682 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.6 m -149.63 149.41 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 C-N-CA 122.846 0.458 . . . . 0.0 110.734 172.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.79 109.44 21.39 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.51 1.131 . . . . 0.0 108.327 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.7 mm? -90.44 113.42 25.35 Favored 'General case' 0 C--N 1.275 -2.667 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.54 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 40.3 mt-10 -88.39 106.36 18.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 174.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' ILE . 1.6 pt? -132.61 158.61 41.8 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.893 0.378 . . . . 0.0 110.442 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.6 t -116.19 125.16 51.89 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 16.7 tpp85 -98.22 142.62 29.67 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . 149.33 -9.4 0.93 Allowed Glycine 0 C--N 1.303 -1.3 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.105 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -108.29 92.14 9.23 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.97 129.68 20.09 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 106.146 -2.29 . . . . 0.0 106.146 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -38.96 97.59 0.14 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 125.174 1.546 . . . . 0.0 112.384 -172.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -95.99 -2.21 2.02 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.887 2.391 . . . . 0.0 113.229 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.66 157.52 42.53 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 17.0 t70 -91.76 135.12 27.95 Favored Pre-proline 0 CA--C 1.48 -1.718 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 26.7 Cg_endo -104.92 12.84 0.22 Allowed 'Trans proline' 0 N--CA 1.418 -2.934 0 C-N-CA 123.366 2.711 . . . . 0.0 110.888 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.31 -32.4 9.58 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.751 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -35.42 127.21 0.58 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 127.297 2.239 . . . . 0.0 113.079 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -23.09 -137.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.215 1 C-N-CA 128.748 6.299 . . . . 0.0 119.85 -173.158 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 153' ' ' SER . 4.2 m-20 75.35 -34.55 0.26 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 125.971 1.708 . . . . 0.0 112.955 -178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 m 73.08 161.72 0.25 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.504 1.122 . . . . 0.0 110.104 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.1 t -122.57 128.01 50.18 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' B' ' 154' ' ' ARG . 8.6 mt -76.77 104.21 7.15 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.84 109.73 29.57 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.157 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.462 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.8 t -70.58 151.52 44.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 m -81.64 89.9 6.27 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.364 1.078 . . . . 0.0 108.572 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.42 135.12 42.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.9 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . . . -141.99 98.77 3.39 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.226 1.012 . . . . 0.0 110.029 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.9 mt -100.15 7.64 8.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 124.301 2.0 . . . . 0.0 106.054 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.48 146.95 31.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 112.525 -2.125 . . . . 0.0 107.113 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 t70 76.61 -5.59 2.16 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.04 1.336 . . . . 0.0 112.511 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 54.8 mttm -126.52 148.98 49.64 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -98.06 117.88 64.43 Favored Pre-proline 0 C--N 1.28 -2.445 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.977 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.445 -1.344 0 C-N-CA 122.639 2.226 . . . . 0.0 110.661 172.45 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.576 ' HD2' ' O ' ' B' ' 151' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.218 0.533 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 18.6 t -123.05 138.52 54.66 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 63.2 m 65.52 -176.95 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.302 1.002 . . . . 0.0 109.513 -174.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ARG . . . . . 0.59 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -128.12 -175.38 3.48 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 121.446 -0.784 . . . . 0.0 112.735 -176.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.461 ' HA ' ' H ' ' A' ' 114' ' ' LEU . 3.1 m -61.18 -23.31 65.49 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.126 0.965 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' B' ' 154' ' ' ARG . 10.1 mmt85 -46.58 105.11 0.06 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 128.167 2.587 . . . . 0.0 111.652 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 32' ' ' VAL 0.262 12.6 ptm180 161.24 -52.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.322 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 11.5 pt-20 -155.15 130.51 9.68 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 31' ' ' VAL . 29.4 m -113.3 131.52 55.9 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' THR . 33.4 tt0 -102.84 120.9 41.41 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 22.7 m . . . . . 0 N--CA 1.432 -1.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.383 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.246 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -163.96 159.86 21.29 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 62.9 mtt 64.97 -167.67 0.22 Allowed 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.875 0.735 . . . . 0.0 111.484 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 101.7 3.63 52.51 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.11 158.28 32.44 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -68.94 124.63 11.63 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.094 1.196 . . . . 0.0 108.994 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -99.8 130.36 45.99 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.127 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -148.21 136.58 21.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.869 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.9 t -178.05 33.47 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.709 1.204 . . . . 0.0 109.883 168.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.649 ' O ' HD21 ' A' ' 73' ' ' LEU . 13.3 ptm180 49.69 27.81 2.37 Favored 'General case' 0 N--CA 1.515 2.82 0 C-N-CA 126.499 1.919 . . . . 0.0 113.026 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.746 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.8 m-80 -96.33 115.28 65.53 Favored Pre-proline 1 C--N 1.22 -5.044 0 CA-C-N 112.894 -1.957 . . . . 0.0 112.283 174.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.315 26.7 Cg_exo -62.48 -34.66 75.19 Favored 'Trans proline' 0 CA--C 1.475 -2.465 0 CA-C-O 124.201 1.667 . . . . 0.0 108.301 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -65.16 -28.26 69.29 Favored 'General case' 1 N--CA 1.344 -5.738 0 CA-C-N 109.855 -3.339 . . . . 0.0 111.69 -175.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.3 pt-20 -80.59 -33.11 36.25 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.0 128.75 37.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.696 1.236 . . . . 0.0 110.361 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 10.7 ptmm? -83.08 -172.24 4.02 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.33 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 77.32 -135.17 15.95 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.963 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -114.45 139.2 49.72 Favored 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 124.072 0.949 . . . . 0.0 109.309 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.34 114.86 28.89 Favored 'General case' 0 C--N 1.26 -3.283 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -131.65 152.3 36.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.188 -175.13 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . 0.522 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 18.7 t60 -126.73 102.81 7.22 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -130.96 146.83 52.49 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.711 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -81.08 133.7 35.52 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 122.713 0.405 . . . . 0.0 111.695 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.54 125.7 48.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -85.36 119.65 25.96 Favored 'General case' 0 N--CA 1.395 -3.176 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.135 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -52.32 101.29 0.04 OUTLIER 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 89' ' ' ILE . 11.1 t -83.08 -94.71 0.06 Allowed 'General case' 0 N--CA 1.411 -2.391 0 O-C-N 124.816 1.323 . . . . 0.0 109.628 -176.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -96.03 73.93 3.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.578 ' N ' HG12 ' A' ' 89' ' ' ILE . 32.0 ttt180 59.98 40.75 18.49 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.425 1.49 . . . . 0.0 111.909 176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 163.68 -138.05 5.1 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.735 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 83.8 m-85 -121.91 -84.09 0.66 Allowed 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.786 -0.207 . . . . 0.0 111.321 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.56 53.43 0.13 Allowed Glycine 0 C--N 1.291 -1.949 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.998 -171.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 43' ' ' ILE . 30.7 p90 -161.23 143.24 12.03 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' HA ' ' B' ' 160' ' ' GLN . 20.0 p -106.06 135.69 47.07 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.793 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 0.9 OUTLIER -114.08 163.22 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.559 -168.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 44' ' ' LYS . 2.7 m -121.46 133.31 68.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.173 0 C-N-CA 124.293 1.037 . . . . 0.0 109.689 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 114.18 -130.96 9.6 Favored Glycine 0 C--O 1.279 2.946 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.123 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.568 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.77 62.26 1.01 Allowed Glycine 0 CA--C 1.453 -3.817 0 O-C-N 126.462 1.919 . . . . 0.0 110.837 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.605 ' OD2' ' HB3' ' B' ' 156' ' ' ARG . 8.5 t70 -110.8 -36.1 5.79 Favored 'General case' 0 C--N 1.249 -3.795 0 CA-C-N 113.735 -1.232 . . . . 0.0 109.719 -170.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.5 pt-20 -158.3 174.71 3.78 Favored Pre-proline 0 CA--C 1.481 -1.686 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.227 -169.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 73.1 Cg_exo -60.15 -30.43 91.32 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 122.617 2.211 . . . . 0.0 109.516 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.85 -39.37 79.96 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.889 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.67 119.78 37.88 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -88.97 165.95 14.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.876 2.07 . . . . 0.0 108.538 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -89.27 144.17 26.29 Favored 'General case' 0 C--O 1.18 -2.597 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.689 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.562 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -133.85 169.4 17.14 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 29' ' ' PHE . 36.8 mm -113.54 126.1 70.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 -173.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.609 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -102.28 -20.31 14.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.6 m -155.75 126.92 7.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.186 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -78.6 108.99 12.4 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 89.3 t -84.86 126.42 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.5 144.55 55.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.331 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 82.68 2.83 1.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 125.205 1.566 . . . . 0.0 110.071 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.682 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.11 160.3 38.39 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.34 -25.3 18.59 Favored 'Trans proline' 0 C--O 1.18 -2.398 0 CA-C-N 121.092 2.446 . . . . 0.0 109.62 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -63.69 -44.18 94.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.523 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.94 68.9 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 122.655 1.217 . . . . 0.0 109.8 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 52.1 mt -72.54 -50.07 28.2 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.356 -2.202 . . . . 0.0 115.9 -172.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.51 -21.43 41.91 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.4 -169.59 54.87 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.395 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt 58.5 30.29 19.54 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 112.784 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' MET . . . . . 0.672 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.5 tmt? -159.83 131.97 6.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 171.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -147.85 160.27 42.95 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.477 0.656 . . . . 0.0 112.26 -169.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -54.69 119.91 6.0 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.386 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.54 4.1 15.81 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.867 -1.158 . . . . 0.0 112.752 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 p30 -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.214 171.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 6.5 p -100.42 117.87 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.398 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 50.4 mm -74.59 111.41 10.38 Favored 'Isoleucine or valine' 0 C--O 1.301 3.794 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.277 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 73' ' ' LEU . 58.6 t -89.18 -58.09 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.476 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -160.55 173.64 15.23 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.031 -0.418 . . . . 0.0 110.852 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.1 p -140.5 121.33 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.378 30.0 p-10 33.03 -89.84 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -92.5 -34.09 14.22 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -93.09 130.87 38.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.227 1.013 . . . . 0.0 112.719 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 t -84.7 90.16 7.66 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 41' ' ' LEU . 40.8 t -78.89 -0.34 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 122.857 1.313 . . . . 0.0 109.039 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 6' ' ' ARG . 20.8 tp -68.1 111.47 4.49 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.363 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.5 43.04 93.28 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.792 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -92.42 137.8 32.05 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.9 m -69.55 143.87 53.26 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CG ' ' HA ' ' B' ' 156' ' ' ARG . 60.3 t-80 -47.49 -49.18 26.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.147 0.885 . . . . 0.0 112.548 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.83 71.95 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.684 0.754 . . . . 0.0 110.97 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 14.1 mm-40 -80.1 -50.0 10.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.854 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.711 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -64.71 -42.27 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.427 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.7 p -63.07 -35.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -43.77 98.28 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.9 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.59 -50.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 122.196 0.998 . . . . 0.0 109.357 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -67.25 -28.69 68.25 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.41 -1.723 . . . . 0.0 112.759 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 78.7 mm-40 -88.49 -17.26 30.72 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 p -94.86 -13.6 25.34 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.665 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -52.02 154.8 3.61 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 177.338 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -95.45 148.14 1.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.093 3.195 . . . . 0.0 112.325 -176.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.578 HG12 ' N ' ' A' ' 25' ' ' ARG . 50.6 mt -65.26 124.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.897 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.65 11.28 44.59 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-O 119.746 -0.475 . . . . 0.0 113.354 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -93.06 -178.09 4.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.033 0.916 . . . . 0.0 111.626 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 t -139.29 150.51 45.51 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 110.496 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.566 HG22 ' HE2' ' A' ' 22' ' ' LYS . 2.5 m -151.39 156.66 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.149 0.98 . . . . 0.0 110.854 174.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.522 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 23.6 m-20 -105.21 107.33 18.26 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 20' ' ' LEU . 13.5 tp -94.33 125.92 39.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.26 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 9.8 pt-20 -108.74 113.8 27.06 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.887 0.851 . . . . 0.0 108.789 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.554 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.7 pt? -142.13 155.5 45.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.324 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 63' ' ' VAL . 58.8 m -113.58 107.11 15.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.573 0.702 . . . . 0.0 109.33 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.672 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 4.9 ttp-105 -85.83 133.67 33.96 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.152 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.31 40.23 0.97 Allowed Glycine 0 C--N 1.283 -2.369 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.812 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -108.14 125.79 31.19 Favored Pre-proline 0 N--CA 1.409 -2.488 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 35.7 Cg_exo -59.29 138.35 84.04 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.318 2.012 . . . . 0.0 112.814 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER -98.14 91.62 1.22 Allowed Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 48.5 Cg_endo -88.58 20.44 1.14 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.087 2.524 . . . . 0.0 113.675 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 103' ' ' LEU . 95.0 m-85 -142.42 179.07 7.16 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.1 m-20 -79.64 146.48 65.22 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.7 Cg_endo -97.48 9.2 1.22 Allowed 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 123.772 2.981 . . . . 0.0 107.126 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.1 -25.76 10.96 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.929 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.28 113.7 28.23 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.474 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.02 153.06 76.14 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 C-N-CA 123.792 2.994 . . . . 0.0 113.694 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.506 ' HB3' HD21 ' A' ' 114' ' ' LEU . 95.8 m-20 164.38 68.31 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 129.6 3.16 . . . . 0.0 109.683 165.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' B' ' 158' ' ' GLU . 57.2 m -85.11 -40.6 16.58 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.604 1.192 . . . . 0.0 110.331 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.806 ' HA ' HG22 ' B' ' 155' ' ' THR . 10.2 t -91.89 99.04 11.97 Favored 'General case' 0 C--N 1.251 -3.701 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.393 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' H ' ' HA ' ' B' ' 155' ' ' THR . 57.1 mt -123.34 104.99 9.46 Favored 'General case' 0 N--CA 1.416 -2.175 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.05 123.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.5 t -71.03 144.62 50.35 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.2 t -110.61 156.24 21.24 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.11 101.41 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-O 122.023 0.916 . . . . 0.0 110.397 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.53 73.67 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.8 mm -110.4 -9.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.861 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.3 mt -130.49 163.94 25.91 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.052 0.453 . . . . 0.0 111.647 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -98.94 101.81 13.33 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.464 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -93.1 135.59 34.14 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.693 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -90.54 111.74 49.21 Favored Pre-proline 0 C--N 1.269 -2.894 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.957 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.462 -0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.439 -175.925 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.8 t -95.97 111.39 23.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -144.98 119.22 9.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.364 0.602 . . . . 0.0 111.738 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -90.25 151.31 21.58 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 113' ' ' SER . 27.1 p 62.63 139.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.647 1.179 . . . . 0.0 114.132 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.605 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 48.7 mtm180 -153.44 165.4 35.93 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 157' ' ' ARG . . . . . 0.447 ' HA ' ' H ' ' A' ' 33' ' ' GLY . 22.5 tpp180 75.25 -77.58 0.05 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.068 0.547 . . . . 0.0 111.897 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 32.8 mt-10 -86.59 91.11 8.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.429 0.633 . . . . 0.0 112.239 -173.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 159' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 31' ' ' VAL . 7.8 m -88.65 110.2 20.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' THR . 21.1 mt-30 -84.26 120.93 26.81 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.9 m . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.386 15.0 t . . . . . 0 N--CA 1.417 -2.084 0 CA-C-O 119.466 -0.302 . . . . 0.0 111.147 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' THR . 18.2 ptt-85 155.18 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.745 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.6 t-20 -55.86 111.88 3.67 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 112.779 -2.01 . . . . 0.0 112.913 -175.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.2 Cg_exo -63.96 -27.16 66.38 Favored 'Trans proline' 0 CA--C 1.476 -2.407 0 C-N-CA 121.234 1.289 . . . . 0.0 109.997 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -85.4 -14.92 44.78 Favored 'General case' 1 N--CA 1.358 -5.063 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.652 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.4 pt-20 -72.69 -36.2 67.83 Favored 'General case' 0 C--N 1.376 1.752 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.0 mt -59.99 136.0 57.88 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.16 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -98.34 177.49 5.35 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.648 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.6 -99.71 2.48 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.765 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -145.79 128.22 15.94 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.408 0.623 . . . . 0.0 109.352 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.73 115.21 29.8 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -126.12 152.41 33.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.058 -175.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.691 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 14.7 t-160 -127.33 99.89 5.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 HG22 HD21 ' A' ' 97' ' ' LEU . 15.3 t -124.2 141.3 52.17 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.047 -172.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -86.71 131.14 34.22 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.685 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.7 mp -115.02 123.35 48.85 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -86.22 115.44 23.78 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -45.17 102.35 0.03 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 123.95 0.9 . . . . 0.0 109.234 169.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -123.14 135.93 54.56 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 125.274 1.609 . . . . 0.0 108.939 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m 55.12 28.62 11.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.068 0.947 . . . . 0.0 113.143 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.744 ' N ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 77.5 102.91 0.07 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.632 1.573 . . . . 0.0 108.368 176.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.55 -137.32 13.53 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.289 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.649 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.6 m-85 -124.29 -82.76 0.64 Allowed 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.54 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 119.64 56.02 0.25 Allowed Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.455 ' HA ' ' H ' ' A' ' 47' ' ' VAL . 28.2 p90 -160.9 143.65 12.79 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' CB ' ' B' ' 160' ' ' GLN . 40.0 p -107.99 134.94 50.19 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-O 122.134 0.969 . . . . 0.0 109.199 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.584 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 2.2 p -135.55 136.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.957 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.044 -169.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' HB3' ' A' ' 44' ' ' LYS . 15.2 m -115.39 131.82 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.261 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.1 -145.35 17.13 Favored Glycine 0 CA--C 1.457 -3.57 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 48.39 70.11 0.82 Allowed Glycine 0 CA--C 1.464 -3.137 0 O-C-N 126.599 1.999 . . . . 0.0 112.031 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -116.93 -29.25 6.06 Favored 'General case' 0 C--N 1.259 -3.332 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.296 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.6 pt-20 -159.21 174.23 4.23 Favored Pre-proline 0 CA--C 1.467 -2.242 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.579 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 77.1 Cg_exo -61.72 -25.83 79.23 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 122.435 2.09 . . . . 0.0 109.388 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -84.01 -21.39 31.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.347 -2.206 . . . . 0.0 112.306 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -122.75 119.41 30.58 Favored 'General case' 0 C--O 1.264 1.837 0 O-C-N 121.492 -0.755 . . . . 0.0 110.471 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.0 165.67 12.74 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.249 2.22 . . . . 0.0 108.495 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.3 mp -93.08 146.47 23.62 Favored 'General case' 0 C--O 1.183 -2.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.583 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 63' ' ' VAL . 15.0 tt0 -137.18 144.49 42.93 Favored 'General case' 0 C--O 1.191 -2.006 0 CA-C-N 118.56 0.618 . . . . 0.0 110.318 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.445 HD12 ' CD1' ' A' ' 29' ' ' PHE . 23.4 mm -79.94 119.63 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 O-C-N 121.829 -0.544 . . . . 0.0 109.848 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 32' ' ' VAL . 1.2 pptp? -103.28 -19.79 14.34 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.951 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.418 ' OG ' ' HD2' ' A' ' 44' ' ' LYS . 45.6 m -161.14 128.16 4.08 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 59' ' ' GLU . 1.5 pp -87.63 128.35 35.28 Favored 'General case' 0 N--CA 1.395 -3.183 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.725 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.54 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.6 t -80.2 127.51 39.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 86.8 mt -64.5 133.99 53.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.6 t70 84.73 11.08 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.385 1.678 . . . . 0.0 109.608 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.93 155.57 23.17 Favored Glycine 0 CA--C 1.487 -1.702 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.572 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.5 Cg_endo -72.02 -25.32 19.64 Favored 'Trans proline' 0 N--CA 1.425 -2.556 0 CA-C-N 121.266 2.533 . . . . 0.0 110.486 -170.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.85 85.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.62 88.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 122.861 1.315 . . . . 0.0 109.879 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 87.4 mt -72.42 -45.73 58.36 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 112.785 -2.007 . . . . 0.0 114.459 -174.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -68.78 -24.69 64.45 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.74 3.2 9.43 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-N 114.186 -1.37 . . . . 0.0 115.893 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -110.44 19.42 18.8 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.996 1.379 . . . . 0.0 109.802 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ttt -146.67 133.21 19.77 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.613 ' HA ' HD23 ' A' ' 46' ' ' LEU . 44.4 mt-10 -140.43 162.11 36.11 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.354 0.662 . . . . 0.0 109.738 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.0 m -57.02 119.01 5.56 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.51 -18.5 5.73 Favored Glycine 0 C--N 1.302 -1.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.47 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' A' ' 99' ' ' ARG . 11.1 m-20 -67.79 136.63 54.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HG3' ' A' ' 42' ' ' GLN . 1.8 m -101.38 130.35 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 43.3 mm -82.22 111.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.299 3.702 0 C-N-CA 123.343 0.657 . . . . 0.0 109.856 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 60.4 t -91.85 -57.92 3.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 126.346 2.279 . . . . 0.0 108.764 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -157.74 170.96 21.19 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.925 -0.484 . . . . 0.0 111.24 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -152.67 120.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.018 0.437 . . . . 0.0 112.145 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.18 58.63 5.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.907 1.283 . . . . 0.0 111.258 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.26 -30.09 0.2 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.504 -1.68 . . . . 0.0 113.033 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 m -65.83 127.12 30.73 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 121.444 0.64 . . . . 0.0 111.14 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.9 t -79.05 78.24 5.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.233 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 87.2 t -83.89 5.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 122.786 1.279 . . . . 0.0 109.49 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.463 HD13 HG13 ' A' ' 65' ' ' VAL . 13.3 tp -66.62 110.13 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.92 45.0 95.73 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.205 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 1.7 t60 -79.72 147.99 31.7 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.5 m -74.87 143.57 43.78 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 117.73 -1.128 . . . . 0.0 108.821 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -48.07 -49.28 32.16 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.246 0.93 . . . . 0.0 112.33 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.7 71.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 124.063 0.852 . . . . 0.0 110.988 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 81.0 mm-40 -80.28 -48.57 12.83 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.125 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 41' ' ' LEU . 7.3 p -63.8 -43.14 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.7 p -64.53 -35.97 76.06 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -42.99 85.89 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.261 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -72.25 -50.65 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 CA-C-O 122.474 1.131 . . . . 0.0 109.528 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.66 -29.67 69.75 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.049 -1.887 . . . . 0.0 113.327 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 mp0 -86.71 -25.18 24.88 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 p -85.57 -22.36 28.1 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -52.43 151.35 7.6 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.4 Cg_endo -102.49 159.54 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.242 3.961 . . . . 0.0 112.302 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.744 HG12 ' N ' ' A' ' 25' ' ' ARG . 26.9 mt -67.96 131.21 33.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.297 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.03 11.4 34.43 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.961 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -103.39 176.88 5.0 Favored 'General case' 0 C--O 1.202 -1.444 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.496 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.492 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 30.1 t -134.57 148.32 50.44 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.082 -0.386 . . . . 0.0 110.675 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 22' ' ' LYS . 3.2 m -149.07 149.75 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 C-N-CA 124.104 0.961 . . . . 0.0 111.169 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.691 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.9 m-20 -100.23 111.75 24.04 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.526 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.32 125.09 35.97 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.937 0.399 . . . . 0.0 110.315 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 35.2 mt-10 -104.27 105.45 15.59 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 18' ' ' THR . 0.4 OUTLIER -141.43 157.29 45.36 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.254 -172.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.9 t -131.7 120.09 22.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.344 0.592 . . . . 0.0 109.739 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 19.4 ttp85 -114.98 158.62 21.8 Favored 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 124.086 0.955 . . . . 0.0 109.858 -174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.22 -15.34 2.54 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 . . . . . 0 N--CA 1.432 -1.34 0 CA-C-N 113.989 -1.105 . . . . 0.0 108.222 177.978 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.44 -0.971 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 8.5 m -115.67 89.01 3.0 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.496 ' CB ' HG22 ' A' ' 30' ' ' THR . 5.1 pm0 -76.97 114.06 15.34 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.263 0.554 . . . . 0.0 110.631 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.2 m . . . . . 0 N--CA 1.427 -1.593 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.63 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.432 -1.345 0 CA-C-O 121.585 0.707 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 47.67 41.12 13.22 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 124.049 1.881 . . . . 0.0 112.107 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.787 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -111.42 114.81 52.64 Favored Pre-proline 0 C--N 1.248 -3.845 0 CA-C-N 112.82 -1.991 . . . . 0.0 112.98 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.305 14.6 Cg_exo -57.53 -36.06 98.72 Favored 'Trans proline' 0 CA--C 1.48 -2.203 0 CA-C-O 123.948 1.562 . . . . 0.0 109.076 172.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -73.94 -15.87 61.11 Favored 'General case' 1 N--CA 1.344 -5.737 0 CA-C-N 110.626 -2.988 . . . . 0.0 112.403 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.787 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.1 pt-20 -80.85 -30.42 35.66 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.6 mt -66.76 137.22 56.48 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.473 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -82.86 179.86 7.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.453 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.55 -129.73 9.47 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.619 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 144.98 50.49 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 122.757 0.423 . . . . 0.0 110.362 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -113.03 112.26 23.57 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.08 152.54 35.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.229 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.82 108.13 14.01 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -131.96 147.17 52.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.682 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -92.8 140.82 29.12 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.952 0.501 . . . . 0.0 111.368 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -122.14 127.4 50.04 Favored 'General case' 0 C--O 1.258 1.512 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -85.88 113.95 22.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.81 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -42.35 106.07 0.06 Allowed 'General case' 0 CA--C 1.475 -1.921 0 C-N-CA 125.441 1.496 . . . . 0.0 112.267 172.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -120.34 129.91 54.19 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.623 ' C ' HG12 ' A' ' 89' ' ' ILE . 10.9 m 61.16 -165.22 0.22 Allowed 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -84.57 61.03 6.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.636 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.41 -121.0 1.05 Allowed Glycine 0 N--CA 1.406 -3.313 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.284 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 87' ' ' ILE . 76.4 m-85 -135.28 -101.02 0.22 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.921 -1.14 . . . . 0.0 112.032 -168.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.26 57.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.518 ' HA ' HG23 ' A' ' 47' ' ' VAL . 50.7 p90 -160.55 143.58 13.28 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -101.35 135.31 43.04 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 117.792 -1.563 . . . . 0.0 109.932 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 159' ' ' THR . 11.3 p -126.0 143.42 39.57 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.516 -170.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.7 m -115.65 132.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.837 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 127.22 -144.36 15.02 Favored Glycine 0 C--N 1.277 -2.727 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.264 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.561 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.76 63.52 2.48 Favored Glycine 0 CA--C 1.457 -3.592 0 O-C-N 126.483 1.931 . . . . 0.0 111.946 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 76' ' ' THR . 8.5 t70 -105.18 -42.48 5.27 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.322 -0.939 . . . . 0.0 108.514 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.1 pt-20 -160.03 172.61 5.75 Favored Pre-proline 0 CA--C 1.472 -2.026 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.324 -170.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 18.7 Cg_exo -76.01 64.53 6.91 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.152 3.235 . . . . 0.0 108.57 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -172.83 -47.27 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 111.789 -2.46 . . . . 0.0 107.373 -174.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -105.11 119.32 38.75 Favored 'General case' 0 C--O 1.273 2.335 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.947 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.12 166.22 12.45 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 128.682 2.793 . . . . 0.0 108.905 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.561 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.1 mp -96.37 145.87 25.25 Favored 'General case' 0 C--O 1.172 -3.016 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.421 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 40.4 tt0 -139.78 144.34 37.34 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 118.488 0.586 . . . . 0.0 110.093 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.2 mp -81.82 118.42 29.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 O-C-N 121.913 -0.492 . . . . 0.0 109.683 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -98.75 -24.39 15.04 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.432 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -152.37 127.99 10.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.644 -0.66 . . . . 0.0 109.673 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 60' ' ' THR . 3.0 pp -86.97 116.51 25.08 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 29' ' ' PHE . 67.0 t -87.91 134.73 27.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.273 -173.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 95.7 mt -60.24 142.54 54.39 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.7 t70 79.87 3.42 2.06 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.784 1.302 . . . . 0.0 110.558 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -95.05 155.74 21.57 Favored Glycine 0 CA--C 1.489 -1.571 0 CA-C-O 118.362 -1.243 . . . . 0.0 110.45 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.627 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 18.1 Cg_endo -71.89 -25.64 19.71 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 CA-C-N 120.931 2.365 . . . . 0.0 111.062 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.8 97.12 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.9 74.45 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.542 1.163 . . . . 0.0 109.954 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 79.7 mt -71.58 -40.3 70.0 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-N 112.933 -1.94 . . . . 0.0 114.165 -172.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.77 -24.58 58.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.94 -3.98 11.49 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.997 -1.456 . . . . 0.0 115.893 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -94.08 -42.58 8.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.431 ' HG3' HD11 ' A' ' 97' ' ' LEU . 22.5 ttt -82.12 133.84 35.29 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -139.76 168.74 19.12 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.094 0.949 . . . . 0.0 112.073 -169.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.459 ' H ' HD23 ' A' ' 46' ' ' LEU . 20.7 m -64.16 126.23 27.08 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.383 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.09 -9.93 12.01 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.618 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 18.9 m-20 -78.37 144.17 36.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.327 0.1 OUTLIER -115.48 119.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.544 0.688 . . . . 0.0 111.094 171.086 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 43' ' ' ILE . 40.7 mm -68.67 113.76 4.77 Favored 'Isoleucine or valine' 0 C--O 1.299 3.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.215 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.641 HG13 HD13 ' A' ' 73' ' ' LEU . 87.6 t -102.39 -54.96 6.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 112.254 -2.248 . . . . 0.0 110.203 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.9 t -143.65 158.22 43.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.388 -0.82 . . . . 0.0 110.213 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.15 112.1 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.03 0.443 . . . . 0.0 111.641 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 93' ' ' VAL . 21.9 t-20 71.24 -66.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.137 1.375 . . . . 0.0 111.875 175.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.66 -37.61 0.1 Allowed 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.844 1.658 . . . . 0.0 109.035 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -67.71 127.69 33.7 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.781 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.3 t -85.69 90.3 7.98 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.526 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 9.7 p -80.26 4.09 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 122.701 1.239 . . . . 0.0 109.928 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.641 HD13 HG13 ' A' ' 65' ' ' VAL . 19.6 tp -67.43 111.79 4.27 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.563 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.78 37.54 88.74 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.528 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -82.49 148.22 28.25 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 83.2 m -78.77 143.22 36.32 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.776 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 83.2 t60 -47.26 -50.55 21.15 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.288 0.949 . . . . 0.0 113.096 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.12 74.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.845 0.716 . . . . 0.0 110.702 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 34.3 mm-40 -75.68 -50.41 15.49 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 41' ' ' LEU . 7.0 p -62.02 -45.25 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.667 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.57 -36.0 76.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.416 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -59.08 -47.88 83.62 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.486 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -72.46 -49.96 38.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.385 0 CA-C-O 122.18 0.991 . . . . 0.0 110.121 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HB3' HG11 ' B' ' 161' ' ' VAL . 7.2 m-85 -61.41 -40.44 94.42 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.529 -1.668 . . . . 0.0 113.141 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.63 -14.07 46.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -91.76 -2.21 57.05 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.119 0.485 . . . . 0.0 110.824 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.753 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.2 mt -53.35 140.51 44.97 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.051 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 83.6 Cg_endo -97.82 150.78 0.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.618 2.879 . . . . 0.0 113.042 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.623 HG12 ' C ' ' A' ' 24' ' ' SER . 23.6 mt -67.59 135.89 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.432 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.6 12.43 58.23 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.222 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -108.5 -170.63 1.71 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.147 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.409 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.0 t -150.04 142.17 24.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.81 HG22 ' HE3' ' A' ' 22' ' ' LYS . 27.4 m -145.51 155.35 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.818 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.775 173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.05 113.81 27.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 124.929 1.393 . . . . 0.0 109.197 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.7 mm? -91.12 120.32 31.97 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 20.4 mt-10 -98.71 110.21 22.84 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.431 HD11 ' HG3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.49 156.52 45.74 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.046 -170.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 63.3 m -109.99 125.91 53.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.606 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 tpp85 -102.82 153.52 20.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.98 -5.77 7.84 Favored Glycine 0 CA--C 1.486 -1.72 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.938 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 . . . . . 0 N--CA 1.43 -1.447 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.1 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 158' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.565 0 CA-C-O 122.182 0.991 . . . . 0.0 110.714 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.537 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.4 m -75.83 107.82 8.27 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.95 93.94 9.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.704 -0.622 . . . . 0.0 110.629 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 m . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.717 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 8.8 t . . . . . 0 N--CA 1.419 -1.995 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 5' ' ' THR . 10.2 ptm180 56.02 13.47 1.16 Allowed 'General case' 0 N--CA 1.516 2.842 0 C-N-CA 126.423 1.889 . . . . 0.0 113.653 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.7 m-80 -93.8 115.03 64.59 Favored Pre-proline 0 C--N 1.251 -3.712 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.288 10.8 Cg_exo -62.06 -29.69 81.71 Favored 'Trans proline' 0 CA--C 1.475 -2.444 0 N-CA-C 108.019 -1.57 . . . . 0.0 108.019 170.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 t -69.79 -25.68 63.91 Favored 'General case' 1 N--CA 1.354 -5.255 0 CA-C-N 111.271 -2.695 . . . . 0.0 110.962 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.0 pt-20 -78.27 -31.26 48.96 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 86.9 mt -63.01 133.92 55.35 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.547 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 176.08 6.72 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.803 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.23 -116.19 5.44 Favored Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.324 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.4 156.42 48.21 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -122.07 112.47 18.28 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -119.85 152.22 22.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-O 121.209 0.528 . . . . 0.0 110.737 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.605 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.3 t-160 -133.26 99.64 4.6 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 14.9 t -126.27 142.09 51.66 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.677 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -86.84 133.36 33.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.019 0.928 . . . . 0.0 111.637 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -115.45 127.34 55.26 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -88.06 103.94 16.19 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.687 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.53 118.23 1.03 Allowed 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 19.3 t -92.51 -137.05 0.17 Allowed 'General case' 0 N--CA 1.403 -2.785 0 O-C-N 126.104 2.128 . . . . 0.0 106.717 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -63.84 83.29 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.505 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 60.69 27.99 17.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.395 1.878 . . . . 0.0 112.009 174.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.45 -139.48 5.41 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.69 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.601 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.7 m-85 -124.66 -87.84 0.61 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.493 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.92 52.54 0.11 Allowed Glycine 0 C--N 1.295 -1.72 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.037 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 42.2 p90 -160.96 141.94 11.61 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 172.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.6 p -107.62 138.04 44.57 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 41' ' ' LEU . 19.3 m -124.89 159.29 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -167.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.9 m -115.87 133.7 61.48 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 C-N-CA 124.516 1.127 . . . . 0.0 109.968 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 116.18 -143.91 18.24 Favored Glycine 0 C--N 1.278 -2.689 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.467 175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.77 58.09 4.34 Favored Glycine 0 CA--C 1.452 -3.87 0 O-C-N 126.115 1.714 . . . . 0.0 111.228 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.46 ' O ' ' HA ' ' A' ' 76' ' ' THR . 6.3 t70 -102.67 -35.49 8.67 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.328 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.9 pt-20 -158.45 168.44 12.44 Favored Pre-proline 0 CA--C 1.469 -2.151 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.404 -169.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -75.94 58.18 5.39 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 124.298 3.332 . . . . 0.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -170.81 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 112.085 -2.325 . . . . 0.0 106.732 -173.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.42 118.73 34.55 Favored 'General case' 0 C--O 1.272 2.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.279 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.18 165.96 13.65 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 127.976 2.51 . . . . 0.0 108.348 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.9 mp -95.76 144.38 26.2 Favored 'General case' 0 C--O 1.175 -2.858 0 C-N-CA 118.506 -1.277 . . . . 0.0 109.639 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 36.5 tt0 -130.1 156.28 44.8 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' A' ' 29' ' ' PHE . 12.6 mm -90.01 127.27 42.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.67 -19.86 13.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.0 m -155.73 127.28 7.3 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 tp -83.14 114.96 21.69 Favored 'General case' 0 N--CA 1.402 -2.84 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.493 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 58.4 t -86.99 122.71 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.19 146.17 50.93 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 84.37 3.03 0.79 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.489 1.743 . . . . 0.0 109.795 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.658 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -86.91 158.98 31.06 Favored Glycine 0 C--O 1.207 -1.579 0 CA-C-O 117.872 -1.516 . . . . 0.0 109.576 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.6 Cg_endo -72.59 -25.17 17.92 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 CA-C-N 121.725 2.762 . . . . 0.0 110.633 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.38 -42.2 98.83 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.241 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.36 82.12 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.668 1.223 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 82.6 mt -71.67 -44.74 63.73 Favored 'General case' 0 N--CA 1.405 -2.715 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.517 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.16 -19.61 50.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.36 1.076 . . . . 0.0 108.242 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.98 27.92 65.39 Favored Glycine 0 CA--C 1.48 -2.097 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.593 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 26.4 tptp -102.06 -13.08 17.66 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.331 -173.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.619 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 67.5 mtp -123.11 144.31 49.4 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.43 141.39 25.9 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -45.16 114.14 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.726 1.21 . . . . 0.0 111.332 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.6 -18.77 5.12 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.461 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CB ' HD12 ' A' ' 97' ' ' LEU . 5.0 m-20 -60.64 146.51 45.2 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.288 1.2 p -117.87 116.18 50.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.964 174.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.08 120.02 25.25 Favored 'Isoleucine or valine' 0 C--O 1.284 2.882 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.692 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.434 HG11 ' HG3' ' A' ' 8' ' ' PRO . 37.4 t -99.12 -34.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-N 112.334 -2.212 . . . . 0.0 110.138 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -170.62 169.49 7.16 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 95' ' ' LEU . 6.9 p -155.17 115.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 63.3 t30 37.43 76.59 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.14 1.776 . . . . 0.0 113.918 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 70.89 -18.93 0.24 Allowed 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.76 122.53 33.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.39 77.2 8.29 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 122.023 0.916 . . . . 0.0 110.134 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.94 -0.91 4.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.426 1.108 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 6' ' ' ARG . 30.7 tp -59.04 110.52 1.06 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 170.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.59 48.77 84.54 Favored Glycine 0 N--CA 1.431 -1.641 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.298 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -89.17 141.14 28.78 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.541 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 24.0 m -74.04 144.09 45.22 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.247 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.431 ' HA ' HG12 ' A' ' 80' ' ' VAL . 73.2 t60 -46.72 -47.54 20.53 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.135 0.879 . . . . 0.0 113.103 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.901 0.857 . . . . 0.0 111.081 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 79.2 mm-40 -78.51 -49.75 12.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.651 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 41' ' ' LEU . 12.7 p -64.46 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.93 -44.64 98.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -72.79 -27.04 61.75 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.27 -1.372 . . . . 0.0 113.276 -175.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -73.02 -51.21 27.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 122.03 0.919 . . . . 0.0 109.003 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.46 -39.09 92.3 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.703 -1.59 . . . . 0.0 112.755 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' B' ' 161' ' ' VAL . 14.2 mm100 -85.65 -20.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -96.17 4.96 52.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.211 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.687 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 3.1 mt -48.47 147.08 4.35 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.302 1.041 . . . . 0.0 112.709 170.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -94.27 150.56 2.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.246 2.631 . . . . 0.0 111.436 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.505 HG12 ' H ' ' A' ' 25' ' ' ARG . 24.8 mt -68.75 143.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.305 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.52 12.06 70.4 Favored Glycine 0 CA--C 1.497 -1.052 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.483 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.71 -176.34 3.71 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.274 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.556 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.7 t -147.03 142.68 27.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.255 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 4.7 m -151.98 144.24 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 O-C-N 124.2 0.938 . . . . 0.0 111.002 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.605 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 2.5 m-20 -97.79 117.73 32.76 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.696 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 3.2 mm? -90.67 121.98 33.05 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -91.05 108.18 19.7 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.577 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -141.61 147.74 38.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.062 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.28 136.77 44.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.841 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 18.4 tpp85 -114.08 149.98 34.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.24 3.95 6.61 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' A' ' 11' ' ' LEU . 65.3 m-85 . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 122.788 0.435 . . . . 0.0 111.389 179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.2 mp0 . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 14.3 m -81.44 128.29 33.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.43 ' HA ' HG22 ' A' ' 30' ' ' THR . 50.6 mt-30 -98.47 124.91 43.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.458 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.5 t . . . . . 0 CA--C 1.561 1.396 0 CA-C-O 121.031 0.443 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 5' ' ' THR . 31.1 ptt180 54.67 15.53 1.1 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 126.159 1.784 . . . . 0.0 113.559 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.81 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.9 m-80 -94.62 114.22 62.94 Favored Pre-proline 1 C--N 1.242 -4.065 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.269 7.2 Cg_exo -58.36 -29.97 89.78 Favored 'Trans proline' 0 CA--C 1.483 -2.034 0 C-N-CA 121.552 1.501 . . . . 0.0 109.336 170.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -72.99 -25.43 60.98 Favored 'General case' 1 N--CA 1.365 -4.721 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.313 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -76.02 -34.54 59.69 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -55.07 130.61 42.51 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 122.406 1.098 . . . . 0.0 111.748 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.17 170.88 12.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.282 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.67 -109.65 3.05 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.045 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -147.33 145.13 29.22 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 123.082 0.553 . . . . 0.0 110.646 -176.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -110.22 111.45 22.77 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.005 0.907 . . . . 0.0 112.152 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -118.05 99.79 7.12 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -129.69 137.02 50.39 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.562 0.696 . . . . 0.0 111.588 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -73.36 133.54 43.83 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.07 0.948 . . . . 0.0 112.008 -176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 tp -124.49 134.41 53.04 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -93.66 114.72 27.09 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.555 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -42.71 99.5 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 125.0 1.32 . . . . 0.0 111.099 168.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.3 m -118.48 125.44 49.9 Favored 'General case' 0 N--CA 1.417 -2.092 0 O-C-N 125.527 1.767 . . . . 0.0 107.655 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 58.46 47.7 13.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.777 0.799 . . . . 0.0 111.035 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.546 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.7 mpt_? 84.7 -62.74 0.08 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 126.635 1.974 . . . . 0.0 111.702 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . -100.29 -115.06 3.74 Favored Glycine 0 N--CA 1.406 -3.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.211 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.635 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 81.2 m-85 -129.97 -84.5 0.54 Allowed 'General case' 0 N--CA 1.397 -3.12 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.002 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 134.26 53.86 0.07 OUTLIER Glycine 0 C--N 1.295 -1.73 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.008 -170.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' HD12 ' A' ' 43' ' ' ILE . 44.0 p90 -161.64 142.85 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.517 HG22 ' HB2' ' B' ' 160' ' ' GLN . 76.9 p -104.24 135.12 46.31 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.823 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 159' ' ' THR . 1.0 OUTLIER -115.77 162.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.791 -171.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.0 132.31 47.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 C-N-CA 123.505 0.722 . . . . 0.0 109.237 173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 131.91 -147.85 18.84 Favored Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.46 60.64 3.59 Favored Glycine 0 CA--C 1.462 -3.263 0 O-C-N 126.352 1.854 . . . . 0.0 113.085 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -106.03 -24.23 12.44 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 114.348 -0.926 . . . . 0.0 109.148 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 3.0 pt-20 -158.49 172.06 6.63 Favored Pre-proline 0 C--O 1.196 -1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.426 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -67.54 -15.34 44.8 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 123.117 2.545 . . . . 0.0 109.439 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.42 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 21.5 t70 -92.6 -24.04 18.83 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.995 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -123.22 117.93 26.45 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -84.61 165.54 17.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.253 2.221 . . . . 0.0 108.619 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -91.37 144.72 25.29 Favored 'General case' 0 C--O 1.183 -2.441 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.085 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 16.3 tt0 -128.07 169.49 14.0 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.3 mm -112.9 135.68 51.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' C ' HG23 ' A' ' 60' ' ' THR . 21.6 pttp -114.54 -13.64 12.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -159.75 127.98 4.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 3.7 pp -90.92 119.28 30.99 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' H ' ' HA ' ' A' ' 29' ' ' PHE . 92.4 t -75.67 126.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-O 121.142 0.496 . . . . 0.0 109.711 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.63 135.02 56.45 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.4 t70 87.47 2.2 0.41 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 125.422 1.701 . . . . 0.0 110.255 -173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.39 159.54 37.07 Favored Glycine 0 C--O 1.208 -1.5 0 CA-C-O 118.175 -1.347 . . . . 0.0 110.887 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.635 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -72.46 -25.52 17.96 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 121.307 2.554 . . . . 0.0 110.155 -170.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -67.4 -43.11 82.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.476 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.35 76.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.499 1.143 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 95.2 mt -71.86 -39.7 69.5 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.926 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.97 -17.26 47.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 122.554 1.168 . . . . 0.0 109.773 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.84 46.38 76.44 Favored Glycine 0 CA--C 1.494 -1.233 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.106 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.2 tpmt? -126.9 6.34 6.62 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.588 0.709 . . . . 0.0 110.956 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.613 ' SD ' ' HB1' ' A' ' 52' ' ' ALA . 1.8 tmt? -147.93 150.57 34.3 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 10.8 pt-20 -136.02 166.95 22.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.275 1.036 . . . . 0.0 111.152 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.495 ' N ' HD23 ' A' ' 46' ' ' LEU . 69.0 m -68.75 119.62 13.42 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.39 -25.69 4.77 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.59 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.575 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.2 m-20 -54.99 150.71 9.87 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.179 0.514 . . . . 0.0 111.625 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.267 0.8 OUTLIER -115.15 120.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 175.344 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.4 mm -78.03 119.35 26.7 Favored 'Isoleucine or valine' 0 C--O 1.302 3.82 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.496 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 73' ' ' LEU . 47.9 t -100.63 -52.87 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.112 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 p -164.1 174.06 11.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.683 0.278 . . . . 0.0 111.543 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.95 152.6 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.582 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 3.8 t30 -26.66 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.526 1.53 . . . . 0.0 112.725 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 t70 85.03 -52.42 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.26 1.824 . . . . 0.0 114.11 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -93.95 127.19 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.384 1.088 . . . . 0.0 113.322 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.15 89.37 5.99 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.605 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.27 9.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 122.408 1.099 . . . . 0.0 109.599 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 6' ' ' ARG . 23.6 tp -64.18 110.19 2.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.89 43.61 87.46 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.979 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.2 150.53 38.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -77.42 143.1 38.87 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.675 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.469 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.0 t60 -47.7 -49.99 26.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.871 0.759 . . . . 0.0 112.191 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.84 75.29 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.829 0.706 . . . . 0.0 110.944 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -76.65 -50.4 13.83 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.881 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 41' ' ' LEU . 7.2 p -63.31 -44.49 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.367 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.9 p -64.79 -36.07 76.66 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.669 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.3 tmmm? -60.63 -45.84 92.52 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.733 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -73.12 -50.32 32.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.394 1.092 . . . . 0.0 109.425 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.29 -28.69 69.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.467 -1.697 . . . . 0.0 113.306 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 15.6 mm-40 -88.19 -17.47 30.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 p -95.63 -4.07 45.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -61.99 154.52 68.3 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.959 0.409 . . . . 0.0 111.212 174.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 35.6 Cg_endo -102.86 153.57 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.778 3.652 . . . . 0.0 112.704 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 25' ' ' ARG . 59.9 mt -65.58 128.86 29.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.014 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.4 10.7 33.09 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.613 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.08 177.06 5.2 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.432 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 31.3 t -140.0 150.84 44.93 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 123.427 0.691 . . . . 0.0 110.155 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.8 m -155.55 164.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 124.894 1.278 . . . . 0.0 109.96 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.582 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 14.5 m-20 -107.38 107.7 18.71 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.73 122.19 34.05 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -103.28 110.67 22.73 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' A' ' 62' ' ' ASP . 1.1 pt? -141.51 156.76 45.71 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 84.7 m -111.5 126.41 54.93 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.3 146.11 25.45 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.17 -19.66 2.86 Favored Glycine 0 CA--C 1.491 -1.453 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.825 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 120.752 0.311 . . . . 0.0 110.82 176.446 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 37.7 tt0 . . . . . 0 N--CA 1.429 -1.524 0 CA-C-O 121.535 0.683 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.643 ' HB ' HG22 ' A' ' 31' ' ' VAL . 12.3 m -115.23 97.89 6.46 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.517 ' HB2' HG22 ' A' ' 30' ' ' THR . 4.0 pm0 -76.95 120.4 22.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.6 m . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.361 12.1 t . . . . . 0 N--CA 1.415 -2.215 0 CA-C-O 119.402 -0.332 . . . . 0.0 111.798 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.444 ' HB2' HD21 ' A' ' 73' ' ' LEU . 8.7 ptm85 153.88 -29.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 125.64 1.576 . . . . 0.0 107.44 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 21.5 t30 -57.78 114.43 8.43 Favored Pre-proline 0 C--N 1.266 -3.058 0 CA-C-N 112.145 -2.298 . . . . 0.0 114.136 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.259 7.2 Cg_exo -58.86 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.469 -2.737 0 C-N-CA 122.818 2.345 . . . . 0.0 110.666 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.4 m -79.58 -12.65 59.84 Favored 'General case' 1 N--CA 1.348 -5.53 0 CA-C-N 112.464 -2.153 . . . . 0.0 112.257 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -78.45 -35.5 46.7 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -54.52 129.9 37.82 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.693 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -77.14 179.47 6.29 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.372 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.0 -114.84 4.16 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.962 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.59 154.22 46.43 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.084 0.554 . . . . 0.0 110.289 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -119.43 115.62 24.46 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.04 140.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.599 0.714 . . . . 0.0 111.234 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.737 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.1 t60 -124.77 99.59 6.23 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -112.8 133.62 54.71 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.562 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 92' ' ' SER . 0.6 OUTLIER -75.68 137.27 40.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -125.95 121.59 33.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -77.91 123.06 26.31 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.764 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -52.1 108.33 0.28 Allowed 'General case' 0 CA--C 1.471 -2.085 0 C-N-CA 123.905 0.882 . . . . 0.0 112.151 174.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.1 t -83.49 -148.38 0.09 Allowed 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 126.754 2.534 . . . . 0.0 108.389 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -61.62 76.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.7 mmt180 67.04 48.08 1.29 Allowed 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.43 1.11 . . . . 0.0 110.938 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.92 -123.05 1.45 Allowed Glycine 0 N--CA 1.4 -3.732 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.679 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.695 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.8 m-85 -130.47 -83.99 0.53 Allowed 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.068 -1.066 . . . . 0.0 110.637 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.78 49.89 0.12 Allowed Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.239 -171.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.494 ' HA ' HG23 ' A' ' 47' ' ' VAL . 28.4 p90 -161.35 142.72 11.52 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' HA ' ' B' ' 160' ' ' GLN . 16.5 p -104.09 136.3 43.98 Favored 'General case' 0 C--N 1.259 -3.352 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 22.9 m -123.6 157.89 29.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.586 HG13 ' HG2' ' A' ' 44' ' ' LYS . 3.2 m -115.35 174.58 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 C-N-CA 125.281 1.432 . . . . 0.0 111.029 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.92 -130.4 9.89 Favored Glycine 0 CA--C 1.481 -2.089 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 29.92 59.46 0.2 Allowed Glycine 0 CA--C 1.473 -2.579 0 C-N-CA 127.523 2.487 . . . . 0.0 113.81 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.52 -28.44 7.85 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 114.166 -1.017 . . . . 0.0 108.505 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -158.37 169.97 9.7 Favored Pre-proline 0 CA--C 1.47 -2.111 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.959 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 57.6 Cg_exo -61.91 -26.54 79.08 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.459 2.106 . . . . 0.0 109.6 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -75.47 -29.95 59.77 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 112.504 -2.135 . . . . 0.0 111.729 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -122.11 119.09 30.31 Favored 'General case' 0 C--O 1.27 2.165 0 O-C-N 121.77 -0.581 . . . . 0.0 110.739 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 22.8 m-85 -85.97 166.11 16.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.941 2.496 . . . . 0.0 109.547 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.792 HD21 HG21 ' A' ' 80' ' ' VAL . 6.1 mp -88.33 145.57 25.76 Favored 'General case' 0 C--O 1.178 -2.702 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.846 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.4 tt0 -135.54 158.94 43.13 Favored 'General case' 0 C--O 1.18 -2.569 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 62' ' ' ASP . 18.9 mm -87.95 127.74 40.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.586 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.47 -22.83 13.59 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 48.8 m -155.04 126.94 7.57 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 53' ' ' ALA . 3.2 tm? -83.53 106.39 15.22 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 92.9 t -85.36 135.8 24.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.87 0.843 . . . . 0.0 110.974 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.48 141.7 57.81 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.584 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.7 t70 78.94 4.6 2.38 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.722 1.249 . . . . 0.0 110.903 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.73 159.5 36.44 Favored Glycine 0 C--O 1.201 -1.955 0 CA-C-O 118.085 -1.397 . . . . 0.0 109.897 173.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.48 -24.54 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.825 0 CA-C-N 121.438 2.619 . . . . 0.0 109.678 -173.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.64 78.66 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.405 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -69.06 -48.24 63.26 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.572 1.177 . . . . 0.0 109.289 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 77.8 mt -72.08 -43.59 64.6 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 112.461 -2.154 . . . . 0.0 115.558 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' HE3' ' A' ' 57' ' ' LYS . 5.0 t0 -83.26 -20.75 33.92 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -140.89 19.04 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 119.913 -1.136 . . . . 0.0 110.87 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HE3' ' OD1' ' A' ' 55' ' ' ASP 0.344 0.0 OUTLIER 53.36 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.472 1.909 . . . . 0.0 115.42 -176.704 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.424 ' HE1' HD23 ' A' ' 95' ' ' LEU . 39.8 ttm -68.83 141.37 55.15 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 109.282 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -151.0 144.47 24.92 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 m -45.38 114.73 0.79 Allowed 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 124.635 1.209 . . . . 0.0 110.869 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.3 -30.42 3.03 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 43' ' ' ILE 0.375 0.9 OUTLIER -69.16 143.29 54.12 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.669 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -103.2 118.27 49.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.131 -174.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 mt -74.9 123.24 30.14 Favored 'Isoleucine or valine' 1 C--O 1.307 4.101 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG13 HD13 ' A' ' 73' ' ' LEU . 58.5 t -99.9 -45.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 111.498 -2.592 . . . . 0.0 110.105 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -160.27 170.67 20.62 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.356 -0.84 . . . . 0.0 112.016 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.93 112.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.184 0.516 . . . . 0.0 112.109 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 65.9 -48.04 0.4 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.489 2.316 . . . . 0.0 115.57 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.49 -39.86 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 125.605 1.562 . . . . 0.0 109.347 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.408 HG21 HD13 ' A' ' 83' ' ' ILE . 6.7 m -71.44 134.35 46.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.625 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.2 t -84.28 84.44 7.63 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.541 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -86.27 17.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 123.763 1.744 . . . . 0.0 109.796 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 65' ' ' VAL . 12.5 tp -71.72 110.83 6.53 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.48 -1.691 . . . . 0.0 106.459 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 61.46 36.72 92.97 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.998 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -77.16 128.29 34.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 36.9 m -62.58 145.82 53.45 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.208 0.943 . . . . 0.0 110.439 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -45.59 -51.42 12.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.189 0.596 . . . . 0.0 112.47 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.97 78.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 124.299 0.999 . . . . 0.0 110.538 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 74.5 mm-40 -76.03 -50.15 15.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.318 -175.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.792 HG21 HD21 ' A' ' 41' ' ' LEU . 14.5 p -65.06 -42.24 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.827 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.85 -36.38 76.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -62.15 -41.5 98.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.243 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 70' ' ' THR . 75.7 mt -73.0 -50.41 32.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 122.502 1.144 . . . . 0.0 109.717 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 7.5 m-85 -66.65 -35.59 80.54 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.446 -1.707 . . . . 0.0 112.969 -174.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -85.58 -13.51 48.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.2 t -77.73 -23.75 49.3 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.612 HD12 ' CE2' ' A' ' 27' ' ' PHE . 2.0 mt -48.37 136.62 12.13 Favored Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 86.0 Cg_endo -99.13 153.45 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.212 3.274 . . . . 0.0 112.398 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 25' ' ' ARG . 41.1 mt -68.6 140.59 18.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.107 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.51 12.31 61.28 Favored Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.012 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.543 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.9 -169.77 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.501 -171.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 11.1 p -149.27 138.46 21.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -169.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.764 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.3 m -145.56 156.13 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.737 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 31.7 m-20 -99.46 106.96 19.06 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.424 HD23 ' HE1' ' A' ' 58' ' ' MET . 9.8 tp -95.96 125.94 40.85 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.015 0.436 . . . . 0.0 110.942 -174.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -107.74 115.2 29.72 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.639 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.21 157.68 44.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.235 0.541 . . . . 0.0 111.382 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.0 m -117.89 140.01 50.32 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.717 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.0 tpp85 -110.08 132.22 54.36 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.97 -30.21 0.14 Allowed Glycine 0 C--N 1.296 -1.671 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 C--N 1.297 -1.688 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.408 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 43.8 mt-10 . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 121.304 0.573 . . . . 0.0 111.072 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -150.49 119.55 6.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.537 ' HA ' HG22 ' A' ' 30' ' ' THR . 29.3 tt0 -84.07 130.53 34.86 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 27' ' ' PHE . 10.7 m . . . . . 0 N--CA 1.407 -2.611 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.355 12.9 t . . . . . 0 N--CA 1.423 -1.78 0 N-CA-C 111.261 0.097 . . . . 0.0 111.261 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.513 ' HB2' HD21 ' A' ' 73' ' ' LEU . 15.6 ptm180 152.77 -19.45 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 126.667 1.987 . . . . 0.0 108.379 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.815 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.1 m-80 -66.42 118.46 53.87 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -171.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.307 21.4 Cg_exo -62.48 -35.87 69.01 Favored 'Trans proline' 0 CA--C 1.467 -2.844 0 N-CA-C 107.734 -1.679 . . . . 0.0 107.734 172.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m -66.78 -23.64 66.1 Favored 'General case' 1 N--CA 1.333 -6.297 0 CA-C-N 109.925 -3.307 . . . . 0.0 112.236 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.815 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.7 pt-20 -79.48 -30.9 42.24 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.1 mt -59.12 133.95 56.56 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.385 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -81.26 168.57 18.33 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.453 -1.703 . . . . 0.0 113.887 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 90.85 -114.61 4.49 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.61 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.594 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -140.8 146.51 37.72 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.551 1.14 . . . . 0.0 110.118 -178.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -113.56 116.91 30.26 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 154.47 40.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 123.403 0.681 . . . . 0.0 112.358 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.1 p-80 -126.71 112.5 15.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.263 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 58' ' ' MET . 7.5 t -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.308 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -85.07 136.61 33.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -124.66 129.04 49.77 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 69.9 ttt180 -86.95 112.64 22.0 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.1 mptp? -36.12 111.26 0.13 Allowed 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 125.225 1.41 . . . . 0.0 111.579 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -89.0 -143.19 0.14 Allowed 'General case' 0 N--CA 1.415 -2.194 0 O-C-N 125.48 1.738 . . . . 0.0 108.186 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -58.89 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.8 mtp180 57.29 40.27 27.91 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 125.474 1.51 . . . . 0.0 112.486 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.75 -130.72 2.21 Favored Glycine 0 N--CA 1.406 -3.313 0 CA-C-N 113.49 -1.686 . . . . 0.0 108.956 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.679 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.4 m-85 -134.61 -75.58 0.46 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.07 46.53 0.2 Allowed Glycine 0 C--N 1.294 -1.765 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.239 -169.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 45.0 p90 -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 172.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' B' ' 160' ' ' GLN . 69.9 p -108.39 136.23 48.37 Favored 'General case' 0 C--N 1.271 -2.814 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.259 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.646 HG21 HD23 ' A' ' 41' ' ' LEU . 1.1 m -114.9 162.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 m -125.36 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 174.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.63 -132.03 10.03 Favored Glycine 0 C--O 1.27 2.4 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.244 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.675 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.95 45.27 7.53 Favored Glycine 0 CA--C 1.458 -3.472 0 C-N-CA 126.245 1.878 . . . . 0.0 112.594 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -95.12 -22.2 18.03 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-O 121.296 0.57 . . . . 0.0 110.612 -173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 39' ' ' GLU . 7.2 pt-20 -157.28 171.3 7.63 Favored Pre-proline 0 N--CA 1.413 -2.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 -168.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 51.5 Cg_exo -64.02 -36.28 49.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.874 1.716 . . . . 0.0 108.201 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.16 -27.24 66.25 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.982 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 41.0 tt0 -125.5 117.69 24.16 Favored 'General case' 0 C--O 1.267 1.988 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.372 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -84.22 165.26 18.53 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 126.669 2.481 . . . . 0.0 108.25 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.675 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.4 mp -86.43 144.53 27.25 Favored 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.708 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -128.88 164.78 22.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.4 mm -107.04 123.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 118.795 0.725 . . . . 0.0 110.963 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -100.93 -26.69 13.65 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 123.436 0.46 . . . . 0.0 111.954 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 44.3 m -149.87 126.99 11.26 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.646 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.16 113.15 15.84 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 85.0 t -87.04 121.51 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.7 mt -67.4 142.73 56.62 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.33 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 34.9 t70 82.91 5.99 0.87 Allowed 'General case' 0 C--O 1.216 -0.668 0 O-C-N 125.103 1.502 . . . . 0.0 109.579 -172.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -88.81 165.4 33.34 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-O 118.113 -1.382 . . . . 0.0 110.175 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 27.9 Cg_endo -72.41 -25.47 18.17 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.338 2.569 . . . . 0.0 110.547 -170.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -68.66 -37.08 79.36 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.871 175.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.64 65.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 122.81 1.29 . . . . 0.0 109.264 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 81.2 mt -72.4 -46.19 56.35 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.537 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.48 -26.71 58.43 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.89 -165.88 51.43 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 18' ' ' THR . 6.2 ttpm? 72.81 -49.95 0.7 Allowed 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -87.21 133.02 33.7 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.14 166.85 24.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.543 0.687 . . . . 0.0 111.359 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -58.12 129.89 44.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.438 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.86 -6.27 25.76 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.132 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 43' ' ' ILE . 14.8 m-20 -79.91 129.35 34.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 2.7 p -98.11 115.93 39.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.852 173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.3 mm -71.03 113.78 7.9 Favored 'Isoleucine or valine' 0 C--O 1.294 3.432 0 C-N-CA 125.078 1.351 . . . . 0.0 110.669 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.4 t -103.22 -54.72 6.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.687 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.8 t -144.92 160.27 41.58 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.077 -0.389 . . . . 0.0 110.159 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 95' ' ' LEU . 5.3 p -146.31 105.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.454 ' CB ' HG12 ' A' ' 93' ' ' VAL . 27.6 t-20 65.97 -65.58 0.18 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.718 1.607 . . . . 0.0 114.341 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.22 -39.64 0.25 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 124.98 1.312 . . . . 0.0 108.884 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.5 m -70.04 127.33 32.48 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.304 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.2 t -87.26 87.23 7.38 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 66' ' ' SER . 10.1 p -77.11 2.25 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 122.496 1.141 . . . . 0.0 109.591 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 6' ' ' ARG . 22.9 tp -63.75 111.6 2.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.226 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 68.35 27.78 73.59 Favored Glycine 0 N--CA 1.425 -2.073 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.95 138.3 46.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 62.1 m -71.05 143.01 50.86 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.42 ' O ' HG12 ' A' ' 81' ' ' VAL . 51.1 t-80 -49.08 -45.05 42.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -174.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.94 81.37 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.656 0.598 . . . . 0.0 110.471 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 73.4 mm-40 -69.32 -56.0 8.81 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.276 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 41' ' ' LEU . 5.4 p -61.25 -47.36 93.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.611 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.1 p -62.7 -35.9 72.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.618 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -41.18 96.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 123.152 0.283 . . . . 0.0 111.418 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -51.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 122.401 1.096 . . . . 0.0 108.741 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -64.01 -30.26 71.35 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.236 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.611 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 tp-100 -85.96 -23.22 27.01 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.4 p -94.98 2.91 55.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.587 . . . . 0.0 111.511 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.465 HD13 ' HG3' ' A' ' 22' ' ' LYS . 7.0 mt -48.13 143.52 6.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.791 1.236 . . . . 0.0 114.081 173.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 39.8 Cg_endo -95.75 142.86 1.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.632 2.888 . . . . 0.0 110.467 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.566 HG12 ' H ' ' A' ' 25' ' ' ARG . 39.0 mt -68.45 142.97 15.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.835 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.66 72.34 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.068 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -98.65 -171.41 2.11 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.615 -171.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.446 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.7 p -147.85 138.24 22.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -168.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG13 ' HE2' ' A' ' 22' ' ' LYS . 1.3 m -151.24 155.72 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.834 174.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.36 109.76 21.86 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.726 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.9 mm? -90.66 113.72 25.85 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 46.7 mt-10 -92.19 107.83 19.5 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -139.48 153.8 47.6 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 120.926 0.393 . . . . 0.0 110.545 -172.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.5 t -113.87 126.73 55.51 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.485 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.594 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 21.5 tpp85 -96.92 137.91 35.28 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.13 1.92 Allowed Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.772 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.422 -1.861 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.274 176.487 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.544 ' HB3' HE22 ' B' ' 160' ' ' GLN . 48.2 mm-40 . . . . . 0 N--CA 1.432 -1.328 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.474 ' HB ' HG22 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.43 93.28 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.544 HE22 ' HB3' ' B' ' 158' ' ' GLU . 2.7 mp0 -82.38 110.05 17.18 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 27' ' ' PHE . 14.2 m . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.5 t . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.709 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.3 ptm180 57.21 19.14 4.67 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.921 2.088 . . . . 0.0 112.789 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.75 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.5 114.24 58.84 Favored Pre-proline 1 C--N 1.231 -4.549 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.081 176.451 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 10.5 Cg_exo -58.0 -29.49 86.92 Favored 'Trans proline' 0 CA--C 1.48 -2.214 0 C-N-CA 121.528 1.485 . . . . 0.0 109.278 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -71.46 -24.27 61.98 Favored 'General case' 1 N--CA 1.366 -4.658 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.671 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.75 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -79.33 -31.62 43.16 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.1 129.74 41.19 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.745 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -80.23 179.19 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.031 -1.895 . . . . 0.0 113.231 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.01 -126.59 8.01 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.845 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -128.54 146.87 50.71 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.91 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.18 116.87 28.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 153.39 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.736 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.649 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.8 t-160 -125.31 111.44 15.19 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 97' ' ' LEU . 12.6 t -128.42 151.49 49.31 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.93 136.34 42.94 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 2.4 mp -117.59 116.48 27.18 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -86.47 106.78 17.72 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.86 117.72 0.53 Allowed 'General case' 0 CA--C 1.472 -2.035 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 25.2 t -87.87 -152.95 0.22 Allowed 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 126.236 2.21 . . . . 0.0 108.306 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.4 ' HA ' HG12 ' A' ' 89' ' ' ILE . 23.2 m -65.61 80.43 0.06 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.588 ' N ' HG12 ' A' ' 89' ' ' ILE . 24.4 mmt180 71.44 73.88 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.47 1.108 . . . . 0.0 111.392 174.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.48 -131.9 10.13 Favored Glycine 0 N--CA 1.405 -3.372 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.886 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.645 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.9 m-85 -129.08 -78.9 0.56 Allowed 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.437 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.608 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.64 55.41 0.18 Allowed Glycine 0 C--N 1.285 -2.265 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -170.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 43' ' ' ILE . 19.3 p90 -162.2 146.5 12.28 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.0 p -108.31 135.04 50.29 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.219 1.009 . . . . 0.0 109.577 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 3.2 p -131.59 144.11 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.96 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.256 -167.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 44' ' ' LYS . 20.0 m -120.42 132.54 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 124.317 1.047 . . . . 0.0 111.347 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.77 -139.19 10.73 Favored Glycine 0 N--CA 1.396 -3.997 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 42.51 44.37 5.2 Favored Glycine 0 C--O 1.18 -3.278 0 O-C-N 125.898 1.587 . . . . 0.0 110.184 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 15.9 t70 -82.44 -41.97 19.15 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 113.252 -1.474 . . . . 0.0 107.875 -172.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 4.1 pt-20 -160.28 170.88 7.89 Favored Pre-proline 0 CA--C 1.48 -1.712 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -73.74 59.08 4.12 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 124.49 3.46 . . . . 0.0 108.842 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t70 -166.88 -39.46 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 111.871 -2.422 . . . . 0.0 108.257 -172.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 37.2 tt0 -122.21 122.23 38.67 Favored 'General case' 0 C--O 1.27 2.147 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.978 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.28 166.06 14.02 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 128.673 2.789 . . . . 0.0 109.937 -174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -90.39 144.81 25.46 Favored 'General case' 0 C--O 1.168 -3.221 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.184 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 2.6 tt0 -138.53 145.33 40.59 Favored 'General case' 0 C--O 1.185 -2.34 0 CA-C-N 118.67 0.668 . . . . 0.0 109.575 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 29' ' ' PHE . 37.0 mm -88.27 121.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.99 0 O-C-N 121.477 -0.765 . . . . 0.0 111.855 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' C ' HG23 ' A' ' 60' ' ' THR . 46.5 mtmt -101.39 -19.35 15.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.889 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 58.5 m -150.47 127.3 11.02 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.185 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 tp -84.02 109.15 17.42 Favored 'General case' 0 N--CA 1.386 -3.636 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.608 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.5 t -83.05 121.57 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.64 150.42 48.77 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.396 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 76.47 12.13 2.63 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 125.012 1.445 . . . . 0.0 109.59 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.45 160.83 27.06 Favored Glycine 0 C--O 1.201 -1.962 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.671 171.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 3.8 Cg_endo -71.97 -25.21 19.9 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 CA-C-N 121.672 2.736 . . . . 0.0 109.931 -172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 58' ' ' MET . . . -62.85 -45.15 93.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.99 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.29 -45.51 80.14 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.367 1.079 . . . . 0.0 110.432 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.7 mt -72.18 -35.69 69.06 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.795 -172.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.7 t70 -83.57 -23.83 31.82 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.67 69.57 Favored Glycine 0 CA--C 1.492 -1.351 0 CA-C-N 113.219 -1.809 . . . . 0.0 113.287 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -99.72 -15.62 18.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.963 -0.618 . . . . 0.0 111.142 -173.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.548 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 35.5 ttm -122.98 139.73 53.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB2' ' HE ' ' A' ' 99' ' ' ARG . 34.9 mt-10 -147.41 164.0 34.72 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.478 0.656 . . . . 0.0 109.469 -175.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 44' ' ' LYS . 8.5 m -54.2 117.91 3.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.914 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.94 -1.67 9.19 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.583 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.621 ' CG ' HD12 ' A' ' 97' ' ' LEU . 1.2 p30 -102.25 156.61 17.46 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.664 -0.903 . . . . 0.0 112.667 172.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -113.18 122.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.748 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.05 116.69 19.44 Favored 'Isoleucine or valine' 0 C--O 1.304 3.964 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.14 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 73' ' ' LEU . 47.6 t -99.4 -53.84 7.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.758 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.413 ' HA ' HG12 ' A' ' 72' ' ' VAL . 50.4 m -143.44 161.83 37.39 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.131 -0.981 . . . . 0.0 112.189 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.6 p -142.19 97.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.896 0.855 . . . . 0.0 112.501 -175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 93' ' ' VAL . 41.8 t-20 65.12 -84.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.769 1.628 . . . . 0.0 112.918 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.34 -7.23 3.77 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.295 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.448 ' HB ' HG13 ' A' ' 67' ' ' VAL . 77.5 m -98.72 133.16 43.44 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.479 0.657 . . . . 0.0 109.336 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 t -87.65 82.79 7.31 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.514 ' HB ' HG12 ' A' ' 67' ' ' VAL . 9.9 p -75.81 -3.08 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.774 1.274 . . . . 0.0 109.471 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 6' ' ' ARG . 22.4 tp -64.23 111.03 2.41 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.384 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 38.87 96.76 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.644 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.44 149.92 31.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.7 m -73.24 141.92 47.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.548 ' HA ' HG12 ' A' ' 80' ' ' VAL . 39.6 t-80 -52.89 -47.89 67.57 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 118.893 0.77 . . . . 0.0 112.026 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.75 -35.4 68.57 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -76.2 -50.47 14.42 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.277 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 77' ' ' HIS . 6.6 p -61.12 -44.42 98.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 123.312 0.382 . . . . 0.0 111.531 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.8 p -64.02 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.686 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.9 tmmm? -58.27 -42.86 87.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.52 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -72.89 -51.04 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.32 1.057 . . . . 0.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -65.01 -30.58 71.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 113.506 -1.679 . . . . 0.0 113.51 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -85.95 -22.76 27.22 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 122.112 -0.368 . . . . 0.0 111.88 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.0 m -79.33 -14.82 58.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.808 0.337 . . . . 0.0 110.95 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 22' ' ' LYS . 4.7 mt -47.94 135.67 11.18 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.0 Cg_endo -99.58 156.46 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.35 3.367 . . . . 0.0 111.43 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -68.02 138.53 22.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.816 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.46 55.83 Favored Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.554 -1.308 . . . . 0.0 112.079 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -97.39 -175.37 3.19 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.058 -172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.538 ' N ' ' HE3' ' A' ' 22' ' ' LYS . 11.4 p -148.22 136.82 21.58 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 68' ' ' ASN . 10.0 m -154.16 147.84 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 124.02 0.928 . . . . 0.0 111.229 175.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 1.9 m-20 -105.22 108.13 19.49 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 124.272 1.029 . . . . 0.0 109.519 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.8 mm? -91.43 124.25 35.48 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.349 0.595 . . . . 0.0 111.715 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -97.31 119.0 35.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.621 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.9 pt? -142.7 159.06 42.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 60.4 m -120.49 108.52 14.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.131 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.545 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.28 144.5 28.06 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.776 0.831 . . . . 0.0 108.807 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.99 14.84 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.574 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.7 t80 . . . . . 0 N--CA 1.419 -1.999 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.306 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . 0.256 10.7 pt-20 . . . . . 0 C--O 1.244 0.773 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.497 ' HB ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -100.86 120.65 40.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 30' ' ' THR . 25.2 tt0 -99.75 115.59 29.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 27' ' ' PHE . 21.8 m . . . . . 0 N--CA 1.434 -1.242 0 O-C-N 123.38 0.425 . . . . 0.0 109.973 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.427 -1.577 0 CA-C-O 121.621 0.724 . . . . 0.0 109.153 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.587 ' O ' HD21 ' A' ' 73' ' ' LEU . 28.8 ptt180 50.64 26.83 2.64 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.994 2.118 . . . . 0.0 113.662 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.775 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 9.8 m-80 -103.18 114.56 65.01 Favored Pre-proline 1 C--N 1.236 -4.362 0 CA-C-N 113.588 -1.642 . . . . 0.0 114.264 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.281 11.9 Cg_exo -55.95 -33.93 90.53 Favored 'Trans proline' 0 CA--C 1.479 -2.227 0 C-N-CA 121.583 1.522 . . . . 0.0 109.197 168.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 t -65.97 -26.73 67.7 Favored 'General case' 1 N--CA 1.371 -4.378 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.648 -177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.775 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -77.81 -31.95 52.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.08 133.94 55.94 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.254 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 100' ' ' GLY . 17.1 ptmt -82.53 -177.52 6.72 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.579 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 84.73 -112.63 3.66 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.479 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 4.6 ptmt -146.46 149.13 33.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.017 0.927 . . . . 0.0 109.565 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.37 116.11 28.41 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.15 152.44 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.44 0.638 . . . . 0.0 111.846 -177.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.73 110.69 12.88 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.027 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -129.53 142.6 50.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -73.44 133.86 43.82 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.3 128.01 53.74 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -82.96 108.33 16.2 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.331 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.4 mptp? -40.04 106.34 0.05 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 124.144 0.978 . . . . 0.0 111.136 170.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -127.38 141.58 51.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 125.131 1.52 . . . . 0.0 110.141 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 54.73 32.63 17.82 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.477 1.511 . . . . 0.0 114.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.596 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.9 mmt180 73.79 53.89 0.11 Allowed 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 122.63 1.205 . . . . 0.0 109.605 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.26 -120.45 1.17 Allowed Glycine 0 N--CA 1.401 -3.7 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.711 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.0 m-85 -135.48 -78.52 0.43 Allowed 'General case' 0 C--N 1.275 -2.649 0 C-N-CA 122.743 0.417 . . . . 0.0 111.763 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.499 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.96 48.56 0.12 Allowed Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.728 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -161.47 143.53 11.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.561 HG22 ' HA ' ' B' ' 160' ' ' GLN . 37.9 p -105.11 135.48 46.38 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.598 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.79 147.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.107 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.511 ' CG2' ' HG3' ' A' ' 44' ' ' LYS . 15.2 m -120.32 135.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.867 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.37 -131.25 8.28 Favored Glycine 0 C--N 1.281 -2.522 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 36.82 60.08 1.03 Allowed Glycine 0 CA--C 1.479 -2.182 0 C-N-CA 126.647 2.07 . . . . 0.0 113.99 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -115.76 -18.68 10.75 Favored 'General case' 0 C--N 1.25 -3.742 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.712 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.35 168.43 12.49 Favored Pre-proline 0 CA--C 1.466 -2.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -61.38 -38.52 63.74 Favored 'Trans proline' 0 CA--C 1.49 -1.708 0 C-N-CA 122.074 1.85 . . . . 0.0 108.513 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -73.15 -12.06 60.75 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 111.961 -2.381 . . . . 0.0 111.709 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -132.34 118.18 19.09 Favored 'General case' 0 C--O 1.279 2.61 0 O-C-N 121.823 -0.548 . . . . 0.0 111.74 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -85.76 166.19 16.29 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.748 2.819 . . . . 0.0 107.981 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -91.2 145.17 24.89 Favored 'General case' 0 C--O 1.17 -3.129 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.891 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.4 tt0 -128.91 160.44 32.64 Favored 'General case' 0 C--O 1.169 -3.146 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.485 HG12 ' CE ' ' A' ' 58' ' ' MET . 1.2 mp -105.65 127.19 60.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HG3' ' CG2' ' A' ' 32' ' ' VAL 0.305 42.1 mtmt -113.28 -7.94 13.52 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.926 172.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 73.1 m -149.69 127.51 11.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.632 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.89 117.69 24.06 Favored 'General case' 0 N--CA 1.404 -2.77 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 86.4 t -88.29 128.55 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.05 145.99 41.9 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 81.44 5.72 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 125.501 1.75 . . . . 0.0 108.502 -171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.45 159.52 38.82 Favored Glycine 0 C--O 1.204 -1.758 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.42 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 19.9 Cg_endo -72.8 -25.78 16.55 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 120.853 2.327 . . . . 0.0 109.971 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -45.23 90.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.428 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.24 -50.94 63.89 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.681 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.5 mt -71.48 -36.5 71.18 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 112.688 -2.051 . . . . 0.0 114.854 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -79.75 -19.7 48.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.0 108.751 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.54 42.97 99.87 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.827 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.99 -25.47 2.52 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.035 -0.583 . . . . 0.0 111.485 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.485 ' CE ' HG12 ' A' ' 43' ' ' ILE . 1.6 tmt? -120.24 146.03 46.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -142.9 166.99 23.14 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.557 1.17 . . . . 0.0 113.498 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.401 HG23 ' C ' ' A' ' 44' ' ' LYS . 28.4 m -63.57 123.04 17.8 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 113.807 -1.542 . . . . 0.0 107.469 171.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.21 -11.23 10.71 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.965 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.489 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 15.0 m-20 -74.34 157.9 34.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -128.22 123.81 61.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 49.2 mm -73.93 113.18 11.76 Favored 'Isoleucine or valine' 0 C--O 1.3 3.733 0 C-N-CA 125.041 1.336 . . . . 0.0 110.683 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.9 t -105.4 -54.79 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 126.019 2.074 . . . . 0.0 110.673 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 40.3 t -147.56 158.33 43.95 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.959 -0.463 . . . . 0.0 110.943 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.91 89.52 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 CA-C-O 122.22 1.01 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 93' ' ' VAL 0.435 43.6 p30 42.15 -89.12 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -171.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -93.53 -30.95 14.74 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.827 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.7 m -91.25 131.11 36.98 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.085 0.945 . . . . 0.0 110.962 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.7 t -88.69 86.63 7.03 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.253 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.51 1.59 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 122.54 1.162 . . . . 0.0 109.628 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 6' ' ' ARG . 28.7 tp -60.68 111.7 1.72 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.999 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.43 38.6 95.04 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.41 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -81.07 133.23 35.44 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -62.36 145.29 54.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.447 ' O ' HG12 ' A' ' 81' ' ' VAL . 2.6 t60 -45.61 -51.89 11.46 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.622 0.646 . . . . 0.0 112.19 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.92 72.65 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 124.102 0.877 . . . . 0.0 111.186 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -80.55 -47.36 14.32 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.489 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 41' ' ' LEU . 12.0 p -65.17 -42.28 93.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.3 p -65.87 -37.79 80.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.676 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -58.86 -45.16 90.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.307 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.1 mt -73.75 -51.21 25.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-O 122.174 0.988 . . . . 0.0 109.615 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.92 -29.48 69.9 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.098 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -86.32 -23.81 26.11 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -80.25 -12.0 59.67 Favored 'General case' 0 C--O 1.249 1.062 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.813 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.593 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 6.7 mt -47.69 139.98 8.41 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.8 1.24 . . . . 0.0 113.5 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -99.0 145.11 0.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.894 3.062 . . . . 0.0 111.333 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 ' H ' ' A' ' 25' ' ' ARG . 37.7 mt -68.3 142.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.45 11.32 57.27 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -105.43 -177.03 3.25 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.828 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.8 p -148.95 145.89 27.59 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -153.37 158.41 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 C-N-CA 123.754 0.822 . . . . 0.0 111.038 174.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -96.55 107.5 19.93 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' LEU . 12.8 tp -94.45 114.04 26.0 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 30.3 mt-10 -97.7 111.75 23.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.07 157.46 45.27 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.799 -173.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.0 t -112.55 130.2 56.1 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 21.6 tpp85 -103.17 152.38 21.52 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 12' ' ' LYS . . . 110.9 8.18 24.43 Favored Glycine 0 CA--C 1.493 -1.283 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.366 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.421 -1.921 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.779 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 . . . . . 0 CA--C 1.548 0.888 0 CA-C-O 121.005 0.431 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 23.2 m -132.51 117.73 18.38 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.561 ' HA ' HG22 ' A' ' 30' ' ' THR . 53.9 tt0 -79.62 122.41 26.48 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.354 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 N--CA 1.408 -2.569 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t . . . . . 0 N--CA 1.419 -2.001 0 CA-C-O 121.692 0.758 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 61.13 36.1 18.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.585 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.799 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -121.86 120.11 28.67 Favored Pre-proline 0 C--N 1.268 -2.95 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.28 16.3 Cg_exo -62.92 -32.93 76.55 Favored 'Trans proline' 0 CA--C 1.473 -2.528 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 172.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -71.09 -22.25 62.13 Favored 'General case' 1 N--CA 1.365 -4.708 0 CA-C-N 111.899 -2.41 . . . . 0.0 110.97 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.799 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.2 pt-20 -77.07 -36.62 55.7 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.28 131.31 41.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.271 0.982 . . . . 0.0 111.146 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -86.06 169.16 13.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.048 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.57 -108.24 3.65 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.249 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.551 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 144.88 29.95 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 122.834 0.453 . . . . 0.0 110.911 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -111.19 122.08 46.95 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -135.57 152.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.26 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.1 t60 -128.27 101.49 6.26 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -117.66 137.02 52.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.15 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -79.17 133.6 36.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.115 -0.366 . . . . 0.0 110.273 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -118.02 119.46 34.87 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -81.25 104.64 11.86 Favored 'General case' 0 N--CA 1.403 -2.797 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.88 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.703 ' HE2' HG13 ' A' ' 93' ' ' VAL . 1.9 mptp? -33.41 106.76 0.04 OUTLIER 'General case' 0 CA--C 1.483 -1.632 0 C-N-CA 125.357 1.463 . . . . 0.0 112.112 174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 t -81.65 -150.78 0.08 Allowed 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 125.983 2.052 . . . . 0.0 108.283 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -61.69 83.25 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.503 ' H ' HG12 ' A' ' 89' ' ' ILE . 27.2 mtp85 58.31 44.26 18.82 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.852 1.261 . . . . 0.0 113.66 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.6 -133.91 3.83 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.619 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.4 m-85 -129.77 -77.79 0.55 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.62 52.1 0.16 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.741 -171.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 43' ' ' ILE . 37.2 p90 -161.64 142.6 11.0 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.4 p -106.25 136.56 45.75 Favored 'General case' 0 C--N 1.265 -3.074 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.269 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 17.5 m -123.39 158.02 28.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.887 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 44' ' ' LYS . 8.9 m -121.53 133.06 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.854 0 C-N-CA 124.334 1.053 . . . . 0.0 109.599 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.64 -142.06 13.34 Favored Glycine 0 CA--C 1.455 -3.708 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.009 177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.45 57.07 1.5 Allowed Glycine 0 CA--C 1.458 -3.475 0 O-C-N 127.136 2.316 . . . . 0.0 111.385 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -104.72 -32.16 9.0 Favored 'General case' 0 C--N 1.251 -3.676 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -137.76 170.68 9.93 Favored Pre-proline 0 N--CA 1.405 -2.701 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.102 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 32.0 Cg_exo -71.81 -8.72 23.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.296 2.664 . . . . 0.0 108.709 174.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -111.67 -10.66 14.07 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.837 1.655 . . . . 0.0 110.811 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.82 120.18 30.99 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 121.999 -0.438 . . . . 0.0 109.989 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -87.32 165.45 15.62 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 127.444 2.297 . . . . 0.0 110.61 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.5 mp -93.15 145.24 24.56 Favored 'General case' 0 C--O 1.176 -2.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.304 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 37.0 tt0 -133.92 155.91 49.06 Favored 'General case' 0 C--O 1.162 -3.515 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 29' ' ' PHE . 12.2 mm -87.27 126.38 41.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 118.88 0.764 . . . . 0.0 109.243 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' HG13 ' A' ' 32' ' ' VAL . 20.9 ptmt -102.09 -23.46 14.07 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 123.137 0.273 . . . . 0.0 110.317 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.472 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 38.7 m -151.49 126.43 9.74 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.88 108.96 19.0 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 79.8 t -85.76 127.63 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 121.87 0.843 . . . . 0.0 111.661 -173.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.52 85.33 4.6 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.459 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 54' ' ' LEU . 5.7 t70 165.12 -22.52 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 125.115 1.509 . . . . 0.0 109.822 -170.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -99.55 166.28 20.6 Favored Glycine 0 CA--C 1.48 -2.116 0 CA-C-N 115.456 -0.793 . . . . 0.0 114.045 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.631 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 6.1 Cg_endo -67.72 -23.85 41.71 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.142 1.895 . . . . 0.0 111.077 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -58.35 -52.34 66.01 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.971 0.909 . . . . 0.0 111.395 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.688 ' HB3' HD23 ' A' ' 54' ' ' LEU . . . -73.74 -37.15 65.18 Favored 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 122.879 1.324 . . . . 0.0 110.049 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -71.25 -38.44 71.92 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 111.755 -2.475 . . . . 0.0 111.175 -170.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.87 -26.07 37.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.564 1.173 . . . . 0.0 108.049 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.73 86.06 Favored Glycine 0 CA--C 1.481 -2.076 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.429 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -122.08 0.67 9.68 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.694 -174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.611 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 67.3 mtp -128.04 159.2 35.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.42 164.16 30.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.476 0.655 . . . . 0.0 110.719 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -71.24 116.73 11.9 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 131.36 -23.89 4.24 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 7.3 m-20 -58.16 140.96 51.86 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 120.716 0.294 . . . . 0.0 110.62 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.323 0.2 OUTLIER -109.17 115.96 50.85 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-O 121.578 0.704 . . . . 0.0 111.891 174.23 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.8 mm -68.82 114.62 5.88 Favored 'Isoleucine or valine' 0 C--O 1.301 3.777 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.791 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.613 HG13 HD13 ' A' ' 73' ' ' LEU . 65.1 t -95.83 -58.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 112.361 -2.199 . . . . 0.0 110.1 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.5 m -158.31 173.32 16.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.0 -0.438 . . . . 0.0 110.471 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 72' ' ' VAL . 9.1 p -145.55 153.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.475 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 9.8 t30 -31.31 113.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.01 1.324 . . . . 0.0 111.782 172.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 75.04 -38.9 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.98 1.712 . . . . 0.0 115.231 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -100.2 122.66 43.38 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.894 0.854 . . . . 0.0 111.497 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.4 t -83.56 83.38 7.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.973 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 67' ' ' VAL . 78.8 t -72.55 -2.62 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.346 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.613 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -66.77 110.48 3.28 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.12 28.51 70.13 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.74 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.05 140.97 43.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 122.017 -0.696 . . . . 0.0 109.693 178.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 m -74.78 143.61 43.93 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 117.526 -1.225 . . . . 0.0 108.044 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -47.84 -49.46 29.17 Favored 'General case' 0 CA--C 1.485 -1.52 0 CA-C-N 118.952 0.796 . . . . 0.0 111.7 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.05 74.33 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 124.758 1.286 . . . . 0.0 111.084 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -75.23 -53.37 8.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -61.65 -42.66 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.579 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 8.9 p -62.49 -45.34 99.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 C-N-CA 121.264 -0.174 . . . . 0.0 110.532 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.1 tmmm? -57.12 -41.51 79.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.697 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -72.65 -50.23 35.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.161 0.981 . . . . 0.0 108.912 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.95 -29.1 70.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.453 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.7 pt20 -86.69 -24.01 25.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -93.08 2.81 56.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.564 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 4.3 mt -51.19 144.04 15.95 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.964 1.306 . . . . 0.0 113.618 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 29.9 Cg_endo -92.74 140.43 1.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.517 2.811 . . . . 0.0 111.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.9 mt -68.49 138.91 21.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.47 12.52 62.77 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -101.48 -171.47 1.99 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.648 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.5 t -148.88 144.39 26.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.855 -0.528 . . . . 0.0 112.187 -171.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.703 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -152.95 154.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 C-N-CA 124.221 1.008 . . . . 0.0 110.25 173.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.654 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 5.5 m-20 -99.74 107.7 19.83 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.46 HD22 HD22 ' A' ' 20' ' ' LEU . 12.9 tp -99.73 115.24 29.04 Favored 'General case' 0 C--N 1.269 -2.929 0 CA-C-O 120.803 0.335 . . . . 0.0 110.166 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -103.3 123.8 47.46 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.4 OUTLIER -141.52 163.26 33.4 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.705 -173.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.2 t -116.69 128.33 55.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.611 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 22.2 tpp85 -103.66 152.49 21.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.88 -43.03 1.26 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 . . . . . 0 C--N 1.297 -1.686 0 CA-C-N 114.644 -0.778 . . . . 0.0 109.342 174.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.4 pm0 . . . . . 0 N--CA 1.414 -2.245 0 CA-C-O 121.816 0.817 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 18.1 m -105.4 110.21 22.47 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.465 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.1 mp0 -85.17 104.44 15.05 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.428 -1.546 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.439 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 15.0 t . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' THR . 33.2 ptt180 56.97 14.03 1.74 Allowed 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 127.486 2.314 . . . . 0.0 114.889 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.713 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 14.4 m-80 -92.6 124.7 58.24 Favored Pre-proline 1 C--N 1.241 -4.135 0 CA-C-N 114.18 -1.373 . . . . 0.0 113.109 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.272 11.3 Cg_exo -60.35 -32.57 94.21 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 122.046 1.83 . . . . 0.0 108.781 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -68.72 -22.86 64.31 Favored 'General case' 1 N--CA 1.367 -4.59 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.219 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.6 pt-20 -79.34 -38.5 35.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.43 130.06 44.58 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.509 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -77.34 177.95 7.54 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.153 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.25 -122.65 6.55 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.321 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ARG . 13.4 mmmm -107.8 149.61 28.01 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 123.473 0.709 . . . . 0.0 109.317 -177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.51 111.25 16.59 Favored 'General case' 1 C--N 1.241 -4.121 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 151.99 36.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.952 0.882 . . . . 0.0 112.854 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.2 t60 -132.95 103.45 6.07 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -128.66 140.15 51.9 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.238 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -73.54 135.2 43.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.495 177.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.84 120.87 37.73 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -72.73 124.29 25.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.116 0.484 . . . . 0.0 109.9 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.661 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -57.56 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 123.59 0.756 . . . . 0.0 110.989 171.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -107.93 126.11 52.3 Favored 'General case' 0 N--CA 1.405 -2.707 0 O-C-N 126.187 2.179 . . . . 0.0 108.09 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' ILE . 3.5 m 47.15 56.34 6.96 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.297 1.439 . . . . 0.0 113.974 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.663 ' N ' HG12 ' A' ' 89' ' ' ILE . 19.9 mmt180 68.31 42.71 1.62 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.248 0.547 . . . . 0.0 112.123 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.9 -124.43 1.48 Allowed Glycine 0 N--CA 1.403 -3.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.235 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.648 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -132.74 -87.06 0.45 Allowed 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 114.367 -0.916 . . . . 0.0 111.753 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.482 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 123.9 52.28 0.2 Allowed Glycine 0 C--N 1.289 -2.062 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -167.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.483 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.0 p90 -160.71 143.72 13.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' HA ' ' B' ' 160' ' ' GLN . 17.3 p -107.45 135.14 49.44 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 122.173 0.987 . . . . 0.0 109.68 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 3.5 p -130.46 137.61 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.753 -169.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 44' ' ' LYS . 4.6 m -114.49 154.1 15.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 125.03 1.332 . . . . 0.0 113.545 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.86 -127.88 9.37 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.701 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 40.53 74.66 0.14 Allowed Glycine 1 CA--C 1.449 -4.068 0 O-C-N 126.648 2.028 . . . . 0.0 113.194 178.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -130.75 -20.44 2.86 Favored 'General case' 0 C--N 1.259 -3.333 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.169 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.523 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 7.7 pt-20 -156.68 170.92 8.1 Favored Pre-proline 0 N--CA 1.415 -2.203 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.031 -166.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 75.8 Cg_exo -61.14 -38.13 69.43 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 122.649 2.233 . . . . 0.0 108.895 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -72.22 -25.3 61.6 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.88 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 25.7 tt0 -127.36 118.83 24.89 Favored 'General case' 0 C--O 1.274 2.367 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.134 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.576 ' CD1' HD12 ' A' ' 73' ' ' LEU . 3.1 m-85 -87.27 165.67 15.49 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 128.134 2.574 . . . . 0.0 108.795 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.701 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.1 mp -89.27 147.01 24.36 Favored 'General case' 0 C--O 1.18 -2.582 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.077 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 6.6 tt0 -136.04 144.99 45.55 Favored 'General case' 0 C--O 1.175 -2.844 0 CA-C-N 118.698 0.681 . . . . 0.0 109.163 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 62' ' ' ASP . 34.4 mm -83.25 117.81 29.75 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 O-C-N 121.599 -0.688 . . . . 0.0 111.081 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -96.56 -18.95 19.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -159.6 127.84 4.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 60' ' ' THR . 3.4 pp -82.31 117.04 22.09 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 90.3 t -83.45 129.24 37.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.1 142.05 54.8 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.117 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 80.09 5.29 1.84 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.58 1.175 . . . . 0.0 109.744 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.686 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -93.31 160.38 24.7 Favored Glycine 0 CA--C 1.484 -1.904 0 CA-C-O 118.153 -1.359 . . . . 0.0 109.886 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.648 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 32.1 Cg_endo -72.01 -25.21 19.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.95 2.375 . . . . 0.0 110.208 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -61.03 -49.25 78.16 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.468 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.91 86.53 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.134 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.0 mt -72.06 -38.3 69.5 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 112.921 -1.945 . . . . 0.0 114.55 -172.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 12.9 t70 -71.75 -27.26 62.86 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.66 2.72 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.887 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 17.3 ptpt -77.32 -34.34 55.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.824 1.312 . . . . 0.0 112.549 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -79.44 139.04 37.78 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.76 167.94 21.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.458 1.123 . . . . 0.0 112.242 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.442 ' H ' HD23 ' A' ' 46' ' ' LEU . 18.2 m -61.23 135.37 57.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.573 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.87 -16.03 43.77 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.551 ' O ' HG12 ' A' ' 43' ' ' ILE . 10.4 m-20 -66.47 132.99 49.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.268 0.2 OUTLIER -101.13 120.71 51.05 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.759 176.094 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -73.0 115.62 14.08 Favored 'Isoleucine or valine' 0 C--O 1.302 3.848 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.15 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 73' ' ' LEU . 72.8 t -102.2 -58.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 126.395 2.309 . . . . 0.0 109.814 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 13.4 m -146.3 172.06 14.05 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.43 154.78 14.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -34.18 112.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 64.36 15.59 9.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.2 1.4 . . . . 0.0 114.045 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.1 m -142.18 125.15 16.17 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.477 1.132 . . . . 0.0 112.493 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.5 108.94 14.54 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.231 -1.35 . . . . 0.0 107.967 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 41.1 t -86.04 -2.71 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 40' ' ' PHE . 2.6 mm? -66.92 123.28 19.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.205 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 36' ' ' GLU . . . 81.46 9.44 85.81 Favored Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.832 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.8 111.03 10.73 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 92.1 m -62.0 149.73 40.02 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.23 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -47.55 -43.79 25.44 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.97 0.804 . . . . 0.0 111.713 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -36.01 82.49 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 27.5 mm-40 -79.32 -48.27 14.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.291 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 14.9 p -63.87 -40.74 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.137 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.51 -36.27 76.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 4.5 tmmm? -57.2 -47.97 79.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.44 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.2 mt -72.94 -50.28 33.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 CA-C-O 122.283 1.039 . . . . 0.0 109.883 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 5.4 m-85 -63.96 -38.04 89.62 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.308 -1.769 . . . . 0.0 114.017 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 12.4 mm-40 -86.2 -19.87 29.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.117 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.8 m -75.6 -17.62 59.97 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.653 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.8 mt -44.74 135.68 4.65 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.463 1.105 . . . . 0.0 113.459 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 74.0 Cg_endo -97.79 154.42 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.179 3.253 . . . . 0.0 112.127 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' N ' ' A' ' 25' ' ' ARG . 7.3 mt -69.05 143.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.263 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.24 11.93 71.5 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.832 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.511 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.45 -170.5 1.76 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.88 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 36.9 p -149.66 138.29 20.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.5 m -133.47 152.3 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.373 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.07 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.585 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -94.23 107.32 19.26 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.08 123.3 45.71 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.335 0.588 . . . . 0.0 109.995 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.1 tt0 -103.17 115.14 30.0 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.92 159.13 42.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.584 -175.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.3 t -122.57 140.06 53.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 20.1 tpp85 -110.64 142.2 42.85 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.71 -18.19 1.63 Allowed Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.914 -1.136 . . . . 0.0 111.89 178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.1 pm0 . . . . . 0 N--CA 1.446 -0.674 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 17.9 m -114.11 109.76 18.94 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 102.527 -3.138 . . . . 0.0 102.527 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.558 ' HA ' HG22 ' A' ' 30' ' ' THR . 46.9 tt0 -86.94 96.07 10.13 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.564 0.697 . . . . 0.0 111.078 -174.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.0 m . . . . . 0 N--CA 1.418 -2.036 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.205 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 10' ' ' GLU . 13.6 t . . . . . 0 N--CA 1.428 -1.533 0 CA-C-O 122.273 1.035 . . . . 0.0 108.36 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.0 ptt180 46.15 36.12 2.99 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 126.249 1.82 . . . . 0.0 112.974 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.783 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -108.14 111.54 61.85 Favored Pre-proline 1 C--N 1.219 -5.096 0 CA-C-N 112.29 -2.232 . . . . 0.0 113.645 178.783 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.299 17.3 Cg_exo -58.13 -36.44 97.9 Favored 'Trans proline' 0 CA--C 1.478 -2.306 0 C-N-CA 121.757 1.638 . . . . 0.0 109.355 172.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 m -66.01 -26.65 67.63 Favored 'General case' 1 N--CA 1.36 -4.941 0 CA-C-N 111.284 -2.689 . . . . 0.0 112.571 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.1 pt-20 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.7 131.58 48.38 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -80.94 -175.18 5.24 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.097 -1.411 . . . . 0.0 113.365 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.2 -119.77 4.95 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.468 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.17 157.87 45.11 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 123.821 0.848 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.93 111.11 16.67 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.27 135.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.264 0.554 . . . . 0.0 111.378 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.444 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 21.6 t60 -112.66 99.65 8.1 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.458 ' CB ' ' HG2' ' A' ' 57' ' ' LYS . 10.6 t -118.34 140.16 50.26 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.298 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -81.24 130.41 35.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.1 mp -115.73 132.56 56.6 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -92.13 119.57 31.91 Favored 'General case' 0 N--CA 1.387 -3.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -53.21 99.97 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 166.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 89' ' ' ILE . 70.9 m -87.25 -54.89 4.06 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 124.509 1.131 . . . . 0.0 113.365 -167.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -144.89 70.8 1.28 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' N ' HG12 ' A' ' 89' ' ' ILE . 29.2 mmt180 67.78 78.8 0.23 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 104.63 -141.31 15.26 Favored Glycine 0 N--CA 1.411 -3.017 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.063 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.706 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.4 m-85 -119.3 -82.33 0.64 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.325 -0.938 . . . . 0.0 111.562 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.52 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.24 50.34 0.2 Allowed Glycine 0 C--N 1.291 -1.948 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.995 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 43' ' ' ILE . 46.2 p90 -161.59 143.35 11.52 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.454 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.1 p -104.73 146.21 29.27 Favored 'General case' 0 C--N 1.256 -3.46 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.71 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 43' ' ' ILE . 29.9 m -128.26 157.2 40.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.499 HG13 ' HD2' ' A' ' 44' ' ' LYS . 10.5 m -119.74 132.59 69.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 C-N-CA 124.959 1.304 . . . . 0.0 110.205 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 124.88 -144.25 15.08 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.57 61.56 3.24 Favored Glycine 0 CA--C 1.466 -2.986 0 O-C-N 125.93 1.606 . . . . 0.0 112.048 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.68 -32.7 6.57 Favored 'General case' 0 C--N 1.261 -3.274 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.403 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.03 170.43 8.93 Favored Pre-proline 0 CA--C 1.478 -1.791 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.633 -171.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.92 63.29 8.11 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.968 3.112 . . . . 0.0 107.76 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.78 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 111.822 -2.445 . . . . 0.0 106.851 -172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.33 119.52 39.27 Favored 'General case' 0 C--O 1.269 2.122 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.357 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.433 ' O ' ' HA3' ' A' ' 33' ' ' GLY . 37.7 m-85 -95.09 164.91 12.68 Favored 'General case' 0 N--CA 1.508 2.427 0 C-N-CA 127.858 2.463 . . . . 0.0 108.408 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -96.3 144.83 26.12 Favored 'General case' 0 C--O 1.169 -3.151 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.609 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 tt0 -134.49 151.34 51.07 Favored 'General case' 0 C--O 1.168 -3.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.573 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.6 mm -78.46 126.6 38.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' HG13 ' A' ' 32' ' ' VAL . 10.3 ptmm? -105.35 -22.21 13.08 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 122.342 0.257 . . . . 0.0 111.188 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 15.9 m -156.03 126.91 6.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.3 tp -83.29 114.77 21.62 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 57.4 t -90.45 119.88 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.63 144.0 55.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.319 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 83.49 8.02 0.65 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 125.412 1.695 . . . . 0.0 109.702 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.6 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.16 158.11 27.62 Favored Glycine 0 C--O 1.203 -1.817 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 172.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 58.5 Cg_endo -73.22 -25.37 15.84 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 CA-C-N 121.852 2.826 . . . . 0.0 110.112 -170.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -64.16 -39.84 94.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.189 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.31 66.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-O 122.621 1.2 . . . . 0.0 110.076 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 89.1 mt -71.4 -48.07 52.1 Favored 'General case' 0 N--CA 1.395 -3.191 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.875 -172.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.9 t70 -70.52 -28.29 64.83 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.07 26.97 70.74 Favored Glycine 0 CA--C 1.487 -1.707 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.828 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -90.62 -20.53 22.45 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.457 -0.871 . . . . 0.0 109.563 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.562 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 66.3 mtp -125.72 152.35 45.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.872 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.37 167.34 26.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.603 0.716 . . . . 0.0 111.882 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 44' ' ' LYS . 7.3 m -60.4 116.52 4.35 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.56 -42.03 1.43 Allowed Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.3 148.94 50.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.302 0.3 OUTLIER -110.51 119.15 58.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -172.403 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.1 mm -64.83 115.03 2.78 Favored 'Isoleucine or valine' 0 C--O 1.302 3.842 0 C-N-CA 126.478 1.911 . . . . 0.0 110.765 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 93.0 t -98.49 -58.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.183 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.9 m -154.9 173.35 16.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.306 -0.871 . . . . 0.0 112.147 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 9.8 p -140.97 159.32 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -31.96 105.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.396 1.478 . . . . 0.0 114.76 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.95 33.78 9.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.772 1.629 . . . . 0.0 112.224 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.473 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 15.5 m -140.61 120.71 13.76 Favored 'General case' 0 N--CA 1.421 -1.901 0 O-C-N 121.424 -0.797 . . . . 0.0 109.371 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 24.1 t -81.58 77.07 8.47 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.516 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 91.2 t -74.08 -8.0 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 123.173 1.463 . . . . 0.0 108.62 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 6' ' ' ARG . 24.7 tp -64.89 111.13 2.68 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.138 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.71 74.01 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.477 -176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -74.6 139.78 43.89 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 30.7 m -72.84 145.08 47.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 117.458 -1.258 . . . . 0.0 108.381 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.439 ' HA ' HG12 ' A' ' 80' ' ' VAL . 70.3 t60 -47.33 -48.44 25.3 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.276 0.944 . . . . 0.0 112.216 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.44 70.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.816 0.698 . . . . 0.0 110.843 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 64.8 mm-40 -80.14 -49.4 11.74 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.835 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 41' ' ' LEU . 8.2 p -63.72 -42.68 96.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.445 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.5 p -65.33 -36.05 76.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.834 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 38.6 ttpt -55.26 -48.19 74.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.436 0.294 . . . . 0.0 111.428 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -72.27 -50.26 37.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 122.706 1.241 . . . . 0.0 109.515 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.34 -28.27 68.54 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.024 -1.898 . . . . 0.0 112.792 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.1 mp0 -86.65 -22.93 25.84 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 p -90.0 -18.48 25.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -54.47 151.41 14.27 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -102.84 163.05 0.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.874 3.716 . . . . 0.0 112.283 -177.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 23' ' ' SER . 64.4 mt -67.92 131.91 32.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.931 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.28 10.97 46.74 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.79 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.88 -179.2 4.09 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 118.456 1.128 . . . . 0.0 111.82 -175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 17.2 t -138.68 153.62 48.56 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 109.94 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.3 m -153.89 151.16 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 C-N-CA 124.341 1.057 . . . . 0.0 110.391 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 14.8 m-20 -95.57 107.59 19.78 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.04 116.39 31.88 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.29 125.05 52.72 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.396 0.617 . . . . 0.0 110.77 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 2.1 pt? -141.95 163.21 33.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.656 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 78.7 m -109.57 124.4 51.07 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.328 0.585 . . . . 0.0 110.662 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.578 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 6.7 tpp85 -98.95 147.31 25.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.32 -28.88 2.44 Favored Glycine 0 CA--C 1.486 -1.773 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 N--CA 1.429 -1.502 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.404 175.697 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.429 -1.487 0 CA-C-O 121.297 0.57 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 15.0 m -132.78 122.82 25.08 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.454 ' HA ' HG22 ' A' ' 30' ' ' THR . 2.3 mp0 -92.77 110.77 22.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 29' ' ' PHE . 13.9 m . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.839 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.425 -1.699 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 41.81 42.86 2.33 Favored 'General case' 0 C--N 1.372 1.558 0 C-N-CA 126.527 1.931 . . . . 0.0 113.189 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.813 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.6 m-80 -112.5 119.45 43.44 Favored Pre-proline 1 C--N 1.223 -4.893 0 CA-C-N 112.412 -2.177 . . . . 0.0 113.315 176.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.317 24.1 Cg_exo -60.71 -37.33 79.74 Favored 'Trans proline' 0 CA--C 1.474 -2.491 0 C-N-CA 121.788 1.659 . . . . 0.0 108.436 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.1 m -64.8 -23.62 67.3 Favored 'General case' 1 N--CA 1.346 -5.653 0 CA-C-N 109.848 -3.342 . . . . 0.0 112.432 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.813 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.9 pt-20 -80.97 -34.59 32.99 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 98.9 mt -55.79 129.98 41.57 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 122.772 1.273 . . . . 0.0 112.052 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.84 173.74 7.85 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 112.801 -1.999 . . . . 0.0 112.376 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 78.01 -121.35 5.7 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.597 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.67 155.52 49.55 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.916 0.486 . . . . 0.0 109.914 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.33 111.63 20.37 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.41 152.88 37.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-O 121.484 0.659 . . . . 0.0 111.961 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -125.91 113.79 17.67 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.664 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 11.2 t -125.48 137.3 53.96 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.269 0.557 . . . . 0.0 110.633 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -74.82 131.35 40.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.561 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.46 126.31 53.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.45 105.46 17.63 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -39.8 113.97 0.39 Allowed 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 175.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.8 t -89.26 -149.65 0.19 Allowed 'General case' 0 N--CA 1.406 -2.628 0 O-C-N 126.182 2.176 . . . . 0.0 107.951 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -61.96 80.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 89' ' ' ILE . 17.4 mmm180 65.54 56.9 0.91 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.59 -131.55 5.22 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.149 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.669 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -130.0 -83.64 0.55 Allowed 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.305 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.578 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 135.03 53.18 0.07 OUTLIER Glycine 0 C--N 1.297 -1.595 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.877 -170.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 43' ' ' ILE . 35.4 p90 -162.39 152.11 16.09 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.3 p -112.03 144.07 42.0 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.051 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 76.1 t -113.45 149.38 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.072 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 42' ' ' GLN . 1.2 m -119.87 129.76 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.47 -132.7 9.15 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.613 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 33.46 59.98 0.5 Allowed Glycine 1 CA--C 1.445 -4.327 0 O-C-N 126.215 1.773 . . . . 0.0 111.391 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.55 -29.6 9.55 Favored 'General case' 0 C--N 1.252 -3.67 0 CA-C-N 113.933 -1.134 . . . . 0.0 109.214 -170.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -159.15 173.78 4.65 Favored Pre-proline 0 CA--C 1.483 -1.606 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.655 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 73.6 Cg_exo -62.22 -25.95 77.24 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.907 2.405 . . . . 0.0 109.921 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.66 -22.76 27.75 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.996 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.44 119.98 31.61 Favored 'General case' 0 C--O 1.264 1.849 0 O-C-N 121.735 -0.603 . . . . 0.0 110.368 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -86.62 164.87 16.58 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.766 2.026 . . . . 0.0 110.805 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.664 HD21 HG21 ' A' ' 80' ' ' VAL . 6.8 mp -89.16 144.82 25.84 Favored 'General case' 0 C--O 1.183 -2.398 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.2 tt0 -138.76 158.73 43.68 Favored 'General case' 0 C--O 1.188 -2.16 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 29' ' ' PHE . 32.0 mm -92.6 124.15 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 122.527 0.331 . . . . 0.0 110.216 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -104.85 -18.93 14.05 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 123.452 0.47 . . . . 0.0 110.404 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 54.4 m -154.94 127.63 8.03 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.904 0.383 . . . . 0.0 110.539 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.2 tp -81.14 106.72 13.35 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.1 t -79.82 115.02 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.95 143.52 57.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.614 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.507 ' HA ' HD21 ' A' ' 54' ' ' LEU . 33.1 t70 79.43 14.69 1.01 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 125.252 1.595 . . . . 0.0 109.51 -172.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -97.18 165.27 22.73 Favored Glycine 0 C--O 1.207 -1.579 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.5 Cg_endo -72.51 -25.12 18.22 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 121.816 2.808 . . . . 0.0 110.772 -169.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.81 -45.41 89.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.77 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.36 -46.08 71.05 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 124.637 1.175 . . . . 0.0 110.301 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 92.2 mt -71.66 -34.01 69.36 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.506 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 14.1 t70 -77.91 -27.6 49.54 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.59 29.33 69.83 Favored Glycine 0 CA--C 1.484 -1.898 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.336 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.493 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 5.0 tppp? -97.12 -50.81 4.45 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.209 -0.995 . . . . 0.0 111.349 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.61 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 62.7 mtp -88.86 158.34 18.14 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.352 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.78 159.0 43.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 m -62.98 118.68 8.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.28 -31.18 3.05 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' HD12 ' A' ' 97' ' ' LEU . 9.1 m-20 -53.25 140.43 26.59 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.018 0.481 . . . . 0.0 111.615 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.5 OUTLIER -107.8 114.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.175 0.512 . . . . 0.0 111.497 175.805 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -70.25 116.5 11.58 Favored 'Isoleucine or valine' 0 C--O 1.298 3.641 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.166 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.512 HG13 HD13 ' A' ' 73' ' ' LEU . 88.3 t -99.57 -59.17 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.395 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 p -151.79 166.21 32.07 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.452 -175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.95 110.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.872 ' ND2' ' HB ' ' A' ' 93' ' ' VAL . 14.7 m-80 43.13 65.21 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 76.46 -38.05 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.663 1.585 . . . . 0.0 112.869 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 m -59.23 122.74 14.61 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.728 0.775 . . . . 0.0 110.382 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -83.33 76.75 9.88 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.602 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 75' ' ' HIS . 43.8 t -77.93 -7.18 10.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.635 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.512 HD13 HG13 ' A' ' 65' ' ' VAL . 16.2 tp -69.43 110.7 4.86 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 76.84 32.68 48.97 Favored Glycine 0 N--CA 1.411 -2.974 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.959 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -88.78 137.26 32.48 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 38.1 m -72.35 144.18 48.35 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 117.942 -1.028 . . . . 0.0 108.838 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 67.2 t60 -47.71 -50.86 23.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 119.046 0.839 . . . . 0.0 112.849 -176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.7 72.15 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.64 0.587 . . . . 0.0 110.969 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 33.5 mm-40 -75.95 -52.46 10.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.362 0.601 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.664 HG21 HD21 ' A' ' 41' ' ' LEU . 7.2 p -64.43 -43.49 96.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.811 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.57 -35.84 74.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.413 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.83 95.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.905 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.2 -50.54 35.73 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 122.383 1.087 . . . . 0.0 109.455 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.13 -34.87 79.43 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.83 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -85.9 -15.2 42.47 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -82.72 -16.43 48.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.225 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.606 HG23 ' HG2' ' A' ' 22' ' ' LYS . 5.5 mt -43.8 138.82 3.04 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 53.4 Cg_endo -95.96 148.06 1.28 Allowed 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 123.478 2.786 . . . . 0.0 110.858 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.49 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -67.54 139.86 20.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.72 57.08 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.851 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.96 -176.65 3.5 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.007 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.44 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 5.9 p -149.39 138.13 21.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.909 -0.495 . . . . 0.0 111.828 -173.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.872 ' HB ' ' ND2' ' A' ' 68' ' ' ASN . 2.5 m -153.36 143.18 14.54 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 C-N-CA 122.645 0.378 . . . . 0.0 111.953 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.714 ' N ' HD21 ' A' ' 68' ' ' ASN . 19.9 m-20 -78.07 106.98 10.3 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 125.865 1.666 . . . . 0.0 107.749 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.4 tp -96.12 118.75 33.33 Favored 'General case' 0 C--N 1.26 -3.307 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.6 116.51 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.603 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -141.94 159.98 41.12 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 -175.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 73.8 m -112.82 127.45 56.17 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.532 0.682 . . . . 0.0 110.631 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.597 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 22.7 tpp85 -97.2 146.01 25.5 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.36 -32.24 2.18 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.799 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 . . . . . 0 C--N 1.311 -1.079 0 CA-C-O 120.641 0.257 . . . . 0.0 110.472 177.299 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.413 -2.317 0 CA-C-O 121.548 0.689 . . . . 0.0 111.334 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 19.9 m -94.69 101.55 13.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.44 ' HA ' HG22 ' A' ' 30' ' ' THR . 10.6 mt-30 -83.88 122.57 28.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.312 -1.027 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.4 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 7' ' ' ASN 0.383 9.9 t . . . . . 0 N--CA 1.421 -1.909 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.51 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' A' ' 40' ' ' PHE . 18.0 ptt180 157.88 -33.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.74 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 20.2 t30 -53.94 111.45 2.83 Favored Pre-proline 0 C--N 1.269 -2.904 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.637 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.274 7.6 Cg_exo -57.4 -36.54 98.82 Favored 'Trans proline' 0 CA--C 1.463 -3.035 0 C-N-CA 122.921 2.414 . . . . 0.0 111.241 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.1 m -77.94 -9.32 59.03 Favored 'General case' 1 N--CA 1.347 -5.611 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.424 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.74 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.3 pt-20 -80.23 -36.56 34.58 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.3 mt -57.23 134.51 55.99 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.941 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.62 170.8 16.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.153 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 93.87 -117.01 5.37 Favored Glycine 0 N--CA 1.424 -2.106 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.052 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -150.38 145.78 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 110.465 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.92 112.49 24.18 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 152.49 37.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.471 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 p-80 -123.48 116.38 23.12 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.396 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -122.46 140.98 52.11 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.631 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -73.77 132.73 42.92 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.978 178.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.04 127.39 54.86 Favored 'General case' 0 C--O 1.256 1.435 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -86.87 105.84 17.33 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.702 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.767 ' HE3' HG13 ' A' ' 93' ' ' VAL . 1.6 mptm? -36.65 108.74 0.08 Allowed 'General case' 0 C--O 1.257 1.495 0 C-N-CA 125.115 1.366 . . . . 0.0 112.38 173.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 t -124.32 142.42 51.29 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 125.034 1.459 . . . . 0.0 108.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 m 52.56 39.4 27.98 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.535 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 67.52 35.15 4.3 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.013 1.325 . . . . 0.0 110.989 176.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.31 -120.95 0.83 Allowed Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.602 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.5 m-85 -137.92 -93.25 0.21 Allowed 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 50' ' ' GLY . . . 153.03 54.46 0.01 OUTLIER Glycine 0 C--N 1.292 -1.916 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 44.7 p90 -160.64 166.48 28.82 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.575 HG22 ' HA ' ' B' ' 160' ' ' GLN . 29.3 p -120.51 136.23 54.83 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 121.192 -0.942 . . . . 0.0 109.126 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.67 140.09 47.52 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.687 -170.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.8 m -115.24 169.05 6.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.101 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 84.8 -125.79 7.35 Favored Glycine 0 C--O 1.191 -2.558 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 31.89 58.5 0.36 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 125.87 1.7 . . . . 0.0 113.863 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.57 -32.11 5.98 Favored 'General case' 1 C--N 1.233 -4.494 0 CA-C-N 113.033 -1.583 . . . . 0.0 109.431 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -158.6 172.24 6.39 Favored Pre-proline 0 CA--C 1.466 -2.274 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.397 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 50.0 Cg_exo -63.83 -26.02 67.65 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.206 1.937 . . . . 0.0 108.914 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -71.43 -35.47 70.95 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.638 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.87 119.11 26.94 Favored 'General case' 0 C--O 1.275 2.415 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.188 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 8.6 m-85 -82.46 166.03 19.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.849 2.46 . . . . 0.0 110.699 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.769 HD21 HG21 ' A' ' 80' ' ' VAL . 3.9 mp -85.36 145.42 27.5 Favored 'General case' 0 C--O 1.187 -2.214 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.122 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.2 tt0 -145.04 148.38 33.64 Favored 'General case' 0 C--O 1.191 -1.977 0 CA-C-N 118.817 0.735 . . . . 0.0 109.264 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.4 mm -81.7 123.26 37.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' C ' HG23 ' A' ' 60' ' ' THR . 42.8 pttt -103.41 -19.96 14.24 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.053 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.2 m -155.31 127.74 7.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.11 111.3 18.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.2 t -86.67 121.47 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.0 145.42 55.42 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.542 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 t70 84.41 6.03 0.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 125.56 1.788 . . . . 0.0 109.319 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.72 158.51 25.2 Favored Glycine 0 C--O 1.2 -1.995 0 CA-C-O 118.322 -1.266 . . . . 0.0 110.66 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.3 Cg_endo -72.13 -25.11 19.49 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 CA-C-N 120.858 2.329 . . . . 0.0 110.192 -171.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -62.43 -46.81 86.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.977 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.64 81.76 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.609 1.164 . . . . 0.0 110.753 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.5 mt -71.92 -41.58 67.71 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 113.336 -1.756 . . . . 0.0 114.378 -174.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.8 -25.09 61.02 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.78 -0.32 86.42 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 117.941 1.937 . . . . 0.0 117.941 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -94.47 -49.54 5.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 120.348 2.074 . . . . 0.0 114.03 -176.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.601 ' HG2' HD11 ' A' ' 97' ' ' LEU . 65.8 mtp -64.62 139.46 58.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.187 0.304 . . . . 0.0 110.894 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.27 167.12 18.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.343 0.592 . . . . 0.0 110.939 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 44' ' ' LYS . 25.7 m -60.83 128.19 35.29 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.54 -35.03 4.02 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.455 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 43' ' ' ILE . 3.5 m-20 -52.78 129.07 28.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.383 0.673 . . . . 0.0 110.613 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.255 0.8 OUTLIER -93.4 116.23 34.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.335 0.588 . . . . 0.0 112.184 -179.161 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.8 mm -72.77 115.52 13.6 Favored 'Isoleucine or valine' 0 C--O 1.295 3.476 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.829 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 73' ' ' LEU . 98.7 t -98.45 -56.69 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 112.293 -2.23 . . . . 0.0 110.54 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.4 m -157.66 174.66 15.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.699 -0.626 . . . . 0.0 110.98 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.471 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.9 p -140.02 159.78 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.521 ' OD1' HG12 ' A' ' 93' ' ' VAL . 28.4 p-10 -29.22 109.86 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.524 1.129 . . . . 0.0 113.31 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 69.8 -37.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.995 1.318 . . . . 0.0 113.729 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.0 m -82.67 124.35 30.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.076 0.941 . . . . 0.0 111.865 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.82 78.72 9.83 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.985 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 23.8 t -77.17 3.71 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.302 1.049 . . . . 0.0 109.068 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.651 HD13 HG13 ' A' ' 65' ' ' VAL . 12.1 tp -65.74 111.55 3.28 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.514 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 62.96 37.9 95.7 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.589 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -74.13 137.85 43.5 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 47.3 m -72.76 146.96 46.01 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.527 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.537 ' O ' HG12 ' A' ' 81' ' ' VAL . 1.2 t60 -44.43 -49.63 9.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.236 0.614 . . . . 0.0 112.045 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.81 80.35 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 123.748 0.655 . . . . 0.0 111.102 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 25.6 mm-40 -75.33 -53.41 8.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 41' ' ' LEU . 11.7 p -59.72 -44.59 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.725 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.7 p -69.48 -36.13 69.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.062 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 3.7 tmmm? -59.96 -44.07 94.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.7 -50.68 37.31 Favored 'Isoleucine or valine' 0 C--O 1.262 1.729 0 CA-C-O 122.507 1.146 . . . . 0.0 108.895 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 13.2 m-85 -66.18 -33.76 76.49 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.398 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.82 -19.21 32.84 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.349 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.3 m -84.08 -10.01 58.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.069 0.461 . . . . 0.0 110.879 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 22' ' ' LYS . 6.1 mt -49.78 138.07 18.0 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -101.58 149.16 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.209 3.273 . . . . 0.0 111.254 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.535 HG12 ' H ' ' A' ' 25' ' ' ARG . 22.8 mt -68.4 143.25 15.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.052 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.19 11.42 57.44 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.427 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -107.09 -173.36 2.27 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.547 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.567 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 31.1 t -149.52 151.94 34.73 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -169.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HE3' ' A' ' 22' ' ' LYS . 1.1 m -157.12 153.72 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 C-N-CA 124.206 1.002 . . . . 0.0 111.245 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.02 107.49 19.54 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.7 tp -96.03 116.57 29.16 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.55 113.96 25.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.601 HD11 ' HG2' ' A' ' 58' ' ' MET . 1.4 pt? -141.48 157.8 44.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.1 t -111.63 123.58 50.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.588 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.7 tpp85 -92.12 143.06 26.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.15 -36.16 1.41 Allowed Glycine 0 C--N 1.294 -1.769 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.09 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 N--CA 1.438 -1.025 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.457 HG22 HG13 ' B' ' 161' ' ' VAL . 54.4 m -147.33 117.02 7.09 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.575 ' HA ' HG22 ' A' ' 30' ' ' THR . 9.8 tt0 -91.51 109.22 20.51 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.276 -2.596 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.305 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.605 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.3 t . . . . . 0 N--CA 1.43 -1.434 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 5' ' ' THR . 12.8 ptm180 53.23 16.43 0.81 Allowed 'General case' 0 N--CA 1.518 2.933 0 C-N-CA 127.12 2.168 . . . . 0.0 113.686 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.729 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.78 110.28 36.26 Favored Pre-proline 0 C--N 1.257 -3.426 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.793 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.263 7.7 Cg_exo -58.38 -31.86 94.91 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 121.225 1.283 . . . . 0.0 109.114 171.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -72.74 -19.52 61.37 Favored 'General case' 1 N--CA 1.361 -4.9 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.851 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.8 pt-20 -79.77 -31.53 40.9 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 40' ' ' PHE . 86.7 mt -63.46 137.55 58.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.649 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.84 174.0 7.47 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.652 -174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.83 -115.52 5.33 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.382 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.38 149.15 46.75 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.54 115.55 23.03 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -134.89 153.13 34.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 -176.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -129.44 123.64 32.11 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.59 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.483 HG21 ' HB2' ' A' ' 58' ' ' MET . 15.2 t -127.89 133.05 49.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.292 0.568 . . . . 0.0 111.758 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -81.86 128.3 33.89 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 mp -111.06 127.97 55.72 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -87.49 108.26 18.95 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.693 ' HG3' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -40.48 108.43 0.09 Allowed 'General case' 0 CA--C 1.462 -2.434 0 C-N-CA 125.857 1.663 . . . . 0.0 112.246 175.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -87.54 -143.21 0.12 Allowed 'General case' 0 N--CA 1.401 -2.896 0 O-C-N 126.598 2.436 . . . . 0.0 107.298 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -67.01 82.6 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.458 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER 64.13 24.34 13.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 112.063 176.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -130.33 1.68 Allowed Glycine 0 C--O 1.276 2.78 0 C-N-CA 118.588 -1.768 . . . . 0.0 113.692 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.6 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 78.8 m-85 -133.83 -91.65 0.35 Allowed 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.511 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.33 53.15 0.1 Allowed Glycine 0 C--N 1.306 -1.089 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -169.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 32.8 p90 -162.0 145.86 12.27 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -108.13 135.87 48.76 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG13 ' HB ' ' B' ' 159' ' ' THR . 1.9 p -123.41 140.4 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 CA-C-N 113.403 -1.726 . . . . 0.0 111.02 -171.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.5 m -124.02 133.65 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 C-N-CA 124.677 1.191 . . . . 0.0 110.691 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 -140.78 12.2 Favored Glycine 0 CA--C 1.461 -3.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.4 55.86 2.47 Favored Glycine 0 CA--C 1.45 -3.977 0 O-C-N 126.695 2.056 . . . . 0.0 112.101 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.24 -31.62 15.36 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.639 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 4.7 pt-20 -158.7 167.69 13.92 Favored Pre-proline 0 CA--C 1.48 -1.724 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.484 -171.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' GLU . 15.0 Cg_exo -77.76 64.45 8.16 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 124.189 3.259 . . . . 0.0 107.805 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.15 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.065 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.35 119.97 40.85 Favored 'General case' 0 C--O 1.267 1.992 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 11' ' ' LEU . 20.5 m-85 -84.32 164.37 19.03 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 127.804 2.442 . . . . 0.0 111.778 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -90.45 147.89 23.12 Favored 'General case' 0 C--O 1.201 -1.473 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.9 tt0 -139.63 155.27 47.53 Favored 'General case' 0 C--O 1.184 -2.367 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 29' ' ' PHE . 44.7 mm -100.3 123.47 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.588 -0.695 . . . . 0.0 110.811 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -102.62 -23.59 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 123.357 0.411 . . . . 0.0 112.02 -177.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 m -151.88 127.05 9.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.48 108.17 19.25 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.511 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 62.9 t -85.82 134.35 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.494 0.664 . . . . 0.0 110.197 -173.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.15 140.92 57.53 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.189 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 80.54 5.29 1.65 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.238 1.415 . . . . 0.0 110.996 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.68 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -81.62 159.36 40.32 Favored Glycine 0 C--O 1.203 -1.817 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.558 173.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 13.5 Cg_endo -72.0 -25.09 19.94 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 CA-C-N 121.559 2.68 . . . . 0.0 109.855 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -64.97 -42.37 94.62 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.64 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.43 76.99 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.767 1.27 . . . . 0.0 109.782 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 65.9 mt -72.11 -46.91 54.79 Favored 'General case' 0 C--N 1.267 -3.007 0 CA-C-N 112.64 -2.073 . . . . 0.0 115.188 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.76 -24.65 56.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.05 -155.94 33.6 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.007 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.7 tttp 70.25 -58.79 0.53 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.135 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 18' ' ' THR . 26.9 ttt -77.65 137.64 38.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.639 0.776 . . . . 0.0 109.076 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -152.16 143.69 23.47 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.741 0.416 . . . . 0.0 109.941 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 m -45.81 116.38 1.19 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.215 1.006 . . . . 0.0 110.811 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.78 -11.04 7.05 Favored Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.57 145.45 56.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 3.4 m -106.99 132.65 53.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 117.961 -1.496 . . . . 0.0 107.213 168.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.272 5.8 mt -83.74 119.55 33.16 Favored 'Isoleucine or valine' 1 C--O 1.31 4.267 0 CA-C-O 121.564 0.697 . . . . 0.0 112.599 -178.531 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 73' ' ' LEU . 93.7 t -109.23 -50.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 O-C-N 127.356 2.91 . . . . 0.0 112.382 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 72' ' ' VAL . 29.2 m -145.48 158.63 43.81 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.491 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.508 HG13 ' HB ' ' A' ' 70' ' ' THR . 5.2 p -135.23 86.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.482 37.3 p30 54.93 -90.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.361 2.265 . . . . 0.0 114.761 -171.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -89.59 -37.65 14.52 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.609 0.719 . . . . 0.0 110.172 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 ' HB ' HG13 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -77.91 127.84 33.0 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.842 -172.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.98 96.68 10.35 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 14.5 p -90.67 -1.11 9.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.783 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 65' ' ' VAL . 17.4 tp -69.56 112.0 5.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.43 27.33 43.93 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.599 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -81.42 150.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 63.3 m -76.48 142.47 40.94 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 117.824 -1.084 . . . . 0.0 108.764 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.7 t-80 -48.27 -48.66 35.47 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.061 0.846 . . . . 0.0 112.894 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.49 69.55 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.303 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 29.3 mm-40 -80.55 -46.23 16.11 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 HD21 ' A' ' 41' ' ' LEU . 7.6 p -61.92 -43.73 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.917 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.3 -35.93 74.1 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.559 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.81 -46.69 81.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.733 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.5 -50.69 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.208 1.004 . . . . 0.0 109.362 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -62.26 -36.28 81.58 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.479 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.57 -20.04 32.12 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.699 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 t -80.8 -13.08 59.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.693 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.6 mt -48.67 134.11 13.79 Favored Pre-proline 0 CA--C 1.565 1.558 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 88.3 Cg_endo -99.95 157.63 0.53 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.233 3.288 . . . . 0.0 112.286 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' SER . 22.7 mt -68.97 142.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 123.656 0.782 . . . . 0.0 110.425 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.99 13.27 69.51 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.206 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -109.94 -170.19 1.61 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.486 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.459 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.4 t -149.95 148.88 29.61 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.917 -0.489 . . . . 0.0 112.281 -172.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.639 HG22 ' HE3' ' A' ' 22' ' ' LYS . 6.5 m -155.24 145.92 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 124.844 1.258 . . . . 0.0 110.05 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.5 ' H ' ' HB3' ' A' ' 68' ' ' ASN . 7.0 m-20 -95.9 107.75 20.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.682 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.6 mm? -92.06 120.87 33.08 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.092 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.77 122.44 38.55 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.51 151.57 35.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.891 0.744 . . . . 0.0 109.737 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 63' ' ' VAL . 8.3 t -117.92 111.51 19.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 168.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.504 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 13.4 tpp85 -100.28 158.01 16.19 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.4 -15.52 6.38 Favored Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 N--CA 1.42 -1.938 0 CA-C-N 113.889 -1.156 . . . . 0.0 108.165 176.692 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 15.0 pt-20 . . . . . 0 N--CA 1.429 -1.48 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.523 ' HB ' HG13 ' A' ' 31' ' ' VAL . 11.0 m -93.04 124.16 36.82 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 172.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -106.11 101.89 11.34 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.724 -0.61 . . . . 0.0 109.977 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.722 -172.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 121.584 0.706 . . . . 0.0 112.019 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 6.8 tpt180 61.75 30.97 18.57 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.413 1.578 . . . . 0.0 109.97 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.781 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -120.29 108.18 38.35 Favored Pre-proline 0 C--N 1.263 -3.193 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -177.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.276 8.0 Cg_exo -55.22 -30.19 70.33 Favored 'Trans proline' 0 CA--C 1.486 -1.882 0 C-N-CA 121.527 1.485 . . . . 0.0 110.289 169.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -75.36 -23.01 57.1 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.601 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.781 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -73.99 -33.23 63.75 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 74.8 mt -62.09 133.28 55.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.785 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.31 175.81 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.451 -1.704 . . . . 0.0 113.672 -171.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 87.94 -132.0 10.95 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.47 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.608 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.39 142.8 51.01 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 123.819 0.848 . . . . 0.0 109.331 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -107.22 116.15 31.42 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -133.67 151.94 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.66 -177.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 13.2 t-160 -123.31 105.23 9.68 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -124.18 136.9 54.51 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.158 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.65 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -78.12 129.84 35.66 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.331 0.653 . . . . 0.0 110.324 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -117.31 120.17 37.39 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 176.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -84.77 103.1 13.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.97 115.07 0.36 Allowed 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 176.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -88.52 -148.31 0.16 Allowed 'General case' 0 N--CA 1.41 -2.431 0 O-C-N 126.241 2.213 . . . . 0.0 108.056 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -62.69 83.79 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.547 ' H ' HG12 ' A' ' 89' ' ' ILE . 22.2 mmt180 67.35 49.61 1.03 Allowed 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 124.964 1.306 . . . . 0.0 112.492 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.32 -123.16 2.22 Favored Glycine 0 N--CA 1.401 -3.682 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.685 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.694 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 64.1 m-85 -125.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.261 -3.265 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.471 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.479 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.26 49.64 0.18 Allowed Glycine 0 C--N 1.292 -1.867 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.052 -172.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 27' ' ' PHE . 28.3 p90 -161.16 142.26 11.52 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 73.9 p -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 11.0 m -125.7 159.16 33.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.885 -170.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.496 HG13 ' CD ' ' A' ' 44' ' ' LYS . 4.2 m -120.53 131.59 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 C-N-CA 124.07 0.948 . . . . 0.0 110.519 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 130.58 -137.24 9.36 Favored Glycine 0 C--O 1.291 3.701 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.527 174.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.83 61.86 3.21 Favored Glycine 1 CA--C 1.436 -4.886 0 O-C-N 127.109 2.299 . . . . 0.0 110.953 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 76' ' ' THR . 13.5 t0 -99.19 -48.66 4.76 Favored 'General case' 0 C--N 1.248 -3.833 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 5.9 pt-20 -160.35 175.97 2.84 Favored Pre-proline 0 C--N 1.287 -2.14 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.661 -170.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.424 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 32.2 Cg_exo -72.42 64.89 3.68 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.154 3.236 . . . . 0.0 107.97 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 1.8 t70 -171.66 -41.49 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.498 -2.137 . . . . 0.0 108.637 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.87 120.09 28.36 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.204 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -88.61 166.1 14.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 128.242 2.617 . . . . 0.0 108.114 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.572 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -89.77 144.13 26.23 Favored 'General case' 0 C--O 1.166 -3.329 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.903 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 tt0 -130.59 156.28 45.12 Favored 'General case' 0 C--O 1.17 -3.089 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.421 HD11 HG12 ' A' ' 64' ' ' ILE . 13.3 mm -93.05 128.9 44.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 CA-C-N 119.161 0.891 . . . . 0.0 109.823 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CD ' HG13 ' A' ' 32' ' ' VAL . 4.5 ptmm? -107.82 -23.96 11.86 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 39.7 m -151.61 126.96 9.95 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.686 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.1 112.33 18.37 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 57.6 t -89.93 122.56 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.05 146.3 54.84 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.605 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 83.05 4.27 0.94 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 125.055 1.472 . . . . 0.0 109.771 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.98 158.77 36.93 Favored Glycine 0 C--O 1.205 -1.673 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.541 173.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.9 Cg_endo -72.17 -25.26 19.18 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 CA-C-N 121.549 2.674 . . . . 0.0 109.716 -171.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -60.65 -48.18 82.93 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.88 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.89 82.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.163 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 83.9 mt -72.07 -39.51 68.96 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.975 -172.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.45 -21.07 45.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.42 40.97 98.35 Favored Glycine 0 CA--C 1.49 -1.503 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.753 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -141.95 27.54 1.8 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.185 0.993 . . . . 0.0 110.315 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.647 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.7 tmt? -160.24 137.49 9.4 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HG2' ' NE ' ' A' ' 99' ' ' ARG . 7.9 pt-20 -154.95 160.07 40.86 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 119.309 0.959 . . . . 0.0 112.336 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -53.72 123.15 11.47 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.519 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.56 -1.09 21.93 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.954 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.1 p30 -100.94 161.92 13.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.432 172.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.727 HG13 ' SG ' ' A' ' 98' ' ' CYS 0.342 0.2 OUTLIER -118.31 125.3 74.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -179.093 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.421 HG12 HD11 ' A' ' 43' ' ' ILE . 47.4 mm -69.77 114.17 6.71 Favored 'Isoleucine or valine' 0 C--O 1.303 3.914 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.605 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.67 HG13 HD13 ' A' ' 73' ' ' LEU . 88.2 t -93.59 -58.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 112.471 -2.15 . . . . 0.0 110.007 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -162.22 173.96 13.54 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.99 -0.444 . . . . 0.0 110.871 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.0 p -143.68 156.64 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 1.8 t30 -30.18 111.28 0.07 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.8 1.64 . . . . 0.0 113.033 170.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.5 t70 75.39 -27.2 0.19 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.63 1.572 . . . . 0.0 113.677 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 m -112.44 116.24 29.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.979 0.895 . . . . 0.0 111.403 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.3 t -82.75 96.0 8.04 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.47 0.09 4.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.431 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.67 HD13 HG13 ' A' ' 65' ' ' VAL . 15.2 tp -65.07 110.99 2.69 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.256 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.26 80.62 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.433 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -74.03 145.4 44.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 44.2 m -76.69 142.83 40.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.216 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.432 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.7 t60 -48.08 -49.22 32.4 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 118.993 0.815 . . . . 0.0 112.537 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.06 75.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 124.298 0.999 . . . . 0.0 110.517 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 68.1 mm-40 -77.95 -49.96 13.11 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.012 -176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -63.59 -43.92 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.444 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.8 p -63.78 -40.26 88.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.228 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' SER . 4.6 tmmm? -58.45 -44.21 89.14 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.825 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.28 -48.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 122.057 0.932 . . . . 0.0 109.977 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.52 -32.24 73.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.958 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.81 -16.64 38.13 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.877 0.37 . . . . 0.0 110.968 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 27.4 t -77.81 -23.45 49.07 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.617 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.6 mt -50.28 139.36 19.23 Favored Pre-proline 0 N--CA 1.434 -1.261 0 C-N-CA 124.382 1.073 . . . . 0.0 113.292 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 71.7 Cg_endo -99.69 158.5 0.56 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 124.185 3.257 . . . . 0.0 111.422 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.547 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.6 mt -68.32 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.245 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.72 12.61 60.56 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.561 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -100.02 -175.27 2.9 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.281 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.65 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 13.2 t -148.22 139.2 23.18 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.886 -0.509 . . . . 0.0 112.338 -172.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.9 m -151.64 158.98 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.063 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.559 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 8.2 m-20 -102.87 108.01 19.06 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.551 HD22 HD22 ' A' ' 20' ' ' LEU . 12.5 tp -100.79 120.96 40.88 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 12.6 pt-20 -103.16 124.4 48.51 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 58' ' ' MET . 4.2 pp -141.64 165.31 27.83 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.407 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.727 ' SG ' HG13 ' A' ' 63' ' ' VAL . 3.0 p -118.73 113.42 21.12 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.458 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -90.38 137.32 32.45 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.484 -173.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.94 23.79 5.44 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.599 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.6 t80 . . . . . 0 C--N 1.303 -1.421 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.584 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.448 0.642 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 4.8 m -115.01 102.78 10.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.436 ' HA ' HG22 ' A' ' 30' ' ' THR . 77.3 mt-30 -86.28 95.22 9.55 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.58 HG23 ' HB2' ' A' ' 27' ' ' PHE . 9.1 m . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.427 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 7' ' ' ASN 0.32 12.6 t . . . . . 0 N--CA 1.419 -2.01 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' HD21 ' A' ' 73' ' ' LEU . 26.7 ptt180 156.39 -30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.29 1.836 . . . . 0.0 106.276 177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 39.4 t-20 -40.6 107.68 0.49 Allowed Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.414 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.261 9.6 Cg_exo -61.67 -32.95 87.16 Favored 'Trans proline' 0 CA--C 1.465 -2.932 0 C-N-CA 121.918 1.745 . . . . 0.0 110.374 -178.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -80.04 -18.92 48.88 Favored 'General case' 1 N--CA 1.338 -6.046 0 CA-C-N 111.972 -2.376 . . . . 0.0 111.726 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.2 pt-20 -73.24 -36.22 66.4 Favored 'General case' 0 C--N 1.379 1.859 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 85.3 mt -54.94 129.37 37.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.785 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.9 -162.58 0.55 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.26 -171.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 65.92 -102.0 0.66 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.003 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 149.06 32.93 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 123.259 0.624 . . . . 0.0 109.861 178.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 8' ' ' PRO . 2.5 t80 -112.64 110.98 21.46 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.18 153.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.708 -177.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 26.8 p-80 -132.05 107.59 8.76 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.928 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -122.51 132.18 54.2 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -76.29 136.26 39.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.43 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.0 130.53 54.78 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -82.89 124.23 30.14 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 109.46 0.44 Allowed 'General case' 0 CA--C 1.466 -2.257 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 173.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.7 t -85.14 -146.18 0.1 Allowed 'General case' 0 N--CA 1.413 -2.306 0 O-C-N 126.624 2.453 . . . . 0.0 107.82 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 m -64.12 84.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.553 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.0 mpt_? 59.86 43.99 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 125.698 1.599 . . . . 0.0 111.353 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.24 -127.0 1.8 Allowed Glycine 1 N--CA 1.394 -4.143 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.935 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.7 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m-85 -133.68 -82.57 0.46 Allowed 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 114.349 -0.926 . . . . 0.0 111.356 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.53 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.33 54.76 0.18 Allowed Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -169.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.8 p90 -161.32 148.77 15.04 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -113.08 136.66 52.46 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.909 0.861 . . . . 0.0 109.154 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 6.2 p -128.63 150.54 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.523 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.472 -167.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' A' ' 42' ' ' GLN . 12.3 m -114.33 154.3 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 124.829 1.252 . . . . 0.0 113.106 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.23 -123.91 6.8 Favored Glycine 0 C--O 1.291 3.706 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.94 177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.64 47.79 3.06 Favored Glycine 0 CA--C 1.47 -2.781 0 O-C-N 126.455 1.914 . . . . 0.0 112.081 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -95.4 -29.31 14.5 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . 13.2 mt-10 -140.95 172.64 5.86 Favored Pre-proline 0 N--CA 1.41 -2.442 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.062 -169.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_exo -73.66 -8.4 21.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.532 2.822 . . . . 0.0 108.149 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -108.03 -9.13 15.69 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.047 -1.888 . . . . 0.0 110.183 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -131.24 119.41 21.77 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.639 -0.663 . . . . 0.0 110.9 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 8.4 m-85 -86.57 166.18 15.62 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.428 2.291 . . . . 0.0 110.232 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.8 mp -93.77 146.38 23.91 Favored 'General case' 0 C--O 1.181 -2.535 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.468 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 28.7 tt0 -138.48 144.92 40.26 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-N 118.803 0.729 . . . . 0.0 109.949 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 29' ' ' PHE . 27.0 mm -80.28 120.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.743 0 O-C-N 121.498 -0.751 . . . . 0.0 110.734 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.413 ' C ' HG23 ' A' ' 60' ' ' THR . 44.1 pttt -100.75 -22.0 15.01 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 123.473 0.483 . . . . 0.0 111.544 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.7 m -158.46 127.48 5.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 60' ' ' THR . 2.9 pp -84.44 121.07 27.05 Favored 'General case' 0 N--CA 1.402 -2.872 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.7 t -85.0 129.3 37.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.63 138.59 58.53 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.434 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 t70 81.65 8.04 1.02 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.777 1.298 . . . . 0.0 110.766 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.654 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.1 161.12 27.66 Favored Glycine 0 C--O 1.21 -1.395 0 CA-C-O 117.894 -1.504 . . . . 0.0 109.798 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.3 Cg_endo -72.13 -24.74 19.9 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 CA-C-N 121.501 2.651 . . . . 0.0 110.271 -169.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -49.94 75.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.188 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.44 80.76 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.961 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 74.3 mt -71.77 -40.31 69.36 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-N 112.745 -2.025 . . . . 0.0 115.46 -172.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.07 -21.58 56.59 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.696 1.236 . . . . 0.0 107.785 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.76 30.98 73.99 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 112.894 -1.957 . . . . 0.0 114.022 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.07 -1.27 3.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.742 0.782 . . . . 0.0 111.058 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -132.5 125.41 30.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.19 167.53 21.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.702 0.763 . . . . 0.0 112.122 -167.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.489 ' H ' HD23 ' A' ' 46' ' ' LEU . 4.7 m -56.35 119.93 6.8 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.778 174.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.43 5.85 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 26.7 m-20 -72.18 135.36 46.12 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.1 OUTLIER -104.77 120.2 54.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 CA-C-O 121.519 0.676 . . . . 0.0 110.837 173.254 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.89 111.75 4.09 Favored 'Isoleucine or valine' 0 C--O 1.299 3.679 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.595 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.581 HG13 HD13 ' A' ' 73' ' ' LEU . 91.8 t -93.61 -58.25 3.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.53 0 O-C-N 126.315 2.259 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -151.43 171.06 18.11 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.833 -0.542 . . . . 0.0 110.102 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 7.7 p -146.87 114.4 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 93' ' ' VAL 0.4 0.2 OUTLIER 31.23 66.88 0.14 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.951 1.3 . . . . 0.0 114.146 -171.31 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.44 -37.43 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.283 1.433 . . . . 0.0 114.102 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.4 m -57.81 121.99 11.8 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.446 0.641 . . . . 0.0 110.754 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 36.0 t -80.88 78.73 7.64 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.32 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 56.0 t -80.83 0.23 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 123.325 1.536 . . . . 0.0 108.851 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -67.68 110.74 3.86 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 65.62 43.02 95.15 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.486 -174.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -87.58 141.89 28.27 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.6 m -68.77 141.73 55.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.543 ' HA ' HG12 ' A' ' 80' ' ' VAL . 6.4 t60 -54.17 -38.35 65.47 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.428 1.091 . . . . 0.0 112.079 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.7 90.23 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.109 0.881 . . . . 0.0 110.067 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.47 -48.84 18.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.811 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.09 -43.0 97.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.883 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.2 p -65.46 -36.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.263 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -42.16 97.45 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.378 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.51 -50.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 122.394 1.092 . . . . 0.0 108.991 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.63 -33.63 76.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.411 -1.722 . . . . 0.0 113.706 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -85.71 -22.66 27.72 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 m -83.28 -10.94 58.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.418 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.5 mt -46.74 136.58 7.69 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.357 1.063 . . . . 0.0 113.823 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.3 Cg_endo -97.28 150.65 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.798 2.999 . . . . 0.0 112.08 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' ARG . 17.8 mt -68.05 142.02 16.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.519 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.31 11.48 64.49 Favored Glycine 0 CA--C 1.485 -1.831 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.162 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.37 -170.1 1.7 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.77 -171.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.44 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 24.3 t -149.86 146.07 26.91 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.734 HG22 ' HE2' ' A' ' 22' ' ' LYS . 17.2 m -150.6 153.9 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 C-N-CA 123.483 0.713 . . . . 0.0 109.725 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 19.7 t70 -100.81 112.68 25.15 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.0 mm? -90.8 113.76 25.98 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.513 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 38.3 tt0 -94.97 109.21 21.26 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.48 159.34 42.43 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 0.0 112.359 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 t -110.27 122.98 48.95 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 17.3 tpp85 -104.21 147.22 27.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.51 -13.92 4.24 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.064 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 . . . . . 0 C--N 1.306 -1.312 0 CA-C-O 120.509 0.195 . . . . 0.0 110.852 177.13 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 . . . . . 0 C--O 1.237 0.422 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.556 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 5.3 m -89.68 125.87 35.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -109.54 115.34 29.74 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 27' ' ' PHE . 31.7 m . . . . . 0 N--CA 1.426 -1.651 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.402 -173.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 15.1 t . . . . . 0 N--CA 1.425 -1.682 0 CA-C-O 122.307 1.051 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 45.55 42.75 8.39 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 123.991 1.853 . . . . 0.0 112.606 178.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.801 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.8 OUTLIER -115.2 114.02 43.41 Favored Pre-proline 1 C--N 1.242 -4.085 0 CA-C-N 113.083 -1.871 . . . . 0.0 114.186 178.367 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.9 Cg_exo -56.72 -30.52 84.53 Favored 'Trans proline' 0 CA--C 1.481 -2.154 0 C-N-CA 121.314 1.343 . . . . 0.0 109.693 168.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -79.54 -13.22 59.69 Favored 'General case' 1 N--CA 1.362 -4.857 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.485 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -81.38 -32.11 32.99 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 63' ' ' VAL . 79.2 mt -61.81 143.32 56.49 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.896 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.72 -179.33 7.09 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.426 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.2 -128.36 9.38 Favored Glycine 0 N--CA 1.432 -1.603 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.833 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 2.4 ptmm? -127.53 151.62 48.65 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 123.882 0.873 . . . . 0.0 110.847 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.84 119.32 37.6 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.404 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -138.02 152.82 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 121.647 0.737 . . . . 0.0 111.923 -177.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.5 p-80 -135.35 105.08 6.11 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.476 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -115.83 140.19 49.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.277 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.15 131.89 41.71 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.4 tp -117.12 121.67 41.93 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.89 114.53 21.25 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.48 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.778 ' HA ' ' HZ2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -48.42 111.49 0.46 Allowed 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 125.108 1.363 . . . . 0.0 112.802 177.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 22.8 t -88.17 -144.28 0.14 Allowed 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 127.159 2.787 . . . . 0.0 107.327 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 p -62.56 84.27 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.555 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.3 mpt_? 59.88 29.85 19.4 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 126.414 1.886 . . . . 0.0 112.215 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.42 -123.05 1.02 Allowed Glycine 0 N--CA 1.412 -2.94 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.173 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.712 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 76.3 m-85 -130.88 -90.45 0.45 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.055 -1.073 . . . . 0.0 111.324 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.602 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 128.07 54.99 0.12 Allowed Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.002 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.454 ' O ' HG22 ' B' ' 161' ' ' VAL . 38.4 p90 -161.52 142.95 11.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.55 HG22 ' HA ' ' B' ' 160' ' ' GLN . 25.5 p -105.68 136.04 46.01 Favored 'General case' 0 C--N 1.284 -2.283 0 O-C-N 121.336 -0.852 . . . . 0.0 109.497 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 14.4 m -125.78 160.01 33.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.724 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG13 ' HD3' ' A' ' 44' ' ' LYS . 25.2 m -124.04 132.49 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 174.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' HA2' ' OE2' ' A' ' 39' ' ' GLU . . . 129.77 -139.73 11.18 Favored Glycine 0 N--CA 1.41 -3.091 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.068 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.644 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.41 48.52 8.55 Favored Glycine 1 CA--C 1.443 -4.413 0 C-N-CA 125.754 1.645 . . . . 0.0 111.204 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -88.99 -32.64 17.52 Favored 'General case' 0 C--N 1.252 -3.669 0 CA-C-N 114.566 -0.817 . . . . 0.0 109.712 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -158.67 167.9 13.49 Favored Pre-proline 0 N--CA 1.415 -2.21 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.464 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 16.6 Cg_exo -77.46 51.15 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.409 3.406 . . . . 0.0 109.916 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -162.79 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.194 -2.275 . . . . 0.0 108.257 -171.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.527 ' OE2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 tt0 -111.78 120.15 41.0 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.48 165.67 16.96 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 128.29 2.636 . . . . 0.0 109.282 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.644 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 3.9 mp -95.06 146.14 24.48 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.003 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 1.2 tm0? -131.79 151.58 51.57 Favored 'General case' 0 C--O 1.169 -3.147 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 62' ' ' ASP . 8.2 mm -90.54 122.34 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 118.827 0.74 . . . . 0.0 109.237 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HD3' HG13 ' A' ' 32' ' ' VAL . 53.6 pttt -106.02 -18.18 14.11 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.765 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.9 m -156.34 127.74 7.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.023 0.439 . . . . 0.0 111.326 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.01 121.28 21.74 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.602 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 97.2 t -92.98 123.44 45.07 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.88 148.93 48.4 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.708 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.3 t70 80.6 4.71 1.67 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.982 1.426 . . . . 0.0 109.743 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.633 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.5 164.63 31.91 Favored Glycine 0 C--O 1.209 -1.468 0 CA-C-O 117.893 -1.504 . . . . 0.0 110.544 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 10.1 Cg_endo -72.5 -25.72 17.61 Favored 'Trans proline' 0 C--O 1.191 -1.868 0 CA-C-N 121.639 2.719 . . . . 0.0 110.482 -171.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.24 87.53 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.676 0.751 . . . . 0.0 109.408 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.39 68.06 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 122.536 1.16 . . . . 0.0 109.252 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.4 mt -72.13 -50.0 31.43 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 112.619 -2.082 . . . . 0.0 115.522 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.01 -24.52 55.29 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.77 45.62 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.086 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 69.85 -61.37 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.366 1.466 . . . . 0.0 112.637 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.535 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.3 tmt? -77.7 136.24 38.16 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -146.02 167.05 24.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.151 0.5 . . . . 0.0 111.107 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.8 m -58.24 128.04 35.11 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.6 -13.28 10.89 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.521 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 43' ' ' ILE . 24.8 m-20 -75.65 161.49 29.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 11' ' ' LEU . 10.4 m -123.31 133.95 67.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 40.1 mm -81.0 109.22 15.14 Favored 'Isoleucine or valine' 0 C--O 1.302 3.866 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 73' ' ' LEU . 86.9 t -95.84 -56.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 O-C-N 126.225 2.203 . . . . 0.0 109.717 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -156.44 173.23 17.21 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.518 -0.739 . . . . 0.0 110.054 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.443 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.5 p -145.68 120.84 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.252 4.8 p-10 16.58 84.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.542 1.937 . . . . 0.0 115.216 -172.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 74.73 -37.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.403 1.481 . . . . 0.0 113.09 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.6 m -66.46 125.25 25.11 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-O 121.922 0.867 . . . . 0.0 110.195 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 47.3 t -89.14 91.41 8.78 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.542 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 67' ' ' VAL . 57.1 t -86.46 3.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.76 1.267 . . . . 0.0 108.767 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 65' ' ' VAL . 13.1 tp -76.38 111.08 11.45 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.78 38.36 60.82 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.846 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -82.17 145.92 29.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.4 m -75.43 142.31 43.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 117.468 -1.253 . . . . 0.0 107.691 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.405 ' O ' HG12 ' A' ' 81' ' ' VAL . 62.2 t60 -48.58 -48.04 39.19 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 119.211 0.914 . . . . 0.0 112.815 -176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -36.13 76.23 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 124.367 1.042 . . . . 0.0 110.536 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -75.0 -51.56 13.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.666 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.4 p -63.93 -44.08 97.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.6 p -60.47 -42.13 90.11 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.535 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 35.4 ttpt -65.26 -39.13 92.23 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -71.5 -46.59 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 122.187 0.994 . . . . 0.0 108.402 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.0 -28.89 69.22 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.745 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.09 -23.77 26.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.6 t -92.55 -2.64 56.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.38 0.61 . . . . 0.0 110.163 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.605 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -54.49 138.26 60.25 Favored Pre-proline 0 N--CA 1.424 -1.754 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.787 173.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -93.39 149.27 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.239 2.626 . . . . 0.0 111.794 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.555 HG12 ' H ' ' A' ' 25' ' ' ARG . 26.3 mt -67.86 141.81 17.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.46 12.37 63.01 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.637 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.589 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -106.89 -169.06 1.49 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.804 -171.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.547 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 27.9 t -148.14 148.1 30.21 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.841 -0.537 . . . . 0.0 112.218 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.3 m -146.58 161.15 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.014 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.553 173.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -107.41 107.75 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.6 tp -92.01 114.09 26.53 Favored 'General case' 0 C--N 1.253 -3.591 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.976 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -90.76 107.63 19.31 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.47 161.72 37.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.507 ' HB2' HG22 ' A' ' 63' ' ' VAL . 74.4 m -124.27 123.49 40.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.966 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' CG ' ' A' ' 14' ' ' LYS . 18.9 tpp85 -93.35 147.17 23.16 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 137.54 5.64 1.71 Allowed Glycine 0 C--N 1.296 -1.661 0 C-N-CA 119.101 -1.523 . . . . 0.0 112.586 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 . . . . . 0 N--CA 1.43 -1.469 0 CA-C-N 116.714 0.257 . . . . 0.0 110.469 176.412 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.476 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 2.9 m -100.06 113.89 26.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 30' ' ' THR . 55.0 tt0 -88.66 104.8 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 29' ' ' PHE . 10.1 m . . . . . 0 N--CA 1.418 -2.062 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.096 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 7' ' ' ASN 0.335 8.9 t . . . . . 0 N--CA 1.418 -2.038 0 CA-C-O 120.553 0.216 . . . . 0.0 111.104 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.2 ptm180 164.03 -30.12 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.6 t-20 -46.07 108.66 0.85 Allowed Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.846 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.1 -27.35 73.38 Favored 'Trans proline' 0 CA--C 1.469 -2.755 0 C-N-CA 121.565 1.51 . . . . 0.0 110.882 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -81.83 -19.71 40.52 Favored 'General case' 1 N--CA 1.354 -5.235 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.031 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.703 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.9 pt-20 -75.26 -34.41 61.37 Favored 'General case' 0 C--N 1.372 1.571 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.5 132.86 49.55 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.921 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -80.06 171.16 15.46 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.772 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 97.42 -123.49 7.82 Favored Glycine 0 N--CA 1.417 -2.569 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.271 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -135.72 141.38 44.88 Favored 'General case' 0 C--N 1.282 -2.349 0 C-N-CA 123.479 0.712 . . . . 0.0 109.55 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -108.83 111.64 23.48 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.44 152.13 23.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.564 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.1 t60 -131.84 99.71 4.85 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -114.22 145.57 41.54 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.759 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -84.88 134.68 34.27 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -117.23 119.98 36.84 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -81.49 110.95 17.36 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.19 104.4 0.04 OUTLIER 'General case' 0 CA--C 1.465 -2.3 0 O-C-N 123.85 0.719 . . . . 0.0 109.398 170.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 65.1 m -92.34 -117.32 0.08 Allowed 'General case' 0 N--CA 1.388 -3.534 0 O-C-N 125.125 1.515 . . . . 0.0 109.953 -176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.6 m -78.81 79.53 5.21 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 119.907 1.23 . . . . 0.0 113.079 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' H ' HG12 ' A' ' 89' ' ' ILE . 16.8 mmt180 62.84 51.19 3.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.143 0.973 . . . . 0.0 111.322 173.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.85 -124.78 2.93 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.692 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 74.5 m-85 -127.79 -81.33 0.59 Allowed 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.5 51.41 0.1 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.456 -172.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 43' ' ' ILE . 27.4 p90 -162.05 146.81 12.71 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.96 0.904 . . . . 0.0 108.715 174.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.0 p -109.92 136.14 49.68 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.891 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 15.4 m -117.45 168.45 9.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.193 -168.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.7 m -127.38 133.06 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 125.482 1.513 . . . . 0.0 109.739 173.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 115.87 -135.6 12.3 Favored Glycine 0 C--N 1.273 -2.951 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.811 177.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 38.66 50.8 2.48 Favored Glycine 0 CA--C 1.461 -3.299 0 O-C-N 126.214 1.773 . . . . 0.0 111.142 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -95.75 -36.05 11.31 Favored 'General case' 0 C--N 1.251 -3.69 0 CA-C-N 113.324 -1.438 . . . . 0.0 110.361 -172.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.1 pt-20 -158.82 173.65 4.79 Favored Pre-proline 0 N--CA 1.411 -2.38 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.756 -172.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 52.0 Cg_exo -66.42 -13.89 41.81 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 123.012 2.475 . . . . 0.0 109.538 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.77 -14.55 24.6 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.234 -1.803 . . . . 0.0 111.826 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -139.25 120.28 14.56 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 111.301 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 14.5 m-85 -79.97 166.04 22.0 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 127.412 2.285 . . . . 0.0 111.569 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.892 HD21 HG21 ' A' ' 80' ' ' VAL . 4.6 mp -88.41 146.04 25.46 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.638 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 tt0 -142.38 154.71 44.86 Favored 'General case' 0 C--O 1.181 -2.539 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 29' ' ' PHE . 18.9 mm -93.22 127.01 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 118.914 0.779 . . . . 0.0 109.065 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -105.49 -21.21 13.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.1 m -157.24 128.43 6.79 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.76 123.07 27.36 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 123.714 0.806 . . . . 0.0 108.83 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.3 t -94.96 111.82 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.9 145.43 52.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.902 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.5 t70 86.01 3.05 0.56 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 125.824 1.953 . . . . 0.0 109.098 -171.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.43 159.97 34.09 Favored Glycine 0 C--O 1.204 -1.773 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.072 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 34.2 Cg_endo -72.61 -25.85 17.11 Favored 'Trans proline' 0 N--CA 1.435 -1.929 0 CA-C-N 121.148 2.474 . . . . 0.0 110.515 -171.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.28 -46.04 91.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.737 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.91 85.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.501 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.1 mt -72.0 -40.09 68.77 Favored 'General case' 0 N--CA 1.405 -2.699 0 CA-C-N 113.384 -1.734 . . . . 0.0 114.832 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -75.05 -24.7 58.3 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.24 15.38 65.45 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 113.296 -1.775 . . . . 0.0 115.486 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.05 22.37 7.96 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.8 1.286 . . . . 0.0 109.805 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.8 ttt -140.17 128.69 22.83 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.38 149.32 30.67 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -167.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.2 m -44.75 117.52 1.33 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.643 1.177 . . . . 0.0 110.819 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.11 -7.56 8.66 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.532 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.63 150.33 39.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -108.36 129.7 62.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.5 mm -84.93 115.93 27.61 Favored 'Isoleucine or valine' 0 C--O 1.302 3.83 0 CA-C-O 121.701 0.762 . . . . 0.0 109.26 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 73' ' ' LEU . 95.3 t -96.24 -58.21 3.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.81 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.727 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -155.59 166.74 32.61 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.899 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 95' ' ' LEU . 8.1 p -152.9 115.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 51.33 52.41 14.88 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.945 1.298 . . . . 0.0 111.78 173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 69.33 -6.76 0.91 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.889 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.4 m -81.06 126.48 31.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.2 t -82.45 73.82 9.46 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.955 0.883 . . . . 0.0 110.595 -172.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 80.0 t -79.55 -4.11 6.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 122.66 1.219 . . . . 0.0 109.202 177.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 6' ' ' ARG . 13.6 tp -66.93 112.03 4.1 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 70.92 37.01 65.12 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.418 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -82.61 147.17 28.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 87.7 m -76.24 143.28 41.09 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 117.599 -1.191 . . . . 0.0 109.171 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' HA ' HG12 ' A' ' 80' ' ' VAL . 83.2 t60 -46.77 -47.66 20.76 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.336 0.971 . . . . 0.0 113.164 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 82' ' ' LYS . . . -63.53 -32.25 73.65 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.474 0.654 . . . . 0.0 110.821 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.511 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 32.0 mm-40 -77.82 -49.91 13.36 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.15 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -61.35 -44.75 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.148 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 11.6 p -60.85 -45.13 98.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.416 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -60.18 -38.75 84.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.3 mt -73.12 -48.28 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-O 122.502 1.144 . . . . 0.0 108.909 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.108 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.8 pt20 -86.71 -24.46 25.18 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.769 -0.582 . . . . 0.0 111.798 174.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -75.46 -26.22 58.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.584 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -59.61 152.23 57.68 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.4 Cg_endo -102.25 159.51 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.063 3.842 . . . . 0.0 111.942 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' SER . 45.4 mt -67.78 131.01 33.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.97 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.45 10.88 40.19 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 119.773 -0.46 . . . . 0.0 113.981 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -99.35 -176.43 3.29 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.578 1.189 . . . . 0.0 111.902 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.555 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.2 t -140.99 145.39 35.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.704 -0.623 . . . . 0.0 111.75 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.43 157.64 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 C-N-CA 123.964 0.905 . . . . 0.0 111.486 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.506 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 4.2 m-20 -104.56 107.11 17.88 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.481 HD22 HD22 ' A' ' 20' ' ' LEU . 15.4 tp -99.53 121.51 41.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-O 121.123 0.487 . . . . 0.0 111.608 -172.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.02 114.47 26.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.52 148.12 40.57 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.113 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.0 t -117.64 120.1 36.99 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.642 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.3 tpp85 -95.18 139.87 30.89 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.84 -28.35 1.03 Allowed Glycine 0 C--N 1.3 -1.444 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.306 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 . . . . . 0 C--N 1.306 -1.292 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.457 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 41.4 tt0 . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 120.826 0.346 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 6.7 m -123.39 133.66 54.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.507 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.7 OUTLIER -100.02 116.58 32.39 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.2 m . . . . . 0 N--CA 1.419 -1.975 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.664 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 13.5 t . . . . . 0 N--CA 1.426 -1.644 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 5' ' ' THR . 5.7 ptm180 60.13 12.5 3.29 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 127.264 2.225 . . . . 0.0 113.413 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.792 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 12.0 m-80 -97.39 115.25 65.71 Favored Pre-proline 0 C--N 1.251 -3.686 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.289 13.2 Cg_exo -61.06 -30.17 88.93 Favored 'Trans proline' 0 CA--C 1.483 -2.069 0 N-CA-C 107.906 -1.613 . . . . 0.0 107.906 170.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 t -68.66 -25.6 64.89 Favored 'General case' 1 N--CA 1.363 -4.815 0 CA-C-N 110.993 -2.822 . . . . 0.0 111.003 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.3 pt-20 -80.3 -33.79 37.32 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.72 135.29 57.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.655 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 100' ' ' GLY . 45.8 pttt -78.66 166.01 23.0 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.337 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 98.82 -122.98 7.74 Favored Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.514 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.0 147.07 46.04 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 124.712 1.205 . . . . 0.0 110.014 -177.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.5 123.4 49.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -135.6 152.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 43.5 p-80 -126.11 100.49 6.35 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 122.384 1.088 . . . . 0.0 110.265 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 t -102.77 130.66 49.81 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.539 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -83.16 130.32 35.09 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.9 mp -117.26 123.46 46.64 Favored 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -84.72 125.19 32.31 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.682 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -56.92 103.77 0.13 Allowed 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 172.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.03 -78.27 0.17 Allowed 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 125.346 1.654 . . . . 0.0 109.971 -172.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -116.23 78.64 1.21 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.694 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.625 ' N ' HG12 ' A' ' 89' ' ' ILE . 14.0 ttt180 63.78 24.74 13.9 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.22 -140.76 5.6 Favored Glycine 0 N--CA 1.409 -3.106 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.456 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.634 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 89.1 m-85 -125.67 -85.85 0.62 Allowed 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 114.481 -0.86 . . . . 0.0 112.083 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.39 52.89 0.19 Allowed Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.109 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 43' ' ' ILE . 29.8 p90 -160.9 150.5 17.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HA ' ' B' ' 160' ' ' GLN . 36.0 p -112.03 136.42 51.42 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.0 0.905 . . . . 0.0 109.242 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 4.5 p -125.27 148.4 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.608 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.702 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.451 HG23 ' HB3' ' A' ' 42' ' ' GLN . 10.8 m -114.98 164.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 124.492 1.117 . . . . 0.0 113.283 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.96 -124.62 6.55 Favored Glycine 0 C--O 1.284 3.249 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.132 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.34 53.67 5.74 Favored Glycine 1 CA--C 1.443 -4.425 0 O-C-N 127.235 2.374 . . . . 0.0 112.173 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 51.3 t0 -86.14 -47.89 9.08 Favored 'General case' 1 C--N 1.244 -4.012 0 CA-C-N 113.276 -1.462 . . . . 0.0 109.241 -176.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.8 pt-20 -158.93 174.51 3.98 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.032 -164.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 24.8 Cg_exo -75.46 59.61 5.53 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 124.662 3.575 . . . . 0.0 108.021 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 22.9 t70 -178.58 -23.7 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.348 -2.205 . . . . 0.0 109.324 -169.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 9.7 tp10 -131.23 120.54 23.4 Favored 'General case' 0 C--O 1.257 1.488 0 C-N-CA 122.997 0.519 . . . . 0.0 110.022 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.51 166.18 14.36 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 127.258 2.223 . . . . 0.0 110.261 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.639 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -96.85 145.25 26.03 Favored 'General case' 0 C--O 1.175 -2.844 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.648 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 14.9 tt0 -135.03 147.7 49.72 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 118.866 0.757 . . . . 0.0 109.928 -177.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 29' ' ' PHE . 34.7 mm -79.5 114.9 20.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.531 -0.731 . . . . 0.0 110.188 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -98.46 -22.05 16.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 37.6 m -155.72 127.14 7.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.7 tp -86.01 112.11 20.91 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.47 104.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.62 145.85 27.16 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.098 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 86.16 3.87 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.438 1.711 . . . . 0.0 109.74 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.666 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.44 163.08 36.95 Favored Glycine 0 C--O 1.212 -1.264 0 CA-C-O 117.773 -1.571 . . . . 0.0 110.21 171.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 22.1 Cg_endo -72.48 -25.48 17.92 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 CA-C-N 121.732 2.766 . . . . 0.0 110.458 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -62.39 -43.69 98.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.428 175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.49 75.37 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.449 1.119 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 69.7 mt -72.18 -40.88 67.61 Favored 'General case' 0 N--CA 1.396 -3.169 0 CA-C-N 112.401 -2.181 . . . . 0.0 114.704 -171.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.24 -24.99 46.69 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.42 27.03 71.16 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-N 113.543 -1.662 . . . . 0.0 115.416 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -110.65 -0.71 17.08 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.789 0.804 . . . . 0.0 110.437 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.421 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 42.8 ttm -129.28 126.97 40.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -142.69 144.93 32.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 m -45.14 114.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.234 1.414 . . . . 0.0 111.284 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.9 -36.95 1.96 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.61 145.21 50.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.8 0.81 . . . . 0.0 111.981 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.258 0.2 OUTLIER -110.33 126.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.27 -175.571 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.43 116.47 15.79 Favored 'Isoleucine or valine' 0 C--O 1.294 3.441 0 C-N-CA 125.673 1.589 . . . . 0.0 110.649 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 37.5 t -103.22 -58.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.99 -177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 20.4 m -136.87 157.87 45.76 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.055 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 5.9 p -137.61 104.1 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 0.0 112.519 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.06 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 125.766 1.627 . . . . 0.0 112.079 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -131.98 -12.09 3.3 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.0 0.429 . . . . 0.0 110.838 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -89.68 134.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.759 0.79 . . . . 0.0 110.382 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 45.1 t -80.88 80.03 7.43 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.604 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 67' ' ' VAL . 7.5 p -77.23 -5.81 8.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.245 1.022 . . . . 0.0 108.504 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . 44.6 tp -56.35 111.11 0.89 Allowed 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.789 -1.551 . . . . 0.0 107.174 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 58.88 37.96 91.68 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.886 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.29 145.13 37.63 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 39.8 m -73.53 141.82 46.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.495 ' HA ' HG12 ' A' ' 80' ' ' VAL . 56.7 t-80 -51.28 -40.47 59.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.72 -176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.18 85.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.092 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 80.7 mm-40 -75.3 -48.6 22.44 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.769 -177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.06 -43.14 97.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.651 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 77' ' ' HIS . 13.8 p -63.18 -37.85 80.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.436 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.83 90.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.22 -50.8 33.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-O 122.161 0.982 . . . . 0.0 109.383 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 9.0 m-85 -64.68 -35.13 80.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.799 -175.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -85.49 -21.42 28.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.67 0.272 . . . . 0.0 110.933 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 m -90.82 -2.52 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.967 -0.458 . . . . 0.0 111.409 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -47.65 142.43 6.59 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.84 156.66 0.68 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 124.035 3.157 . . . . 0.0 112.575 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' N ' ' A' ' 25' ' ' ARG . 64.3 mt -69.01 142.39 16.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 124.414 1.086 . . . . 0.0 110.628 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.9 74.41 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.138 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.603 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -101.05 -172.94 2.26 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -149.9 138.37 20.67 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -167.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.682 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.6 m -149.63 149.41 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 C-N-CA 122.846 0.458 . . . . 0.0 110.734 172.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.79 109.44 21.39 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.51 1.131 . . . . 0.0 108.327 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.7 mm? -90.44 113.42 25.35 Favored 'General case' 0 C--N 1.275 -2.667 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.54 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 40.3 mt-10 -88.39 106.36 18.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 174.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' ILE . 1.6 pt? -132.61 158.61 41.8 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.893 0.378 . . . . 0.0 110.442 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.6 t -116.19 125.16 51.89 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 16.7 tpp85 -98.22 142.62 29.67 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . 149.33 -9.4 0.93 Allowed Glycine 0 C--N 1.303 -1.3 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.105 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 . . . . . 0 C--N 1.31 -1.152 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.151 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 11.5 pt-20 . . . . . 0 C--O 1.238 0.476 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 31' ' ' VAL . 29.4 m -113.3 131.52 55.9 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' THR . 33.4 tt0 -102.84 120.9 41.41 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 22.7 m . . . . . 0 N--CA 1.432 -1.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.383 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.9 t . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.042 0.448 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.649 ' O ' HD21 ' A' ' 73' ' ' LEU . 13.3 ptm180 49.69 27.81 2.37 Favored 'General case' 0 N--CA 1.515 2.82 0 C-N-CA 126.499 1.919 . . . . 0.0 113.026 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.746 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.8 m-80 -96.33 115.28 65.53 Favored Pre-proline 1 C--N 1.22 -5.044 0 CA-C-N 112.894 -1.957 . . . . 0.0 112.283 174.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.315 26.7 Cg_exo -62.48 -34.66 75.19 Favored 'Trans proline' 0 CA--C 1.475 -2.465 0 CA-C-O 124.201 1.667 . . . . 0.0 108.301 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -65.16 -28.26 69.29 Favored 'General case' 1 N--CA 1.344 -5.738 0 CA-C-N 109.855 -3.339 . . . . 0.0 111.69 -175.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.3 pt-20 -80.59 -33.11 36.25 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.0 128.75 37.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.696 1.236 . . . . 0.0 110.361 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 10.7 ptmm? -83.08 -172.24 4.02 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.33 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 77.32 -135.17 15.95 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.963 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -114.45 139.2 49.72 Favored 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 124.072 0.949 . . . . 0.0 109.309 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.34 114.86 28.89 Favored 'General case' 0 C--N 1.26 -3.283 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -131.65 152.3 36.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.188 -175.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . 0.522 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 18.7 t60 -126.73 102.81 7.22 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -130.96 146.83 52.49 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.711 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -81.08 133.7 35.52 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 122.713 0.405 . . . . 0.0 111.695 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.54 125.7 48.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -85.36 119.65 25.96 Favored 'General case' 0 N--CA 1.395 -3.176 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.135 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -52.32 101.29 0.04 OUTLIER 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 89' ' ' ILE . 11.1 t -83.08 -94.71 0.06 Allowed 'General case' 0 N--CA 1.411 -2.391 0 O-C-N 124.816 1.323 . . . . 0.0 109.628 -176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -96.03 73.93 3.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.578 ' N ' HG12 ' A' ' 89' ' ' ILE . 32.0 ttt180 59.98 40.75 18.49 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.425 1.49 . . . . 0.0 111.909 176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 163.68 -138.05 5.1 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.735 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 83.8 m-85 -121.91 -84.09 0.66 Allowed 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.786 -0.207 . . . . 0.0 111.321 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.56 53.43 0.13 Allowed Glycine 0 C--N 1.291 -1.949 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.998 -171.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 43' ' ' ILE . 30.7 p90 -161.23 143.24 12.03 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' HA ' ' B' ' 160' ' ' GLN . 20.0 p -106.06 135.69 47.07 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.793 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 0.9 OUTLIER -114.08 163.22 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.559 -168.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 44' ' ' LYS . 2.7 m -121.46 133.31 68.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.173 0 C-N-CA 124.293 1.037 . . . . 0.0 109.689 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 114.18 -130.96 9.6 Favored Glycine 0 C--O 1.279 2.946 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.123 176.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.568 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.77 62.26 1.01 Allowed Glycine 0 CA--C 1.453 -3.817 0 O-C-N 126.462 1.919 . . . . 0.0 110.837 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' HB3' ' HG2' ' A' ' 36' ' ' GLU . 8.5 t70 -110.8 -36.1 5.79 Favored 'General case' 0 C--N 1.249 -3.795 0 CA-C-N 113.735 -1.232 . . . . 0.0 109.719 -170.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.5 pt-20 -158.3 174.71 3.78 Favored Pre-proline 0 CA--C 1.481 -1.686 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.227 -169.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 73.1 Cg_exo -60.15 -30.43 91.32 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 122.617 2.211 . . . . 0.0 109.516 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.85 -39.37 79.96 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.889 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.67 119.78 37.88 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -88.97 165.95 14.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.876 2.07 . . . . 0.0 108.538 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -89.27 144.17 26.29 Favored 'General case' 0 C--O 1.18 -2.597 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.689 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.562 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -133.85 169.4 17.14 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 29' ' ' PHE . 36.8 mm -113.54 126.1 70.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 -173.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.609 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -102.28 -20.31 14.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.6 m -155.75 126.92 7.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.186 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -78.6 108.99 12.4 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 89.3 t -84.86 126.42 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.5 144.55 55.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.331 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 82.68 2.83 1.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 125.205 1.566 . . . . 0.0 110.071 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.682 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.11 160.3 38.39 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.34 -25.3 18.59 Favored 'Trans proline' 0 C--O 1.18 -2.398 0 CA-C-N 121.092 2.446 . . . . 0.0 109.62 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -63.69 -44.18 94.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.523 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.94 68.9 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 122.655 1.217 . . . . 0.0 109.8 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 52.1 mt -72.54 -50.07 28.2 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.356 -2.202 . . . . 0.0 115.9 -172.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.51 -21.43 41.91 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.4 -169.59 54.87 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.395 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt 58.5 30.29 19.54 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 112.784 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' MET . . . . . 0.672 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.5 tmt? -159.83 131.97 6.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 171.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -147.85 160.27 42.95 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.477 0.656 . . . . 0.0 112.26 -169.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -54.69 119.91 6.0 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.386 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.54 4.1 15.81 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.867 -1.158 . . . . 0.0 112.752 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.554 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 p30 -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.214 171.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 6.5 p -100.42 117.87 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.398 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 50.4 mm -74.59 111.41 10.38 Favored 'Isoleucine or valine' 0 C--O 1.301 3.794 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.277 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 73' ' ' LEU . 58.6 t -89.18 -58.09 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.476 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -160.55 173.64 15.23 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.031 -0.418 . . . . 0.0 110.852 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.444 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.1 p -140.5 121.33 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.378 30.0 p-10 33.03 -89.84 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -92.5 -34.09 14.22 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -93.09 130.87 38.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.227 1.013 . . . . 0.0 112.719 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 t -84.7 90.16 7.66 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 41' ' ' LEU . 40.8 t -78.89 -0.34 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 122.857 1.313 . . . . 0.0 109.039 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 6' ' ' ARG . 20.8 tp -68.1 111.47 4.49 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.363 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.5 43.04 93.28 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.792 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -92.42 137.8 32.05 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.9 m -69.55 143.87 53.26 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -47.49 -49.18 26.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.147 0.885 . . . . 0.0 112.548 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.83 71.95 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.684 0.754 . . . . 0.0 110.97 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 14.1 mm-40 -80.1 -50.0 10.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.854 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.711 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -64.71 -42.27 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.427 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.7 p -63.07 -35.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -43.77 98.28 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.9 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.59 -50.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 122.196 0.998 . . . . 0.0 109.357 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -67.25 -28.69 68.25 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.41 -1.723 . . . . 0.0 112.759 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 78.7 mm-40 -88.49 -17.26 30.72 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 p -94.86 -13.6 25.34 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.665 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -52.02 154.8 3.61 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 177.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -95.45 148.14 1.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.093 3.195 . . . . 0.0 112.325 -176.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.578 HG12 ' N ' ' A' ' 25' ' ' ARG . 50.6 mt -65.26 124.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.897 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.65 11.28 44.59 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-O 119.746 -0.475 . . . . 0.0 113.354 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -93.06 -178.09 4.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.033 0.916 . . . . 0.0 111.626 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 t -139.29 150.51 45.51 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 110.496 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.566 HG22 ' HE2' ' A' ' 22' ' ' LYS . 2.5 m -151.39 156.66 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.149 0.98 . . . . 0.0 110.854 174.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.522 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 23.6 m-20 -105.21 107.33 18.26 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 20' ' ' LEU . 13.5 tp -94.33 125.92 39.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.26 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 9.8 pt-20 -108.74 113.8 27.06 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.887 0.851 . . . . 0.0 108.789 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.554 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.7 pt? -142.13 155.5 45.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.324 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 63' ' ' VAL . 58.8 m -113.58 107.11 15.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.573 0.702 . . . . 0.0 109.33 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.672 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 4.9 ttp-105 -85.83 133.67 33.96 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.152 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.31 40.23 0.97 Allowed Glycine 0 C--N 1.283 -2.369 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.812 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 . . . . . 0 N--CA 1.409 -2.488 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.183 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 32.8 mt-10 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.429 0.633 . . . . 0.0 112.239 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 31' ' ' VAL . 7.8 m -88.65 110.2 20.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' THR . 21.1 mt-30 -84.26 120.93 26.81 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.9 m . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.742 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . 0.425 ' O ' ' HE2' ' A' ' 1' ' ' LYS . . . 54.86 53.45 10.43 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.791 1.236 . . . . 0.0 111.882 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -84.94 86.35 7.38 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.627 ' HA2' ' O ' ' A' ' 122' ' ' ASP . . . -118.46 29.22 6.47 Favored Glycine 0 N--CA 1.436 -1.323 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.79 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.425 ' HE2' ' O ' ' A' ' -2' ' ' ALA . 0.0 OUTLIER -117.34 155.13 50.3 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 -175.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -67.39 119.86 6.89 Favored 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 121.603 1.535 . . . . 0.0 112.008 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -69.64 144.64 52.88 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.404 -179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.528 ' CE2' ' HA ' ' A' ' 38' ' ' ASP . 10.6 t80 -145.59 140.47 27.42 Favored 'General case' 0 C--N 1.269 -2.931 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.507 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.465 ' O ' ' HB3' ' A' ' 6' ' ' ARG 0.386 15.0 t -156.72 -52.78 0.08 Allowed 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.733 -1.576 . . . . 0.0 111.147 161.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 5' ' ' THR . 18.2 ptt-85 155.18 -21.96 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.904 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.745 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 33.6 t-20 -55.86 111.88 3.67 Favored Pre-proline 0 C--N 1.282 -2.331 0 CA-C-N 112.779 -2.01 . . . . 0.0 112.913 -175.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 11' ' ' LEU . 3.2 Cg_exo -63.96 -27.16 66.38 Favored 'Trans proline' 0 CA--C 1.476 -2.407 0 C-N-CA 121.234 1.289 . . . . 0.0 109.997 177.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -85.4 -14.92 44.78 Favored 'General case' 1 N--CA 1.358 -5.063 0 CA-C-N 113.712 -1.585 . . . . 0.0 110.652 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.745 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.4 pt-20 -72.69 -36.2 67.83 Favored 'General case' 0 C--N 1.376 1.752 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 174.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.0 mt -59.99 136.0 57.88 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.16 176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -98.34 177.49 5.35 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.648 -172.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.6 -99.71 2.48 Favored Glycine 0 N--CA 1.426 -1.995 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.765 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -145.79 128.22 15.94 Favored 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 121.408 0.623 . . . . 0.0 109.352 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -106.73 115.21 29.8 Favored 'General case' 0 C--N 1.272 -2.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.405 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -126.12 152.41 33.4 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.41 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.058 -175.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.691 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 14.7 t-160 -127.33 99.89 5.83 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 177.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 HG22 HD21 ' A' ' 97' ' ' LEU . 15.3 t -124.2 141.3 52.17 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.047 -172.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.536 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -86.71 131.14 34.22 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.685 -178.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.7 mp -115.02 123.35 48.85 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 56.2 ttt180 -86.22 115.44 23.78 Favored 'General case' 0 N--CA 1.392 -3.374 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -45.17 102.35 0.03 OUTLIER 'General case' 0 CA--C 1.485 -1.53 0 C-N-CA 123.95 0.9 . . . . 0.0 109.234 169.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 23.3 t -123.14 135.93 54.56 Favored 'General case' 0 N--CA 1.423 -1.786 0 O-C-N 125.274 1.609 . . . . 0.0 108.939 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 33.0 m 55.12 28.62 11.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.068 0.947 . . . . 0.0 113.143 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.744 ' N ' HG12 ' A' ' 89' ' ' ILE . 0.7 OUTLIER 77.5 102.91 0.07 Allowed 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 125.632 1.573 . . . . 0.0 108.368 176.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.55 -137.32 13.53 Favored Glycine 0 N--CA 1.419 -2.441 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.289 -177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.649 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.6 m-85 -124.29 -82.76 0.64 Allowed 'General case' 0 N--CA 1.411 -2.41 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.54 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 119.64 56.02 0.25 Allowed Glycine 0 N--CA 1.421 -2.3 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -168.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' HA ' ' H ' ' A' ' 47' ' ' VAL . 28.2 p90 -160.9 143.65 12.79 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 173.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.496 HG22 ' CB ' ' B' ' 160' ' ' GLN . 40.0 p -107.99 134.94 50.19 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-O 122.134 0.969 . . . . 0.0 109.199 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.584 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 2.2 p -135.55 136.33 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.957 0 CA-C-N 113.854 -1.521 . . . . 0.0 111.044 -169.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 15.2 m -115.39 131.82 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.413 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.261 -177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' ' CB ' ' B' ' 156' ' ' ARG . . . 137.1 -145.35 17.13 Favored Glycine 0 CA--C 1.457 -3.57 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.497 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 48.39 70.11 0.82 Allowed Glycine 0 CA--C 1.464 -3.137 0 O-C-N 126.599 1.999 . . . . 0.0 112.031 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -116.93 -29.25 6.06 Favored 'General case' 0 C--N 1.259 -3.332 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.296 -177.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 5.6 pt-20 -159.21 174.23 4.23 Favored Pre-proline 0 CA--C 1.467 -2.242 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.579 -172.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 77.1 Cg_exo -61.72 -25.83 79.23 Favored 'Trans proline' 0 C--N 1.319 -1.006 0 C-N-CA 122.435 2.09 . . . . 0.0 109.388 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 19.5 t70 -84.01 -21.39 31.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 112.347 -2.206 . . . . 0.0 112.306 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -122.75 119.41 30.58 Favored 'General case' 0 C--O 1.264 1.837 0 O-C-N 121.492 -0.755 . . . . 0.0 110.471 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -93.0 165.67 12.74 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 127.249 2.22 . . . . 0.0 108.495 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.3 mp -93.08 146.47 23.62 Favored 'General case' 0 C--O 1.183 -2.434 0 C-N-CA 119.142 -1.023 . . . . 0.0 109.583 -178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' HG3' HG12 ' A' ' 63' ' ' VAL . 15.0 tt0 -137.18 144.49 42.93 Favored 'General case' 0 C--O 1.191 -2.006 0 CA-C-N 118.56 0.618 . . . . 0.0 110.318 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.445 HD12 ' CD1' ' A' ' 29' ' ' PHE . 23.4 mm -79.94 119.63 29.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.198 0 O-C-N 121.829 -0.544 . . . . 0.0 109.848 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB3' HG22 ' A' ' 32' ' ' VAL . 1.2 pptp? -103.28 -19.79 14.34 Favored 'General case' 0 CA--C 1.507 -0.688 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.951 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.418 ' OG ' ' HD2' ' A' ' 44' ' ' LYS . 45.6 m -161.14 128.16 4.08 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 173.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.613 HD23 ' HA ' ' A' ' 59' ' ' GLU . 1.5 pp -87.63 128.35 35.28 Favored 'General case' 0 N--CA 1.395 -3.183 0 C-N-CA 118.792 -1.163 . . . . 0.0 109.725 172.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.54 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.6 t -80.2 127.51 39.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.604 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -176.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.476 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 86.8 mt -64.5 133.99 53.54 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.476 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.6 t70 84.73 11.08 0.33 Allowed 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.385 1.678 . . . . 0.0 109.608 -171.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.93 155.57 23.17 Favored Glycine 0 CA--C 1.487 -1.702 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.572 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.5 Cg_endo -72.02 -25.32 19.64 Favored 'Trans proline' 0 N--CA 1.425 -2.556 0 CA-C-N 121.266 2.533 . . . . 0.0 110.486 -170.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.06 -46.85 85.53 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.91 -46.62 88.56 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 122.861 1.315 . . . . 0.0 109.879 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 87.4 mt -72.42 -45.73 58.36 Favored 'General case' 0 N--CA 1.401 -2.878 0 CA-C-N 112.785 -2.007 . . . . 0.0 114.459 -174.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -68.78 -24.69 64.45 Favored 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.74 3.2 9.43 Favored Glycine 0 C--O 1.227 -0.335 0 CA-C-N 114.186 -1.37 . . . . 0.0 115.893 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -110.44 19.42 18.8 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.996 1.379 . . . . 0.0 109.802 -176.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.4 ttt -146.67 133.21 19.77 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 105.296 -2.113 . . . . 0.0 105.296 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.613 ' HA ' HD23 ' A' ' 46' ' ' LEU . 44.4 mt-10 -140.43 162.11 36.11 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 123.354 0.662 . . . . 0.0 109.738 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 28.0 m -57.02 119.01 5.56 Favored 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 174.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.51 -18.5 5.73 Favored Glycine 0 C--N 1.302 -1.328 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.47 -173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.547 ' OD1' ' HB2' ' A' ' 99' ' ' ARG . 11.1 m-20 -67.79 136.63 54.47 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 174.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG12 ' HG3' ' A' ' 42' ' ' GLN . 1.8 m -101.38 130.35 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.137 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 174.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.515 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 43.3 mm -82.22 111.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.299 3.702 0 C-N-CA 123.343 0.657 . . . . 0.0 109.856 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 60.4 t -91.85 -57.92 3.96 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.326 0 O-C-N 126.346 2.279 . . . . 0.0 108.764 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -157.74 170.96 21.19 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 121.925 -0.484 . . . . 0.0 111.24 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -152.67 120.8 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-O 121.018 0.437 . . . . 0.0 112.145 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 50.18 58.63 5.27 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.907 1.283 . . . . 0.0 111.258 173.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.1 t70 74.26 -30.09 0.2 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.504 -1.68 . . . . 0.0 113.033 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 16.2 m -65.83 127.12 30.73 Favored 'General case' 0 C--O 1.255 1.37 0 CA-C-O 121.444 0.64 . . . . 0.0 111.14 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.9 t -79.05 78.24 5.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.233 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 87.2 t -83.89 5.44 2.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 CA-C-O 122.786 1.279 . . . . 0.0 109.49 178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.463 HD13 HG13 ' A' ' 65' ' ' VAL . 13.3 tp -66.62 110.13 3.08 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.92 45.0 95.73 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.205 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 1.7 t60 -79.72 147.99 31.7 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.414 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.5 m -74.87 143.57 43.78 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-O 117.73 -1.128 . . . . 0.0 108.821 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -48.07 -49.28 32.16 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-N 119.246 0.93 . . . . 0.0 112.33 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.7 71.25 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 124.063 0.852 . . . . 0.0 110.988 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 81.0 mm-40 -80.28 -48.57 12.83 Favored 'General case' 0 N--CA 1.424 -1.728 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.125 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.492 HG11 HD21 ' A' ' 41' ' ' LEU . 7.3 p -63.8 -43.14 97.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.06 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.7 p -64.53 -35.97 76.06 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.56 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.91 -42.99 85.89 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.261 177.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.0 mt -72.25 -50.65 34.66 Favored 'Isoleucine or valine' 0 C--O 1.248 1.024 0 CA-C-O 122.474 1.131 . . . . 0.0 109.528 -177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.66 -29.67 69.75 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 113.049 -1.887 . . . . 0.0 113.327 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.589 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 mp0 -86.71 -25.18 24.88 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 176.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 66.0 p -85.57 -22.36 28.1 Favored 'General case' 0 C--O 1.243 0.72 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -176.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.621 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -52.43 151.35 7.6 Favored Pre-proline 0 CA--C 1.541 0.599 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 42.4 Cg_endo -102.49 159.54 0.3 Allowed 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 125.242 3.961 . . . . 0.0 112.302 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.744 HG12 ' N ' ' A' ' 25' ' ' ARG . 26.9 mt -67.96 131.21 33.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.297 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 103.03 11.4 34.43 Favored Glycine 0 N--CA 1.432 -1.568 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.961 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -103.39 176.88 5.0 Favored 'General case' 0 C--O 1.202 -1.444 0 C-N-CA 118.814 -1.154 . . . . 0.0 111.496 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.492 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 30.1 t -134.57 148.32 50.44 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.082 -0.386 . . . . 0.0 110.675 -175.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.547 HG22 ' HE2' ' A' ' 22' ' ' LYS . 3.2 m -149.07 149.75 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.749 0 C-N-CA 124.104 0.961 . . . . 0.0 111.169 172.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.691 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 10.9 m-20 -100.23 111.75 24.04 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 113.823 -1.535 . . . . 0.0 107.526 178.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.553 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.7 mm? -91.32 125.09 35.97 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 120.937 0.399 . . . . 0.0 110.315 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 35.2 mt-10 -104.27 105.45 15.59 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 174.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.423 HD21 HG22 ' A' ' 18' ' ' THR . 0.4 OUTLIER -141.43 157.29 45.36 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.254 -172.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 7.9 t -131.7 120.09 22.26 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.344 0.592 . . . . 0.0 109.739 -176.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 19.4 ttp85 -114.98 158.62 21.8 Favored 'General case' 0 C--N 1.286 -2.173 0 C-N-CA 124.086 0.955 . . . . 0.0 109.858 -174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.22 -15.34 2.54 Favored Glycine 0 CA--C 1.49 -1.479 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -91.33 112.27 53.18 Favored Pre-proline 0 N--CA 1.432 -1.34 0 CA-C-N 113.989 -1.105 . . . . 0.0 108.222 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.407 ' HG3' HD13 ' A' ' 120' ' ' ILE . 45.7 Cg_endo -75.75 142.78 26.05 Favored 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 121.391 1.394 . . . . 0.0 110.961 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.71 109.61 6.46 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.412 ' HG3' ' HA ' ' A' ' 118' ' ' VAL . 11.2 Cg_endo -94.92 -79.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.626 2.217 . . . . 0.0 113.829 -176.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -86.1 150.52 24.37 Favored 'General case' 0 C--O 1.246 0.895 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.5 m-20 -78.65 126.04 83.36 Favored Pre-proline 0 CA--C 1.48 -1.743 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -173.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.1 Cg_endo -97.7 12.04 0.94 Allowed 'Trans proline' 0 N--CA 1.432 -2.114 0 C-N-CA 123.096 2.53 . . . . 0.0 107.003 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 24.4 t70 -91.67 -17.79 24.96 Favored 'General case' 0 N--CA 1.413 -2.303 0 CA-C-N 112.935 -1.939 . . . . 0.0 108.428 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.03 108.4 51.78 Favored Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.054 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 108' ' ' ASP . 45.9 Cg_exo -70.89 -159.27 0.06 OUTLIER 'Trans proline' 0 N--CA 1.481 0.737 0 C-N-CA 123.587 2.858 . . . . 0.0 114.197 176.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 76.43 26.87 0.86 Allowed 'General case' 0 CA--C 1.493 -1.226 0 C-N-CA 126.347 1.859 . . . . 0.0 112.773 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 97.8 m -166.96 154.85 9.5 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 17.9 m -75.85 113.87 13.82 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 169.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 28.0 mt -79.58 104.38 10.14 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-O 121.461 0.648 . . . . 0.0 112.034 -165.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 98.5 t -124.8 99.0 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.537 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 170.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.0 t -75.85 142.23 42.23 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 53.0 m -102.52 114.56 28.86 Favored 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 119' ' ' ALA . 9.1 p -92.97 140.7 15.85 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.755 -171.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 118' ' ' VAL . . . -90.97 166.15 13.18 Favored 'General case' 0 N--CA 1.417 -2.108 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 119' ' ' ALA . 2.3 mp 74.04 22.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-O 125.149 2.404 . . . . 0.0 108.028 -175.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.4 tp -92.96 148.62 21.85 Favored 'General case' 0 N--CA 1.4 -2.943 0 CA-C-N 112.691 -2.05 . . . . 0.0 106.942 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.627 ' O ' ' HA2' ' A' ' 0' ' ' GLY . 6.6 m-20 -74.49 121.31 21.3 Favored 'General case' 0 CA--C 1.484 -1.584 0 CA-C-O 121.078 0.466 . . . . 0.0 109.881 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' A' ' 123' ' ' LYS . 10.3 mmpt? -105.3 57.72 0.68 Allowed 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 107.44 -1.318 . . . . 0.0 107.44 178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 122' ' ' ASP . 25.6 mt-10 -82.52 147.65 56.57 Favored Pre-proline 0 C--N 1.314 -0.96 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -172.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 C-N-CA 122.747 2.298 . . . . 0.0 111.836 179.056 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.498 ' HA ' ' NE ' ' B' ' 151' ' ' ARG . 0.9 OUTLIER . . . . . 0 C--O 1.235 0.324 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 1.5 p -88.34 148.21 24.38 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.1 t -119.87 -58.11 1.91 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.67 -174.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 -77.1 85.49 3.59 Favored 'General case' 0 C--O 1.239 0.542 0 O-C-N 121.924 -0.485 . . . . 0.0 111.983 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 10.3 t -156.58 113.52 3.12 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.111 173.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.538 ' CB ' ' HA2' ' A' ' 33' ' ' GLY . 8.6 ptp180 -73.22 125.38 27.64 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.905 -1.043 . . . . 0.0 112.722 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 23.4 mmt180 -89.34 142.76 27.37 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.137 -171.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -77.58 110.75 12.65 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 124.245 0.965 . . . . 0.0 109.042 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 8.5 m -115.67 89.01 3.0 Favored 'General case' 0 C--N 1.274 -2.716 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.496 ' CB ' HG22 ' A' ' 30' ' ' THR . 5.1 pm0 -76.97 114.06 15.34 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.263 0.554 . . . . 0.0 110.631 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.571 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.2 m . . . . . 0 N--CA 1.427 -1.593 0 CA-C-O 118.918 -0.563 . . . . 0.0 110.63 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.217 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 54.93 64.35 1.83 Allowed 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 124.17 0.988 . . . . 0.0 110.677 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? -74.29 69.6 1.6 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.005 0.907 . . . . 0.0 112.845 -177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -127.93 37.79 2.23 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 108.268 -1.933 . . . . 0.0 108.268 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 151' ' ' ARG . 0.8 OUTLIER -87.24 148.79 45.64 Favored Pre-proline 0 N--CA 1.44 -0.927 0 CA-C-N 114.797 -0.701 . . . . 0.0 110.009 -178.255 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.76 125.41 17.15 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.635 2.223 . . . . 0.0 110.197 177.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -59.04 126.9 29.62 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 113.835 -1.529 . . . . 0.0 114.391 -170.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 38' ' ' ASP . 33.7 t80 -148.68 133.39 17.86 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.64 -1.618 . . . . 0.0 109.742 175.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.8 t -167.07 30.31 0.03 OUTLIER 'General case' 0 C--N 1.288 -2.078 0 O-C-N 124.141 0.901 . . . . 0.0 109.604 166.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.5 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 47.67 41.12 13.22 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-O 124.049 1.881 . . . . 0.0 112.107 179.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.787 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -111.42 114.81 52.64 Favored Pre-proline 0 C--N 1.248 -3.845 0 CA-C-N 112.82 -1.991 . . . . 0.0 112.98 176.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.305 14.6 Cg_exo -57.53 -36.06 98.72 Favored 'Trans proline' 0 CA--C 1.48 -2.203 0 CA-C-O 123.948 1.562 . . . . 0.0 109.076 172.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.9 m -73.94 -15.87 61.11 Favored 'General case' 1 N--CA 1.344 -5.737 0 CA-C-N 110.626 -2.988 . . . . 0.0 112.403 -175.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.787 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.1 pt-20 -80.85 -30.42 35.66 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 87.6 mt -66.76 137.22 56.48 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 114.011 -1.449 . . . . 0.0 107.473 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.5 ptmt -82.86 179.86 7.65 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.453 -174.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.55 -129.73 9.47 Favored Glycine 0 N--CA 1.422 -2.241 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.619 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.0 144.98 50.49 Favored 'General case' 0 C--N 1.28 -2.418 0 C-N-CA 122.757 0.423 . . . . 0.0 110.362 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -113.03 112.26 23.57 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -175.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.08 152.54 35.22 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.591 -0.732 . . . . 0.0 111.229 -175.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.82 108.13 14.01 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.4 t -131.96 147.17 52.44 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.682 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -92.8 140.82 29.12 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 122.952 0.501 . . . . 0.0 111.368 -175.092 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.627 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -122.14 127.4 50.04 Favored 'General case' 0 C--O 1.258 1.512 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 174.022 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -85.88 113.95 22.42 Favored 'General case' 0 N--CA 1.407 -2.611 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -177.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.81 ' HE3' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -42.35 106.07 0.06 Allowed 'General case' 0 CA--C 1.475 -1.921 0 C-N-CA 125.441 1.496 . . . . 0.0 112.267 172.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -120.34 129.91 54.19 Favored 'General case' 0 N--CA 1.414 -2.269 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.623 ' C ' HG12 ' A' ' 89' ' ' ILE . 10.9 m 61.16 -165.22 0.22 Allowed 'General case' 0 C--O 1.249 1.067 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -169.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -84.57 61.03 6.44 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.636 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.41 -121.0 1.05 Allowed Glycine 0 N--CA 1.406 -3.313 0 C-N-CA 120.393 -0.908 . . . . 0.0 113.284 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.542 ' CE2' HD12 ' A' ' 87' ' ' ILE . 76.4 m-85 -135.28 -101.02 0.22 Allowed 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 113.921 -1.14 . . . . 0.0 112.032 -168.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 142.26 57.6 0.03 OUTLIER Glycine 0 N--CA 1.434 -1.491 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.518 ' HA ' HG23 ' A' ' 47' ' ' VAL . 50.7 p90 -160.55 143.58 13.28 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.7 p -101.35 135.31 43.04 Favored 'General case' 0 C--N 1.284 -2.248 0 C-N-CA 117.792 -1.563 . . . . 0.0 109.932 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.537 HG12 ' O ' ' B' ' 159' ' ' THR . 11.3 p -126.0 143.42 39.57 Favored 'Isoleucine or valine' 1 N--CA 1.374 -4.249 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.516 -170.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 5.7 m -115.65 132.11 66.03 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.385 0 CA-C-N 114.568 -1.196 . . . . 0.0 109.837 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' B' ' 156' ' ' ARG . . . 127.22 -144.36 15.02 Favored Glycine 0 C--N 1.277 -2.727 0 C-N-CA 119.602 -1.285 . . . . 0.0 111.264 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.561 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.76 63.52 2.48 Favored Glycine 0 CA--C 1.457 -3.592 0 O-C-N 126.483 1.931 . . . . 0.0 111.946 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' O ' ' HA ' ' A' ' 76' ' ' THR . 8.5 t70 -105.18 -42.48 5.27 Favored 'General case' 0 C--N 1.25 -3.726 0 CA-C-N 114.322 -0.939 . . . . 0.0 108.514 -176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.444 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.1 pt-20 -160.03 172.61 5.75 Favored Pre-proline 0 CA--C 1.472 -2.026 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.324 -170.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.429 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 18.7 Cg_exo -76.01 64.53 6.91 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.152 3.235 . . . . 0.0 108.57 178.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.498 ' HA ' ' CD1' ' A' ' 4' ' ' PHE . 28.1 t0 -172.83 -47.27 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 111.789 -2.46 . . . . 0.0 107.373 -174.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' B' ' 154' ' ' ARG . 6.2 tp10 -105.11 119.32 38.75 Favored 'General case' 0 C--O 1.273 2.335 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.947 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -93.12 166.22 12.45 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 128.682 2.793 . . . . 0.0 108.905 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.561 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.1 mp -96.37 145.87 25.25 Favored 'General case' 0 C--O 1.172 -3.016 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.421 -176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 40.4 tt0 -139.78 144.34 37.34 Favored 'General case' 0 C--O 1.194 -1.827 0 CA-C-N 118.488 0.586 . . . . 0.0 110.093 -176.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 43' ' ' ILE . 1.2 mp -81.82 118.42 29.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 O-C-N 121.913 -0.492 . . . . 0.0 109.683 -176.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 17.6 pttp -98.75 -24.39 15.04 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.432 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.0 m -152.37 127.99 10.1 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.644 -0.66 . . . . 0.0 109.673 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.459 HD23 ' H ' ' A' ' 60' ' ' THR . 3.0 pp -86.97 116.51 25.08 Favored 'General case' 0 N--CA 1.407 -2.58 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 29' ' ' PHE . 67.0 t -87.91 134.73 27.19 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.273 -173.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 95.7 mt -60.24 142.54 54.39 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 176.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 32.7 t70 79.87 3.42 2.06 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.784 1.302 . . . . 0.0 110.558 -177.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -95.05 155.74 21.57 Favored Glycine 0 CA--C 1.489 -1.571 0 CA-C-O 118.362 -1.243 . . . . 0.0 110.45 175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.627 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 18.1 Cg_endo -71.89 -25.64 19.71 Favored 'Trans proline' 0 N--CA 1.432 -2.138 0 CA-C-N 120.931 2.365 . . . . 0.0 111.062 -169.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.2 -43.8 97.12 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 174.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.05 -48.9 74.45 Favored 'General case' 0 CA--C 1.489 -1.371 0 CA-C-O 122.542 1.163 . . . . 0.0 109.954 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 79.7 mt -71.58 -40.3 70.0 Favored 'General case' 0 N--CA 1.4 -2.956 0 CA-C-N 112.933 -1.94 . . . . 0.0 114.165 -172.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.77 -24.58 58.71 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.94 -3.98 11.49 Favored Glycine 0 CA--C 1.501 -0.798 0 CA-C-N 113.997 -1.456 . . . . 0.0 115.893 176.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -94.08 -42.58 8.93 Favored 'General case' 0 C--N 1.283 -2.285 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -174.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.431 ' HG3' HD11 ' A' ' 97' ' ' LEU . 22.5 ttt -82.12 133.84 35.29 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -139.76 168.74 19.12 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-O 122.094 0.949 . . . . 0.0 112.073 -169.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.459 ' H ' HD23 ' A' ' 46' ' ' LEU . 20.7 m -64.16 126.23 27.08 Favored 'General case' 0 N--CA 1.405 -2.689 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.383 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.09 -9.93 12.01 Favored Glycine 0 N--CA 1.426 -2.031 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.618 -174.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 18.9 m-20 -78.37 144.17 36.21 Favored 'General case' 0 CA--C 1.487 -1.466 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 173.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.553 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.327 0.1 OUTLIER -115.48 119.02 60.65 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.794 0 CA-C-O 121.544 0.688 . . . . 0.0 111.094 171.086 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.407 HG12 ' CD1' ' A' ' 43' ' ' ILE . 40.7 mm -68.67 113.76 4.77 Favored 'Isoleucine or valine' 0 C--O 1.299 3.66 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.215 -177.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.641 HG13 HD13 ' A' ' 73' ' ' LEU . 87.6 t -102.39 -54.96 6.24 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 CA-C-N 112.254 -2.248 . . . . 0.0 110.203 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.491 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.9 t -143.65 158.22 43.83 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.388 -0.82 . . . . 0.0 110.213 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.7 p -144.15 112.1 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.03 0.443 . . . . 0.0 111.641 -176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.435 HD22 ' HA ' ' A' ' 93' ' ' VAL . 21.9 t-20 71.24 -66.02 0.32 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.137 1.375 . . . . 0.0 111.875 175.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.66 -37.61 0.1 Allowed 'General case' 0 C--N 1.276 -2.589 0 C-N-CA 125.844 1.658 . . . . 0.0 109.035 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 m -67.71 127.69 33.7 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.781 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 20.3 t -85.69 90.3 7.98 Favored 'General case' 0 N--CA 1.404 -2.749 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.526 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 9.7 p -80.26 4.09 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 122.701 1.239 . . . . 0.0 109.928 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.641 HD13 HG13 ' A' ' 65' ' ' VAL . 19.6 tp -67.43 111.79 4.27 Favored 'General case' 0 N--CA 1.42 -1.966 0 CA-C-N 114.258 -1.337 . . . . 0.0 107.563 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.78 37.54 88.74 Favored Glycine 0 N--CA 1.43 -1.76 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.528 -176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.526 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -82.49 148.22 28.25 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 83.2 m -78.77 143.22 36.32 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 117.664 -1.16 . . . . 0.0 108.776 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.409 ' HA ' HG12 ' A' ' 80' ' ' VAL . 83.2 t60 -47.26 -50.55 21.15 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 119.288 0.949 . . . . 0.0 113.096 -177.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.12 74.01 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 123.845 0.716 . . . . 0.0 110.702 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 34.3 mm-40 -75.68 -50.41 15.49 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.461 HG21 HD21 ' A' ' 41' ' ' LEU . 7.0 p -62.02 -45.25 99.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.667 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.57 -36.0 76.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.416 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -59.08 -47.88 83.62 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.486 177.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.5 mt -72.46 -49.96 38.33 Favored 'Isoleucine or valine' 0 C--O 1.255 1.385 0 CA-C-O 122.18 0.991 . . . . 0.0 110.121 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.411 ' HB3' HG11 ' B' ' 161' ' ' VAL . 7.2 m-85 -61.41 -40.44 94.42 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-N 113.529 -1.668 . . . . 0.0 113.141 -177.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -85.63 -14.07 46.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.5 m -91.76 -2.21 57.05 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-O 121.119 0.485 . . . . 0.0 110.824 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.753 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.2 mt -53.35 140.51 44.97 Favored Pre-proline 0 CA--C 1.572 1.814 0 CA-C-N 115.575 -0.738 . . . . 0.0 112.051 171.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 83.6 Cg_endo -97.82 150.78 0.85 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.618 2.879 . . . . 0.0 113.042 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.623 HG12 ' C ' ' A' ' 24' ' ' SER . 23.6 mt -67.59 135.89 27.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.432 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.6 12.43 58.23 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.222 176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.737 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -108.5 -170.63 1.71 Allowed 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.982 -0.687 . . . . 0.0 111.147 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.409 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 16.0 t -150.04 142.17 24.05 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.81 HG22 ' HE3' ' A' ' 22' ' ' LYS . 27.4 m -145.51 155.35 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.818 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.775 173.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.05 113.81 27.51 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 124.929 1.393 . . . . 0.0 109.197 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.555 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.7 mm? -91.12 120.32 31.97 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.525 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 20.4 mt-10 -98.71 110.21 22.84 Favored 'General case' 0 C--N 1.278 -2.524 0 N-CA-C 103.774 -2.676 . . . . 0.0 103.774 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.431 HD11 ' HG3' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.49 156.52 45.74 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.046 -170.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 63.3 m -109.99 125.91 53.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.606 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.506 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 22.0 tpp85 -102.82 153.52 20.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -178.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.98 -5.77 7.84 Favored Glycine 0 CA--C 1.486 -1.72 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.938 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -89.16 113.45 56.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.411 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 13.0 Cg_exo -72.28 150.21 52.58 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.065 1.843 . . . . 0.0 109.796 176.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.444 HD12 ' O ' ' A' ' 105' ' ' PHE . 0.2 OUTLIER -96.47 103.99 16.15 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.603 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 86.2 Cg_endo -86.7 26.38 0.63 Allowed 'Trans proline' 0 C--O 1.24 0.583 0 C-N-CA 123.122 2.548 . . . . 0.0 114.039 -172.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.444 ' O ' HD12 ' A' ' 103' ' ' LEU . 52.1 p90 -162.04 169.43 21.02 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 23.9 t70 -91.27 130.97 37.93 Favored Pre-proline 0 CA--C 1.474 -1.974 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 174.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 18.0 Cg_endo -103.73 7.2 0.34 Allowed 'Trans proline' 0 N--CA 1.413 -3.216 0 C-N-CA 123.249 2.632 . . . . 0.0 111.303 -171.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -89.8 -36.8 14.92 Favored 'General case' 0 N--CA 1.408 -2.563 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 177.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -57.26 131.27 80.83 Favored Pre-proline 0 N--CA 1.442 -0.864 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.413 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.262 0.0 OUTLIER -37.18 89.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.497 -1.359 1 C-N-CA 126.04 4.493 . . . . 0.0 117.22 176.503 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -126.9 86.24 2.48 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 118.054 -1.458 . . . . 0.0 110.297 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 12.0 t -80.4 -177.07 6.0 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.264 174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 114.06 6.49 Favored 'General case' 0 N--CA 1.416 -2.174 0 CA-C-O 121.715 0.769 . . . . 0.0 112.987 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.604 ' O ' ' HA ' ' B' ' 155' ' ' THR . 0.0 OUTLIER -77.05 115.45 16.86 Favored 'General case' 0 N--CA 1.399 -3.011 0 N-CA-C 104.331 -2.47 . . . . 0.0 104.331 166.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.426 ' HA ' HG22 ' B' ' 155' ' ' THR . 11.6 p -112.01 122.34 66.13 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -165.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.3 t -97.01 144.29 27.05 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 63.9 m -149.91 143.17 25.09 Favored 'General case' 0 C--N 1.276 -2.592 0 CA-C-O 121.081 0.467 . . . . 0.0 110.132 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.9 t -93.08 101.22 12.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.35 72.83 5.97 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.15 0.976 . . . . 0.0 110.44 -175.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 50.6 mm -143.15 -35.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.402 ' O ' ' HD2' ' A' ' 123' ' ' LYS . 90.1 mt -89.48 -177.09 5.24 Favored 'General case' 0 CA--C 1.501 -0.917 0 CA-C-N 114.343 -1.299 . . . . 0.0 109.791 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -80.33 90.01 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.535 ' H ' ' HD2' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -36.09 114.74 0.3 Allowed 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 126.831 2.052 . . . . 0.0 112.471 -178.686 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 11.1 tp10 -89.08 117.33 68.14 Favored Pre-proline 0 C--N 1.286 -2.181 0 CA-C-N 114.573 -1.194 . . . . 0.0 108.027 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 12.3 Cg_exo . . . . . 0 C--N 1.351 0.664 0 C-N-CA 123.156 2.57 . . . . 0.0 112.802 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 1' ' ' LYS . 94.4 mtt180 . . . . . 0 C--O 1.212 -0.92 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 40.5 m -155.58 -32.37 0.09 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 119.459 1.027 . . . . 0.0 113.384 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 18.0 m -82.53 121.76 27.19 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-O 121.457 0.646 . . . . 0.0 112.171 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.42 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 45.8 mmt-85 -130.64 42.93 3.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.604 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 17.0 p -63.38 -48.27 78.6 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 112.56 -2.109 . . . . 0.0 109.835 -178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.45 ' HA ' ' HA2' ' A' ' 33' ' ' GLY 0.348 9.6 ptp180 50.07 95.47 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 176.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 13.4 mmt180 -81.89 156.4 24.82 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 114.345 -1.298 . . . . 0.0 108.102 -177.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' B' ' 158' ' ' GLU . 0.1 OUTLIER -95.49 83.34 3.79 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-O 122.182 0.991 . . . . 0.0 110.714 -179.01 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.537 ' O ' HG12 ' A' ' 31' ' ' VAL . 7.4 m -75.83 107.82 8.27 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.95 93.94 9.77 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.704 -0.622 . . . . 0.0 110.629 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 27' ' ' PHE . 5.2 m . . . . . 0 N--CA 1.429 -1.517 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.717 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.623 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -142.6 141.25 31.93 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . 0.412 ' HA ' ' HE2' ' A' ' 1' ' ' LYS . 24.1 mmt 64.69 33.38 10.55 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.374 1.069 . . . . 0.0 113.599 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -97.91 43.5 1.94 Allowed Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.702 -0.959 . . . . 0.0 110.702 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' -1' ' ' MET . 0.0 OUTLIER -111.79 143.5 28.76 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -178.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -74.86 145.68 32.31 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 107.609 -1.727 . . . . 0.0 107.609 172.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -68.3 117.73 10.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 121.835 0.826 . . . . 0.0 112.2 -173.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 32.5 t80 -147.5 134.56 20.36 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.814 -1.539 . . . . 0.0 109.303 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.62 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 8.8 t -173.92 41.29 0.01 OUTLIER 'General case' 0 N--CA 1.419 -1.995 0 O-C-N 124.32 1.013 . . . . 0.0 109.605 168.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.62 ' HG2' ' O ' ' A' ' 5' ' ' THR . 10.2 ptm180 56.02 13.47 1.16 Allowed 'General case' 0 N--CA 1.516 2.842 0 C-N-CA 126.423 1.889 . . . . 0.0 113.653 174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 6.7 m-80 -93.8 115.03 64.59 Favored Pre-proline 0 C--N 1.251 -3.712 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.288 10.8 Cg_exo -62.06 -29.69 81.71 Favored 'Trans proline' 0 CA--C 1.475 -2.444 0 N-CA-C 108.019 -1.57 . . . . 0.0 108.019 170.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.4 t -69.79 -25.68 63.91 Favored 'General case' 1 N--CA 1.354 -5.255 0 CA-C-N 111.271 -2.695 . . . . 0.0 110.962 -176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.0 pt-20 -78.27 -31.26 48.96 Favored 'General case' 0 CA--C 1.492 -1.267 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.407 ' HA ' ' OH ' ' A' ' 101' ' ' TYR . 86.9 mt -63.01 133.92 55.35 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.547 174.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 176.08 6.72 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.803 -174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.23 -116.19 5.44 Favored Glycine 0 N--CA 1.421 -2.362 0 CA-C-N 115.221 -0.9 . . . . 0.0 111.324 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.4 156.42 48.21 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 178.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -122.07 112.47 18.28 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 -175.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.402 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -119.85 152.22 22.51 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-O 121.209 0.528 . . . . 0.0 110.737 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.605 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.3 t-160 -133.26 99.64 4.6 Favored 'General case' 0 C--N 1.291 -1.966 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 14.9 t -126.27 142.09 51.66 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.054 -0.975 . . . . 0.0 112.677 -173.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.556 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -86.84 133.36 33.64 Favored 'General case' 0 C--N 1.311 -1.073 0 C-N-CA 124.019 0.928 . . . . 0.0 111.637 -176.681 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -115.45 127.34 55.26 Favored 'General case' 0 CA--C 1.483 -1.62 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 50.1 ttt-85 -88.06 103.94 16.19 Favored 'General case' 0 N--CA 1.4 -2.926 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.687 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.53 118.23 1.03 Allowed 'General case' 0 CA--C 1.47 -2.129 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 174.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 19.3 t -92.51 -137.05 0.17 Allowed 'General case' 0 N--CA 1.403 -2.785 0 O-C-N 126.104 2.128 . . . . 0.0 106.717 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.8 m -63.84 83.29 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.292 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.505 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 60.69 27.99 17.72 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.395 1.878 . . . . 0.0 112.009 174.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.45 -139.48 5.41 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.592 -1.29 . . . . 0.0 111.69 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.601 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.7 m-85 -124.66 -87.84 0.61 Allowed 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.92 52.54 0.11 Allowed Glycine 0 C--N 1.295 -1.72 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.037 -169.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 42.2 p90 -160.96 141.94 11.61 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 172.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 36.6 p -107.62 138.04 44.57 Favored 'General case' 0 C--N 1.275 -2.653 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.515 HG21 HD23 ' A' ' 41' ' ' LEU . 19.3 m -124.89 159.29 31.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -167.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.9 m -115.87 133.7 61.48 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 C-N-CA 124.516 1.127 . . . . 0.0 109.968 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' N ' ' HG3' ' B' ' 156' ' ' ARG . . . 116.18 -143.91 18.24 Favored Glycine 0 C--N 1.278 -2.689 0 C-N-CA 119.786 -1.197 . . . . 0.0 111.467 175.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.77 58.09 4.34 Favored Glycine 0 CA--C 1.452 -3.87 0 O-C-N 126.115 1.714 . . . . 0.0 111.228 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.545 ' OD2' ' HG2' ' B' ' 157' ' ' ARG . 6.3 t70 -102.67 -35.49 8.67 Favored 'General case' 0 C--N 1.256 -3.458 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.328 -175.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.9 pt-20 -158.45 168.44 12.44 Favored Pre-proline 0 CA--C 1.469 -2.151 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.404 -169.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -75.94 58.18 5.39 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 124.298 3.332 . . . . 0.0 110.266 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.546 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 6.1 t70 -170.81 -46.49 0.02 OUTLIER 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 112.085 -2.325 . . . . 0.0 106.732 -173.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -97.42 118.73 34.55 Favored 'General case' 0 C--O 1.272 2.265 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.279 178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -90.18 165.96 13.65 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 127.976 2.51 . . . . 0.0 108.348 -177.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.655 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.9 mp -95.76 144.38 26.2 Favored 'General case' 0 C--O 1.175 -2.858 0 C-N-CA 118.506 -1.277 . . . . 0.0 109.639 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 36.5 tt0 -130.1 156.28 44.8 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.491 HD12 ' CD1' ' A' ' 29' ' ' PHE . 12.6 mm -90.01 127.27 42.69 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 -177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.619 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -107.67 -19.86 13.41 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.509 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.487 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.0 m -155.73 127.28 7.3 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 174.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.0 tp -83.14 114.96 21.69 Favored 'General case' 0 N--CA 1.402 -2.84 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 174.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.493 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 58.4 t -86.99 122.71 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.144 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.8 mt -70.19 146.17 50.93 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.2 t70 84.37 3.03 0.79 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.489 1.743 . . . . 0.0 109.795 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.658 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -86.91 158.98 31.06 Favored Glycine 0 C--O 1.207 -1.579 0 CA-C-O 117.872 -1.516 . . . . 0.0 109.576 173.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.6 Cg_endo -72.59 -25.17 17.92 Favored 'Trans proline' 0 N--CA 1.436 -1.905 0 CA-C-N 121.725 2.762 . . . . 0.0 110.633 -170.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.619 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.38 -42.2 98.83 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 114.814 -1.085 . . . . 0.0 109.241 174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.93 -45.36 82.12 Favored 'General case' 0 CA--C 1.492 -1.251 0 CA-C-O 122.668 1.223 . . . . 0.0 110.091 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 82.6 mt -71.67 -44.74 63.73 Favored 'General case' 0 N--CA 1.405 -2.715 0 CA-C-N 112.821 -1.991 . . . . 0.0 114.517 -172.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -79.16 -19.61 50.56 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 122.36 1.076 . . . . 0.0 108.242 177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 59.98 27.92 65.39 Favored Glycine 0 CA--C 1.48 -2.097 0 CA-C-N 113.243 -1.799 . . . . 0.0 113.593 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HG2' ' OG1' ' A' ' 18' ' ' THR . 26.4 tptp -102.06 -13.08 17.66 Favored 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 114.946 -0.627 . . . . 0.0 110.331 -173.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.619 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 67.5 mtp -123.11 144.31 49.4 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 178.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -147.43 141.39 25.9 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -174.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.7 m -45.16 114.14 0.68 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 124.726 1.21 . . . . 0.0 111.332 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 130.6 -18.77 5.12 Favored Glycine 0 N--CA 1.422 -2.29 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.461 -175.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CB ' HD12 ' A' ' 97' ' ' LEU . 5.0 m-20 -60.64 146.51 45.2 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.594 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.288 1.2 p -117.87 116.18 50.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 C-N-CA 119.918 -0.713 . . . . 0.0 111.964 174.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 47.8 mt -76.08 120.02 25.25 Favored 'Isoleucine or valine' 0 C--O 1.284 2.882 0 CA-C-N 114.362 -1.29 . . . . 0.0 111.692 -177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.434 HG11 ' HG3' ' A' ' 8' ' ' PRO . 37.4 t -99.12 -34.96 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 CA-C-N 112.334 -2.212 . . . . 0.0 110.138 -177.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.9 t -170.62 169.49 7.16 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 HD13 ' A' ' 95' ' ' LEU . 6.9 p -155.17 115.76 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.408 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 63.3 t30 37.43 76.59 0.05 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 126.14 1.776 . . . . 0.0 113.918 173.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t70 70.89 -18.93 0.24 Allowed 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.8 m -90.76 122.53 33.59 Favored 'General case' 0 N--CA 1.432 -1.35 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -81.39 77.2 8.29 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-O 122.023 0.916 . . . . 0.0 110.134 -174.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 88.5 t -80.94 -0.91 4.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-O 122.426 1.108 . . . . 0.0 110.595 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD21 ' O ' ' A' ' 6' ' ' ARG . 30.7 tp -59.04 110.52 1.06 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.094 -1.446 . . . . 0.0 107.094 170.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.59 48.77 84.54 Favored Glycine 0 N--CA 1.431 -1.641 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.298 -175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.442 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -89.17 141.14 28.78 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.541 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 24.0 m -74.04 144.09 45.22 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.247 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.431 ' HA ' HG12 ' A' ' 80' ' ' VAL . 73.2 t60 -46.72 -47.54 20.53 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.135 0.879 . . . . 0.0 113.103 -177.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.98 73.37 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 121.901 0.857 . . . . 0.0 111.081 -177.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 79.2 mm-40 -78.51 -49.75 12.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.651 -178.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.474 HG21 HD21 ' A' ' 41' ' ' LEU . 12.7 p -64.46 -40.67 89.88 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.119 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.387 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.93 -44.64 98.03 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . 0.273 0.0 OUTLIER -72.79 -27.04 61.75 Favored 'General case' 0 N--CA 1.427 -1.622 0 C-N-CA 118.27 -1.372 . . . . 0.0 113.276 -175.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.9 mt -73.02 -51.21 27.45 Favored 'Isoleucine or valine' 0 C--O 1.247 0.928 0 CA-C-O 122.03 0.919 . . . . 0.0 109.003 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -62.46 -39.09 92.3 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.703 -1.59 . . . . 0.0 112.755 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.458 ' OE1' ' HA ' ' B' ' 161' ' ' VAL . 14.2 mm100 -85.65 -20.13 29.91 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.2 m -96.17 4.96 52.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 119.682 -0.807 . . . . 0.0 111.211 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.687 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 3.1 mt -48.47 147.08 4.35 Favored Pre-proline 0 CA--C 1.577 1.981 0 C-N-CA 124.302 1.041 . . . . 0.0 112.709 170.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -94.27 150.56 2.02 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 123.246 2.631 . . . . 0.0 111.436 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.505 HG12 ' H ' ' A' ' 25' ' ' ARG . 24.8 mt -68.75 143.32 15.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.305 177.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.52 12.06 70.4 Favored Glycine 0 CA--C 1.497 -1.052 0 C-N-CA 120.447 -0.882 . . . . 0.0 111.483 176.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.71 -176.34 3.71 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.274 -171.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.556 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.7 t -147.03 142.68 27.72 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.255 -173.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.545 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 4.7 m -151.98 144.24 15.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.586 0 O-C-N 124.2 0.938 . . . . 0.0 111.002 175.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.605 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 2.5 m-20 -97.79 117.73 32.76 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.622 -1.172 . . . . 0.0 108.696 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 3.2 mm? -90.67 121.98 33.05 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.515 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -91.05 108.18 19.7 Favored 'General case' 0 CA--C 1.497 -1.089 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 170.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.577 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.7 OUTLIER -141.61 147.74 38.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 120.084 -0.647 . . . . 0.0 111.062 -176.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 80.0 m -105.28 136.77 44.19 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.841 179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.516 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 18.4 tpp85 -114.08 149.98 34.71 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.24 3.95 6.61 Favored Glycine 0 C--N 1.302 -1.337 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.407 ' OH ' ' HA ' ' A' ' 11' ' ' LEU . 65.3 m-85 -107.44 142.35 24.94 Favored Pre-proline 0 C--N 1.301 -1.505 0 C-N-CA 122.788 0.435 . . . . 0.0 111.389 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 68.9 Cg_endo -90.72 179.0 1.85 Allowed 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 122.453 2.102 . . . . 0.0 109.303 172.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.0 92.15 3.45 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 93.3 Cg_endo -88.6 40.89 0.56 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 123.414 2.743 . . . . 0.0 111.325 -173.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -168.23 145.94 4.21 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 -173.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.491 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.5 t70 -108.26 132.09 21.32 Favored Pre-proline 0 CA--C 1.475 -1.936 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 175.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 19.2 Cg_endo -103.07 5.84 0.39 Allowed 'Trans proline' 0 N--CA 1.413 -3.236 0 C-N-CA 123.422 2.748 . . . . 0.0 111.282 -171.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -100.53 -34.72 9.8 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.07 143.18 72.9 Favored Pre-proline 0 C--N 1.304 -1.379 0 CA-C-N 112.424 -2.171 . . . . 0.0 111.279 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -37.56 -28.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.369 1.643 1 C-N-CA 126.615 4.877 . . . . 0.0 117.613 176.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.77 81.38 2.72 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-O 121.6 0.714 . . . . 0.0 111.114 -176.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 8.3 t -69.8 -131.28 0.0 OUTLIER 'General case' 0 C--N 1.268 -2.974 0 CA-C-N 113.532 -1.667 . . . . 0.0 109.578 172.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HB3' ' CD ' ' B' ' 157' ' ' ARG . 5.1 p -54.98 133.85 48.61 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 123.551 0.74 . . . . 0.0 112.434 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' O ' ' HA ' ' B' ' 155' ' ' THR . 48.4 mt -89.65 105.02 17.52 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.574 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 74.4 t -123.55 107.53 19.15 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 t -79.87 151.44 30.2 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.238 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.3 m -93.88 103.29 15.41 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.868 0.842 . . . . 0.0 109.94 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.429 HG22 HG12 ' A' ' 120' ' ' ILE . 6.4 p -133.71 135.07 55.95 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -80.96 76.31 7.91 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.651 0.738 . . . . 0.0 112.424 -175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.429 HG12 HG22 ' A' ' 118' ' ' VAL . 49.6 mm -117.17 -56.78 3.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 73.8 mt -97.47 140.52 31.78 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.892 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.0 99.55 10.49 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 174.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -61.19 134.41 56.98 Favored 'General case' 0 N--CA 1.421 -1.886 0 CA-C-O 122.715 1.245 . . . . 0.0 112.695 -173.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -92.8 145.6 30.58 Favored Pre-proline 0 C--N 1.258 -3.381 0 CA-C-N 113.025 -1.898 . . . . 0.0 109.121 179.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo . . . . . 0 CA--C 1.547 1.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.919 179.819 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.473 ' HG2' ' H ' ' B' ' 152' ' ' SER 0.266 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.234 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.473 ' H ' ' HG2' ' B' ' 151' ' ' ARG . 16.6 m -78.68 9.54 4.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.701 0.762 . . . . 0.0 112.709 -171.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 2.6 p -81.71 -16.0 52.61 Favored 'General case' 0 N--CA 1.419 -2.024 0 C-N-CA 124.52 1.128 . . . . 0.0 109.894 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 27.6 mmt180 71.07 -63.0 0.44 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.222 1.409 . . . . 0.0 113.531 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.518 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 5.2 m 67.13 -67.31 0.17 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.182 1.393 . . . . 0.0 110.675 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 33' ' ' GLY . 20.8 ttm180 69.22 110.07 0.05 Allowed 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 172.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.545 ' HG2' ' OD2' ' A' ' 35' ' ' ASP . 8.0 mmm180 -111.13 165.66 11.72 Favored 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.286 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.2 mp0 -99.63 85.48 3.13 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.042 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.416 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 14.3 m -81.44 128.29 33.71 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.43 ' HA ' HG22 ' A' ' 30' ' ' THR . 50.6 mt-30 -98.47 124.91 43.46 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 176.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.458 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 10.2 m . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.027 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.14 -34.94 71.48 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 121.958 0.885 . . . . 0.0 108.686 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 23.1 ptp -123.19 169.37 11.32 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 114.25 -1.341 . . . . 0.0 107.909 177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 88.87 31.83 11.88 Favored Glycine 0 N--CA 1.433 -1.555 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.66 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.83 135.55 67.57 Favored Pre-proline 0 C--N 1.315 -0.9 0 C-N-CA 120.534 -0.466 . . . . 0.0 110.3 179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -68.43 145.96 66.82 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.514 2.143 . . . . 0.0 109.805 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.95 135.03 57.67 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.251 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 22.6 t80 -146.88 134.99 21.57 Favored 'General case' 0 C--N 1.281 -2.377 0 CA-C-N 114.617 -1.174 . . . . 0.0 110.936 -176.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.601 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.5 t 179.96 39.78 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.396 0 O-C-N 125.071 1.482 . . . . 0.0 110.357 169.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 5' ' ' THR . 31.1 ptt180 54.67 15.53 1.1 Allowed 'General case' 0 N--CA 1.512 2.631 0 C-N-CA 126.159 1.784 . . . . 0.0 113.559 175.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.81 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.9 m-80 -94.62 114.22 62.94 Favored Pre-proline 1 C--N 1.242 -4.065 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.269 7.2 Cg_exo -58.36 -29.97 89.78 Favored 'Trans proline' 0 CA--C 1.483 -2.034 0 C-N-CA 121.552 1.501 . . . . 0.0 109.336 170.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -72.99 -25.43 60.98 Favored 'General case' 1 N--CA 1.365 -4.721 0 CA-C-N 112.408 -2.178 . . . . 0.0 111.313 -175.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -76.02 -34.54 59.69 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -55.07 130.61 42.51 Favored 'General case' 0 C--O 1.246 0.898 0 CA-C-O 122.406 1.098 . . . . 0.0 111.748 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.17 170.88 12.04 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 113.034 -1.894 . . . . 0.0 112.282 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.425 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.67 -109.65 3.05 Favored Glycine 0 N--CA 1.427 -1.927 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.045 -179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -147.33 145.13 29.22 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 123.082 0.553 . . . . 0.0 110.646 -176.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -110.22 111.45 22.77 Favored 'General case' 0 C--N 1.283 -2.323 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -178.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.07 147.74 28.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.184 0 CA-C-O 122.005 0.907 . . . . 0.0 112.152 -177.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -118.05 99.79 7.12 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.7 t -129.69 137.02 50.39 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.562 0.696 . . . . 0.0 111.588 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.1 OUTLIER -73.36 133.54 43.83 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 124.07 0.948 . . . . 0.0 112.008 -176.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 tp -124.49 134.41 53.04 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 173.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 40.9 ttt-85 -93.66 114.72 27.09 Favored 'General case' 0 N--CA 1.402 -2.868 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.555 -177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -42.71 99.5 0.02 OUTLIER 'General case' 0 CA--C 1.485 -1.543 0 C-N-CA 125.0 1.32 . . . . 0.0 111.099 168.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 51.3 m -118.48 125.44 49.9 Favored 'General case' 0 N--CA 1.417 -2.092 0 O-C-N 125.527 1.767 . . . . 0.0 107.655 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.5 m 58.46 47.7 13.22 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.777 0.799 . . . . 0.0 111.035 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.546 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.7 mpt_? 84.7 -62.74 0.08 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 126.635 1.974 . . . . 0.0 111.702 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . -100.29 -115.06 3.74 Favored Glycine 0 N--CA 1.406 -3.339 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.211 -175.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.635 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 81.2 m-85 -129.97 -84.5 0.54 Allowed 'General case' 0 N--CA 1.397 -3.12 0 CA-C-N 115.181 -0.509 . . . . 0.0 111.002 -174.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 134.26 53.86 0.07 OUTLIER Glycine 0 C--N 1.295 -1.73 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.008 -170.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.488 ' CD1' HD12 ' A' ' 43' ' ' ILE . 44.0 p90 -161.64 142.85 11.15 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.517 HG22 ' HB2' ' B' ' 160' ' ' GLN . 76.9 p -104.24 135.12 46.31 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 118.63 -1.228 . . . . 0.0 109.823 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.643 HG22 ' HB ' ' B' ' 159' ' ' THR . 1.0 OUTLIER -115.77 162.92 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.791 -171.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' B' ' 156' ' ' ARG . 6.8 m -137.0 132.31 47.11 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.31 0 C-N-CA 123.505 0.722 . . . . 0.0 109.237 173.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' B' ' 156' ' ' ARG . . . 131.91 -147.85 18.84 Favored Glycine 0 CA--C 1.476 -2.405 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.46 60.64 3.59 Favored Glycine 0 CA--C 1.462 -3.263 0 O-C-N 126.352 1.854 . . . . 0.0 113.085 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -106.03 -24.23 12.44 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 114.348 -0.926 . . . . 0.0 109.148 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 38' ' ' ASP . 3.0 pt-20 -158.49 172.06 6.63 Favored Pre-proline 0 C--O 1.196 -1.732 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.426 -173.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -67.54 -15.34 44.8 Favored 'Trans proline' 0 C--N 1.322 -0.857 0 C-N-CA 123.117 2.545 . . . . 0.0 109.439 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.42 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 21.5 t70 -92.6 -24.04 18.83 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 112.973 -1.921 . . . . 0.0 110.995 -178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.64 ' OE1' ' HD3' ' B' ' 154' ' ' ARG . 35.3 tt0 -123.22 117.93 26.45 Favored 'General case' 0 C--O 1.262 1.716 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -84.61 165.54 17.88 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.253 2.221 . . . . 0.0 108.619 -177.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -91.37 144.72 25.29 Favored 'General case' 0 C--O 1.183 -2.441 0 C-N-CA 118.232 -1.387 . . . . 0.0 109.085 -177.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 16.3 tt0 -128.07 169.49 14.0 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' VAL . 27.3 mm -112.9 135.68 51.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' O ' ' HB3' ' A' ' 107' ' ' PRO . 21.6 pttp -114.54 -13.64 12.16 Favored 'General case' 0 CA--C 1.499 -0.986 0 C-N-CA 120.383 -0.527 . . . . 0.0 112.197 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 m -159.75 127.98 4.9 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 59' ' ' GLU . 3.7 pp -90.92 119.28 30.99 Favored 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' H ' ' HA ' ' A' ' 29' ' ' PHE . 92.4 t -75.67 126.47 36.45 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-O 121.142 0.496 . . . . 0.0 109.711 -175.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.6 mt -63.63 135.02 56.45 Favored 'General case' 0 CA--C 1.492 -1.261 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 32.4 t70 87.47 2.2 0.41 Allowed 'General case' 0 N--CA 1.48 1.063 0 O-C-N 125.422 1.701 . . . . 0.0 110.255 -173.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.498 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.39 159.54 37.07 Favored Glycine 0 C--O 1.208 -1.5 0 CA-C-O 118.175 -1.347 . . . . 0.0 110.887 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.635 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.5 Cg_endo -72.46 -25.52 17.96 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 CA-C-N 121.307 2.554 . . . . 0.0 110.155 -170.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.613 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -67.4 -43.11 82.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.476 175.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.27 -47.35 76.98 Favored 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 122.499 1.143 . . . . 0.0 109.78 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 95.2 mt -71.86 -39.7 69.5 Favored 'General case' 0 N--CA 1.399 -2.981 0 CA-C-N 113.051 -1.886 . . . . 0.0 114.926 -174.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.97 -17.26 47.58 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 122.554 1.168 . . . . 0.0 109.773 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.84 46.38 76.44 Favored Glycine 0 CA--C 1.494 -1.233 0 CA-C-N 112.813 -1.994 . . . . 0.0 113.106 177.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 1.2 tpmt? -126.9 6.34 6.62 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.588 0.709 . . . . 0.0 110.956 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.613 ' SD ' ' HB1' ' A' ' 52' ' ' ALA . 1.8 tmt? -147.93 150.57 34.3 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 10.8 pt-20 -136.02 166.95 22.15 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 122.275 1.036 . . . . 0.0 111.152 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.495 ' N ' HD23 ' A' ' 46' ' ' LEU . 69.0 m -68.75 119.62 13.42 Favored 'General case' 0 N--CA 1.409 -2.501 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 128.39 -25.69 4.77 Favored Glycine 0 N--CA 1.428 -1.875 0 C-N-CA 120.173 -1.013 . . . . 0.0 111.59 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.575 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 5.2 m-20 -54.99 150.71 9.87 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.179 0.514 . . . . 0.0 111.625 178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.267 0.8 OUTLIER -115.15 120.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.202 0 CA-C-O 121.429 0.633 . . . . 0.0 111.101 175.344 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.472 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.4 mm -78.03 119.35 26.7 Favored 'Isoleucine or valine' 0 C--O 1.302 3.82 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.496 -176.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 73' ' ' LEU . 47.9 t -100.63 -52.87 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 CA-C-N 112.716 -2.038 . . . . 0.0 110.112 -177.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.6 p -164.1 174.06 11.74 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.683 0.278 . . . . 0.0 111.543 -177.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 p -143.95 152.6 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.402 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.582 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 3.8 t30 -26.66 106.19 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.526 1.53 . . . . 0.0 112.725 172.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.7 t70 85.03 -52.42 0.09 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.26 1.824 . . . . 0.0 114.11 -177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.0 m -93.95 127.19 39.59 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-O 122.384 1.088 . . . . 0.0 113.322 -168.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.15 89.37 5.99 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-N 114.422 -1.263 . . . . 0.0 108.605 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.8 t -84.27 9.74 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-O 122.408 1.099 . . . . 0.0 109.599 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.577 HD21 ' O ' ' A' ' 6' ' ' ARG . 23.6 tp -64.18 110.19 2.11 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 55.89 43.61 87.46 Favored Glycine 0 N--CA 1.434 -1.472 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.979 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -75.2 150.53 38.64 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -77.42 143.1 38.87 Favored 'General case' 0 C--N 1.284 -2.255 0 CA-C-O 117.908 -1.044 . . . . 0.0 108.675 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.469 ' O ' HG12 ' A' ' 81' ' ' VAL . 73.0 t60 -47.7 -49.99 26.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 118.871 0.759 . . . . 0.0 112.191 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.9 -34.84 75.29 Favored 'General case' 0 C--N 1.309 -1.159 0 O-C-N 123.829 0.706 . . . . 0.0 110.944 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -76.65 -50.4 13.83 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.881 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 41' ' ' LEU . 7.2 p -63.31 -44.49 99.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.367 -178.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.9 p -64.79 -36.07 76.66 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.204 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.669 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.3 tmmm? -60.63 -45.84 92.52 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.733 178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.6 mt -73.12 -50.32 32.57 Favored 'Isoleucine or valine' 0 C--O 1.245 0.86 0 CA-C-O 122.394 1.092 . . . . 0.0 109.425 -176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -65.29 -28.69 69.5 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.467 -1.697 . . . . 0.0 113.306 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.436 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 15.6 mm-40 -88.19 -17.47 30.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 173.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.6 p -95.63 -4.07 45.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.537 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.1 OUTLIER -61.99 154.52 68.3 Favored Pre-proline 0 N--CA 1.442 -0.867 0 CA-C-O 120.959 0.409 . . . . 0.0 111.212 174.093 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 35.6 Cg_endo -102.86 153.57 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 124.778 3.652 . . . . 0.0 112.704 -177.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' H ' ' A' ' 25' ' ' ARG . 59.9 mt -65.58 128.86 29.15 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.014 178.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.4 10.7 33.09 Favored Glycine 0 N--CA 1.427 -1.926 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.613 176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.08 177.06 5.2 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 118.251 -1.38 . . . . 0.0 111.432 -175.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.557 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 31.3 t -140.0 150.84 44.93 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 123.427 0.691 . . . . 0.0 110.155 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.608 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.8 m -155.55 164.92 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.474 -1.974 0 C-N-CA 124.894 1.278 . . . . 0.0 109.96 174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.582 ' H ' ' HB2' ' A' ' 68' ' ' ASN . 14.5 m-20 -107.38 107.7 18.71 Favored 'General case' 0 N--CA 1.408 -2.549 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -91.73 122.19 34.05 Favored 'General case' 0 C--N 1.266 -3.046 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -103.28 110.67 22.73 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.422 HD12 ' HB3' ' A' ' 62' ' ' ASP . 1.1 pt? -141.51 156.76 45.71 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.027 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 84.7 m -111.5 126.41 54.93 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.41 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.579 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.3 146.11 25.45 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 -179.062 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.17 -19.66 2.86 Favored Glycine 0 CA--C 1.491 -1.453 0 C-N-CA 119.77 -1.205 . . . . 0.0 110.825 -178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -88.88 128.55 51.76 Favored Pre-proline 0 C--N 1.302 -1.498 0 CA-C-O 120.752 0.311 . . . . 0.0 110.82 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -89.42 177.62 2.72 Favored 'Trans proline' 0 N--CA 1.441 -1.614 0 C-N-CA 122.508 2.139 . . . . 0.0 110.59 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -121.59 81.06 39.63 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -89.78 59.18 1.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.704 2.936 . . . . 0.0 109.192 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -158.83 159.09 34.68 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 103.77 -2.678 . . . . 0.0 103.77 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 12.8 m-20 -82.96 130.78 56.21 Favored Pre-proline 0 CA--C 1.485 -1.554 0 C-N-CA 119.971 -0.692 . . . . 0.0 109.188 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.3 Cg_endo -96.12 11.55 1.32 Allowed 'Trans proline' 0 N--CA 1.445 -1.377 0 C-N-CA 123.364 2.709 . . . . 0.0 106.484 178.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.435 ' O ' ' HD3' ' A' ' 110' ' ' PRO . 27.2 t70 -106.31 -10.48 16.36 Favored 'General case' 0 N--CA 1.402 -2.829 0 CA-C-N 112.106 -2.315 . . . . 0.0 108.926 -175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -99.61 108.91 53.34 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 114.79 -1.095 . . . . 0.0 111.11 -174.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 108' ' ' ASP . 17.4 Cg_exo -83.18 -140.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 124.177 3.251 . . . . 0.0 112.914 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . 0.302 10.7 m120 100.33 -72.88 0.0 OUTLIER 'General case' 0 N--CA 1.426 -1.639 0 C-N-CA 128.706 2.802 . . . . 0.0 114.137 169.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 6.2 t -178.29 172.46 1.53 Allowed 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 -173.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' B' ' 157' ' ' ARG . 69.2 m -93.77 109.99 21.64 Favored 'General case' 0 N--CA 1.405 -2.694 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.583 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -75.31 136.93 40.85 Favored 'General case' 0 N--CA 1.404 -2.754 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.389 177.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.71 106.37 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.03 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.879 177.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.9 t -96.2 148.72 22.43 Favored 'General case' 0 N--CA 1.404 -2.772 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 173.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 p -144.77 171.42 14.44 Favored 'General case' 0 C--N 1.26 -3.32 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 -175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.1 p -94.32 100.95 11.98 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.431 ' HB1' ' HB3' ' A' ' 123' ' ' LYS . . . -145.8 79.16 1.55 Allowed 'General case' 0 N--CA 1.419 -1.975 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.832 -174.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -114.1 -30.43 2.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 122.865 1.317 . . . . 0.0 107.656 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.68 -17.06 17.17 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 113.532 -1.667 . . . . 0.0 111.199 -174.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -155.69 94.61 1.58 Allowed 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -178.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.431 ' HB3' ' HB1' ' A' ' 119' ' ' ALA . 17.8 pttp -132.59 129.27 38.75 Favored 'General case' 0 C--N 1.277 -2.557 0 CA-C-N 115.131 -0.94 . . . . 0.0 112.94 -174.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.1 OUTLIER -97.46 121.01 59.62 Favored Pre-proline 0 N--CA 1.412 -2.357 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.096 177.302 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo . . . . . 0 N--CA 1.456 -0.69 0 C-N-CA 122.879 2.386 . . . . 0.0 112.433 -177.217 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.552 ' HD3' ' H ' ' B' ' 152' ' ' SER . 5.1 tpp180 . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.552 ' H ' ' HD3' ' B' ' 151' ' ' ARG . 17.2 m 82.16 -45.88 0.17 Allowed 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.497 1.519 . . . . 0.0 110.845 175.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -87.8 133.15 33.93 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.64 ' HD3' ' OE1' ' A' ' 39' ' ' GLU . 10.0 tpp180 -115.28 122.14 45.03 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 178.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 22.2 m -114.6 -51.1 2.76 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.993 -0.683 . . . . 0.0 111.885 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.538 ' HA ' ' HA2' ' A' ' 33' ' ' GLY . 69.5 mtp180 61.45 72.04 0.53 Allowed 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.73 0.776 . . . . 0.0 110.161 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.501 ' HA ' ' OG ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -77.18 127.1 32.03 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.812 -177.096 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 37.7 tt0 -72.99 110.97 7.68 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.243 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.643 ' HB ' HG22 ' A' ' 31' ' ' VAL . 12.3 m -115.23 97.89 6.46 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.517 ' HB2' HG22 ' A' ' 30' ' ' THR . 4.0 pm0 -76.95 120.4 22.02 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.564 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.6 m . . . . . 0 N--CA 1.415 -2.177 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.547 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -84.38 -46.92 11.22 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.364 0.602 . . . . 0.0 109.701 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 56.4 ttp -132.08 151.54 51.71 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 178.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 121' ' ' LEU . . . 112.33 14.72 10.38 Favored Glycine 0 CA--C 1.484 -1.851 0 C-N-CA 119.946 -1.121 . . . . 0.0 112.871 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.428 ' HG2' ' NH2' ' B' ' 151' ' ' ARG . 0.0 OUTLIER -101.91 157.06 34.41 Favored Pre-proline 0 N--CA 1.424 -1.747 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -66.12 169.42 13.65 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 122.011 1.808 . . . . 0.0 110.666 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 p90 -66.92 134.36 51.87 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.524 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.445 ' CE2' ' HA ' ' A' ' 38' ' ' ASP . 16.3 t80 -146.76 140.11 25.61 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.297 -177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.361 12.1 t -154.61 -49.04 0.09 Allowed 'General case' 0 N--CA 1.415 -2.215 0 CA-C-N 114.181 -1.372 . . . . 0.0 111.798 161.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.444 ' HB2' HD21 ' A' ' 73' ' ' LEU . 8.7 ptm85 153.88 -29.3 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 125.64 1.576 . . . . 0.0 107.44 -176.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.773 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 21.5 t30 -57.78 114.43 8.43 Favored Pre-proline 0 C--N 1.266 -3.058 0 CA-C-N 112.145 -2.298 . . . . 0.0 114.136 -170.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.259 7.2 Cg_exo -58.86 -35.28 98.87 Favored 'Trans proline' 0 CA--C 1.469 -2.737 0 C-N-CA 122.818 2.345 . . . . 0.0 110.666 -178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 71.4 m -79.58 -12.65 59.84 Favored 'General case' 1 N--CA 1.348 -5.53 0 CA-C-N 112.464 -2.153 . . . . 0.0 112.257 -173.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.773 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -78.45 -35.5 46.7 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 173.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -54.52 129.9 37.82 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.428 -1.26 . . . . 0.0 110.693 177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -77.14 179.47 6.29 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.827 -1.533 . . . . 0.0 113.372 -173.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.0 -114.84 4.16 Favored Glycine 0 N--CA 1.44 -1.076 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.962 -178.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.59 154.22 46.43 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 123.084 0.554 . . . . 0.0 110.289 -178.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -119.43 115.62 24.46 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.04 140.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-O 121.599 0.714 . . . . 0.0 111.234 -176.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.737 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 6.1 t60 -124.77 99.59 6.23 Favored 'General case' 0 C--N 1.279 -2.479 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.3 t -112.8 133.62 54.71 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.562 -175.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 92' ' ' SER . 0.6 OUTLIER -75.68 137.27 40.56 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -125.95 121.59 33.53 Favored 'General case' 0 N--CA 1.422 -1.855 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -77.91 123.06 26.31 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.764 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -52.1 108.33 0.28 Allowed 'General case' 0 CA--C 1.471 -2.085 0 C-N-CA 123.905 0.882 . . . . 0.0 112.151 174.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.1 t -83.49 -148.38 0.09 Allowed 'General case' 0 N--CA 1.428 -1.533 0 O-C-N 126.754 2.534 . . . . 0.0 108.389 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.2 m -61.62 76.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.567 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.7 mmt180 67.04 48.08 1.29 Allowed 'General case' 0 CA--C 1.492 -1.266 0 CA-C-O 122.43 1.11 . . . . 0.0 110.938 174.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.92 -123.05 1.45 Allowed Glycine 0 N--CA 1.4 -3.732 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.679 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.695 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.8 m-85 -130.47 -83.99 0.53 Allowed 'General case' 0 N--CA 1.393 -3.292 0 CA-C-N 114.068 -1.066 . . . . 0.0 110.637 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.561 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 129.78 49.89 0.12 Allowed Glycine 0 C--N 1.298 -1.541 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.239 -171.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.494 ' HA ' HG23 ' A' ' 47' ' ' VAL . 28.4 p90 -161.35 142.72 11.52 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 172.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.537 HG22 ' HA ' ' B' ' 160' ' ' GLN . 16.5 p -104.09 136.3 43.98 Favored 'General case' 0 C--N 1.259 -3.352 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 22.9 m -123.6 157.89 29.6 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 3.2 m -115.35 174.58 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.454 0 C-N-CA 125.281 1.432 . . . . 0.0 111.029 177.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' B' ' 156' ' ' ARG . . . 85.92 -130.4 9.89 Favored Glycine 0 CA--C 1.481 -2.089 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 176.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.58 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 29.92 59.46 0.2 Allowed Glycine 0 CA--C 1.473 -2.579 0 C-N-CA 127.523 2.487 . . . . 0.0 113.81 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -112.52 -28.44 7.85 Favored 'General case' 1 C--N 1.239 -4.22 0 CA-C-N 114.166 -1.017 . . . . 0.0 108.505 -175.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -158.37 169.97 9.7 Favored Pre-proline 0 CA--C 1.47 -2.111 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.959 -174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.463 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 57.6 Cg_exo -61.91 -26.54 79.08 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.459 2.106 . . . . 0.0 109.6 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.445 ' HA ' ' CE2' ' A' ' 4' ' ' PHE . 18.6 t70 -75.47 -29.95 59.77 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 112.504 -2.135 . . . . 0.0 111.729 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -122.11 119.09 30.31 Favored 'General case' 0 C--O 1.27 2.165 0 O-C-N 121.77 -0.581 . . . . 0.0 110.739 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.406 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 22.8 m-85 -85.97 166.11 16.18 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 127.941 2.496 . . . . 0.0 109.547 -175.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.792 HD21 HG21 ' A' ' 80' ' ' VAL . 6.1 mp -88.33 145.57 25.76 Favored 'General case' 0 C--O 1.178 -2.702 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.846 -176.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 10.4 tt0 -135.54 158.94 43.13 Favored 'General case' 0 C--O 1.18 -2.569 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 HG12 ' O ' ' A' ' 62' ' ' ASP . 18.9 mm -87.95 127.74 40.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.586 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -103.47 -22.83 13.59 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.489 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 48.8 m -155.04 126.94 7.57 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 53' ' ' ALA . 3.2 tm? -83.53 106.39 15.22 Favored 'General case' 0 N--CA 1.415 -2.222 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 92.9 t -85.36 135.8 24.14 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 121.87 0.843 . . . . 0.0 110.974 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.48 141.7 57.81 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.761 -1.109 . . . . 0.0 109.584 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.7 t70 78.94 4.6 2.38 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.722 1.249 . . . . 0.0 110.903 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.73 159.5 36.44 Favored Glycine 0 C--O 1.201 -1.955 0 CA-C-O 118.085 -1.397 . . . . 0.0 109.897 173.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.695 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.48 -24.54 18.98 Favored 'Trans proline' 0 N--CA 1.437 -1.825 0 CA-C-N 121.438 2.619 . . . . 0.0 109.678 -173.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.73 -36.64 78.66 Favored 'General case' 0 C--O 1.209 -1.037 0 CA-C-N 114.638 -1.164 . . . . 0.0 109.405 174.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' HA ' HD11 ' A' ' 46' ' ' LEU . . . -69.06 -48.24 63.26 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.572 1.177 . . . . 0.0 109.289 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 77.8 mt -72.08 -43.59 64.6 Favored 'General case' 0 N--CA 1.405 -2.708 0 CA-C-N 112.461 -2.154 . . . . 0.0 115.558 -173.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.441 ' OD1' ' HE3' ' A' ' 57' ' ' LYS . 5.0 t0 -83.26 -20.75 33.92 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.87 -140.89 19.04 Favored Glycine 0 N--CA 1.421 -2.321 0 C-N-CA 119.913 -1.136 . . . . 0.0 110.87 -178.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' HE3' ' OD1' ' A' ' 55' ' ' ASP 0.344 0.0 OUTLIER 53.36 -63.92 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.472 1.909 . . . . 0.0 115.42 -176.704 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.424 ' HE1' HD23 ' A' ' 95' ' ' LEU . 39.8 ttm -68.83 141.37 55.15 Favored 'General case' 0 C--O 1.242 0.699 0 C-N-CA 123.577 0.751 . . . . 0.0 109.282 -176.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -151.0 144.47 24.92 Favored 'General case' 0 CA--C 1.484 -1.561 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -173.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.8 m -45.38 114.73 0.79 Allowed 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 124.635 1.209 . . . . 0.0 110.869 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.3 -30.42 3.03 Favored Glycine 0 N--CA 1.429 -1.795 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.947 -176.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' O ' HG12 ' A' ' 43' ' ' ILE 0.375 0.9 OUTLIER -69.16 143.29 54.12 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 179.669 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -103.2 118.27 49.91 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.146 . . . . 0.0 113.131 -174.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 mt -74.9 123.24 30.14 Favored 'Isoleucine or valine' 1 C--O 1.307 4.101 0 CA-C-N 114.329 -1.305 . . . . 0.0 111.688 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG13 HD13 ' A' ' 73' ' ' LEU . 58.5 t -99.9 -45.34 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.691 0 CA-C-N 111.498 -2.592 . . . . 0.0 110.105 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 70.8 m -160.27 170.67 20.62 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.356 -0.84 . . . . 0.0 112.016 -176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -147.93 112.1 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.72 0 CA-C-O 121.184 0.516 . . . . 0.0 112.109 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.9 t30 65.9 -48.04 0.4 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 127.489 2.316 . . . . 0.0 115.57 172.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -162.49 -39.86 0.04 OUTLIER 'General case' 0 C--N 1.281 -2.375 0 C-N-CA 125.605 1.562 . . . . 0.0 109.347 -175.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.408 HG21 HD13 ' A' ' 83' ' ' ILE . 6.7 m -71.44 134.35 46.54 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.625 -175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 50.2 t -84.28 84.44 7.63 Favored 'General case' 0 N--CA 1.41 -2.444 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.541 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.7 t -86.27 17.54 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 CA-C-O 123.763 1.744 . . . . 0.0 109.796 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD13 HG13 ' A' ' 65' ' ' VAL . 12.5 tp -71.72 110.83 6.53 Favored 'General case' 0 N--CA 1.412 -2.371 0 CA-C-N 113.48 -1.691 . . . . 0.0 106.459 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.463 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 61.46 36.72 92.97 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.998 -175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.9 OUTLIER -77.16 128.29 34.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.458 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 36.9 m -62.58 145.82 53.45 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 124.208 0.943 . . . . 0.0 110.439 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 42.9 t60 -45.59 -51.42 12.05 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.189 0.596 . . . . 0.0 112.47 -177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.0 -37.97 78.11 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 124.299 0.999 . . . . 0.0 110.538 -176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.458 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 74.5 mm-40 -76.03 -50.15 15.59 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.318 -175.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.792 HG21 HD21 ' A' ' 41' ' ' LEU . 14.5 p -65.06 -42.24 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.827 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.7 p -63.85 -36.38 76.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -62.15 -41.5 98.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.243 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 70' ' ' THR . 75.7 mt -73.0 -50.41 32.43 Favored 'Isoleucine or valine' 0 C--O 1.25 1.099 0 CA-C-O 122.502 1.144 . . . . 0.0 109.717 -177.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 7.5 m-85 -66.65 -35.59 80.54 Favored 'General case' 0 C--N 1.289 -2.048 0 CA-C-N 113.446 -1.707 . . . . 0.0 112.969 -174.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -85.58 -13.51 48.62 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.2 t -77.73 -23.75 49.3 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.612 HD12 ' CE2' ' A' ' 27' ' ' PHE . 2.0 mt -48.37 136.62 12.13 Favored Pre-proline 0 CA--C 1.563 1.458 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 86.0 Cg_endo -99.13 153.45 0.62 Allowed 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 124.212 3.274 . . . . 0.0 112.398 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.567 HG12 ' H ' ' A' ' 25' ' ' ARG . 41.1 mt -68.6 140.59 18.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.107 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.51 12.31 61.28 Favored Glycine 0 CA--C 1.495 -1.177 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.012 175.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.543 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.9 -169.77 1.63 Allowed 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.018 -0.673 . . . . 0.0 112.501 -171.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . 11.1 p -149.27 138.46 21.43 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -169.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.764 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.3 m -145.56 156.13 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.924 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 172.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.737 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 31.7 m-20 -99.46 106.96 19.06 Favored 'General case' 0 C--N 1.278 -2.5 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.424 HD23 ' HE1' ' A' ' 58' ' ' MET . 9.8 tp -95.96 125.94 40.85 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-O 121.015 0.436 . . . . 0.0 110.942 -174.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -107.74 115.2 29.72 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.639 -178.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -142.21 157.68 44.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.235 0.541 . . . . 0.0 111.382 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 72.0 m -117.89 140.01 50.32 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.717 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 19.0 tpp85 -110.08 132.22 54.36 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.97 -30.21 0.14 Allowed Glycine 0 C--N 1.296 -1.671 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -93.65 141.6 24.04 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 175.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.57 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 43.3 Cg_endo -96.95 -162.88 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.953 2.436 . . . . 0.0 109.151 173.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.65 85.87 3.26 Favored Pre-proline 0 C--N 1.306 -1.301 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.57 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 80.9 Cg_endo -91.79 50.96 0.67 Allowed 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.492 2.795 . . . . 0.0 114.039 -170.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -172.95 164.26 4.97 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 4.4 m-20 -99.37 132.54 23.11 Favored Pre-proline 0 C--N 1.295 -1.799 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.0 Cg_exo -92.74 0.45 3.79 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 123.136 2.557 . . . . 0.0 108.21 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -71.43 -27.51 63.34 Favored 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 112.995 -1.911 . . . . 0.0 109.04 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -83.58 131.02 53.69 Favored Pre-proline 0 C--N 1.307 -1.28 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.35 -166.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.571 2.847 . . . . 0.0 114.869 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.0 m120 88.69 131.47 0.03 OUTLIER 'General case' 0 N--CA 1.416 -2.164 0 C-N-CA 127.483 2.313 . . . . 0.0 110.651 -177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.2 m -67.69 -133.66 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.808 173.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' B' ' 157' ' ' ARG . 4.9 m -72.85 99.26 2.62 Favored 'General case' 0 C--N 1.288 -2.074 0 O-C-N 120.664 -1.272 . . . . 0.0 109.279 176.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -93.64 132.99 37.44 Favored 'General case' 0 N--CA 1.413 -2.294 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.828 175.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -92.42 131.48 39.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-O 120.974 0.416 . . . . 0.0 109.886 -176.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 15.1 t -133.83 146.01 50.24 Favored 'General case' 0 N--CA 1.41 -2.437 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.0 t -97.11 121.56 39.13 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -176.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 47.6 t -104.37 103.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -178.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.432 ' HA ' ' HA3' ' A' ' 0' ' ' GLY . . . -130.78 74.47 1.6 Allowed 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.66 0.743 . . . . 0.0 109.056 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.2 mm -83.9 -55.77 6.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.459 HD12 ' N ' ' A' ' 122' ' ' ASP 0.449 4.3 pp 71.42 -56.51 0.63 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 118.18 2.659 . . . . 0.0 118.18 165.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.459 ' N ' HD12 ' A' ' 121' ' ' LEU . 17.1 t70 -174.52 128.77 0.34 Allowed 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -176.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -119.95 90.95 3.43 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.297 0.57 . . . . 0.0 111.156 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.47 142.73 24.99 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.124 -0.944 . . . . 0.0 111.273 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 CA--C 1.541 0.845 0 C-N-CA 122.413 2.075 . . . . 0.0 112.479 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.428 ' NH2' ' HG2' ' A' ' 1' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 11.3 p -162.52 29.74 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.919 0.781 . . . . 0.0 112.781 -175.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 62.7 m 57.05 43.26 24.67 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-O 122.136 0.97 . . . . 0.0 112.582 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -122.54 128.05 50.27 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 104.541 -2.392 . . . . 0.0 104.541 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 23.8 m 68.09 53.09 0.64 Allowed 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -166.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -113.4 152.01 30.58 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.763 -171.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.631 ' C ' ' HD2' ' B' ' 157' ' ' ARG . 0.0 OUTLIER -124.52 173.29 8.57 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 175.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 43.8 mt-10 -105.36 151.12 24.58 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.304 0.573 . . . . 0.0 111.072 176.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -150.49 119.55 6.72 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 174.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.537 ' HA ' HG22 ' A' ' 30' ' ' THR . 29.3 tt0 -84.07 130.53 34.86 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.562 HG23 ' HB2' ' A' ' 27' ' ' PHE . 10.7 m . . . . . 0 N--CA 1.407 -2.611 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -142.7 31.79 1.45 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.632 0.729 . . . . 0.0 109.566 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -87.37 60.06 5.87 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.659 0.742 . . . . 0.0 111.629 -177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -103.29 40.32 2.48 Favored Glycine 0 N--CA 1.431 -1.661 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 177.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.77 150.2 43.0 Favored Pre-proline 0 C--N 1.306 -1.284 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -73.32 135.46 22.56 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 C-N-CA 121.275 1.316 . . . . 0.0 110.755 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.441 ' HE2' ' HA ' ' A' ' 11' ' ' LEU . 30.5 p90 -101.91 130.5 48.43 Favored 'General case' 0 C--N 1.277 -2.581 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.381 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -146.97 143.03 28.15 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.881 -178.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . 0.355 12.9 t -157.67 -44.79 0.06 Allowed 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 114.119 -1.4 . . . . 0.0 111.261 162.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.513 ' HB2' HD21 ' A' ' 73' ' ' LEU . 15.6 ptm180 152.77 -19.45 0.0 OUTLIER 'General case' 0 C--O 1.204 -1.294 0 C-N-CA 126.667 1.987 . . . . 0.0 108.379 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.815 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 24.1 m-80 -66.42 118.46 53.87 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -171.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.472 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.307 21.4 Cg_exo -62.48 -35.87 69.01 Favored 'Trans proline' 0 CA--C 1.467 -2.844 0 N-CA-C 107.734 -1.679 . . . . 0.0 107.734 172.257 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.4 m -66.78 -23.64 66.1 Favored 'General case' 1 N--CA 1.333 -6.297 0 CA-C-N 109.925 -3.307 . . . . 0.0 112.236 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.815 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.7 pt-20 -79.48 -30.9 42.24 Favored 'General case' 0 C--N 1.378 1.84 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 174.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.1 mt -59.12 133.95 56.56 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.385 175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -81.26 168.57 18.33 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 113.453 -1.703 . . . . 0.0 113.887 -173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.457 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 90.85 -114.61 4.49 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.995 -1.457 . . . . 0.0 112.61 -178.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.594 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -140.8 146.51 37.72 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 124.551 1.14 . . . . 0.0 110.118 -178.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -113.56 116.91 30.26 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -173.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 154.47 40.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 C-N-CA 123.403 0.681 . . . . 0.0 112.358 -175.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 13.1 p-80 -126.71 112.5 15.5 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.263 176.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.517 HG21 ' HB2' ' A' ' 58' ' ' MET . 7.5 t -121.42 137.39 54.73 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.308 -177.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.446 ' HE3' ' CB ' ' A' ' 92' ' ' SER . 0.5 OUTLIER -85.07 136.61 33.49 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.323 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -124.66 129.04 49.77 Favored 'General case' 0 CA--C 1.472 -2.028 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 91' ' ' ALA . 69.9 ttt180 -86.95 112.64 22.0 Favored 'General case' 0 N--CA 1.384 -3.767 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.595 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.1 mptp? -36.12 111.26 0.13 Allowed 'General case' 0 CA--C 1.478 -1.818 0 C-N-CA 125.225 1.41 . . . . 0.0 111.579 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.9 t -89.0 -143.19 0.14 Allowed 'General case' 0 N--CA 1.415 -2.194 0 O-C-N 125.48 1.738 . . . . 0.0 108.186 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -58.89 79.26 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -177.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.566 ' H ' HG12 ' A' ' 89' ' ' ILE . 82.8 mtp180 57.29 40.27 27.91 Favored 'General case' 0 CA--C 1.485 -1.54 0 C-N-CA 125.474 1.51 . . . . 0.0 112.486 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 165.75 -130.72 2.21 Favored Glycine 0 N--CA 1.406 -3.313 0 CA-C-N 113.49 -1.686 . . . . 0.0 108.956 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.679 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.4 m-85 -134.61 -75.58 0.46 Allowed 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -174.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.07 46.53 0.2 Allowed Glycine 0 C--N 1.294 -1.765 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.239 -169.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.491 ' CD1' HD12 ' A' ' 43' ' ' ILE . 45.0 p90 -159.2 142.45 14.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 172.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.507 ' CG2' ' HG3' ' B' ' 160' ' ' GLN . 69.9 p -108.39 136.23 48.37 Favored 'General case' 0 C--N 1.271 -2.814 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.259 -176.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.646 HG21 HD23 ' A' ' 41' ' ' LEU . 1.1 m -114.9 162.5 12.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 11.4 m -125.36 133.24 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 C-N-CA 124.522 1.129 . . . . 0.0 110.869 174.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 115.63 -132.03 10.03 Favored Glycine 0 C--O 1.27 2.4 0 C-N-CA 120.947 -0.644 . . . . 0.0 113.244 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.675 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.95 45.27 7.53 Favored Glycine 0 CA--C 1.458 -3.472 0 C-N-CA 126.245 1.878 . . . . 0.0 112.594 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.502 ' OD1' ' HB2' ' B' ' 156' ' ' ARG . 18.6 t70 -95.12 -22.2 18.03 Favored 'General case' 0 C--N 1.262 -3.203 0 CA-C-O 121.296 0.57 . . . . 0.0 110.612 -173.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 39' ' ' GLU . 7.2 pt-20 -157.28 171.3 7.63 Favored Pre-proline 0 N--CA 1.413 -2.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.199 -168.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 51.5 Cg_exo -64.02 -36.28 49.59 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 121.874 1.716 . . . . 0.0 108.201 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.16 -27.24 66.25 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.982 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 41.0 tt0 -125.5 117.69 24.16 Favored 'General case' 0 C--O 1.267 1.988 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.372 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 12.6 m-85 -84.22 165.26 18.53 Favored 'General case' 0 C--O 1.246 0.908 0 O-C-N 126.669 2.481 . . . . 0.0 108.25 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.675 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.4 mp -86.43 144.53 27.25 Favored 'General case' 0 C--O 1.18 -2.589 0 C-N-CA 119.141 -1.024 . . . . 0.0 108.708 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -128.88 164.78 22.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 62' ' ' ASP . 31.4 mm -107.04 123.76 62.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.336 0 CA-C-N 118.795 0.725 . . . . 0.0 110.963 -175.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HA ' HD21 ' A' ' 103' ' ' LEU . 17.9 pttm -100.93 -26.69 13.65 Favored 'General case' 0 CA--C 1.506 -0.728 0 O-C-N 123.436 0.46 . . . . 0.0 111.954 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 44.3 m -149.87 126.99 11.26 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 118.978 -1.089 . . . . 0.0 111.646 177.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.16 113.15 15.84 Favored 'General case' 0 N--CA 1.382 -3.829 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 168.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.472 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 85.0 t -87.04 121.51 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.422 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 83.7 mt -67.4 142.73 56.62 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.33 -179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 34.9 t70 82.91 5.99 0.87 Allowed 'General case' 0 C--O 1.216 -0.668 0 O-C-N 125.103 1.502 . . . . 0.0 109.579 -172.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -88.81 165.4 33.34 Favored Glycine 0 C--O 1.206 -1.626 0 CA-C-O 118.113 -1.382 . . . . 0.0 110.175 174.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.679 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 27.9 Cg_endo -72.41 -25.47 18.17 Favored 'Trans proline' 0 N--CA 1.441 -1.602 0 CA-C-N 121.338 2.569 . . . . 0.0 110.547 -170.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.485 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -68.66 -37.08 79.36 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.871 175.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.85 -46.64 65.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 122.81 1.29 . . . . 0.0 109.264 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 81.2 mt -72.4 -46.19 56.35 Favored 'General case' 0 N--CA 1.4 -2.96 0 CA-C-N 112.558 -2.11 . . . . 0.0 114.537 -173.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -75.48 -26.71 58.43 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 176.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.89 -165.88 51.43 Favored Glycine 0 N--CA 1.432 -1.627 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -174.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.504 ' HE2' ' OG1' ' A' ' 18' ' ' THR . 6.2 ttpm? 72.81 -49.95 0.7 Allowed 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 173.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.551 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -87.21 133.02 33.7 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -145.14 166.85 24.22 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.543 0.687 . . . . 0.0 111.359 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.4 m -58.12 129.89 44.06 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.107 -0.951 . . . . 0.0 108.438 173.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.86 -6.27 25.76 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 119.953 -1.118 . . . . 0.0 111.132 -176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.586 ' O ' HG12 ' A' ' 43' ' ' ILE . 14.8 m-20 -79.91 129.35 34.41 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 173.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 2.7 p -98.11 115.93 39.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 C-N-CA 120.156 -0.618 . . . . 0.0 109.852 173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.473 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.3 mm -71.03 113.78 7.9 Favored 'Isoleucine or valine' 0 C--O 1.294 3.432 0 C-N-CA 125.078 1.351 . . . . 0.0 110.669 -177.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 39.4 t -103.22 -54.72 6.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.809 0 CA-C-N 113.074 -1.876 . . . . 0.0 110.687 -176.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.8 t -144.92 160.27 41.58 Favored 'General case' 0 C--N 1.313 -1.004 0 O-C-N 122.077 -0.389 . . . . 0.0 110.159 -175.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.432 HG23 HD13 ' A' ' 95' ' ' LEU . 5.3 p -146.31 105.23 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 113.437 0.902 . . . . 0.0 113.437 -177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.454 ' CB ' HG12 ' A' ' 93' ' ' VAL . 27.6 t-20 65.97 -65.58 0.18 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.718 1.607 . . . . 0.0 114.341 172.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -145.22 -39.64 0.25 Allowed 'General case' 0 C--N 1.271 -2.809 0 C-N-CA 124.98 1.312 . . . . 0.0 108.884 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.5 m -70.04 127.33 32.48 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.304 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 28.2 t -87.26 87.23 7.38 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 66' ' ' SER . 10.1 p -77.11 2.25 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 122.496 1.141 . . . . 0.0 109.591 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 6' ' ' ARG . 22.9 tp -63.75 111.6 2.5 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.242 -1.344 . . . . 0.0 108.226 177.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 68.35 27.78 73.59 Favored Glycine 0 N--CA 1.425 -2.073 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.656 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -72.95 138.3 46.03 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.495 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 62.1 m -71.05 143.01 50.86 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.522 ' CG ' ' HA ' ' B' ' 156' ' ' ARG . 51.1 t-80 -49.08 -45.05 42.53 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 -174.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.25 -36.94 81.37 Favored 'General case' 0 C--N 1.308 -1.204 0 O-C-N 123.656 0.598 . . . . 0.0 110.471 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.495 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 73.4 mm-40 -69.32 -56.0 8.81 Favored 'General case' 0 C--O 1.251 1.136 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.276 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 41' ' ' LEU . 5.4 p -61.25 -47.36 93.84 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.665 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.611 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 8.1 p -62.7 -35.9 72.77 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.394 0 CA-C-N 116.751 -0.204 . . . . 0.0 110.618 -178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.15 -41.18 96.28 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 123.152 0.283 . . . . 0.0 111.418 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.6 mt -71.83 -51.03 34.27 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-O 122.401 1.096 . . . . 0.0 108.741 -176.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -64.01 -30.26 71.35 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.045 -1.889 . . . . 0.0 113.236 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.611 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.6 tp-100 -85.96 -23.22 27.01 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 54.4 p -94.98 2.91 55.42 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.334 0.587 . . . . 0.0 111.511 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.465 HD13 ' HG3' ' A' ' 22' ' ' LYS . 7.0 mt -48.13 143.52 6.73 Favored Pre-proline 0 CA--C 1.559 1.295 0 C-N-CA 124.791 1.236 . . . . 0.0 114.081 173.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 39.8 Cg_endo -95.75 142.86 1.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.632 2.888 . . . . 0.0 110.467 174.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.566 HG12 ' H ' ' A' ' 25' ' ' ARG . 39.0 mt -68.45 142.97 15.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.835 -178.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.15 11.66 72.34 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 121.421 -0.419 . . . . 0.0 112.068 176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.506 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -98.65 -171.41 2.11 Favored 'General case' 0 C--O 1.202 -1.422 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.615 -171.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.446 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.7 p -147.85 138.24 22.99 Favored 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -168.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG13 ' HE2' ' A' ' 22' ' ' LYS . 1.3 m -151.24 155.72 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 C-N-CA 123.618 0.767 . . . . 0.0 111.834 174.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -105.36 109.76 21.86 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 113.787 -1.552 . . . . 0.0 107.726 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.9 mm? -90.66 113.72 25.85 Favored 'General case' 0 C--N 1.274 -2.683 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 46.7 mt-10 -92.19 107.83 19.5 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 174.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.551 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -139.48 153.8 47.6 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 120.926 0.393 . . . . 0.0 110.545 -172.375 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 14.5 t -113.87 126.73 55.51 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.485 -177.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.594 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 21.5 tpp85 -96.92 137.91 35.28 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.13 1.92 Allowed Glycine 0 CA--C 1.487 -1.678 0 C-N-CA 119.998 -1.096 . . . . 0.0 110.772 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -79.87 134.91 56.12 Favored Pre-proline 0 N--CA 1.422 -1.861 0 CA-C-N 114.786 -0.707 . . . . 0.0 110.274 176.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 83.4 Cg_endo -88.92 175.63 3.5 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 121.86 1.707 . . . . 0.0 109.643 174.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER -112.6 86.41 8.45 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 176.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 10.5 Cg_endo -85.8 46.31 1.67 Allowed 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.302 2.668 . . . . 0.0 111.12 -176.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -156.27 176.89 12.09 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -103.44 132.36 21.16 Favored Pre-proline 0 C--N 1.288 -2.094 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 16.6 Cg_endo -102.55 5.2 0.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.626 0 C-N-CA 123.495 2.796 . . . . 0.0 110.757 -172.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -96.8 -32.6 12.04 Favored 'General case' 0 N--CA 1.394 -3.269 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.516 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -45.82 130.3 6.86 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 126.202 1.801 . . . . 0.0 111.641 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.423 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -16.34 -94.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.369 1.656 1 C-N-CA 127.645 5.563 . . . . 0.0 117.621 -177.854 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.641 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.6 OUTLIER 65.2 88.46 0.1 Allowed 'General case' 0 N--CA 1.431 -1.379 0 C-N-CA 125.904 1.682 . . . . 0.0 112.62 175.199 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.3 t -87.32 -158.74 0.46 Allowed 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.854 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.568 ' HA ' ' CG2' ' B' ' 155' ' ' THR . 9.2 m -70.01 102.05 1.93 Allowed 'General case' 0 N--CA 1.414 -2.256 0 O-C-N 121.937 -0.477 . . . . 0.0 110.591 178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.543 ' O ' ' HA ' ' B' ' 155' ' ' THR . 33.5 mt -77.63 105.24 8.67 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.22 132.54 65.48 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.239 0 CA-C-O 121.254 0.55 . . . . 0.0 111.498 -173.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.6 t -80.46 142.03 34.67 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 174.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 12.6 p -86.13 91.15 8.34 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.697 0.761 . . . . 0.0 112.162 -173.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -105.14 101.49 12.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.933 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' HB1' ' HB3' ' A' ' 122' ' ' ASP . . . -135.59 79.71 1.79 Allowed 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.2 -174.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.9 mm -101.03 -14.24 8.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 175.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.72 -19.78 18.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.73 -176.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.542 ' C ' ' HD3' ' A' ' 123' ' ' LYS . 8.6 t70 -88.5 -160.86 0.68 Allowed 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.96 -173.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.542 ' HD3' ' C ' ' A' ' 122' ' ' ASP . 0.0 OUTLIER 38.99 38.12 0.27 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.852 2.061 . . . . 0.0 113.311 -176.789 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -73.81 111.23 11.4 Favored Pre-proline 0 C--O 1.242 0.686 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.066 -175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo . . . . . 0 N--CA 1.433 -2.031 0 C-N-CA 122.819 2.346 . . . . 0.0 109.838 174.745 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 20.7 tpp85 . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -95.41 73.34 3.27 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.5 m -67.88 -87.36 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 43.07 32.64 0.45 Allowed 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.384 1.088 . . . . 0.0 112.111 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 113' ' ' SER . 0.9 OUTLIER -83.54 -171.19 3.44 Favored 'General case' 0 N--CA 1.42 -1.944 0 C-N-CA 126.333 1.853 . . . . 0.0 112.026 -175.376 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.522 ' HA ' ' CG ' ' A' ' 77' ' ' HIS . 6.7 ptm180 -152.7 146.43 25.12 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 170.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 24.6 mmm180 72.4 -57.78 0.61 Allowed 'General case' 0 C--N 1.37 1.467 0 CA-C-N 120.314 1.416 . . . . 0.0 110.823 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.544 ' HB3' HE22 ' B' ' 160' ' ' GLN . 48.2 mm-40 -80.37 85.61 5.83 Favored 'General case' 0 C--N 1.296 -1.719 0 C-N-CA 124.927 1.291 . . . . 0.0 113.44 -177.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.474 ' HB ' HG22 ' A' ' 31' ' ' VAL . 0.5 OUTLIER -100.43 93.28 5.56 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.544 HE22 ' HB3' ' B' ' 158' ' ' GLU . 2.7 mp0 -82.38 110.05 17.18 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 27' ' ' PHE . 14.2 m . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.477 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 78.52 1.18 2.6 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 125.676 1.59 . . . . 0.0 114.687 176.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 95.7 mmm 52.34 62.66 2.58 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 125.311 1.444 . . . . 0.0 113.846 176.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -90.43 11.74 70.4 Favored Glycine 0 C--N 1.314 -0.642 0 N-CA-C 111.114 -0.795 . . . . 0.0 111.114 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.22 140.24 22.69 Favored Pre-proline 0 N--CA 1.428 -1.559 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.88 146.85 73.3 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.505 2.137 . . . . 0.0 110.822 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -93.05 128.49 38.95 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 121.151 0.501 . . . . 0.0 110.629 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -147.46 129.39 15.35 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.333 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.646 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.5 t -166.41 26.24 0.04 OUTLIER 'General case' 0 C--N 1.275 -2.662 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.15 166.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.709 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.3 ptm180 57.21 19.14 4.67 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 126.921 2.088 . . . . 0.0 112.789 175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.75 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.5 114.24 58.84 Favored Pre-proline 1 C--N 1.231 -4.549 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.081 176.451 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.28 10.5 Cg_exo -58.0 -29.49 86.92 Favored 'Trans proline' 0 CA--C 1.48 -2.214 0 C-N-CA 121.528 1.485 . . . . 0.0 109.278 171.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -71.46 -24.27 61.98 Favored 'General case' 1 N--CA 1.366 -4.658 0 CA-C-N 112.425 -2.171 . . . . 0.0 110.671 -175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.75 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.7 pt-20 -79.33 -31.62 43.16 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.7 mt -64.1 129.74 41.19 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.504 -1.225 . . . . 0.0 110.745 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -80.23 179.19 7.78 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 113.031 -1.895 . . . . 0.0 113.231 -172.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.01 -126.59 8.01 Favored Glycine 0 N--CA 1.432 -1.616 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.845 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 98' ' ' CYS . 0.0 OUTLIER -128.54 146.87 50.71 Favored 'General case' 0 C--N 1.284 -2.241 0 C-N-CA 123.792 0.837 . . . . 0.0 109.91 -179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -117.18 116.87 28.14 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -171.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.27 153.39 38.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.736 -176.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.649 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 20.8 t-160 -125.31 111.44 15.19 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.4 HG22 HD21 ' A' ' 97' ' ' LEU . 12.6 t -128.42 151.49 49.31 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.387 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -102.93 136.34 42.94 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 2.4 mp -117.59 116.48 27.18 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -86.47 106.78 17.72 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.621 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.86 117.72 0.53 Allowed 'General case' 0 CA--C 1.472 -2.035 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 177.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 25.2 t -87.87 -152.95 0.22 Allowed 'General case' 0 N--CA 1.413 -2.319 0 O-C-N 126.236 2.21 . . . . 0.0 108.306 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.4 ' HA ' HG12 ' A' ' 89' ' ' ILE . 23.2 m -65.61 80.43 0.06 Allowed 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -177.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.588 ' N ' HG12 ' A' ' 89' ' ' ILE . 24.4 mmt180 71.44 73.88 0.18 Allowed 'General case' 0 CA--C 1.494 -1.201 0 C-N-CA 124.47 1.108 . . . . 0.0 111.392 174.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 114.48 -131.9 10.13 Favored Glycine 0 N--CA 1.405 -3.372 0 CA-C-N 113.996 -1.456 . . . . 0.0 110.886 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.645 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 68.9 m-85 -129.08 -78.9 0.56 Allowed 'General case' 0 N--CA 1.401 -2.9 0 CA-C-N 114.931 -0.635 . . . . 0.0 111.437 -172.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.608 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.64 55.41 0.18 Allowed Glycine 0 C--N 1.285 -2.265 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -170.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.475 ' CD1' HD12 ' A' ' 43' ' ' ILE . 19.3 p90 -162.2 146.5 12.28 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 172.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.0 p -108.31 135.04 50.29 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-O 122.219 1.009 . . . . 0.0 109.577 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 3.2 p -131.59 144.11 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.38 -3.96 0 CA-C-N 113.839 -1.528 . . . . 0.0 111.256 -167.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 20.0 m -120.42 132.54 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.136 0 C-N-CA 124.317 1.047 . . . . 0.0 111.347 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.671 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 132.77 -139.19 10.73 Favored Glycine 0 N--CA 1.396 -3.997 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.403 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 42.51 44.37 5.2 Favored Glycine 0 C--O 1.18 -3.278 0 O-C-N 125.898 1.587 . . . . 0.0 110.184 -177.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.666 ' OD2' ' HB2' ' B' ' 156' ' ' ARG . 15.9 t70 -82.44 -41.97 19.15 Favored 'General case' 0 C--N 1.255 -3.509 0 CA-C-N 113.252 -1.474 . . . . 0.0 107.875 -172.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 4.1 pt-20 -160.28 170.88 7.89 Favored Pre-proline 0 CA--C 1.48 -1.712 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.745 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -73.74 59.08 4.12 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 124.49 3.46 . . . . 0.0 108.842 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.423 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 5.2 t70 -166.88 -39.46 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.698 0 CA-C-N 111.871 -2.422 . . . . 0.0 108.257 -172.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 37.2 tt0 -122.21 122.23 38.67 Favored 'General case' 0 C--O 1.27 2.147 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.978 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.28 166.06 14.02 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 128.673 2.789 . . . . 0.0 109.937 -174.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 5.6 mp -90.39 144.81 25.46 Favored 'General case' 0 C--O 1.168 -3.221 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.184 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 2.6 tt0 -138.53 145.33 40.59 Favored 'General case' 0 C--O 1.185 -2.34 0 CA-C-N 118.67 0.668 . . . . 0.0 109.575 -175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 29' ' ' PHE . 37.0 mm -88.27 121.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.99 0 O-C-N 121.477 -0.765 . . . . 0.0 111.855 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.559 ' O ' ' HB3' ' A' ' 107' ' ' PRO . 46.5 mtmt -101.39 -19.35 15.63 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.889 174.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 58.5 m -150.47 127.3 11.02 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.185 177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 19.3 tp -84.02 109.15 17.42 Favored 'General case' 0 N--CA 1.386 -3.636 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 172.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.608 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.5 t -83.05 121.57 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.581 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.0 mt -67.64 150.42 48.77 Favored 'General case' 0 N--CA 1.421 -1.891 0 CA-C-N 115.628 -0.714 . . . . 0.0 111.396 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 37.9 t70 76.47 12.13 2.63 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 125.012 1.445 . . . . 0.0 109.59 -172.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.45 160.83 27.06 Favored Glycine 0 C--O 1.201 -1.962 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.671 171.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 3.8 Cg_endo -71.97 -25.21 19.9 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 CA-C-N 121.672 2.736 . . . . 0.0 109.931 -172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' A' ' 58' ' ' MET . . . -62.85 -45.15 93.91 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.531 -1.213 . . . . 0.0 108.99 174.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.29 -45.51 80.14 Favored 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.367 1.079 . . . . 0.0 110.432 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.608 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.7 mt -72.18 -35.69 69.06 Favored 'General case' 0 N--CA 1.399 -2.99 0 CA-C-N 113.116 -1.856 . . . . 0.0 114.795 -172.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.507 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.7 t70 -83.57 -23.83 31.82 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 173.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.83 21.67 69.57 Favored Glycine 0 CA--C 1.492 -1.351 0 CA-C-N 113.219 -1.809 . . . . 0.0 113.287 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -99.72 -15.62 18.43 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 114.963 -0.618 . . . . 0.0 111.142 -173.481 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.548 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 35.5 ttm -122.98 139.73 53.77 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.638 -1.615 . . . . 0.0 106.638 177.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.502 ' HB2' ' HE ' ' A' ' 99' ' ' ARG . 34.9 mt-10 -147.41 164.0 34.72 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.478 0.656 . . . . 0.0 109.469 -175.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.463 HG23 ' C ' ' A' ' 44' ' ' LYS . 8.5 m -54.2 117.91 3.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.914 175.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 123.94 -1.67 9.19 Favored Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 119.73 -1.224 . . . . 0.0 113.583 -177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.621 ' CG ' HD12 ' A' ' 97' ' ' LEU . 1.2 p30 -102.25 156.61 17.46 Favored 'General case' 0 CA--C 1.494 -1.196 0 O-C-N 121.664 -0.903 . . . . 0.0 112.667 172.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -113.18 122.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.732 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.748 177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 51.2 mm -76.05 116.69 19.44 Favored 'Isoleucine or valine' 0 C--O 1.304 3.964 0 CA-C-N 114.167 -1.379 . . . . 0.0 110.14 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.485 HG13 HD13 ' A' ' 73' ' ' LEU . 47.6 t -99.4 -53.84 7.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.163 0 CA-C-N 112.74 -2.027 . . . . 0.0 110.758 -176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.413 ' HA ' HG12 ' A' ' 72' ' ' VAL . 50.4 m -143.44 161.83 37.39 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 121.131 -0.981 . . . . 0.0 112.189 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.514 HG12 ' HB ' ' A' ' 72' ' ' VAL . 7.6 p -142.19 97.94 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-O 121.896 0.855 . . . . 0.0 112.501 -175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.402 HD22 ' HA ' ' A' ' 93' ' ' VAL . 41.8 t-20 65.12 -84.2 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 125.769 1.628 . . . . 0.0 112.918 175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -131.34 -7.23 3.77 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.295 -178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.448 ' HB ' HG13 ' A' ' 67' ' ' VAL . 77.5 m -98.72 133.16 43.44 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 121.479 0.657 . . . . 0.0 109.336 -178.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.9 t -87.65 82.79 7.31 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.514 ' HB ' HG12 ' A' ' 67' ' ' VAL . 9.9 p -75.81 -3.08 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 122.774 1.274 . . . . 0.0 109.471 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 6' ' ' ARG . 22.4 tp -64.23 111.03 2.41 Favored 'General case' 0 N--CA 1.409 -2.483 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.384 176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 38.87 96.76 Favored Glycine 0 N--CA 1.428 -1.844 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.644 -176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -79.44 149.92 31.43 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 98.7 m -73.24 141.92 47.27 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.565 ' HB2' ' HB3' ' B' ' 156' ' ' ARG . 39.6 t-80 -52.89 -47.89 67.57 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-N 118.893 0.77 . . . . 0.0 112.026 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.75 -35.4 68.57 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 113.946 -1.479 . . . . 0.0 110.526 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -76.2 -50.47 14.42 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.277 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 77' ' ' HIS . 6.6 p -61.12 -44.42 98.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 O-C-N 123.312 0.382 . . . . 0.0 111.531 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.8 p -64.02 -39.24 84.75 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.5 0 C-N-CA 120.948 -0.301 . . . . 0.0 110.686 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.9 tmmm? -58.27 -42.86 87.45 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.52 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.1 mt -72.89 -51.04 28.82 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 CA-C-O 122.32 1.057 . . . . 0.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -65.01 -30.58 71.57 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 113.506 -1.679 . . . . 0.0 113.51 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -85.95 -22.76 27.22 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 122.112 -0.368 . . . . 0.0 111.88 176.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 71.0 m -79.33 -14.82 58.75 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 120.808 0.337 . . . . 0.0 110.95 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.621 HG23 ' HG2' ' A' ' 22' ' ' LYS . 4.7 mt -47.94 135.67 11.18 Favored Pre-proline 0 N--CA 1.429 -1.493 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.0 Cg_endo -99.58 156.46 0.57 Allowed 'Trans proline' 0 CA--C 1.551 1.352 0 C-N-CA 124.35 3.367 . . . . 0.0 111.43 176.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -68.02 138.53 22.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.816 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.3 13.46 55.83 Favored Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 119.554 -1.308 . . . . 0.0 112.079 176.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -97.39 -175.37 3.19 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.058 -172.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.538 ' N ' ' HE3' ' A' ' 22' ' ' LYS . 11.4 p -148.22 136.82 21.58 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.402 ' HA ' HD22 ' A' ' 68' ' ' ASN . 10.0 m -154.16 147.84 13.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 C-N-CA 124.02 0.928 . . . . 0.0 111.229 175.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 1.9 m-20 -105.22 108.13 19.49 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 124.272 1.029 . . . . 0.0 109.519 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.497 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.8 mm? -91.43 124.25 35.48 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.349 0.595 . . . . 0.0 111.715 -177.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -97.31 119.0 35.03 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 105.647 -1.983 . . . . 0.0 105.647 171.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.621 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.9 pt? -142.7 159.06 42.97 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -174.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 14' ' ' LYS . 60.4 m -120.49 108.52 14.19 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.131 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.545 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -85.28 144.5 28.06 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.776 0.831 . . . . 0.0 108.807 -178.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.03 9.99 14.84 Favored Glycine 0 C--N 1.297 -1.636 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.574 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -88.5 127.09 57.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.593 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 25.4 Cg_endo -60.64 151.92 72.58 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 122.633 2.222 . . . . 0.0 113.86 -173.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.46 HD21 ' O ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -110.37 76.83 1.13 Allowed Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.01 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.593 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 22.0 Cg_endo -92.67 37.69 0.23 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 122.863 2.376 . . . . 0.0 109.736 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CD2' ' HD2' ' A' ' 104' ' ' PRO . 57.6 m-85 -138.22 149.98 46.3 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 17.7 t70 -79.38 136.38 56.52 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.559 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 1.3 Cg_endo -91.35 -8.3 3.27 Favored 'Trans proline' 0 N--CA 1.411 -3.324 0 C-N-CA 123.381 2.721 . . . . 0.0 110.533 -171.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -92.83 -29.06 16.16 Favored 'General case' 0 N--CA 1.38 -3.94 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.021 -179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -46.87 109.15 0.98 Allowed Pre-proline 0 N--CA 1.479 1.016 0 C-N-CA 127.621 2.368 . . . . 0.0 115.683 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -90.83 -146.64 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 124.204 3.27 . . . . 0.0 110.584 168.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.5 m120 76.81 87.31 0.08 Allowed 'General case' 0 N--CA 1.417 -2.12 0 C-N-CA 126.415 1.886 . . . . 0.0 112.795 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.505 ' OG1' ' HG3' ' B' ' 154' ' ' ARG . 12.1 t -129.54 160.82 32.04 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 115.209 -0.905 . . . . 0.0 108.944 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.617 ' O ' ' HA ' ' B' ' 155' ' ' THR . 26.6 m -137.04 101.07 4.45 Favored 'General case' 0 N--CA 1.383 -3.8 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 170.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 52.3 mt -80.94 122.0 26.71 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.256 0.551 . . . . 0.0 110.442 -173.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.7 t -123.66 109.75 24.05 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.8 t -74.1 148.35 41.92 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.8 m -99.62 134.04 43.08 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.242 0.544 . . . . 0.0 112.088 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.6 p -133.89 123.11 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.976 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.021 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -100.46 83.53 2.63 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 121.315 0.579 . . . . 0.0 111.607 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.1 mm -98.32 -39.01 7.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 173.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 77.1 mt -130.55 170.99 13.53 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 113.202 -1.817 . . . . 0.0 108.511 178.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.0 t70 60.92 72.96 0.5 Allowed 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.919 1.343 . . . . 0.0 112.62 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.09 131.83 54.18 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 173.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -80.04 116.87 64.4 Favored Pre-proline 0 C--N 1.289 -2.051 0 O-C-N 123.547 0.53 . . . . 0.0 110.991 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.436 -1.864 0 C-N-CA 122.564 2.176 . . . . 0.0 109.859 174.147 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 . . . . . 0 CA--C 1.514 -0.442 0 CA-C-O 121.124 0.488 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 20.1 m -159.29 -60.57 0.07 Allowed 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 8.1 p -152.33 116.36 4.9 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.877 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.505 ' HG3' ' OG1' ' A' ' 112' ' ' THR . 6.1 tpp180 -131.7 72.15 1.49 Allowed 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.603 0.716 . . . . 0.0 109.332 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.617 ' HA ' ' O ' ' A' ' 113' ' ' SER . 12.8 p -110.16 -10.89 14.64 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.239 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.666 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 3.5 mpt_? -141.44 -148.75 0.25 Allowed 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 174.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 33' ' ' GLY 0.327 83.8 mtt180 82.01 -68.47 0.08 Allowed 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 116.968 2.21 . . . . 0.0 116.968 170.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . 0.256 10.7 pt-20 -84.05 96.02 8.76 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 -172.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.497 ' HB ' HG13 ' A' ' 31' ' ' VAL . 3.9 m -100.86 120.65 40.45 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.461 ' HA ' HG22 ' A' ' 30' ' ' THR . 25.2 tt0 -99.75 115.59 29.89 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.507 HG23 ' HB2' ' A' ' 27' ' ' PHE . 21.8 m . . . . . 0 N--CA 1.434 -1.242 0 O-C-N 123.38 0.425 . . . . 0.0 109.973 -175.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.614 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -76.0 -29.72 58.28 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 120.889 0.376 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -97.8 55.23 1.19 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.991 0.9 . . . . 0.0 109.481 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.596 ' HA2' HG22 ' A' ' 120' ' ' ILE . . . -107.12 36.12 4.6 Favored Glycine 0 N--CA 1.428 -1.834 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.961 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.13 160.56 26.5 Favored Pre-proline 0 C--N 1.31 -1.139 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -63.01 132.2 35.84 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 C-N-CA 121.904 1.736 . . . . 0.0 110.141 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -81.5 131.05 35.26 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.592 -172.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.471 ' CG ' ' HA ' ' A' ' 38' ' ' ASP . 24.3 t80 -148.13 134.22 19.29 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 113.569 -1.65 . . . . 0.0 110.66 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -171.11 35.72 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.153 167.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.587 ' O ' HD21 ' A' ' 73' ' ' LEU . 28.8 ptt180 50.64 26.83 2.64 Favored 'General case' 0 N--CA 1.504 2.242 0 C-N-CA 126.994 2.118 . . . . 0.0 113.662 175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.775 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 9.8 m-80 -103.18 114.56 65.01 Favored Pre-proline 1 C--N 1.236 -4.362 0 CA-C-N 113.588 -1.642 . . . . 0.0 114.264 178.049 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.281 11.9 Cg_exo -55.95 -33.93 90.53 Favored 'Trans proline' 0 CA--C 1.479 -2.227 0 C-N-CA 121.583 1.522 . . . . 0.0 109.197 168.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 27.9 t -65.97 -26.73 67.7 Favored 'General case' 1 N--CA 1.371 -4.378 0 CA-C-N 112.604 -2.089 . . . . 0.0 111.648 -177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.775 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -77.81 -31.95 52.07 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.08 133.94 55.94 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.254 173.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' HE2' ' O ' ' A' ' 100' ' ' GLY . 17.1 ptmt -82.53 -177.52 6.72 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 114.196 -1.366 . . . . 0.0 112.579 -174.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 84.73 -112.63 3.66 Favored Glycine 0 N--CA 1.44 -1.041 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.479 -178.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 4.6 ptmt -146.46 149.13 33.09 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 124.017 0.927 . . . . 0.0 109.565 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -114.37 116.11 28.41 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.15 152.44 37.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 CA-C-O 121.44 0.638 . . . . 0.0 111.846 -177.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -127.73 110.69 12.88 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.027 176.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.5 t -129.53 142.6 50.73 Favored 'General case' 0 C--N 1.28 -2.438 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.835 -177.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.566 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -73.44 133.86 43.82 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.576 -178.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.495 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.3 128.01 53.74 Favored 'General case' 0 N--CA 1.426 -1.666 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 173.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -82.96 108.33 16.2 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.331 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.709 ' HE2' HG13 ' A' ' 93' ' ' VAL . 2.4 mptp? -40.04 106.34 0.05 Allowed 'General case' 0 C--O 1.254 1.314 0 C-N-CA 124.144 0.978 . . . . 0.0 111.136 170.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.5 m -127.38 141.58 51.65 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 125.131 1.52 . . . . 0.0 110.141 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.3 m 54.73 32.63 17.82 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 125.477 1.511 . . . . 0.0 114.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.596 ' H ' HG12 ' A' ' 89' ' ' ILE . 23.9 mmt180 73.79 53.89 0.11 Allowed 'General case' 0 CA--C 1.501 -0.917 0 CA-C-O 122.63 1.205 . . . . 0.0 109.605 175.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.26 -120.45 1.17 Allowed Glycine 0 N--CA 1.401 -3.7 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.711 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.0 m-85 -135.48 -78.52 0.43 Allowed 'General case' 0 C--N 1.275 -2.649 0 C-N-CA 122.743 0.417 . . . . 0.0 111.763 -176.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.499 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.96 48.56 0.12 Allowed Glycine 0 C--N 1.299 -1.478 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.728 -170.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -161.47 143.53 11.81 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 173.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.561 HG22 ' HA ' ' B' ' 160' ' ' GLN . 37.9 p -105.11 135.48 46.38 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.598 -178.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -119.79 147.19 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.364 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.107 -172.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.628 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 15.2 m -120.32 135.38 60.76 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.304 0 CA-C-N 114.326 -1.306 . . . . 0.0 109.867 -178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 122.37 -131.25 8.28 Favored Glycine 0 C--N 1.281 -2.522 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.637 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 36.82 60.08 1.03 Allowed Glycine 0 CA--C 1.479 -2.182 0 C-N-CA 126.647 2.07 . . . . 0.0 113.99 176.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -115.76 -18.68 10.75 Favored 'General case' 0 C--N 1.25 -3.742 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.712 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -157.35 168.43 12.49 Favored Pre-proline 0 CA--C 1.466 -2.277 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 -171.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -61.38 -38.52 63.74 Favored 'Trans proline' 0 CA--C 1.49 -1.708 0 C-N-CA 122.074 1.85 . . . . 0.0 108.513 -176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HA ' ' CG ' ' A' ' 4' ' ' PHE . 29.1 t70 -73.15 -12.06 60.75 Favored 'General case' 0 N--CA 1.415 -2.202 0 CA-C-N 111.961 -2.381 . . . . 0.0 111.709 -177.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -132.34 118.18 19.09 Favored 'General case' 0 C--O 1.279 2.61 0 O-C-N 121.823 -0.548 . . . . 0.0 111.74 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -85.76 166.19 16.29 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 128.748 2.819 . . . . 0.0 107.981 -179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.637 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -91.2 145.17 24.89 Favored 'General case' 0 C--O 1.17 -3.129 0 C-N-CA 117.917 -1.513 . . . . 0.0 108.891 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 18.4 tt0 -128.91 160.44 32.64 Favored 'General case' 0 C--O 1.169 -3.146 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.485 HG12 ' CE ' ' A' ' 58' ' ' MET . 1.2 mp -105.65 127.19 60.76 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.342 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' HG3' ' CG2' ' A' ' 32' ' ' VAL 0.305 42.1 mtmt -113.28 -7.94 13.52 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 119.739 -0.784 . . . . 0.0 112.926 172.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 73.1 m -149.69 127.51 11.78 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 119.708 -0.797 . . . . 0.0 112.632 173.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.0 tp -84.89 117.69 24.06 Favored 'General case' 0 N--CA 1.404 -2.77 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 172.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 86.4 t -88.29 128.55 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.088 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 74.0 mt -75.05 145.99 41.9 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 81.44 5.72 1.29 Allowed 'General case' 0 CA--C 1.54 0.594 0 O-C-N 125.501 1.75 . . . . 0.0 108.502 -171.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.45 159.52 38.82 Favored Glycine 0 C--O 1.204 -1.758 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.42 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.711 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 19.9 Cg_endo -72.8 -25.78 16.55 Favored 'Trans proline' 0 N--CA 1.443 -1.463 0 CA-C-N 120.853 2.327 . . . . 0.0 109.971 -171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.81 -45.23 90.59 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 114.599 -1.182 . . . . 0.0 109.428 175.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.24 -50.94 63.89 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.035 -1.439 . . . . 0.0 109.681 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.5 mt -71.48 -36.5 71.18 Favored 'General case' 0 N--CA 1.406 -2.658 0 CA-C-N 112.688 -2.051 . . . . 0.0 114.854 -173.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -79.75 -19.7 48.12 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 122.318 1.056 . . . . 0.0 108.751 176.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 61.54 42.97 99.87 Favored Glycine 0 CA--C 1.486 -1.764 0 CA-C-N 113.201 -1.818 . . . . 0.0 111.827 177.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -129.99 -25.47 2.52 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.035 -0.583 . . . . 0.0 111.485 -171.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.485 ' CE ' HG12 ' A' ' 43' ' ' ILE . 1.6 tmt? -120.24 146.03 46.45 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -174.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -142.9 166.99 23.14 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-O 122.557 1.17 . . . . 0.0 113.498 -169.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.401 HG23 ' C ' ' A' ' 44' ' ' LYS . 28.4 m -63.57 123.04 17.8 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-N 113.807 -1.542 . . . . 0.0 107.469 171.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 120.21 -11.23 10.71 Favored Glycine 0 C--N 1.298 -1.551 0 C-N-CA 119.665 -1.255 . . . . 0.0 110.965 -174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.489 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 15.0 m-20 -74.34 157.9 34.92 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.7 p -128.22 123.81 61.02 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.399 0 CA-C-O 121.18 0.514 . . . . 0.0 109.965 173.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 49.2 mm -73.93 113.18 11.76 Favored 'Isoleucine or valine' 0 C--O 1.3 3.733 0 C-N-CA 125.041 1.336 . . . . 0.0 110.683 -175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.9 t -105.4 -54.79 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 O-C-N 126.019 2.074 . . . . 0.0 110.673 -177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.497 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 40.3 t -147.56 158.33 43.95 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 121.959 -0.463 . . . . 0.0 110.943 -175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.91 89.52 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.258 0 CA-C-O 122.22 1.01 . . . . 0.0 109.852 -178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.418 ' ND2' HG12 ' A' ' 93' ' ' VAL 0.435 43.6 p30 42.15 -89.12 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 116.616 2.08 . . . . 0.0 116.616 -171.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -93.53 -30.95 14.74 Favored 'General case' 0 C--N 1.278 -2.543 0 C-N-CA 123.673 0.789 . . . . 0.0 111.827 -175.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 87.7 m -91.25 131.11 36.98 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 122.085 0.945 . . . . 0.0 110.962 -176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.7 t -88.69 86.63 7.03 Favored 'General case' 0 N--CA 1.418 -2.066 0 CA-C-N 114.952 -1.022 . . . . 0.0 108.253 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.9 p -80.51 1.59 2.9 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.153 0 CA-C-O 122.54 1.162 . . . . 0.0 109.628 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.587 HD21 ' O ' ' A' ' 6' ' ' ARG . 28.7 tp -60.68 111.7 1.72 Allowed 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.219 -1.355 . . . . 0.0 107.999 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.43 38.6 95.04 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 115.143 -0.935 . . . . 0.0 112.41 -178.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 1.0 OUTLIER -81.07 133.23 35.44 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 50.9 m -62.36 145.29 54.29 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.463 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.505 ' HB2' ' HE ' ' B' ' 157' ' ' ARG . 2.6 t60 -45.61 -51.89 11.46 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.622 0.646 . . . . 0.0 112.19 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.38 -31.92 72.65 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 124.102 0.877 . . . . 0.0 111.186 -175.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -80.55 -47.36 14.32 Favored 'General case' 0 N--CA 1.425 -1.7 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.489 -176.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.55 HG21 HD21 ' A' ' 41' ' ' LEU . 12.0 p -65.17 -42.28 93.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.188 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 77' ' ' HIS . 14.3 p -65.87 -37.79 80.68 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.898 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.676 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -58.86 -45.16 90.76 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.912 -0.586 . . . . 0.0 112.307 178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.1 mt -73.75 -51.21 25.56 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 CA-C-O 122.174 0.988 . . . . 0.0 109.615 -176.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -65.92 -29.48 69.9 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 113.398 -1.728 . . . . 0.0 113.098 -174.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -86.32 -23.81 26.11 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 176.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 49.2 m -80.25 -12.0 59.67 Favored 'General case' 0 C--O 1.249 1.062 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.813 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.593 ' O ' ' HD3' ' A' ' 25' ' ' ARG . 6.7 mt -47.69 139.98 8.41 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 124.8 1.24 . . . . 0.0 113.5 175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -99.0 145.11 0.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.894 3.062 . . . . 0.0 111.333 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.596 HG12 ' H ' ' A' ' 25' ' ' ARG . 37.7 mt -68.3 142.93 15.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.45 11.32 57.27 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 110.936 -0.866 . . . . 0.0 110.936 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.526 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -105.43 -177.03 3.25 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.828 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.449 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 11.8 p -148.95 145.89 27.59 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -169.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.709 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -153.37 158.41 4.0 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.738 0 C-N-CA 123.754 0.822 . . . . 0.0 111.038 174.323 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -96.55 107.5 19.93 Favored 'General case' 0 CA--C 1.479 -1.788 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.428 HD12 ' HA ' ' A' ' 95' ' ' LEU . 12.8 tp -94.45 114.04 26.0 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HB2' ' HB3' ' A' ' 66' ' ' SER . 30.3 mt-10 -97.7 111.75 23.91 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.07 157.46 45.27 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.799 -173.383 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 5.0 t -112.55 130.2 56.1 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.489 ' HE ' ' CG ' ' A' ' 62' ' ' ASP . 21.6 tpp85 -103.17 152.38 21.52 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' O ' ' HE2' ' A' ' 12' ' ' LYS . . . 110.9 8.18 24.43 Favored Glycine 0 CA--C 1.493 -1.283 0 C-N-CA 119.964 -1.112 . . . . 0.0 111.366 178.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -90.21 118.78 69.1 Favored Pre-proline 0 N--CA 1.421 -1.921 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.454 ' C ' ' HD3' ' A' ' 104' ' ' PRO . 51.5 Cg_endo -69.24 153.88 70.63 Favored 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 122.395 2.063 . . . . 0.0 115.079 -172.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -115.63 73.64 4.32 Favored Pre-proline 0 C--N 1.314 -0.964 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.3 175.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.454 ' HD3' ' C ' ' A' ' 102' ' ' PRO . 7.5 Cg_endo -89.06 -3.31 6.17 Favored 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 122.54 2.16 . . . . 0.0 110.906 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -125.8 137.91 53.81 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.438 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.1 m-20 -78.46 154.06 79.01 Favored Pre-proline 0 C--N 1.296 -1.732 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.899 -171.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 10.0 Cg_endo -102.02 3.13 0.51 Allowed 'Trans proline' 0 N--CA 1.434 -2.016 0 C-N-CA 123.603 2.869 . . . . 0.0 108.115 173.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -89.08 -54.17 4.24 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.83 -175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.59 137.58 82.18 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.866 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -56.9 -155.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.362 1.271 0 C-N-CA 124.503 3.469 . . . . 0.0 115.428 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.8 m120 82.23 122.59 0.04 OUTLIER 'General case' 0 N--CA 1.416 -2.14 0 C-N-CA 125.805 1.642 . . . . 0.0 110.232 -178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 m -66.21 -32.49 73.95 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.233 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.499 ' HA ' ' OG1' ' B' ' 155' ' ' THR . 0.0 OUTLIER -85.92 115.98 23.87 Favored 'General case' 0 C--N 1.257 -3.438 0 CA-C-N 113.097 -1.865 . . . . 0.0 110.054 176.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' B' ' 155' ' ' THR . 12.0 mt -100.39 104.29 15.71 Favored 'General case' 0 N--CA 1.424 -1.763 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 -179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 8.6 m -110.95 133.05 57.75 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.034 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.2 t -103.2 142.34 34.34 Favored 'General case' 0 N--CA 1.397 -3.099 0 N-CA-C 104.095 -2.557 . . . . 0.0 104.095 169.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.8 m -78.03 119.59 21.67 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.515 ' O ' ' HE2' ' A' ' 123' ' ' LYS . 3.3 p -93.28 99.95 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.33 0 CA-C-O 122.459 1.123 . . . . 0.0 110.673 -175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -105.73 73.1 0.99 Allowed 'General case' 0 N--CA 1.426 -1.646 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.596 HG22 ' HA2' ' A' ' 0' ' ' GLY . 47.5 mm -136.95 -44.73 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 -177.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.9 tt -66.23 135.74 54.9 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 170.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -81.89 85.98 6.58 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 122.156 0.979 . . . . 0.0 112.124 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.556 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 0.3 OUTLIER -106.85 109.84 21.84 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 171.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -97.81 99.92 7.57 Favored Pre-proline 0 C--N 1.296 -1.759 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.039 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 3.4 Cg_endo . . . . . 0 N--CA 1.439 -1.712 0 C-N-CA 122.877 2.384 . . . . 0.0 111.23 177.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 CA--C 1.519 -0.247 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.7 t -100.14 -55.47 2.61 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 120.474 -0.49 . . . . 0.0 111.168 -177.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 9.9 m -106.61 157.11 17.93 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 120.142 -0.623 . . . . 0.0 112.199 -177.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -127.12 22.71 6.6 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.705 0.765 . . . . 0.0 109.85 175.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.499 ' OG1' ' HA ' ' A' ' 113' ' ' SER . 1.7 t -137.52 120.87 16.98 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.111 179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 32' ' ' VAL . 10.2 mmt180 -63.34 136.28 57.56 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 177.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 3.3 tmm_? -90.32 144.23 26.02 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -101.91 125.43 48.59 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 121.919 -0.488 . . . . 0.0 110.555 -177.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 23.2 m -132.51 117.73 18.38 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.561 ' HA ' HG22 ' A' ' 30' ' ' THR . 53.9 tt0 -79.62 122.41 26.48 Favored 'General case' 0 N--CA 1.426 -1.666 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.354 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 N--CA 1.408 -2.569 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -91.24 -0.75 57.74 Favored 'General case' 0 C--O 1.213 -0.833 0 CA-C-O 121.08 0.467 . . . . 0.0 111.899 -175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.0 ttt -124.46 44.06 2.85 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.86 3.44 87.0 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.067 -0.97 . . . . 0.0 112.288 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.2 mppt? -92.46 146.45 32.47 Favored Pre-proline 0 C--N 1.308 -1.212 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.32 123.23 11.49 Favored 'Trans proline' 0 N--CA 1.443 -1.475 0 C-N-CA 122.092 1.861 . . . . 0.0 110.19 176.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -81.09 155.5 26.26 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 113.075 -1.875 . . . . 0.0 113.286 -171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -145.42 132.26 20.11 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.155 175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 t -161.77 29.64 0.12 Allowed 'General case' 0 C--N 1.289 -2.063 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 167.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 61.13 36.1 18.34 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.901 -1.5 . . . . 0.0 109.585 175.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.799 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -121.86 120.11 28.67 Favored Pre-proline 0 C--N 1.268 -2.95 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -178.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.494 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.28 16.3 Cg_exo -62.92 -32.93 76.55 Favored 'Trans proline' 0 CA--C 1.473 -2.528 0 N-CA-C 108.296 -1.463 . . . . 0.0 108.296 172.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.1 t -71.09 -22.25 62.13 Favored 'General case' 1 N--CA 1.365 -4.708 0 CA-C-N 111.899 -2.41 . . . . 0.0 110.97 -175.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.799 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.2 pt-20 -77.07 -36.62 55.7 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.9 mt -54.28 131.31 41.48 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.271 0.982 . . . . 0.0 111.146 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -86.06 169.16 13.42 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.311 -1.313 . . . . 0.0 113.048 -174.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.57 -108.24 3.65 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-N 114.629 -1.169 . . . . 0.0 111.249 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.551 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 144.88 29.95 Favored 'General case' 0 C--N 1.297 -1.674 0 C-N-CA 122.834 0.453 . . . . 0.0 110.911 179.453 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -111.19 122.08 46.95 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.435 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -135.57 152.23 31.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-O 121.194 0.521 . . . . 0.0 111.26 -177.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.654 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 12.1 t60 -128.27 101.49 6.26 Favored 'General case' 0 C--N 1.295 -1.775 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -176.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -117.66 137.02 52.93 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.15 -177.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.517 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.4 OUTLIER -79.17 133.6 36.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 122.115 -0.366 . . . . 0.0 110.273 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.631 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -118.02 119.46 34.87 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -81.25 104.64 11.86 Favored 'General case' 0 N--CA 1.403 -2.797 0 CA-C-N 114.523 -1.217 . . . . 0.0 108.88 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.703 ' HE2' HG13 ' A' ' 93' ' ' VAL . 1.9 mptp? -33.41 106.76 0.04 OUTLIER 'General case' 0 CA--C 1.483 -1.632 0 C-N-CA 125.357 1.463 . . . . 0.0 112.112 174.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.8 t -81.65 -150.78 0.08 Allowed 'General case' 0 N--CA 1.42 -1.951 0 O-C-N 125.983 2.052 . . . . 0.0 108.283 178.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.2 m -61.69 83.25 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.503 ' H ' HG12 ' A' ' 89' ' ' ILE . 27.2 mtp85 58.31 44.26 18.82 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 124.852 1.261 . . . . 0.0 113.66 176.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 156.6 -133.91 3.83 Favored Glycine 0 N--CA 1.412 -2.956 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.619 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.4 m-85 -129.77 -77.79 0.55 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.615 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.62 52.1 0.16 Allowed Glycine 0 C--N 1.304 -1.235 0 C-N-CA 120.163 -1.018 . . . . 0.0 112.741 -171.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.507 ' CD2' HD12 ' A' ' 43' ' ' ILE . 37.2 p90 -161.64 142.6 11.0 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 68.4 p -106.25 136.56 45.75 Favored 'General case' 0 C--N 1.265 -3.074 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.269 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 17.5 m -123.39 158.02 28.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 C-N-CA 120.804 -0.358 . . . . 0.0 111.887 -171.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.502 HG13 ' HD2' ' A' ' 44' ' ' LYS . 8.9 m -121.53 133.06 69.21 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.854 0 C-N-CA 124.334 1.053 . . . . 0.0 109.599 176.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.422 ' HA2' ' HG2' ' B' ' 156' ' ' ARG . . . 130.64 -142.06 13.34 Favored Glycine 0 CA--C 1.455 -3.708 0 C-N-CA 119.486 -1.34 . . . . 0.0 110.009 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.536 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.45 57.07 1.5 Allowed Glycine 0 CA--C 1.458 -3.475 0 O-C-N 127.136 2.316 . . . . 0.0 111.385 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 48.7 t0 -104.72 -32.16 9.0 Favored 'General case' 0 C--N 1.251 -3.676 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -173.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -137.76 170.68 9.93 Favored Pre-proline 0 N--CA 1.405 -2.701 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.102 -171.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.621 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 32.0 Cg_exo -71.81 -8.72 23.6 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 123.296 2.664 . . . . 0.0 108.709 174.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -111.67 -10.66 14.07 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 125.837 1.655 . . . . 0.0 110.811 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.82 120.18 30.99 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 121.999 -0.438 . . . . 0.0 109.989 -177.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -87.32 165.45 15.62 Favored 'General case' 0 N--CA 1.504 2.256 0 C-N-CA 127.444 2.297 . . . . 0.0 110.61 -173.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.536 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.5 mp -93.15 145.24 24.56 Favored 'General case' 0 C--O 1.176 -2.772 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.304 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 37.0 tt0 -133.92 155.91 49.06 Favored 'General case' 0 C--O 1.162 -3.515 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.507 HD12 ' CD2' ' A' ' 29' ' ' PHE . 12.2 mm -87.27 126.38 41.03 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 118.88 0.764 . . . . 0.0 109.243 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HD2' HG13 ' A' ' 32' ' ' VAL . 20.9 ptmt -102.09 -23.46 14.07 Favored 'General case' 0 CA--C 1.503 -0.861 0 O-C-N 123.137 0.273 . . . . 0.0 110.317 178.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.472 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 38.7 m -151.49 126.43 9.74 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 174.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -86.88 108.96 19.0 Favored 'General case' 0 N--CA 1.403 -2.816 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 79.8 t -85.76 127.63 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-O 121.87 0.843 . . . . 0.0 111.661 -173.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -78.52 85.33 4.6 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.459 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.445 ' N ' HD21 ' A' ' 54' ' ' LEU . 5.7 t70 165.12 -22.52 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 O-C-N 125.115 1.509 . . . . 0.0 109.822 -170.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 54' ' ' LEU . . . -99.55 166.28 20.6 Favored Glycine 0 CA--C 1.48 -2.116 0 CA-C-N 115.456 -0.793 . . . . 0.0 114.045 -177.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.631 ' HB2' ' HG ' ' A' ' 20' ' ' LEU . 6.1 Cg_endo -67.72 -23.85 41.71 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.142 1.895 . . . . 0.0 111.077 -166.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -58.35 -52.34 66.01 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.971 0.909 . . . . 0.0 111.395 175.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.688 ' HB3' HD23 ' A' ' 54' ' ' LEU . . . -73.74 -37.15 65.18 Favored 'General case' 0 CA--C 1.471 -2.074 0 CA-C-O 122.879 1.324 . . . . 0.0 110.049 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.688 HD23 ' HB3' ' A' ' 53' ' ' ALA . 1.0 OUTLIER -71.25 -38.44 71.92 Favored 'General case' 0 C--N 1.264 -3.142 0 CA-C-N 111.755 -2.475 . . . . 0.0 111.175 -170.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -80.87 -26.07 37.18 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 122.564 1.173 . . . . 0.0 108.049 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 68.71 38.73 86.06 Favored Glycine 0 CA--C 1.481 -2.076 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.429 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -122.08 0.67 9.68 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.694 -174.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.611 ' HA ' ' NH2' ' A' ' 99' ' ' ARG . 67.3 mtp -128.04 159.2 35.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -138.42 164.16 30.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.476 0.655 . . . . 0.0 110.719 -178.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -71.24 116.73 11.9 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' A' ' 43' ' ' ILE . . . 131.36 -23.89 4.24 Favored Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -175.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 7.3 m-20 -58.16 140.96 51.86 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 120.716 0.294 . . . . 0.0 110.62 176.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.323 0.2 OUTLIER -109.17 115.96 50.85 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-O 121.578 0.704 . . . . 0.0 111.891 174.23 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.8 mm -68.82 114.62 5.88 Favored 'Isoleucine or valine' 0 C--O 1.301 3.777 0 CA-C-N 113.523 -1.672 . . . . 0.0 109.791 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.613 HG13 HD13 ' A' ' 73' ' ' LEU . 65.1 t -95.83 -58.69 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.84 0 CA-C-N 112.361 -2.199 . . . . 0.0 110.1 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.5 m -158.31 173.32 16.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 122.0 -0.438 . . . . 0.0 110.471 -175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.442 HG12 HG23 ' A' ' 72' ' ' VAL . 9.1 p -145.55 153.03 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.95 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.475 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 9.8 t30 -31.31 113.63 0.11 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 125.01 1.324 . . . . 0.0 111.782 172.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.6 t70 75.04 -38.9 0.39 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 125.98 1.712 . . . . 0.0 115.231 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.8 m -100.2 122.66 43.38 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.894 0.854 . . . . 0.0 111.497 -172.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 15.4 t -83.56 83.38 7.92 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.408 -0.814 . . . . 0.0 108.973 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.442 HG23 HG12 ' A' ' 67' ' ' VAL . 78.8 t -72.55 -2.62 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.346 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.613 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -66.77 110.48 3.28 Favored 'General case' 0 N--CA 1.415 -2.178 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.12 28.51 70.13 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.74 -176.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.489 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.05 140.97 43.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 122.017 -0.696 . . . . 0.0 109.693 178.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 39.7 m -74.78 143.61 43.93 Favored 'General case' 0 N--CA 1.421 -1.913 0 CA-C-O 117.526 -1.225 . . . . 0.0 108.044 178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -47.84 -49.46 29.17 Favored 'General case' 0 CA--C 1.485 -1.52 0 CA-C-N 118.952 0.796 . . . . 0.0 111.7 -175.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.63 -38.05 74.33 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 124.758 1.286 . . . . 0.0 111.084 -177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 77.8 mm-40 -75.23 -53.37 8.91 Favored 'General case' 0 N--CA 1.432 -1.337 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.01 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -61.65 -42.66 95.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.579 -177.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 8.9 p -62.49 -45.34 99.03 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.939 0 C-N-CA 121.264 -0.174 . . . . 0.0 110.532 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 4.1 tmmm? -57.12 -41.51 79.13 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 123.771 0.828 . . . . 0.0 112.697 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 78.0 mt -72.65 -50.23 35.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 122.161 0.981 . . . . 0.0 108.912 -177.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -62.95 -29.1 70.54 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.555 -1.657 . . . . 0.0 113.453 -176.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.7 pt20 -86.69 -24.01 25.37 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 175.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.2 m -93.08 2.81 56.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.52 0.676 . . . . 0.0 111.376 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.564 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 4.3 mt -51.19 144.04 15.95 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.964 1.306 . . . . 0.0 113.618 172.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 29.9 Cg_endo -92.74 140.43 1.93 Allowed 'Trans proline' 0 N--CA 1.447 -1.24 0 C-N-CA 123.517 2.811 . . . . 0.0 111.048 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.503 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.9 mt -68.49 138.91 21.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.47 12.52 62.77 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.831 -1.176 . . . . 0.0 111.857 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.581 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -101.48 -171.47 1.99 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.648 -173.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.517 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.5 t -148.88 144.39 26.86 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.855 -0.528 . . . . 0.0 112.187 -171.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.703 HG13 ' HE2' ' A' ' 22' ' ' LYS . 0.2 OUTLIER -152.95 154.18 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.874 0 C-N-CA 124.221 1.008 . . . . 0.0 110.25 173.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 5.5 m-20 -99.74 107.7 19.83 Favored 'General case' 0 C--N 1.27 -2.884 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.46 HD22 HD22 ' A' ' 20' ' ' LEU . 12.9 tp -99.73 115.24 29.04 Favored 'General case' 0 C--N 1.269 -2.929 0 CA-C-O 120.803 0.335 . . . . 0.0 110.166 -174.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -103.3 123.8 47.46 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.791 0.805 . . . . 0.0 110.135 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.4 OUTLIER -141.52 163.26 33.4 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.705 -173.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 15.2 t -116.69 128.33 55.24 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.611 ' NH2' ' HA ' ' A' ' 58' ' ' MET . 22.2 tpp85 -103.66 152.49 21.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 -177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.88 -43.03 1.26 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -67.74 135.96 92.49 Favored Pre-proline 0 C--N 1.297 -1.686 0 CA-C-N 114.644 -0.778 . . . . 0.0 109.342 174.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 47.6 Cg_endo -97.38 -161.35 0.06 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 122.72 2.28 . . . . 0.0 109.014 172.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.65 81.0 11.07 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 176.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 86.9 Cg_endo -91.83 7.46 3.25 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 123.282 2.655 . . . . 0.0 114.475 -170.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -144.92 121.63 11.18 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 177.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 8.9 m-20 -79.24 125.98 82.35 Favored Pre-proline 0 CA--C 1.481 -1.693 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 4.1 Cg_exo -95.05 -0.95 2.55 Favored 'Trans proline' 0 N--CA 1.438 -1.783 0 C-N-CA 123.059 2.506 . . . . 0.0 107.337 176.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -72.84 -37.32 67.47 Favored 'General case' 0 N--CA 1.419 -2.004 0 CA-C-N 113.042 -1.89 . . . . 0.0 107.654 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -73.55 123.86 89.82 Favored Pre-proline 0 N--CA 1.444 -0.775 0 CA-C-N 113.422 -1.717 . . . . 0.0 107.18 177.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.05 -175.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.139 0 C-N-CA 123.657 2.905 . . . . 0.0 115.647 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.6 m120 80.71 43.48 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.341 0 C-N-CA 126.7 2.0 . . . . 0.0 110.761 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.427 HG23 ' O ' ' B' ' 154' ' ' ARG . 55.8 m -94.68 138.31 32.68 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.643 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.0 m -124.29 102.44 7.69 Favored 'General case' 0 N--CA 1.395 -3.213 0 C-N-CA 123.815 0.846 . . . . 0.0 111.127 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' B' ' 157' ' ' ARG . 1.8 mm? -77.27 123.84 27.02 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-O 121.07 0.462 . . . . 0.0 110.02 176.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG22 ' CG2' ' B' ' 155' ' ' THR . 12.2 m -111.03 133.33 56.92 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.3 -177.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 t -71.19 142.53 50.65 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.6 m -87.05 149.8 24.48 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 23.4 t -93.59 100.12 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.443 ' N ' HD12 ' A' ' 120' ' ' ILE . . . -148.53 74.06 1.26 Allowed 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 119' ' ' ALA . 4.3 mp -121.23 -16.45 6.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.766 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 2.5 pp -108.14 -166.01 1.09 Allowed 'General case' 0 N--CA 1.423 -1.824 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.841 -169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -54.07 103.97 0.09 Allowed 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 122.365 1.079 . . . . 0.0 112.424 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -113.4 101.3 9.25 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.707 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -76.85 118.1 69.46 Favored Pre-proline 0 C--N 1.313 -1.012 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 176.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo . . . . . 0 N--CA 1.439 -1.72 0 C-N-CA 122.086 1.858 . . . . 0.0 112.523 -177.725 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 37.2 mtm180 . . . . . 0 CA--C 1.505 -0.778 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 23.1 t 62.98 -167.13 0.22 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 124.082 0.864 . . . . 0.0 112.251 172.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.5 m -156.93 52.58 0.5 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 125.861 1.664 . . . . 0.0 106.733 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 112' ' ' THR . 98.5 mtt180 70.12 85.97 0.13 Allowed 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 125.137 1.375 . . . . 0.0 109.996 -175.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.4 ' CG2' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -86.9 -156.65 0.33 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 174.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.422 ' HG2' ' HA2' ' A' ' 33' ' ' GLY . 73.9 mtt180 78.76 130.16 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.052 0.941 . . . . 0.0 112.901 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.649 ' HB2' HD11 ' A' ' 114' ' ' LEU . 22.5 tpt180 -109.34 141.65 41.38 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.4 pm0 -75.25 116.83 16.41 Favored 'General case' 0 N--CA 1.414 -2.245 0 CA-C-O 121.816 0.817 . . . . 0.0 110.374 176.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.502 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 18.1 m -105.4 110.21 22.47 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.465 ' HG3' ' CG2' ' A' ' 30' ' ' THR . 2.1 mp0 -85.17 104.44 15.05 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.462 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.428 -1.546 0 C-N-CA 120.051 -0.66 . . . . 0.0 109.439 -177.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.846 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -90.66 -36.61 14.28 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 66.5 mtt -114.39 -177.29 3.09 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.274 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 91.41 28.96 13.07 Favored Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 -177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -120.5 157.31 54.29 Favored Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -65.81 133.52 34.17 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.695 1.597 . . . . 0.0 108.508 172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.7 p90 -88.23 154.97 20.01 Favored 'General case' 0 C--N 1.273 -2.723 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 8.9 t80 -148.65 134.35 18.83 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 113.153 -1.84 . . . . 0.0 110.116 175.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.506 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 15.0 t -174.14 26.15 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 124.439 1.096 . . . . 0.0 109.478 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 5' ' ' THR . 33.2 ptt180 56.97 14.03 1.74 Allowed 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 127.486 2.314 . . . . 0.0 114.889 173.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.713 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 14.4 m-80 -92.6 124.7 58.24 Favored Pre-proline 1 C--N 1.241 -4.135 0 CA-C-N 114.18 -1.373 . . . . 0.0 113.109 177.854 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.272 11.3 Cg_exo -60.35 -32.57 94.21 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 122.046 1.83 . . . . 0.0 108.781 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 t -68.72 -22.86 64.31 Favored 'General case' 1 N--CA 1.367 -4.59 0 CA-C-N 112.102 -2.317 . . . . 0.0 111.219 -176.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.713 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.6 pt-20 -79.34 -38.5 35.01 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 92.1 mt -57.43 130.06 44.58 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.509 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -77.34 177.95 7.54 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 113.201 -1.818 . . . . 0.0 113.153 -173.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.25 -122.65 6.55 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.321 178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 99' ' ' ARG . 13.4 mmmm -107.8 149.61 28.01 Favored 'General case' 0 CA--C 1.458 -2.56 0 C-N-CA 123.473 0.709 . . . . 0.0 109.317 -177.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -122.51 111.25 16.59 Favored 'General case' 1 C--N 1.241 -4.121 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.22 151.99 36.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 121.952 0.882 . . . . 0.0 112.854 -177.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.585 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.2 t60 -132.95 103.45 6.07 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -128.66 140.15 51.9 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.238 -176.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -73.54 135.2 43.95 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.495 177.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.557 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 tp -119.84 120.87 37.73 Favored 'General case' 0 C--O 1.249 1.064 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 175.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.3 ttm180 -72.73 124.29 25.03 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-O 121.116 0.484 . . . . 0.0 109.9 -176.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.661 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -57.56 99.28 0.04 OUTLIER 'General case' 0 CA--C 1.461 -2.456 0 C-N-CA 123.59 0.756 . . . . 0.0 110.989 171.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.8 t -107.93 126.11 52.3 Favored 'General case' 0 N--CA 1.405 -2.707 0 O-C-N 126.187 2.179 . . . . 0.0 108.09 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.411 ' H ' HG23 ' A' ' 89' ' ' ILE . 3.5 m 47.15 56.34 6.96 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 125.297 1.439 . . . . 0.0 113.974 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.663 ' N ' HG12 ' A' ' 89' ' ' ILE . 19.9 mmt180 68.31 42.71 1.62 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.248 0.547 . . . . 0.0 112.123 173.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.9 -124.43 1.48 Allowed Glycine 0 N--CA 1.403 -3.534 0 C-N-CA 119.434 -1.365 . . . . 0.0 112.235 177.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.648 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -132.74 -87.06 0.45 Allowed 'General case' 0 N--CA 1.395 -3.215 0 CA-C-N 114.367 -0.916 . . . . 0.0 111.753 -172.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.482 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 123.9 52.28 0.2 Allowed Glycine 0 C--N 1.289 -2.062 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 -167.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.483 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.0 p90 -160.71 143.72 13.12 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 174.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' HA ' ' B' ' 160' ' ' GLN . 17.3 p -107.45 135.14 49.44 Favored 'General case' 0 C--N 1.274 -2.68 0 CA-C-O 122.173 0.987 . . . . 0.0 109.68 178.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.703 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 3.5 p -130.46 137.61 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.753 -169.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.509 HG13 ' HG2' ' A' ' 44' ' ' LYS . 4.6 m -114.49 154.1 15.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 125.03 1.332 . . . . 0.0 113.545 -174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.86 -127.88 9.37 Favored Glycine 0 N--CA 1.419 -2.438 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.701 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 40.53 74.66 0.14 Allowed Glycine 1 CA--C 1.449 -4.068 0 O-C-N 126.648 2.028 . . . . 0.0 113.194 178.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -130.75 -20.44 2.86 Favored 'General case' 0 C--N 1.259 -3.333 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.169 -176.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.523 ' O ' ' HA2' ' A' ' 74' ' ' GLY . 7.7 pt-20 -156.68 170.92 8.1 Favored Pre-proline 0 N--CA 1.415 -2.203 0 C-N-CA 118.986 -1.086 . . . . 0.0 111.031 -166.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.522 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 75.8 Cg_exo -61.14 -38.13 69.43 Favored 'Trans proline' 0 CA--C 1.495 -1.465 0 C-N-CA 122.649 2.233 . . . . 0.0 108.895 -178.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.476 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 13.1 t70 -72.22 -25.3 61.6 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 112.773 -2.012 . . . . 0.0 112.88 -179.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG3' ' A' ' 36' ' ' GLU . 25.7 tt0 -127.36 118.83 24.89 Favored 'General case' 0 C--O 1.274 2.367 0 C-N-CA 118.636 -1.226 . . . . 0.0 112.134 -177.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.576 ' CD1' HD12 ' A' ' 73' ' ' LEU . 3.1 m-85 -87.27 165.67 15.49 Favored 'General case' 0 C--O 1.249 1.042 0 C-N-CA 128.134 2.574 . . . . 0.0 108.795 -177.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.701 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 6.1 mp -89.27 147.01 24.36 Favored 'General case' 0 C--O 1.18 -2.582 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.077 -176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 6.6 tt0 -136.04 144.99 45.55 Favored 'General case' 0 C--O 1.175 -2.844 0 CA-C-N 118.698 0.681 . . . . 0.0 109.163 -176.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 ' O ' ' A' ' 62' ' ' ASP . 34.4 mm -83.25 117.81 29.75 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 O-C-N 121.599 -0.688 . . . . 0.0 111.081 -175.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -96.56 -18.95 19.43 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -179.226 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 62.8 m -159.6 127.84 4.96 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 60' ' ' THR . 3.4 pp -82.31 117.04 22.09 Favored 'General case' 0 N--CA 1.405 -2.691 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 170.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 90.3 t -83.45 129.24 37.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.64 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -175.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 97.2 mt -60.1 142.05 54.8 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.117 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 33.9 t70 80.09 5.29 1.84 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 124.58 1.175 . . . . 0.0 109.744 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.686 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -93.31 160.38 24.7 Favored Glycine 0 CA--C 1.484 -1.904 0 CA-C-O 118.153 -1.359 . . . . 0.0 109.886 175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.648 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 32.1 Cg_endo -72.01 -25.21 19.77 Favored 'Trans proline' 0 N--CA 1.445 -1.354 0 CA-C-N 120.95 2.375 . . . . 0.0 110.208 -169.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.569 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -61.03 -49.25 78.16 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 113.974 -1.466 . . . . 0.0 109.468 174.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.37 -46.91 86.53 Favored 'General case' 0 CA--C 1.49 -1.341 0 CA-C-N 114.343 -1.299 . . . . 0.0 110.134 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.0 mt -72.06 -38.3 69.5 Favored 'General case' 0 N--CA 1.406 -2.665 0 CA-C-N 112.921 -1.945 . . . . 0.0 114.55 -172.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.502 ' OD1' ' HG2' ' A' ' 57' ' ' LYS . 12.9 t70 -71.75 -27.26 62.86 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 175.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.03 -32.66 2.72 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.887 176.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG2' ' OD1' ' A' ' 55' ' ' ASP . 17.3 ptpt -77.32 -34.34 55.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 118.824 1.312 . . . . 0.0 112.549 -174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -79.44 139.04 37.78 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -178.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -143.76 167.94 21.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 122.458 1.123 . . . . 0.0 112.242 -170.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.442 ' H ' HD23 ' A' ' 46' ' ' LEU . 18.2 m -61.23 135.37 57.71 Favored 'General case' 0 N--CA 1.41 -2.454 0 CA-C-N 113.995 -1.457 . . . . 0.0 108.573 173.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 105.87 -16.03 43.77 Favored Glycine 0 N--CA 1.424 -2.132 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.551 ' O ' HG12 ' A' ' 43' ' ' ILE . 10.4 m-20 -66.47 132.99 49.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 173.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.268 0.2 OUTLIER -101.13 120.71 51.05 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 O-C-N 121.841 -0.537 . . . . 0.0 110.759 176.094 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -73.0 115.62 14.08 Favored 'Isoleucine or valine' 0 C--O 1.302 3.848 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.15 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.406 HG13 HD11 ' A' ' 73' ' ' LEU . 72.8 t -102.2 -58.64 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 O-C-N 126.395 2.309 . . . . 0.0 109.814 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 13.4 m -146.3 172.06 14.05 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.237 0.541 . . . . 0.0 110.786 -176.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.43 154.78 14.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -34.18 112.29 0.13 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 64.36 15.59 9.59 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.2 1.4 . . . . 0.0 114.045 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 85.1 m -142.18 125.15 16.17 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-O 122.477 1.132 . . . . 0.0 112.493 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 49.7 t -80.5 108.94 14.54 Favored 'General case' 0 C--N 1.287 -2.117 0 CA-C-N 114.231 -1.35 . . . . 0.0 107.967 177.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 41.1 t -86.04 -2.71 8.12 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 40' ' ' PHE . 2.6 mm? -66.92 123.28 19.74 Favored 'General case' 0 CA--C 1.479 -1.75 0 C-N-CA 119.48 -0.888 . . . . 0.0 109.205 174.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 36' ' ' GLU . . . 81.46 9.44 85.81 Favored Glycine 0 N--CA 1.414 -2.817 0 CA-C-N 114.381 -1.281 . . . . 0.0 113.832 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.58 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -75.8 111.03 10.73 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.437 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 92.1 m -62.0 149.73 40.02 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.154 -1.385 . . . . 0.0 109.23 178.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -47.55 -43.79 25.44 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-N 118.97 0.804 . . . . 0.0 111.713 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.77 -36.01 82.49 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.437 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 27.5 mm-40 -79.32 -48.27 14.39 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-O 121.414 0.626 . . . . 0.0 110.291 -177.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 14.9 p -63.87 -40.74 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.137 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -64.51 -36.27 76.86 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 4.5 tmmm? -57.2 -47.97 79.95 Favored 'General case' 0 N--CA 1.434 -1.25 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.44 177.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 39.2 mt -72.94 -50.28 33.66 Favored 'Isoleucine or valine' 0 C--O 1.252 1.221 0 CA-C-O 122.283 1.039 . . . . 0.0 109.883 -176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' O ' ' HB ' ' A' ' 87' ' ' ILE . 5.4 m-85 -63.96 -38.04 89.62 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 113.308 -1.769 . . . . 0.0 114.017 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.415 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 12.4 mm-40 -86.2 -19.87 29.39 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.114 -0.635 . . . . 0.0 112.117 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.8 m -75.6 -17.62 59.97 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.653 174.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.597 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.8 mt -44.74 135.68 4.65 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.463 1.105 . . . . 0.0 113.459 174.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 74.0 Cg_endo -97.79 154.42 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.179 3.253 . . . . 0.0 112.127 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.663 HG12 ' N ' ' A' ' 25' ' ' ARG . 7.3 mt -69.05 143.34 15.13 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.263 178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 86.24 11.93 71.5 Favored Glycine 0 CA--C 1.498 -0.988 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.832 175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.511 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.45 -170.5 1.76 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.88 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.404 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 36.9 p -149.66 138.29 20.87 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -171.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.661 HG22 ' HE2' ' A' ' 22' ' ' LYS . 27.5 m -133.47 152.3 35.0 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.373 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.07 171.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.585 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 16.6 m-20 -94.23 107.32 19.26 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 173.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 11.9 tp -102.08 123.3 45.71 Favored 'General case' 0 C--N 1.277 -2.565 0 CA-C-O 121.335 0.588 . . . . 0.0 109.995 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 66' ' ' SER . 39.1 tt0 -103.17 115.14 30.0 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.92 159.13 42.85 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.584 -175.402 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 6.3 t -122.57 140.06 53.21 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.529 ' HB3' ' HB2' ' A' ' 14' ' ' LYS . 20.1 tpp85 -110.64 142.2 42.85 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -175.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.401 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . 146.71 -18.19 1.63 Allowed Glycine 0 CA--C 1.491 -1.465 0 C-N-CA 119.914 -1.136 . . . . 0.0 111.89 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -97.45 112.39 61.03 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 100' ' ' GLY . 4.3 Cg_exo -79.4 131.08 9.36 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 N-CA-C 106.144 -2.291 . . . . 0.0 106.144 168.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.493 HD22 ' OE1' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -41.08 100.14 0.22 Allowed Pre-proline 0 N--CA 1.493 1.695 0 C-N-CA 124.98 1.312 . . . . 0.0 109.72 -176.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -85.15 23.47 0.84 Allowed 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 123.525 2.817 . . . . 0.0 113.927 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' O ' HD12 ' A' ' 103' ' ' LEU . 47.7 p90 -162.38 156.74 21.66 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 4.6 m-20 -103.05 127.99 28.65 Favored Pre-proline 0 C--N 1.273 -2.747 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -93.55 1.61 3.32 Favored 'Trans proline' 0 N--CA 1.431 -2.19 0 C-N-CA 122.884 2.389 . . . . 0.0 107.636 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -86.83 -20.1 28.0 Favored 'General case' 0 N--CA 1.404 -2.762 0 CA-C-N 113.338 -1.756 . . . . 0.0 107.298 175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.427 ' CG ' ' HD2' ' A' ' 110' ' ' PRO . 32.0 t70 -93.8 159.19 35.15 Favored Pre-proline 0 N--CA 1.433 -1.308 0 C-N-CA 126.655 1.982 . . . . 0.0 106.121 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.427 ' HD2' ' CG ' ' A' ' 109' ' ' ASP . 16.9 Cg_exo -45.66 -165.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 124.718 3.612 . . . . 0.0 117.588 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.7 m120 68.81 66.35 0.3 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.748 -1.569 . . . . 0.0 107.447 -176.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 11.7 t -86.82 177.79 7.19 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 113.043 -1.889 . . . . 0.0 111.208 -171.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.621 ' HB2' ' HB2' ' B' ' 157' ' ' ARG . 33.5 t -87.21 101.59 13.65 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.776 -175.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.688 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -89.44 124.1 34.17 Favored 'General case' 0 N--CA 1.382 -3.826 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 170.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.539 HG22 HG23 ' B' ' 155' ' ' THR . 48.3 t -92.67 105.74 17.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.707 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 10.2 t -71.34 141.8 50.42 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.9 m -109.17 89.26 2.94 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -178.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.2 p -107.44 100.87 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.263 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.016 -173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.1 73.02 0.83 Allowed 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.4 mm -126.61 -3.98 4.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 164.33 27.25 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.181 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -100.12 134.33 43.2 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 101.87 14.18 Favored 'General case' 0 C--N 1.277 -2.579 0 CA-C-N 115.34 -0.845 . . . . 0.0 111.174 -177.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -89.11 110.93 41.84 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 CA--C 1.534 0.514 0 C-N-CA 122.716 2.277 . . . . 0.0 112.088 -178.444 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 57.3 p 61.88 16.6 8.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.695 1.598 . . . . 0.0 114.459 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . 0.426 ' C ' ' HD2' ' B' ' 154' ' ' ARG 0.255 58.3 m -88.49 -104.07 0.08 Allowed 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.174 175.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' B' ' 153' ' ' SER . 5.5 mpt_? -135.76 -83.39 0.39 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 118.3 -1.36 . . . . 0.0 114.615 -174.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.539 HG23 HG22 ' A' ' 115' ' ' VAL . 14.3 m -88.67 12.98 13.31 Favored 'General case' 0 CA--C 1.565 1.537 0 CA-C-O 121.565 0.698 . . . . 0.0 112.662 -165.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' B' ' 156' ' ' ARG . 0.0 OUTLIER -52.07 109.81 0.42 Allowed 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 124.53 1.132 . . . . 0.0 113.813 177.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.621 ' HB2' ' HB2' ' A' ' 113' ' ' SER . 17.5 ttp180 175.54 -153.54 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.703 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 1.1 pm0 -82.77 142.4 31.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 17.9 m -114.11 109.76 18.94 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 102.527 -3.138 . . . . 0.0 102.527 169.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.558 ' HA ' HG22 ' A' ' 30' ' ' THR . 46.9 tt0 -86.94 96.07 10.13 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.564 0.697 . . . . 0.0 111.078 -174.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 27' ' ' PHE . 20.0 m . . . . . 0 N--CA 1.418 -2.036 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.205 -173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.995 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.42 97.19 1.58 Allowed 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.883 0.373 . . . . 0.0 110.769 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 94.7 mmm 66.5 71.37 0.39 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 124.348 1.059 . . . . 0.0 112.705 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -88.95 4.75 84.87 Favored Glycine 0 C--N 1.318 -0.467 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -118.69 148.02 43.41 Favored Pre-proline 0 C--N 1.303 -1.439 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -71.31 141.95 40.21 Favored 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 121.582 1.521 . . . . 0.0 109.945 177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -104.65 143.25 33.33 Favored 'General case' 0 N--CA 1.409 -2.496 0 CA-C-O 121.256 0.551 . . . . 0.0 112.258 -176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -146.93 133.3 19.59 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.067 176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.416 HG22 ' OE1' ' A' ' 10' ' ' GLU . 13.6 t -168.76 37.18 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.181 0 O-C-N 124.438 1.086 . . . . 0.0 108.36 166.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.619 ' O ' HD21 ' A' ' 73' ' ' LEU . 36.0 ptt180 46.15 36.12 2.99 Favored 'General case' 0 C--N 1.369 1.451 0 C-N-CA 126.249 1.82 . . . . 0.0 112.974 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.783 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -108.14 111.54 61.85 Favored Pre-proline 1 C--N 1.219 -5.096 0 CA-C-N 112.29 -2.232 . . . . 0.0 113.645 178.783 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 7' ' ' ASN 0.299 17.3 Cg_exo -58.13 -36.44 97.9 Favored 'Trans proline' 0 CA--C 1.478 -2.306 0 C-N-CA 121.757 1.638 . . . . 0.0 109.355 172.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.0 m -66.01 -26.65 67.63 Favored 'General case' 1 N--CA 1.36 -4.941 0 CA-C-N 111.284 -2.689 . . . . 0.0 112.571 -177.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.783 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.1 pt-20 -76.25 -33.89 59.17 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.6 mt -63.7 131.58 48.38 Favored 'General case' 0 N--CA 1.436 -1.159 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.425 175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -80.94 -175.18 5.24 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.097 -1.411 . . . . 0.0 113.365 -175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 81.2 -119.77 4.95 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 114.689 -1.141 . . . . 0.0 112.468 -177.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.578 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.17 157.87 45.11 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 123.821 0.848 . . . . 0.0 109.143 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -121.93 111.11 16.67 Favored 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -119.27 135.94 58.04 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-O 121.264 0.554 . . . . 0.0 111.378 -177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.444 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 21.6 t60 -112.66 99.65 8.1 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.458 ' CB ' ' HG2' ' A' ' 57' ' ' LYS . 10.6 t -118.34 140.16 50.26 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.298 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -81.24 130.41 35.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.1 mp -115.73 132.56 56.6 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -92.13 119.57 31.91 Favored 'General case' 0 N--CA 1.387 -3.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.571 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -53.21 99.97 0.03 OUTLIER 'General case' 0 CA--C 1.487 -1.475 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 166.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 89' ' ' ILE . 70.9 m -87.25 -54.89 4.06 Favored 'General case' 0 C--N 1.287 -2.129 0 O-C-N 124.509 1.131 . . . . 0.0 113.365 -167.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 46.7 m -144.89 70.8 1.28 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' N ' HG12 ' A' ' 89' ' ' ILE . 29.2 mmt180 67.78 78.8 0.23 Allowed 'General case' 0 CA--C 1.505 -0.768 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.382 -177.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 104.63 -141.31 15.26 Favored Glycine 0 N--CA 1.411 -3.017 0 CA-C-N 114.471 -1.24 . . . . 0.0 112.063 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.706 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 79.4 m-85 -119.3 -82.33 0.64 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 114.325 -0.938 . . . . 0.0 111.562 -173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.52 ' O ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.24 50.34 0.2 Allowed Glycine 0 C--N 1.291 -1.948 0 C-N-CA 119.305 -1.426 . . . . 0.0 111.995 -171.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.497 ' CD2' HD12 ' A' ' 43' ' ' ILE . 46.2 p90 -161.59 143.35 11.52 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 172.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.454 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.1 p -104.73 146.21 29.27 Favored 'General case' 0 C--N 1.256 -3.46 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.71 -178.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 43' ' ' ILE . 29.9 m -128.26 157.2 40.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.499 HG13 ' HD2' ' A' ' 44' ' ' LYS . 10.5 m -119.74 132.59 69.05 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 C-N-CA 124.959 1.304 . . . . 0.0 110.205 175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 40' ' ' PHE . . . 124.88 -144.25 15.08 Favored Glycine 0 N--CA 1.414 -2.797 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 177.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.596 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.57 61.56 3.24 Favored Glycine 0 CA--C 1.466 -2.986 0 O-C-N 125.93 1.606 . . . . 0.0 112.048 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -111.68 -32.7 6.57 Favored 'General case' 0 C--N 1.261 -3.274 0 CA-C-N 114.685 -0.757 . . . . 0.0 109.403 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -159.03 170.43 8.93 Favored Pre-proline 0 CA--C 1.478 -1.791 0 C-N-CA 120.2 -0.6 . . . . 0.0 109.633 -171.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -77.92 63.29 8.11 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 123.968 3.112 . . . . 0.0 107.76 176.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -173.78 -45.66 0.01 OUTLIER 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 111.822 -2.445 . . . . 0.0 106.851 -172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.33 119.52 39.27 Favored 'General case' 0 C--O 1.269 2.122 0 CA-C-N 114.933 -1.031 . . . . 0.0 110.357 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.433 ' O ' ' HA3' ' A' ' 33' ' ' GLY . 37.7 m-85 -95.09 164.91 12.68 Favored 'General case' 0 N--CA 1.508 2.427 0 C-N-CA 127.858 2.463 . . . . 0.0 108.408 -177.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.596 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 4.7 mp -96.3 144.83 26.12 Favored 'General case' 0 C--O 1.169 -3.151 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.609 -177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 tt0 -134.49 151.34 51.07 Favored 'General case' 0 C--O 1.168 -3.235 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.573 ' HA ' HG12 ' A' ' 31' ' ' VAL . 11.6 mm -78.46 126.6 38.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' HG13 ' A' ' 32' ' ' VAL . 10.3 ptmm? -105.35 -22.21 13.08 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 122.342 0.257 . . . . 0.0 111.188 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 15.9 m -156.03 126.91 6.91 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 33.3 tp -83.29 114.77 21.62 Favored 'General case' 0 N--CA 1.397 -3.102 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 173.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 28' ' ' GLY . 57.4 t -90.45 119.88 38.35 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.179 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.63 144.0 55.75 Favored 'General case' 0 N--CA 1.426 -1.646 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.319 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.7 t70 83.49 8.02 0.65 Allowed 'General case' 0 N--CA 1.469 0.485 0 O-C-N 125.412 1.695 . . . . 0.0 109.702 -171.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.6 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.16 158.11 27.62 Favored Glycine 0 C--O 1.203 -1.817 0 N-CA-C 108.895 -1.682 . . . . 0.0 108.895 172.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 58.5 Cg_endo -73.22 -25.37 15.84 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 CA-C-N 121.852 2.826 . . . . 0.0 110.112 -170.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.562 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -64.16 -39.84 94.86 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.189 174.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.31 66.05 Favored 'General case' 0 CA--C 1.487 -1.47 0 CA-C-O 122.621 1.2 . . . . 0.0 110.076 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 89.1 mt -71.4 -48.07 52.1 Favored 'General case' 0 N--CA 1.395 -3.191 0 CA-C-N 112.934 -1.939 . . . . 0.0 113.875 -172.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 11.9 t70 -70.52 -28.29 64.83 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 175.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.07 26.97 70.74 Favored Glycine 0 CA--C 1.487 -1.707 0 CA-C-N 112.951 -1.932 . . . . 0.0 113.828 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 0.1 OUTLIER -90.62 -20.53 22.45 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 114.457 -0.871 . . . . 0.0 109.563 -177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.562 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 66.3 mtp -125.72 152.35 45.42 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.42 -0.809 . . . . 0.0 108.872 -174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -149.37 167.34 26.4 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.603 0.716 . . . . 0.0 111.882 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 44' ' ' LYS . 7.3 m -60.4 116.52 4.35 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 175.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.56 -42.03 1.43 Allowed Glycine 0 N--CA 1.424 -2.106 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.401 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.565 ' O ' HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -68.3 148.94 50.06 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -176.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.302 0.3 OUTLIER -110.51 119.15 58.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -172.403 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.1 mm -64.83 115.03 2.78 Favored 'Isoleucine or valine' 0 C--O 1.302 3.842 0 C-N-CA 126.478 1.911 . . . . 0.0 110.765 178.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 73' ' ' LEU . 93.0 t -98.49 -58.0 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.584 0 CA-C-N 112.359 -2.2 . . . . 0.0 110.183 -178.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.9 m -154.9 173.35 16.63 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 121.306 -0.871 . . . . 0.0 112.147 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 9.8 p -140.97 159.32 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -31.96 105.15 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 125.396 1.478 . . . . 0.0 114.76 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.0 t70 50.95 33.78 9.44 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.772 1.629 . . . . 0.0 112.224 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.473 ' HB ' ' CG1' ' A' ' 67' ' ' VAL . 15.5 m -140.61 120.71 13.76 Favored 'General case' 0 N--CA 1.421 -1.901 0 O-C-N 121.424 -0.797 . . . . 0.0 109.371 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 24.1 t -81.58 77.07 8.47 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.516 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 91.2 t -74.08 -8.0 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 123.173 1.463 . . . . 0.0 108.62 175.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.619 HD21 ' O ' ' A' ' 6' ' ' ARG . 24.7 tp -64.89 111.13 2.68 Favored 'General case' 0 N--CA 1.41 -2.475 0 CA-C-N 113.495 -1.684 . . . . 0.0 107.138 174.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.93 26.71 74.01 Favored Glycine 0 N--CA 1.436 -1.327 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.477 -176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -74.6 139.78 43.89 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 30.7 m -72.84 145.08 47.2 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 117.458 -1.258 . . . . 0.0 108.381 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.439 ' HA ' HG12 ' A' ' 80' ' ' VAL . 70.3 t60 -47.33 -48.44 25.3 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 119.276 0.944 . . . . 0.0 112.216 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.72 -33.44 70.22 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 123.816 0.698 . . . . 0.0 110.843 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 64.8 mm-40 -80.14 -49.4 11.74 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.835 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 41' ' ' LEU . 8.2 p -63.72 -42.68 96.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.445 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.621 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 7.5 p -65.33 -36.05 76.78 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.834 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 79' ' ' GLN . 38.6 ttpt -55.26 -48.19 74.36 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 122.436 0.294 . . . . 0.0 111.428 177.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 71.1 mt -72.27 -50.26 37.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 122.706 1.241 . . . . 0.0 109.515 -174.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -66.34 -28.27 68.54 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 113.024 -1.898 . . . . 0.0 112.792 -175.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 1.1 mp0 -86.65 -22.93 25.84 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 p -90.0 -18.48 25.91 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -176.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.571 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -54.47 151.41 14.27 Favored Pre-proline 0 N--CA 1.452 -0.36 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 179.442 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -102.84 163.05 0.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.874 3.716 . . . . 0.0 112.283 -177.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 23' ' ' SER . 64.4 mt -67.92 131.91 32.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.931 175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.28 10.97 46.74 Favored Glycine 0 N--CA 1.429 -1.826 0 C-N-CA 120.956 -0.64 . . . . 0.0 113.79 174.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -99.88 -179.2 4.09 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-N 118.456 1.128 . . . . 0.0 111.82 -175.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.423 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 17.2 t -138.68 153.62 48.56 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.582 0.753 . . . . 0.0 109.94 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.3 m -153.89 151.16 11.58 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.77 0 C-N-CA 124.341 1.057 . . . . 0.0 110.391 174.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 14.8 m-20 -95.57 107.59 19.78 Favored 'General case' 0 C--N 1.281 -2.379 0 N-CA-C 105.655 -1.98 . . . . 0.0 105.655 173.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.7 tp -108.04 116.39 31.88 Favored 'General case' 0 C--N 1.27 -2.862 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -110.29 125.05 52.72 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-O 121.396 0.617 . . . . 0.0 110.77 -179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 2.1 pt? -141.95 163.21 33.51 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.656 -176.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 78.7 m -109.57 124.4 51.07 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.328 0.585 . . . . 0.0 110.662 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.578 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 6.7 tpp85 -98.95 147.31 25.11 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.32 -28.88 2.44 Favored Glycine 0 CA--C 1.486 -1.773 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -86.58 135.08 36.54 Favored Pre-proline 0 N--CA 1.429 -1.502 0 CA-C-N 114.581 -0.809 . . . . 0.0 109.404 175.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.568 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 72.0 Cg_endo -98.05 -162.76 0.06 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.723 0 C-N-CA 122.615 2.21 . . . . 0.0 107.223 168.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -93.98 98.96 3.13 Favored Pre-proline 0 C--N 1.298 -1.666 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 7.3 Cg_exo -74.01 -8.62 21.36 Favored 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 123.217 2.611 . . . . 0.0 112.012 -175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 t80 -151.62 139.9 20.35 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -79.55 149.07 71.03 Favored Pre-proline 0 CA--C 1.485 -1.532 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -175.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -95.91 10.41 1.49 Allowed 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 123.415 2.743 . . . . 0.0 108.448 -177.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -81.42 -32.64 32.61 Favored 'General case' 0 N--CA 1.403 -2.818 0 CA-C-N 113.353 -1.748 . . . . 0.0 108.606 -177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -71.24 121.84 85.37 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 114.028 -1.442 . . . . 0.0 109.127 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -58.8 -164.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 124.52 3.48 . . . . 0.0 116.068 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.0 m120 84.61 13.02 0.27 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.318 2.247 . . . . 0.0 113.393 178.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 14.6 t 42.88 -142.67 0.11 Allowed 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.243 1.417 . . . . 0.0 111.575 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.493 ' HB3' HG22 ' B' ' 155' ' ' THR . 5.9 m -60.74 101.88 0.16 Allowed 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.678 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -97.9 136.72 37.79 Favored 'General case' 0 N--CA 1.392 -3.348 0 CA-C-O 121.681 0.753 . . . . 0.0 112.819 -178.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 5.0 m -117.36 131.99 68.46 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.136 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 171.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.9 t -94.42 140.96 29.14 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.9 m -105.2 89.58 3.17 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-O 122.434 1.111 . . . . 0.0 108.786 -177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.546 HG22 HG12 ' A' ' 120' ' ' ILE . 7.1 p -96.3 132.64 40.08 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.375 0 CA-C-N 113.973 -1.467 . . . . 0.0 109.103 -177.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.492 ' HB1' ' HE3' ' A' ' 123' ' ' LYS . . . -79.06 74.34 5.59 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 121.592 0.71 . . . . 0.0 112.783 -175.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.546 HG12 HG22 ' A' ' 118' ' ' VAL . 33.0 mm -132.37 13.97 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 176.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 121' ' ' LEU . 1.5 pt? -82.81 -71.08 0.51 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.712 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' H ' ' HG ' ' A' ' 121' ' ' LEU . 32.2 t70 -159.98 115.86 2.42 Favored 'General case' 0 C--N 1.258 -3.376 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.492 ' HE3' ' HB1' ' A' ' 119' ' ' ALA . 36.7 mtpt -121.49 143.54 49.2 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-O 120.906 0.384 . . . . 0.0 110.076 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -81.6 133.26 52.98 Favored Pre-proline 0 C--N 1.286 -2.165 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 N--CA 1.444 -1.431 0 C-N-CA 122.13 1.887 . . . . 0.0 111.187 177.114 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . 0.274 58.6 p 63.95 -97.05 0.06 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.56 1.544 . . . . 0.0 115.029 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 15.0 m -72.55 70.26 0.91 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 122.191 0.996 . . . . 0.0 113.176 -175.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -131.67 3.64 4.18 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.367 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.493 HG22 ' HB3' ' A' ' 113' ' ' SER . 11.4 m -84.06 55.32 3.26 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 122.381 1.086 . . . . 0.0 108.836 -176.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -90.12 128.54 36.35 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.856 -174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -99.73 142.3 31.39 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.227 -178.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.41 132.96 36.55 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 121.297 0.57 . . . . 0.0 111.468 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 15.0 m -132.78 122.82 25.08 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 177.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.454 ' HA ' HG22 ' A' ' 30' ' ' THR . 2.3 mp0 -92.77 110.77 22.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 29' ' ' PHE . 13.9 m . . . . . 0 C--N 1.304 -1.388 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.839 -177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.367 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -151.81 -79.94 0.11 Allowed 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 118.12 0.96 . . . . 0.0 112.997 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.4 ttt -58.29 118.29 5.35 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 -167.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . 0.46 ' C ' ' HD3' ' A' ' 1' ' ' LYS . . . 103.61 -7.57 50.31 Favored Glycine 0 C--N 1.333 0.402 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.183 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.46 ' HD3' ' C ' ' A' ' 0' ' ' GLY . 0.0 OUTLIER -143.07 174.01 4.02 Favored Pre-proline 0 C--N 1.309 -1.194 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -177.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -86.02 155.58 9.86 Favored 'Trans proline' 0 N--CA 1.435 -1.916 0 N-CA-C 108.017 -1.57 . . . . 0.0 108.017 165.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.419 ' HE1' ' HA ' ' A' ' 11' ' ' LEU . 12.1 p90 -94.11 137.96 32.71 Favored 'General case' 0 N--CA 1.409 -2.478 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -141.31 132.05 25.73 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.057 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.9 t -168.89 33.0 0.02 OUTLIER 'General case' 0 C--N 1.276 -2.613 0 CA-C-N 113.587 -1.642 . . . . 0.0 108.025 165.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 32.9 ptt180 41.81 42.86 2.33 Favored 'General case' 0 C--N 1.372 1.558 0 C-N-CA 126.527 1.931 . . . . 0.0 113.189 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.813 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 5.6 m-80 -112.5 119.45 43.44 Favored Pre-proline 1 C--N 1.223 -4.893 0 CA-C-N 112.412 -2.177 . . . . 0.0 113.315 176.263 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.317 24.1 Cg_exo -60.71 -37.33 79.74 Favored 'Trans proline' 0 CA--C 1.474 -2.491 0 C-N-CA 121.788 1.659 . . . . 0.0 108.436 173.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.1 m -64.8 -23.62 67.3 Favored 'General case' 1 N--CA 1.346 -5.653 0 CA-C-N 109.848 -3.342 . . . . 0.0 112.432 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.813 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.9 pt-20 -80.97 -34.59 32.99 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.419 ' HA ' ' HE1' ' A' ' 3' ' ' PHE . 98.9 mt -55.79 129.98 41.57 Favored 'General case' 0 C--O 1.247 0.925 0 CA-C-O 122.772 1.273 . . . . 0.0 112.052 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -71.84 173.74 7.85 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 112.801 -1.999 . . . . 0.0 112.376 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.574 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 78.01 -121.35 5.7 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.597 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -133.67 155.52 49.55 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.916 0.486 . . . . 0.0 109.914 -179.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -116.33 111.63 20.37 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.41 152.88 37.91 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-O 121.484 0.659 . . . . 0.0 111.961 -174.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -125.91 113.79 17.67 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.664 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.447 ' OG1' ' HG2' ' A' ' 57' ' ' LYS . 11.2 t -125.48 137.3 53.96 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 121.269 0.557 . . . . 0.0 110.633 -179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -74.82 131.35 40.71 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.561 179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.629 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.46 126.31 53.21 Favored 'General case' 0 CA--C 1.479 -1.769 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 176.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -88.45 105.46 17.63 Favored 'General case' 0 N--CA 1.399 -2.995 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.606 ' HG2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -39.8 113.97 0.39 Allowed 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 175.754 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.8 t -89.26 -149.65 0.19 Allowed 'General case' 0 N--CA 1.406 -2.628 0 O-C-N 126.182 2.176 . . . . 0.0 107.951 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.8 m -61.96 80.36 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.49 ' N ' HG12 ' A' ' 89' ' ' ILE . 17.4 mmm180 65.54 56.9 0.91 Allowed 'General case' 0 CA--C 1.503 -0.843 0 CA-C-O 122.397 1.094 . . . . 0.0 111.406 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 139.59 -131.55 5.22 Favored Glycine 0 N--CA 1.403 -3.502 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.149 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.669 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 71.1 m-85 -130.0 -83.64 0.55 Allowed 'General case' 0 C--N 1.278 -2.521 0 CA-C-N 115.352 -0.424 . . . . 0.0 111.305 -173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.578 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 135.03 53.18 0.07 OUTLIER Glycine 0 C--N 1.297 -1.595 0 C-N-CA 120.471 -0.871 . . . . 0.0 111.877 -170.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.455 ' CD1' HD12 ' A' ' 43' ' ' ILE . 35.4 p90 -162.39 152.11 16.09 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 33.3 p -112.03 144.07 42.0 Favored 'General case' 0 C--N 1.278 -2.526 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.051 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 76.1 t -113.45 149.38 15.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.072 -171.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 42' ' ' GLN . 1.2 m -119.87 129.76 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 165.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 121.47 -132.7 9.15 Favored Glycine 0 C--N 1.256 -3.881 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 174.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.613 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 33.46 59.98 0.5 Allowed Glycine 1 CA--C 1.445 -4.327 0 O-C-N 126.215 1.773 . . . . 0.0 111.391 -179.045 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -106.55 -29.6 9.55 Favored 'General case' 0 C--N 1.252 -3.67 0 CA-C-N 113.933 -1.134 . . . . 0.0 109.214 -170.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.451 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -159.15 173.78 4.65 Favored Pre-proline 0 CA--C 1.483 -1.606 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.655 -172.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 73.6 Cg_exo -62.22 -25.95 77.24 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 122.907 2.405 . . . . 0.0 109.921 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.66 -22.76 27.75 Favored 'General case' 0 N--CA 1.408 -2.546 0 CA-C-N 112.636 -2.074 . . . . 0.0 111.996 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -123.44 119.98 31.61 Favored 'General case' 0 C--O 1.264 1.849 0 O-C-N 121.735 -0.603 . . . . 0.0 110.368 -176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -86.62 164.87 16.58 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.766 2.026 . . . . 0.0 110.805 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD21 HG21 ' A' ' 80' ' ' VAL . 6.8 mp -89.16 144.82 25.84 Favored 'General case' 0 C--O 1.183 -2.398 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -175.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.591 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 29.2 tt0 -138.76 158.73 43.68 Favored 'General case' 0 C--O 1.188 -2.16 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.455 HD12 ' CD1' ' A' ' 29' ' ' PHE . 32.0 mm -92.6 124.15 44.95 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 C-N-CA 122.527 0.331 . . . . 0.0 110.216 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -104.85 -18.93 14.05 Favored 'General case' 0 CA--C 1.503 -0.857 0 O-C-N 123.452 0.47 . . . . 0.0 110.404 177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.528 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 54.4 m -154.94 127.63 8.03 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 120.904 0.383 . . . . 0.0 110.539 173.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.2 tp -81.14 106.72 13.35 Favored 'General case' 0 N--CA 1.399 -3.009 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 170.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.578 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.1 t -79.82 115.02 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.208 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 -177.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.95 143.52 57.9 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.614 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.507 ' HA ' HD21 ' A' ' 54' ' ' LEU . 33.1 t70 79.43 14.69 1.01 Allowed 'General case' 0 CA--C 1.54 0.59 0 O-C-N 125.252 1.595 . . . . 0.0 109.51 -172.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.563 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -97.18 165.27 22.73 Favored Glycine 0 C--O 1.207 -1.579 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 171.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.5 Cg_endo -72.51 -25.12 18.22 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 CA-C-N 121.816 2.808 . . . . 0.0 110.772 -169.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.61 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -63.81 -45.41 89.77 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.405 -1.27 . . . . 0.0 108.77 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.36 -46.08 71.05 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 124.637 1.175 . . . . 0.0 110.301 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.563 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 92.2 mt -71.66 -34.01 69.36 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 113.765 -1.561 . . . . 0.0 114.506 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.493 ' OD1' ' HB2' ' A' ' 57' ' ' LYS . 14.1 t70 -77.91 -27.6 49.54 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 173.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 70.59 29.33 69.83 Favored Glycine 0 CA--C 1.484 -1.898 0 CA-C-N 112.69 -2.05 . . . . 0.0 112.336 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' HB2' ' OD1' ' A' ' 55' ' ' ASP . 5.0 tppp? -97.12 -50.81 4.45 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 114.209 -0.995 . . . . 0.0 111.349 -173.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.61 ' HB2' ' HB1' ' A' ' 52' ' ' ALA . 62.7 mtp -88.86 158.34 18.14 Favored 'General case' 0 C--O 1.247 0.968 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.352 -174.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -139.78 159.0 43.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.9 m -62.98 118.68 8.15 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.28 -31.18 3.05 Favored Glycine 0 N--CA 1.423 -2.205 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.536 ' HB3' HD12 ' A' ' 97' ' ' LEU . 9.1 m-20 -53.25 140.43 26.59 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.018 0.481 . . . . 0.0 111.615 178.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.5 OUTLIER -107.8 114.64 46.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 CA-C-O 121.175 0.512 . . . . 0.0 111.497 175.805 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 47.7 mm -70.25 116.5 11.58 Favored 'Isoleucine or valine' 0 C--O 1.298 3.641 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.166 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.512 HG13 HD13 ' A' ' 73' ' ' LEU . 88.3 t -99.57 -59.17 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.698 0 CA-C-N 112.467 -2.151 . . . . 0.0 110.395 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.0 p -151.79 166.21 32.07 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.452 -175.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 p -146.95 110.11 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.421 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.872 ' ND2' ' HB ' ' A' ' 93' ' ' VAL . 14.7 m-80 43.13 65.21 1.0 Allowed 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 171.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.4 t70 76.46 -38.05 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.663 1.585 . . . . 0.0 112.869 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 28.6 m -59.23 122.74 14.61 Favored 'General case' 0 C--O 1.258 1.506 0 CA-C-O 121.728 0.775 . . . . 0.0 110.382 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 35.1 t -83.33 76.75 9.88 Favored 'General case' 0 N--CA 1.423 -1.788 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.602 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HA ' ' HB2' ' A' ' 75' ' ' HIS . 43.8 t -77.93 -7.18 10.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.635 176.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.512 HD13 HG13 ' A' ' 65' ' ' VAL . 16.2 tp -69.43 110.7 4.86 Favored 'General case' 0 N--CA 1.408 -2.564 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 172.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 76.84 32.68 48.97 Favored Glycine 0 N--CA 1.411 -2.974 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.959 -174.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -88.78 137.26 32.48 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 175.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.534 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 38.1 m -72.35 144.18 48.35 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-O 117.942 -1.028 . . . . 0.0 108.838 178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.445 ' CD2' ' HD3' ' B' ' 157' ' ' ARG . 67.2 t60 -47.71 -50.86 23.93 Favored 'General case' 0 CA--C 1.494 -1.188 0 CA-C-N 119.046 0.839 . . . . 0.0 112.849 -176.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.07 -31.7 72.15 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.64 0.587 . . . . 0.0 110.969 -176.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 33.5 mm-40 -75.95 -52.46 10.23 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-O 121.362 0.601 . . . . 0.0 109.933 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.664 HG21 HD21 ' A' ' 41' ' ' LEU . 7.2 p -64.43 -43.49 96.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.811 -177.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.57 -35.84 74.15 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.413 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.59 -41.83 95.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.905 177.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 67.9 mt -72.2 -50.54 35.73 Favored 'Isoleucine or valine' 0 C--O 1.257 1.489 0 CA-C-O 122.383 1.087 . . . . 0.0 109.455 -176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.13 -34.87 79.43 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.158 -1.837 . . . . 0.0 112.83 -175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 72.0 mm-40 -85.9 -15.2 42.47 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -82.72 -16.43 48.07 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.225 175.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.606 HG23 ' HG2' ' A' ' 22' ' ' LYS . 5.5 mt -43.8 138.82 3.04 Favored Pre-proline 0 CA--C 1.56 1.344 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 53.4 Cg_endo -95.96 148.06 1.28 Allowed 'Trans proline' 0 N--CA 1.441 -1.564 0 C-N-CA 123.478 2.786 . . . . 0.0 110.858 175.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.49 HG12 ' N ' ' A' ' 25' ' ' ARG . 20.2 mt -67.54 139.86 20.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.2 11.72 57.08 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.248 -0.977 . . . . 0.0 111.851 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -97.96 -176.65 3.5 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.02 -0.672 . . . . 0.0 111.007 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.44 ' CB ' ' HE3' ' A' ' 19' ' ' LYS . 5.9 p -149.39 138.13 21.05 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.909 -0.495 . . . . 0.0 111.828 -173.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.872 ' HB ' ' ND2' ' A' ' 68' ' ' ASN . 2.5 m -153.36 143.18 14.54 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.917 0 C-N-CA 122.645 0.378 . . . . 0.0 111.953 174.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.714 ' N ' HD21 ' A' ' 68' ' ' ASN . 19.9 m-20 -78.07 106.98 10.3 Favored 'General case' 0 C--O 1.248 1.003 0 C-N-CA 125.865 1.666 . . . . 0.0 107.749 171.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 95' ' ' LEU . 8.4 tp -96.12 118.75 33.33 Favored 'General case' 0 C--N 1.26 -3.307 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -100.6 116.51 32.7 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.603 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.6 OUTLIER -141.94 159.98 41.12 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.438 -175.12 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 73.8 m -112.82 127.45 56.17 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.532 0.682 . . . . 0.0 110.631 178.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.597 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 22.7 tpp85 -97.2 146.01 25.5 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 140.36 -32.24 2.18 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.809 -1.186 . . . . 0.0 111.799 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 -77.2 125.18 86.91 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-O 120.641 0.257 . . . . 0.0 110.472 177.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.59 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 86.5 Cg_endo -85.73 -175.48 1.9 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 121.991 1.794 . . . . 0.0 109.785 175.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.99 89.82 5.92 Favored Pre-proline 0 C--N 1.293 -1.852 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 176.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.59 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 9.4 Cg_exo -74.54 -15.4 21.99 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 122.747 2.298 . . . . 0.0 110.117 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -100.74 166.44 10.87 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 109' ' ' ASP . 6.5 m-20 -111.91 150.33 42.19 Favored Pre-proline 0 C--N 1.268 -2.958 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 176.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -96.77 12.44 1.08 Allowed 'Trans proline' 0 N--CA 1.426 -2.496 0 C-N-CA 124.063 3.175 . . . . 0.0 106.771 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -115.47 1.84 13.74 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-N 112.34 -2.209 . . . . 0.0 107.665 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 106' ' ' ASP . 27.1 t70 -116.25 145.22 34.55 Favored Pre-proline 0 C--N 1.305 -1.329 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.39 -172.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 111' ' ' ASN . 0.0 OUTLIER -18.75 -88.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.923 1 C-N-CA 126.91 5.074 . . . . 0.0 117.98 175.388 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' H ' ' HB2' ' A' ' 110' ' ' PRO . 7.3 m120 57.05 71.58 0.57 Allowed 'General case' 0 C--N 1.313 -1.012 0 C-N-CA 126.268 1.827 . . . . 0.0 112.741 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.4 t -83.88 -161.34 0.52 Allowed 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.764 -1.562 . . . . 0.0 108.2 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.513 ' HA ' HG23 ' B' ' 155' ' ' THR . 6.7 p -61.63 115.42 3.93 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-O 121.12 0.486 . . . . 0.0 112.195 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 61.7 mt -84.49 105.59 15.42 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 57.3 t -99.24 126.8 52.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.051 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.245 -173.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.4 t -127.02 152.13 47.67 Favored 'General case' 0 N--CA 1.417 -2.114 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 178.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 14.5 m -72.21 115.8 11.88 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.813 0.816 . . . . 0.0 111.307 -174.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.98 147.11 30.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.319 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -114.32 110.84 20.54 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.584 0.706 . . . . 0.0 109.661 179.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 39.9 mt -126.02 -51.96 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.0 mt -102.29 160.08 14.84 Favored 'General case' 0 CA--C 1.482 -1.656 0 CA-C-N 114.887 -1.052 . . . . 0.0 110.358 -178.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -82.05 89.98 6.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.563 -1.199 . . . . 0.0 108.521 175.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.434 ' O ' ' HD3' ' A' ' 125' ' ' PRO . 72.7 mmtt -74.3 134.02 42.58 Favored 'General case' 0 N--CA 1.404 -2.774 0 CA-C-N 114.136 -1.393 . . . . 0.0 110.208 -178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.465 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.4 OUTLIER -92.66 107.51 24.71 Favored Pre-proline 0 C--N 1.262 -3.208 0 CA-C-N 113.617 -1.629 . . . . 0.0 110.673 -179.435 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 123' ' ' LYS . 66.7 Cg_endo . . . . . 0 N--CA 1.436 -1.855 0 C-N-CA 122.859 2.373 . . . . 0.0 111.71 178.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.516 ' HB3' HG21 ' A' ' 76' ' ' THR . 19.4 m -79.05 41.06 0.43 Allowed 'General case' 0 CA--C 1.558 1.276 0 C-N-CA 124.612 1.165 . . . . 0.0 113.986 -173.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 57.4 m -158.84 159.57 35.2 Favored 'General case' 0 C--O 1.253 1.252 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' B' ' 155' ' ' THR . 0.0 OUTLIER 69.57 144.7 0.05 Allowed 'General case' 0 CA--C 1.558 1.267 0 O-C-N 124.4 1.062 . . . . 0.0 112.632 179.663 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.513 HG23 ' HA ' ' A' ' 113' ' ' SER 0.267 13.2 m 111.73 -45.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 126.292 1.837 . . . . 0.0 113.888 -177.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.422 ' CA ' ' HE ' ' B' ' 156' ' ' ARG . 0.1 OUTLIER 69.52 90.55 0.1 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -174.065 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.445 ' HD3' ' CD2' ' A' ' 77' ' ' HIS . 46.9 mtt180 -92.31 152.12 19.95 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 114.568 1.321 . . . . 0.0 114.568 -164.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.722 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 0.5 OUTLIER -93.43 104.6 16.73 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 113.374 -1.739 . . . . 0.0 111.334 -179.117 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 19.9 m -94.69 101.55 13.4 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.44 ' HA ' HG22 ' A' ' 30' ' ' THR . 10.6 mt-30 -83.88 122.57 28.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 26.8 m . . . . . 0 C--N 1.312 -1.027 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.4 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.207 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -87.04 135.51 33.25 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.36 -178.77 4.13 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 107.76 20.24 8.61 Favored Glycine 0 C--N 1.303 -1.3 0 C-N-CA 120.143 -1.027 . . . . 0.0 111.536 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.52 146.49 34.76 Favored Pre-proline 0 C--N 1.311 -1.092 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.31 139.9 85.44 Favored 'Trans proline' 0 CA--C 1.501 -1.139 0 C-N-CA 122.407 2.071 . . . . 0.0 111.997 -178.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -107.94 144.12 35.64 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.807 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' CE1' ' HA ' ' A' ' 38' ' ' ASP . 8.7 t80 -147.37 139.51 24.42 Favored 'General case' 0 C--N 1.289 -2.024 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.612 -178.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.429 HG23 ' H ' ' A' ' 7' ' ' ASN 0.383 9.9 t -156.82 -54.08 0.08 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 113.955 -1.475 . . . . 0.0 111.51 162.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' HA ' ' CE1' ' A' ' 40' ' ' PHE . 18.0 ptt180 157.88 -33.64 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 -176.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.74 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 20.2 t30 -53.94 111.45 2.83 Favored Pre-proline 0 C--N 1.269 -2.904 0 CA-C-N 112.332 -2.213 . . . . 0.0 113.637 -171.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 11' ' ' LEU 0.274 7.6 Cg_exo -57.4 -36.54 98.82 Favored 'Trans proline' 0 CA--C 1.463 -3.035 0 C-N-CA 122.921 2.414 . . . . 0.0 111.241 -179.231 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.1 m -77.94 -9.32 59.03 Favored 'General case' 1 N--CA 1.347 -5.611 0 CA-C-N 112.195 -2.275 . . . . 0.0 112.424 -175.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.74 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.3 pt-20 -80.23 -36.56 34.58 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 8' ' ' PRO . 96.3 mt -57.23 134.51 55.99 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.254 -1.339 . . . . 0.0 109.941 177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.62 170.8 16.03 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-N 114.337 -1.301 . . . . 0.0 112.153 -177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 93.87 -117.01 5.37 Favored Glycine 0 N--CA 1.424 -2.106 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.052 -175.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.588 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -150.38 145.78 26.3 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 123.573 0.749 . . . . 0.0 110.465 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.92 112.49 24.18 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.23 152.49 37.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.471 -176.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.454 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 44.3 p-80 -123.48 116.38 23.12 Favored 'General case' 0 N--CA 1.411 -2.38 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.396 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.3 t -122.46 140.98 52.11 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.631 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.653 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -73.77 132.73 42.92 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.978 178.777 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.553 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.0 OUTLIER -116.04 127.39 54.86 Favored 'General case' 0 C--O 1.256 1.435 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 173.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -86.87 105.84 17.33 Favored 'General case' 0 N--CA 1.408 -2.547 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.702 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.767 ' HE3' HG13 ' A' ' 93' ' ' VAL . 1.6 mptm? -36.65 108.74 0.08 Allowed 'General case' 0 C--O 1.257 1.495 0 C-N-CA 125.115 1.366 . . . . 0.0 112.38 173.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 8.8 t -124.32 142.42 51.29 Favored 'General case' 0 N--CA 1.42 -1.953 0 O-C-N 125.034 1.459 . . . . 0.0 108.532 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.2 m 52.56 39.4 27.98 Favored 'General case' 0 CA--C 1.565 1.55 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.535 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.0 OUTLIER 67.52 35.15 4.3 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 125.013 1.325 . . . . 0.0 110.989 176.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 173.31 -120.95 0.83 Allowed Glycine 0 N--CA 1.409 -3.152 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.602 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 63.5 m-85 -137.92 -93.25 0.21 Allowed 'General case' 0 N--CA 1.408 -2.572 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 50' ' ' GLY . . . 153.03 54.46 0.01 OUTLIER Glycine 0 C--N 1.292 -1.916 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -177.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 44.7 p90 -160.64 166.48 28.82 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 175.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.575 HG22 ' HA ' ' B' ' 160' ' ' GLN . 29.3 p -120.51 136.23 54.83 Favored 'General case' 0 C--N 1.273 -2.741 0 O-C-N 121.192 -0.942 . . . . 0.0 109.126 175.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -122.67 140.09 47.52 Favored 'Isoleucine or valine' 1 N--CA 1.372 -4.34 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.687 -170.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 6.8 m -115.24 169.05 6.32 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 113.678 -1.601 . . . . 0.0 111.101 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.794 ' O ' ' HB3' ' B' ' 157' ' ' ARG . . . 84.8 -125.79 7.35 Favored Glycine 0 C--O 1.191 -2.558 0 N-CA-C 108.457 -1.857 . . . . 0.0 108.457 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.494 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 31.89 58.5 0.36 Allowed Glycine 0 N--CA 1.497 2.751 0 C-N-CA 125.87 1.7 . . . . 0.0 113.863 176.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -114.57 -32.11 5.98 Favored 'General case' 1 C--N 1.233 -4.494 0 CA-C-N 113.033 -1.583 . . . . 0.0 109.431 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.407 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 4.0 pt-20 -158.6 172.24 6.39 Favored Pre-proline 0 CA--C 1.466 -2.274 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.397 -174.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.569 ' HA ' ' HA3' ' A' ' 74' ' ' GLY . 50.0 Cg_exo -63.83 -26.02 67.65 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.206 1.937 . . . . 0.0 108.914 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.521 ' HA ' ' CE1' ' A' ' 4' ' ' PHE . 9.8 t70 -71.43 -35.47 70.95 Favored 'General case' 0 N--CA 1.405 -2.681 0 CA-C-N 112.505 -2.134 . . . . 0.0 111.638 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -125.87 119.11 26.94 Favored 'General case' 0 C--O 1.275 2.415 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.188 179.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 6' ' ' ARG . 8.6 m-85 -82.46 166.03 19.7 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 127.849 2.46 . . . . 0.0 110.699 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.769 HD21 HG21 ' A' ' 80' ' ' VAL . 3.9 mp -85.36 145.42 27.5 Favored 'General case' 0 C--O 1.187 -2.214 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.122 -172.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 8.2 tt0 -145.04 148.38 33.64 Favored 'General case' 0 C--O 1.191 -1.977 0 CA-C-N 118.817 0.735 . . . . 0.0 109.264 -178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.574 HG12 ' O ' ' A' ' 62' ' ' ASP . 36.4 mm -81.7 123.26 37.78 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.602 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' C ' HG23 ' A' ' 60' ' ' THR . 42.8 pttt -103.41 -19.96 14.24 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 120.353 -0.539 . . . . 0.0 110.053 177.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.2 m -155.31 127.74 7.83 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 175.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 16.4 tp -83.11 111.3 18.77 Favored 'General case' 0 N--CA 1.405 -2.716 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 92.2 t -86.67 121.47 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.033 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 79.8 mt -67.0 145.42 55.42 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.542 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.7 t70 84.41 6.03 0.61 Allowed 'General case' 0 N--CA 1.476 0.827 0 O-C-N 125.56 1.788 . . . . 0.0 109.319 -171.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.554 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.72 158.51 25.2 Favored Glycine 0 C--O 1.2 -1.995 0 CA-C-O 118.322 -1.266 . . . . 0.0 110.66 173.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.3 Cg_endo -72.13 -25.11 19.49 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 CA-C-N 120.858 2.329 . . . . 0.0 110.192 -171.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' HB1' ' HB2' ' A' ' 58' ' ' MET . . . -62.43 -46.81 86.85 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.779 -1.1 . . . . 0.0 108.977 172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.64 81.76 Favored 'General case' 0 CA--C 1.495 -1.14 0 C-N-CA 124.609 1.164 . . . . 0.0 110.753 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 84.5 mt -71.92 -41.58 67.71 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 113.336 -1.756 . . . . 0.0 114.378 -174.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.8 -25.09 61.02 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.78 -0.32 86.42 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 117.941 1.937 . . . . 0.0 117.941 171.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' HG2' ' N ' ' A' ' 58' ' ' MET . 0.0 OUTLIER -94.47 -49.54 5.63 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 120.348 2.074 . . . . 0.0 114.03 -176.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.601 ' HG2' HD11 ' A' ' 97' ' ' LEU . 65.8 mtp -64.62 139.46 58.77 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.187 0.304 . . . . 0.0 110.894 -175.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -130.27 167.12 18.97 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.343 0.592 . . . . 0.0 110.939 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 44' ' ' LYS . 25.7 m -60.83 128.19 35.29 Favored 'General case' 0 N--CA 1.417 -2.077 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 174.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.54 -35.03 4.02 Favored Glycine 0 N--CA 1.427 -1.966 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.455 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.574 ' O ' HG12 ' A' ' 43' ' ' ILE . 3.5 m-20 -52.78 129.07 28.77 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.383 0.673 . . . . 0.0 110.613 -177.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.255 0.8 OUTLIER -93.4 116.23 34.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-O 121.335 0.588 . . . . 0.0 112.184 -179.161 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 46.8 mm -72.77 115.52 13.6 Favored 'Isoleucine or valine' 0 C--O 1.295 3.476 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.829 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.651 HG13 HD13 ' A' ' 73' ' ' LEU . 98.7 t -98.45 -56.69 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.528 0 CA-C-N 112.293 -2.23 . . . . 0.0 110.54 -175.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.4 m -157.66 174.66 15.0 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.699 -0.626 . . . . 0.0 110.98 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.471 ' CG2' ' HB ' ' A' ' 93' ' ' VAL . 9.9 p -140.02 159.78 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.737 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.521 ' OD1' HG12 ' A' ' 93' ' ' VAL . 28.4 p-10 -29.22 109.86 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.524 1.129 . . . . 0.0 113.31 179.033 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.4 t70 69.8 -37.4 0.38 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.995 1.318 . . . . 0.0 113.729 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.0 m -82.67 124.35 30.11 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 122.076 0.941 . . . . 0.0 111.865 -171.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 33.9 t -84.82 78.72 9.83 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-N 114.948 -1.024 . . . . 0.0 108.985 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' HA ' ' CG ' ' A' ' 75' ' ' HIS . 23.8 t -77.17 3.71 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 122.302 1.049 . . . . 0.0 109.068 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD13 HG13 ' A' ' 65' ' ' VAL . 12.1 tp -65.74 111.55 3.28 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 115.155 -0.93 . . . . 0.0 108.514 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.569 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 62.96 37.9 95.7 Favored Glycine 0 N--CA 1.418 -2.524 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.589 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -74.13 137.85 43.5 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.503 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 47.3 m -72.76 146.96 46.01 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.527 -177.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.573 ' NE2' ' HB2' ' A' ' 117' ' ' SER . 1.2 t60 -44.43 -49.63 9.67 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.236 0.614 . . . . 0.0 112.045 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.81 80.35 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 123.748 0.655 . . . . 0.0 111.102 -177.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.503 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 25.6 mm-40 -75.33 -53.41 8.79 Favored 'General case' 0 N--CA 1.436 -1.131 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.014 -177.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.769 HG21 HD21 ' A' ' 41' ' ' LEU . 11.7 p -59.72 -44.59 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.838 -1.074 . . . . 0.0 112.725 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.7 p -69.48 -36.13 69.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 C-N-CA 119.713 -0.795 . . . . 0.0 111.062 -177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 3.7 tmmm? -59.96 -44.07 94.64 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 179.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.6 mt -71.7 -50.68 37.31 Favored 'Isoleucine or valine' 0 C--O 1.262 1.729 0 CA-C-O 122.507 1.146 . . . . 0.0 108.895 -174.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.506 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 13.2 m-85 -66.18 -33.76 76.49 Favored 'General case' 0 N--CA 1.414 -2.231 0 CA-C-N 112.914 -1.948 . . . . 0.0 113.398 -174.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -84.82 -19.21 32.84 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.44 -0.504 . . . . 0.0 112.349 177.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.3 m -84.08 -10.01 58.16 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.069 0.461 . . . . 0.0 110.879 177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 22' ' ' LYS . 6.1 mt -49.78 138.07 18.0 Favored Pre-proline 0 CA--C 1.558 1.282 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 174.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -101.58 149.16 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 124.209 3.273 . . . . 0.0 111.254 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.535 HG12 ' H ' ' A' ' 25' ' ' ARG . 22.8 mt -68.4 143.25 15.37 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.052 178.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 94.19 11.42 57.44 Favored Glycine 0 CA--C 1.492 -1.359 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.427 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -107.09 -173.36 2.27 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.575 -0.85 . . . . 0.0 111.547 -172.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.567 ' N ' ' HD3' ' A' ' 22' ' ' LYS . 31.1 t -149.52 151.94 34.73 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.261 0.838 . . . . 0.0 113.261 -169.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.767 HG13 ' HE3' ' A' ' 22' ' ' LYS . 1.1 m -157.12 153.72 6.5 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.46 0 C-N-CA 124.206 1.002 . . . . 0.0 111.245 173.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -95.02 107.49 19.54 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 173.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.7 tp -96.03 116.57 29.16 Favored 'General case' 0 C--N 1.274 -2.678 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -96.55 113.96 25.58 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -177.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.601 HD11 ' HG2' ' A' ' 58' ' ' MET . 1.4 pt? -141.48 157.8 44.68 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.897 0.379 . . . . 0.0 111.013 -176.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.1 t -111.63 123.58 50.52 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.588 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.7 tpp85 -92.12 143.06 26.83 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 145.15 -36.16 1.41 Allowed Glycine 0 C--N 1.294 -1.769 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -88.32 129.04 51.01 Favored Pre-proline 0 C--N 1.306 -1.308 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -104.56 -166.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.329 0 C-N-CA 122.696 2.264 . . . . 0.0 110.815 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -114.99 79.64 6.24 Favored Pre-proline 0 C--N 1.314 -0.964 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 173.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' HD2' ' CD2' ' A' ' 105' ' ' PHE . 57.6 Cg_endo -87.98 5.37 5.42 Favored 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.783 2.322 . . . . 0.0 110.96 179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.406 ' CD2' ' HD2' ' A' ' 104' ' ' PRO . 52.7 p90 -138.41 172.14 13.34 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 104.488 -2.412 . . . . 0.0 104.488 177.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.437 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.7 m-20 -126.88 146.39 57.24 Favored Pre-proline 0 C--N 1.291 -1.97 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.561 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.0 Cg_endo -92.32 1.25 4.04 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 123.965 3.11 . . . . 0.0 107.345 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -86.46 -30.5 21.98 Favored 'General case' 0 N--CA 1.413 -2.324 0 CA-C-N 112.419 -2.173 . . . . 0.0 107.366 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -87.68 143.85 34.37 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.437 -179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -59.03 -163.37 0.02 OUTLIER 'Trans proline' 0 C--O 1.237 0.474 0 C-N-CA 123.679 2.919 . . . . 0.0 115.427 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' B' ' 152' ' ' SER . 11.6 m120 71.82 32.86 1.83 Allowed 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.235 -1.802 . . . . 0.0 108.901 -175.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 m -171.11 135.14 0.97 Allowed 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 105.425 -2.065 . . . . 0.0 105.425 -179.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.492 ' HB2' ' O ' ' B' ' 154' ' ' ARG . 71.0 m -103.61 116.09 31.71 Favored 'General case' 0 N--CA 1.402 -2.828 0 CA-C-O 121.329 0.585 . . . . 0.0 111.401 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.439 HD13 ' O ' ' B' ' 156' ' ' ARG . 1.0 OUTLIER -92.95 116.17 28.8 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.838 175.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 90.6 t -121.23 122.57 67.79 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 t -71.27 151.41 44.27 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.573 ' HB2' ' NE2' ' A' ' 77' ' ' HIS . 32.7 t -84.26 108.12 16.95 Favored 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.3 p -126.88 123.48 62.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.093 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.38 76.46 1.03 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -175.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.0 mm -88.0 -35.05 7.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 N-CA-C 104.999 -2.222 . . . . 0.0 104.999 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.4 mt -93.68 177.4 6.02 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.346 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.47 71.98 4.97 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -172.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.83 49.15 1.79 Allowed 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.793 -1.549 . . . . 0.0 107.921 169.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -85.72 118.39 70.5 Favored Pre-proline 0 C--N 1.311 -1.085 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.416 -175.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.544 0.999 0 C-N-CA 123.454 2.769 . . . . 0.0 112.979 178.765 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 111' ' ' ASN . 46.6 m -75.92 93.15 3.18 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.089 0.471 . . . . 0.0 111.468 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 19.9 m -77.94 121.42 24.15 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 174.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.492 ' O ' ' HB2' ' A' ' 113' ' ' SER . 79.9 mtm180 -69.94 -14.88 62.92 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.757 0.313 . . . . 0.0 111.57 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 2.2 p -148.85 97.57 2.73 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.771 0.828 . . . . 0.0 110.141 168.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.439 ' O ' HD13 ' A' ' 114' ' ' LEU . 34.4 ttm180 -103.53 115.5 30.63 Favored 'General case' 0 N--CA 1.409 -2.479 0 N-CA-C 104.452 -2.425 . . . . 0.0 104.452 169.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.794 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -73.82 151.85 40.43 Favored 'General case' 0 C--N 1.275 -2.664 0 CA-C-N 115.228 -0.897 . . . . 0.0 113.343 -171.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -113.82 130.37 56.48 Favored 'General case' 0 N--CA 1.438 -1.025 0 C-N-CA 126.685 1.994 . . . . 0.0 107.844 173.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.72 ' OG1' ' HD3' ' B' ' 157' ' ' ARG . 54.4 m -147.33 117.02 7.09 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.575 ' HA ' HG22 ' A' ' 30' ' ' THR . 9.8 tt0 -91.51 109.22 20.51 Favored 'General case' 0 N--CA 1.42 -1.96 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.276 -2.596 0 CA-C-N 114.836 -1.074 . . . . 0.0 109.305 -177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -85.01 100.11 11.45 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.231 0.538 . . . . 0.0 109.857 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.7 mmt -128.26 153.37 47.03 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.486 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 89.76 21.87 38.4 Favored Glycine 0 C--N 1.308 -0.975 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.147 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.49 150.98 38.96 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 116.696 0.248 . . . . 0.0 110.397 178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -66.8 127.83 17.77 Favored 'Trans proline' 0 C--O 1.255 1.337 0 C-N-CA 121.941 1.761 . . . . 0.0 110.461 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -101.21 131.37 47.24 Favored 'General case' 0 C--N 1.275 -2.636 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.541 -173.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -148.37 132.12 16.96 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.815 176.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.605 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 9.3 t -169.96 34.48 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.862 0.726 . . . . 0.0 109.495 168.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 5' ' ' THR . 12.8 ptm180 53.23 16.43 0.81 Allowed 'General case' 0 N--CA 1.518 2.933 0 C-N-CA 127.12 2.168 . . . . 0.0 113.686 177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.729 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -88.78 110.28 36.26 Favored Pre-proline 0 C--N 1.257 -3.426 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.793 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.263 7.7 Cg_exo -58.38 -31.86 94.91 Favored 'Trans proline' 0 CA--C 1.476 -2.422 0 C-N-CA 121.225 1.283 . . . . 0.0 109.114 171.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.3 t -72.74 -19.52 61.37 Favored 'General case' 1 N--CA 1.361 -4.9 0 CA-C-N 112.553 -2.112 . . . . 0.0 111.851 -176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.8 pt-20 -79.77 -31.53 40.9 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 177.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.456 HD21 ' CE2' ' A' ' 40' ' ' PHE . 86.7 mt -63.46 137.55 58.19 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 114.122 -1.399 . . . . 0.0 108.649 175.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.84 174.0 7.47 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.652 -174.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 99.83 -115.52 5.33 Favored Glycine 0 N--CA 1.416 -2.669 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.382 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.38 149.15 46.75 Favored 'General case' 0 C--N 1.289 -2.029 0 C-N-CA 123.171 0.589 . . . . 0.0 110.407 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -121.54 115.55 23.03 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 -173.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.402 HD13 ' N ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -134.89 153.13 34.13 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.521 -176.222 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -129.44 123.64 32.11 Favored 'General case' 0 C--N 1.276 -2.598 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.59 -179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.483 HG21 ' HB2' ' A' ' 58' ' ' MET . 15.2 t -127.89 133.05 49.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.292 0.568 . . . . 0.0 111.758 178.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.6 OUTLIER -81.86 128.3 33.89 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 52' ' ' ALA . 1.5 mp -111.06 127.97 55.72 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -87.49 108.26 18.95 Favored 'General case' 0 N--CA 1.394 -3.253 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -178.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.693 ' HG3' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -40.48 108.43 0.09 Allowed 'General case' 0 CA--C 1.462 -2.434 0 C-N-CA 125.857 1.663 . . . . 0.0 112.246 175.148 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.506 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -87.54 -143.21 0.12 Allowed 'General case' 0 N--CA 1.401 -2.896 0 O-C-N 126.598 2.436 . . . . 0.0 107.298 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -67.01 82.6 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.458 ' H ' HG12 ' A' ' 89' ' ' ILE . 0.1 OUTLIER 64.13 24.34 13.44 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.659 1.984 . . . . 0.0 112.063 176.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 176.03 -130.33 1.68 Allowed Glycine 0 C--O 1.276 2.78 0 C-N-CA 118.588 -1.768 . . . . 0.0 113.692 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.6 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 78.8 m-85 -133.83 -91.65 0.35 Allowed 'General case' 0 N--CA 1.412 -2.345 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -171.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.33 53.15 0.1 Allowed Glycine 0 C--N 1.306 -1.089 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -169.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' HA ' HG23 ' A' ' 47' ' ' VAL . 32.8 p90 -162.0 145.86 12.27 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 107.796 -1.186 . . . . 0.0 107.796 173.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -108.13 135.87 48.76 Favored 'General case' 0 C--N 1.279 -2.483 0 C-N-CA 118.993 -1.083 . . . . 0.0 110.182 178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG13 ' HB ' ' B' ' 159' ' ' THR . 1.9 p -123.41 140.4 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.322 0 CA-C-N 113.403 -1.726 . . . . 0.0 111.02 -171.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 5.5 m -124.02 133.65 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.546 0 C-N-CA 124.677 1.191 . . . . 0.0 110.691 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 126.73 -140.78 12.2 Favored Glycine 0 CA--C 1.461 -3.296 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.4 55.86 2.47 Favored Glycine 0 CA--C 1.45 -3.977 0 O-C-N 126.695 2.056 . . . . 0.0 112.101 178.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -92.24 -31.62 15.36 Favored 'General case' 0 N--CA 1.388 -3.56 0 CA-C-N 114.428 -0.886 . . . . 0.0 108.639 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 4.7 pt-20 -158.7 167.69 13.92 Favored Pre-proline 0 CA--C 1.48 -1.724 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.484 -171.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 36' ' ' GLU . 15.0 Cg_exo -77.76 64.45 8.16 Favored 'Trans proline' 0 CA--C 1.498 -1.308 0 C-N-CA 124.189 3.259 . . . . 0.0 107.805 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -175.15 -46.69 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 111.714 -2.494 . . . . 0.0 108.065 -172.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -107.35 119.97 40.85 Favored 'General case' 0 C--O 1.267 1.992 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.456 ' CE2' HD21 ' A' ' 11' ' ' LEU . 20.5 m-85 -84.32 164.37 19.03 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 127.804 2.442 . . . . 0.0 111.778 -173.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -90.45 147.89 23.12 Favored 'General case' 0 C--O 1.201 -1.473 0 C-N-CA 120.094 -0.643 . . . . 0.0 110.439 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.9 tt0 -139.63 155.27 47.53 Favored 'General case' 0 C--O 1.184 -2.367 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -177.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 29' ' ' PHE . 44.7 mm -100.3 123.47 53.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 O-C-N 121.588 -0.695 . . . . 0.0 110.811 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' CB ' ' HG2' ' A' ' 107' ' ' PRO . 56.7 pttt -102.62 -23.59 13.84 Favored 'General case' 0 CA--C 1.504 -0.819 0 O-C-N 123.357 0.411 . . . . 0.0 112.02 -177.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 m -151.88 127.05 9.82 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -88.48 108.17 19.25 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 174.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.511 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 62.9 t -85.82 134.35 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-O 121.494 0.664 . . . . 0.0 110.197 -173.115 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 85.3 mt -67.15 140.92 57.53 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.189 -178.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.0 t70 80.54 5.29 1.65 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.238 1.415 . . . . 0.0 110.996 -176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.68 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -81.62 159.36 40.32 Favored Glycine 0 C--O 1.203 -1.817 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.558 173.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 13.5 Cg_endo -72.0 -25.09 19.94 Favored 'Trans proline' 0 N--CA 1.435 -1.914 0 CA-C-N 121.559 2.68 . . . . 0.0 109.855 -172.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.545 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -64.97 -42.37 94.62 Favored 'General case' 0 C--O 1.214 -0.766 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.64 174.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.18 -47.43 76.99 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 122.767 1.27 . . . . 0.0 109.782 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.68 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 65.9 mt -72.11 -46.91 54.79 Favored 'General case' 0 C--N 1.267 -3.007 0 CA-C-N 112.64 -2.073 . . . . 0.0 115.188 -172.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -75.76 -24.65 56.07 Favored 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.05 -155.94 33.6 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.007 -175.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.7 tttp 70.25 -58.79 0.53 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.753 1.221 . . . . 0.0 113.135 175.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.483 ' HB2' HG21 ' A' ' 18' ' ' THR . 26.9 ttt -77.65 137.64 38.65 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 123.639 0.776 . . . . 0.0 109.076 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -152.16 143.69 23.47 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.741 0.416 . . . . 0.0 109.941 -169.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.2 m -45.81 116.38 1.19 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.215 1.006 . . . . 0.0 110.811 -179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.78 -11.04 7.05 Favored Glycine 0 N--CA 1.436 -1.333 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -64.57 145.45 56.12 Favored 'General case' 0 CA--C 1.492 -1.26 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 174.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 3.4 m -106.99 132.65 53.81 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.137 0 C-N-CA 117.961 -1.496 . . . . 0.0 107.213 168.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . 0.272 5.8 mt -83.74 119.55 33.16 Favored 'Isoleucine or valine' 1 C--O 1.31 4.267 0 CA-C-O 121.564 0.697 . . . . 0.0 112.599 -178.531 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.599 ' HA ' HD13 ' A' ' 73' ' ' LEU . 93.7 t -109.23 -50.5 6.97 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 O-C-N 127.356 2.91 . . . . 0.0 112.382 -176.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.469 ' HA ' HG12 ' A' ' 72' ' ' VAL . 29.2 m -145.48 158.63 43.81 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 118.944 -1.102 . . . . 0.0 112.491 -175.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.508 HG13 ' HB ' ' A' ' 70' ' ' THR . 5.2 p -135.23 86.84 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 94' ' ' ASP 0.482 37.3 p30 54.93 -90.65 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.361 2.265 . . . . 0.0 114.761 -171.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -89.59 -37.65 14.52 Favored 'General case' 0 C--N 1.273 -2.753 0 CA-C-O 121.609 0.719 . . . . 0.0 110.172 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 ' HB ' HG13 ' A' ' 67' ' ' VAL . 0.7 OUTLIER -77.91 127.84 33.0 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.845 -1.071 . . . . 0.0 111.842 -172.297 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.98 96.68 10.35 Favored 'General case' 0 N--CA 1.417 -2.091 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 14.5 p -90.67 -1.11 9.56 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.783 -176.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD13 ' HA ' ' A' ' 65' ' ' VAL . 17.4 tp -69.56 112.0 5.76 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.43 27.33 43.93 Favored Glycine 0 N--CA 1.427 -1.953 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.599 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.5 OUTLIER -81.42 150.04 28.53 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 176.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.448 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 63.3 m -76.48 142.47 40.94 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-O 117.824 -1.084 . . . . 0.0 108.764 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.421 ' HA ' HG12 ' A' ' 80' ' ' VAL . 45.7 t-80 -48.27 -48.66 35.47 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 119.061 0.846 . . . . 0.0 112.894 -177.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.97 -28.49 69.55 Favored 'General case' 0 C--N 1.307 -1.282 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.303 -178.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.448 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 29.3 mm-40 -80.55 -46.23 16.11 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.014 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.624 HG21 HD21 ' A' ' 41' ' ' LEU . 7.6 p -61.92 -43.73 97.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.917 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.1 p -63.3 -35.93 74.1 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.559 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.81 -46.69 81.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.733 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.5 -50.69 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 CA-C-O 122.208 1.004 . . . . 0.0 109.362 -175.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -62.26 -36.28 81.58 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 113.476 -1.693 . . . . 0.0 113.479 -175.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -84.57 -20.04 32.12 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 120.709 -0.396 . . . . 0.0 111.699 177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 t -80.8 -13.08 59.28 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.693 ' CG2' ' HG3' ' A' ' 22' ' ' LYS . 2.6 mt -48.67 134.11 13.79 Favored Pre-proline 0 CA--C 1.565 1.558 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 176.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 88.3 Cg_endo -99.95 157.63 0.53 Allowed 'Trans proline' 0 CA--C 1.552 1.377 0 C-N-CA 124.233 3.288 . . . . 0.0 112.286 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' SER . 22.7 mt -68.97 142.69 15.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 123.656 0.782 . . . . 0.0 110.425 177.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.99 13.27 69.51 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.366 -1.397 . . . . 0.0 112.206 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.674 ' HB3' ' HG2' ' A' ' 22' ' ' LYS . . . -109.94 -170.19 1.61 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.486 -171.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.459 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.4 t -149.95 148.88 29.61 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 121.917 -0.489 . . . . 0.0 112.281 -172.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.639 HG22 ' HE3' ' A' ' 22' ' ' LYS . 6.5 m -155.24 145.92 13.02 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.899 0 C-N-CA 124.844 1.258 . . . . 0.0 110.05 171.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.5 ' H ' ' HB3' ' A' ' 68' ' ' ASN . 7.0 m-20 -95.9 107.75 20.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.181 -0.918 . . . . 0.0 108.682 178.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.475 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 2.6 mm? -92.06 120.87 33.08 Favored 'General case' 0 C--N 1.278 -2.529 0 CA-C-O 121.167 0.508 . . . . 0.0 110.092 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.77 122.44 38.55 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -116.51 151.57 35.86 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 123.891 0.744 . . . . 0.0 109.737 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.445 ' HB3' HG22 ' A' ' 63' ' ' VAL . 8.3 t -117.92 111.51 19.09 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 168.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.504 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 13.4 tpp85 -100.28 158.01 16.19 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -175.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 127.4 -15.52 6.38 Favored Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -94.77 125.79 49.83 Favored Pre-proline 0 N--CA 1.42 -1.938 0 CA-C-N 113.889 -1.156 . . . . 0.0 108.165 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.6 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 84.6 Cg_endo -85.61 -172.2 1.07 Allowed 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 121.828 1.685 . . . . 0.0 109.696 175.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.3 83.83 1.57 Allowed Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.6 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 16.4 Cg_exo -67.77 -52.46 0.54 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.259 1.973 . . . . 0.0 110.138 -176.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -105.43 120.38 41.46 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.407 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.8 m-20 -79.36 148.46 70.54 Favored Pre-proline 0 CA--C 1.468 -2.196 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 44' ' ' LYS . 2.7 Cg_endo -93.59 9.13 2.32 Favored 'Trans proline' 0 N--CA 1.439 -1.714 0 C-N-CA 123.759 2.973 . . . . 0.0 107.537 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.34 -31.75 43.11 Favored 'General case' 0 N--CA 1.408 -2.572 0 CA-C-N 112.394 -2.185 . . . . 0.0 106.193 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.1 142.13 92.61 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 112.583 -2.098 . . . . 0.0 106.583 174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -50.85 178.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.664 3.576 . . . . 0.0 117.154 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 81.72 -38.33 0.12 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.81 2.044 . . . . 0.0 114.417 174.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 38.8 m 68.63 -73.6 0.09 Allowed 'General case' 0 C--O 1.243 0.761 0 C-N-CA 124.517 1.127 . . . . 0.0 111.329 -177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.411 ' HB3' HG23 ' B' ' 155' ' ' THR . 50.9 m -76.06 102.55 5.72 Favored 'General case' 0 C--N 1.26 -3.324 0 C-N-CA 125.641 1.576 . . . . 0.0 107.938 175.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 46.3 mt -97.54 103.87 15.84 Favored 'General case' 0 CA--C 1.486 -1.499 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.514 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 66.8 t -104.65 112.22 37.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.0 t -91.89 150.85 20.83 Favored 'General case' 0 N--CA 1.419 -1.986 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 11.4 p -94.58 122.74 37.47 Favored 'General case' 0 N--CA 1.407 -2.62 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 55.9 t -92.99 100.48 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.699 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.402 ' O ' ' HD3' ' A' ' 123' ' ' LYS . . . -133.69 80.7 1.88 Allowed 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 115.091 -0.959 . . . . 0.0 108.742 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.5 mp -102.51 -18.11 6.69 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 5.7 mp -123.37 151.73 42.24 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 114.214 -1.357 . . . . 0.0 109.018 -176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 72.73 2.45 4.36 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 122.456 1.122 . . . . 0.0 112.307 174.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 119' ' ' ALA . 29.3 ttpp -83.62 81.48 8.73 Favored 'General case' 0 C--N 1.278 -2.507 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.988 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -98.12 117.72 64.59 Favored Pre-proline 0 C--N 1.305 -1.354 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.032 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.438 -1.753 0 C-N-CA 122.523 2.149 . . . . 0.0 111.362 177.042 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 11.3 mmt180 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 14.5 m -88.95 109.29 20.12 Favored 'General case' 0 N--CA 1.42 -1.946 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 33.4 m -58.27 129.33 41.49 Favored 'General case' 0 N--CA 1.436 -1.13 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -84.97 -14.01 48.86 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.824 -177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.435 HG22 ' H ' ' B' ' 156' ' ' ARG . 7.0 m -169.5 169.78 8.64 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 102.911 -2.996 . . . . 0.0 102.911 169.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.435 ' H ' HG22 ' B' ' 155' ' ' THR . 39.2 ptt180 -179.55 142.2 0.17 Allowed 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 176.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.421 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 75.2 mtm180 -131.48 161.45 32.5 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.312 -0.555 . . . . 0.0 111.135 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 15.0 pt-20 -102.45 112.55 25.33 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -171.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.523 ' HB ' HG13 ' A' ' 31' ' ' VAL . 11.0 m -93.04 124.16 36.82 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 172.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -106.11 101.89 11.34 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.724 -0.61 . . . . 0.0 109.977 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 27' ' ' PHE . 18.3 m . . . . . 0 C--N 1.293 -1.873 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.722 -172.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.818 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -103.72 150.37 24.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . 0.401 ' SD ' ' HB2' ' A' ' 1' ' ' LYS . 13.8 tpt -134.29 83.49 2.04 Favored 'General case' 0 C--N 1.302 -1.47 0 CA-C-O 121.646 0.736 . . . . 0.0 111.265 -179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -120.57 25.42 7.28 Favored Glycine 0 C--N 1.301 -1.399 0 N-CA-C 108.071 -2.012 . . . . 0.0 108.071 172.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.47 ' N ' ' HD2' ' A' ' 1' ' ' LYS . 3.7 mptp? -77.41 142.62 67.4 Favored Pre-proline 0 N--CA 1.44 -0.959 0 CA-C-N 114.155 -1.023 . . . . 0.0 110.049 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.55 159.94 42.11 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.865 2.376 . . . . 0.0 113.376 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 p90 -105.5 135.78 46.26 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 113.97 -1.468 . . . . 0.0 107.848 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.57 134.44 20.16 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.204 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.9 t -169.41 35.92 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.914 0.759 . . . . 0.0 112.019 168.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 6' ' ' ARG . 6.8 tpt180 61.75 30.97 18.57 Favored 'General case' 0 CA--C 1.556 1.176 0 CA-C-O 123.413 1.578 . . . . 0.0 109.97 172.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.781 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.9 OUTLIER -120.29 108.18 38.35 Favored Pre-proline 0 C--N 1.263 -3.193 0 N-CA-C 114.839 1.422 . . . . 0.0 114.839 -177.632 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.276 8.0 Cg_exo -55.22 -30.19 70.33 Favored 'Trans proline' 0 CA--C 1.486 -1.882 0 C-N-CA 121.527 1.485 . . . . 0.0 110.289 169.521 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.2 t -75.36 -23.01 57.1 Favored 'General case' 1 N--CA 1.367 -4.585 0 CA-C-N 113.643 -1.617 . . . . 0.0 111.601 -175.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.781 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 14.5 pt-20 -73.99 -33.23 63.75 Favored 'General case' 0 C--N 1.366 1.323 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.433 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 74.8 mt -62.09 133.28 55.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 114.083 -1.417 . . . . 0.0 110.785 175.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.31 175.81 10.32 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 113.451 -1.704 . . . . 0.0 113.672 -171.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 87.94 -132.0 10.95 Favored Glycine 0 N--CA 1.426 -2.03 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.47 -177.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.608 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -124.39 142.8 51.01 Favored 'General case' 0 C--N 1.288 -2.102 0 C-N-CA 123.819 0.848 . . . . 0.0 109.331 179.049 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -107.22 116.15 31.42 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.407 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -133.67 151.94 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.66 -177.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.559 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 13.2 t-160 -123.31 105.23 9.68 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -179.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -124.18 136.9 54.51 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.158 -174.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.65 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.3 OUTLIER -78.12 129.84 35.66 Favored 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 123.331 0.653 . . . . 0.0 110.324 -179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.633 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 0.8 OUTLIER -117.31 120.17 37.39 Favored 'General case' 0 C--O 1.253 1.268 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 176.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 33.5 ttt180 -84.77 103.1 13.56 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.617 ' HG2' ' CG2' ' A' ' 87' ' ' ILE . 0.0 OUTLIER -36.97 115.07 0.36 Allowed 'General case' 0 CA--C 1.477 -1.862 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 176.344 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 33.5 t -88.52 -148.31 0.16 Allowed 'General case' 0 N--CA 1.41 -2.431 0 O-C-N 126.241 2.213 . . . . 0.0 108.056 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.2 m -62.69 83.79 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.547 ' H ' HG12 ' A' ' 89' ' ' ILE . 22.2 mmt180 67.35 49.61 1.03 Allowed 'General case' 0 CA--C 1.489 -1.374 0 C-N-CA 124.964 1.306 . . . . 0.0 112.492 172.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 141.32 -123.16 2.22 Favored Glycine 0 N--CA 1.401 -3.682 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.685 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.694 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 64.1 m-85 -125.33 -77.76 0.59 Allowed 'General case' 0 C--N 1.261 -3.265 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.471 -174.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 126.26 49.64 0.18 Allowed Glycine 0 C--N 1.292 -1.867 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.052 -172.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 27' ' ' PHE . 28.3 p90 -161.16 142.26 11.52 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.53 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 73.9 p -103.79 138.68 40.06 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -178.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.517 ' HB ' ' O ' ' A' ' 42' ' ' GLN . 11.0 m -125.7 159.16 33.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 C-N-CA 120.628 -0.429 . . . . 0.0 111.885 -170.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.496 HG13 ' CD ' ' A' ' 44' ' ' LYS . 4.2 m -120.53 131.59 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.244 0 C-N-CA 124.07 0.948 . . . . 0.0 110.519 174.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.694 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 130.58 -137.24 9.36 Favored Glycine 0 C--O 1.291 3.701 0 CA-C-N 115.289 -0.868 . . . . 0.0 111.527 174.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.572 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.83 61.86 3.21 Favored Glycine 1 CA--C 1.436 -4.886 0 O-C-N 127.109 2.299 . . . . 0.0 110.953 179.256 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 76' ' ' THR . 13.5 t0 -99.19 -48.66 4.76 Favored 'General case' 0 C--N 1.248 -3.833 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -175.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.601 ' HG3' ' HB3' ' A' ' 38' ' ' ASP . 5.9 pt-20 -160.35 175.97 2.84 Favored Pre-proline 0 C--N 1.287 -2.14 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.661 -170.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.424 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 32.2 Cg_exo -72.42 64.89 3.68 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 124.154 3.236 . . . . 0.0 107.97 172.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.601 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 1.8 t70 -171.66 -41.49 0.02 OUTLIER 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 112.498 -2.137 . . . . 0.0 108.637 -172.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.87 120.09 28.36 Favored 'General case' 0 C--O 1.259 1.568 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.204 177.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -88.61 166.1 14.35 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 128.242 2.617 . . . . 0.0 108.114 -178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.0 mp -89.77 144.13 26.23 Favored 'General case' 0 C--O 1.166 -3.329 0 C-N-CA 117.876 -1.53 . . . . 0.0 108.903 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.602 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 tt0 -130.59 156.28 45.12 Favored 'General case' 0 C--O 1.17 -3.089 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 -178.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.421 HD11 HG12 ' A' ' 64' ' ' ILE . 13.3 mm -93.05 128.9 44.26 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 CA-C-N 119.161 0.891 . . . . 0.0 109.823 -176.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' CD ' HG13 ' A' ' 32' ' ' VAL . 4.5 ptmm? -107.82 -23.96 11.86 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.53 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 39.7 m -151.61 126.96 9.95 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.731 -0.787 . . . . 0.0 110.686 176.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.1 112.33 18.37 Favored 'General case' 0 N--CA 1.415 -2.224 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 57.6 t -89.93 122.56 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 78.3 mt -66.05 146.3 54.84 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.605 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 83.05 4.27 0.94 Allowed 'General case' 0 CA--C 1.544 0.73 0 O-C-N 125.055 1.472 . . . . 0.0 109.771 -173.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.603 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -82.98 158.77 36.93 Favored Glycine 0 C--O 1.205 -1.673 0 CA-C-O 117.932 -1.482 . . . . 0.0 109.541 173.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.694 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 9.9 Cg_endo -72.17 -25.26 19.18 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 CA-C-N 121.549 2.674 . . . . 0.0 109.716 -171.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.447 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -60.65 -48.18 82.93 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.88 174.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.89 82.24 Favored 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.163 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 83.9 mt -72.07 -39.51 68.96 Favored 'General case' 0 N--CA 1.406 -2.67 0 CA-C-N 112.914 -1.948 . . . . 0.0 114.975 -172.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -79.45 -21.07 45.99 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 122.47 1.128 . . . . 0.0 108.534 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.42 40.97 98.35 Favored Glycine 0 CA--C 1.49 -1.503 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.753 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -141.95 27.54 1.8 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 122.185 0.993 . . . . 0.0 110.315 -173.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.647 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.7 tmt? -160.24 137.49 9.4 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.64 ' HG2' ' NE ' ' A' ' 99' ' ' ARG . 7.9 pt-20 -154.95 160.07 40.86 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 119.309 0.959 . . . . 0.0 112.336 -170.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.7 m -53.72 123.15 11.47 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.519 178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.56 -1.09 21.93 Favored Glycine 0 N--CA 1.421 -2.347 0 C-N-CA 119.656 -1.259 . . . . 0.0 111.954 -178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.678 ' HB3' ' HD3' ' A' ' 99' ' ' ARG . 3.1 p30 -100.94 161.92 13.25 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.797 -1.161 . . . . 0.0 110.432 172.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.727 HG13 ' SG ' ' A' ' 98' ' ' CYS 0.342 0.2 OUTLIER -118.31 125.3 74.19 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -179.093 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.421 HG12 HD11 ' A' ' 43' ' ' ILE . 47.4 mm -69.77 114.17 6.71 Favored 'Isoleucine or valine' 0 C--O 1.303 3.914 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.605 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.67 HG13 HD13 ' A' ' 73' ' ' LEU . 88.2 t -93.59 -58.78 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 112.471 -2.15 . . . . 0.0 110.007 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 67.5 m -162.22 173.96 13.54 Favored 'General case' 0 C--N 1.319 -0.758 0 O-C-N 121.99 -0.444 . . . . 0.0 110.871 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.0 p -143.68 156.64 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.902 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.49 ' HB2' ' H ' ' A' ' 94' ' ' ASP . 1.8 t30 -30.18 111.28 0.07 Allowed 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 125.8 1.64 . . . . 0.0 113.033 170.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.5 t70 75.39 -27.2 0.19 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 125.63 1.572 . . . . 0.0 113.677 175.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.5 m -112.44 116.24 29.97 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.979 0.895 . . . . 0.0 111.403 -176.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 22.3 t -82.75 96.0 8.04 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.7 t -81.47 0.09 4.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.431 -178.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.67 HD13 HG13 ' A' ' 65' ' ' VAL . 15.2 tp -65.07 110.99 2.69 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.256 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.26 80.62 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-N 114.637 -1.165 . . . . 0.0 112.433 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.7 OUTLIER -74.03 145.4 44.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 44.2 m -76.69 142.83 40.39 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 117.613 -1.184 . . . . 0.0 109.216 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.432 ' O ' HG12 ' A' ' 81' ' ' VAL . 72.7 t60 -48.08 -49.22 32.4 Favored 'General case' 0 CA--C 1.493 -1.217 0 CA-C-N 118.993 0.815 . . . . 0.0 112.537 -176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.45 -36.06 75.21 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 124.298 0.999 . . . . 0.0 110.517 -177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.407 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 68.1 mm-40 -77.95 -49.96 13.11 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.012 -176.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.2 p -63.59 -43.92 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.444 -178.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.8 p -63.78 -40.26 88.39 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.618 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.228 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 86' ' ' SER . 4.6 tmmm? -58.45 -44.21 89.14 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.825 178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 70.5 mt -73.28 -48.72 41.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 CA-C-O 122.057 0.932 . . . . 0.0 109.977 -175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -65.52 -32.24 73.73 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.29 -1.323 . . . . 0.0 112.958 -177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -85.81 -16.64 38.13 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 120.877 0.37 . . . . 0.0 110.968 176.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 27.4 t -77.81 -23.45 49.07 Favored 'General case' 0 C--O 1.243 0.75 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.617 ' CG2' ' HG2' ' A' ' 22' ' ' LYS . 4.6 mt -50.28 139.36 19.23 Favored Pre-proline 0 N--CA 1.434 -1.261 0 C-N-CA 124.382 1.073 . . . . 0.0 113.292 178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 71.7 Cg_endo -99.69 158.5 0.56 Allowed 'Trans proline' 0 CA--C 1.548 1.225 0 C-N-CA 124.185 3.257 . . . . 0.0 111.422 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.547 HG12 ' H ' ' A' ' 25' ' ' ARG . 23.6 mt -68.32 143.32 15.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.245 177.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 90.72 12.61 60.56 Favored Glycine 0 CA--C 1.497 -1.091 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.561 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -100.02 -175.27 2.9 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 120.091 -0.643 . . . . 0.0 112.281 -171.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.65 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 13.2 t -148.22 139.2 23.18 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 121.886 -0.509 . . . . 0.0 112.338 -172.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 2.9 m -151.64 158.98 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.469 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.063 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.559 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 8.2 m-20 -102.87 108.01 19.06 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.551 HD22 HD22 ' A' ' 20' ' ' LEU . 12.5 tp -100.79 120.96 40.88 Favored 'General case' 0 C--N 1.27 -2.87 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -174.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.466 ' HB3' ' CD2' ' A' ' 17' ' ' HIS . 12.6 pt-20 -103.16 124.4 48.51 Favored 'General case' 0 C--O 1.257 1.469 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 58' ' ' MET . 4.2 pp -141.64 165.31 27.83 Favored 'General case' 0 N--CA 1.417 -2.121 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.407 -176.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.727 ' SG ' HG13 ' A' ' 63' ' ' VAL . 3.0 p -118.73 113.42 21.12 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.458 178.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.678 ' HD3' ' HB3' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -90.38 137.32 32.45 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.484 -173.724 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 111.94 23.79 5.44 Favored Glycine 0 C--N 1.312 -0.783 0 C-N-CA 119.453 -1.356 . . . . 0.0 114.599 177.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 20.6 t80 -95.32 127.56 41.79 Favored Pre-proline 0 C--N 1.303 -1.421 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.468 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 17.9 Cg_endo -58.2 134.24 60.5 Favored 'Trans proline' 0 C--O 1.246 0.905 0 C-N-CA 122.339 2.026 . . . . 0.0 113.206 -175.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.61 77.18 3.22 Favored Pre-proline 0 C--N 1.301 -1.507 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 176.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 74.4 Cg_endo -89.98 32.92 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.755 2.303 . . . . 0.0 112.455 -173.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -138.45 162.19 35.11 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 108' ' ' ASP . 21.3 t70 -90.15 136.88 28.26 Favored Pre-proline 0 C--N 1.288 -2.071 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 172.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 10.2 Cg_endo -97.45 3.23 1.56 Allowed 'Trans proline' 0 N--CA 1.412 -3.279 0 C-N-CA 123.139 2.559 . . . . 0.0 111.098 -173.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' HB3' ' OD2' ' A' ' 106' ' ' ASP . 11.7 t70 -87.95 -48.3 7.89 Favored 'General case' 0 N--CA 1.403 -2.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -49.06 122.16 11.34 Favored Pre-proline 0 C--O 1.235 0.329 0 CA-C-N 113.715 -1.584 . . . . 0.0 112.437 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -34.9 82.99 0.0 OUTLIER 'Trans proline' 0 CA--C 1.495 -1.428 1 C-N-CA 126.858 5.038 . . . . 0.0 118.577 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -129.05 37.06 4.11 Favored 'General case' 0 C--N 1.272 -2.788 0 C-N-CA 118.683 -1.207 . . . . 0.0 108.538 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.45 HG23 ' HG2' ' B' ' 158' ' ' GLU . 54.5 m -73.99 -38.14 64.23 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.145 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.3 t -117.57 105.54 12.18 Favored 'General case' 1 C--N 1.242 -4.104 0 CA-C-N 112.972 -1.922 . . . . 0.0 107.901 -177.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' H ' ' HA ' ' B' ' 155' ' ' THR . 31.1 mt -75.55 104.46 6.12 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 61.8 t -119.05 102.18 12.64 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.345 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.246 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.1 t -96.33 142.97 27.82 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 16.3 m -87.62 135.39 33.38 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.2 p -93.56 134.94 29.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.07 85.51 5.53 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-O 121.498 0.666 . . . . 0.0 111.387 -176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 47.9 mm -94.82 -43.33 13.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.13 -171.24 3.46 Favored 'General case' 0 C--O 1.25 1.129 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.468 173.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -84.04 67.74 9.79 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.488 1.137 . . . . 0.0 111.999 -174.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -96.69 73.75 2.7 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-N 114.165 -1.38 . . . . 0.0 108.553 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -97.61 102.48 13.17 Favored Pre-proline 0 C--N 1.302 -1.48 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.455 -0.767 0 C-N-CA 122.808 2.338 . . . . 0.0 112.572 -176.061 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . 0.491 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 16.9 m -63.96 96.02 0.13 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.502 1.121 . . . . 0.0 111.523 -178.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 20.3 m -150.11 97.64 2.59 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.538 178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 55.57 166.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 126.951 2.1 . . . . 0.0 115.572 176.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.554 ' HA ' ' H ' ' A' ' 114' ' ' LEU . 80.9 p 56.15 50.74 12.96 Favored 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 126.003 1.721 . . . . 0.0 112.833 -177.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -123.83 -153.69 0.57 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -175.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.694 ' HA ' ' H ' ' A' ' 33' ' ' GLY 0.352 97.4 mtt180 79.47 -74.41 0.06 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 177.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 112' ' ' THR . 9.0 tp10 -62.87 98.07 0.12 Allowed 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.067 0.854 . . . . 0.0 111.815 -174.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 4.8 m -115.01 102.78 10.27 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 175.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.436 ' HA ' HG22 ' A' ' 30' ' ' THR . 77.3 mt-30 -86.28 95.22 9.55 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.58 HG23 ' HB2' ' A' ' 27' ' ' PHE . 9.1 m . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.427 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.673 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.52 -31.17 63.55 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.411 0.624 . . . . 0.0 109.738 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -177.56 6.6 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.907 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 94.99 -1.63 65.37 Favored Glycine 0 C--N 1.311 -0.848 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.992 177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -127.29 143.83 48.57 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -68.82 137.48 38.4 Favored 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 122.297 1.998 . . . . 0.0 110.789 177.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -109.18 141.41 41.46 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.59 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.658 ' CZ ' ' HA ' ' A' ' 38' ' ' ASP . 11.4 t80 -147.46 142.72 27.28 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.765 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 7' ' ' ASN 0.32 12.6 t -157.57 -48.14 0.07 Allowed 'General case' 0 N--CA 1.419 -2.01 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.264 161.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.483 ' O ' HD21 ' A' ' 73' ' ' LEU . 26.7 ptt180 156.39 -30.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 126.29 1.836 . . . . 0.0 106.276 177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.744 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 39.4 t-20 -40.6 107.68 0.49 Allowed Pre-proline 0 C--N 1.294 -1.812 0 CA-C-N 112.028 -2.351 . . . . 0.0 112.414 -175.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.462 ' HB3' HG11 ' A' ' 65' ' ' VAL 0.261 9.6 Cg_exo -61.67 -32.95 87.16 Favored 'Trans proline' 0 CA--C 1.465 -2.932 0 C-N-CA 121.918 1.745 . . . . 0.0 110.374 -178.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 58.0 m -80.04 -18.92 48.88 Favored 'General case' 1 N--CA 1.338 -6.046 0 CA-C-N 111.972 -2.376 . . . . 0.0 111.726 -173.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.2 pt-20 -73.24 -36.22 66.4 Favored 'General case' 0 C--N 1.379 1.859 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 173.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HB3' ' SG ' ' A' ' 98' ' ' CYS . 85.3 mt -54.94 129.37 37.41 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.785 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.9 -162.58 0.55 Allowed 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 112.955 -1.93 . . . . 0.0 113.26 -171.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 65.92 -102.0 0.66 Allowed Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.003 -177.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.601 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -146.48 149.06 32.93 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 123.259 0.624 . . . . 0.0 109.861 178.564 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . 0.419 ' CZ ' ' HB2' ' A' ' 8' ' ' PRO . 2.5 t80 -112.64 110.98 21.46 Favored 'General case' 0 N--CA 1.416 -2.134 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.417 HG12 HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -130.18 153.16 38.53 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.708 -177.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 26.8 p-80 -132.05 107.59 8.76 Favored 'General case' 0 N--CA 1.414 -2.234 0 CA-C-N 115.422 -0.808 . . . . 0.0 108.928 176.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -122.51 132.18 54.2 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.125 -175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.5 OUTLIER -76.29 136.26 39.62 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.43 179.91 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.0 130.53 54.78 Favored 'General case' 0 C--O 1.263 1.796 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 175.199 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -82.89 124.23 30.14 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.734 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -53.28 109.46 0.44 Allowed 'General case' 0 CA--C 1.466 -2.257 0 C-N-CA 123.59 0.756 . . . . 0.0 110.635 173.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 32.7 t -85.14 -146.18 0.1 Allowed 'General case' 0 N--CA 1.413 -2.306 0 O-C-N 126.624 2.453 . . . . 0.0 107.82 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 36.4 m -64.12 84.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.241 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.553 ' H ' HG12 ' A' ' 89' ' ' ILE . 3.0 mpt_? 59.86 43.99 14.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 125.698 1.599 . . . . 0.0 111.353 175.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.24 -127.0 1.8 Allowed Glycine 1 N--CA 1.394 -4.143 0 C-N-CA 119.479 -1.343 . . . . 0.0 111.935 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.7 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m-85 -133.68 -82.57 0.46 Allowed 'General case' 0 N--CA 1.395 -3.19 0 CA-C-N 114.349 -0.926 . . . . 0.0 111.356 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 124.33 54.76 0.18 Allowed Glycine 0 N--CA 1.425 -2.038 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -169.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.425 ' CD1' HD12 ' A' ' 43' ' ' ILE . 18.8 p90 -161.32 148.77 15.04 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 175.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -113.08 136.66 52.46 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-O 121.909 0.861 . . . . 0.0 109.154 177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.577 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 6.2 p -128.63 150.54 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.523 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.472 -167.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.758 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 12.3 m -114.33 154.3 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 C-N-CA 124.829 1.252 . . . . 0.0 113.106 -175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 87.23 -123.91 6.8 Favored Glycine 0 C--O 1.291 3.706 0 CA-C-N 114.478 -1.237 . . . . 0.0 112.94 177.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.612 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 39.64 47.79 3.06 Favored Glycine 0 CA--C 1.47 -2.781 0 O-C-N 126.455 1.914 . . . . 0.0 112.081 -174.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' B' ' 156' ' ' ARG . 6.1 t70 -95.4 -29.31 14.5 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -173.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.405 ' HB3' ' CD ' ' A' ' 37' ' ' PRO . 13.2 mt-10 -140.95 172.64 5.86 Favored Pre-proline 0 N--CA 1.41 -2.442 0 C-N-CA 118.642 -1.223 . . . . 0.0 110.062 -169.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' GLY . 33.2 Cg_exo -73.66 -8.4 21.47 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.532 2.822 . . . . 0.0 108.149 172.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.658 ' HA ' ' CZ ' ' A' ' 4' ' ' PHE . 17.6 t70 -108.03 -9.13 15.69 Favored 'General case' 0 N--CA 1.422 -1.836 0 CA-C-N 113.047 -1.888 . . . . 0.0 110.183 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -131.24 119.41 21.77 Favored 'General case' 0 C--O 1.244 0.789 0 O-C-N 121.639 -0.663 . . . . 0.0 110.9 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 8.4 m-85 -86.57 166.18 15.62 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.428 2.291 . . . . 0.0 110.232 -175.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.612 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.8 mp -93.77 146.38 23.91 Favored 'General case' 0 C--O 1.181 -2.535 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.468 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 28.7 tt0 -138.48 144.92 40.26 Favored 'General case' 0 C--O 1.173 -2.957 0 CA-C-N 118.803 0.729 . . . . 0.0 109.949 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.425 HD12 ' CD1' ' A' ' 29' ' ' PHE . 27.0 mm -80.28 120.34 31.58 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.743 0 O-C-N 121.498 -0.751 . . . . 0.0 110.734 -175.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' CD ' ' HB2' ' A' ' 107' ' ' PRO . 44.1 pttt -100.75 -22.0 15.01 Favored 'General case' 0 CA--C 1.502 -0.868 0 O-C-N 123.473 0.483 . . . . 0.0 111.544 -178.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.7 m -158.46 127.48 5.57 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 176.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.489 HD23 ' H ' ' A' ' 60' ' ' THR . 2.9 pp -84.44 121.07 27.05 Favored 'General case' 0 N--CA 1.402 -2.872 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 172.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 94.7 t -85.0 129.3 37.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.0 mt -62.63 138.59 58.53 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.434 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 t70 81.65 8.04 1.02 Allowed 'General case' 0 N--CA 1.476 0.863 0 O-C-N 124.777 1.298 . . . . 0.0 110.766 -176.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.654 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -91.1 161.12 27.66 Favored Glycine 0 C--O 1.21 -1.395 0 CA-C-O 117.894 -1.504 . . . . 0.0 109.798 174.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.7 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 37.3 Cg_endo -72.13 -24.74 19.9 Favored 'Trans proline' 0 N--CA 1.435 -1.924 0 CA-C-N 121.501 2.651 . . . . 0.0 110.271 -169.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -49.94 75.48 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.188 174.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.7 -48.44 80.76 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.961 -178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 74.3 mt -71.77 -40.31 69.36 Favored 'General case' 0 N--CA 1.402 -2.833 0 CA-C-N 112.745 -2.025 . . . . 0.0 115.46 -172.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -76.07 -21.58 56.59 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.696 1.236 . . . . 0.0 107.785 178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.76 30.98 73.99 Favored Glycine 0 CA--C 1.494 -1.249 0 CA-C-N 112.894 -1.957 . . . . 0.0 114.022 176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -133.07 -1.27 3.29 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.742 0.782 . . . . 0.0 111.058 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.599 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.5 tmt? -132.5 125.41 30.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -142.19 167.53 21.89 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.702 0.763 . . . . 0.0 112.122 -167.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.489 ' H ' HD23 ' A' ' 46' ' ' LEU . 4.7 m -56.35 119.93 6.8 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.778 174.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 126.54 -22.43 5.85 Favored Glycine 0 N--CA 1.426 -2.006 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -177.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' CG ' ' HE ' ' A' ' 99' ' ' ARG . 26.7 m-20 -72.18 135.36 46.12 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 175.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.564 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.278 0.1 OUTLIER -104.77 120.2 54.89 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 CA-C-O 121.519 0.676 . . . . 0.0 110.837 173.254 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 46.7 mm -69.89 111.75 4.09 Favored 'Isoleucine or valine' 0 C--O 1.299 3.679 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.595 -178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.581 HG13 HD13 ' A' ' 73' ' ' LEU . 91.8 t -93.61 -58.25 3.8 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.53 0 O-C-N 126.315 2.259 . . . . 0.0 108.904 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -151.43 171.06 18.11 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.833 -0.542 . . . . 0.0 110.102 -176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 7.7 p -146.87 114.4 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-O 120.805 0.336 . . . . 0.0 110.451 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.497 ' OD1' ' HA ' ' A' ' 93' ' ' VAL 0.4 0.2 OUTLIER 31.23 66.88 0.14 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.951 1.3 . . . . 0.0 114.146 -171.31 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.6 t70 73.44 -37.43 0.38 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.283 1.433 . . . . 0.0 114.102 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 60.4 m -57.81 121.99 11.8 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.446 0.641 . . . . 0.0 110.754 -178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 36.0 t -80.88 78.73 7.64 Favored 'General case' 0 N--CA 1.425 -1.721 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.32 -169.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' HA ' ' ND1' ' A' ' 75' ' ' HIS . 56.0 t -80.83 0.23 3.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-O 123.325 1.536 . . . . 0.0 108.851 174.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.581 HD13 HG13 ' A' ' 65' ' ' VAL . 17.1 tp -67.68 110.74 3.86 Favored 'General case' 0 N--CA 1.41 -2.436 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 174.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.499 ' O ' ' HA ' ' A' ' 37' ' ' PRO . . . 65.62 43.02 95.15 Favored Glycine 0 N--CA 1.421 -2.351 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.486 -174.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.487 ' ND1' ' HA ' ' A' ' 72' ' ' VAL . 0.9 OUTLIER -87.58 141.89 28.27 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 177.295 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.6 m -68.77 141.73 55.13 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.645 ' HB3' ' HD3' ' B' ' 156' ' ' ARG . 6.4 t60 -54.17 -38.35 65.47 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 124.428 1.091 . . . . 0.0 112.079 -177.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.24 -38.7 90.23 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.109 0.881 . . . . 0.0 110.067 178.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -76.47 -48.84 18.23 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.811 -176.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.09 -43.0 97.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.883 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.419 HG12 ' O ' ' A' ' 77' ' ' HIS . 11.2 p -65.46 -36.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.563 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.263 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.89 -42.16 97.45 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.378 179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 69.4 mt -72.51 -50.8 32.32 Favored 'Isoleucine or valine' 0 C--O 1.245 0.829 0 CA-C-O 122.394 1.092 . . . . 0.0 108.991 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -63.63 -33.63 76.04 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 113.411 -1.722 . . . . 0.0 113.706 -175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -85.71 -22.66 27.72 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 m -83.28 -10.94 58.23 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.418 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.596 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.5 mt -46.74 136.58 7.69 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.357 1.063 . . . . 0.0 113.823 176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 72.3 Cg_endo -97.28 150.65 0.96 Allowed 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.798 2.999 . . . . 0.0 112.08 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.553 HG12 ' H ' ' A' ' 25' ' ' ARG . 17.8 mt -68.05 142.02 16.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.519 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.31 11.48 64.49 Favored Glycine 0 CA--C 1.485 -1.831 0 C-N-CA 121.077 -0.582 . . . . 0.0 112.162 176.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -105.37 -170.1 1.7 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.77 -171.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.44 ' N ' ' HD2' ' A' ' 22' ' ' LYS . 24.3 t -149.86 146.07 26.91 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.353 0.871 . . . . 0.0 113.353 -171.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.734 HG22 ' HE2' ' A' ' 22' ' ' LYS . 17.2 m -150.6 153.9 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.714 0 C-N-CA 123.483 0.713 . . . . 0.0 109.725 172.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.543 ' O ' ' HA ' ' A' ' 67' ' ' VAL . 19.7 t70 -100.81 112.68 25.15 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.576 ' CD2' ' HB2' ' A' ' 20' ' ' LEU . 3.0 mm? -90.8 113.76 25.98 Favored 'General case' 0 C--N 1.278 -2.511 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.032 177.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.513 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 38.3 tt0 -94.97 109.21 21.26 Favored 'General case' 0 N--CA 1.4 -2.943 0 N-CA-C 104.859 -2.274 . . . . 0.0 104.859 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.599 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.2 OUTLIER -141.48 159.34 42.43 Favored 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 121.581 0.705 . . . . 0.0 112.359 -169.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.608 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 6.9 t -110.27 122.98 48.95 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.141 -177.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.601 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 17.3 tpp85 -104.21 147.22 27.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.51 -13.92 4.24 Favored Glycine 0 C--N 1.307 -1.039 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.064 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -94.53 114.06 62.51 Favored Pre-proline 0 C--N 1.306 -1.312 0 CA-C-O 120.509 0.195 . . . . 0.0 110.852 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.598 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 3.7 Cg_exo -76.89 163.73 30.8 Favored 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 122.001 1.801 . . . . 0.0 111.176 176.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.2 81.83 1.78 Allowed Pre-proline 0 C--N 1.307 -1.256 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.513 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 58.0 Cg_endo -96.47 52.12 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.691 2.927 . . . . 0.0 108.598 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -161.98 140.63 9.31 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -173.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 14.3 t70 -91.24 120.63 68.41 Favored Pre-proline 0 N--CA 1.413 -2.312 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 175.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 28.4 Cg_endo -103.01 10.0 0.36 Allowed 'Trans proline' 0 C--N 1.284 -2.827 0 C-N-CA 123.376 2.717 . . . . 0.0 109.998 -171.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -100.26 -29.56 12.38 Favored 'General case' 0 N--CA 1.395 -3.224 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -63.35 122.47 76.0 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.982 175.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . 0.267 0.0 OUTLIER -40.34 88.6 0.01 OUTLIER 'Trans proline' 0 CA--C 1.5 -1.204 1 C-N-CA 125.912 4.408 . . . . 0.0 117.704 174.346 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -124.25 32.04 5.62 Favored 'General case' 0 C--N 1.283 -2.318 0 C-N-CA 117.722 -1.591 . . . . 0.0 109.927 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.1 t -171.13 174.13 4.75 Favored 'General case' 0 N--CA 1.417 -2.093 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.635 ' O ' ' HA ' ' B' ' 155' ' ' THR . 64.3 m -141.95 109.47 5.66 Favored 'General case' 0 N--CA 1.394 -3.238 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -75.63 106.36 7.16 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 -173.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 16.4 m -94.65 131.52 41.25 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 103.167 -2.901 . . . . 0.0 103.167 166.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.8 t -72.84 144.89 47.3 Favored 'General case' 0 C--N 1.279 -2.471 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.375 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.4 p -105.04 117.87 35.09 Favored 'General case' 0 N--CA 1.403 -2.815 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.494 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -133.54 106.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.161 -178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -111.18 74.02 0.85 Allowed 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.784 0.802 . . . . 0.0 112.109 -176.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.09 -10.26 6.77 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 123' ' ' LYS . 1.8 pt? -118.79 -166.82 1.28 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.303 -171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -69.75 102.66 1.96 Allowed 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 121.619 0.723 . . . . 0.0 109.447 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 121' ' ' LEU . 31.7 mmmt -99.24 92.52 5.48 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.41 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.7 119.29 75.3 Favored Pre-proline 0 C--N 1.301 -1.521 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.84 176.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo . . . . . 0 N--CA 1.445 -1.355 0 C-N-CA 122.422 2.082 . . . . 0.0 111.313 179.944 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 5.1 p -166.89 164.28 16.25 Favored 'General case' 0 N--CA 1.435 -1.185 0 CA-C-O 121.164 0.507 . . . . 0.0 112.106 -172.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 42.3 m -151.28 -44.28 0.11 Allowed 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.612 175.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 63.2 mtm180 -142.26 45.85 1.64 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.445 0.64 . . . . 0.0 111.032 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 113' ' ' SER . 10.2 p -126.38 0.8 7.0 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.923 0.868 . . . . 0.0 110.213 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.645 ' HD3' ' HB3' ' A' ' 77' ' ' HIS . 0.0 OUTLIER -129.93 -140.76 0.23 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 -170.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.758 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 38.6 ttm180 75.65 -12.4 0.99 Allowed 'General case' 0 C--O 1.196 -1.736 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 175.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -135.96 88.97 2.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 119.449 1.022 . . . . 0.0 111.907 177.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.556 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 5.3 m -89.68 125.87 35.43 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 174.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -109.54 115.34 29.74 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.478 HG23 ' HB2' ' A' ' 27' ' ' PHE . 31.7 m . . . . . 0 N--CA 1.426 -1.651 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.402 -173.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.41 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -82.16 58.02 3.81 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.547 0.689 . . . . 0.0 110.789 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 87.1 mmm -117.24 50.27 1.11 Allowed 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.702 0.763 . . . . 0.0 111.39 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -88.92 27.03 7.67 Favored Glycine 0 C--N 1.311 -0.845 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.28 150.75 74.97 Favored Pre-proline 0 C--N 1.308 -1.218 0 N-CA-C 106.03 -1.841 . . . . 0.0 106.03 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -68.99 138.42 40.23 Favored 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 121.656 1.57 . . . . 0.0 110.0 178.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -99.61 147.92 24.86 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.177 -174.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -147.95 130.78 16.1 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.949 178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' C ' ' HG3' ' A' ' 6' ' ' ARG . 15.1 t -168.02 33.63 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.357 -1.292 . . . . 0.0 108.93 165.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 45.55 42.75 8.39 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 123.991 1.853 . . . . 0.0 112.606 178.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.801 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 0.8 OUTLIER -115.2 114.02 43.41 Favored Pre-proline 1 C--N 1.242 -4.085 0 CA-C-N 113.083 -1.871 . . . . 0.0 114.186 178.367 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HA ' HD12 ' A' ' 11' ' ' LEU . 2.9 Cg_exo -56.72 -30.52 84.53 Favored 'Trans proline' 0 CA--C 1.481 -2.154 0 C-N-CA 121.314 1.343 . . . . 0.0 109.693 168.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 9.3 t -79.54 -13.22 59.69 Favored 'General case' 1 N--CA 1.362 -4.857 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.485 -175.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.801 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.8 pt-20 -81.38 -32.11 32.99 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 175.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.587 HD13 HG21 ' A' ' 63' ' ' VAL . 79.2 mt -61.81 143.32 56.49 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.896 175.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -84.72 -179.33 7.09 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.834 -1.53 . . . . 0.0 112.426 -175.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 76.2 -128.36 9.38 Favored Glycine 0 N--CA 1.432 -1.603 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.833 -179.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.502 ' CG ' ' HB3' ' A' ' 99' ' ' ARG . 2.4 ptmm? -127.53 151.62 48.65 Favored 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 123.882 0.873 . . . . 0.0 110.847 -176.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -112.84 119.32 37.6 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 -173.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.404 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -138.02 152.82 26.5 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.658 0 CA-C-O 121.647 0.737 . . . . 0.0 111.923 -177.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 1.5 p-80 -135.35 105.08 6.11 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.476 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.6 t -115.83 140.19 49.46 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.277 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.4 OUTLIER -74.15 131.89 41.71 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.4 tp -117.12 121.67 41.93 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -82.89 114.53 21.25 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.48 -176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.778 ' HA ' ' HZ2' ' A' ' 22' ' ' LYS . 0.0 OUTLIER -48.42 111.49 0.46 Allowed 'General case' 0 CA--C 1.467 -2.23 0 C-N-CA 125.108 1.363 . . . . 0.0 112.802 177.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 22.8 t -88.17 -144.28 0.14 Allowed 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 127.159 2.787 . . . . 0.0 107.327 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.6 p -62.56 84.27 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.555 ' H ' HG12 ' A' ' 89' ' ' ILE . 5.3 mpt_? 59.88 29.85 19.4 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 126.414 1.886 . . . . 0.0 112.215 176.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.42 -123.05 1.02 Allowed Glycine 0 N--CA 1.412 -2.94 0 C-N-CA 119.038 -1.553 . . . . 0.0 113.173 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.712 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 76.3 m-85 -130.88 -90.45 0.45 Allowed 'General case' 0 N--CA 1.392 -3.332 0 CA-C-N 114.055 -1.073 . . . . 0.0 111.324 -173.219 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.602 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 128.07 54.99 0.12 Allowed Glycine 0 C--N 1.3 -1.466 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.002 -168.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.454 ' O ' HG22 ' B' ' 161' ' ' VAL . 38.4 p90 -161.52 142.95 11.4 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 171.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.55 HG22 ' HA ' ' B' ' 160' ' ' GLN . 25.5 p -105.68 136.04 46.01 Favored 'General case' 0 C--N 1.284 -2.283 0 O-C-N 121.336 -0.852 . . . . 0.0 109.497 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.476 ' CG2' ' HB ' ' B' ' 159' ' ' THR . 14.4 m -125.78 160.01 33.02 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.724 -172.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 25.2 m -124.04 132.49 71.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 121.755 0.788 . . . . 0.0 111.497 174.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' B' ' 157' ' ' ARG . . . 129.77 -139.73 11.18 Favored Glycine 0 N--CA 1.41 -3.091 0 CA-C-N 114.674 -1.148 . . . . 0.0 112.068 176.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.644 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 44.41 48.52 8.55 Favored Glycine 1 CA--C 1.443 -4.413 0 C-N-CA 125.754 1.645 . . . . 0.0 111.204 179.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' B' ' 156' ' ' ARG . 35.3 t70 -88.99 -32.64 17.52 Favored 'General case' 0 C--N 1.252 -3.669 0 CA-C-N 114.566 -0.817 . . . . 0.0 109.712 -174.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -158.67 167.9 13.49 Favored Pre-proline 0 N--CA 1.415 -2.21 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.464 -170.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.421 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 16.6 Cg_exo -77.46 51.15 3.42 Favored 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 124.409 3.406 . . . . 0.0 109.916 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -162.79 -39.8 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 112.194 -2.275 . . . . 0.0 108.257 -171.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.527 ' OE2' ' HA2' ' A' ' 33' ' ' GLY . 39.4 tt0 -111.78 120.15 41.0 Favored 'General case' 0 C--O 1.271 2.224 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -85.48 165.67 16.96 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 128.29 2.636 . . . . 0.0 109.282 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.644 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 3.9 mp -95.06 146.14 24.48 Favored 'General case' 0 C--O 1.194 -1.833 0 C-N-CA 118.26 -1.376 . . . . 0.0 109.003 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 1.2 tm0? -131.79 151.58 51.57 Favored 'General case' 0 C--O 1.169 -3.147 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.5 HG12 ' O ' ' A' ' 62' ' ' ASP . 8.2 mm -90.54 122.34 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 CA-C-N 118.827 0.74 . . . . 0.0 109.237 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HA ' HD21 ' A' ' 103' ' ' LEU . 53.6 pttt -106.02 -18.18 14.11 Favored 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.765 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.471 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 67.9 m -156.34 127.74 7.11 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.023 0.439 . . . . 0.0 111.326 177.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 23.0 tp -75.01 121.28 21.74 Favored 'General case' 0 N--CA 1.393 -3.275 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 170.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.602 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 97.2 t -92.98 123.44 45.07 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.48 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.3 mt -69.88 148.93 48.4 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.708 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.3 t70 80.6 4.71 1.67 Allowed 'General case' 0 CA--C 1.551 0.981 0 O-C-N 124.982 1.426 . . . . 0.0 109.743 -173.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.633 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -89.5 164.63 31.91 Favored Glycine 0 C--O 1.209 -1.468 0 CA-C-O 117.893 -1.504 . . . . 0.0 110.544 173.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 10.1 Cg_endo -72.5 -25.72 17.61 Favored 'Trans proline' 0 C--O 1.191 -1.868 0 CA-C-N 121.639 2.719 . . . . 0.0 110.482 -171.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.94 -40.24 87.53 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-O 121.676 0.751 . . . . 0.0 109.408 176.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.96 -49.39 68.06 Favored 'General case' 0 CA--C 1.494 -1.211 0 CA-C-O 122.536 1.16 . . . . 0.0 109.252 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 75.4 mt -72.13 -50.0 31.43 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 112.619 -2.082 . . . . 0.0 115.522 -172.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -76.01 -24.52 55.29 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.65 -160.77 45.62 Favored Glycine 0 N--CA 1.435 -1.399 0 CA-C-N 114.353 -1.294 . . . . 0.0 111.086 -176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 60.1 tttp 69.85 -61.37 0.45 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.366 1.466 . . . . 0.0 112.637 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.535 ' HG2' HD11 ' A' ' 97' ' ' LEU . 1.3 tmt? -77.7 136.24 38.16 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -146.02 167.05 24.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.151 0.5 . . . . 0.0 111.107 -170.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 17.8 m -58.24 128.04 35.11 Favored 'General case' 0 N--CA 1.423 -1.775 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 119.6 -13.28 10.89 Favored Glycine 0 N--CA 1.433 -1.517 0 C-N-CA 119.945 -1.122 . . . . 0.0 111.521 -177.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 43' ' ' ILE . 24.8 m-20 -75.65 161.49 29.06 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 172.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.587 HG21 HD13 ' A' ' 11' ' ' LEU . 10.4 m -123.31 133.95 67.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 174.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 40.1 mm -81.0 109.22 15.14 Favored 'Isoleucine or valine' 0 C--O 1.302 3.866 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 73' ' ' LEU . 86.9 t -95.84 -56.19 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.569 0 O-C-N 126.225 2.203 . . . . 0.0 109.717 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.8 m -156.44 173.23 17.21 Favored 'General case' 0 C--N 1.312 -1.023 0 O-C-N 121.518 -0.739 . . . . 0.0 110.054 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.443 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.5 p -145.68 120.84 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.252 4.8 p-10 16.58 84.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 126.542 1.937 . . . . 0.0 115.216 -172.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 t70 74.73 -37.43 0.35 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 125.403 1.481 . . . . 0.0 113.09 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 91.6 m -66.46 125.25 25.11 Favored 'General case' 0 C--O 1.256 1.432 0 CA-C-O 121.922 0.867 . . . . 0.0 110.195 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 47.3 t -89.14 91.41 8.78 Favored 'General case' 0 N--CA 1.417 -2.077 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.542 -174.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 67' ' ' VAL . 57.1 t -86.46 3.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-O 122.76 1.267 . . . . 0.0 108.767 177.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 65' ' ' VAL . 13.1 tp -76.38 111.08 11.45 Favored 'General case' 0 N--CA 1.403 -2.803 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 71.78 38.36 60.82 Favored Glycine 0 N--CA 1.415 -2.701 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.846 -173.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.435 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -82.17 145.92 29.83 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 87.4 m -75.43 142.31 43.04 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 117.468 -1.253 . . . . 0.0 107.691 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' HD2' HG23 ' B' ' 155' ' ' THR . 62.2 t60 -48.58 -48.04 39.19 Favored 'General case' 0 CA--C 1.487 -1.455 0 CA-C-N 119.211 0.914 . . . . 0.0 112.815 -176.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.86 -36.13 76.23 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 124.367 1.042 . . . . 0.0 110.536 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -75.0 -51.56 13.3 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.666 -178.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 75' ' ' HIS . 7.4 p -63.93 -44.08 97.89 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.855 -178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 77' ' ' HIS . 10.6 p -60.47 -42.13 90.11 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.535 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 82' ' ' LYS . 35.4 ttpt -65.26 -39.13 92.23 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 74.9 mt -71.5 -46.59 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.796 0 CA-C-O 122.187 0.994 . . . . 0.0 108.402 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -66.0 -28.89 69.22 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-N 113.509 -1.678 . . . . 0.0 111.745 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -86.09 -23.77 26.55 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 175.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 12.6 t -92.55 -2.64 56.03 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-O 121.38 0.61 . . . . 0.0 110.163 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.605 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -54.49 138.26 60.25 Favored Pre-proline 0 N--CA 1.424 -1.754 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.787 173.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 55.4 Cg_endo -93.39 149.27 2.4 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.239 2.626 . . . . 0.0 111.794 -179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.555 HG12 ' H ' ' A' ' 25' ' ' ARG . 26.3 mt -67.86 141.81 17.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.46 12.37 63.01 Favored Glycine 0 CA--C 1.498 -0.97 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.637 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.589 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -106.89 -169.06 1.49 Allowed 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 120.49 -0.484 . . . . 0.0 111.804 -171.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.547 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 27.9 t -148.14 148.1 30.21 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 121.841 -0.537 . . . . 0.0 112.218 -171.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.722 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.3 m -146.58 161.15 9.85 Favored 'Isoleucine or valine' 0 CA--C 1.473 -2.014 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.553 173.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -107.41 107.75 18.78 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 173.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 11.6 tp -92.01 114.09 26.53 Favored 'General case' 0 C--N 1.253 -3.591 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.976 -175.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -90.76 107.63 19.31 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 58' ' ' MET . 0.3 OUTLIER -141.47 161.72 37.23 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -174.481 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.507 ' HB2' HG22 ' A' ' 63' ' ' VAL . 74.4 m -124.27 123.49 40.34 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.087 0.47 . . . . 0.0 111.966 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' CG ' ' A' ' 14' ' ' LYS . 18.9 tpp85 -93.35 147.17 23.16 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 102' ' ' PRO . . . 137.54 5.64 1.71 Allowed Glycine 0 C--N 1.296 -1.661 0 C-N-CA 119.101 -1.523 . . . . 0.0 112.586 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -105.93 99.94 25.31 Favored Pre-proline 0 N--CA 1.43 -1.469 0 CA-C-N 116.714 0.257 . . . . 0.0 110.469 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 100' ' ' GLY . 18.0 Cg_exo -66.74 132.21 28.03 Favored 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 121.949 1.766 . . . . 0.0 107.732 175.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.641 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -69.94 104.86 0.9 Allowed Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -178.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -95.48 41.45 0.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.018 2.479 . . . . 0.0 111.578 -172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.43 ' O ' HD12 ' A' ' 103' ' ' LEU . 31.5 t80 -167.0 168.43 13.83 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 9.4 m-20 -79.33 140.26 56.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 1.8 Cg_endo -93.14 0.54 3.56 Favored 'Trans proline' 0 N--CA 1.44 -1.674 0 C-N-CA 123.018 2.479 . . . . 0.0 107.421 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -79.06 -33.77 44.35 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.435 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -51.41 114.42 5.02 Favored Pre-proline 0 C--O 1.246 0.894 0 CA-C-N 113.184 -1.826 . . . . 0.0 112.108 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -62.06 -153.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.046 0 C-N-CA 124.094 3.196 . . . . 0.0 113.293 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.82 70.8 0.43 Allowed 'General case' 0 N--CA 1.422 -1.844 0 CA-C-N 114.711 -1.131 . . . . 0.0 109.239 -178.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 113' ' ' SER . 3.1 m -78.53 -149.37 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.429 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.441 ' H ' HG22 ' A' ' 112' ' ' THR . 0.3 OUTLIER -56.1 102.52 0.08 Allowed 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 119.215 0.916 . . . . 0.0 111.936 -173.373 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.71 ' O ' ' HA ' ' B' ' 155' ' ' THR . 0.0 OUTLIER -74.82 119.53 19.14 Favored 'General case' 1 N--CA 1.379 -4.004 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.566 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.598 ' HA ' ' O ' ' B' ' 154' ' ' ARG . 9.7 p -123.45 114.11 40.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.034 0 CA-C-O 122.112 0.958 . . . . 0.0 109.763 178.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 t -102.18 146.28 28.2 Favored 'General case' 0 N--CA 1.391 -3.393 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 31.1 t -120.06 137.29 54.2 Favored 'General case' 0 C--N 1.271 -2.831 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.71 108.45 23.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 N-CA-C 106.924 -1.51 . . . . 0.0 106.924 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.43 73.92 1.48 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.686 0.755 . . . . 0.0 112.102 -175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.0 mp -129.38 -30.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 122.546 1.165 . . . . 0.0 108.355 176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.95 -132.43 0.33 Allowed 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -69.12 107.56 3.24 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-O 122.874 1.321 . . . . 0.0 110.129 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -121.06 41.22 3.37 Favored 'General case' 0 C--N 1.277 -2.548 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.52 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 125' ' ' PRO . 37.6 mt-10 -76.04 125.44 88.04 Favored Pre-proline 0 N--CA 1.429 -1.495 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 124' ' ' GLU . 32.5 Cg_exo . . . . . 0 C--N 1.347 0.477 0 C-N-CA 123.007 2.472 . . . . 0.0 112.659 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 43.8 m -79.45 89.22 5.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 24.8 m 74.63 154.38 0.15 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.73 1.212 . . . . 0.0 112.266 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -147.03 -71.25 0.23 Allowed 'General case' 0 C--O 1.209 -1.059 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.885 178.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.71 ' HA ' ' O ' ' A' ' 114' ' ' LEU . 2.0 t -158.35 143.13 16.23 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 102.382 -3.192 . . . . 0.0 102.382 176.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.446 ' HB2' ' OD1' ' A' ' 35' ' ' ASP . 4.9 ptm180 -159.96 155.66 25.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 120.27 1.395 . . . . 0.0 112.211 -175.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.773 ' HA ' ' O ' ' A' ' 33' ' ' GLY 0.414 23.3 ptt180 62.05 -62.89 0.1 Allowed 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 116.416 2.006 . . . . 0.0 116.416 174.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -73.57 87.02 1.61 Allowed 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 123.008 0.523 . . . . 0.0 109.824 -173.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.476 ' HB ' ' CG2' ' A' ' 31' ' ' VAL . 2.9 m -100.06 113.89 26.83 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.55 ' HA ' HG22 ' A' ' 30' ' ' THR . 55.0 tt0 -88.66 104.8 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 29' ' ' PHE . 10.1 m . . . . . 0 N--CA 1.418 -2.062 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.096 -175.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.17 90.9 1.6 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.383 0.673 . . . . 0.0 110.404 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.32 20.88 17.6 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -71.87 -19.75 78.38 Favored Glycine 0 C--N 1.318 -0.439 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.52 141.75 24.29 Favored Pre-proline 0 N--CA 1.424 -1.765 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 177.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -76.43 171.29 18.34 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.755 2.303 . . . . 0.0 109.005 172.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -57.33 112.95 1.55 Allowed 'General case' 0 N--CA 1.441 -0.89 0 CA-C-O 122.22 1.01 . . . . 0.0 109.149 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' HZ ' ' O ' ' A' ' 37' ' ' PRO . 4.1 t80 -147.0 144.17 28.97 Favored 'General case' 0 N--CA 1.415 -2.18 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.128 -172.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.501 HG23 ' H ' ' A' ' 7' ' ' ASN 0.335 8.9 t -156.45 -53.77 0.08 Allowed 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.104 163.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.573 ' O ' HD21 ' A' ' 73' ' ' LEU . 10.2 ptm180 164.03 -30.12 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 -178.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.703 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.6 t-20 -46.07 108.66 0.85 Allowed Pre-proline 0 C--N 1.307 -1.248 0 CA-C-N 112.572 -2.104 . . . . 0.0 112.846 -175.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -63.1 -27.35 73.38 Favored 'Trans proline' 0 CA--C 1.469 -2.755 0 C-N-CA 121.565 1.51 . . . . 0.0 110.882 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.6 t -81.83 -19.71 40.52 Favored 'General case' 1 N--CA 1.354 -5.235 0 CA-C-N 114.04 -1.436 . . . . 0.0 111.031 -173.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.703 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.9 pt-20 -75.26 -34.41 61.37 Favored 'General case' 0 C--N 1.372 1.571 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 174.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 76.3 mt -55.5 132.86 49.55 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.506 -1.225 . . . . 0.0 110.921 178.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -80.06 171.16 15.46 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 114.707 -1.133 . . . . 0.0 111.772 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.408 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 97.42 -123.49 7.82 Favored Glycine 0 N--CA 1.417 -2.569 0 CA-C-N 114.627 -1.169 . . . . 0.0 111.271 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.642 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -135.72 141.38 44.88 Favored 'General case' 0 C--N 1.282 -2.349 0 C-N-CA 123.479 0.712 . . . . 0.0 109.55 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -108.83 111.64 23.48 Favored 'General case' 0 C--N 1.264 -3.114 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.44 152.13 23.35 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.458 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.564 -177.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 11.1 t60 -131.84 99.71 4.85 Favored 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.2 t -114.22 145.57 41.54 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.759 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HE3' ' OG ' ' A' ' 92' ' ' SER . 0.2 OUTLIER -84.88 134.68 34.27 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.419 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.2 mp -117.23 119.98 36.84 Favored 'General case' 0 CA--C 1.476 -1.885 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -81.49 110.95 17.36 Favored 'General case' 0 N--CA 1.39 -3.433 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.584 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -41.19 104.4 0.04 OUTLIER 'General case' 0 CA--C 1.465 -2.3 0 O-C-N 123.85 0.719 . . . . 0.0 109.398 170.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.551 ' O ' ' HA ' ' A' ' 89' ' ' ILE . 65.1 m -92.34 -117.32 0.08 Allowed 'General case' 0 N--CA 1.388 -3.534 0 O-C-N 125.125 1.515 . . . . 0.0 109.953 -176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 43.6 m -78.81 79.53 5.21 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 119.907 1.23 . . . . 0.0 113.079 -176.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' H ' HG12 ' A' ' 89' ' ' ILE . 16.8 mmt180 62.84 51.19 3.05 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.143 0.973 . . . . 0.0 111.322 173.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 138.85 -124.78 2.93 Favored Glycine 0 N--CA 1.409 -3.156 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.692 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 74.5 m-85 -127.79 -81.33 0.59 Allowed 'General case' 0 N--CA 1.407 -2.617 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 130.5 51.41 0.1 Allowed Glycine 0 C--N 1.298 -1.578 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.456 -172.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 43' ' ' ILE . 27.4 p90 -162.05 146.81 12.71 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 123.96 0.904 . . . . 0.0 108.715 174.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.507 HG22 ' HA ' ' B' ' 160' ' ' GLN . 68.0 p -109.92 136.14 49.68 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 118.605 -1.238 . . . . 0.0 108.891 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.599 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 15.4 m -117.45 168.45 9.16 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.193 -168.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' HG2' ' A' ' 44' ' ' LYS . 5.7 m -127.38 133.06 68.78 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 C-N-CA 125.482 1.513 . . . . 0.0 109.739 173.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.651 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 115.87 -135.6 12.3 Favored Glycine 0 C--N 1.273 -2.951 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.811 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.513 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 38.66 50.8 2.48 Favored Glycine 0 CA--C 1.461 -3.299 0 O-C-N 126.214 1.773 . . . . 0.0 111.142 -177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.554 ' OD1' ' HD2' ' B' ' 156' ' ' ARG . 36.0 t0 -95.75 -36.05 11.31 Favored 'General case' 0 C--N 1.251 -3.69 0 CA-C-N 113.324 -1.438 . . . . 0.0 110.361 -172.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.1 pt-20 -158.82 173.65 4.79 Favored Pre-proline 0 N--CA 1.411 -2.38 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.756 -172.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.48 ' HA ' ' CA ' ' A' ' 74' ' ' GLY . 52.0 Cg_exo -66.42 -13.89 41.81 Favored 'Trans proline' 0 C--N 1.325 -0.663 0 C-N-CA 123.012 2.475 . . . . 0.0 109.538 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.77 -14.55 24.6 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.234 -1.803 . . . . 0.0 111.826 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -139.25 120.28 14.56 Favored 'General case' 0 C--O 1.255 1.383 0 O-C-N 121.359 -0.838 . . . . 0.0 111.301 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' CZ ' ' HA ' ' A' ' 6' ' ' ARG . 14.5 m-85 -79.97 166.04 22.0 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 127.412 2.285 . . . . 0.0 111.569 -175.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.892 HD21 HG21 ' A' ' 80' ' ' VAL . 4.6 mp -88.41 146.04 25.46 Favored 'General case' 0 N--CA 1.421 -1.903 0 CA-C-N 114.867 -1.06 . . . . 0.0 108.638 -177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 tt0 -142.38 154.71 44.86 Favored 'General case' 0 C--O 1.181 -2.539 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 177.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 29' ' ' PHE . 18.9 mm -93.22 127.01 45.57 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 118.914 0.779 . . . . 0.0 109.065 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -105.49 -21.21 13.26 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -178.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.1 m -157.24 128.43 6.79 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 tp -79.76 123.07 27.36 Favored 'General case' 0 N--CA 1.401 -2.904 0 C-N-CA 123.714 0.806 . . . . 0.0 108.83 174.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 93.3 t -94.96 111.82 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.277 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 176.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.9 145.43 52.82 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.902 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.5 t70 86.01 3.05 0.56 Allowed 'General case' 0 N--CA 1.467 0.423 0 O-C-N 125.824 1.953 . . . . 0.0 109.098 -171.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.616 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.43 159.97 34.09 Favored Glycine 0 C--O 1.204 -1.773 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.072 173.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 34.2 Cg_endo -72.61 -25.85 17.11 Favored 'Trans proline' 0 N--CA 1.435 -1.929 0 CA-C-N 121.148 2.474 . . . . 0.0 110.515 -171.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.28 -46.04 91.99 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.535 -1.211 . . . . 0.0 108.737 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.62 -44.91 85.06 Favored 'General case' 0 CA--C 1.498 -1.046 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.501 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 88.1 mt -72.0 -40.09 68.77 Favored 'General case' 0 N--CA 1.405 -2.699 0 CA-C-N 113.384 -1.734 . . . . 0.0 114.832 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -75.05 -24.7 58.3 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.24 15.38 65.45 Favored Glycine 0 CA--C 1.484 -1.881 0 CA-C-N 113.296 -1.775 . . . . 0.0 115.486 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.05 22.37 7.96 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 122.8 1.286 . . . . 0.0 109.805 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . . . . . . . . . 24.8 ttt -140.17 128.69 22.83 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 104.667 -2.346 . . . . 0.0 104.667 175.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.38 149.32 30.67 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -167.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.2 m -44.75 117.52 1.33 Allowed 'General case' 0 N--CA 1.438 -1.035 0 C-N-CA 124.643 1.177 . . . . 0.0 110.819 -177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 124.11 -7.56 8.66 Favored Glycine 0 N--CA 1.421 -2.336 0 C-N-CA 120.47 -0.872 . . . . 0.0 111.532 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -74.63 150.33 39.66 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 174.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 1.8 m -108.36 129.7 62.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 45.5 mm -84.93 115.93 27.61 Favored 'Isoleucine or valine' 0 C--O 1.302 3.83 0 CA-C-O 121.701 0.762 . . . . 0.0 109.26 -179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 73' ' ' LEU . 95.3 t -96.24 -58.21 3.92 Favored 'Isoleucine or valine' 0 C--O 1.195 -1.81 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.727 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.7 t -155.59 166.74 32.61 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.899 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' A' ' 95' ' ' LEU . 8.1 p -152.9 115.36 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 51.33 52.41 14.88 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.945 1.298 . . . . 0.0 111.78 173.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 69.33 -6.76 0.91 Allowed 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 113.364 -1.744 . . . . 0.0 113.889 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 26.4 m -81.06 126.48 31.48 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 34.2 t -82.45 73.82 9.46 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.955 0.883 . . . . 0.0 110.595 -172.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.523 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 80.0 t -79.55 -4.11 6.77 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 122.66 1.219 . . . . 0.0 109.202 177.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.573 HD21 ' O ' ' A' ' 6' ' ' ARG . 13.6 tp -66.93 112.03 4.1 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 172.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' A' ' 37' ' ' PRO . . . 70.92 37.01 65.12 Favored Glycine 0 N--CA 1.424 -2.121 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.418 -175.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 0.6 OUTLIER -82.61 147.17 28.73 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 178.56 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.511 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 87.7 m -76.24 143.28 41.09 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-O 117.599 -1.191 . . . . 0.0 109.171 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.52 ' NE2' ' HA ' ' B' ' 154' ' ' ARG . 83.2 t60 -46.77 -47.66 20.76 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 119.336 0.971 . . . . 0.0 113.164 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 82' ' ' LYS . . . -63.53 -32.25 73.65 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.474 0.654 . . . . 0.0 110.821 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.511 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 32.0 mm-40 -77.82 -49.91 13.36 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.15 -178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.892 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -61.35 -44.75 99.04 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.064 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.148 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 11.6 p -60.85 -45.13 98.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.631 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.416 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -60.18 -38.75 84.2 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -178.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 58.3 mt -73.12 -48.28 44.21 Favored 'Isoleucine or valine' 0 C--O 1.248 1.002 0 CA-C-O 122.502 1.144 . . . . 0.0 108.909 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -66.04 -28.59 68.97 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.142 -1.844 . . . . 0.0 113.108 -175.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 81' ' ' VAL . 3.8 pt20 -86.71 -24.46 25.18 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.769 -0.582 . . . . 0.0 111.798 174.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -75.46 -26.22 58.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.584 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.7 OUTLIER -59.61 152.23 57.68 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 37.4 Cg_endo -102.25 159.51 0.32 Allowed 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 125.063 3.842 . . . . 0.0 111.942 -178.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 23' ' ' SER . 45.4 mt -67.78 131.01 33.4 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.97 177.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 101.45 10.88 40.19 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 119.773 -0.46 . . . . 0.0 113.981 175.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -99.35 -176.43 3.29 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 118.578 1.189 . . . . 0.0 111.902 -175.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.555 ' OG ' ' HE3' ' A' ' 19' ' ' LYS . 28.2 t -140.99 145.39 35.89 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.704 -0.623 . . . . 0.0 111.75 -174.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' LYS . 3.2 m -149.43 157.64 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 C-N-CA 123.964 0.905 . . . . 0.0 111.486 175.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.506 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 4.2 m-20 -104.56 107.11 17.88 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -177.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.481 HD22 HD22 ' A' ' 20' ' ' LEU . 15.4 tp -99.53 121.51 41.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-O 121.123 0.487 . . . . 0.0 111.608 -172.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -98.02 114.47 26.63 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -140.52 148.12 40.57 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.113 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 10.0 t -117.64 120.1 36.99 Favored 'General case' 0 N--CA 1.426 -1.642 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.642 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 14.3 tpp85 -95.18 139.87 30.89 Favored 'General case' 0 C--N 1.282 -2.363 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.84 -28.35 1.03 Allowed Glycine 0 C--N 1.3 -1.444 0 C-N-CA 119.962 -1.114 . . . . 0.0 111.306 -177.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -99.18 98.67 6.86 Favored Pre-proline 0 C--N 1.306 -1.292 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.539 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 95.6 Cg_endo -79.31 -175.34 2.69 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.664 2.243 . . . . 0.0 111.36 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.67 101.06 6.14 Favored Pre-proline 0 C--N 1.301 -1.506 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 177.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 3.0 Cg_exo -78.51 -0.83 11.06 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 123.359 2.706 . . . . 0.0 111.52 -178.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -140.93 163.75 32.11 Favored 'General case' 0 N--CA 1.412 -2.364 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 6.0 m-20 -98.3 144.39 28.01 Favored Pre-proline 0 C--N 1.282 -2.332 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 174.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 3.1 Cg_endo -93.58 16.66 1.18 Allowed 'Trans proline' 0 N--CA 1.437 -1.801 0 C-N-CA 123.566 2.844 . . . . 0.0 107.267 -177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.35 -24.02 29.92 Favored 'General case' 0 N--CA 1.41 -2.467 0 CA-C-N 112.009 -2.36 . . . . 0.0 107.239 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -62.22 135.67 95.15 Favored Pre-proline 0 C--O 1.237 0.422 0 CA-C-N 113.636 -1.62 . . . . 0.0 108.281 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -12.34 -92.41 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.042 1 C-N-CA 127.142 5.228 . . . . 0.0 117.854 -178.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 4.6 m120 49.45 57.56 6.37 Favored 'General case' 0 C--N 1.312 -1.06 0 C-N-CA 125.814 1.646 . . . . 0.0 111.59 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.7 m -61.21 134.81 57.4 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.539 -1.21 . . . . 0.0 108.406 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.4 p -73.57 101.24 3.52 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -172.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.618 ' H ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -91.12 131.89 36.4 Favored 'General case' 0 N--CA 1.399 -2.985 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 171.144 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 154' ' ' ARG . 12.0 p -102.12 124.1 55.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.435 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.96 -176.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.0 t -135.81 133.44 37.88 Favored 'General case' 0 N--CA 1.396 -3.133 0 N-CA-C 106.503 -1.665 . . . . 0.0 106.503 175.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.2 t -95.65 -173.9 3.0 Favored 'General case' 0 C--N 1.269 -2.903 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 -173.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG21 ' CG2' ' A' ' 76' ' ' THR . 33.6 t -112.74 100.39 10.63 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.77 73.99 0.99 Allowed 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.918 0.866 . . . . 0.0 110.163 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -126.86 -60.46 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.14 177.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 44.1 mt -84.8 178.81 7.5 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.939 -176.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -78.16 71.83 4.66 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.167 -1.379 . . . . 0.0 111.519 -178.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.36 120.91 18.25 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.932 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.57 132.07 25.87 Favored Pre-proline 0 C--N 1.302 -1.479 0 C-N-CA 120.01 -0.676 . . . . 0.0 112.701 179.112 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.538 0.717 0 C-N-CA 123.153 2.568 . . . . 0.0 112.526 179.694 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 . . . . . 0 CA--C 1.518 -0.257 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 17.9 m -72.8 58.39 0.45 Allowed 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 123.154 0.581 . . . . 0.0 111.738 -177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -76.17 60.91 1.53 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.879 0.847 . . . . 0.0 112.047 -178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.52 ' HA ' ' NE2' ' A' ' 77' ' ' HIS . 18.6 mtp180 -136.25 34.64 2.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 174.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . . . . . . . . . 5.9 t -100.64 13.68 33.97 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 113.25 -1.796 . . . . 0.0 110.888 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.554 ' HD2' ' OD1' ' A' ' 35' ' ' ASP . 15.9 mmt85 73.04 147.5 0.09 Allowed 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.746 1.218 . . . . 0.0 107.812 -171.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.651 ' HA ' ' H ' ' A' ' 33' ' ' GLY . 49.3 mtp85 72.99 -71.76 0.13 Allowed 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 118.851 0.75 . . . . 0.0 112.773 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 41.4 tt0 -73.29 108.67 6.3 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 120.826 0.346 . . . . 0.0 110.183 179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . . . . . . . . . 6.7 m -123.39 133.66 54.07 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.507 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.7 OUTLIER -100.02 116.58 32.39 Favored 'General case' 0 CA--C 1.494 -1.194 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 178.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.2 m . . . . . 0 N--CA 1.419 -1.975 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -179.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.907 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -89.88 71.42 7.58 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 90.0 mtp -125.74 42.62 3.25 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 122.026 0.917 . . . . 0.0 109.831 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -87.48 1.18 85.75 Favored Glycine 0 C--N 1.315 -0.598 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.063 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -104.09 160.77 24.97 Favored Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 176.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -65.54 119.64 6.7 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 121.394 1.396 . . . . 0.0 110.429 177.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -109.13 145.3 35.95 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 113.644 -1.616 . . . . 0.0 112.249 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -147.16 135.15 21.39 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.098 174.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.664 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 13.5 t -167.68 38.81 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.841 0 C-N-CA 124.333 1.053 . . . . 0.0 108.787 166.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.664 ' HG2' ' O ' ' A' ' 5' ' ' THR . 5.7 ptm180 60.13 12.5 3.29 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 127.264 2.225 . . . . 0.0 113.413 175.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.792 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 12.0 m-80 -97.39 115.25 65.71 Favored Pre-proline 0 C--N 1.251 -3.686 0 N-CA-C 115.199 1.555 . . . . 0.0 115.199 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.289 13.2 Cg_exo -61.06 -30.17 88.93 Favored 'Trans proline' 0 CA--C 1.483 -2.069 0 N-CA-C 107.906 -1.613 . . . . 0.0 107.906 170.016 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.0 t -68.66 -25.6 64.89 Favored 'General case' 1 N--CA 1.363 -4.815 0 CA-C-N 110.993 -2.822 . . . . 0.0 111.003 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.792 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 13.3 pt-20 -80.3 -33.79 37.32 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.72 135.29 57.39 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.655 176.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 100' ' ' GLY . 45.8 pttt -78.66 166.01 23.0 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 114.293 -1.321 . . . . 0.0 112.337 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 98.82 -122.98 7.74 Favored Glycine 0 N--CA 1.42 -2.398 0 CA-C-N 114.186 -1.37 . . . . 0.0 113.514 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.502 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.0 147.07 46.04 Favored 'General case' 0 C--N 1.291 -1.938 0 C-N-CA 124.712 1.205 . . . . 0.0 110.014 -177.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -113.5 123.4 49.93 Favored 'General case' 0 C--N 1.277 -2.557 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -173.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.409 ' O ' HD23 ' A' ' 97' ' ' LEU . 0.1 OUTLIER -135.6 152.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.963 -178.277 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.569 ' HA ' ' O ' ' A' ' 95' ' ' LEU . 43.5 p-80 -126.11 100.49 6.35 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 122.384 1.088 . . . . 0.0 110.265 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.8 t -102.77 130.66 49.81 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.539 -174.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.7 OUTLIER -83.16 130.32 35.09 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.079 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 51' ' ' PRO . 1.9 mp -117.26 123.46 46.64 Favored 'General case' 0 CA--C 1.46 -2.504 0 N-CA-C 107.0 -1.482 . . . . 0.0 107.0 178.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -84.72 125.19 32.31 Favored 'General case' 0 N--CA 1.392 -3.354 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.682 ' HE2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -56.92 103.77 0.13 Allowed 'General case' 0 CA--C 1.471 -2.092 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 172.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 89' ' ' ILE . 22.9 t -80.03 -78.27 0.17 Allowed 'General case' 0 N--CA 1.414 -2.241 0 O-C-N 125.346 1.654 . . . . 0.0 109.971 -172.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.3 m -116.23 78.64 1.21 Allowed 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.694 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.625 ' N ' HG12 ' A' ' 89' ' ' ILE . 14.0 ttt180 63.78 24.74 13.9 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 125.013 1.325 . . . . 0.0 112.271 175.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 174.22 -140.76 5.6 Favored Glycine 0 N--CA 1.409 -3.106 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.456 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.634 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 89.1 m-85 -125.67 -85.85 0.62 Allowed 'General case' 0 N--CA 1.404 -2.729 0 CA-C-N 114.481 -0.86 . . . . 0.0 112.083 -172.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.39 52.89 0.19 Allowed Glycine 0 C--N 1.303 -1.271 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.109 -170.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 43' ' ' ILE . 29.8 p90 -160.9 150.5 17.17 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 HG22 ' HA ' ' B' ' 160' ' ' GLN . 36.0 p -112.03 136.42 51.42 Favored 'General case' 0 C--N 1.276 -2.609 0 CA-C-O 122.0 0.905 . . . . 0.0 109.242 176.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.625 ' CG2' ' HB3' ' A' ' 41' ' ' LEU . 4.5 p -125.27 148.4 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.608 0 CA-C-N 113.956 -1.474 . . . . 0.0 110.702 -168.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' B' ' 157' ' ' ARG . 10.8 m -114.98 164.89 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 124.492 1.117 . . . . 0.0 113.283 -176.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.96 -124.62 6.55 Favored Glycine 0 C--O 1.284 3.249 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.132 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.639 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 43.34 53.67 5.74 Favored Glycine 1 CA--C 1.443 -4.425 0 O-C-N 127.235 2.374 . . . . 0.0 112.173 -179.304 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.528 ' HB3' ' HB3' ' A' ' 39' ' ' GLU . 51.3 t0 -86.14 -47.89 9.08 Favored 'General case' 1 C--N 1.244 -4.012 0 CA-C-N 113.276 -1.462 . . . . 0.0 109.241 -176.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.456 ' HB2' ' CD ' ' A' ' 37' ' ' PRO . 7.8 pt-20 -158.93 174.51 3.98 Favored Pre-proline 0 C--N 1.301 -1.533 0 C-N-CA 119.236 -0.986 . . . . 0.0 111.032 -164.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.456 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 24.8 Cg_exo -75.46 59.61 5.53 Favored 'Trans proline' 0 C--O 1.247 0.941 0 C-N-CA 124.662 3.575 . . . . 0.0 108.021 176.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' HB3' ' HG3' ' A' ' 36' ' ' GLU . 22.9 t70 -178.58 -23.7 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 112.348 -2.205 . . . . 0.0 109.324 -169.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.528 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 9.7 tp10 -131.23 120.54 23.4 Favored 'General case' 0 C--O 1.257 1.488 0 C-N-CA 122.997 0.519 . . . . 0.0 110.022 178.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -88.51 166.18 14.36 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 127.258 2.223 . . . . 0.0 110.261 -176.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.639 ' HG ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 mp -96.85 145.25 26.03 Favored 'General case' 0 C--O 1.175 -2.844 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.648 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 14.9 tt0 -135.03 147.7 49.72 Favored 'General case' 0 C--O 1.189 -2.1 0 CA-C-N 118.866 0.757 . . . . 0.0 109.928 -177.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 29' ' ' PHE . 34.7 mm -79.5 114.9 20.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 O-C-N 121.531 -0.731 . . . . 0.0 110.188 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -98.46 -22.05 16.23 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 120.96 -0.296 . . . . 0.0 111.64 -179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.436 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 37.6 m -155.72 127.14 7.23 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 176.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.7 tp -86.01 112.11 20.91 Favored 'General case' 0 N--CA 1.4 -2.937 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.7 t -87.47 104.76 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.961 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.4 mt -56.62 145.85 27.16 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.098 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.8 t70 86.16 3.87 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 O-C-N 125.438 1.711 . . . . 0.0 109.74 -172.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.666 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -85.44 163.08 36.95 Favored Glycine 0 C--O 1.212 -1.264 0 CA-C-O 117.773 -1.571 . . . . 0.0 110.21 171.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 22.1 Cg_endo -72.48 -25.48 17.92 Favored 'Trans proline' 0 N--CA 1.443 -1.491 0 CA-C-N 121.732 2.766 . . . . 0.0 110.458 -170.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 20' ' ' LEU . . . -62.39 -43.69 98.23 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.428 175.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.65 -47.49 75.37 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-O 122.449 1.119 . . . . 0.0 110.088 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.666 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 69.7 mt -72.18 -40.88 67.61 Favored 'General case' 0 N--CA 1.396 -3.169 0 CA-C-N 112.401 -2.181 . . . . 0.0 114.704 -171.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -78.24 -24.99 46.69 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 175.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.42 27.03 71.16 Favored Glycine 0 CA--C 1.494 -1.263 0 CA-C-N 113.543 -1.662 . . . . 0.0 115.416 178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -110.65 -0.71 17.08 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-O 121.789 0.804 . . . . 0.0 110.437 -179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.421 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 42.8 ttm -129.28 126.97 40.22 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -142.69 144.93 32.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.3 m -45.14 114.62 0.76 Allowed 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 125.234 1.414 . . . . 0.0 111.284 -176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 135.9 -36.95 1.96 Allowed Glycine 0 N--CA 1.426 -2.012 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 -176.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -70.61 145.21 50.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.8 0.81 . . . . 0.0 111.981 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 42' ' ' GLN 0.258 0.2 OUTLIER -110.33 126.3 67.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.27 -175.571 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.2 mm -73.43 116.47 15.79 Favored 'Isoleucine or valine' 0 C--O 1.294 3.441 0 C-N-CA 125.673 1.589 . . . . 0.0 110.649 -178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 96' ' ' GLU . 37.5 t -103.22 -58.08 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.99 -177.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.475 ' HB2' ' HB2' ' A' ' 96' ' ' GLU . 20.4 m -136.87 157.87 45.76 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.055 -177.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.491 HG12 ' HB ' ' A' ' 72' ' ' VAL . 5.9 p -137.61 104.1 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 0.0 112.519 -176.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.06 -83.84 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 C-N-CA 125.766 1.627 . . . . 0.0 112.079 175.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -131.98 -12.09 3.3 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.0 0.429 . . . . 0.0 110.838 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 98.7 m -89.68 134.79 33.98 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-O 121.759 0.79 . . . . 0.0 110.382 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.558 ' SG ' ' HB3' ' A' ' 73' ' ' LEU . 45.1 t -80.88 80.03 7.43 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.771 -1.104 . . . . 0.0 109.604 -178.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 67' ' ' VAL . 7.5 p -77.23 -5.81 8.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 122.245 1.022 . . . . 0.0 108.504 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.558 ' HB3' ' SG ' ' A' ' 71' ' ' CYS . 44.6 tp -56.35 111.11 0.89 Allowed 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 113.789 -1.551 . . . . 0.0 107.174 173.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.429 ' HA3' ' HA ' ' A' ' 37' ' ' PRO . . . 58.88 37.96 91.68 Favored Glycine 0 N--CA 1.426 -2.001 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.886 -177.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -77.29 145.13 37.63 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ASP . 39.8 m -73.53 141.82 46.72 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.495 ' HA ' HG12 ' A' ' 80' ' ' VAL . 56.7 t-80 -51.28 -40.47 59.02 Favored 'General case' 0 CA--C 1.493 -1.227 0 C-N-CA 125.179 1.392 . . . . 0.0 112.72 -176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.76 -37.18 85.64 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.092 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.427 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 80.7 mm-40 -75.3 -48.6 22.44 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.769 -177.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.495 HG12 ' HA ' ' A' ' 77' ' ' HIS . 7.4 p -62.06 -43.14 97.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.651 -178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 77' ' ' HIS . 13.8 p -63.18 -37.85 80.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.436 178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.45 -45.83 90.47 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 61.6 mt -72.22 -50.8 33.84 Favored 'Isoleucine or valine' 0 C--O 1.247 0.93 0 CA-C-O 122.161 0.982 . . . . 0.0 109.383 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.429 ' HB3' ' CG1' ' B' ' 161' ' ' VAL . 9.0 m-85 -64.68 -35.13 80.03 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.799 -175.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -85.49 -21.42 28.67 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 120.67 0.272 . . . . 0.0 110.933 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 40.7 m -90.82 -2.52 57.77 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.967 -0.458 . . . . 0.0 111.409 178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.63 HD12 ' CE2' ' A' ' 27' ' ' PHE . 1.2 mt -47.65 142.43 6.59 Favored Pre-proline 0 CA--C 1.573 1.86 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.84 156.66 0.68 Allowed 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 124.035 3.157 . . . . 0.0 112.575 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' N ' ' A' ' 25' ' ' ARG . 64.3 mt -69.01 142.39 16.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 C-N-CA 124.414 1.086 . . . . 0.0 110.628 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.9 74.41 Favored Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.138 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.603 ' H ' ' HB2' ' A' ' 22' ' ' LYS . . . -101.05 -172.94 2.26 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -171.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.6 p -149.9 138.37 20.67 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -167.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.682 HG22 ' HE2' ' A' ' 22' ' ' LYS . 18.6 m -149.63 149.41 14.71 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.363 0 C-N-CA 122.846 0.458 . . . . 0.0 110.734 172.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -104.79 109.44 21.39 Favored 'General case' 0 C--N 1.291 -1.953 0 O-C-N 124.51 1.131 . . . . 0.0 108.327 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.569 ' O ' ' HA ' ' A' ' 17' ' ' HIS . 2.7 mm? -90.44 113.42 25.35 Favored 'General case' 0 C--N 1.275 -2.667 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.54 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 66' ' ' SER . 40.3 mt-10 -88.39 106.36 18.2 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 174.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' ILE . 1.6 pt? -132.61 158.61 41.8 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 120.893 0.378 . . . . 0.0 110.442 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . . . . . . . . . 9.6 t -116.19 125.16 51.89 Favored 'General case' 0 N--CA 1.413 -2.28 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.502 ' HB3' ' HG2' ' A' ' 14' ' ' LYS . 16.7 tpp85 -98.22 142.62 29.67 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.449 ' O ' ' HE3' ' A' ' 12' ' ' LYS . . . 149.33 -9.4 0.93 Allowed Glycine 0 C--N 1.303 -1.3 0 C-N-CA 119.721 -1.228 . . . . 0.0 112.105 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -108.29 92.14 9.23 Favored Pre-proline 0 C--N 1.31 -1.152 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -67.97 129.68 20.09 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 N-CA-C 106.146 -2.29 . . . . 0.0 106.146 170.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -38.96 97.59 0.14 Allowed Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 125.174 1.546 . . . . 0.0 112.384 -172.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -95.99 -2.21 2.02 Favored 'Trans proline' 0 N--CA 1.445 -1.328 0 C-N-CA 122.887 2.391 . . . . 0.0 113.229 -175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -130.66 157.52 42.53 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 17.0 t70 -91.76 135.12 27.95 Favored Pre-proline 0 CA--C 1.48 -1.718 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 26.7 Cg_endo -104.92 12.84 0.22 Allowed 'Trans proline' 0 N--CA 1.418 -2.934 0 C-N-CA 123.366 2.711 . . . . 0.0 110.888 -171.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -103.31 -32.4 9.58 Favored 'General case' 0 N--CA 1.408 -2.54 0 CA-C-N 115.098 -0.955 . . . . 0.0 108.751 -177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -35.42 127.21 0.58 Allowed Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 127.297 2.239 . . . . 0.0 113.079 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -23.09 -137.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.38 2.215 1 C-N-CA 128.748 6.299 . . . . 0.0 119.85 -173.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 153' ' ' SER . 0.8 OUTLIER 75.35 -34.55 0.26 Allowed 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 125.971 1.708 . . . . 0.0 112.955 -178.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.6 m 73.08 161.72 0.25 Allowed 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.504 1.122 . . . . 0.0 110.104 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.1 t -122.57 128.01 50.18 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.59 ' HG ' ' HA ' ' B' ' 154' ' ' ARG . 8.6 mt -76.77 104.21 7.15 Favored 'General case' 0 CA--C 1.479 -1.786 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.5 t -113.84 109.73 29.57 Favored 'Isoleucine or valine' 1 C--N 1.24 -4.157 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.462 -179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.8 t -70.58 151.52 44.94 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.3 m -81.64 89.9 6.27 Favored 'General case' 0 N--CA 1.418 -2.033 0 CA-C-O 122.364 1.078 . . . . 0.0 108.572 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.42 135.12 42.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.9 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.409 ' HB3' ' HE2' ' A' ' 123' ' ' LYS . . . -141.99 98.77 3.39 Favored 'General case' 0 N--CA 1.415 -2.214 0 CA-C-O 122.226 1.012 . . . . 0.0 110.029 178.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 51.9 mt -100.15 7.64 8.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-O 124.301 2.0 . . . . 0.0 106.054 175.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.4 mp -107.48 146.95 31.1 Favored 'General case' 0 N--CA 1.425 -1.685 0 CA-C-N 112.525 -2.125 . . . . 0.0 107.113 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.8 t70 76.61 -5.59 2.16 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 125.04 1.336 . . . . 0.0 112.511 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 119' ' ' ALA . 54.8 mttm -126.52 148.98 49.64 Favored 'General case' 0 C--N 1.266 -3.034 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -98.06 117.88 64.43 Favored Pre-proline 0 C--N 1.28 -2.445 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.977 178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 N--CA 1.445 -1.344 0 C-N-CA 122.639 2.226 . . . . 0.0 110.661 172.45 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.576 ' HD2' ' O ' ' B' ' 151' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.411 0 CA-C-O 121.218 0.533 . . . . 0.0 111.903 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 18.6 t -123.05 138.52 54.66 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 63.2 m 65.52 -176.95 0.18 Allowed 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.302 1.002 . . . . 0.0 109.513 -174.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . 0.59 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.3 OUTLIER -128.12 -175.38 3.48 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 121.446 -0.784 . . . . 0.0 112.735 -176.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.461 ' HA ' ' H ' ' A' ' 114' ' ' LEU . 3.1 m -61.18 -23.31 65.49 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.126 0.965 . . . . 0.0 110.256 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.492 ' HG2' ' HB2' ' B' ' 154' ' ' ARG . 10.1 mmt85 -46.58 105.11 0.06 Allowed 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 128.167 2.587 . . . . 0.0 111.652 -175.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.487 ' O ' ' HA ' ' A' ' 32' ' ' VAL 0.262 12.6 ptm180 161.24 -52.26 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -176.322 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 11.5 pt-20 -155.15 130.51 9.68 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 31' ' ' VAL . 29.4 m -113.3 131.52 55.9 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.067 -1.456 . . . . 0.0 107.067 177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.488 ' HA ' HG22 ' A' ' 30' ' ' THR . 33.4 tt0 -102.84 120.9 41.41 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.429 ' CG1' ' HB3' ' A' ' 84' ' ' PHE . 22.7 m . . . . . 0 N--CA 1.432 -1.362 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.383 -175.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.246 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -163.96 159.86 21.29 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 62.9 mtt 64.97 -167.67 0.22 Allowed 'General case' 0 C--O 1.243 0.749 0 O-C-N 123.875 0.735 . . . . 0.0 111.484 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 101.7 3.63 52.51 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.745 -0.942 . . . . 0.0 110.745 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.11 158.28 32.44 Favored Pre-proline 0 C--N 1.305 -1.327 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -68.94 124.63 11.63 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 121.094 1.196 . . . . 0.0 108.994 174.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -99.8 130.36 45.99 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.127 -170.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -148.21 136.58 21.38 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.869 178.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 ' O ' ' HG2' ' A' ' 6' ' ' ARG . 12.9 t -178.05 33.47 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 124.709 1.204 . . . . 0.0 109.883 168.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.649 ' O ' HD21 ' A' ' 73' ' ' LEU . 13.3 ptm180 49.69 27.81 2.37 Favored 'General case' 0 N--CA 1.515 2.82 0 C-N-CA 126.499 1.919 . . . . 0.0 113.026 177.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.746 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 3.8 m-80 -96.33 115.28 65.53 Favored Pre-proline 1 C--N 1.22 -5.044 0 CA-C-N 112.894 -1.957 . . . . 0.0 112.283 174.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HG3' HG11 ' A' ' 65' ' ' VAL 0.315 26.7 Cg_exo -62.48 -34.66 75.19 Favored 'Trans proline' 0 CA--C 1.475 -2.465 0 CA-C-O 124.201 1.667 . . . . 0.0 108.301 173.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.6 m -65.16 -28.26 69.29 Favored 'General case' 1 N--CA 1.344 -5.738 0 CA-C-N 109.855 -3.339 . . . . 0.0 111.69 -175.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.746 ' HG2' ' O ' ' A' ' 7' ' ' ASN . 15.3 pt-20 -80.59 -33.11 36.25 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.0 mt -61.0 128.75 37.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.696 1.236 . . . . 0.0 110.361 176.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 10.7 ptmm? -83.08 -172.24 4.02 Favored 'General case' 0 C--N 1.286 -2.158 0 CA-C-N 113.327 -1.76 . . . . 0.0 113.33 -169.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 99' ' ' ARG . . . 77.32 -135.17 15.95 Favored Glycine 0 N--CA 1.417 -2.604 0 CA-C-N 114.282 -1.327 . . . . 0.0 110.963 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.458 ' HG2' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -114.45 139.2 49.72 Favored 'General case' 0 C--N 1.275 -2.638 0 C-N-CA 124.072 0.949 . . . . 0.0 109.309 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -109.34 114.86 28.89 Favored 'General case' 0 C--N 1.26 -3.283 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.401 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -131.65 152.3 36.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.188 -175.13 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . 0.522 ' NE2' ' HB3' ' A' ' 94' ' ' ASP . 18.7 t60 -126.73 102.81 7.22 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 t -130.96 146.83 52.49 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.711 -174.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 93' ' ' VAL . 0.3 OUTLIER -81.08 133.7 35.52 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 122.713 0.405 . . . . 0.0 111.695 -177.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 95' ' ' LEU . 0.9 OUTLIER -120.54 125.7 48.5 Favored 'General case' 0 CA--C 1.49 -1.33 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.2 ttm180 -85.36 119.65 25.96 Favored 'General case' 0 N--CA 1.395 -3.176 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.135 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.665 ' HG3' HD12 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -52.32 101.29 0.04 OUTLIER 'General case' 0 CA--C 1.475 -1.927 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 168.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.52 ' O ' HG23 ' A' ' 89' ' ' ILE . 11.1 t -83.08 -94.71 0.06 Allowed 'General case' 0 N--CA 1.411 -2.391 0 O-C-N 124.816 1.323 . . . . 0.0 109.628 -176.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 m -96.03 73.93 3.01 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 121.308 -0.87 . . . . 0.0 110.215 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.578 ' N ' HG12 ' A' ' 89' ' ' ILE . 32.0 ttt180 59.98 40.75 18.49 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.425 1.49 . . . . 0.0 111.909 176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 22' ' ' LYS . . . 163.68 -138.05 5.1 Favored Glycine 0 N--CA 1.411 -2.995 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.735 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 83.8 m-85 -121.91 -84.09 0.66 Allowed 'General case' 0 N--CA 1.41 -2.468 0 CA-C-N 115.786 -0.207 . . . . 0.0 111.321 -175.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.526 ' C ' ' HB ' ' A' ' 47' ' ' VAL . . . 127.56 53.43 0.13 Allowed Glycine 0 C--N 1.291 -1.949 0 C-N-CA 120.119 -1.039 . . . . 0.0 111.998 -171.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.481 ' CD1' HD12 ' A' ' 43' ' ' ILE . 30.7 p90 -161.23 143.24 12.03 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' HA ' ' B' ' 160' ' ' GLN . 20.0 p -106.06 135.69 47.07 Favored 'General case' 0 C--N 1.274 -2.684 0 C-N-CA 119.528 -0.869 . . . . 0.0 108.793 -179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.741 ' O ' ' HA ' ' B' ' 158' ' ' GLU . 0.9 OUTLIER -114.08 163.22 11.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.559 -168.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.609 HG13 ' HG2' ' A' ' 44' ' ' LYS . 2.7 m -121.46 133.31 68.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.173 0 C-N-CA 124.293 1.037 . . . . 0.0 109.689 171.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.447 ' H ' ' HA ' ' B' ' 157' ' ' ARG . . . 114.18 -130.96 9.6 Favored Glycine 0 C--O 1.279 2.946 0 CA-C-O 119.03 -0.872 . . . . 0.0 111.123 176.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.568 ' HA3' ' HG ' ' A' ' 41' ' ' LEU . . . 37.77 62.26 1.01 Allowed Glycine 0 CA--C 1.453 -3.817 0 O-C-N 126.462 1.919 . . . . 0.0 110.837 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.605 ' OD2' ' HB3' ' B' ' 156' ' ' ARG . 8.5 t70 -110.8 -36.1 5.79 Favored 'General case' 0 C--N 1.249 -3.795 0 CA-C-N 113.735 -1.232 . . . . 0.0 109.719 -170.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.501 ' HG2' ' HB3' ' A' ' 35' ' ' ASP . 5.5 pt-20 -158.3 174.71 3.78 Favored Pre-proline 0 CA--C 1.481 -1.686 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.227 -169.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' CD ' ' HB2' ' A' ' 36' ' ' GLU . 73.1 Cg_exo -60.15 -30.43 91.32 Favored 'Trans proline' 0 CA--C 1.503 -1.029 0 C-N-CA 122.617 2.211 . . . . 0.0 109.516 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -68.85 -39.37 79.96 Favored 'General case' 0 N--CA 1.418 -2.07 0 CA-C-N 112.527 -2.124 . . . . 0.0 111.889 175.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -114.67 119.78 37.88 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -171.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -88.97 165.95 14.24 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.876 2.07 . . . . 0.0 108.538 -177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.711 HD21 HG21 ' A' ' 80' ' ' VAL . 5.9 mp -89.27 144.17 26.29 Favored 'General case' 0 C--O 1.18 -2.597 0 C-N-CA 118.469 -1.292 . . . . 0.0 108.689 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.562 ' O ' ' HB ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -133.85 169.4 17.14 Favored 'General case' 0 C--N 1.281 -2.403 0 N-CA-C 104.519 -2.4 . . . . 0.0 104.519 178.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.481 HD12 ' CD1' ' A' ' 29' ' ' PHE . 36.8 mm -113.54 126.1 70.93 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 119.741 1.155 . . . . 0.0 112.195 -173.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.609 ' HG2' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -102.28 -20.31 14.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.5 ' HB2' ' OG1' ' A' ' 30' ' ' THR . 49.6 m -155.75 126.92 7.1 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.186 175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.2 tp -78.6 108.99 12.4 Favored 'General case' 0 N--CA 1.407 -2.603 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' HB ' ' C ' ' A' ' 28' ' ' GLY . 89.3 t -84.86 126.42 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.915 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -67.5 144.55 55.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.331 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 82.68 2.83 1.13 Allowed 'General case' 0 N--CA 1.469 0.494 0 O-C-N 125.205 1.566 . . . . 0.0 110.071 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.682 ' O ' ' HG ' ' A' ' 54' ' ' LEU . . . -83.11 160.3 38.39 Favored Glycine 0 N--CA 1.431 -1.668 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 172.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.735 ' HD3' ' O ' ' A' ' 27' ' ' PHE . 18.1 Cg_endo -72.34 -25.3 18.59 Favored 'Trans proline' 0 C--O 1.18 -2.398 0 CA-C-N 121.092 2.446 . . . . 0.0 109.62 -171.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB1' ' SD ' ' A' ' 58' ' ' MET . . . -63.69 -44.18 94.44 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.523 175.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.71 -49.94 68.9 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 122.655 1.217 . . . . 0.0 109.8 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 50' ' ' GLY . 52.1 mt -72.54 -50.07 28.2 Favored 'General case' 0 C--N 1.268 -2.939 0 CA-C-N 112.356 -2.202 . . . . 0.0 115.9 -172.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -80.51 -21.43 41.91 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 -177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.4 -169.59 54.87 Favored Glycine 0 N--CA 1.425 -2.057 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.395 -175.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt 58.5 30.29 19.54 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.877 1.271 . . . . 0.0 112.784 175.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' MET . . . . . 0.672 ' HA ' ' NH1' ' A' ' 99' ' ' ARG . 1.5 tmt? -159.83 131.97 6.36 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 171.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -147.85 160.27 42.95 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 121.477 0.656 . . . . 0.0 112.26 -169.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 m -54.69 119.91 6.0 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.386 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 117.54 4.1 15.81 Favored Glycine 0 N--CA 1.428 -1.863 0 C-N-CA 119.867 -1.158 . . . . 0.0 112.752 -175.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.554 ' CG ' HD12 ' A' ' 97' ' ' LEU . 2.3 p30 -99.56 144.77 28.27 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.214 171.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 42' ' ' GLN . 6.5 p -100.42 117.87 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 CA-C-N 114.992 -1.003 . . . . 0.0 110.398 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 41' ' ' LEU . 50.4 mm -74.59 111.41 10.38 Favored 'Isoleucine or valine' 0 C--O 1.301 3.794 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.277 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.562 HG13 HD13 ' A' ' 73' ' ' LEU . 58.6 t -89.18 -58.09 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 CA-C-N 112.587 -2.097 . . . . 0.0 109.476 -177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 66.5 m -160.55 173.64 15.23 Favored 'General case' 0 C--N 1.319 -0.719 0 O-C-N 122.031 -0.418 . . . . 0.0 110.852 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.444 HG12 ' CG2' ' A' ' 72' ' ' VAL . 11.1 p -140.5 121.33 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . 0.378 30.0 p-10 33.03 -89.84 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -92.5 -34.09 14.22 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -176.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 95.6 m -93.09 130.87 38.57 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-O 122.227 1.013 . . . . 0.0 112.719 -173.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 18.9 t -84.7 90.16 7.66 Favored 'General case' 0 N--CA 1.418 -2.046 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 178.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.484 HG12 HD13 ' A' ' 41' ' ' LEU . 40.8 t -78.89 -0.34 3.51 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-O 122.857 1.313 . . . . 0.0 109.039 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.649 HD21 ' O ' ' A' ' 6' ' ' ARG . 20.8 tp -68.1 111.47 4.49 Favored 'General case' 0 N--CA 1.411 -2.402 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.363 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.5 43.04 93.28 Favored Glycine 0 N--CA 1.425 -2.056 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.792 -176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.462 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 0.8 OUTLIER -92.42 137.8 32.05 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 176.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 79' ' ' GLN . 35.9 m -69.55 143.87 53.26 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 117.918 -1.039 . . . . 0.0 109.099 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CG ' ' HA ' ' B' ' 156' ' ' ARG . 19.1 t60 -47.49 -49.18 26.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 119.147 0.885 . . . . 0.0 112.548 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.64 -31.83 71.95 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.684 0.754 . . . . 0.0 110.97 -176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.51 ' HG2' ' HB ' ' A' ' 76' ' ' THR . 14.1 mm-40 -80.1 -50.0 10.94 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.854 -176.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.711 HG21 HD21 ' A' ' 41' ' ' LEU . 7.4 p -64.71 -42.27 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.427 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 9.7 p -63.07 -35.45 71.76 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.446 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -43.77 98.28 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.9 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 45.7 mt -72.59 -50.65 32.96 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 122.196 0.998 . . . . 0.0 109.357 -175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -67.25 -28.69 68.25 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.41 -1.723 . . . . 0.0 112.759 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 81' ' ' VAL . 78.7 mm-40 -88.49 -17.26 30.72 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 174.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 67.5 p -94.86 -13.6 25.34 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -177.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.665 HD12 ' HG3' ' A' ' 22' ' ' LYS . 0.3 OUTLIER -52.02 154.8 3.61 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 177.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 87' ' ' ILE . 19.5 Cg_endo -95.45 148.14 1.46 Allowed 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.093 3.195 . . . . 0.0 112.325 -176.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.578 HG12 ' N ' ' A' ' 25' ' ' ARG . 50.6 mt -65.26 124.55 20.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.897 178.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 99.65 11.28 44.59 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-O 119.746 -0.475 . . . . 0.0 113.354 178.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HB3' ' HB2' ' A' ' 22' ' ' LYS . . . -93.06 -178.09 4.68 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 118.033 0.916 . . . . 0.0 111.626 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 t -139.29 150.51 45.51 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 121.981 -0.449 . . . . 0.0 110.496 -176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.566 HG22 ' HE2' ' A' ' 22' ' ' LYS . 2.5 m -151.39 156.66 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.047 0 C-N-CA 124.149 0.98 . . . . 0.0 110.854 174.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.522 ' HB3' ' NE2' ' A' ' 17' ' ' HIS . 23.6 m-20 -105.21 107.33 18.26 Favored 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 177.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.493 HD22 HD22 ' A' ' 20' ' ' LEU . 13.5 tp -94.33 125.92 39.27 Favored 'General case' 0 C--N 1.263 -3.195 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.26 -173.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.434 ' O ' ' HB ' ' A' ' 65' ' ' VAL . 9.8 pt-20 -108.74 113.8 27.06 Favored 'General case' 0 C--O 1.255 1.384 0 CA-C-O 121.887 0.851 . . . . 0.0 108.789 176.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.554 HD12 ' CG ' ' A' ' 62' ' ' ASP . 1.7 pt? -142.13 155.5 45.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.324 -172.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' CYS . . . . . 0.47 ' O ' HG12 ' A' ' 63' ' ' VAL . 58.8 m -113.58 107.11 15.36 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.573 0.702 . . . . 0.0 109.33 177.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.672 ' NH1' ' HA ' ' A' ' 58' ' ' MET . 4.9 ttp-105 -85.83 133.67 33.96 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.152 -178.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 114.31 40.23 0.97 Allowed Glycine 0 C--N 1.283 -2.369 0 C-N-CA 119.819 -1.181 . . . . 0.0 110.812 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -108.14 125.79 31.19 Favored Pre-proline 0 N--CA 1.409 -2.488 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 175.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.55 ' O ' ' HD3' ' A' ' 104' ' ' PRO . 35.7 Cg_exo -59.29 138.35 84.04 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.318 2.012 . . . . 0.0 112.814 -177.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.45 HD21 ' HA ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER -98.14 91.62 1.22 Allowed Pre-proline 0 C--N 1.309 -1.156 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 173.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.55 ' HD3' ' O ' ' A' ' 102' ' ' PRO . 48.5 Cg_endo -88.58 20.44 1.14 Allowed 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.087 2.524 . . . . 0.0 113.675 -169.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.411 ' O ' HD12 ' A' ' 103' ' ' LEU . 95.0 m-85 -142.42 179.07 7.16 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 18.1 m-20 -79.64 146.48 65.22 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 175.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 106' ' ' ASP . 2.7 Cg_endo -97.48 9.2 1.22 Allowed 'Trans proline' 0 N--CA 1.44 -1.643 0 C-N-CA 123.772 2.981 . . . . 0.0 107.126 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -108.1 -25.76 10.96 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.929 -175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.28 113.7 28.23 Favored Pre-proline 0 C--O 1.24 0.562 0 CA-C-N 114.679 -1.146 . . . . 0.0 112.474 -174.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -63.02 153.06 76.14 Favored 'Trans proline' 0 CA--C 1.494 -1.487 0 C-N-CA 123.792 2.994 . . . . 0.0 113.694 177.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.506 ' HB3' HD21 ' A' ' 114' ' ' LEU . 8.8 m120 164.38 68.31 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.431 0 C-N-CA 129.6 3.16 . . . . 0.0 109.683 165.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.425 ' HA ' ' HB2' ' B' ' 158' ' ' GLU . 57.2 m -85.11 -40.6 16.58 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 122.604 1.192 . . . . 0.0 110.331 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.806 ' HA ' HG22 ' B' ' 155' ' ' THR . 10.2 t -91.89 99.04 11.97 Favored 'General case' 0 C--N 1.251 -3.701 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.393 -176.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.558 ' H ' ' HA ' ' B' ' 155' ' ' THR . 57.1 mt -123.34 104.99 9.46 Favored 'General case' 0 N--CA 1.416 -2.175 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 173.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.05 123.72 49.53 Favored 'Isoleucine or valine' 0 C--N 1.256 -3.493 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.5 t -71.03 144.62 50.35 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 -178.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.2 t -110.61 156.24 21.24 Favored 'General case' 0 C--N 1.267 -2.992 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -93.11 101.41 12.58 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-O 122.023 0.916 . . . . 0.0 110.397 -177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -136.53 73.67 1.46 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 43.8 mm -110.4 -9.38 11.62 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.861 -174.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 24.3 mt -130.49 163.94 25.91 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 121.052 0.453 . . . . 0.0 111.647 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -98.94 101.81 13.33 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.464 178.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -93.1 135.59 34.14 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.305 -0.861 . . . . 0.0 108.693 -179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -90.54 111.74 49.21 Favored Pre-proline 0 C--N 1.269 -2.894 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.957 177.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.462 -0.354 0 C-N-CA 122.563 2.175 . . . . 0.0 112.439 -175.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' SER . . . . . . . . . . . . . 22.8 t -95.97 111.39 23.41 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 106.035 -1.839 . . . . 0.0 106.035 175.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' SER . . . . . . . . . . . . . 50.6 m -144.98 119.22 9.51 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-O 121.364 0.602 . . . . 0.0 111.738 -174.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -90.25 151.31 21.58 Favored 'General case' 0 N--CA 1.421 -1.918 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 174.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' THR . . . . . 0.806 HG22 ' HA ' ' A' ' 113' ' ' SER . 27.1 p 62.63 139.87 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.647 1.179 . . . . 0.0 114.132 -178.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.605 ' HB3' ' OD2' ' A' ' 35' ' ' ASP . 48.7 mtm180 -153.44 165.4 35.93 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' ARG . . . . . 0.447 ' HA ' ' H ' ' A' ' 33' ' ' GLY . 22.5 tpp180 75.25 -77.58 0.05 Allowed 'General case' 0 C--N 1.352 0.717 0 C-N-CA 123.068 0.547 . . . . 0.0 111.897 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' GLU . . . . . 0.741 ' HA ' ' O ' ' A' ' 31' ' ' VAL . 32.8 mt-10 -86.59 91.11 8.47 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.429 0.633 . . . . 0.0 112.239 -173.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 31' ' ' VAL . 7.8 m -88.65 110.2 20.75 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.521 ' HA ' HG22 ' A' ' 30' ' ' THR . 21.1 mt-30 -84.26 120.93 26.81 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.574 HG23 ' HB2' ' A' ' 27' ' ' PHE . 12.9 m . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.509 . . . . . . . . 1 1 . 1 stop_ save_